Citrus Sinensis ID: 025816
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 247 | 2.2.26 [Sep-21-2011] | |||||||
| O80719 | 365 | Probable receptor-like pr | no | no | 0.987 | 0.668 | 0.930 | 1e-126 | |
| Q41328 | 354 | Pto-interacting protein 1 | N/A | no | 0.975 | 0.680 | 0.909 | 1e-122 | |
| Q8H1G6 | 361 | PTI1-like tyrosine-protei | no | no | 0.951 | 0.650 | 0.842 | 1e-110 | |
| O49339 | 366 | PTI1-like tyrosine-protei | no | no | 0.951 | 0.642 | 0.829 | 1e-110 | |
| B9DFG5 | 408 | PTI1-like tyrosine-protei | no | no | 0.955 | 0.578 | 0.822 | 1e-109 | |
| P93749 | 365 | Probable protein kinase A | no | no | 0.991 | 0.671 | 0.768 | 1e-108 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.910 | 0.302 | 0.514 | 2e-61 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.902 | 0.310 | 0.519 | 1e-59 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.975 | 0.528 | 0.493 | 2e-59 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.939 | 0.340 | 0.470 | 1e-58 |
| >sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 451 bits (1159), Expect = e-126, Method: Compositional matrix adjust.
Identities = 227/244 (93%), Positives = 237/244 (97%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKH+NFVQLLGYCVDG SR+L+YEFA+NGSLHDILHGRKGVKGAQPGPVLSW QRV
Sbjct: 119 MVSRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHGRKGVKGAQPGPVLSWYQRV 178
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAA+GLEYLHEKA+PHIIHRDIKSSNVL+F+DDVAKIADFDLSNQAPDMAARLHST
Sbjct: 179 KIAVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKIADFDLSNQAPDMAARLHST 238
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH LPRGQQSLVTWATPK
Sbjct: 239 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHRLPRGQQSLVTWATPK 298
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKV+QCVDARLGGDYPPKAVAK+AAVAALCVQYEADFRPNMSIVVKALQPLLNAR
Sbjct: 299 LSEDKVKQCVDARLGGDYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNARAV 358
Query: 241 PAGE 244
GE
Sbjct: 359 APGE 362
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 436 bits (1121), Expect = e-122, Method: Compositional matrix adjust.
Identities = 220/242 (90%), Positives = 230/242 (95%), Gaps = 1/242 (0%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLK EN V+LLGYCVDG RVLAYE+A NGSLHDILHGRKGVKGAQPGPVLSW QRV
Sbjct: 114 MVSRLKDENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRV 173
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAAKGLEYLHEKA PHIIHRDIKSSN+L+FDDDVAKIADFDLSNQAPDMAARLHST
Sbjct: 174 KIAVGAAKGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHST 233
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQL++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+
Sbjct: 234 RVLGTFGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPR 293
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKV+QCVDARL DYPPKA+AKMAAVAALCVQYEADFRPNMSIVVKALQPLL RP
Sbjct: 294 LSEDKVKQCVDARLNTDYPPKAIAKMAAVAALCVQYEADFRPNMSIVVKALQPLL-PRPV 352
Query: 241 PA 242
P+
Sbjct: 353 PS 354
|
A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1024), Expect = e-110, Method: Compositional matrix adjust.
Identities = 198/235 (84%), Positives = 216/235 (91%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKHEN +QLLG+CVDG RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L W RV
Sbjct: 116 MVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRV 175
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAV AA+GLEYLHEK+ P +IHRDI+SSNVL+F+D AKIADF+LSNQAPD AARLHST
Sbjct: 176 KIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLHST 235
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+
Sbjct: 236 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 295
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235
LSEDKV+QC+D +L DYPPKAVAK+AAVAALCVQYEA+FRPNMSIVVKALQPLL
Sbjct: 296 LSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 350
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 398 bits (1022), Expect = e-110, Method: Compositional matrix adjust.
Identities = 195/235 (82%), Positives = 215/235 (91%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKHEN +QL+GYCVD RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L W RV
Sbjct: 119 MVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWLTRV 178
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAV AA+GLEYLHEK P +IHRDI+SSNVL+F+D AK+ADF+LSNQAPD AARLHST
Sbjct: 179 KIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNAARLHST 238
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+
Sbjct: 239 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 298
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235
LSEDKV+QCVD +L G+YPPK+VAK+AAVAALCVQYE++FRPNMSIVVKALQPLL
Sbjct: 299 LSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPLL 353
|
Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 395 bits (1014), Expect = e-109, Method: Compositional matrix adjust.
Identities = 194/236 (82%), Positives = 218/236 (92%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
VS+LKH+NFV+L GYCV+G R+LAYEFA+ GSLHDILHGRKGV+GAQPGP L W QRV+
Sbjct: 162 VSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVR 221
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
IAV AA+GLEYLHEK P +IHRDI+SSNVL+F+D AKIADF+LSNQ+PDMAARLHSTR
Sbjct: 222 IAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTR 281
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 181
VLGTFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+L
Sbjct: 282 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 341
Query: 182 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
SEDKV+QCVD +L G+YPPKAVAK+AAVAALCVQYE++FRPNMSIVVKALQPLL +
Sbjct: 342 SEDKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRS 397
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 390 bits (1003), Expect = e-108, Method: Compositional matrix adjust.
Identities = 189/246 (76%), Positives = 224/246 (91%), Gaps = 1/246 (0%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+VSRLKH++FV+LLGYC++ +R+L Y+FA+ GSLHD+LHGRKGV+GA+PGPVL+W QRV
Sbjct: 120 VVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRV 179
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIA GAAKGLE+LHEK P I+HRD++SSNVL+FDD VAK+ADF+L+N + D AARLHST
Sbjct: 180 KIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHST 239
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ+ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTWATP+
Sbjct: 240 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 299
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP- 239
LSEDKV+QC+D +L D+PPKAVAK+AAVAALCVQYEADFRPNM+IVVKALQPLLN++P
Sbjct: 300 LSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA 359
Query: 240 GPAGES 245
GP S
Sbjct: 360 GPESTS 365
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 235 bits (600), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 122/237 (51%), Positives = 163/237 (68%), Gaps = 12/237 (5%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M+SRL H N V+L+G C++G +R L YE NGS+ LH +G L W R+
Sbjct: 396 MLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH-----EG-----TLDWDARL 445
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIA+GAA+GL YLHE ++P +IHRD K+SNVL+ DD K++DF L+ +A + + + ST
Sbjct: 446 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI-ST 504
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RV+GTFGY APEYAMTG L KSDVYS+GVVLLELLTGR+PVD + P G+++LVTWA P
Sbjct: 505 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPL 564
Query: 181 LSE-DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236
L+ + + Q VD L G Y +AK+AA+A++CV E RP M VV+AL+ + N
Sbjct: 565 LANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYN 621
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 229 bits (585), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 122/235 (51%), Positives = 155/235 (65%), Gaps = 12/235 (5%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++SR+ H + V L+GYC+ R L YEF N +L LHG+ PVL W +RV
Sbjct: 417 IISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNL-------PVLEWSRRV 469
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+IA+GAAKGL YLHE P IIHRDIKSSN+L+ D+ A++ADF L+ + D A ST
Sbjct: 470 RIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLA-RLNDTAQSHIST 528
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RV+GTFGY APEYA +G+L +SDV+SFGVVLLEL+TGRKPVD + P G++SLV WA P+
Sbjct: 529 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPR 588
Query: 181 LSE----DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231
L E + + VD RL DY V KM AA CV++ A RP M VV+AL
Sbjct: 589 LIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 229 bits (583), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 122/247 (49%), Positives = 160/247 (64%), Gaps = 6/247 (2%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M+S L H N V L+GYC DG R+L YEF GSL D LH K A L W R+
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-----LDWNMRM 188
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIA GAAKGLE+LH+KA+P +I+RD KSSN+L+ + K++DF L+ P ST
Sbjct: 189 KIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVST 248
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RV+GT+GY APEYAMTGQL KSDVYSFGVV LEL+TGRK +D +P G+Q+LV WA P
Sbjct: 249 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPL 308
Query: 181 LSE-DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 239
++ K + D RL G +P +A+ + AVA++C+Q +A RP ++ VV AL L N
Sbjct: 309 FNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQAY 368
Query: 240 GPAGESA 246
P+ + +
Sbjct: 369 DPSKDDS 375
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (576), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 119/253 (47%), Positives = 164/253 (64%), Gaps = 21/253 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG-PVLSWQQR 59
++SR+ H + V L+GYC+ R+L Y++ N +LH LH PG PV++W+ R
Sbjct: 386 IISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHA--------PGRPVMTWETR 437
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH- 118
V++A GAA+G+ YLHE P IIHRDIKSSN+L+ + A +ADF L+ A ++ H
Sbjct: 438 VRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHV 497
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
STRV+GTFGY APEYA +G+L+ K+DVYS+GV+LLEL+TGRKPVD + P G +SLV WA
Sbjct: 498 STRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWAR 557
Query: 179 PKLSE----DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234
P L + ++ + VD RLG ++ P + +M AA CV++ A RP MS VV+AL L
Sbjct: 558 PLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTL 617
Query: 235 LNA-------RPG 240
A RPG
Sbjct: 618 EEATDITNGMRPG 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 247 | ||||||
| 255548287 | 362 | Serine/threonine-protein kinase PBS1, pu | 1.0 | 0.682 | 0.979 | 1e-133 | |
| 449523892 | 433 | PREDICTED: LOW QUALITY PROTEIN: probable | 1.0 | 0.570 | 0.898 | 1e-132 | |
| 449436713 | 362 | PREDICTED: LOW QUALITY PROTEIN: probable | 1.0 | 0.682 | 0.898 | 1e-131 | |
| 359811321 | 361 | pto-interacting protein 1-like [Glycine | 0.987 | 0.675 | 0.963 | 1e-131 | |
| 358248598 | 334 | pto-interacting protein 1-like [Glycine | 0.991 | 0.733 | 0.959 | 1e-131 | |
| 351725893 | 361 | serine/threonine protein kinase [Glycine | 0.991 | 0.678 | 0.959 | 1e-131 | |
| 357442089 | 476 | Pto kinase interactor [Medicago truncatu | 1.0 | 0.518 | 0.951 | 1e-131 | |
| 224064746 | 362 | predicted protein [Populus trichocarpa] | 1.0 | 0.682 | 0.959 | 1e-131 | |
| 357442087 | 361 | Pto kinase interactor [Medicago truncatu | 1.0 | 0.684 | 0.951 | 1e-131 | |
| 356505673 | 361 | PREDICTED: pto-interacting protein 1-lik | 0.991 | 0.678 | 0.955 | 1e-130 |
| >gi|255548287|ref|XP_002515200.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223545680|gb|EEF47184.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 480 bits (1236), Expect = e-133, Method: Compositional matrix adjust.
Identities = 242/247 (97%), Positives = 243/247 (98%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKHENFVQLLGYCVDG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV
Sbjct: 115 MVSRLKHENFVQLLGYCVDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST
Sbjct: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKVRQCVD RL GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG
Sbjct: 295 LSEDKVRQCVDTRLQGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 354
Query: 241 PAGESAS 247
PAGE+ S
Sbjct: 355 PAGETPS 361
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523892|ref|XP_004168957.1| PREDICTED: LOW QUALITY PROTEIN: probable receptor-like protein kinase At2g47060-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1226), Expect = e-132, Method: Compositional matrix adjust.
Identities = 222/247 (89%), Positives = 236/247 (95%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKH+NF+ L+GYCV G SR+LAYE+ASNGSLHDILHGRKGVKG+QPGPVLSW QRV
Sbjct: 186 MVSRLKHDNFLNLIGYCVGGNSRILAYEYASNGSLHDILHGRKGVKGSQPGPVLSWAQRV 245
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAAKGLEYLHEK DPHI HRDIKSSNVLIFDDD+AKIADFDLSNQAPDMAARLHST
Sbjct: 246 KIAVGAAKGLEYLHEKVDPHITHRDIKSSNVLIFDDDLAKIADFDLSNQAPDMAARLHST 305
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQLN+KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 306 RVLGTFGYHAPEYAMTGQLNSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 365
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
L EDKV+QCVDA+LG +YPPK+VAK AAVAALCVQYEADFRPNMSIVVKALQPLLNARPG
Sbjct: 366 LCEDKVKQCVDAKLGNEYPPKSVAKFAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 425
Query: 241 PAGESAS 247
P GE+ +
Sbjct: 426 PXGETTN 432
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449436713|ref|XP_004136137.1| PREDICTED: LOW QUALITY PROTEIN: probable receptor-like protein kinase At2g47060-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 474 bits (1221), Expect = e-131, Method: Compositional matrix adjust.
Identities = 222/247 (89%), Positives = 236/247 (95%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKH+NF+ L+GYCV G SR+LAYE+ASNGSLHDILHGRKGVKG+QPGPVLSW QRV
Sbjct: 115 MVSRLKHDNFLNLIGYCVGGNSRILAYEYASNGSLHDILHGRKGVKGSQPGPVLSWAQRV 174
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAAKGLEYLHEK DPHI HRDIKSSNVLIFDDD+AKIADFDLSNQAPDMAARLHST
Sbjct: 175 KIAVGAAKGLEYLHEKVDPHITHRDIKSSNVLIFDDDLAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQLN+KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGQLNSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
L EDKV+QCVDA+LG +YPPK+VAK AAVAALCVQYEADFRPNMSIVVKALQPLLNARPG
Sbjct: 295 LCEDKVKQCVDAKLGNEYPPKSVAKFAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 354
Query: 241 PAGESAS 247
P GE+ +
Sbjct: 355 PXGETTN 361
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359811321|ref|NP_001241285.1| pto-interacting protein 1-like [Glycine max] gi|223452480|gb|ACM89567.1| serine/threonine protein kinase [Glycine max] gi|255639418|gb|ACU20004.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1217), Expect = e-131, Method: Compositional matrix adjust.
Identities = 235/244 (96%), Positives = 241/244 (98%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKHENFVQLLGYC+DG+SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRV
Sbjct: 115 MVSRLKHENFVQLLGYCIDGSSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRV 174
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAA+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST
Sbjct: 175 KIAVGAARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKVRQCVD RLGG+YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL ARPG
Sbjct: 295 LSEDKVRQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARPG 354
Query: 241 PAGE 244
PAGE
Sbjct: 355 PAGE 358
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248598|ref|NP_001239908.1| pto-interacting protein 1-like [Glycine max] gi|223452484|gb|ACM89569.1| Pto kinase interactor [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1217), Expect = e-131, Method: Compositional matrix adjust.
Identities = 235/245 (95%), Positives = 242/245 (98%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKHENFVQLLGYC+DGTSR+LAY+FASNGSLHDILHGRKGVKGAQPGPVL+W QRV
Sbjct: 88 MVSRLKHENFVQLLGYCIDGTSRILAYQFASNGSLHDILHGRKGVKGAQPGPVLTWAQRV 147
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAA+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST
Sbjct: 148 KIAVGAARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 207
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 208 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 267
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKVRQCVD RLGG+YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL ARPG
Sbjct: 268 LSEDKVRQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARPG 327
Query: 241 PAGES 245
PAGE+
Sbjct: 328 PAGET 332
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725893|ref|NP_001237620.1| serine/threonine protein kinase [Glycine max] gi|223452365|gb|ACM89510.1| serine/threonine protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1217), Expect = e-131, Method: Compositional matrix adjust.
Identities = 235/245 (95%), Positives = 242/245 (98%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKH+NFVQLLGYC+DG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRV
Sbjct: 115 MVSRLKHDNFVQLLGYCIDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWTQRV 174
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAAKGLEYLHE+ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST
Sbjct: 175 KIAVGAAKGLEYLHERADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+
Sbjct: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPR 294
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKVRQCVDARLGG+YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR G
Sbjct: 295 LSEDKVRQCVDARLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARHG 354
Query: 241 PAGES 245
PAGE+
Sbjct: 355 PAGET 359
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442089|ref|XP_003591322.1| Pto kinase interactor [Medicago truncatula] gi|355480370|gb|AES61573.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1216), Expect = e-131, Method: Compositional matrix adjust.
Identities = 235/247 (95%), Positives = 242/247 (97%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKH+NFVQLLGYCVDG SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRV
Sbjct: 230 MVSRLKHDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRV 289
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAA+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST
Sbjct: 290 KIAVGAARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 349
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 350 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 409
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKVRQCVD RLGG+YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL AR G
Sbjct: 410 LSEDKVRQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARAG 469
Query: 241 PAGESAS 247
PAGE+A+
Sbjct: 470 PAGETAN 476
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224064746|ref|XP_002301545.1| predicted protein [Populus trichocarpa] gi|222843271|gb|EEE80818.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1213), Expect = e-131, Method: Compositional matrix adjust.
Identities = 237/247 (95%), Positives = 242/247 (97%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKHENFVQLLGYCVDG SRVL YEFASNGSLHDILHGRKGVKGAQPGPVL+W QRV
Sbjct: 115 MVSRLKHENFVQLLGYCVDGGSRVLIYEFASNGSLHDILHGRKGVKGAQPGPVLTWPQRV 174
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAAKGLEYLHEKADPHI+HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST
Sbjct: 175 KIAVGAAKGLEYLHEKADPHIVHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKV+QCVDARL G+YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG
Sbjct: 295 LSEDKVKQCVDARLQGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 354
Query: 241 PAGESAS 247
PAGE+ S
Sbjct: 355 PAGEAPS 361
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442087|ref|XP_003591321.1| Pto kinase interactor [Medicago truncatula] gi|355480369|gb|AES61572.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1213), Expect = e-131, Method: Compositional matrix adjust.
Identities = 235/247 (95%), Positives = 242/247 (97%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKH+NFVQLLGYCVDG SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRV
Sbjct: 115 MVSRLKHDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRV 174
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAA+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST
Sbjct: 175 KIAVGAARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKVRQCVD RLGG+YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL AR G
Sbjct: 295 LSEDKVRQCVDTRLGGEYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLTARAG 354
Query: 241 PAGESAS 247
PAGE+A+
Sbjct: 355 PAGETAN 361
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505673|ref|XP_003521614.1| PREDICTED: pto-interacting protein 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 469 bits (1206), Expect = e-130, Method: Compositional matrix adjust.
Identities = 234/245 (95%), Positives = 241/245 (98%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKH+NFVQLLGYC+DG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRV
Sbjct: 115 MVSRLKHDNFVQLLGYCIDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWTQRV 174
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAAKGLEYLHE+ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST
Sbjct: 175 KIAVGAAKGLEYLHERADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP+
Sbjct: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPR 294
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKVRQCVDARLGG+Y PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR G
Sbjct: 295 LSEDKVRQCVDARLGGEYLPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARHG 354
Query: 241 PAGES 245
PAGE+
Sbjct: 355 PAGET 359
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 247 | ||||||
| TAIR|locus:2098083 | 361 | AT3G62220 [Arabidopsis thalian | 0.995 | 0.681 | 0.873 | 3.9e-115 | |
| TAIR|locus:2088990 | 364 | AT3G17410 [Arabidopsis thalian | 0.975 | 0.662 | 0.855 | 2.6e-109 | |
| TAIR|locus:2023767 | 363 | AT1G48210 [Arabidopsis thalian | 0.975 | 0.663 | 0.805 | 6e-103 | |
| TAIR|locus:2009115 | 361 | AT1G06700 [Arabidopsis thalian | 0.991 | 0.678 | 0.780 | 1.3e-100 | |
| TAIR|locus:2054502 | 366 | AT2G30740 [Arabidopsis thalian | 0.975 | 0.658 | 0.780 | 5.6e-100 | |
| TAIR|locus:2081277 | 408 | AT3G59350 [Arabidopsis thalian | 0.975 | 0.590 | 0.767 | 1.2e-99 | |
| TAIR|locus:2064557 | 365 | AT2G41970 [Arabidopsis thalian | 0.991 | 0.671 | 0.727 | 3.1e-99 | |
| TAIR|locus:2054492 | 338 | AT2G30730 [Arabidopsis thalian | 0.959 | 0.701 | 0.729 | 3.1e-90 | |
| TAIR|locus:2023752 | 364 | AT1G48220 [Arabidopsis thalian | 0.975 | 0.662 | 0.699 | 7.5e-89 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.963 | 0.629 | 0.487 | 7.8e-55 |
| TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1135 (404.6 bits), Expect = 3.9e-115, P = 3.9e-115
Identities = 215/246 (87%), Positives = 227/246 (92%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKH NFV+LLGY VDG SR+L +EFA NGSLHDILHGRKGVKGA+PGP+LSW QRV
Sbjct: 115 MVSRLKHVNFVELLGYSVDGNSRILVFEFAQNGSLHDILHGRKGVKGAKPGPLLSWHQRV 174
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAA+GLEYLHEKA+PH+IHRDIKSSNVLIFD+DVAKIADFDLSNQAPDMAARLHST
Sbjct: 175 KIAVGAARGLEYLHEKANPHVIHRDIKSSNVLIFDNDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQL+AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGQLSAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 294
Query: 181 LSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKV+QCVD+RLGGDYPP LCVQYEADFRPNMSIVVKALQPLLNAR G
Sbjct: 295 LSEDKVKQCVDSRLGGDYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNARTG 354
Query: 241 PAGESA 246
PAGE A
Sbjct: 355 PAGEGA 360
|
|
| TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1080 (385.2 bits), Expect = 2.6e-109, P = 2.6e-109
Identities = 207/242 (85%), Positives = 217/242 (89%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRL+ EN V LLGYCVDG RVLAYE+A NGSLHDILHGRKGVKGAQPGPVLSW QRV
Sbjct: 115 MVSRLRQENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWHQRV 174
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAA+GLEYLHEKA+PH+IHRDIKSSNVL+FDDDVAKIADFDLSNQAPDMAARLHST
Sbjct: 175 KIAVGAARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHST 234
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTG L+ KSDVYSFGVVLLELLTGRKPVDHTLPRGQQS+VTWATPK
Sbjct: 235 RVLGTFGYHAPEYAMTGTLSTKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSVVTWATPK 294
Query: 181 LSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNA-RP 239
LSEDKV+QCVDARL G+YPP LCVQYEADFRPNMSIVVKALQPLLN R
Sbjct: 295 LSEDKVKQCVDARLNGEYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNPPRS 354
Query: 240 GP 241
P
Sbjct: 355 AP 356
|
|
| TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1020 (364.1 bits), Expect = 6.0e-103, P = 6.0e-103
Identities = 195/242 (80%), Positives = 210/242 (86%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRL+H+N L+GYCVDG RVLAYEFA GSLHD LHG+KG KGA GPV++WQQRV
Sbjct: 114 MVSRLRHDNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHGKKGAKGALRGPVMTWQQRV 173
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAVGAA+GLEYLHEK P +IHRDIKSSNVL+FDDDVAKI DFDLS+QAPDMAARLHST
Sbjct: 174 KIAVGAARGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKIGDFDLSDQAPDMAARLHST 233
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTG L++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK
Sbjct: 234 RVLGTFGYHAPEYAMTGTLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 293
Query: 181 LSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNA-RP 239
LSEDKV+QCVDARL G+YPP LCVQYEA+FRPNMSIVVKALQPLLN R
Sbjct: 294 LSEDKVKQCVDARLLGEYPPKAVGKLAAVAALCVQYEANFRPNMSIVVKALQPLLNPPRS 353
Query: 240 GP 241
P
Sbjct: 354 AP 355
|
|
| TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 998 (356.4 bits), Expect = 1.3e-100, P = 1.3e-100
Identities = 192/246 (78%), Positives = 209/246 (84%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKHEN +QLLG+CVDG RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L W RV
Sbjct: 116 MVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRV 175
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAV AA+GLEYLHEK+ P +IHRDI+SSNVL+F+D AKIADF+LSNQAPD AARLHST
Sbjct: 176 KIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLHST 235
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+
Sbjct: 236 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 295
Query: 181 LSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNA-RP 239
LSEDKV+QC+D +L DYPP LCVQYEA+FRPNMSIVVKALQPLL
Sbjct: 296 LSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKPPAA 355
Query: 240 GPAGES 245
PA ES
Sbjct: 356 APAPES 361
|
|
| TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 992 (354.3 bits), Expect = 5.6e-100, P = 5.6e-100
Identities = 189/242 (78%), Positives = 207/242 (85%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKHEN +QL+GYCVD RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L W RV
Sbjct: 119 MVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWLTRV 178
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAV AA+GLEYLHEK P +IHRDI+SSNVL+F+D AK+ADF+LSNQAPD AARLHST
Sbjct: 179 KIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNAARLHST 238
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+
Sbjct: 239 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 298
Query: 181 LSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARPG 240
LSEDKV+QCVD +L G+YPP LCVQYE++FRPNMSIVVKALQPLL P
Sbjct: 299 LSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLKP-PA 357
Query: 241 PA 242
PA
Sbjct: 358 PA 359
|
|
| TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 989 (353.2 bits), Expect = 1.2e-99, P = 1.2e-99
Identities = 185/241 (76%), Positives = 208/241 (86%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
VS+LKH+NFV+L GYCV+G R+LAYEFA+ GSLHDILHGRKGV+GAQPGP L W QRV+
Sbjct: 162 VSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVR 221
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
IAV AA+GLEYLHEK P +IHRDI+SSNVL+F+D AKIADF+LSNQ+PDMAARLHSTR
Sbjct: 222 IAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTR 281
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL 181
VLGTFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWATP+L
Sbjct: 282 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 341
Query: 182 SEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARPGP 241
SEDKV+QCVD +L G+YPP LCVQYE++FRPNMSIVVKALQPLL +
Sbjct: 342 SEDKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRSSTAA 401
Query: 242 A 242
A
Sbjct: 402 A 402
|
|
| TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 3.1e-99, P = 3.1e-99
Identities = 179/246 (72%), Positives = 213/246 (86%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+VSRLKH++FV+LLGYC++ +R+L Y+FA+ GSLHD+LHGRKGV+GA+PGPVL+W QRV
Sbjct: 120 VVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRV 179
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIA GAAKGLE+LHEK P I+HRD++SSNVL+FDD VAK+ADF+L+N + D AARLHST
Sbjct: 180 KIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHST 239
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLGTFGYHAPEYAMTGQ+ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTWATP+
Sbjct: 240 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 299
Query: 181 LSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNARP- 239
LSEDKV+QC+D +L D+PP LCVQYEADFRPNM+IVVKALQPLLN++P
Sbjct: 300 LSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA 359
Query: 240 GPAGES 245
GP S
Sbjct: 360 GPESTS 365
|
|
| TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 900 (321.9 bits), Expect = 3.1e-90, P = 3.1e-90
Identities = 173/237 (72%), Positives = 194/237 (81%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRLKHEN +QL+GYCVD RVLAYEFA+ GSLHDILHGRKGV+ A PGP L W RV
Sbjct: 95 MVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQDALPGPTLDWITRV 154
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAV AA+GLEYLHEK P +IHRDI+SSN+L+FDD AKIADF+LSNQ+PD AARL ST
Sbjct: 155 KIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKIADFNLSNQSPDNAARLQST 214
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
RVLG+FGY++PEYAMTG+L KSDVY FGVVLLELLTGRKPVDHT+PRGQQSLVTWATPK
Sbjct: 215 RVLGSFGYYSPEYAMTGELTHKSDVYGFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPK 274
Query: 181 LSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNA 237
LSED V +CVD +L G+Y P LCVQYE++ RP MS VVKALQ LL A
Sbjct: 275 LSEDTVEECVDPKLKGEYSPKSVAKLAAVAALCVQYESNCRPKMSTVVKALQQLLIA 331
|
|
| TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 887 (317.3 bits), Expect = 7.5e-89, P = 7.5e-89
Identities = 170/243 (69%), Positives = 198/243 (81%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MVSRL HEN V L+ YCVDG RVLAYEFA+ G+LHD+LHG+ GV GA GPV++WQ+RV
Sbjct: 114 MVSRLHHENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVIGALQGPVMTWQRRV 173
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIA+GAA+GLEYLH+K +P +IHRDIK+SN+L+FDDD+AKI DFDL +QAP+MA RLHS
Sbjct: 174 KIALGAARGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDLYDQAPNMAGRLHSC 233
Query: 121 RV-LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
R+ LG H PE+AMTG L KSDVYSFGVVLLELLTGRKPVD TLPRGQQ+LVTWATP
Sbjct: 234 RMALGASRSHCPEHAMTGILTTKSDVYSFGVVLLELLTGRKPVDRTLPRGQQNLVTWATP 293
Query: 180 KLSEDKVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNA-R 238
KLS+DKV+QCVDARL G+YPP CV Y+ DFRP+MSIVVKALQPLLN+ R
Sbjct: 294 KLSKDKVKQCVDARLLGEYPPKAVAKLAAVSARCVHYDPDFRPDMSIVVKALQPLLNSSR 353
Query: 239 PGP 241
P
Sbjct: 354 SSP 356
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 7.8e-55, P = 7.8e-55
Identities = 120/246 (48%), Positives = 153/246 (62%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M+S L H N V L+GYC DG R+L YE+ GSL D LH G QP L W R+
Sbjct: 121 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDIS--PGKQP---LDWNTRM 175
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-S 119
KIA GAAKGLEYLH+K P +I+RD+K SN+L+ DD K++DF L+ P + + H S
Sbjct: 176 KIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGP-VGDKSHVS 234
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
TRV+GT+GY APEYAMTGQL KSDVYSFGVVLLE++TGRK +D + G+Q+LV WA P
Sbjct: 235 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARP 294
Query: 180 KLSED-KVRQCVDARLGGDYPPXXXXXXXXXXXLCVQYEADFRPNMSIVVKALQPLLNAR 238
+ K Q D L G YPP +CVQ + + RP ++ VV AL L + +
Sbjct: 295 LFKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALSYLASQK 354
Query: 239 PGPAGE 244
P +
Sbjct: 355 FDPLAQ 360
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O80719 | Y2706_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9303 | 0.9878 | 0.6684 | no | no |
| Q41328 | PTI1_SOLLC | 2, ., 7, ., 1, 1, ., 1 | 0.9090 | 0.9757 | 0.6807 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_II1773 | hypothetical protein (362 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 247 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-36 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.002 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-43
Identities = 56/155 (36%), Positives = 77/155 (49%), Gaps = 15/155 (9%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+L H N V+L G D L E+ GSL D+L +G LS + ++I
Sbjct: 46 KKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDEILRI 97
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTR 121
+ +GLEYLH IIHRD+K N+L+ D+ K+ADF LS + L +
Sbjct: 98 LLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154
Query: 122 VLGTFGYHAPE-YAMTGQLNAKSDVYSFGVVLLEL 155
GT Y APE G + KSD++S GV+L EL
Sbjct: 155 --GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 3e-42
Identities = 66/242 (27%), Positives = 102/242 (42%), Gaps = 53/242 (21%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+L H N V+LLG C + + E+ G L L + P LS +
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR--------PKLSLSDLLSF 107
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
A+ A+G+EYL K + IHRD+ + N L+ ++ V KI+DF LS R
Sbjct: 108 ALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLS-------------RD 151
Query: 123 LGTFGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRG 169
L Y+ APE G+ +KSDV+SFGV+L E+ T G +P
Sbjct: 152 LYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY------- 204
Query: 170 QQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229
P +S ++V + + PP ++ + C + + RP S +V+
Sbjct: 205 ---------PGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
Query: 230 AL 231
L
Sbjct: 256 IL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-41
Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 30/231 (12%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+L H N V+LLG C + ++ E+ G L D L + LS +
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-------KELSLSDLLSF 108
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-RLHSTR 121
A+ A+G+EYL K + IHRD+ + N L+ ++ V KI+DF LS D ++ +
Sbjct: 109 ALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK 165
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180
+ + APE G+ +KSDV+SFGV+L E+ T G +P P
Sbjct: 166 L--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP----------------YPG 207
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231
+S +V + + PP ++ + C + + RP S +V+ L
Sbjct: 208 MSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-41
Identities = 72/236 (30%), Positives = 109/236 (46%), Gaps = 26/236 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +L H N V+LLG C + L E+ G L D L + V + LS + +
Sbjct: 49 VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARLHS 119
A+ AKG+EYL K +HRD+ + N L+ +D V KI+DF LS + D R +
Sbjct: 109 SFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 178
L + APE G +KSDV+SFGV+L E+ T G P
Sbjct: 166 GGKLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY---------------- 208
Query: 179 PKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
P LS ++V + + RL P ++ + C Q + + RP S +V+ L+
Sbjct: 209 PGLSNEEVLEYLRKGYRL--PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-38
Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +L H N V+LLG C G + E+ G L D L + G L+ + +
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--------KHGEKLTLKDLL 105
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHS 119
++A+ AKG+EYL K + +HRD+ + N L+ ++ V KI+DF LS D R
Sbjct: 106 QMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG 162
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 178
L APE G+ +KSDV+SFGV+L E+ T G +P
Sbjct: 163 GGKLPIKWM-APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY---------------- 205
Query: 179 PKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231
P +S ++V + ++ RL P ++ + C Y+ + RP S +V+ L
Sbjct: 206 PGMSNEEVLELLEDGYRL--PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-36
Identities = 63/172 (36%), Positives = 84/172 (48%), Gaps = 15/172 (8%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
RL H N V+L+ D L E+ G L D L LS + KIA
Sbjct: 54 RLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---------PLSEDEAKKIA 104
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
+ +GLEYLH IIHRD+K N+L+ ++ V KIADF L+ + ++ +T V
Sbjct: 105 LQILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV- 159
Query: 124 GTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
GT Y APE + G K DV+S GV+L ELLTG+ P Q L+
Sbjct: 160 GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-36
Identities = 55/159 (34%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+LKH N V+L D L E+ G L D+L R LS +
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFY 102
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
LEYLH K I+HRD+K N+L+ +D K+ADF L+ Q +T V
Sbjct: 103 LRQILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV 157
Query: 123 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT Y APE + D++S GV+L ELLTG+ P
Sbjct: 158 -GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 16/164 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
++S L+H N V+ G D L E+ S GSL +L + P PV+ ++
Sbjct: 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL----PEPVI--RK 105
Query: 59 RVK-IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 117
+ I +GL YLH I+HRDIK +N+L+ D V K+ADF + + D+
Sbjct: 106 YTRQI----LEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158
Query: 118 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ V GT + APE + +D++S G ++E+ TG+ P
Sbjct: 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-31
Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
KH N V+ G + + EF S GSL D+L L+ Q +
Sbjct: 54 CKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVCK 105
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
KGLEYLH IIHRDIK++N+L+ D K+ DF LS Q ++ ++G
Sbjct: 106 ELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ---LSDTKARNTMVG 159
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T + APE + K+D++S G+ +EL G+ P
Sbjct: 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-27
Identities = 56/162 (34%), Positives = 88/162 (54%), Gaps = 20/162 (12%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+ L+H N VQLLG + G + E+ + GSL D L R G V++ Q++
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR----GRA---VITLAQQLGF 107
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
A+ +G+EYL EK + +HRD+ + NVL+ +D VAK++DF L+ +A +
Sbjct: 108 ALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA-------SQGQD 157
Query: 123 LGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
G + APE + + KSDV+SFG++L E+ + GR P
Sbjct: 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 60/162 (37%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
+ + V G + + E+ GSL IL K V+G P +L K
Sbjct: 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILG-----K 104
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
IAV KGL YLHEK IIHRD+K SN+L+ K+ DF +S Q + A+ T
Sbjct: 105 IAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TF 159
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
V GT Y APE + KSD++S G+ L+EL TGR P
Sbjct: 160 V-GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 4e-26
Identities = 57/167 (34%), Positives = 82/167 (49%), Gaps = 28/167 (16%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKG-----VKGAQPGPVL 54
+ LKH N V+ +G S + E+A NGSL I+ G V Q VL
Sbjct: 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ---VL 109
Query: 55 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 114
+GL YLHE+ +IHRDIK++N+L D V K+ADF ++ + D++
Sbjct: 110 -------------QGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153
Query: 115 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
S V+GT + APE + SD++S G ++ELLTG P
Sbjct: 154 KDDAS--VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-26
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 32/170 (18%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+L H N ++ + + E+A G L + +K + G +Q +
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQK-----KEGKPFPEEQILDW 108
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR- 121
V L+YLH + I+HRDIK N+ + + + K+ DF +S L ST
Sbjct: 109 FVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-------LSSTVD 158
Query: 122 ----VLGTFGYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
V+GT Y +PE Y N KSD++S G VL EL T + P
Sbjct: 159 LAKTVVGTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-25
Identities = 56/165 (33%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 66
N V+L + D S L E+ GSL D+L LS + + I
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKI------GRKGPLSESEALFILAQI 110
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTR---- 121
LEYLH K IIHRDIK N+L+ D V K+ DF L+ PD +
Sbjct: 111 LSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
Query: 122 VLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVD 163
+GT GY APE + ++ SD++S G+ L ELLTG P +
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 57/174 (32%), Positives = 88/174 (50%), Gaps = 23/174 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV---LS 55
+++ +HEN V+ G C +G ++ +E+ +G L+ L HG P L+
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 56 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 115
Q ++IAV A G+ YL A H +HRD+ + N L+ D V KI DF +S
Sbjct: 121 LSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD------ 171
Query: 116 RLHST---RVLGT----FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+++T RV G + PE M + +SDV+SFGVVL E+ T G++P
Sbjct: 172 -VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-24
Identities = 55/157 (35%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 6 KHENFVQLLG-YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
+ V+ G + +G + E+ GSL D+L + P PVL+ IA
Sbjct: 57 ESPYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKI----PEPVLA-----YIAR 106
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
KGL+YLH K HIIHRDIK SN+LI KIADF +S + + +T V G
Sbjct: 107 QILKGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-G 162
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T Y +PE + +D++S G+ LLE G+ P
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 7e-24
Identities = 59/166 (35%), Positives = 86/166 (51%), Gaps = 26/166 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L+H+ VQL C + + E+ S GSL D L +G K L Q V +A
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-------LRLPQLVDMA 109
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-----H 118
A+G+ YL + + IHRD+ + N+L+ ++ V KIADF L ARL +
Sbjct: 110 AQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL--------ARLIEDDEY 158
Query: 119 STRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ R F + APE A G+ KSDV+SFG++L E++T GR P
Sbjct: 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-22
Identities = 52/166 (31%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L+H +QL C + E GSL + L G G L Q + +A
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-------LKLPQLIDMA 109
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-----H 118
A G+ YL + + IHRD+ + NVL+ ++++ K+ADF L AR+ +
Sbjct: 110 AQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGL--------ARVIKEDIY 158
Query: 119 STRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
R F + APE A+ + + KSDV+SFG++L E++T GR P
Sbjct: 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-22
Identities = 58/173 (33%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 6 KHENFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV--K 61
K V+ G +D +S + A E+ GSL D ++ + +G + G ++V K
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIG------EKVLGK 109
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
IA KGL YLH + IIHRDIK SN+L+ K+ DF +S + + A T
Sbjct: 110 IAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTF 163
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
GT Y APE + SDV+S G+ LLE+ R P P G+ L
Sbjct: 164 T-GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-22
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 34/226 (15%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++++L ++ +D + E+A NG LH +L Q G L Q
Sbjct: 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLK-------MQRGRPLPEDQVW 104
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ + GL +LH K I+HRDIKS N+ + D KI D ++ D +
Sbjct: 105 RFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFAN 159
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
++GT Y +PE N KSDV++ GVVL E TG+ P D Q +L+
Sbjct: 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALIL----- 211
Query: 181 LSEDKVRQCVDARLGGDYPP---KAVAKMAAVAALCVQYEADFRPN 223
K+ + G +PP ++A + C+ + RP+
Sbjct: 212 ----KI-------IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 6e-22
Identities = 65/231 (28%), Positives = 98/231 (42%), Gaps = 33/231 (14%)
Query: 4 RLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
L HEN V+ G C G S L E+ +GSL D L + ++ ++ +
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--------DQINLKRLLL 113
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP--DMAARLHS 119
+ KG++YL + IHRD+ + N+L+ +D+ KI+DF L+ P +
Sbjct: 114 FSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE 170
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK-------PVDHTLPRGQQ 171
F Y APE T + ++ SDV+SFGV L EL T G + Q
Sbjct: 171 PGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229
Query: 172 SLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP 222
+VT L E + RL PP ++ + LC + E RP
Sbjct: 230 MIVTRLLELLKEGE-------RL--PRPPSCPDEVYDLMKLCWEAEPQDRP 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-21
Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 32/229 (13%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 66
H N V+L+G CV + E GSL L +K L+ ++ +++++ A
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR--------LTVKKLLQMSLDA 102
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 126
A G+EYL K + IHRD+ + N L+ +++V KI+DF +S + +
Sbjct: 103 AAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159
Query: 127 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 185
+ APE G+ ++SDV+S+G++L E + G P P +S +
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY----------------PGMSNQQ 203
Query: 186 VRQCVDARLGGDYPPKAV--AKMAAVAALCVQYEADFRPNMSIVVKALQ 232
R+ +++ G P + ++ + C Y+ + RP+ S + LQ
Sbjct: 204 TRERIES--GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-21
Identities = 57/165 (34%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
L HEN ++L G + ++ E A GSL D L RK G L V+IA
Sbjct: 52 SLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRL--RKDALGHFLISTL-CDYAVQIA 107
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD------MAARL 117
G+ YL K IHRD+ + N+L+ DD KI DF L P M L
Sbjct: 108 ----NGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 118 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+V F + APE T + SDV+ FGV L E+ T G +P
Sbjct: 161 ---KV--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-21
Identities = 67/244 (27%), Positives = 110/244 (45%), Gaps = 24/244 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV--LSW 56
+++ L+HE+ V+ G CV+G ++ +E+ +G L+ L HG V A+ L+
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 57 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 116
Q + IA A G+ YL A H +HRD+ + N L+ ++ + KI DF +S
Sbjct: 120 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 117 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT 175
+ + PE M + +SDV+S GVVL E+ T G++P
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-------------- 222
Query: 176 WATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235
W +LS ++V +C+ P ++ + C Q E R N+ + LQ L
Sbjct: 223 WY--QLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280
Query: 236 NARP 239
A P
Sbjct: 281 KASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 22/234 (9%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L+H N V+L+G C L +E+ +L ++L LSW++R KIA
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------------LSWERRRKIA 786
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
+G AK L +LH + P ++ ++ ++I D LS P + T+
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLRLS--LPGLLCT--DTKCF 839
Query: 124 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSE 183
+ Y APE T + KSD+Y FG++L+ELLTG+ P D S+V WA S+
Sbjct: 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSD 898
Query: 184 DKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235
+ +D + GD + ++ +A C + RP + V+K L+
Sbjct: 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-20
Identities = 60/232 (25%), Positives = 114/232 (49%), Gaps = 33/232 (14%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
+++L H+N V+LLG + ++ E S G+L + L R + Q ++
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRG--RALVSVI-----QLLQ 104
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
++ A+G+EYL K ++HRD+ + N+L+ +D VAK++DF L+ + +++
Sbjct: 105 FSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSK 158
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180
+ + APE + ++KSDV+S+GV+L E+ + GR P PK
Sbjct: 159 L--PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY----------------PK 200
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
+S +V++CV+ + P A + + C + E RP+ + + L+
Sbjct: 201 MSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-20
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 18/165 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQ 58
+ L H N VQ LG+ + E+ GS+ L +GR + V + +
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTE 115
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
+V +GL YLH K I+HRD+K+ N+L+ D + KI+DF +S ++ D+
Sbjct: 116 QV------LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ 166
Query: 119 STRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKP 161
+ + G+ + APE + +AK D++S G V+LE+ GR+P
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-20
Identities = 70/243 (28%), Positives = 103/243 (42%), Gaps = 37/243 (15%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++S H N V+LLG C+ + + E G L L R P+L+ ++ +
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELL 109
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFDLSNQAPDMAA 115
I + AKG YL H IHRD+ + N L+ + V KI DF L A D+
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL---ARDIYK 163
Query: 116 ----RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 171
R +L + APE + G+ +SDV+SFGV++ E+LT GQQ
Sbjct: 164 SDYYRKEGEGLL-PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT----------LGQQ 212
Query: 172 SLVTWATPKLSEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229
P L+ +V Q V A GG P K+ + C + RP + +
Sbjct: 213 PY-----PALNNQEVLQHVTA--GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265
Query: 230 ALQ 232
LQ
Sbjct: 266 ILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-20
Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 23/172 (13%)
Query: 28 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 87
E+ GS+ DI+ L+ ++ I KGLEYLH IHRDIK
Sbjct: 78 EYCGAGSVSDIMKIT--------NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIK 126
Query: 88 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 147
+ N+L+ ++ AK+ADF +S Q D A+ ++ V+GT + APE N K+D++S
Sbjct: 127 AGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNKADIWS 184
Query: 148 FGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSE---------DKVRQC 189
G+ +E+ G+ P P R + P LS+ D V++C
Sbjct: 185 LGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 4e-20
Identities = 71/233 (30%), Positives = 98/233 (42%), Gaps = 33/233 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+S+ H N V+ V G L + S GSL DI +K + P L
Sbjct: 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDI------MKSSYPRGGLDEAIIA 105
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ KGLEYLH IHRDIK+ N+L+ +D KIADF +S D R
Sbjct: 106 TVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162
Query: 121 R--VLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 176
R +GT + APE M + K+D++SFG+ +EL TG P P + ++T
Sbjct: 163 RKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATGAAPY-SKYPPMKVLMLTL 220
Query: 177 --ATPKLSEDKVRQCVDARLGGDYPP--KAVAKMAAVAALCVQYEADFRPNMS 225
P L DY K+ KM +LC+Q + RP
Sbjct: 221 QNDPPSLETGA-----------DYKKYSKSFRKM---ISLCLQKDPSKRPTAE 259
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-20
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 33/231 (14%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L H N VQL G C + E+ +NG L + L RKG G + + +
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGT--------EWLLDMC 106
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
+ +EYL IHRD+ + N L+ +D+V K++DF L+ D T
Sbjct: 107 SDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----QYTSSQ 159
Query: 124 GT---FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
GT + PE + ++KSDV+SFGV++ E+ + K +P +
Sbjct: 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK-----MP----------YER 204
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231
S +V + V A P A ++ + C + + RP ++ L
Sbjct: 205 FSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 9e-20
Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 16/162 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++S+L+H N VQ LG + + + E GSL +L G+ P PV+ R
Sbjct: 55 LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQ 110
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ GLEYLH++ + +HRDIK +N+L+ + V K+ADF ++ Q + + +
Sbjct: 111 IL-----LGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AK 159
Query: 121 RVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKP 161
G+ + APE G +D++S G +LE+ TG+ P
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-19
Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 12/169 (7%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGR-----KGVKGAQPGPV 53
+++ L+H++ V+ G C +G ++ +E+ +G L+ L HG G + PG
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ- 118
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
L+ Q + IA A G+ YL A H +HRD+ + N L+ V KI DF +S
Sbjct: 119 LTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 175
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
R + + PE + + +SD++SFGVVL E+ T G++P
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-19
Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
RL+H++ + L C G + E GSL L + G VL + +A
Sbjct: 58 RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMA 110
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
A+G+ YL E+ + IHRD+ + N+L+ +D V K+ADF L+ + ++
Sbjct: 111 CQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI- 166
Query: 124 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
+ + APE A G + KSDV+SFG++L E+ T
Sbjct: 167 -PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-19
Identities = 54/235 (22%), Positives = 105/235 (44%), Gaps = 32/235 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++S L+H N + + +D + ++ E+A+ G+L+D + +KG +++ +
Sbjct: 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG---------QLFEEEM 102
Query: 61 KIAV--GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
+ + Y+H+ I+HRDIK+ N+ + + K+ DF +S
Sbjct: 103 VLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS--EYSM 157
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
+ V+GT Y +PE + N KSD+++ G VL ELLT ++ D T P +LV
Sbjct: 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV--- 211
Query: 179 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233
K+ Q + Y +++ ++ +Q + + RP V+
Sbjct: 212 ------KIVQGNYTPVVSVYS----SELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 15/171 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPV 53
++S L+H N V LLG C + +E+ ++G LH+ L
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--AP 111
L + IA+ A G+EYL + H +HRD+ + N L+ + KI+DF LS +
Sbjct: 121 LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 112 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
D R+ S +L + PE + G+ +SD++SFGVVL E+ + G +P
Sbjct: 178 DY-YRVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-19
Identities = 66/246 (26%), Positives = 106/246 (43%), Gaps = 45/246 (18%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQR 59
++S+ H+N V+L+G + R + E + G L L R + +P L+ +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRP--RPERPSS-LTMKDL 118
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAAR 116
+ A AKG +YL E H IHRDI + N L+ VAKIADF MA
Sbjct: 119 LFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFG-------MARD 168
Query: 117 LHST-------RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 168
++ R + + PE + G +K+DV+SFGV+L E+ + G P
Sbjct: 169 IYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY------ 222
Query: 169 GQQSLVTWATPKLSEDKVRQCV--DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226
P + +V + V RL D P + + C Q+ + RPN +
Sbjct: 223 ----------PGRTNQEVMEFVTGGGRL--DPPKGCPGPVYRIMTDCWQHTPEDRPNFAT 270
Query: 227 VVKALQ 232
+++ +Q
Sbjct: 271 ILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 3e-19
Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 25/166 (15%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
++L H V+L+G C G +L E A G L L R+ + + + +V
Sbjct: 51 AQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQV-- 104
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
A G+ YL K H +HRD+ + NVL+ + AKI+DF +S A S
Sbjct: 105 ----AMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSR-----ALGAGSDYY 152
Query: 123 LGTFG------YHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
T ++APE G+ ++KSDV+S+GV L E + G KP
Sbjct: 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-19
Identities = 52/159 (32%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPVLSWQQ 58
KH+N + LLG C + E+A++G+L D L R P L+ +
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
V A A+G+E+L K IHRD+ + NVL+ +D V KIADF L+ +
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
+T + APE +SDV+SFGV+L E+ T
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-19
Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGA-----QPGPVLSWQQ 58
KH+N + LLG C + E+AS G+L + L R+ G+ + P L+++
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
V A A+G+EYL A IHRD+ + NVL+ +D+V KIADF L+ ++
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
+T + APE +SDV+SFGV+L E+ T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-19
Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 35/226 (15%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
++ +L+HE VQL Y V + + E+ S GSL D L G + G L Q
Sbjct: 54 VMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQL 104
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
V +A A G+ Y+ + +HRD++++N+L+ ++ V K+ADF L+ D ++
Sbjct: 105 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YT 158
Query: 120 TRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 176
R F + APE A+ G+ KSDV+SFG++L EL T GR P
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY-------------- 204
Query: 177 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP 222
P + +V V+ PP+ + + C + E + RP
Sbjct: 205 --PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-19
Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP------------V 53
KH+N + LLG C + E+A+ G+L + L R+ PGP
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARR-----PPGPDYTFDITKVPEEQ 130
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
LS++ V A A+G+EYL + IHRD+ + NVL+ +D+V KIADF L+ D+
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
++ + APE +SDV+SFG+++ E+ T
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-18
Identities = 66/233 (28%), Positives = 107/233 (45%), Gaps = 35/233 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L HE VQL G C + E+ SNG L + L R+ K QP Q +++
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL--REHGKRFQP------SQLLEMC 106
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
+G+ YL K IHRD+ + N L+ D K++DF LS D +++ V
Sbjct: 107 KDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVG 160
Query: 124 GTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180
F + PE + + ++KSDV++FGV++ E+ + G+ P + R S
Sbjct: 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE----RFNNSETV----- 211
Query: 181 LSEDKVRQCVDARLGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
+KV Q RL Y P A K+ A+ C +A+ RP ++ +++
Sbjct: 212 ---EKVSQ--GLRL---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 53/164 (32%), Positives = 74/164 (45%), Gaps = 25/164 (15%)
Query: 4 RLKHENFVQLLG-YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
KH N V Y V V E+ GSL DI+ Q ++ Q +
Sbjct: 71 DCKHPNIVDYYDSYLVGDELWV-VMEYMDGGSLTDII--------TQNFVRMNEPQIAYV 121
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL---HS 119
+GLEYLH + ++IHRDIKS N+L+ D K+ADF AA+L S
Sbjct: 122 CREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF-------AAQLTKEKS 171
Query: 120 TR--VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
R V+GT + APE K D++S G++ +E+ G P
Sbjct: 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-18
Identities = 53/135 (39%), Positives = 67/135 (49%), Gaps = 27/135 (20%)
Query: 50 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109
P +L KIAV K LEYLH K +IHRD+K SNVLI + K+ DF +S
Sbjct: 101 PEDILG-----KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGY 153
Query: 110 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNA-----KSDVYSFGVVLLELLTGRKPVDH 164
D A+ T G Y APE + +LN KSDV+S G+ ++EL TGR P D
Sbjct: 154 LVDSVAK---TIDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFPYD- 208
Query: 165 TLPRGQQSLVTWATP 179
+W TP
Sbjct: 209 ----------SWKTP 213
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-18
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 26/232 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ + H N V+L+G C + E G L GP L ++ +
Sbjct: 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--------GPRLKVKELI 97
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
++ AA G+EYL K H IHRD+ + N L+ + +V KI+DF +S + D
Sbjct: 98 QMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ APE G+ +++SDV+SFG++L E SL
Sbjct: 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF---------------SLGAVPYAN 199
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
LS + R+ ++ + P + + C +Y+ RP+ S V + LQ
Sbjct: 200 LSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-18
Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 27/247 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGV-----KGAQPGPV 53
+++ L+HE+ V+ G C DG ++ +E+ +G L+ L HG + + Q
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
L Q + IA A G+ YL A H +HRD+ + N L+ + + KI DF +S
Sbjct: 120 LGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 172
+ + PE M + +SDV+SFGV+L E+ T G++P
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----------- 225
Query: 173 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
W +LS +V +C+ + P ++ + C Q E R N+ + K L
Sbjct: 226 ---WF--QLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280
Query: 233 PLLNARP 239
L A P
Sbjct: 281 ALGKATP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-18
Identities = 59/165 (35%), Positives = 87/165 (52%), Gaps = 19/165 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
++ +L+H+ VQL Y V + + E+ S GSL D L + G G L
Sbjct: 54 IMKKLRHDKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFL--KDG-----EGRALKLPNL 104
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
V +A A G+ Y+ + IHRD++S+N+L+ D V KIADF L+ D ++
Sbjct: 105 VDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YT 158
Query: 120 TRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
R F + APE A+ G+ KSDV+SFG++L EL+T GR P
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-18
Identities = 53/163 (32%), Positives = 87/163 (53%), Gaps = 17/163 (10%)
Query: 1 MVSRLKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
++++L+H N VQLLG V + + E+ + GSL D L R VL
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCL 104
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
+K ++ + +EYL + +HRD+ + NVL+ +D+VAK++DF L+ + A+
Sbjct: 105 LKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQD 157
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
T L + APE + + KSDV+SFG++L E+ + GR P
Sbjct: 158 TGKL-PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-18
Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 15/163 (9%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L H VQL G C + + L +EF +G L D L ++G S + + +
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--------KFSQETLLGMC 106
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRV 122
+ +G+ YL +IHRD+ + N L+ ++ V K++DF ++ D T+
Sbjct: 107 LDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF 163
Query: 123 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDH 164
+ +PE + ++KSDV+SFGV++ E+ + G+ P ++
Sbjct: 164 --PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 5e-18
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
+ H N + +DG + E+A G L + K + ++ Q+ +I +
Sbjct: 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLS-----KAISKRKKKRKLIPEQEIWRIFI 110
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
+GL+ LHE+ I+HRD+KS+N+L+ +D+ KI D +S A+ +G
Sbjct: 111 QLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQIG 163
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T Y APE + KSD++S G +L E+ T P
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-18
Identities = 54/168 (32%), Positives = 85/168 (50%), Gaps = 17/168 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL----------HGRKGVKGAQP 50
++SRLK N ++LLG CVD + E+ NG L+ L +G V A
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 51 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ- 109
P +S+ + +A+ A G++YL + + +HRD+ + N L+ ++ KIADF +S
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 110 -APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156
A D R+ VL + A E + G+ SDV++FGV L E+L
Sbjct: 189 YAGDY-YRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-18
Identities = 55/159 (34%), Positives = 81/159 (50%), Gaps = 10/159 (6%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVK-----GAQPGPVLSWQQ 58
KH+N + LLG C + E+AS G+L + L R+ G++ P LS++
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
V A A+G+EYL K IHRD+ + NVL+ +D+V KIADF L+ +
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
+T + APE +SDV+SFGV+L E+ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 53/164 (32%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M+ +H N V G + + E+ GSL DI GP LS Q
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-------VTRGP-LSELQIA 104
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ KGL YLHE IHRDIK +N+L+ +D K+ADF +S Q A+ S
Sbjct: 105 YVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS- 160
Query: 121 RVLGTFGYHAPEYA---MTGQLNAKSDVYSFGVVLLELLTGRKP 161
+GT + APE A G + K D+++ G+ +EL + P
Sbjct: 161 -FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-17
Identities = 52/165 (31%), Positives = 81/165 (49%), Gaps = 15/165 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
+++ + H + V+LLG C+ +S+V L + G L D + K G+Q +L+W
Sbjct: 62 VMASVDHPHVVRLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQY--LLNW--- 114
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
V AKG+ YL EK ++HRD+ + NVL+ KI DF L+ H+
Sbjct: 115 ---CVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA 168
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 163
+ A E + KSDV+S+GV + EL+T G KP +
Sbjct: 169 EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-17
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 31/233 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ + H N V+L+G C + E G L +K L +Q V
Sbjct: 45 ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLV 96
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
K A+ AA G+ YL K + IHRD+ + N L+ +++V KI+DF +S Q D ++S+
Sbjct: 97 KFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD---GIYSS 150
Query: 121 RVLGT--FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
L + APE G+ +++SDV+S+G++L E SL
Sbjct: 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF---------------SLGVCPY 195
Query: 179 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231
P ++ + R+ V+ P K + V C Y+ + RP S + K L
Sbjct: 196 PGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 60/232 (25%), Positives = 91/232 (39%), Gaps = 35/232 (15%)
Query: 11 VQLLGYCVDGTSRVLAYEFASNGSLHDILHG-RKGVKGAQPGPVLSWQQRVKIAVGAAKG 69
V+LLG G ++ E + G L L R + + Q+ +++A A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQ---APDMAARLHSTRV 122
+ YL K +HRD+ + N ++ +D KI DF D+ L R
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR- 186
Query: 123 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL 181
+ APE G KSDV+SFGVVL E+ T +P L
Sbjct: 187 -----WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY----------------QGL 225
Query: 182 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233
S ++V + V D P K+ + +C QY RP +V +L+
Sbjct: 226 SNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 55/171 (32%), Positives = 79/171 (46%), Gaps = 31/171 (18%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY-EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
LKH N V+ G V +V + E+ S G+L ++L G +L + V
Sbjct: 54 ELLKHPNLVKYYGVEVH-REKVYIFMEYCSGGTLEELLEH---------GRIL--DEHV- 100
Query: 62 IAVGAA---KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD----LSNQAPDMA 114
I V +GL YLH I+HRDIK +N+ + + V K+ DF L N M
Sbjct: 101 IRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157
Query: 115 ARLHSTRVLGTFGYHAPEY----AMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ S GT Y APE G A +D++S G V+LE+ TG++P
Sbjct: 158 EEVQSLA--GTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 51/169 (30%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIAV K L YL K + IIHRD+K SN+L+ + K+ DF +S Q D A+ T
Sbjct: 111 KIAVATVKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---T 165
Query: 121 RVLGTFGYHAPEYAMTGQLNA---KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
R G Y APE + +SDV+S G+ L E+ TG+ P W
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KWN 214
Query: 178 TPKLSEDKVRQCVDA---RLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223
+ D++ Q V L + LC+ + RP
Sbjct: 215 SVF---DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK 260
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 2e-17
Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 20/160 (12%)
Query: 5 LKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDI--LHGRKGVKGAQPGPVLSWQQRV 60
L+H N V+L S + +E+ HD+ L VK + Q
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVK-------FTESQIK 103
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+GL+YLH I+HRDIK SN+LI +D V K+ADF L+ + ++
Sbjct: 104 CYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160
Query: 121 RVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 159
RV+ T Y PE + + + D++S G +L EL G+
Sbjct: 161 RVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-17
Identities = 38/113 (33%), Positives = 52/113 (46%), Gaps = 14/113 (12%)
Query: 57 QQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 108
Q+VK + K LEYLH K IIHRDIK N+L+ + I DF+++
Sbjct: 92 SQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT 148
Query: 109 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ +T GT GY APE + D +S GV E L G++P
Sbjct: 149 KVTP---DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-17
Identities = 50/155 (32%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
+KH N VQLLG C + EF + G+L D L R+ + VL + +A
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMAT 111
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
+ +EYL +K + IHRD+ + N L+ ++ + K+ADF LS M ++
Sbjct: 112 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGA 165
Query: 125 TF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
F + APE + + KSDV++FGV+L E+ T
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-17
Identities = 50/142 (35%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 24 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV--KIAVGAAKGLEYLHEKADPHI 81
+ EF GSL I +KG GP+ + KIAV +GL YL+ I
Sbjct: 79 CMCMEFMDCGSLDRIY--KKG------GPI---PVEILGKIAVAVVEGLTYLYNVH--RI 125
Query: 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA 141
+HRDIK SN+L+ K+ DF +S + + A T V GT Y +PE G+
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFV-GTSTYMSPERIQGGKYTV 181
Query: 142 KSDVYSFGVVLLELLTGRKPVD 163
KSDV+S G+ ++EL G+ P
Sbjct: 182 KSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-17
Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 19/236 (8%)
Query: 5 LKHENFVQLLGYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
L HEN V+ G C + + L E+ GSL D L P L+ Q +
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHKLNLAQLLLF 112
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHST 120
A +G+ YLH + H IHRD+ + NVL+ +D + KI DF L+ P+ R+
Sbjct: 113 AQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
F Y A E + + SDV+SFGV L ELLT + P+ + ++ +
Sbjct: 170 GDSPVFWY-AVECLKENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFEEMIGPKQGQ 227
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236
++ ++ + ++ + P ++ + C + EA FRP ++ L+ + +
Sbjct: 228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-17
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQ 58
KH+N + LLG C + E+AS G+L + L R+ P ++++
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
V A+G+EYL A IHRD+ + NVL+ +++V KIADF L+ ++
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
+T + APE +SDV+SFGV++ E+ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-17
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 40/209 (19%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPVLSWQQ 58
H N + LLG C + +A E+A G+L D L + + K L+ QQ
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
++ A A G++YL EK IHRD+ + NVL+ ++ +KIADF LS R
Sbjct: 121 LLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLS--------RGE 169
Query: 119 STRVLGTFGYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT-GRKP--------VDH 164
V T G + LN KSDV+SFGV+L E+++ G P +
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229
Query: 165 TLPRGQQSLVTWATPKLSEDKV----RQC 189
LP+G + P+ +D+V RQC
Sbjct: 230 KLPQGYR----MEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-17
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
S LKH N VQ LG + + E GSL +L + G ++ + +++
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI-- 117
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLH--S 119
+GL+YLH+ I+HRDIK NVL+ V KI+DF S + A ++ +
Sbjct: 118 ----LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR----LAGINPCT 166
Query: 120 TRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKP 161
GT Y APE G A +D++S G ++E+ TG+ P
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-17
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 27/201 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
++ +L+H+ V L Y V + + EF GSL D L ++G G L Q
Sbjct: 54 IMKKLRHDKLVPL--YAVVSEEPIYIVTEFMGKGSLLDFL--KEG-----DGKYLKLPQL 104
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
V +A A G+ Y+ + IHRD++++N+L+ D+ V KIADF L+ D ++
Sbjct: 105 VDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YT 158
Query: 120 TRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP--------VDHTLPR 168
R F + APE A+ G+ KSDV+SFG++L EL+T GR P V + R
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218
Query: 169 GQQSLVTWATPKLSEDKVRQC 189
G + P+ + ++ C
Sbjct: 219 GYRMPCPQGCPESLHELMKLC 239
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 8e-17
Identities = 46/172 (26%), Positives = 69/172 (40%), Gaps = 34/172 (19%)
Query: 3 SRLKHENFVQLLGYCV--DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
SR+ H V+L + L E+A G L L +
Sbjct: 48 SRINHPFIVKL--HYAFQTEEKLYLVLEYAPGGELFSHL-----------------SKEG 88
Query: 61 KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 112
+ + A+ LEYLH II+RD+K N+L+ D K+ DF L+ +
Sbjct: 89 RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145
Query: 113 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164
+R ++ GT Y APE + D +S GV+L E+LTG+ P
Sbjct: 146 EGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 9e-17
Identities = 60/192 (31%), Positives = 94/192 (48%), Gaps = 10/192 (5%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK---GVKGAQPGPVLSWQ 57
++SRLK+ N ++LLG CV + E+ NG L+ L R+ A P +S
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 58 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAAR 116
+ +AV A G++YL A + +HRD+ + N L+ + KIADF +S N R
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 117 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 176
+ VL + A E + G+ SDV++FGV L E+ T K ++L +Q V
Sbjct: 187 IQGRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--VIE 243
Query: 177 ATPKLSEDKVRQ 188
T + ++ RQ
Sbjct: 244 NTGEFFRNQGRQ 255
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-16
Identities = 55/180 (30%), Positives = 83/180 (46%), Gaps = 20/180 (11%)
Query: 28 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 87
E GSL +L +K G P +L KI++ +GL YL EK I+HRD+K
Sbjct: 79 EHMDGGSLDQVL--KKA--GRIPENILG-----KISIAVLRGLTYLREKHK--IMHRDVK 127
Query: 88 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 147
SN+L+ K+ DF +S Q D A +GT Y +PE +SD++S
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 148 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMA 207
G+ L+E+ GR P+ P + L +SE + ++ G +PP + MA
Sbjct: 184 LGLSLVEMAIGRYPIP---PPDAKELEAMFGRPVSEGEAKESHRPVSG--HPPDSPRPMA 238
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 2e-16
Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+S+ + + G + G+ + E+ GS D+L +PG L
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL---------KPGK-LDETYIA 101
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
I GLEYLHE+ IHRDIK++N+L+ ++ K+ADF +S Q ++ ++
Sbjct: 102 FILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+GT + APE + K+D++S G+ +EL G P
Sbjct: 159 --VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+H V+LL G+ VL E+ L ++L + +P L Q
Sbjct: 54 QACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEE-----RP---LPEAQVKSY 104
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
KG+ Y+H I+HRD+K +N+LI D V KIADF L+ + RL+S +V
Sbjct: 105 MRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV 161
Query: 123 LGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGR 159
T Y APE + + D+++ G + ELL G
Sbjct: 162 -ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-16
Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 4/157 (2%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M +L H+N V+LLG C + + E+ G L L K P LS +Q+V
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ A G+++L ++ +HRD+ + N L+ K++ LS +
Sbjct: 121 ALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
++ + APE + KSDV+SFGV++ E+ T
Sbjct: 178 ALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-16
Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ L+HEN VQ LG +D + E+ GS+ +L+ GA ++ R
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQ 114
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP----DMAAR 116
+ KGL YLH + IIHRDIK +N+L+ + KI+DF +S +
Sbjct: 115 IL-----KGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166
Query: 117 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ G+ + APE K+D++S G +++E+LTG+ P
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-16
Identities = 40/106 (37%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 61 KIAVGAAKGLEYLHEKADPH-IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
K+ V K L YL EK H +IHRD+K SN+L+ K+ DF +S + D A+
Sbjct: 118 KMTVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--- 171
Query: 120 TRVLGTFGYHAPEY----AMTGQLNAKSDVYSFGVVLLELLTGRKP 161
TR G Y APE + + ++DV+S G+ L+EL TG+ P
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-16
Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 17/175 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR-------------KGVKG 47
+++ H N V+LLG C G L +E+ + G L++ L R K
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 48 AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 107
LS +++ IA A G+ YL E+ +HRD+ + N L+ ++ V KIADF LS
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 108 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
S + PE + +SDV+++GVVL E+ + G +P
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 53/163 (32%), Positives = 78/163 (47%), Gaps = 23/163 (14%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQR 59
H N + LLG C LA E+A +G+L D L + ++ LS QQ
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
+ A A+G++YL +K IHRD+ + N+L+ ++ VAKIADF LS R
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQE 175
Query: 120 TRVLGTFGYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT 157
V T G + LN SDV+S+GV+L E+++
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-15
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ LKH N VQ LG C+D + + EF GS+ IL+ G P PV
Sbjct: 55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFC----- 105
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
K G+ YLH ++HRDIK +NV++ + + K+ DF + + + +
Sbjct: 106 KYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162
Query: 121 RVL----GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+L GT + APE KSD++S G + E+ TG+ P
Sbjct: 163 NMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 46/164 (28%), Positives = 81/164 (49%), Gaps = 22/164 (13%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+ H N ++L G ++ E+ NGSL L G + Q V +
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--------FTVGQLVGML 112
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-- 121
G A G++YL ++ + +HRD+ + N+L+ + V K++DF LS + D A ++T+
Sbjct: 113 RGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGG 168
Query: 122 ---VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ T APE + + SDV+SFG+V+ E+++ G +P
Sbjct: 169 KIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-15
Identities = 66/209 (31%), Positives = 94/209 (44%), Gaps = 42/209 (20%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG--------PVLSWQQ 58
H N + LLG C LA E+A +G+L D L + V P LS QQ
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQ 113
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
+ A A+G++YL +K IHRD+ + N+L+ ++ VAKIADF LS R
Sbjct: 114 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQ 162
Query: 119 STRVLGTFGYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT-GRKP--------VDH 164
V T G + LN SDV+S+GV+L E+++ G P +
Sbjct: 163 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 222
Query: 165 TLPRGQQSLVTWATPKLSEDKV----RQC 189
LP+G + P +D+V RQC
Sbjct: 223 KLPQGYR----LEKPLNCDDEVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (179), Expect = 4e-15
Identities = 50/167 (29%), Positives = 69/167 (41%), Gaps = 35/167 (20%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
LKH N V+LL L +E+ L L R G P + S ++
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIMYQL--- 107
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS---- 119
+GL Y H I+HRD+K N+LI D V K+ADF L AR
Sbjct: 108 ---LRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGL--------ARAFGIPLR 153
Query: 120 --TRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 159
T + T Y APE L +K D++S G + E++TG+
Sbjct: 154 TYTHEVVTLWYRAPEIL----LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-15
Identities = 62/193 (32%), Positives = 90/193 (46%), Gaps = 21/193 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M+ KH N V G + + EF GSL DI H GP LS Q
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH--------VTGP-LSESQIA 109
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
++ +GL YLH K +HRDIK +N+L+ D+ K+ADF +S Q A+ S
Sbjct: 110 YVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS- 165
Query: 121 RVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT-- 175
+GT + APE A G N D+++ G+ +EL + P+ P L+T
Sbjct: 166 -FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS 224
Query: 176 -WATPKLSEDKVR 187
+ PKL +DK++
Sbjct: 225 NFQPPKL-KDKMK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-15
Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 16/164 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ L+H+ V+L + E+ + GSL D L +G K P + +
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP-------KLI 106
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ A+G+ Y+ K + IHRD++++NVL+ + + KIADF L+ D ++
Sbjct: 107 DFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTA 160
Query: 121 RVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
R F + APE G KSDV+SFG++L E++T G+ P
Sbjct: 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-15
Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 27/169 (15%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +L+H V+L V + E+ NGSL D L +G+K L+ + +
Sbjct: 54 LMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIK-------LTINKLI 105
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL--- 117
+A A+G+ ++ K + IHRD++++N+L+ + KIADF L ARL
Sbjct: 106 DMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGL--------ARLIED 154
Query: 118 --HSTRVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
++ R F + APE G KSDV+SFG++L E++T GR P
Sbjct: 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-14
Identities = 53/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 5 LKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
L HEN V+ G C + G L EF +GSL + L K ++ +Q++K
Sbjct: 63 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK--------INLKQQLKY 114
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
AV KG++YL + +HRD+ + NVL+ + KI DF L+
Sbjct: 115 AVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 171
Query: 123 LGT--FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
L + F Y APE + + SDV+SFGV L ELLT
Sbjct: 172 LDSPVFWY-APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-14
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 31/211 (14%)
Query: 28 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 87
E+ GS D+L +PGP L Q I KGL+YLH + IHRDIK
Sbjct: 82 EYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSEKK---IHRDIK 128
Query: 88 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 147
++NVL+ + K+ADF ++ Q D ++ +GT + APE ++K+D++S
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 186
Query: 148 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMA 207
G+ +EL G P P L+ P E G+Y +
Sbjct: 187 LGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE------------GNYS----KPLK 230
Query: 208 AVAALCVQYEADFRPNMSIVVKALQPLLNAR 238
C+ E FRP ++K + A+
Sbjct: 231 EFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 48/179 (26%), Positives = 64/179 (35%), Gaps = 32/179 (17%)
Query: 1 MVSRLKHE---------NFVQLLGYCVDGTSRV-LAYEFASNGSLHDILH--GRKGVKGA 48
V ++ E +V L Y G + L E+ G L +L G
Sbjct: 36 QVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG------- 88
Query: 49 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS- 107
L LEYLH IIHRD+K N+LI + K+ DF LS
Sbjct: 89 ----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSK 141
Query: 108 -----NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
Q R++GT Y APE + + D +S G +L E L G P
Sbjct: 142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-14
Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 7/160 (4%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQ 58
++SRLK N ++LL C+ + E+ NG L+ L H + +S+
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARL 117
+ +A A G++YL + + +HRD+ + N L+ + KIADF +S N R+
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 118 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
VL + + E + G+ SDV++FGV L E+LT
Sbjct: 189 QGRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-14
Identities = 52/165 (31%), Positives = 76/165 (46%), Gaps = 25/165 (15%)
Query: 1 MVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
++S L HEN V LLG C G ++ E+ G L + L RK +LS+ +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQ 149
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL-------SNQAPD 112
V AKG+ +L K + IHRD+ + NVL+ + KI DF L SN
Sbjct: 150 V------AKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK 200
Query: 113 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
ARL + APE +SDV+S+G++L E+ +
Sbjct: 201 GNARL-------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-14
Identities = 48/134 (35%), Positives = 62/134 (46%), Gaps = 20/134 (14%)
Query: 28 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 87
EF GSL V P VL +IAV KGL YL I+HRD+K
Sbjct: 79 EFMDGGSLD--------VYRKIPEHVLG-----RIAVAVVKGLTYLWSL---KILHRDVK 122
Query: 88 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 147
SN+L+ K+ DF +S Q + A+ + +GT Y APE Q SDV+S
Sbjct: 123 PSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY----VGTNAYMAPERISGEQYGIHSDVWS 178
Query: 148 FGVVLLELLTGRKP 161
G+ +EL GR P
Sbjct: 179 LGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-14
Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 25/165 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L H VQL G C + EF NG L + L R+G +LS Q V
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLS--KDMLLSMCQDV--- 109
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
+G+EYL + IHRD+ + N L+ V K++DF ++ D
Sbjct: 110 ---CEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-------DEYT 156
Query: 124 GTFG------YHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ G + PE + ++KSDV+SFGV++ E+ T G+ P
Sbjct: 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-14
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 22/168 (13%)
Query: 1 MVSRLKHENFVQLL-GYCVDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQ 58
++S KH N V L Y + +L EF G+L I L +G+ Q V
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWIL-IEFCDGGALDSIMLELERGLTEPQIRYVCRQ-- 111
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
+ L +LH +IHRD+K+ N+L+ D K+ADF +S + +
Sbjct: 112 -------MLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161
Query: 119 STRVLGTFGYHAPEYAMTGQL-----NAKSDVYSFGVVLLELLTGRKP 161
+ +GT + APE + K+D++S G+ L+EL P
Sbjct: 162 T--FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-14
Identities = 57/220 (25%), Positives = 104/220 (47%), Gaps = 32/220 (14%)
Query: 11 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 70
V+++G C + + +L E AS G L+ L G+K ++ V++ + G+
Sbjct: 58 VRMIGVC-EAEALMLVMEMASGGPLNKFLSGKK--------DEITVSNVVELMHQVSMGM 108
Query: 71 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GY 128
+YL K + +HRD+ + NVL+ + AKI+DF LS +A + R G + +
Sbjct: 109 KYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLS-KALGADDSYYKARSAGKWPLKW 164
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVR 187
+APE + +++SDV+S+G+ + E + G+KP K+ +V
Sbjct: 165 YAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK----------------KMKGPEVM 208
Query: 188 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227
++ D P + +M A+ C Y+ + RPN + V
Sbjct: 209 SFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-14
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 29/171 (16%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+++RL H + +++LG + + L E+ + GS+ +L + G +++ V
Sbjct: 56 LMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS--------KYGA---FKEAV 104
Query: 61 KIAV--GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAA 115
I +GL YLHE IIHRD+K +N+LI D +IADF A +AA
Sbjct: 105 IINYTEQLLRGLSYLHEN---QIIHRDVKGANLLI--DSTGQRLRIADF---GAAARLAA 156
Query: 116 RLHST-----RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ ++LGT + APE Q DV+S G V++E+ T + P
Sbjct: 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-14
Identities = 50/170 (29%), Positives = 81/170 (47%), Gaps = 12/170 (7%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL-----HGRKGVKGAQPGPV-- 53
+++ L H N V LLG + +E+ + G LH+ L H G + G V
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 54 -LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 112
L + IA+ A G+EYL + +H+D+ + N+LI + KI+D LS +
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 113 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ L + PE M G+ ++ SD++SFGVVL E+ + G +P
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-14
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 25/200 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ L+H+ V+L ++ EF + GSL D L +G K QP P L +
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----I 105
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ A+G+ ++ ++ + IHRD++++N+L+ V KIADF L+ D ++
Sbjct: 106 DFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTA 159
Query: 121 RVLGTF--GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP--------VDHTLPRG 169
R F + APE G KSDV+SFG++L+E++T GR P V L RG
Sbjct: 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
Query: 170 QQSLVTWATPKLSEDKVRQC 189
+ P+ + + +C
Sbjct: 220 YRMPRPENCPEELYNIMMRC 239
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 30/173 (17%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 66
H ++L D + E+A NG L + L + A
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---------LDEKCTRFYAAEI 111
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF--------DLSNQAPDMAARLH 118
LEYLH K IIHRD+K N+L+ D KI DF + S ++ A
Sbjct: 112 LLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 119 STR----------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
++ +GT Y +PE SD+++ G ++ ++LTG+ P
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-13
Identities = 58/254 (22%), Positives = 104/254 (40%), Gaps = 41/254 (16%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR- 59
++ ++ H + ++L G C +L E+A GSL L + V P + S R
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKV---GPSYLGSDGNRN 112
Query: 60 -----------------VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 102
+ A ++G++YL E ++HRD+ + NVL+ + KI+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKIS 169
Query: 103 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
DF LS + + + ++ + A E +SDV+SFGV+L E++T G P
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
Query: 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFR 221
P +L+ R+ + P +M + C + E D R
Sbjct: 230 YPGIAPERLFNLLK--------------TGYRM--ERPENCSEEMYNLMLTCWKQEPDKR 273
Query: 222 PNMSIVVKALQPLL 235
P + + K L+ ++
Sbjct: 274 PTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-13
Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 33/232 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQR 59
++ +L H N ++ L ++ + E A G L I H +K K P + W+
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTI-WKYF 112
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
V++ LE++H K I+HRDIK +NV I V K+ D L HS
Sbjct: 113 VQLC----SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
++GT Y +PE N KSD++S G +L E+ + P + ++
Sbjct: 166 --LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLC 217
Query: 180 KLSEDKVRQCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIV 227
K K+ +C DYPP ++ + + C+ + + RP++S V
Sbjct: 218 K----KIEKC-------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-13
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 23/225 (10%)
Query: 11 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG-PVLSWQQRVKIAVGAAKG 69
V+LLG G ++ E ++G L L + PG P + Q+ +++A A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
+ YL+ K +HRD+ + N ++ D KI DF ++ + + L +
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 189
APE G SD++SFGVVL E+ SL LS ++V +
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKF 233
Query: 190 VDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
V GG D P ++ + +C Q+ RP +V L+
Sbjct: 234 VMD--GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 51/164 (31%), Positives = 87/164 (53%), Gaps = 13/164 (7%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+++++KH N V + + E+ G L ++ ++GV ++ +LSW V
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSW--FV 108
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHS 119
+I++G L+++H D I+HRDIKS N+ + + VAK+ DF ++ Q D + L
Sbjct: 109 QISLG----LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAY 160
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
T +GT Y +PE N K+D++S G VL EL T + P +
Sbjct: 161 T-CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-13
Identities = 46/165 (27%), Positives = 68/165 (41%), Gaps = 24/165 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV--LSWQQ 58
++ +L+HEN V L L +E+ +L ++L G G P V WQ
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPG--GLPPDAVRSYIWQ- 108
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
+ + Y H +IIHRDIK N+L+ + V K+ DF + A
Sbjct: 109 -------LLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-P 157
Query: 119 STRVLGTFGYHAPE----YAMTGQLNAKSDVYSFGVVLLELLTGR 159
T + T Y APE G DV++ G ++ ELL G
Sbjct: 158 LTDYVATRWYRAPELLVGDTNYG---KPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-13
Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 15/142 (10%)
Query: 25 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84
L E GS+ D++ G + +++ I +GL YLHE +IHR
Sbjct: 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-----ILRETLRGLAYLHEN---KVIHR 137
Query: 85 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE-----YAMTGQL 139
DIK N+L+ + K+ DF +S Q R ++ +GT + APE
Sbjct: 138 DIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGTPYWMAPEVIACDEQPDASY 195
Query: 140 NAKSDVYSFGVVLLELLTGRKP 161
+A+SDV+S G+ +EL G+ P
Sbjct: 196 DARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 17/164 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ L+HE VQ G D + + E+ GS+ D L G + R
Sbjct: 57 LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--------KAYGALTETVTR- 107
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
K +G+EYLH I+HRDIK +N+L K+ DF S + T
Sbjct: 108 KYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGT 162
Query: 121 ---RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
V GT + +PE K+DV+S G ++E+LT + P
Sbjct: 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-13
Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++S +KH N VQ + + + ++ G L+ ++ ++GV +L W V
Sbjct: 52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDW--FV 108
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+I + L+++H D I+HRDIKS N+ + D K+ DF + A L+ST
Sbjct: 109 QICLA----LKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGI-------ARVLNST 154
Query: 121 RVL-----GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
L GT Y +PE N KSD+++ G VL E+ T
Sbjct: 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 55/175 (31%), Positives = 79/175 (45%), Gaps = 47/175 (26%)
Query: 1 MVSRLKHENFVQ--------------LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK 46
++S+LKH N V ++G+C G D+ H K
Sbjct: 52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG----------------DLYHKLK--- 92
Query: 47 GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD- 105
Q G +L Q V+ V A L+YLHEK HI+HRD+K+ NV + ++ K+ D
Sbjct: 93 -EQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGI 148
Query: 106 ---LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
L NQ DMA+ L +GT Y +PE N KSDV++ G + E+ T
Sbjct: 149 ARVLENQC-DMASTL-----IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 25/176 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR------------KGVKGA 48
M SRL+H N V LLG + + + S+ LH+ L R K VK
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 49 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 108
V I A G+E+L + H++H+D+ + NVL+FD KI+D L
Sbjct: 121 LEPADF-----VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 109 Q--APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ A D + ++ L + +PE M G+ + SD++S+GVVL E+ + G +P
Sbjct: 173 EVYAADYYKLMGNS--LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-13
Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 28 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 87
E GSL +L K + P +L K+++ +GL YL EK I+HRD+K
Sbjct: 83 EHMDGGSLDQVLKEAKRI----PEEILG-----KVSIAVLRGLAYLREKH--QIMHRDVK 131
Query: 88 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 147
SN+L+ K+ DF +S Q D A +GT Y +PE + +SD++S
Sbjct: 132 PSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWS 187
Query: 148 FGVVLLELLTGRKPV 162
G+ L+EL GR P+
Sbjct: 188 MGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-13
Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 5 LKHENFVQLLGYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPV---LSWQQR 59
LKHEN V L+ ++ + L +++A + I R+ + + P + L WQ
Sbjct: 59 LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ-- 116
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSN--QAPDM 113
G+ YLH ++HRD+K +N+L+ + V KI D L+ AP +
Sbjct: 117 ------ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-L 166
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLT 157
V+ T Y APE + + K+ D+++ G + ELLT
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-13
Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 13/158 (8%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
L H V+LLG C G S L + + GSL D + + P +L+W V
Sbjct: 66 LDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLD--PQRLLNW------CV 116
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
AKG+ YL E ++HR++ + N+L+ D + +IADF +++ + +
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ A E + G+ +SDV+S+GV + E+++ G +P
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-13
Identities = 52/165 (31%), Positives = 76/165 (46%), Gaps = 17/165 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
MV KH N V G + + E+ GSL DI H GP LS Q
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH--------VTGP-LSELQIA 109
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ +GL YLH K +HRDIK +N+L+ D+ K+ADF ++ + A+ S
Sbjct: 110 YVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS- 165
Query: 121 RVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPV 162
+GT + APE A G N D+++ G+ +EL + P+
Sbjct: 166 -FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-13
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 31/231 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +L H N ++ L ++ + E A G L ++ K K P + W+ V
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFV 113
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
++ +E++H + ++HRDIK +NV I V K+ D L HS
Sbjct: 114 QLC----SAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS- 165
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
++GT Y +PE N KSD++S G +L E+ + P + +L +
Sbjct: 166 -LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSLC--- 217
Query: 181 LSEDKVRQCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIV 227
K+ QC DYPP K+ + ++C+ + D RP++ V
Sbjct: 218 ---QKIEQC-------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-13
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAV 64
+H N V++ + G + EF G+L DI+ H R ++ +Q + +
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCL 122
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
K L +LH + +IHRDIKS ++L+ D K++DF Q R S ++G
Sbjct: 123 AVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVG 177
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T + APE + D++S G++++E++ G P
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-13
Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 39/243 (16%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ + H N + L G ++ EF NG+L L G Q + Q V
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG----QFTVI----QLV 109
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ G A G++YL ++ + +HRD+ + N+L+ + V K++DF LS D + T
Sbjct: 110 GMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 166
Query: 121 RVLG---TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 176
LG + APE + + SDV+S+G+V+ E+++ G +P W
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-------------W 213
Query: 177 ATPKLSEDKVRQCVDARLGGDY----PPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
D Q V + DY P + + C Q + + RP +V L
Sbjct: 214 -------DMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
Query: 233 PLL 235
++
Sbjct: 267 KMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-13
Identities = 48/140 (34%), Positives = 69/140 (49%), Gaps = 18/140 (12%)
Query: 28 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 87
E+ GSL D L+ P VL +I KGL++L K + +IIHRD+K
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFL--KEEHNIIHRDVK 130
Query: 88 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA------ 141
+NVL+ + K+ DF +S + A L T + G Y APE +G N
Sbjct: 131 PTNVLVNGNGQVKLCDFGVSGN---LVASLAKTNI-GCQSYMAPERIKSGGPNQNPTYTV 186
Query: 142 KSDVYSFGVVLLELLTGRKP 161
+SDV+S G+ +LE+ GR P
Sbjct: 187 QSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-13
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 11 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 70
V+++G C + S +L E A G L+ L K V + ++ + G+
Sbjct: 59 VRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTE---------KNITELVHQVSMGM 108
Query: 71 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GY 128
+YL E + +HRD+ + NVL+ AKI+DF LS +A + + G + +
Sbjct: 109 KYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALGADENYYKAKTHGKWPVKW 164
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVR 187
+APE + ++KSDV+SFGV++ E + G+KP +G + ++V
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY-----KGMKG-----------NEVT 208
Query: 188 QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227
Q +++ + P + +M + LC Y D RP ++V
Sbjct: 209 QMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-13
Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
K+++ KGL YL EK I+HRD+K SN+L+ K+ DF +S Q D A
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 160
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 162
+GT Y +PE + +SD++S G+ L+E+ GR P+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-12
Identities = 51/180 (28%), Positives = 81/180 (45%), Gaps = 18/180 (10%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 65
KH N V L + G + E+ + GSL D++ +G Q +
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRE 123
Query: 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLG 124
+ LE+LH +IHRDIKS N+L+ D K+ DF Q P+ + R + ++G
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVG 177
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLSE 183
T + APE K D++S G++ +E++ G P + P R + T TP+L
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN 237
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 19/165 (11%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
LKH N V+ +D +++ L Y E+ G L ++ K + + W+ +
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQ 113
Query: 62 IAVGAAKGLEYLHEKADPH--IIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAAR 116
+ + L H ++DP ++HRD+K +N+ + ++ K+ DF L+ A
Sbjct: 114 LLLA----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA-- 167
Query: 117 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T V GT Y +PE + KSD++S G ++ EL P
Sbjct: 168 --KTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-12
Identities = 51/158 (32%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 5 LKHENFVQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
L+H+N V+ G C R L E+ GSL D L + + + + Q
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ----- 116
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
KG+EYL K +HRD+ + N+L+ ++ KI DF L+ P + R
Sbjct: 117 ---ICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVRE 169
Query: 123 LG---TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
G F Y APE + + SDV+SFGVVL EL T
Sbjct: 170 PGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-12
Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
G+E LH++ IIHRDIK N+LI K+ DF LS L + + +GT Y
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDY 159
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + + SD +S G V+ E L G P
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 21/163 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ L H N ++LL L +EF I ++G+ + L +Q
Sbjct: 51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYL-YQ--- 106
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLH- 118
+GL + H I+HRD+K N+LI + V K+ADF L+ + H
Sbjct: 107 -----LLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158
Query: 119 -STRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 159
TR Y APE + + D++S G + ELL+ R
Sbjct: 159 VVTR-----WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-12
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 15/147 (10%)
Query: 15 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74
G + GT + E+ GS D+L + GP +Q + KGL+YLH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL---------RAGPFDEFQIATMLK-EILKGLDYLH 118
Query: 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 134
+ IHRDIK++NVL+ + K+ADF ++ Q D ++ +GT + APE
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVI 173
Query: 135 MTGQLNAKSDVYSFGVVLLELLTGRKP 161
++K+D++S G+ +EL G P
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-12
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+++ + H + V+LLG C+ T + L + +G L D +H K G+Q +L+W
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL--LLNW---- 114
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
V AKG+ YL E+ ++HRD+ + NVL+ + KI DF L+ ++
Sbjct: 115 --CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP 179
+ A E + +SDV+S+GV + EL+T G KP D + T P
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--------GIPTREIP 221
Query: 180 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP 222
L E R PP + V C +AD RP
Sbjct: 222 DLLEKGERL--------PQPPICTIDVYMVMVKCWMIDADSRP 256
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-12
Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 15/147 (10%)
Query: 15 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74
G + GT + E+ GS D+L +PGP L I KGL+YLH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIATILREILKGLDYLH 118
Query: 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 134
+ IHRDIK++NVL+ + K+ADF ++ Q D ++ +GT + APE
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVI 173
Query: 135 MTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ K+D++S G+ +EL G P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 50/162 (30%), Positives = 73/162 (45%), Gaps = 24/162 (14%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
LKH N + LL ++ L +EF L ++ + V P + S+
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV--LTPADIKSYMLM----- 110
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
+GLEYLH I+HRD+K +N+LI D V K+ADF L+ R + +V+
Sbjct: 111 -TLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV- 164
Query: 125 TFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 161
T Y APE A+ D++S G + ELL R P
Sbjct: 165 TRWYRAPELLF----GARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 15/170 (8%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP--GPVLSWQQRV 60
SRL N +LLG C + E+ NG L+ L LS+ +
Sbjct: 74 SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLL 133
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+A A G+ YL + +HRD+ + N L+ + KIADF +S ++ + +
Sbjct: 134 YMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSSDYY- 186
Query: 121 RVLGT----FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRKPVDH 164
RV G + A E + G+ KSDV++FGV L E+LT +P +H
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-12
Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 18/183 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ LK+ N V L + G + E+ + GSL D++ + Q
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----------TETCMDEAQIA 118
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHS 119
+ + LE+LH +IHRDIKS NVL+ D K+ DF Q P+ + R
Sbjct: 119 AVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--- 172
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWAT 178
+ ++GT + APE K D++S G++ +E++ G P + P R + T T
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232
Query: 179 PKL 181
P+L
Sbjct: 233 PEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-12
Identities = 56/166 (33%), Positives = 80/166 (48%), Gaps = 32/166 (19%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH-GRKGVKGAQPGPVLSWQQRVKI 62
+L+H N ++ G + + L E+ GS DIL +K + Q V+I
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPL------------QEVEI 117
Query: 63 AV---GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF-DLSNQAPDMAARLH 118
A GA +GL YLH IHRDIK+ N+L+ + K+ADF S +P
Sbjct: 118 AAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP------- 167
Query: 119 STRVLGTFGYHAPE--YAM-TGQLNAKSDVYSFGVVLLELLTGRKP 161
+ +GT + APE AM GQ + K DV+S G+ +E L RKP
Sbjct: 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 53/188 (28%), Positives = 81/188 (43%), Gaps = 39/188 (20%)
Query: 73 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG----Y 128
+H H+IHRDIKS+N+L+ + + K+ DF S M A S V TF Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK----MYAATVSDDVGRTFCGTPYY 211
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ 188
APE + K+D++S GV+L ELLT ++P D E+ + +
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD------------------GEN-MEE 252
Query: 189 CVDARLGGDY---PPKAVAKMAAVAALCVQYEADFRP------NMSIV---VKALQPLLN 236
+ L G Y PP +M + + + RP NM I + L ++
Sbjct: 253 VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQ 312
Query: 237 ARPGPAGE 244
+PG +G
Sbjct: 313 TQPGFSGP 320
|
Length = 496 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-12
Identities = 54/163 (33%), Positives = 72/163 (44%), Gaps = 25/163 (15%)
Query: 4 RLKHENFVQLLGYCVDG--TSRVLAYEFASN--GSLHDILHGRKGVKGAQPGPVLSWQQR 59
L+H N V+L V S L E+ SL D + P P Q
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM----------PTPFSESQ-- 109
Query: 60 VK-IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
VK + + +GL+YLHE IIHRD+K SN+L+ D KIADF L+ A
Sbjct: 110 VKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--P 164
Query: 119 STRVLGTFGYHAPE--YAMTGQLNAKSDVYSFGVVLLELLTGR 159
T + T Y APE T A D+++ G +L ELL +
Sbjct: 165 MTPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-12
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 17/165 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ + H N + L G ++ E+ NGSL L G + Q V
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQLV 109
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ G A G++YL +D +HRD+ + N+L+ + V K++DF LS D ++T
Sbjct: 110 GMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166
Query: 121 RVLG---TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
R G + APE + + SDV+S+G+V+ E+++ G +P
Sbjct: 167 R--GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-12
Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 30/194 (15%)
Query: 1 MVSRLKH---ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 57
++S+L+ N + G + G + E+A GS+ ++ + GP+
Sbjct: 52 LLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPIAEKY 102
Query: 58 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 117
V I L+Y+H+ +IHRDIK++N+L+ + K+ DF + AA L
Sbjct: 103 ISV-IIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGV-------AALL 151
Query: 118 HSTR-----VLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPV-DHTLPRGQ 170
+ +GT + APE G+ + K+D++S G+ + E+ TG P D R
Sbjct: 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211
Query: 171 QSLVTWATPKLSED 184
+ P+L ++
Sbjct: 212 MLIPKSKPPRLEDN 225
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-12
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAV 64
+HEN V++ + G + EF G+L DI+ H R ++ +Q + +
Sbjct: 75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCL 123
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
K L LH + +IHRDIKS ++L+ D K++DF Q R S ++G
Sbjct: 124 AVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVG 178
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T + APE + D++S G++++E++ G P
Sbjct: 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-12
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 27/197 (13%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 65
K+ N V L + G + E+ + GSL D++ +G Q +
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRE 124
Query: 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLG 124
+ LE+LH +IHRDIKS N+L+ D K+ DF Q P+ + R + ++G
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVG 178
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKLS- 182
T + APE K D++S G++ +E++ G P + P R + T TP+L
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238
Query: 183 --------EDKVRQCVD 191
D + +C+D
Sbjct: 239 PEKLSAIFRDFLNRCLD 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-12
Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLA-YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
+RL H N V LL + A +E+ +L ++L A G L + +
Sbjct: 33 ARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL--------AADGA-LPAGETGR 83
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AKIADFDLSNQAPDM--AAR 116
+ + L H + I+HRD+K N+++ V AK+ DF + P + A
Sbjct: 84 LMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADV 140
Query: 117 LHSTR---VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 162
TR VLGT Y APE + SD+Y++G++ LE LTG++ V
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GLE+LH++ I++RD+K NVL+ D +I+D L A ++ GT GY
Sbjct: 107 GLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGL---AVELKGGKKIKGRAGTPGY 160
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + D ++ G L E++ GR P
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GL++LH K I++RD+K N+L+ D KIADF + + +M + GT Y
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKE--NMLGDAKTCTFCGTPDY 162
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + + N D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVG 65
HEN V + + G + EF G+L DI+ H R ++ +Q + +
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCLS 126
Query: 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 125
+ L YLH + +IHRDIKS ++L+ D K++DF Q + S ++GT
Sbjct: 127 VLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGT 181
Query: 126 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ APE + D++S G++++E++ G P
Sbjct: 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 13/151 (8%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN-QAPDMAARLHSTRVLGTF 126
+GL+YLH I+HRDIK N+L+ + V KI DF L+ + PD H T+ + T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQ 168
Query: 127 GYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT--WATPKLSE 183
Y APE M + + D++S G + ELL R P Q L+T TP L
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
Query: 184 DKVRQCVDAR---LGGDYPPKAVAKMAAVAA 211
+ C AR L G + P ++ + +++
Sbjct: 229 MR-SACEGARAHILRGPHKPPSLPVLYTLSS 258
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 24/168 (14%)
Query: 7 HENFVQLLG--YCVD---GTSRVLAYEFASNGSLHDILHG--RKGVKGAQPGPVLSWQQR 59
H N V+ G Y D G L E + GS+ +++ G G + + ++S+
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA--MISY--- 132
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
I GA GL++LH IIHRD+K +N+L+ + K+ DF +S Q + RL
Sbjct: 133 --ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRR 185
Query: 120 TRVLGTFGYHAPEYAMTGQ-----LNAKSDVYSFGVVLLELLTGRKPV 162
+GT + APE Q +A+ DV+S G+ +EL G P+
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 31/167 (18%)
Query: 5 LKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
L H+N + +L C+ DG + Y + + G+L L + A LS QQ V +A
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG-EANNPQALSTQQLVHMA 123
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
+ A G+ YLH++ +IH+DI + N +I ++ KI D LS R L
Sbjct: 124 IQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALS-------------RDL 167
Query: 124 GTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT 157
YH A E + + ++ SDV+SFGV+L EL+T
Sbjct: 168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GL++LH+K II+RD+K NVL+ D KIADF + + +M ++ GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDY 162
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + N D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-11
Identities = 42/114 (36%), Positives = 63/114 (55%), Gaps = 19/114 (16%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN-QAPDMAARLHSTRVLGTF 126
+GL+Y+H ++HRD+K SN+LI ++ KI DF L+ Q P M + STR
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV-STRY---- 170
Query: 127 GYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPV----DHTLPRGQQSLVT 175
Y APE +T Q + + D++S G + E+L G KP+ DH Q S++T
Sbjct: 171 -YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHV---NQFSIIT 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-11
Identities = 45/167 (26%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ + H N ++L G ++ E+ NG+L L G S Q V
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQLV 110
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ G A G++YL +D + +HRD+ + N+L+ + K++DF LS D ++T
Sbjct: 111 GMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT 167
Query: 121 RVLGTFG-----YHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ G + APE + + SDV+SFG+V+ E+++ G +P
Sbjct: 168 ----SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-11
Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 7/102 (6%)
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
A GL++LHE+ II+RD+K NVL+ + KIADF + + + + ++
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG--ILGGVTTSTF 156
Query: 123 LGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVD 163
GT Y APE ++ Q + D ++ GV+L E+L G+ P +
Sbjct: 157 CGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 5e-11
Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 18/178 (10%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 65
K+ N V L + G + E+ + GSL D++ +G Q +
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRE 123
Query: 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLG 124
+ L++LH +IHRDIKS N+L+ D K+ DF Q P+ + R + ++G
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVG 177
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATPKL 181
T + APE K D++S G++ +E++ G P + P R + T TP+L
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-11
Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 5 LKHENFVQLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
H N ++L+G C + +S ++ F +G LH L + + P+ Q
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL---QT 114
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAAR 116
+K V A G+EYL + + IHRD+ + N ++ +D +ADF LS + + D +
Sbjct: 115 LLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ 171
Query: 117 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
++ + A E +KSDV++FGV + E+ T G+ P
Sbjct: 172 GRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-11
Identities = 55/231 (23%), Positives = 98/231 (42%), Gaps = 31/231 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +L H N ++ ++ + E A G L ++ K K P + W+ V
Sbjct: 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-WKYFV 113
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
++ LE++H + ++HRDIK +NV I V K+ D L HS
Sbjct: 114 QLC----SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS- 165
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
++GT Y +PE N KSD++S G +L E+ + P + +L +
Sbjct: 166 -LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK-- 218
Query: 181 LSEDKVRQCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIV 227
K+ QC DYPP ++ + +C+ + + RP+++ V
Sbjct: 219 ----KIEQC-------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-11
Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 28/166 (16%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
+ +LKH N ++ G + + L E+ GS D+L K P+ Q V+
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK-------PL----QEVE 122
Query: 62 IAV---GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
IA GA +GL YLH +IHRDIK+ N+L+ + K+ADF ++++
Sbjct: 123 IAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ 173
Query: 119 STRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKP 161
+ +GT + APE + GQ + K DV+S G+ +E L RKP
Sbjct: 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 8e-11
Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFA-SNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAV 64
H N ++L+ D + LA F + +L++++ GRK +P P ++RVK
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK-----RPLP----EKRVKSYMY 107
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
K L+++H I HRDIK N+LI DD+ K+ADF + ++ T +
Sbjct: 108 QLLKSLDHMHRNG---IFHRDIKPENILI-KDDILKLADF---GSCRGIYSKPPYTEYIS 160
Query: 125 TFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLT 157
T Y APE +T G K D+++ G V E+L+
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-11
Identities = 42/158 (26%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
H + V+L+G + ++ E A G L L K L + +
Sbjct: 64 FDHPHIVKLIGVITENPVWIV-MELAPLGELRSYLQVNKYS--------LDLASLILYSY 114
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
+ L YL K +HRDI + NVL+ D K+ DF LS + + + +++
Sbjct: 115 QLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS-RYLEDESYYKASKGKL 170
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ APE + + SDV+ FGV + E+L G KP
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-11
Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 29/221 (13%)
Query: 12 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 71
+LLG C+ T + L + G L D + K G+Q +L+W V AKG+
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQD--LLNW------CVQIAKGMS 123
Query: 72 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 131
YL E ++HRD+ + NVL+ + KI DF L+ H+ + A
Sbjct: 124 YLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 132 EYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV 190
E + + +SDV+S+GV + EL+T G KP D R P L E R
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGERL-- 230
Query: 191 DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231
PP + + C +++ RP +V
Sbjct: 231 ------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-11
Identities = 44/119 (36%), Positives = 56/119 (47%), Gaps = 24/119 (20%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 125
G+ YLH + HI+HRDIK SN+LI KIADF +S Q D +GT
Sbjct: 180 GIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC-----NSSVGT 231
Query: 126 FGYHAPEYAMTGQLNA------KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
Y +PE T LN D++S GV +LE GR P G+Q WA+
Sbjct: 232 IAYMSPERINT-DLNHGAYDGYAGDIWSLGVSILEFYLGRFP----FGVGRQG--DWAS 283
|
Length = 353 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
++ + H + +++ V G T VL + + L+ L R L Q
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPH---YSSDLYTYLTKRSRP--------LPIDQ 158
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
+ I +GL YLH + IIHRD+K+ N+ I D D I D + Q P +A
Sbjct: 159 ALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA-QFPVVAPAFL 214
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156
+ GT +APE + N+K+D++S G+VL E+L
Sbjct: 215 G--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-10
Identities = 53/167 (31%), Positives = 84/167 (50%), Gaps = 27/167 (16%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
+ R+KH N ++ G + + L E+ GS D+L K P+ Q V+
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK-------PL----QEVE 126
Query: 62 IAV---GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
IA GA +GL YLH ++IHRDIK+ N+L+ + K+ADF + +A+ +
Sbjct: 127 IAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG----SASIASPAN 179
Query: 119 STRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPV 162
S +GT + APE + GQ + K DV+S G+ +EL + P+
Sbjct: 180 S--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+++ + + + +LLG C+ T +++ + G L D + K G+Q +L+W
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW---- 114
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
V AKG+ YL E+ ++HRD+ + NVL+ KI DF L+ H+
Sbjct: 115 --CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 163
+ A E + +SDV+S+GV + EL+T G KP D
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 8/140 (5%)
Query: 25 LAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGA-AKGLEYLHEKADPHI 81
L Y F + G L+ IL +G + V+ ++ VK + A L++LH I
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---I 119
Query: 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA 141
I+RD+K N+L+ ++ K+ DF LS ++ D + +S GT Y APE
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQ 177
Query: 142 KSDVYSFGVVLLELLTGRKP 161
+D +SFGV++ E+LTG P
Sbjct: 178 SADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 23/225 (10%)
Query: 11 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL-SWQQRVKIAVGAAKG 69
V+LLG G ++ E + G L L + P S ++ +++A A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
+ YL+ +HRD+ + N ++ +D KI DF ++ + + L +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC 189
+PE G SDV+SFGVVL E+ T L +S ++V +
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGMSNEQVLRF 233
Query: 190 VDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
V GG D P + + +C QY RP+ ++ +++
Sbjct: 234 VME--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-10
Identities = 42/160 (26%), Positives = 65/160 (40%), Gaps = 14/160 (8%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
L H N +Q LG C++ +L EF G L + L +G+ + QR +A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQR--MAC 107
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
A GL +LH+ IH D+ N + D KI D+ L+ + +
Sbjct: 108 EVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV 164
Query: 125 TFGYHAPEYA-------MTGQLNAKSDVYSFGVVLLELLT 157
+ APE + KS+++S GV + EL T
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 11/94 (11%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHSTRVLGTF 126
+GL+Y+H IIHRD+K SN+ + +D KI DF L+ D M T + T
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATR 179
Query: 127 GYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 159
Y APE + N D++S G ++ ELLTG+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-10
Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 23/167 (13%)
Query: 7 HENFVQLLGYCVDGTSR------VLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQR 59
H N ++L+G C+ V+ F +G LH +L+ R G P L Q
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG---DCP-QYLPTQML 114
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD----MAA 115
VK A G+EYL K IHRD+ + N ++ ++ +ADF LS + +
Sbjct: 115 VKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG 171
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
R+ V + A E KSDV+SFGV + E+ T G+ P
Sbjct: 172 RIAKMPV----KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GL Y H+K + +HRDIK SN+L+ + K+ADF L+ +R ++ +V+ T Y
Sbjct: 128 GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWY 183
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 162
PE + + + DV+S G +L EL T +KP+
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 15/102 (14%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---------SNQAPDMAARLHS 119
G+ YLHE HI+HRDIK++N+LI + + KIADF L + +
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKS--DVYSFGVVLLELLTGR 159
T ++ T Y PE + G+ + D++ G V E+ T R
Sbjct: 184 TNLVVTRWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-10
Identities = 51/176 (28%), Positives = 74/176 (42%), Gaps = 46/176 (26%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL----HG--RKGVKGAQPGPVL 54
++ H N + LLG C+ S GS +L HG R ++ P
Sbjct: 49 IMKDFSHPNVLSLLGICLP-----------SEGSPLVVLPYMKHGDLRNFIRSETHNPT- 96
Query: 55 SWQQRVKIAVG----AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110
VK +G AKG+EYL K +HRD+ + N ++ + K+ADF L+
Sbjct: 97 -----VKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI 148
Query: 111 PD---------MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
D A+L + A E T + KSDV+SFGV+L EL+T
Sbjct: 149 YDKEYYSVHNHTGAKL-------PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 26/145 (17%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+GL+Y+H AD IIHRD+K SN+ + +D KI DF L+ D T + T
Sbjct: 131 RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 182
Query: 128 YHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 186
Y APE + N D++S G ++ ELLTGR TL G + D++
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-----TLFPGTDHI----------DQL 227
Query: 187 RQCVDARLGGDYPPKAVAKMAAVAA 211
+ + RL G + + K+++ +A
Sbjct: 228 KLIL--RLVGTPGAELLKKISSESA 250
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 40/98 (40%), Positives = 57/98 (58%), Gaps = 9/98 (9%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 125
GL+Y+H A+ ++HRD+K N+L+ D KI DF L+ ++ P A T + T
Sbjct: 117 GLKYIHS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG-FMTEYVAT 172
Query: 126 FGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 162
Y APE ++ Q K+ DV+S G +L ELL GRKPV
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 24/173 (13%)
Query: 7 HENFVQLLGY-----CVDGTSRVLAYEFASNGSLHDILHG--RKGVKGAQPGPVLSWQQR 59
H N V+ G +G L E + GS+ D++ G ++G + +P ++++
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP--IIAY--- 128
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
I A GL++LH IHRD+K +N+L+ + K+ DF +S Q + RL
Sbjct: 129 --ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRR 181
Query: 120 TRVLGTFGYHAPEY-AMTGQL----NAKSDVYSFGVVLLELLTGRKPVDHTLP 167
+GT + APE A QL +A+ DV+S G+ +EL G P+ P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 44/183 (24%)
Query: 1 MVSRLKHENFVQLLGYC---VDGTSR-----VLAYEFASNGSLHDILHGRKGVKGAQPGP 52
++ LKHEN V L+ C +R L +EF HD L G
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE----HD-LAG----------- 107
Query: 53 VLSWQQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 104
L + VK + K GL Y+H I+HRD+K++N+LI D + K+ADF
Sbjct: 108 -LLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163
Query: 105 DLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN--AKSDVYSFGVVLLELLTGR 159
L+ + + + ++ RV+ T Y PE + G+ + D++ G ++ E+ T R
Sbjct: 164 GLARAFSLSKNSKPNRYTNRVV-TLWYRPPEL-LLGERDYGPPIDMWGAGCIMAEMWT-R 220
Query: 160 KPV 162
P+
Sbjct: 221 SPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-10
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GL++LH K II+RD+K NV++ D KIADF + + ++ ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPDY 162
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 17/160 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M+ +L+HEN V L+ L +EF + L D+ G L +
Sbjct: 53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---------LDESRVR 103
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS- 119
K +G+E+ H +IIHRDIK N+L+ V K+ DF A +AA
Sbjct: 104 KYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF---ARTLAAPGEVY 157
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTG 158
T + T Y APE + ++ D+++ G ++ E+LTG
Sbjct: 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-10
Identities = 36/99 (36%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL--SNQAPDMAARLHSTRVLG 124
A GL +LH K II+RD+K NV++ + KIADF + N R G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----TFCG 163
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
T Y APE D ++FGV+L E+L G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 6e-10
Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
EYLH + II+RD+K N+L+ + K+ DF + + + + GT Y
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-GQKTWT--FCGTPEYV 159
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + + D +S G++L ELLTGR P
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 6e-10
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTF 126
+GL+YLH ++IHRD+K SN+L+ + KI DF L+ PD + T + T
Sbjct: 114 RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 127 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
Y APE ++ K+ D++S G + ELLT +
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-10
Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 35/180 (19%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMA----ARLHS 119
A+G+E+L A IHRD+ + N+L+ +++V KI DF L+ + PD ARL
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 178
+ APE +SDV+SFGV+L E+ + G P +
Sbjct: 238 -----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP--------------YPG 278
Query: 179 PKLSEDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
++ E+ R+ + R+ P A ++ ++ C + RP S +V+ L LL
Sbjct: 279 VQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-10
Identities = 39/171 (22%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 1 MVSRLKHENFVQLLGY---CVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 56
+ R+ N +++ G+ VD R+ L E+ + G L ++L K LS+
Sbjct: 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---------LSF 121
Query: 57 QQRVKIAVGAAKGLEYLHEKAD-PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 115
+ ++ +A+ KGL L++ + P ++++ S + L+ ++ KI L + +
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEK----ILS 174
Query: 116 RLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDH 164
V Y + + + K D+YS GVVL E+ TG+ P ++
Sbjct: 175 SPPFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-10
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 66
H N V+L G G + ++ E+ SNG+L L +G L Q + + G
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--------LVAGQLMGMLPGL 116
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 126
A G++YL E +H+ + + VL+ D V KI+ F Q A +
Sbjct: 117 ASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR-RLQEDKSEAIYTTMSGKSPV 172
Query: 127 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ APE ++ SDV+SFG+V+ E+++ G +P
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-10
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 65
+H+N V++ + G + EF G+L DI+ + L+ +Q +
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCES 125
Query: 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLG 124
+ L YLH + +IHRDIKS ++L+ D K++DF Q + D+ R ++G
Sbjct: 126 VLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVG 179
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T + APE + D++S G++++E++ G P
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-10
Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 33/168 (19%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
M+ +LKH N V L+ V R L +E+ + L+++ +GV
Sbjct: 53 MLKQLKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPE---------HL 101
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
KI + + + H+ + IHRD+K N+LI K+ DF AR+
Sbjct: 102 IKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF--------ARIL 150
Query: 119 S------TRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTG 158
+ T + T Y APE + G Q DV++ G V ELLTG
Sbjct: 151 TGPGDDYTDYVATRWYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 140
++HRD+KS+N+ + + K+ DF S Q D + ++ GT Y APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 141 AKSDVYSFGVVLLELLTGRKP 161
K+D++S GV+L ELLT +P
Sbjct: 250 KKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
+ +L+H N +Q G + + L E+ GS D+L K +P L +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-----KP---LQEVEIAA 119
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF-DLSNQAPDMAARLHST 120
+ GA +GL YLH ++IHRD+K+ N+L+ + + K+ DF S AP +
Sbjct: 120 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------AN 169
Query: 121 RVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKP 161
+GT + APE + GQ + K DV+S G+ +E L RKP
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 16/105 (15%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS------------NQAPDMAA 115
GL LH+ + +HRD+ +N+ I + KIADF L+ ++ M
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 116 RLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 159
R T + T Y APE M + + D++S G + ELLTG+
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 17/157 (10%)
Query: 25 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ-----RVKIAVGA-AKGLEYLHEKAD 78
L Y F ++ LH IL V G + L ++ V++ + L++LH+
Sbjct: 70 LHYAFQTDTKLHLIL---DYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG- 125
Query: 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 137
II+RDIK N+L+ + + DF LS + + R +S GT Y APE G
Sbjct: 126 --IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEYMAPEVIRGG 181
Query: 138 QL--NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 172
+ D +S GV+ ELLTG P + QS
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-09
Identities = 42/143 (29%), Positives = 67/143 (46%), Gaps = 17/143 (11%)
Query: 25 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84
L EF GS+ D++ KG L + I +GL +LH+ +IHR
Sbjct: 86 LVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQH---KVIHR 135
Query: 85 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-----L 139
DIK NVL+ ++ K+ DF +S Q R ++ +GT + APE +
Sbjct: 136 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATY 193
Query: 140 NAKSDVYSFGVVLLELLTGRKPV 162
+ KSD++S G+ +E+ G P+
Sbjct: 194 DFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 49/191 (25%), Positives = 73/191 (38%), Gaps = 47/191 (24%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQ-R 59
+ L H L Y T L ++ G L +L QPG LS + R
Sbjct: 56 ATLDHPFLPTL--YASFQTETYLCLVMDYCPGGELFRLLQ-------RQPGKCLSEEVAR 106
Query: 60 VKIA-VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-------- 110
A V A LEYLH I++RD+K N+L+ + ++DFDLS Q+
Sbjct: 107 FYAAEVLLA--LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 111 -------PDMAARLHSTRVL------------GTFGYHAPEYAMTGQ-LNAKSDVYSFGV 150
+ + GT Y APE ++G + D ++ G+
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGI 220
Query: 151 VLLELLTGRKP 161
+L E+L G P
Sbjct: 221 LLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-09
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
L YLH+ + I+HRD+ +N+++ +DD I DF L+ Q + T V+GT Y
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
PE K+DV++FG +L ++ T + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 27/177 (15%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHSTRVL 123
A+G+E+L A IHRD+ + N+L+ +++V KI DF L+ + PD R S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARL- 238
Query: 124 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS 182
+ APE +SDV+SFGV+L E+ + G P + +++
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP--------------YPGVQIN 283
Query: 183 EDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238
E+ ++ D R+ P A ++ + C Q + RP S +V+ L LL
Sbjct: 284 EEFCQRLKDGTRMRA--PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-09
Identities = 41/164 (25%), Positives = 81/164 (49%), Gaps = 14/164 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ L H N ++ ++ + ++ E+A G+L + + R +L + ++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQI 110
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHS 119
+A L ++H K I+HRD+K+ N+L+ V KI DF +S ++++ +
Sbjct: 111 LLA------LHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKA 158
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
V+GT Y +PE N KSD+++ G VL EL + ++ +
Sbjct: 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 52 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 111
P LS+ V + A G+E+L K + +HRD+ + NVLI + + KI DF L+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 112 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
+ + + APE SDV+SFG++L E+ T
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+GL+Y+H IIHRD+K SNV + +D +I DF L+ QA D T + T
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRW 180
Query: 128 YHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 159
Y APE + N D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 45/155 (29%), Positives = 71/155 (45%), Gaps = 15/155 (9%)
Query: 10 FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 68
F+ L C R+ E+ + G L + H ++ K +P Q V A +
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEP-------QAVFYAAEISV 112
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GL +LH + II+RD+K NV++ + KIADF + + M + + GT Y
Sbjct: 113 GLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTFCGTPDY 167
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
APE D +++GV+L E+L G+ P D
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-09
Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 26/168 (15%)
Query: 1 MVSRLKHENFVQLL-GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
+++++KH N V + DG ++ E+ G L + ++G K +L W +
Sbjct: 51 LLAKMKHPNIVAFKESFEADGHLYIVM-EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQ 108
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
+ + V +++HEK ++HRDIKS N+ + + K+ DF +ARL +
Sbjct: 109 MCLGV------QHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFG--------SARLLT 151
Query: 120 TRV------LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ +GT Y PE N KSD++S G +L EL T + P
Sbjct: 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-09
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-VLGTFG 127
GLE+LH++ II+RD+K NVL+ +D +I+D L A ++ T+ GT G
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGL---AVELKDGQSKTKGYAGTPG 162
Query: 128 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ APE + + D ++ GV L E++ R P
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 4e-09
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 27/161 (16%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 65
+H N V+L + +E+ G+L+ ++ RKG + S ++
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKP-FSESVIRSIIYQI----- 108
Query: 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 125
+GL ++H+ HRD+K N+L+ +V KIADF L A ++ +R T + T
Sbjct: 109 -LQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGL---AREIRSRPPYTDYVST 161
Query: 126 FGYHAPE-------YAMTGQLNAKSDVYSFGVVLLELLTGR 159
Y APE Y ++ D+++ G ++ EL T R
Sbjct: 162 RWYRAPEILLRSTSY------SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 45/161 (27%), Positives = 67/161 (41%), Gaps = 17/161 (10%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ +H V L C V E+A+ G L ++H V S + V
Sbjct: 56 ANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDV--------FSEPRAV 104
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
A GL+YLHE I++RD+K N+L+ + KIADF L + M ++
Sbjct: 105 FYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE--GMGFGDRTS 159
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT + APE D + GV++ E+L G P
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 4e-09
Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
G+ +LH+ I+HRD+K+SN+L+ + + KI DF L+ + T+++ T Y
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWY 172
Query: 129 HAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKPV 162
APE + + + D++S G + ELLT +KP+
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-09
Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 38/237 (16%)
Query: 1 MVSRLKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
++S+L H++ V+L G CV D V E+ G L LH K L W +
Sbjct: 54 LMSQLSHKHLVKLYGVCVRDENIMVE--EYVKFGPLDVFLHREKN------NVSLHW--K 103
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI--FDDDVAKIADFDLSNQAPDMAARL 117
+ +A A L YL +K ++H ++ N+L+ + + + LS+ +
Sbjct: 104 LDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160
Query: 118 HSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV 174
RV + APE GQ L +D +SFG LLE+ + G +P+
Sbjct: 161 REERVERI-PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL------------ 207
Query: 175 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231
+T SE + + P A++A + C Y+ RP+ +++ L
Sbjct: 208 --STLSSSEKERFY----QDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 21/102 (20%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-------- 119
+GL+Y+H A+ ++HRD+K SN+L+ + KI DF L AR+
Sbjct: 117 RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGL--------ARIADPEHDHTGF 165
Query: 120 -TRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
T + T Y APE + + K+ D++S G +L E+L+ R
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-09
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG--SLHDILHGRKGVKGAQPGPVLSWQQ 58
++ LKHEN V+L +L +E+ D HG +G P V S+
Sbjct: 51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDT-HGVRG--ALDPNTVKSFTY 107
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
++ KG+ + HE ++HRD+K N+LI K+ADF L+ +A +
Sbjct: 108 QL------LKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA-RAFGIPVNTF 157
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
S V+ T Y AP+ + + + S D++S G ++ E++TGR
Sbjct: 158 SNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-09
Identities = 48/164 (29%), Positives = 71/164 (43%), Gaps = 15/164 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
++ L+HE VQ G D + L E+ GS+ D L GA V
Sbjct: 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYT 112
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
R + +G+ YLH I+HRDIK +N+L K+ DF S + +
Sbjct: 113 RQIL-----EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT 164
Query: 119 STR-VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
R V GT + +PE K+DV+S G ++E+LT + P
Sbjct: 165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 8e-09
Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 30/198 (15%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHSTRVLG 124
+GL+Y+H A+ +IHRD+K SN+L+ +D +I DF ++ +P T +
Sbjct: 118 RGLKYIHS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY-FMTEYVA 173
Query: 125 TFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRK---PVDHTLPRGQQSLVTWATP- 179
T Y APE ++ + D++S G + E+L GR+ P + + + + L +P
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILSVLGSPS 232
Query: 180 -----KLSEDKVRQCVDARLGGDYP-------PKAVAKMAAVAALCVQYEADFRPNMSIV 227
++ D+VR+ + L P PKA + + + +Q++ + R V
Sbjct: 233 EEVLNRIGSDRVRKYIQN-LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT---V 288
Query: 228 VKALQ-PLLNARPGPAGE 244
+ALQ P L P E
Sbjct: 289 EQALQHPFLAQYHDPDDE 306
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-09
Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 25 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84
L EF GS+ D++ KG L I +GL +LH +IHR
Sbjct: 96 LVMEFCGAGSVTDLVKNTKG-------NALKEDWIAYICREILRGLAHLHAH---KVIHR 145
Query: 85 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-----L 139
DIK NVL+ ++ K+ DF +S Q R ++ +GT + APE +
Sbjct: 146 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATY 203
Query: 140 NAKSDVYSFGVVLLELLTGRKPV 162
+ +SD++S G+ +E+ G P+
Sbjct: 204 DYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-09
Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++S+L H V+ ++ + + E+ L L K G LS Q
Sbjct: 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELK-----HTGKTLSENQVC 109
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ + G+ Y+H++ I+HRD+K+ N+ + +++ KI DF +S M + +T
Sbjct: 110 EWFIQLLLGVHYMHQR---RILHRDLKAKNIFL-KNNLLKIGDFGVSRLL--MGSCDLAT 163
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155
GT Y +PE ++KSD++S G +L E+
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 17/99 (17%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----TRV 122
+G+++LH I+HRD+K N+L+ D KIADF L AR++S T V
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL--------ARIYSFEMALTSV 166
Query: 123 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ T Y APE + D++S G + EL R+P
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 18/103 (17%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMA----ARLHS 119
AKG+E+L A IHRD+ + N+L+ +++V KI DF L+ + PD ARL
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ APE +SDV+SFGV+L E+ + G P
Sbjct: 244 -----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 49/146 (33%), Positives = 70/146 (47%), Gaps = 17/146 (11%)
Query: 25 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR-----VKIAVGA-AKGLEYLHEKAD 78
L Y F ++ LH IL + G + LS ++R V+I G LE+LH+
Sbjct: 70 LHYAFQTDTKLHLIL---DYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG- 125
Query: 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 137
II+RDIK N+L+ + + DF LS + D R +S GT Y AP+ G
Sbjct: 126 --IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTIEYMAPDIVRGG 181
Query: 138 QL--NAKSDVYSFGVVLLELLTGRKP 161
+ D +S GV++ ELLTG P
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GLE LH++ I++RD+K N+L+ D +I+D L+ P+ + RV GT GY
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 167
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + D ++ G +L E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-08
Identities = 60/237 (25%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M+S+L H++ V G CV G ++ E+ GSL L K + SW+ V
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI------SWKLEV 105
Query: 61 KIAVGAAKGLEY-LHEKADPHIIHRDIKSSNVLIFDDDVAKIAD---FDLSNQAPDMAAR 116
AK L + LH D + H ++ + NVL+ ++ K + LS+ +
Sbjct: 106 ------AKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV- 158
Query: 117 LHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTG-RKPVDHTLPRGQQSLV 174
L +L + PE Q L+ +D +SFG L E+ +G KP+
Sbjct: 159 LPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS----------- 207
Query: 175 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231
L K Q + R P ++A + C+ YE DFRP+ +++ L
Sbjct: 208 -----ALDSQKKLQFYEDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GLE LH + + ++RD+K N+L+ D +I+D L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVGY 167
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + D + G ++ E++ G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 20/140 (14%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
LE+LH++ II+RD+K N+L+ K+ DF L ++ H+ GT Y
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYM 167
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTG---------RKPVDHTLPRGQQSLVTWATPK 180
APE M D +S G ++ ++LTG +K +D L +G+ +L + TP+
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-KGKLNLPPYLTPE 226
Query: 181 LSEDKVRQC----VDARLGG 196
+ D +++ +RLG
Sbjct: 227 -ARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 36/103 (34%), Positives = 53/103 (51%), Gaps = 18/103 (17%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL-------SNQAPDMAARLHS 119
A+G+++L K + IHRD+ + NVL+ D VAKI DF L SN ARL
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL-- 276
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ APE +SDV+S+G++L E+ + G+ P
Sbjct: 277 -----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+ L+YLH IIHRD+K+ NVL+ D K+ADF +S + R S +GT
Sbjct: 121 EALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPY 175
Query: 128 YHAPEYAMTGQL-----NAKSDVYSFGVVLLEL 155
+ APE M + + K+D++S G+ L+E+
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 33/125 (26%), Positives = 54/125 (43%), Gaps = 29/125 (23%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVL--------IFDDDVAKIADF---DLSNQAPDMAARL 117
+EY+H K ++HRD+K N+L I D A DL + D
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 118 HST-----RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT---------GRK-PV 162
+S+ +++GT Y APE + + +D+Y+ GV+L ++LT GRK
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241
Query: 163 DHTLP 167
+
Sbjct: 242 RDVIL 246
|
Length = 932 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-08
Identities = 30/95 (31%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSN-QAPDMAARLHSTRVLGT 125
+GL+Y+H +++HRD+K +NV I +D V KI DF L+ P + + + + L T
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 126 FGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
Y +P ++ K+ D+++ G + E+LTG+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 13/99 (13%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---SNQAPDMAARLHSTRVLG 124
+GL+Y+H +++HRD+K SN+L+ + KI DF L +++ D TR
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR--- 172
Query: 125 TFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPV 162
Y APE + + DV+S G + ELL GRKP+
Sbjct: 173 --WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 6e-08
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 19/102 (18%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---------SNQAPDMAARLH 118
K L+Y+H ++IHRD+K SN+L+ D K+ADF L + + P +
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL----- 169
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
T + T Y APE + K D++S G +L E+L G+
Sbjct: 170 -TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-08
Identities = 49/166 (29%), Positives = 71/166 (42%), Gaps = 19/166 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
++ L HE VQ G D R L+ E GS+ D L GA L+
Sbjct: 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY----GA-----LTENV 107
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
K +G+ YLH I+HRDIK +N+L K+ DF S + + L
Sbjct: 108 TRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC--LS 162
Query: 119 ST---RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T V GT + +PE K+D++S G ++E+LT + P
Sbjct: 163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-08
Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 16/98 (16%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHSTRVLG 124
GLE++H + +++RD+K +N+L+ + +I+D D S + P H++ +G
Sbjct: 109 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS--VG 157
Query: 125 TFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKP 161
T GY APE G ++ +D +S G +L +LL G P
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-08
Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 10/93 (10%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+ L YLHE IIHRD+K+ N+L D K+ADF +S + R S +GT
Sbjct: 114 EALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPY 168
Query: 128 YHAPEYAMTGQ-----LNAKSDVYSFGVVLLEL 155
+ APE M + K+DV+S G+ L+E+
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-08
Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+GL Y H++ I+HRD+K N+LI + K+ADF L+ +A + + +S V+ T
Sbjct: 114 RGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVV-TLW 168
Query: 128 YHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 159
Y P+ + + + + D++ G +L E+ TGR
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 5/101 (4%)
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
A A GL +LH K II+RD+K NV++ + KIADF + + +M + +
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTF 161
Query: 123 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
GT Y APE D ++FGV+L E+L G+ P +
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
KGL+Y+H IIHRD+K N+ + +D KI DF L+ Q TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 128 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR---KPVDH 164
Y APE + ++ D++S G ++ E+LTG+ K DH
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
L+H N V L + + L +EF S L L + V S+ ++
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI---- 110
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
+G+ + H + ++HRD+K N+LI + V K+ADF L+ +A + R+++ V+
Sbjct: 111 --LQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVYTHEVV- 163
Query: 125 TFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 164
T Y APE + + D++S G + E+ T +KP+ H
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 16/98 (16%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHSTRVLG 124
GLE++H + +++RD+K +N+L+ + +I+D D S + P H++ +G
Sbjct: 109 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS--VG 157
Query: 125 TFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 161
T GY APE G ++ +D +S G +L +LL G P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 31/91 (34%), Positives = 44/91 (48%), Gaps = 8/91 (8%)
Query: 71 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 130
EYLH K II+RD+K N+L+ + K+ DF + + PD L GT Y A
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----CGTPEYLA 183
Query: 131 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
PE + D ++ GV+L E + G P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 13/159 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M+ LK EN V+L L +E+ L + + G P V S+ ++
Sbjct: 53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQL 109
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
K + + H+ I+HRDIK N+LI +DV K+ DF + + + + T
Sbjct: 110 ------IKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYT 159
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159
+ T Y +PE + D++S G +L EL G+
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 15/155 (9%)
Query: 10 FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 68
F+ L C TSR+ L E+ + G L + H ++ K L + A
Sbjct: 57 FLVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRK-------LPEEHARFYAAEICI 107
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L +LHE+ II+RD+K NVL+ D K+ D+ + + + ++ GT Y
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNY 162
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
APE + D ++ GV++ E++ GR P D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
KGL + H +++HRD+K N+LI + K+ADF L+ +A + R +S V+ T
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLW 164
Query: 128 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 162
Y P+ +L + S D++S G + EL +P+
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 2e-07
Identities = 30/94 (31%), Positives = 45/94 (47%), Gaps = 10/94 (10%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-GTFG 127
LEYLH I++RD+K N+L+ D KI DF + + T L GT
Sbjct: 113 ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPE 163
Query: 128 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
Y APE ++ D ++ G+++ E+L G P
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-07
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 17/156 (10%)
Query: 10 FVQLLGYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAA 67
F+ L C R+ EF + G L + H +K + + R + A
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA--------RARFYAAEIT 106
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
L +LH+K II+RD+K NVL+ + K+ADF + + + ++ GT
Sbjct: 107 SALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTFCGTPD 161
Query: 128 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
Y APE D ++ GV+L E+L G P +
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-07
Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 15/168 (8%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
L+H N +Q LG C + T +L EF G L L + + P P + Q+ +A
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDP-TTLQR---MAC 107
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
A GL +LH+ + IH D+ N L+ D KI D+ LS+ + ++
Sbjct: 108 EIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV 164
Query: 125 TFGYHAPEYA--MTGQL-----NAKSDVYSFGVVLLELLT-GRKPVDH 164
+ APE + G L +S+V+S GV + EL G +P H
Sbjct: 165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 5/92 (5%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
LEYLH + +++RDIK N+++ D KI DF L + A + + GT Y
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE D + GVV+ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 11/94 (11%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTF 126
GL+Y+H IIHRD+K N+ + +D KI DF L+ A +M T + T
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTR 178
Query: 127 GYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 159
Y APE + N D++S G ++ E+LTG+
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 3/108 (2%)
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
L +Q + I + L YLH + IIHRD+K+ N+ + + + A + DF + +
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT ++PE AK+D++S G+VL E+
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 126
G+ +LH I++RD+K NVL+ D +++D L+ + D T+ GT
Sbjct: 105 TCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTN 158
Query: 127 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GY APE + D ++ G + E++ GR P
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-07
Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 15/164 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
++ L+H+ VQ G D + L+ E+ GS+ D L GA V
Sbjct: 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYT 112
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
R + +G+ YLH I+HRDIK +N+L K+ DF S + +
Sbjct: 113 RQIL-----QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164
Query: 119 STR-VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ V GT + +PE K+DV+S ++E+LT + P
Sbjct: 165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 17/100 (17%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----TRV 122
+GL++LH I+HRD+K N+L+ K+ADF L AR++S T V
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL--------ARIYSCQMALTPV 167
Query: 123 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 162
+ T Y APE + D++S G + E+ RKP+
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 8/98 (8%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
L YLH +++RD+K N+++ D KI DF L + A + + GT Y
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV---DH 164
APE D + GVV+ E++ GR P DH
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GLE LH + I++RD+K N+L+ D +I+D L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + D + G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 16/159 (10%)
Query: 25 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ-----RVKIAVGAA-KGLEYLHEKAD 78
L Y F + LH IL V G + L + V+ G LE+LH+
Sbjct: 70 LHYAFQTEAKLHLIL---DYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG- 125
Query: 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 137
I++RDIK N+L+ + + DF LS + + R +S GT Y APE
Sbjct: 126 --IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEYMAPEIIRGK 181
Query: 138 QLNAKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 175
+ K+ D +S G+++ ELLTG P R QS V+
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-07
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L YLHE+ II+RD+K NVL+ + K+ D+ + + + ++ GT Y
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNY 162
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
APE D ++ GV++ E++ GR P D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 36/126 (28%), Positives = 56/126 (44%), Gaps = 25/126 (19%)
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
I GA +GL YLH+ IHR+IK+S++LI D + ++ + + +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGL---SHLYSLVRNGQKAK 159
Query: 122 VLGTFGYHAPEYAMTGQ--------------LNAKSDVYSFGVVLLELLTGRKPVDHTLP 167
V+ Y P+++ + N KSD+YS G+ EL TGR P +
Sbjct: 160 VV----YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF-QDML 214
Query: 168 RGQQSL 173
R Q L
Sbjct: 215 RTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-07
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GLE L + I++RD+K N+L+ D +I+D L+ Q P+ RV GT GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GETVRGRV-GTVGY 167
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + D + G ++ E++ G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 34/119 (28%), Positives = 45/119 (37%), Gaps = 30/119 (25%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS----------------NQAPDM 113
L+ +H+ IHRDIK N+LI D K+ADF L +
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 114 AARLHSTR-----------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
L R +GT Y APE + D +S GV+L E+L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-07
Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+GL Y H + ++HRD+K N+LI + K+ADF L+ +A + + +S V+ T
Sbjct: 115 RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVV-TLW 169
Query: 128 YHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 159
Y P+ + + + + D++ G + E+ TGR
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-07
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
G+++LH IIHRD+K SN+++ D KI DF L+ A T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 188
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158
APE + D++S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-07
Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 17/100 (17%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----TRV 122
+GL++LH ++HRD+K N+L+ K+ADF L AR++S T V
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTSV 169
Query: 123 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 162
+ T Y APE + D++S G + E+ RKP+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-07
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L+YLH ++ ++++RD+K N+++ D KI DF L + A + + GT Y
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 162
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE D + GVV+ E++ GR P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 28/92 (30%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+GL Y+H++ +I+HRD+K N+LI D K+ADF L+ +A + + +S V+ T
Sbjct: 114 RGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVV-TLW 168
Query: 128 YHAPEYAM-TGQLNAKSDVYSFGVVLLELLTG 158
Y P+ + + + + D++ G + +E++ G
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L+YLH I++RD+K N+++ D KI DF L + AA + + GT Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEY 161
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE D + GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 37/140 (26%), Positives = 69/140 (49%), Gaps = 21/140 (15%)
Query: 35 LHDILHGRKGVK--------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80
LHDI+H ++ + PG + + R+ +GL Y+H + H
Sbjct: 68 LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ---H 123
Query: 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQL 139
I+HRD+K N+LI K+ADF L+ +A + ++ +S+ V+ T Y P+ +
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEVV-TLWYRPPDVLLGATDY 181
Query: 140 NAKSDVYSFGVVLLELLTGR 159
++ D++ G + +E+L G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 10/93 (10%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTF 126
G+++LH IIHRD+K SN+++ D KI DF L+ A M TR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 127 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159
Y APE + D++S G ++ E++ G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 1e-06
Identities = 47/161 (29%), Positives = 69/161 (42%), Gaps = 27/161 (16%)
Query: 6 KHENFVQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+ NF++L Y V T + VL ++ +G L D+L LS + KI
Sbjct: 67 DNPNFIKLY-YSV-TTLKGHVLIMDYIKDGDLFDLLKKEGK---------LSEAEVKKII 115
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRV 122
+ L LH+ +IIH DIK NVL D + D+ L + +
Sbjct: 116 RQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSC 165
Query: 123 L-GTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
GT Y +PE + G S D ++ GV+ ELLTG+ P
Sbjct: 166 YDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ L H N V+LL L +EF LH L +K + + +
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDL--KKFMDASPLSG-IPLPLIK 103
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+GL + H ++HRD+K N+LI + K+ADF L+ +A + R ++
Sbjct: 104 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTH 159
Query: 121 RVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
V+ T Y APE + + + + D++S G + E++T R
Sbjct: 160 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 26/92 (28%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
L +LH +I+RD+K N+L+ + K+ADF + + + + +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYI 163
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + D ++ GV++ E++ G+ P
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
L +LHE+ II+RD+K NVL+ + K+ D+ + + + ++ GT Y
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYI 163
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
APE D ++ GV++ E++ GR P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 7 HENFVQLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
H N ++L+G + ++ ++ F +G LH L + G +P L Q V
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR--IGEEPF-TLPLQTLV 116
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLH 118
+ + A G+EYL K + IHRD+ + N ++ ++ +ADF LS + + D +
Sbjct: 117 RFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
++++ + A E SDV++FGV + E++T G+ P
Sbjct: 174 ASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
LEYLH K I++RD+K N+L+ + K+ DF + + D L GT Y
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----CGTPEYL 165
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + N D ++ G+++ E+L G P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 28/93 (30%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+GL Y H++ ++HRD+K N+LI + K+ADF L+ +A + ++ +S V+ T
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPSKTYSNEVV-TLW 168
Query: 128 YHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 159
Y P+ + + + + D++ G + E+ TGR
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL-------SNQAPDMAARLHS 119
AKG+ +L K + IHRD+ + N+L+ + KI DF L SN ARL
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ APE +SDV+S+G++L E+ + G P
Sbjct: 279 -----PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 35/105 (33%), Positives = 46/105 (43%), Gaps = 16/105 (15%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHS------TR- 121
LEYLH I+HRD+K N+LI K+ DF LS + L+ TR
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 122 -----VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
V GT Y APE + D ++ G++L E L G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 27/93 (29%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+GL Y H + ++HRD+K N+LI + K+ADF L+ +A + + +S V+ T
Sbjct: 115 RGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVV-TLW 169
Query: 128 YHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 159
Y P+ + + + + + D++ G + E+ +GR
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 29/83 (34%), Positives = 37/83 (44%), Gaps = 5/83 (6%)
Query: 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 140
IHRD+K N LI K+ DF LS A +S V+G+ Y APE +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA---NS--VVGSPDYMAPEVLRGKGYD 176
Query: 141 AKSDVYSFGVVLLELLTGRKPVD 163
D +S G +L E L G P
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
LE+LH+ I++RD+K N+L+ + DF LS ++ + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 130 APEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + + K D +S GV++ E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 15/109 (13%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTF 126
+ L+Y+H ++ HRD+K N+L D KI DF L+ A D + T + T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 127 GYHAPEYAMTGQLNAKS----DVYSFGVVLLELLTGR-----KPVDHTL 166
Y APE + G +K D++S G + E+LTG+ K V H L
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 10/135 (7%)
Query: 23 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII 82
R +Y+ +++ + ++L G +G +LS+ +V A+G+E+L K + +
Sbjct: 210 RPASYKGSNDSEVKNLL-SDDGSEGLTTLDLLSFTYQV------ARGMEFLASK---NCV 259
Query: 83 HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAK 142
HRD+ + NVL+ + KI DF L+ + + + APE
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL 319
Query: 143 SDVYSFGVVLLELLT 157
SDV+S+G++L E+ +
Sbjct: 320 SDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 23/162 (14%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL----SWQQRV 60
L H N V+LL L +EF D+ P L +Q
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQ--- 107
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+G+ Y H ++HRD+K N+LI + K+ADF L+ +A + R ++
Sbjct: 108 -----LLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTYTH 158
Query: 121 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 161
V+ T Y APE + Q + D++S G + E++ R+P
Sbjct: 159 EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+ ++YLHE IIHRDIK+ N+ I + DF + D+ A + GT
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIA 248
Query: 128 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159
+APE D++S G+VL E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 29/95 (30%), Positives = 42/95 (44%), Gaps = 5/95 (5%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 126
A L YLH +II+RD+K N+L+ + DF L + + ++ GT
Sbjct: 106 ASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTP 160
Query: 127 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
Y APE + D + G VL E+L G P
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 27/84 (32%), Positives = 39/84 (46%), Gaps = 5/84 (5%)
Query: 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT----G 137
IHRD+K N+L+ K+ADF + D + +GT Y +PE + G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 138 QLNAKSDVYSFGVVLLELLTGRKP 161
+ D +S GV L E+L G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
G+++LH IIHRD+K SN+++ D KI DF L+ A T + T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159
APE + D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-06
Identities = 31/86 (36%), Positives = 40/86 (46%), Gaps = 7/86 (8%)
Query: 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY--AMTGQL 139
+HRDIK NVLI K+ADF S ++S +GT Y APE M G
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 140 NAKSDV----YSFGVVLLELLTGRKP 161
V +S GV+ E++ GR P
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 46/181 (25%), Positives = 62/181 (34%), Gaps = 58/181 (32%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF------------------------- 104
+E +H+ IHRDIK N+LI D K+ DF
Sbjct: 114 IESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 105 --------DLSNQAPDMAARLH---STRVL-----GTFGYHAPEYAMTGQLNAKSDVYSF 148
++ R R L GT Y APE + D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 149 GVVLLELLTGRKPVDHTLPRG-QQSLVTWAT-------PKLSEDK----VRQCVDA--RL 194
GV+L E+L G+ P P Q ++ W T KLS + +R C A RL
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRL 290
Query: 195 G 195
G
Sbjct: 291 G 291
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 40/174 (22%), Positives = 67/174 (38%), Gaps = 35/174 (20%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVK 61
+L+H N + + + + + + GS D+L H +G+ +
Sbjct: 55 QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------------ELA 102
Query: 62 IAV---GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS--------NQA 110
IA L+Y+H K IHR +K+S++L+ D ++ S Q
Sbjct: 103 IAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159
Query: 111 PDMAARLHSTRVLGTFGYHAPEY---AMTGQLNAKSDVYSFGVVLLELLTGRKP 161
S + L + +PE + G N KSD+YS G+ EL G P
Sbjct: 160 VVHDFPKSSVKNLP---WLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-05
Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
G+++LH IIHRD+K SN+++ D KI DF L+ A T + T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 164
APE + D++S G ++ E L GR +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 40/143 (27%), Positives = 53/143 (37%), Gaps = 46/143 (32%)
Query: 82 IHRDIKSSNVLIFDDDVAKIADF--------------------------DLSNQAPD--- 112
IHRDIK N+LI D K+ DF D SN+ D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 113 ------------MAARLH----STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156
AAR H + ++GT Y APE + D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 157 TGRKPVDHTLP-RGQQSLVTWAT 178
G+ P P Q ++ W T
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQT 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-05
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 19/161 (11%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
L+H N +Q LG CV+ +L +E+ G L L + + +L Q ++A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN--SQLLLLQ---RMAC 106
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL--SNQAPDMAARLHSTRV 122
A G+ ++H+ + +H D+ N + D K+ D+ + S D
Sbjct: 107 EIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET--EDDK 161
Query: 123 LGTFGYHAPEYA-------MTGQLNAKSDVYSFGVVLLELL 156
+ APE +T + S+V++ GV L EL
Sbjct: 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-05
Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 33/182 (18%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
++ LKH N + L + R L +++A + H I R +P
Sbjct: 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP-------- 102
Query: 59 RVKIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDL 106
V++ G K G+ YLH ++HRD+K +N+L+ + KIAD
Sbjct: 103 -VQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158
Query: 107 S---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 162
+ N A L V+ TF Y APE + + K+ D+++ G + ELLT +P+
Sbjct: 159 ARLFNSPLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
Query: 163 DH 164
H
Sbjct: 216 FH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-05
Identities = 56/235 (23%), Positives = 105/235 (44%), Gaps = 34/235 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++S++ H + + G CV G+ ++ EF +G L D+ ++ KG P ++W ++
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKE--KGRVP---VAW--KI 120
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD--FDLSNQAPDMAARLH 118
+A A L YL +K +++H ++ + N+L+ +A+ LS+ A
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 119 STRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLEL-LTGRKPVDHTLPRGQQSLVTW 176
RV + APE G L+ +D +SFG LLE+ G P+ P ++
Sbjct: 178 EERV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE----- 231
Query: 177 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231
+ E K R P + ++A + + C+ YE RP+ +++ L
Sbjct: 232 ---RFYEKKHR----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 73 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 132
+H H +HRDIK NVL+ + ++ADF S + + S+ +GT Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 133 Y--AM---TGQLNAKSDVYSFGVVLLELLTGRKP 161
AM G+ + D +S GV + E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-05
Identities = 27/85 (31%), Positives = 40/85 (47%), Gaps = 5/85 (5%)
Query: 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---- 136
+IHRD+K N+L+ K+ADF + D + +GT Y +PE +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 137 GQLNAKSDVYSFGVVLLELLTGRKP 161
G + D +S GV L E+L G P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 9e-05
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 19/175 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
++ LKH N + L + + R L +++A + H I R A P+ +
Sbjct: 51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHR--ASKANKKPMQLPRS 108
Query: 59 RVK-IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLS---NQA 110
VK + G+ YLH ++HRD+K +N+L+ + KIAD + N
Sbjct: 109 MVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 111 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 164
A L V+ TF Y APE + + K+ D+++ G + ELLT +P+ H
Sbjct: 166 LKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMAARLHSTRVLGTF 126
KG+ + H+ ++HRD+K N+L+ + KIAD L +A + + ++ ++ T
Sbjct: 121 KGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIPVKSYTHEIV-TL 175
Query: 127 GYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTG 158
Y APE + + D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 44/177 (24%), Positives = 69/177 (38%), Gaps = 19/177 (10%)
Query: 9 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 68
N V L Y V S L + A G L + + V W + +A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC---VKRWAAEMVVA----- 97
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L+ LH + I+ RD+ +N+L+ D ++ F ++ D + Y
Sbjct: 98 -LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----Y 148
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK-LSED 184
APE + D +S G +L ELLTG K + P G + T P+ +SE+
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSEE 204
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 28/87 (32%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY--AM-- 135
H +HRDIK N+L+ + ++ADF + + + S+ +GT Y +PE AM
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEILQAMED 180
Query: 136 -TGQLNAKSDVYSFGVVLLELLTGRKP 161
G+ + D +S GV + E+L G P
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 5/92 (5%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
LE LH+ ++I+RD+K N+L+ D IA D +M + GT Y
Sbjct: 106 LENLHKF---NVIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE + D ++ GV+L E+LTG P
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 14/95 (14%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR---VLGTF 126
EYL +I++RD+K N+L+ D K+ DF A++ TR + GT
Sbjct: 144 FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF--------AKVVDTRTYTLCGTP 192
Query: 127 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
Y APE + +D ++ G+ + E+L G P
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 33/109 (30%), Positives = 53/109 (48%), Gaps = 15/109 (13%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 126
+ L Y+H K I HRD+K N+LI + K+ DF A ++ A S + +
Sbjct: 181 RALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF---GSAKNLLAGQRSVSYICSR 234
Query: 127 GYHAPEYAMTGQLNAKS--DVYSFGVVLLELLTGRKPVDHTLPRGQQSL 173
Y APE M G N + D++S G ++ E++ G + + GQ S+
Sbjct: 235 FYRAPEL-MLGATNYTTHIDLWSLGCIIAEMILG-----YPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 5e-04
Identities = 21/48 (43%), Positives = 27/48 (56%), Gaps = 3/48 (6%)
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 107
VK A L+YLH IIHRD+K N+LI ++ K+ DF LS
Sbjct: 107 VKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 7e-04
Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 12/108 (11%)
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL---- 117
I G K L+Y+H +HR +K+S++LI D ++ + + RL
Sbjct: 106 ILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162
Query: 118 ----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+S +VL + + G +AKSD+YS G+ EL G P
Sbjct: 163 DFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 31/116 (26%), Positives = 45/116 (38%), Gaps = 36/116 (31%)
Query: 82 IHRDIKSSNVLIFDDDVAKIADFDL---------------------SNQAPDMAARLHST 120
IHRDIK N+L+ K++DF L SN ++ + S
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 121 R---------------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
R +GT Y APE + N + D +S GV++ E+L G P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 29/95 (30%), Positives = 42/95 (44%), Gaps = 5/95 (5%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 126
A L YLH +I++RD+K N+L+ + DF L + + +T GT
Sbjct: 106 ASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTP 160
Query: 127 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
Y APE + D + G VL E+L G P
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 6/87 (6%)
Query: 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY--AM-- 135
+HRDIK NVL+ + ++ADF S + S +GT Y +PE AM
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 136 -TGQLNAKSDVYSFGVVLLELLTGRKP 161
G+ + D +S GV + E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 18/112 (16%)
Query: 52 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 111
P+L Q R I +EY+H+K +IHRDIK N+ + D + DF
Sbjct: 264 PLL-KQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDF------- 311
Query: 112 DMAARLHSTRV------LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
A R +GT ++PE +D++S G++LL++L+
Sbjct: 312 GTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.001
Identities = 27/94 (28%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 126
+G+ Y H ++HRD+K N+LI + K+ADF L+ +A + R + V+ T
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLA-RAFGIPVRTFTHEVV-TL 167
Query: 127 GYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 159
Y APE + + + D++S G + E++ +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 22/201 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M+ ++ H++ V L G CV ++ EF G L D+ RK VL+ +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRK-------SDVLTTPWKF 108
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-AKIADF-DLSNQAPDMAARLH 118
K+A A L YL +K ++H ++ + N+L+ + + + F LS+ + L
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV-LS 164
Query: 119 STRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLEL-LTGRKPV-DHTL---PRGQQS 172
+ + APE + L+ +D +SFG L E+ G P+ D TL R +
Sbjct: 165 RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG 224
Query: 173 LVTWATPKLSE--DKVRQCVD 191
TP E D + C++
Sbjct: 225 QCMLVTPSCKELADLMTHCMN 245
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 29/99 (29%), Positives = 43/99 (43%), Gaps = 5/99 (5%)
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
A A + YLH +II+RD+K N+L+ + DF L + + ++
Sbjct: 102 AAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG--VEPEETTSTF 156
Query: 123 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT Y APE + D + G VL E+L G P
Sbjct: 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 29/99 (29%), Positives = 44/99 (44%), Gaps = 5/99 (5%)
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
A A L YLH +I++RD+K N+L+ + DF L + ++ ++
Sbjct: 102 AAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTF 156
Query: 123 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT Y APE + D + G VL E+L G P
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 33/120 (27%), Positives = 47/120 (39%), Gaps = 33/120 (27%)
Query: 82 IHRDIKSSNVLIFDDDVAKIADFDLS-----------------NQAPDMAAR-LHSTR-- 121
IHRDIK N+L+ K++DF L N D + + ++S R
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 122 -------------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 168
+GT Y APE M N D +S GV++ E+L G P P+
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 32/120 (26%), Positives = 47/120 (39%), Gaps = 33/120 (27%)
Query: 82 IHRDIKSSNVLIFDDDVAKIADF----------------DLSNQAPD--MAARLHSTR-- 121
IHRDIK N+L+ K++DF +L++ P ++S R
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 122 -------------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 168
+GT Y APE M N D +S GV++ E+L G P P+
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 45/175 (25%), Positives = 62/175 (35%), Gaps = 59/175 (33%)
Query: 82 IHRDIKSSNVLIFDDDVAKIADF---------------------------------DLSN 108
IHRDIK N+LI D K+ DF D+SN
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 109 ------------QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156
+A R + ++GT Y APE + D +S GV+L E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 157 TGRKPVDHTLP-RGQQSLVTW-------ATPKLSEDKV----RQCVDA--RLGGD 197
G+ P P Q ++ W KLS + V + C A RLG +
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN 297
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 247 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.6 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.57 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.56 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.49 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.43 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.39 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.39 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.38 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.24 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.17 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.15 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.03 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.95 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.92 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.76 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.73 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.68 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.63 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.51 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.46 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.38 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.27 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.15 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.14 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.8 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.53 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.46 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.27 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.22 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.21 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.89 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.77 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.67 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.45 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.41 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.71 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.66 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.32 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.2 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.11 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.02 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.51 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.43 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.37 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.24 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.97 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.91 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.63 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.54 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.05 | |
| PLN02236 | 344 | choline kinase | 92.67 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.23 | |
| PRK14559 | 645 | putative protein serine/threonine phosphatase; Pro | 92.1 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 91.6 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.48 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 91.23 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 91.22 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 89.95 | |
| PF10140 | 359 | YukC: WXG100 protein secretion system (Wss), prote | 89.15 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 88.88 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.79 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 87.56 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 86.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 85.53 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 85.52 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=292.62 Aligned_cols=199 Identities=28% Similarity=0.405 Sum_probs=169.1
Q ss_pred CcccccCCCccceeeEEeeCCe-eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTS-RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~ 78 (247)
|+++.+|||||.+||.|..+.. .+++|||+++|+|.+++..... +++.....++.++++||.|||. .+
T Consensus 130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~---------i~E~~L~~ia~~VL~GL~YLh~~~~- 199 (364)
T KOG0581|consen 130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGR---------IPEPVLGKIARAVLRGLSYLHEERK- 199 (364)
T ss_pred HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhccC-
Confidence 4678899999999999999994 9999999999999999987632 9999999999999999999995 77
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
|+||||||+|+|++..|.+||+|||++....+. ....+.||..|+|||.+.+..|+.++||||||+.++|++.|
T Consensus 200 --IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~G 273 (364)
T KOG0581|consen 200 --IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIG 273 (364)
T ss_pred --eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhC
Confidence 999999999999999999999999999876544 34667899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccc---cCCCCCHH-HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR---LGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+.||....+ ....+.+.+... .....|.. ++.++++++..||++||.+|||+.++++
T Consensus 274 rfP~~~~~~--------------~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 274 RFPYPPPNP--------------PYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCcCC--------------CCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 999975411 011122222222 22334444 8889999999999999999999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=302.64 Aligned_cols=211 Identities=30% Similarity=0.480 Sum_probs=190.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||++|+|+|||+++++|..+..++|||||+..|+|.+++....+.. +...+.+.++.||++|++||++++
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~-------l~~~~Ll~~a~qIaeGM~YLes~~--- 323 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGL-------LNLPQLLDFAAQIAEGMAYLESKN--- 323 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCc-------cchHHHHHHHHHHHHHHHHHHhCC---
Confidence 5899999999999999999999999999999999999999744333 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
+|||||..+|||++.+..+||+|||+++...+.. ............|.|||.+....|+.+|||||+|++++|++| |+
T Consensus 324 ~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~ 402 (468)
T KOG0197|consen 324 YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGR 402 (468)
T ss_pred ccchhhhhhheeeccCceEEEcccccccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCC
Confidence 9999999999999999999999999999544333 223333445778999999999999999999999999999999 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
.||. ..++.++.+.++.+.+...|..|+.+++++|..||+.+|++|||++.+.+.++++....
T Consensus 403 ~py~----------------~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 403 VPYP----------------GMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCC----------------CCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 9985 56788999999999999999999999999999999999999999999999999987643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=279.49 Aligned_cols=209 Identities=22% Similarity=0.350 Sum_probs=172.0
Q ss_pred CcccccCCCccceee-EEeeCCe-eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC-
Q 025816 1 MVSRLKHENFVQLLG-YCVDGTS-RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA- 77 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~- 77 (247)
+|++|+|||||++|+ .|..++. ++++||+|++|+|.+.++.....+ ..+++..+|+++.|++.||..+|+.-
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qk-----r~ipE~~Vwk~f~QL~~AL~~cH~~~~ 145 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQK-----RLIPEKTVWKYFVQLCRALYHCHSKIP 145 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhcc-----ccCchHHHHHHHHHHHHHHHHHhcccc
Confidence 589999999999999 5666666 899999999999999998766443 45999999999999999999999831
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
.+.|.||||||.||+++.+|.+||+|||+++....... ......||+.|++||.+.+.+|+.++||||+||++|||+.
T Consensus 146 r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca 223 (375)
T KOG0591|consen 146 RGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA 223 (375)
T ss_pred ccceeeccCcchheEEcCCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh
Confidence 12499999999999999999999999999997654333 2356789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC-HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP-PKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
.++||.++ .-..+.+.+.++--...| ..++.++.++|..|+..||..||+.-.++..++
T Consensus 224 L~~PF~g~----------------n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 224 LQSPFYGD----------------NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred cCCCcccc----------------cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 99999754 112233334444333345 578999999999999999999999544444444
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=290.79 Aligned_cols=200 Identities=24% Similarity=0.343 Sum_probs=165.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||++|+|||||+++++|+.....||||||++||+|.+.+..+.. +.+.....++.|++.||.|||++|
T Consensus 229 ILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~G--- 296 (475)
T KOG0615|consen 229 ILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQG--- 296 (475)
T ss_pred HHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHcC---
Confidence 58999999999999999999999999999999999999987764 778888999999999999999999
Q ss_pred eEeccCCCCceeecCC---CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC---CccccchhhhHHHHH
Q 025816 81 IIHRDIKSSNVLIFDD---DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL---NAKSDVYSFGVVLLE 154 (247)
Q Consensus 81 i~h~di~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~~l~~ 154 (247)
|+||||||+|||+..+ -.+||+|||++...+.. ......+||+.|.|||++.+.++ ..+.|+||+||++|-
T Consensus 297 I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfv 373 (475)
T KOG0615|consen 297 IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFV 373 (475)
T ss_pred cccccCCcceEEeccCCcceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEE
Confidence 9999999999999877 56999999999876532 23456789999999999987653 447899999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCC--CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+++|.+||....... .-..++...+..- ..-.+.+++..++|++||..||.+|||+.|+|+
T Consensus 374 cLsG~pPFS~~~~~~--------------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 374 CLSGYPPFSEEYTDP--------------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred EeccCCCcccccCCc--------------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 999999997442211 0112222222211 122467888999999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=290.74 Aligned_cols=214 Identities=35% Similarity=0.547 Sum_probs=182.1
Q ss_pred CcccccCCCccceeeEEeeCC-eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+|++|+|||||+++|++.... ..++||||+.+|+|.+++...... .+++..++.++.+|+.|+.|||+++.
T Consensus 92 il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~-------~l~~~~~l~~aldiArGm~YLH~~~~- 163 (362)
T KOG0192|consen 92 LLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKR-------KLPLKVRLRIALDIARGMEYLHSEGP- 163 (362)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHhcCCC-
Confidence 467899999999999999988 799999999999999999874222 29999999999999999999999972
Q ss_pred CeEeccCCCCceeecCCC-ceeeccccccCCcchhhhcccccceeccccccCchhhh--cCCCCccccchhhhHHHHHHH
Q 025816 80 HIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--TGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~~l~ 156 (247)
|+|||+|++|+|++.++ .+||+|||+++...... .......||..|+|||++. ...|+.++||||+|+++|+|+
T Consensus 164 -iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~ 240 (362)
T KOG0192|consen 164 -IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELL 240 (362)
T ss_pred -eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHH
Confidence 89999999999999998 99999999998654322 1123357899999999999 568999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
+|..||..... ............+...+..++..+..++.+||..||..||++.+|+..|+.+.+
T Consensus 241 t~~~Pf~~~~~---------------~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 241 TGEIPFEDLAP---------------VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred HCCCCCCCCCH---------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 99999975422 233444445566667777788899999999999999999999999999999887
Q ss_pred cCCC
Q 025816 237 ARPG 240 (247)
Q Consensus 237 ~~~~ 240 (247)
....
T Consensus 306 ~~~~ 309 (362)
T KOG0192|consen 306 HISS 309 (362)
T ss_pred hhcc
Confidence 5554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=294.58 Aligned_cols=196 Identities=28% Similarity=0.412 Sum_probs=169.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
-++|+|||||++|++|++.+..|||.|+|..++|..+++++. ++++..++.++.||+.||.|||+.+ |
T Consensus 72 Hr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH~~~---I 139 (592)
T KOG0575|consen 72 HRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLHSLG---I 139 (592)
T ss_pred HHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHHhcC---c
Confidence 478999999999999999999999999999999999998554 3999999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|||||..|++++++..+||+|||+|.......+. ....+||+-|.|||++...+.+..+||||+||++|-|+.|++|
T Consensus 140 iHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PP 217 (592)
T KOG0575|consen 140 IHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPP 217 (592)
T ss_pred eecccchhheeecCcCcEEecccceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCC
Confidence 99999999999999999999999999987654333 2457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|+..+ +.+...... ....|...+.+..+||.++|+.||.+|||+++||..
T Consensus 218 Fetk~-------------------vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 218 FETKT-------------------VKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccch-------------------HHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 97431 122111111 123445667789999999999999999999999973
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=282.03 Aligned_cols=228 Identities=56% Similarity=0.944 Sum_probs=197.6
Q ss_pred CcccccCCCccceeeEEeeCC-eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
++.+++|||+|+++|||.+.+ ..+||+||+.+|+|.+.+...... +++|..+.+|+.++|.||.|||....+
T Consensus 124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~ 196 (361)
T KOG1187|consen 124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPP 196 (361)
T ss_pred HHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCC
Confidence 467899999999999999998 599999999999999999876532 389999999999999999999999888
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccce-eccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV-LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+|||||++|||+|.+...||+|||++...... ....... .||.+|+|||....+..+.++||||+|+++.|+++|
T Consensus 197 ~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitg 274 (361)
T KOG1187|consen 197 PIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITG 274 (361)
T ss_pred CEecCCCCHHHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhC
Confidence 8999999999999999999999999999665431 1111112 789999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC-CCCCH-HHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG-GDYPP-KAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
+.+.....+.....+..|.........+.+++|+.+. ..+.. +....+..+..+|++.+|.+||++.+|++.|+.+..
T Consensus 275 r~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 275 RKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 9988876666666688888888888899999999987 56654 577779999999999999999999999999966654
Q ss_pred c
Q 025816 237 A 237 (247)
Q Consensus 237 ~ 237 (247)
.
T Consensus 355 ~ 355 (361)
T KOG1187|consen 355 L 355 (361)
T ss_pred c
Confidence 4
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=269.13 Aligned_cols=215 Identities=23% Similarity=0.295 Sum_probs=175.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||++|+|+|+|.++.+|......+||+|||+. ++.+-++..+.. ++.+.+.+++.|++.|+.|+|+++
T Consensus 54 mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G--------~~~~~vk~~l~Q~l~ai~~cHk~n--- 121 (396)
T KOG0593|consen 54 MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNG--------VPSELVKKYLYQLLKAIHFCHKNN--- 121 (396)
T ss_pred HHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCC--------CCHHHHHHHHHHHHHHhhhhhhcC---
Confidence 58999999999999999999999999999987 888888777654 889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++||||||+|||++.+|.+||+|||.|+........ -+....|.+|+|||.+.+ ..|..+.||||+||++.||++|.
T Consensus 122 ~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~--YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~ 199 (396)
T KOG0593|consen 122 CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN--YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE 199 (396)
T ss_pred eecccCChhheEEecCCcEEeccchhhHhhcCCcch--hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC
Confidence 999999999999999999999999999976543322 256678999999999988 68999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhccc----ccCCCC----------CHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA----RLGGDY----------PPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
+.|.+....++...+....+........-.-.+ +++... -+..+.-+.++++.||+.||.+|+|.+
T Consensus 200 pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ 279 (396)
T KOG0593|consen 200 PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCE 279 (396)
T ss_pred cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHH
Confidence 999998888776666554444433221111111 111000 023344789999999999999999999
Q ss_pred HHHH
Q 025816 226 IVVK 229 (247)
Q Consensus 226 ~il~ 229 (247)
+++.
T Consensus 280 qll~ 283 (396)
T KOG0593|consen 280 QLLH 283 (396)
T ss_pred HHhc
Confidence 9986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=272.95 Aligned_cols=197 Identities=28% Similarity=0.418 Sum_probs=159.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||+.++|||||.+++.+..++.++||||||.||+|.+++..+.. +++..+..++.|++.|+++||+++
T Consensus 62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~~--- 129 (429)
T KOG0595|consen 62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHENN--- 129 (429)
T ss_pred HHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 57899999999999999999999999999999999999998763 999999999999999999999999
Q ss_pred eEeccCCCCceeecCC------CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 81 IIHRDIKSSNVLIFDD------DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 81 i~h~di~~~nil~~~~------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
|+||||||+|||++.. ..+||.|||+++....... ....+|++.|+|||++....|+.|+|+||+|+++|+
T Consensus 130 IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq 206 (429)
T KOG0595|consen 130 IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQ 206 (429)
T ss_pred eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHH
Confidence 9999999999999865 4589999999998764332 255789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcc--cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD--ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
+++|+.||....... +...+. .......+...+..+.+++...+..++.+|-+..+-.
T Consensus 207 ~l~g~~Pf~a~t~~e----------------L~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 207 CLTGKPPFDAETPKE----------------LLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred HHhCCCCccccCHHH----------------HHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 999999997432211 111111 1111223334445566777777777777777766543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=290.61 Aligned_cols=222 Identities=30% Similarity=0.494 Sum_probs=197.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCC-C----CCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ-P----GPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~-~----~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+|..++|||||+++|+|.+++..+||+||++.|||.+|+..+....... . ..+|+..+.+.++.||+.|+.||-+
T Consensus 542 Lla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 542 LLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred HHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4678999999999999999999999999999999999997655433222 2 3349999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
+. +|||||..+|+|++.+..|||+|||+++..-..+.+...+...-..+|++||.+.+.+||.+|||||+|+++||+
T Consensus 622 ~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEI 698 (774)
T KOG1026|consen 622 HH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEI 698 (774)
T ss_pred Cc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhh
Confidence 98 999999999999999999999999999977666665555455667899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
++ |.-||. ..+++++.+.+.++.-.++|..++.++++||..||+.+|.+|||++||-..|+..
T Consensus 699 FsyG~QPy~----------------glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 699 FSYGKQPYY----------------GLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred hccccCccc----------------ccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 99 999986 3567888888888888999999999999999999999999999999999999999
Q ss_pred HhcCCCC
Q 025816 235 LNARPGP 241 (247)
Q Consensus 235 ~~~~~~~ 241 (247)
.++-+.-
T Consensus 763 ~~~s~~~ 769 (774)
T KOG1026|consen 763 AQASPKY 769 (774)
T ss_pred HhcCccc
Confidence 8876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=275.54 Aligned_cols=214 Identities=24% Similarity=0.351 Sum_probs=180.6
Q ss_pred ccccc-CCCccceeeEEeeCC-eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLK-HENFVQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
|++|+ ||||+++.+++.+.+ .+++||||++ .+|+++++.+.. +|++..+..++.||++||+|+|++|
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~G-- 130 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKHG-- 130 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhcC--
Confidence 57888 999999999998877 9999999997 499999998743 3999999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|||+||+|||+..+..+||+|||+|+........ +.+..|++|+|||++.. ..|+.+.|+|++||+++|+.+-
T Consensus 131 -fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sL 206 (538)
T KOG0661|consen 131 -FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSL 206 (538)
T ss_pred -cccccCChhheEecccceeEecccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999987655443 55678999999999875 5689999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhh------hcccccCCC-------CCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQ------CVDARLGGD-------YPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
++.|.+..+.++-..+..+.+....+.+.+ .+.-.+..- ..+..+.++.++|.+|+++||.+|||+.
T Consensus 207 rPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~ 286 (538)
T KOG0661|consen 207 RPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTAS 286 (538)
T ss_pred cccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHH
Confidence 999999999888777777776666544443 111111110 1124677899999999999999999999
Q ss_pred HHHHH
Q 025816 226 IVVKA 230 (247)
Q Consensus 226 ~il~~ 230 (247)
+.|+.
T Consensus 287 ~al~~ 291 (538)
T KOG0661|consen 287 QALQH 291 (538)
T ss_pred HHhcC
Confidence 99984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=273.52 Aligned_cols=211 Identities=23% Similarity=0.313 Sum_probs=175.5
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
|.+| .||.|+++|-.|.++..+|+|+||+.+|+|.+++.+... |.+..++..+.+|+.||.|||++|
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~G--- 194 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSNG--- 194 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhcC---
Confidence 4556 899999999999999999999999999999999988753 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc---------cc--ccceeccccccCchhhhcCCCCccccchhhh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR---------LH--STRVLGTFGYHAPEYAMTGQLNAKSDVYSFG 149 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~---------~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 149 (247)
||||||||+|||++++++++|+|||-+......... .. ...+.||..|.+||++.....+..+|+|+||
T Consensus 195 IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlG 274 (604)
T KOG0592|consen 195 IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALG 274 (604)
T ss_pred ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHH
Confidence 999999999999999999999999999876543322 11 1447899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|++|+|+.|.+||.+..+ .-..++++. +.-+++..+++...+||+++|..||.+|+|+.+|-+
T Consensus 275 CilyQmlaG~PPFra~Ne---------------yliFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 275 CILYQMLAGQPPFRAANE---------------YLIFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHHhcCCCCCccccH---------------HHHHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 999999999999975421 111122211 223566777788999999999999999999999877
Q ss_pred HH-------HHhHhcCCCC
Q 025816 230 AL-------QPLLNARPGP 241 (247)
Q Consensus 230 ~l-------~~~~~~~~~~ 241 (247)
+- +.+.+..|++
T Consensus 338 HpFF~~Vdw~nlw~~~PP~ 356 (604)
T KOG0592|consen 338 HPFFEGVDWENLWQQTPPK 356 (604)
T ss_pred CcccccCChhhhhhcCCCc
Confidence 43 4555555543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=268.27 Aligned_cols=208 Identities=27% Similarity=0.396 Sum_probs=166.2
Q ss_pred CcccccCCCccceeeEEeeCC--eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGT--SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+|++++|||||+++|...... .++++|||+.+|+|.+++....+ + |++..+...++|+++||.|||++|
T Consensus 67 iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~-------l~E~~v~~ytr~iL~GL~ylHs~g- 137 (313)
T KOG0198|consen 67 ILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-K-------LPEPLVRRYTRQILEGLAYLHSKG- 137 (313)
T ss_pred HHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-C-------CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 478899999999999755444 68999999999999999998764 3 999999999999999999999999
Q ss_pred CCeEeccCCCCceeecC-CCceeeccccccCCcchhhh-cccccceeccccccCchhhhcC-CCCccccchhhhHHHHHH
Q 025816 79 PHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~-~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l 155 (247)
++||||||+|||++. ++.+||+|||.+........ ........||+.|+|||++.+. ....++|||||||++.+|
T Consensus 138 --~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM 215 (313)
T KOG0198|consen 138 --IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEM 215 (313)
T ss_pred --EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEec
Confidence 999999999999999 79999999999886553111 1223456799999999999863 233499999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
+||..||...... ...+..+.........+...+.+..+++.+|+.+||..|||++++|+..-.
T Consensus 216 ~Tg~~PW~~~~~~--------------~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 216 LTGKPPWSEFFEE--------------AEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred cCCCCcchhhcch--------------HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 9999999642000 111111111222235566778889999999999999999999999996543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=272.75 Aligned_cols=198 Identities=25% Similarity=0.367 Sum_probs=164.9
Q ss_pred Cccccc-CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
++++++ ||||+++++++......++|||||.||+|.+++..... +.+..+..++.|+++|+.|||+.|
T Consensus 72 ~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~---------l~E~~ar~~F~Qlisav~y~H~~g-- 140 (370)
T KOG0583|consen 72 ILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGR---------LKEDEARKYFRQLISAVAYCHSRG-- 140 (370)
T ss_pred HHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCC---------CChHHHHHHHHHHHHHHHHHHhCC--
Confidence 367788 99999999999999999999999999999999988332 899999999999999999999999
Q ss_pred CeEeccCCCCceeecCC-CceeeccccccCCcchhhhcccccceeccccccCchhhhcCC-CC-ccccchhhhHHHHHHH
Q 025816 80 HIIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LN-AKSDVYSFGVVLLELL 156 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslG~~l~~l~ 156 (247)
|+||||||+|++++.+ +.+||+|||++.... .........+|++.|.|||++.+.. |+ .++||||+|+++|.|+
T Consensus 141 -i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml 217 (370)
T KOG0583|consen 141 -IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL 217 (370)
T ss_pred -EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH
Confidence 9999999999999999 999999999998764 1112235568999999999999977 86 7899999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHH-HHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKA-VAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||........ ...+... .-.++... +.++..++.+||..||..|+|+.+|++
T Consensus 218 ~G~~PF~d~~~~~l---------------~~ki~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 218 CGRLPFDDSNVPNL---------------YRKIRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred hCCCCCCCccHHHH---------------HHHHhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 99999975321100 0111111 11334444 788999999999999999999999994
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=274.68 Aligned_cols=201 Identities=30% Similarity=0.480 Sum_probs=176.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++|+||||+.|.|+|...--+|||||||..|-|+..++.... ++....+.|..+|+.|+.|||.+. |
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~---------itp~llv~Wsk~IA~GM~YLH~hK---I 233 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRP---------ITPSLLVDWSKGIAGGMNYLHLHK---I 233 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCc---------cCHHHHHHHHHHhhhhhHHHHHhh---H
Confidence 6889999999999999999999999999999999999987663 888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|||+|.-||||+.+..+||+|||-++....... ...+.||..|+|||++.+.+.+++.||||+|+++|+|+||..|
T Consensus 234 IHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiP 310 (904)
T KOG4721|consen 234 IHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIP 310 (904)
T ss_pred hhhccCCCceEeeccceEEeccccchHhhhhhhh---hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCC
Confidence 9999999999999999999999998886654422 2457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
|...+.. ..+.-.-.+.+....|..+++.+.-|++.||+-.|++|||+++|+..|+
T Consensus 311 YkdVdss---------------AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 311 YKDVDSS---------------AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ccccchh---------------eeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 9744322 1222233344556778889999999999999999999999999999885
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=275.37 Aligned_cols=199 Identities=25% Similarity=0.418 Sum_probs=172.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|+..+|+|||.+++.|-.++.+++||||++||+|.|.+.... +.+.++..++++++.||+|||.+|
T Consensus 323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~g--- 389 (550)
T KOG0578|consen 323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARG--- 389 (550)
T ss_pred HHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcc---
Confidence 4788999999999999999999999999999999999998876 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+|||||.+|||++.+|.+||+|||.+........ ......||+.|+|||++....|..+.||||||+++.||+.|.+
T Consensus 390 IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEP 467 (550)
T KOG0578|consen 390 IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEP 467 (550)
T ss_pred eeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCC
Confidence 99999999999999999999999999987765444 3456789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||-..++- ..+.-+.+.+. ....+...+..+.+++.+||..|+.+|||+.|+|+
T Consensus 468 PYlnE~Pl---------------rAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 468 PYLNENPL---------------RALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CccCCChH---------------HHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 99643221 11222222211 22345566778999999999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=260.37 Aligned_cols=192 Identities=23% Similarity=0.273 Sum_probs=162.3
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||.+++||.||.++-.|.+...+|+|++|..||.|...+++... +++..+.-.+..|+.||.|||+.|
T Consensus 78 IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~g--- 145 (357)
T KOG0598|consen 78 ILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSKG--- 145 (357)
T ss_pred HHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhCC---
Confidence 46789999999999999999999999999999999999986553 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+|||+||+|||++..|.++|+|||++...-... ..+...+||..|+|||++.+.+|+..+|.||||+++|+|++|.+
T Consensus 146 IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~p 223 (357)
T KOG0598|consen 146 IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKP 223 (357)
T ss_pred eeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCC
Confidence 9999999999999999999999999998654332 23355789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP 222 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 222 (247)
||...+. ..+.+.+...-....+.-.+.+..++++++|.+||+.|.
T Consensus 224 PF~~~~~----------------~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 224 PFYAEDV----------------KKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCcCccH----------------HHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 9975432 111222222112233334667899999999999999995
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=249.14 Aligned_cols=228 Identities=25% Similarity=0.301 Sum_probs=183.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|+.++|+||+.++++|.....+.+|+||++. +|...++.... .++..++..++.++++||+|||++. |
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H~~~---I 122 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCHSKW---I 122 (318)
T ss_pred HHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHHhhh---h
Confidence 6789999999999999999999999999986 99999987664 3899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+||||||.|+|++.+|.+||+|||+++.+....... .....|.+|+|||.+.|. .|+...|+||+||++.||+.|.+
T Consensus 123 lHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P 200 (318)
T KOG0659|consen 123 LHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP 200 (318)
T ss_pred hcccCCccceEEcCCCcEEeecccchhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC
Confidence 999999999999999999999999999876554433 333679999999999884 69999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhccc-----------ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-----------RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
-|.+....+|-..+-...++...+.+.++..- ..........+.+..+++.++|..||.+|+|+.|.|+
T Consensus 201 ~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 201 FFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred CCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 99888777665555444444444433332211 0111122345667899999999999999999999998
Q ss_pred HHHHhHhcCCCCCCCC
Q 025816 230 ALQPLLNARPGPAGES 245 (247)
Q Consensus 230 ~l~~~~~~~~~~~~~~ 245 (247)
. ..+++.|.|.+++
T Consensus 281 ~--~yf~~~P~pt~~~ 294 (318)
T KOG0659|consen 281 H--PYFKSLPLPTPPS 294 (318)
T ss_pred c--hhhhcCCCCCChh
Confidence 5 3445555555443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=262.28 Aligned_cols=204 Identities=20% Similarity=0.345 Sum_probs=164.9
Q ss_pred CcccccCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 1 MVSRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+|++++||||+++++++.+ ....+++|||+.+|+|.+++..... +++.....++.+++.|+.+||+.
T Consensus 71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~ 141 (283)
T PHA02988 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---------LSFKTKLDMAIDCCKGLYNLYKY 141 (283)
T ss_pred HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCC---------CChhHHHHHHHHHHHHHHHHHhc
Confidence 4688999999999999876 3468899999999999999976432 88899999999999999999985
Q ss_pred -CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc--CCCCccccchhhhHHHH
Q 025816 77 -ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 77 -~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ 153 (247)
+ ++||||||+||+++.++.+||+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|
T Consensus 142 ~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~ 213 (283)
T PHA02988 142 TN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLW 213 (283)
T ss_pred CC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHH
Confidence 6 8899999999999999999999999987543211 12346788999999976 67899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
+|++|..||...... +..........+...+..++..+.+++.+||+.||.+|||++++++.|+.
T Consensus 214 el~~g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 214 EIFTGKIPFENLTTK---------------EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHCCCCCCCCCHH---------------HHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 999999999743211 11111112222233444567789999999999999999999999999988
Q ss_pred hHh
Q 025816 234 LLN 236 (247)
Q Consensus 234 ~~~ 236 (247)
+.+
T Consensus 279 ~~~ 281 (283)
T PHA02988 279 YKF 281 (283)
T ss_pred HHh
Confidence 754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=267.49 Aligned_cols=218 Identities=25% Similarity=0.409 Sum_probs=166.0
Q ss_pred cccc-cCCCccceeeEEeeCC-eeeEEEecCCCCChhhhhcCCCCCCC--------------------------------
Q 025816 2 VSRL-KHENFVQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKG-------------------------------- 47 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~-------------------------------- 47 (247)
|+++ +||||+++++++...+ ..+++|||+.+|+|.+++........
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (338)
T cd05102 64 LIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQAS 143 (338)
T ss_pred HHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCC
Confidence 4556 8999999999887654 57899999999999999875421100
Q ss_pred ---------------------CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccc
Q 025816 48 ---------------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 106 (247)
Q Consensus 48 ---------------------~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~ 106 (247)
.....++++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~ 220 (338)
T cd05102 144 VLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGL 220 (338)
T ss_pred ccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccc
Confidence 000134888899999999999999999999 99999999999999999999999999
Q ss_pred cCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCCCcchhhhccccCCcch
Q 025816 107 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDK 185 (247)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 185 (247)
++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 221 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~---------------~~ 285 (338)
T cd05102 221 ARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN---------------EE 285 (338)
T ss_pred ccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc---------------HH
Confidence 875432222112223345678999999998889999999999999999997 99999753211 01
Q ss_pred hhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 186 VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 286 FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111111222334556799999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=265.81 Aligned_cols=230 Identities=25% Similarity=0.314 Sum_probs=181.7
Q ss_pred CcccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
||++|.||||+++.++..+. ..+|||+||+++ +|.-++.... .+ |++.++..++.|++.||.|||++|
T Consensus 169 ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~-vk-------ft~~qIKc~mkQLl~Gl~~cH~~g- 238 (560)
T KOG0600|consen 169 ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPG-VK-------FTEPQIKCYMKQLLEGLEYCHSRG- 238 (560)
T ss_pred HHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCC-cc-------cChHHHHHHHHHHHHHHHHHhhcC-
Confidence 68999999999999999887 589999999987 9999987532 22 999999999999999999999999
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHh
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~ 157 (247)
|+|||||..||||+++|.+||+|||+++.+....... -+....|.+|+|||.+.|. .|+.++|+||+||++.||+.
T Consensus 239 --vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~ 315 (560)
T KOG0600|consen 239 --VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL 315 (560)
T ss_pred --eeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc
Confidence 9999999999999999999999999999665443322 2445679999999999985 69999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc---CCCCC---------HHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL---GGDYP---------PKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
|++.|.+..+..|...+-.......+..+...--+.. +...+ ...+....+|+..+|..||.+|.|+.
T Consensus 316 gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~ 395 (560)
T KOG0600|consen 316 GKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTAS 395 (560)
T ss_pred CCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHH
Confidence 9999999888777666655555555444431111111 11111 23355688999999999999999999
Q ss_pred HHHHHHHHhHhcCCCCCCCC
Q 025816 226 IVVKALQPLLNARPGPAGES 245 (247)
Q Consensus 226 ~il~~l~~~~~~~~~~~~~~ 245 (247)
++|.. +.+...|.+..|+
T Consensus 396 ~aL~s--eyF~t~p~~~~p~ 413 (560)
T KOG0600|consen 396 SALQS--EYFTTEPLPCDPS 413 (560)
T ss_pred HHhcC--cccccCCCCCCcc
Confidence 99873 2334444444443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=269.56 Aligned_cols=202 Identities=23% Similarity=0.379 Sum_probs=175.4
Q ss_pred CcccccCCCccceeeEEeeCCe-eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTS-RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
++++++|||||.++++|..++. ++|+|+||+||++.+.+.+..+. .++++.+..|+.|++.|+.|||+..
T Consensus 56 lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH~~~-- 126 (426)
T KOG0589|consen 56 LLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLHENR-- 126 (426)
T ss_pred HHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHHhhh--
Confidence 4678999999999999999988 99999999999999999987743 3999999999999999999999888
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
|+|||||+.||++++++.++|+|||+++....... ......||+.|+.||++.+.+|..++|+|||||++|+|++-+
T Consensus 127 -iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk 203 (426)
T KOG0589|consen 127 -VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLK 203 (426)
T ss_pred -hhcccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcc
Confidence 99999999999999999999999999998765442 235678999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
.+|...+- ..+...+........+..++.++..+|+.|+..+|..||++.++|..
T Consensus 204 ~aF~a~~m----------------~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 204 PAFKASNM----------------SELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cccCccch----------------HHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 99975421 11122222223455677888999999999999999999999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=272.33 Aligned_cols=196 Identities=24% Similarity=0.356 Sum_probs=169.3
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||+-+.|||++++|+++++..++|+|.||..+|-|.+++-.... +++..+.++++||+.|+.|||..+
T Consensus 65 iMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~~--- 132 (786)
T KOG0588|consen 65 IMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAFN--- 132 (786)
T ss_pred HHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhhc---
Confidence 57889999999999999999999999999999999999976653 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~ 159 (247)
|+|||+||+|+|++..+.+||+|||+|..-....- -...+|.+.|.+||++.|.+| ..++||||+|+++|.+++|+
T Consensus 133 icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~ 209 (786)
T KOG0588|consen 133 ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGK 209 (786)
T ss_pred ceeccCCchhhhhhcccCEeeeccceeecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCC
Confidence 99999999999999999999999999976433222 244679999999999999999 46899999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCC--CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
.||+++ .++.++.+..++ +.|...+.++.+|+.+|+..||..|.|.+||++.
T Consensus 210 LPFdDd-------------------Nir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 210 LPFDDD-------------------NIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCCCCc-------------------cHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 999733 233333333332 3456777889999999999999999999999994
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=255.79 Aligned_cols=211 Identities=29% Similarity=0.377 Sum_probs=165.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|+.++||||++++..|..++.+|+||+++.+|++.+++...-... +.+..+..+++++++||.|||.+| .
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G-------l~E~~Ia~iLre~LkaL~YLH~~G---~ 147 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG-------LEEASIATILREVLKALDYLHQNG---H 147 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc-------ccHHHHHHHHHHHHHHHHHHHhcC---c
Confidence 678899999999999999999999999999999999998765433 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhc-ccc-cceeccccccCchhhhc--CCCCccccchhhhHHHHHHHh
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHS-TRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~-~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~ 157 (247)
+|||||+.|||++.+|.++|+|||.+......... ... ....|+++|+|||++.. .+|+.|+||||||++..|+.+
T Consensus 148 IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~ 227 (516)
T KOG0582|consen 148 IHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH 227 (516)
T ss_pred eecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc
Confidence 99999999999999999999999987644332211 111 44579999999999654 579999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||....+- +.+........+... ......+....++..+.+++..||.+||++|||++++++
T Consensus 228 G~aPf~k~pPm--kvLl~tLqn~pp~~~-----t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 228 GHAPFSKYPPM--KVLLLTLQNDPPTLL-----TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCCcccCChH--HHHHHHhcCCCCCcc-----cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 99999744221 111111111111000 112222223345558999999999999999999999997
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=255.28 Aligned_cols=228 Identities=24% Similarity=0.325 Sum_probs=186.0
Q ss_pred CcccccCCCccceeeEEee-----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 1 MVSRLKHENFVQLLGYCVD-----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+|+.++|+||+.+++++.. -+..|+|+|+++ .+|.+.++.... ++...+..++.|++.||+|+|+
T Consensus 74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~~---------L~d~H~q~f~YQiLrgLKyiHS 143 (359)
T KOG0660|consen 74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQD---------LTDDHAQYFLYQILRGLKYIHS 143 (359)
T ss_pred HHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcCcc---------ccHHHHHHHHHHHHHhcchhhc
Confidence 4678999999999999876 356899999996 499999987663 8999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
.+ ++|||+||.|++++.+..+||+|||+++...........+....|.+|+|||++.. ..|+.+.||||+||++.|
T Consensus 144 An---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AE 220 (359)
T KOG0660|consen 144 AN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAE 220 (359)
T ss_pred cc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHH
Confidence 99 99999999999999999999999999997754322222245678999999998864 689999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC---------CCC-----CHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG---------GDY-----PPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~-----~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|++.|.+.+...|-.++....+..+.+.+..+.....+ ... -+.......+|+.+||.+||.+
T Consensus 221 mL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~k 300 (359)
T KOG0660|consen 221 MLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKK 300 (359)
T ss_pred HHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccc
Confidence 99999999999998888888888877776655554422221 111 1244567999999999999999
Q ss_pred CCCHHHHHH--HHHHhHhcCCCC
Q 025816 221 RPNMSIVVK--ALQPLLNARPGP 241 (247)
Q Consensus 221 Rps~~~il~--~l~~~~~~~~~~ 241 (247)
|+|++|.|+ -+.....-..+|
T Consensus 301 Rita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 301 RITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred cCCHHHHhcChhhhhhcCCccCC
Confidence 999999998 455555444444
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=255.21 Aligned_cols=213 Identities=27% Similarity=0.419 Sum_probs=169.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCC-------CCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA-------QPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-------~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+++++||||+++++++......+++|||+.+++|.+++......... .....+++..++.++.|++.||.|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 57789999999999999999999999999999999999765321110 00134888999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+
T Consensus 142 ~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 142 SHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred hCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHH
Confidence 999 99999999999999999999999999875432222111223345778999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
|++ |..||.+... ..+.+.+........+..++.++.+++.+||+.||.+|||+.+|++.|+.
T Consensus 219 l~~~g~~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 219 IFSYGLQPYYGFSN----------------QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCCCCCCCCCH----------------HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 998 9999864321 12222222223333455667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=254.82 Aligned_cols=219 Identities=27% Similarity=0.427 Sum_probs=171.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+++++|+||+++++++..+...++||||+.+++|.+++....... .......+++..++.++.|++.||.|||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 578999999999999999999999999999999999997543210 0111223889999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
+++ ++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+
T Consensus 141 ~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 141 SQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred hCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 999 99999999999999999999999999875433222112223345678999999998889999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
|++ |..||..... ....+.+........+...+..+.+++.+||+.+|.+|||++++++.|++
T Consensus 218 l~t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~ 281 (291)
T cd05094 218 IFTYGKQPWFQLSN----------------TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA 281 (291)
T ss_pred HHhCCCCCCCCCCH----------------HHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 998 9999864321 11111111222222233445679999999999999999999999999999
Q ss_pred hHhcCC
Q 025816 234 LLNARP 239 (247)
Q Consensus 234 ~~~~~~ 239 (247)
+.++.|
T Consensus 282 ~~~~~~ 287 (291)
T cd05094 282 LGKATP 287 (291)
T ss_pred HHhhcC
Confidence 987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=267.39 Aligned_cols=195 Identities=27% Similarity=0.356 Sum_probs=169.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
|+++|+||||+.++++|++..+.++|.|||.| +|..++..... ++++.+..++.++++||.|||+.+
T Consensus 54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~---------lpEe~v~~~a~~LVsaL~yLhs~r--- 120 (808)
T KOG0597|consen 54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGK---------LPEEQVRAIAYDLVSALYYLHSNR--- 120 (808)
T ss_pred HHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHhcC---
Confidence 57899999999999999999999999999976 99999987664 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+|||+||+||++.++|.+|++|||+++.+.....- -....||+.|+|||.+.+..|+..+|+|||||++||++.|++
T Consensus 121 ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v--ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 121 ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV--LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred cccccCCcceeeecCCCceeechhhhhhhcccCcee--eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999999977653332 245679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||.. ..+.+.+.....+. .+...+.++..++..+|.+||..|.|..+++.
T Consensus 199 PF~a-------------------~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 199 PFYA-------------------RSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CchH-------------------HHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 9962 22233333333222 34477788999999999999999999999987
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=265.31 Aligned_cols=216 Identities=27% Similarity=0.448 Sum_probs=167.0
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCC-----------------------------------
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV----------------------------------- 45 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----------------------------------- 45 (247)
++.+ +|+||+++++++......++||||+.+|+|.+++......
T Consensus 95 l~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred HHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 4567 8999999999999999999999999999999998543210
Q ss_pred --------------------------CCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCce
Q 025816 46 --------------------------KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 99 (247)
Q Consensus 46 --------------------------~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~ 99 (247)
.......++++..++.++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~ 251 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVA 251 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeE
Confidence 00111234888999999999999999999999 9999999999999999999
Q ss_pred eeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCCCcchhhhcc
Q 025816 100 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 178 (247)
Q Consensus 100 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 178 (247)
+|+|||++................++..|+|||.+.+..++.++||||+|+++|+|++ |..||......
T Consensus 252 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---------- 321 (374)
T cd05106 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---------- 321 (374)
T ss_pred EEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----------
Confidence 9999999875433221111122234567999999988889999999999999999997 99999643211
Q ss_pred ccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 179 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
...............+...+.++.+++.+||+.||.+|||+.++++.|++++
T Consensus 322 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 322 -----SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -----HHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1111222222222233334567999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=255.75 Aligned_cols=197 Identities=25% Similarity=0.368 Sum_probs=168.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||+.|+||||+++|.+|++.+.+.+||||..+|.|+|++.+... |++..+..+++||++|+.|+|+++
T Consensus 106 IMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~---------LsErEaRhfFRQIvSAVhYCHknr--- 173 (668)
T KOG0611|consen 106 IMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS---------LSEREARHFFRQIVSAVHYCHKNR--- 173 (668)
T ss_pred HHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHhhcc---
Confidence 58999999999999999999999999999999999999988764 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~ 159 (247)
++|||+|.+|||++.|+++||.|||++.++...... ..++|++.|.+||+++|.+| .+..|.||||+++|-+..|.
T Consensus 174 VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGt 250 (668)
T KOG0611|consen 174 VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGT 250 (668)
T ss_pred ceecccchhheeecCCCCeeeeccchhhhhccccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcc
Confidence 999999999999999999999999999877554332 56789999999999999988 46799999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
.||.+.+.. .-++++-....+ .++-+.+..-||+|||-.||.+|.|+++|...
T Consensus 251 MPFDG~Dhk---------------~lvrQIs~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 251 MPFDGRDHK---------------RLVRQISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred cccCCchHH---------------HHHHHhhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 999876432 112222222221 22334468889999999999999999999764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=264.20 Aligned_cols=215 Identities=24% Similarity=0.373 Sum_probs=165.9
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCC--------------------------------
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA-------------------------------- 48 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-------------------------------- 48 (247)
|+++ +||||+++++++..+...++||||+.+|+|.+++.........
T Consensus 92 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (375)
T cd05104 92 LSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM 171 (375)
T ss_pred HHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence 4566 8999999999999999999999999999999999754321000
Q ss_pred ----------------------------------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeec
Q 025816 49 ----------------------------------QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF 94 (247)
Q Consensus 49 ----------------------------------~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~ 94 (247)
..+..+++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~ 248 (375)
T cd05104 172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLT 248 (375)
T ss_pred CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEE
Confidence 01124788999999999999999999999 99999999999999
Q ss_pred CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCCCcch
Q 025816 95 DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL 173 (247)
Q Consensus 95 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~ 173 (247)
.++.++|+|||++............+...++..|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 249 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----- 323 (375)
T cd05104 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----- 323 (375)
T ss_pred CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-----
Confidence 999999999999876543222111222334567999999998899999999999999999998 88888643211
Q ss_pred hhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 174 VTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
....+.+........+...+.++.+++.+||+.||.+|||+.+|++.|+..
T Consensus 324 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 324 ----------SKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----------HHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111222222222222333456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=250.15 Aligned_cols=205 Identities=26% Similarity=0.392 Sum_probs=164.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH~~~---i 128 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLSEMG---Y 128 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5678999999999999999999999999999999999875432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+||||+|+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.++||||+|+++|++++ |..
T Consensus 129 iH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~ 207 (266)
T cd05064 129 VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207 (266)
T ss_pred eeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999987653221111 1111234567999999998899999999999999999775 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
||..... ..+.+.+........+..++..+.+++.+||+.+|.+|||+++|++.|..+
T Consensus 208 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 208 PYWDMSG----------------QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CcCcCCH----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9964321 111222222222233455677899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=271.45 Aligned_cols=205 Identities=22% Similarity=0.321 Sum_probs=163.7
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++..+...++||||+.+|+|.+.+..... ...++++..+..++.|++.||.|||+.+
T Consensus 118 ~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~lH~~~--- 189 (478)
T PTZ00267 118 CLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK-----EHLPFQEYEVGLLFYQIVLALDEVHSRK--- 189 (478)
T ss_pred HHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999999999998764321 1123888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.++.++|+|||++................||..|+|||.+.+..++.++|||||||++|+|++|..
T Consensus 190 ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~ 269 (478)
T PTZ00267 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269 (478)
T ss_pred EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999986543322222234568999999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||...... ..+...... .....+...+.++.++|.+||..+|.+|||+++++.
T Consensus 270 Pf~~~~~~---------------~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 270 PFKGPSQR---------------EIMQQVLYG-KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCCHH---------------HHHHHHHhC-CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 99643210 111111111 111223345567999999999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=259.59 Aligned_cols=198 Identities=21% Similarity=0.267 Sum_probs=161.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..++..++||||+.+++|.+.+.... .+++..+..++.|++.||.|||+.+
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~--- 115 (323)
T cd05571 48 VLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALGYLHSCD--- 115 (323)
T ss_pred HHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678899999999999999999999999999999999987543 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||+||++|+|++|..
T Consensus 116 ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 193 (323)
T cd05571 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (323)
T ss_pred eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCC
Confidence 99999999999999999999999999875322111 1233568999999999998899999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~ 229 (247)
||...+... ........ ....+...+.++.+++.+||..||.+|| ++.++++
T Consensus 194 Pf~~~~~~~---------------~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 194 PFYNQDHEK---------------LFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHH---------------HHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 996432110 00011111 1123445567799999999999999999 8999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=274.02 Aligned_cols=214 Identities=23% Similarity=0.301 Sum_probs=172.2
Q ss_pred Cccccc-CCCccceeeEE-ee---C---CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHH
Q 025816 1 MVSRLK-HENFVQLLGYC-VD---G---TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 72 (247)
Q Consensus 1 ~l~~l~-h~~i~~~~~~~-~~---~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 72 (247)
+|++|+ |+|||.++|.. .. . -..+|+||||.||.|-|+++++-... |++..+++|+.+++.|+.+
T Consensus 87 ~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-------lte~eVLkIf~dv~~AVa~ 159 (738)
T KOG1989|consen 87 IMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-------LTEDEVLKIFYDVCEAVAA 159 (738)
T ss_pred HHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-------CChHHHHHHHHHHHHHHHH
Confidence 477887 99999999942 21 1 24679999999999999999776544 9999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc-cc------ccceeccccccCchhhh---cCCCCcc
Q 025816 73 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LH------STRVLGTFGYHAPEYAM---TGQLNAK 142 (247)
Q Consensus 73 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~------~~~~~~~~~y~aPE~~~---~~~~~~~ 142 (247)
||... ++|+|||||-+|||++.+|.+||||||-+......... .. .-...-|+.|+|||++. +...++|
T Consensus 160 mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK 238 (738)
T KOG1989|consen 160 MHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK 238 (738)
T ss_pred HhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch
Confidence 99995 66999999999999999999999999988643222110 00 01134688999999885 5678999
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC
Q 025816 143 SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP 222 (247)
Q Consensus 143 ~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 222 (247)
+|||+|||+||.|+....||+..- -..+++....-.-.+.++..+.+||+.||+.||.+||
T Consensus 239 sDIWALGclLYkLCy~t~PFe~sg-------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP 299 (738)
T KOG1989|consen 239 SDIWALGCLLYKLCYFTTPFEESG-------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERP 299 (738)
T ss_pred hHHHHHHHHHHHHHHhCCCcCcCc-------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCC
Confidence 999999999999999999997431 1233444443344468899999999999999999999
Q ss_pred CHHHHHHHHHHhHhcCCCC
Q 025816 223 NMSIVVKALQPLLNARPGP 241 (247)
Q Consensus 223 s~~~il~~l~~~~~~~~~~ 241 (247)
++.++++.+..+.+.+++=
T Consensus 300 nI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 300 NIYQVLEEIFELANKPCPI 318 (738)
T ss_pred CHHHHHHHHHHHhcCCCCc
Confidence 9999999999998877653
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=254.23 Aligned_cols=204 Identities=30% Similarity=0.528 Sum_probs=160.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||++++|++......++|+||+.+|+|.+++...... .+++..++.++.|++.||.|||+.+ +
T Consensus 55 l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~-------~~~~~~~~~i~~~i~~~l~~Lh~~~---i 124 (259)
T PF07714_consen 55 LRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKE-------PLSEQQRLSIAIQIAEALSYLHSNN---I 124 (259)
T ss_dssp HHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTT-------TSBHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccccccccccccccccc---c
Confidence 56889999999999999888899999999999999999887322 2999999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|++|+++||+++.++.+||+|||++....................|.|||.+.+..++.++||||||++++++++ |..
T Consensus 125 iH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~ 204 (259)
T PF07714_consen 125 IHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKF 204 (259)
T ss_dssp EEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999876532222222233456778999999999889999999999999999999 678
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
||... ....+.+.+....+...+..++..+.+++.+||..+|.+|||+++|++.|
T Consensus 205 p~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 205 PFSDY----------------DNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTTTS----------------CHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccc----------------ccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 87532 22223333334444445556678899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=280.19 Aligned_cols=218 Identities=28% Similarity=0.446 Sum_probs=186.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|+.+.|||||+++|++......++++||+++|+|.+++.+....... ...++....+.++.+|++|..||+++.
T Consensus 748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~~--- 822 (1025)
T KOG1095|consen 748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESKH--- 822 (1025)
T ss_pred HHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhCC---
Confidence 578999999999999999998999999999999999999876433222 234999999999999999999999998
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
+|||||..+|+|++....+||+|||+++.......+.......-...|+|||.+....|+.++||||||+++||+++ |.
T Consensus 823 fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~ 902 (1025)
T KOG1095|consen 823 FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGA 902 (1025)
T ss_pred CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCC
Confidence 99999999999999999999999999995544444433333345678999999999999999999999999999999 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhh-hcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQ-CVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
.||.. ..+.++.. ....+ +.+.|..+++.++++|..||+.+|.+||++..|++.+..+.++.
T Consensus 903 ~PY~~----------------~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 903 TPYPS----------------RSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CCCCC----------------cchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 99963 23444444 44444 88999999999999999999999999999999999998888764
Q ss_pred CC
Q 025816 239 PG 240 (247)
Q Consensus 239 ~~ 240 (247)
-+
T Consensus 966 ~~ 967 (1025)
T KOG1095|consen 966 LG 967 (1025)
T ss_pred cc
Confidence 43
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=243.01 Aligned_cols=187 Identities=24% Similarity=0.368 Sum_probs=164.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||+.+.||.++++++.|.+.+.++|||||..||-|.+++.+... +++..++..+.||+.||.|||+.+
T Consensus 97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~~--- 164 (355)
T KOG0616|consen 97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSLD--- 164 (355)
T ss_pred HHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhcC---
Confidence 57889999999999999999999999999999999999987653 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|++||+||+|||+|++|.+||+|||.+.+.... +-..+||+.|+|||++...+|..++|-|+||+++|||+.|.+
T Consensus 165 iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~p 239 (355)
T KOG0616|consen 165 IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYP 239 (355)
T ss_pred eeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999999876543 245689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFR 221 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 221 (247)
||....+ ......++...+ .+|...+.++.+|++++|+.|-.+|
T Consensus 240 PF~~~~~---------------~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 240 PFYDDNP---------------IQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcCCCh---------------HHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 9985532 223333333333 5677778889999999999999998
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=251.35 Aligned_cols=219 Identities=26% Similarity=0.434 Sum_probs=169.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC----CCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK----GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
+++++||||+++++++......+++|||+.+++|.+++....... .......+++..++.++.|++.||.|||+.+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578899999999999999999999999999999999986443110 0011123899999999999999999999999
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++++|++
T Consensus 141 ---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 141 ---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred ---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999875533222111222334667999999988889999999999999999998
Q ss_pred -CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 158 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 158 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
|..||...... ...+.+........+...+.++.+++.+||+.+|.+|||++++++.|+.+.+
T Consensus 218 ~g~~p~~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 218 YGKQPWYQLSNN----------------EVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CCCCCCCCCCHH----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 89998643211 1111111111111222345679999999999999999999999999999987
Q ss_pred cCC
Q 025816 237 ARP 239 (247)
Q Consensus 237 ~~~ 239 (247)
+-+
T Consensus 282 ~~~ 284 (288)
T cd05093 282 ASP 284 (288)
T ss_pred hcc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=250.01 Aligned_cols=211 Identities=25% Similarity=0.418 Sum_probs=166.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++++.||||+++++++. +...++++||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 63 l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i 130 (279)
T cd05111 63 MGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEHR---M 130 (279)
T ss_pred HhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 46789999999999875 4457789999999999999975432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||||+||+++.++.++|+|||.++...............++..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus 131 iH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~ 210 (279)
T cd05111 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAE 210 (279)
T ss_pred eccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999875432222111223345668999999988889999999999999999998 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCCC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~~ 240 (247)
||.+.... ...+.+........+..++.++.+++.+||..||.+|||+.++++.|..+.+.+|+
T Consensus 211 p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~ 274 (279)
T cd05111 211 PYAGMRPH----------------EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPR 274 (279)
T ss_pred CCCCCCHH----------------HHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcc
Confidence 99654321 11111222222222223455689999999999999999999999999998876643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=251.96 Aligned_cols=217 Identities=25% Similarity=0.425 Sum_probs=171.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC---------------CCCCCCCcCHHHHHHHHHHH
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---------------GAQPGPVLSWQQRVKIAVGA 66 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------------~~~~~~~l~~~~~~~~~~~~ 66 (247)
+++++||||+++++.+..+...+++|||+.+++|.+++....... .......+++..++.++.|+
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 578899999999999999999999999999999999986532110 01112348899999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccch
Q 025816 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY 146 (247)
Q Consensus 67 ~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 146 (247)
+.||.|||+.+ ++|+||+|+||+++.++.++|+|||.++...............++..|+|||.+.+..++.++|+|
T Consensus 137 ~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 137 SRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred HHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 99999999998 999999999999999999999999998755332221112223346679999999888899999999
Q ss_pred hhhHHHHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 147 SFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 147 slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
|||+++++|++ |..||....+ ..+.+..........+...+.++.+++.+||+.+|.+|||+.
T Consensus 214 slG~~l~el~t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~ 277 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAP----------------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA 277 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCH----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 99999999998 9999864321 122222333333334445567899999999999999999999
Q ss_pred HHHHHHHHhHhc
Q 025816 226 IVVKALQPLLNA 237 (247)
Q Consensus 226 ~il~~l~~~~~~ 237 (247)
++++.|++++..
T Consensus 278 ~i~~~l~~~~~~ 289 (290)
T cd05045 278 DISKELEKMMVK 289 (290)
T ss_pred HHHHHHHHHHhc
Confidence 999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=248.23 Aligned_cols=207 Identities=27% Similarity=0.413 Sum_probs=166.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..+...+++|||+.+++|.+++....... +++..++.++.|++.+|.|||+.+ +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------l~~~~~~~~~~ql~~~l~~lH~~~---i 125 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VNAVVLLYMATQISSAMEYLEKKN---F 125 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 578899999999999999999999999999999999987544322 889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++......... ......++..|.|||.+.+..++.++|+||||+++|+|++ |..
T Consensus 126 ~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~ 204 (263)
T cd05052 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 204 (263)
T ss_pred eecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998765432211 1112233567999999988889999999999999999998 899
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
||...+.. ...+.+........+...+..+.+++.+||..+|.+|||+.++++.|+.++
T Consensus 205 p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 205 PYPGIDLS----------------QVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCCCHH----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 98643211 111112222223334455677999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=248.49 Aligned_cols=207 Identities=27% Similarity=0.439 Sum_probs=167.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++......+++|||+.+++|.+++..... .+++..+..++.|++.|+.|||+.+ +
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~---i 127 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMN---Y 127 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5788999999999999999999999999999999999876442 2899999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus 128 ~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~ 207 (266)
T cd05033 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER 207 (266)
T ss_pred ccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999987642222111122234567999999988889999999999999999998 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
||.... .......+........+...+..+.+++.+||+.+|.+|||++++++.|+.++
T Consensus 208 p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 208 PYWDMS----------------NQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCCC----------------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 985321 11122222222222333455677999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=252.23 Aligned_cols=215 Identities=28% Similarity=0.454 Sum_probs=169.0
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++++ +|+||+++++++..+...+++|||+.+|+|.+++....... .......+++..++.++.|++.||.||
T Consensus 69 l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 148 (293)
T cd05053 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148 (293)
T ss_pred HHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4566 89999999999999999999999999999999997542110 001233489999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+||||+++|
T Consensus 149 H~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (293)
T cd05053 149 ASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 225 (293)
T ss_pred HHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHH
Confidence 9998 9999999999999999999999999988654432222222223456799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
++++ |..||..... ....+.+........+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus 226 el~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 226 EIFTLGGSPYPGIPV----------------EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred HHhcCCCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 9997 8888863321 1122222222223344455677999999999999999999999999999
Q ss_pred HhH
Q 025816 233 PLL 235 (247)
Q Consensus 233 ~~~ 235 (247)
.++
T Consensus 290 ~~~ 292 (293)
T cd05053 290 RML 292 (293)
T ss_pred Hhh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=245.62 Aligned_cols=228 Identities=21% Similarity=0.262 Sum_probs=179.5
Q ss_pred CcccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
||.+.+|||||.+-.+.... +..|||||||++ +|..++..... ++....+.-+..|+++|++|||.+.
T Consensus 128 iLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q--------~F~~~evK~L~~QlL~glk~lH~~w- 197 (419)
T KOG0663|consen 128 ILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQ--------PFLPGEVKTLMLQLLRGLKHLHDNW- 197 (419)
T ss_pred HHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccC--------CCchHHHHHHHHHHHHHHHHHhhce-
Confidence 46788999999999887654 479999999987 99999988763 3899999999999999999999999
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHh
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~ 157 (247)
|+|||+|++|+|++..|.+||+|||+|+.++..... .+...-|.+|+|||.+.+. .|+.+.|+||+||++.++++
T Consensus 198 --ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~ 273 (419)
T KOG0663|consen 198 --ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT 273 (419)
T ss_pred --eEecccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh
Confidence 999999999999999999999999999987654322 2445679999999999885 69999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhccc--------------ccCCCCCHH-HHHHHHHHHHhhcccCCCCCC
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--------------RLGGDYPPK-AVAKMAAVAALCVQYEADFRP 222 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rp 222 (247)
+.+.|.+..+.+|...+-......++..+...... .++..+... .++.-++|+..+|..||.+|-
T Consensus 274 ~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~ 353 (419)
T KOG0663|consen 274 QKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI 353 (419)
T ss_pred cCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc
Confidence 99999988887775555444444444333222221 111112211 357789999999999999999
Q ss_pred CHHHHHHHHHHhHhcCCCCCCC
Q 025816 223 NMSIVVKALQPLLNARPGPAGE 244 (247)
Q Consensus 223 s~~~il~~l~~~~~~~~~~~~~ 244 (247)
|+++.|+. ..+...|.|.+|
T Consensus 354 tA~~~L~h--~~F~e~P~p~~P 373 (419)
T KOG0663|consen 354 TAEDGLKH--EYFRETPLPIDP 373 (419)
T ss_pred cHHHhhcc--cccccCCCCCCh
Confidence 99999874 344444444433
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=254.26 Aligned_cols=220 Identities=26% Similarity=0.377 Sum_probs=163.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC----------CCCCCCcCHHHHHHHHHHHHHHH
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG----------AQPGPVLSWQQRVKIAVGAAKGL 70 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~----------~~~~~~l~~~~~~~~~~~~~~~l 70 (247)
+|++++||||+++++++...+..+++|||+.+++|.+++........ ......+++..++.++.|++.||
T Consensus 72 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 151 (304)
T cd05096 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM 151 (304)
T ss_pred HHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 36789999999999999999999999999999999999865432111 11223478889999999999999
Q ss_pred HHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhH
Q 025816 71 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 150 (247)
Q Consensus 71 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 150 (247)
.|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+
T Consensus 152 ~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 152 KYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228 (304)
T ss_pred HHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence 9999999 9999999999999999999999999987543322211122334567899999998888999999999999
Q ss_pred HHHHHHh--CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 151 VLLELLT--GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 151 ~l~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
++|+|++ +..||....... ......... ...........+..++..+.+++.+||+.+|.+|||+++|.
T Consensus 229 ~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDEQ---VIENAGEFF------RDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHHHHHccCCCCCCcCCHHH---HHHHHHHHh------hhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 9999987 556775432110 000000000 00000011122334567799999999999999999999999
Q ss_pred HHHH
Q 025816 229 KALQ 232 (247)
Q Consensus 229 ~~l~ 232 (247)
+.|+
T Consensus 300 ~~l~ 303 (304)
T cd05096 300 AFLT 303 (304)
T ss_pred HHHh
Confidence 8876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=247.18 Aligned_cols=205 Identities=29% Similarity=0.468 Sum_probs=167.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++......+++|||+.+++|.+++....... +++..+..++.|++.||.|||+.+ +
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~~~~~i~~al~~lH~~~---i 125 (261)
T cd05148 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-------LPVASLIDMACQVAEGMAYLEEQN---S 125 (261)
T ss_pred HhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 678999999999999999999999999999999999997654332 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+......... .....++..|+|||...+..++.++|+||||++++++++ |..
T Consensus 126 ~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~ 203 (261)
T cd05148 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203 (261)
T ss_pred eccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998765332211 112335667999999988889999999999999999998 899
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
||..... ......+........+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 204 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 204 PYPGMNN----------------HEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCcCCH----------------HHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 9964321 111112222233344456667899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=263.23 Aligned_cols=211 Identities=32% Similarity=0.476 Sum_probs=181.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|||||++||+...+..+++|||+|.||+|.+++.+.... ++......++.+.+.||.|||+.+
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~--------v~~~ek~~~~~~AA~Gl~YLh~k~--- 282 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKS--------LPTLEKLRFCYDAARGLEYLHSKN--- 282 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCC--------CCHHHHHHHHHHHHhHHHHHHHCC---
Confidence 478899999999999999999999999999999999999987752 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++||||..+|+|++.++.+||+|||+++........ .....-...|+|||.+....|+.++||||+|+++||+++ |.
T Consensus 283 ~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~ 360 (474)
T KOG0194|consen 283 CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGA 360 (474)
T ss_pred CcchhHhHHHheecCCCeEEeCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCC
Confidence 999999999999999999999999998865411111 112235678999999999999999999999999999999 88
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhc-ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCV-DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
.||.+. ....+...+ ....+...+...+.++..++.+||..+|.+|||+.++.+.++.+....
T Consensus 361 ~Py~g~----------------~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 361 EPYPGM----------------KNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred CCCCCC----------------CHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 898643 223444444 566677777788899999999999999999999999999999988765
Q ss_pred CC
Q 025816 239 PG 240 (247)
Q Consensus 239 ~~ 240 (247)
.+
T Consensus 425 ~~ 426 (474)
T KOG0194|consen 425 EA 426 (474)
T ss_pred cc
Confidence 54
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=246.72 Aligned_cols=205 Identities=26% Similarity=0.449 Sum_probs=162.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..+...++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~--- 114 (252)
T cd05084 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP--------RLKVKELIQMVENAAAGMEYLESKH--- 114 (252)
T ss_pred HHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999999999999864321 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|.||+++.++.++|+|||++.................+..|+|||.+.+..++.++|+||||+++|++++ |.
T Consensus 115 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~ 194 (252)
T cd05084 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGA 194 (252)
T ss_pred ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999875432211111111123456999999988889999999999999999997 88
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
.||..... ......+........+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus 195 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 195 VPYANLSN----------------QQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCccccCH----------------HHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 88853211 1122222222223344455677999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=253.99 Aligned_cols=209 Identities=24% Similarity=0.388 Sum_probs=166.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+ ..+++++|+.+|+|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---i 130 (316)
T cd05108 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEERR---L 130 (316)
T ss_pred HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHhcC---e
Confidence 6788999999999998765 56789999999999999976542 2888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+||||||+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus 131 iH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~ 210 (316)
T cd05108 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 210 (316)
T ss_pred eccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999986543222211122234567999999998899999999999999999987 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
||..... ..+.+.+........+..++.++.+++.+||..+|.+|||+.+++..+..+.+.+
T Consensus 211 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 211 PYDGIPA----------------SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCCH----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 9864321 1122222222222333445567999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=257.09 Aligned_cols=196 Identities=23% Similarity=0.309 Sum_probs=160.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..++..+++|||+.+|+|.+.+..... ++...+..++.|++.||.|||+.+
T Consensus 71 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~--- 138 (329)
T PTZ00263 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR---------FPNDVAKFYHAELVLAFEYLHSKD--- 138 (329)
T ss_pred HHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999875432 888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++||||||+||+++.++.++|+|||++....... ....|+..|+|||.+.+..++.++|+|||||++|+|++|..
T Consensus 139 ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 213 (329)
T PTZ00263 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213 (329)
T ss_pred eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCC
Confidence 9999999999999999999999999987543211 23468889999999999889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~~ 230 (247)
||...... .....+.... ...+...+..+.+++.+||+.||.+||+ ++++++.
T Consensus 214 pf~~~~~~---------------~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 214 PFFDDTPF---------------RIYEKILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCHH---------------HHHHHHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99643211 0111111111 1233345567899999999999999997 6888754
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=251.45 Aligned_cols=208 Identities=25% Similarity=0.420 Sum_probs=165.8
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++ +||||+++++++......+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+++
T Consensus 92 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~--- 161 (302)
T cd05055 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES-------FLTLEDLLSFSYQVAKGMAFLASKN--- 161 (302)
T ss_pred HHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5677 7999999999999999999999999999999998754322 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++++|||.+................++..|+|||.+.+..++.++|+||+|+++|++++ |.
T Consensus 162 ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~ 241 (302)
T cd05055 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241 (302)
T ss_pred eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999875543221111122345678999999988889999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
.||...... ....+..........+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus 242 ~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 242 NPYPGMPVD---------------SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCcCCCCch---------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 998643211 111122222222222333456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=248.60 Aligned_cols=213 Identities=27% Similarity=0.447 Sum_probs=166.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC-----CCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG-----AQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-----~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+|++++|+||+++++++..+...+++|||+.+++|.+++........ ......+++..+..++.|++.|+.+||+
T Consensus 61 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 140 (280)
T cd05049 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140 (280)
T ss_pred HHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence 36788999999999999999999999999999999999976432110 1122348899999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ ++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 141 ~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 141 QH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred CC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHH
Confidence 99 999999999999999999999999998754222211112233356789999999988999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
++ |..||..... ....+.+........+...+..+.+++.+||..||.+|||++|+++.|+
T Consensus 218 ~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 218 FTYGKQPWYGLSN----------------EEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HhcCCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 98 9999864321 1111112222222233445677999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=254.34 Aligned_cols=199 Identities=21% Similarity=0.271 Sum_probs=161.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..+...++||||+.+|+|.+.+.... .+++..+..++.|++.||.|||+.+
T Consensus 48 ~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~--- 115 (328)
T cd05593 48 VLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLHSGK--- 115 (328)
T ss_pred HHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678899999999999999999999999999999998886543 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 116 ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 193 (328)
T cd05593 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (328)
T ss_pred eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCC
Confidence 99999999999999999999999999875322111 1123458899999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
||...+... ....... .....+...+.++.+++.+||..||.+|+ +++++++.
T Consensus 194 Pf~~~~~~~---------------~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 194 PFYNQDHEK---------------LFELILM--EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHH---------------HHHHhcc--CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 996432110 0000000 01123344567799999999999999997 89999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=255.74 Aligned_cols=198 Identities=19% Similarity=0.217 Sum_probs=160.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..++..++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+
T Consensus 46 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--- 113 (312)
T cd05585 46 VLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG---------RFDLSRARFYTAELLCALENLHKFN--- 113 (312)
T ss_pred HHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3578899999999999999999999999999999999987543 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++||||+|+++|+|++|..
T Consensus 114 i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~ 191 (312)
T cd05585 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP 191 (312)
T ss_pred eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCC
Confidence 99999999999999999999999999875322111 1233468899999999999899999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC---HHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN---MSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~il~ 229 (247)
||...... ......... ....+...+..+.+++.+||..||.+||+ +.+++.
T Consensus 192 pf~~~~~~---------------~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 192 PFYDENVN---------------EMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CcCCCCHH---------------HHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 99643211 111111111 11233455677999999999999999985 566665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=246.07 Aligned_cols=206 Identities=29% Similarity=0.458 Sum_probs=165.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..+++|||+.+++|.+++...... .+++..+..++.|++.||.+||+.+ +
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i 124 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGR-------ALKLPQLIDMAAQVASGMAYLEAQN---Y 124 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 57899999999999999999999999999999999999765422 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|+||||++++++++ |..
T Consensus 125 ~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 203 (261)
T cd05068 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM 203 (261)
T ss_pred eeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999998765422111 1111223457999999988889999999999999999999 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
||..... ......+........+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 204 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 204 PYPGMTN----------------AEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 9864321 111112222222233344567899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=248.01 Aligned_cols=220 Identities=26% Similarity=0.387 Sum_probs=168.5
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
|++++||||+++++++... ...+++|||+.+++|.+++.... +++..++.++.|++.||.|||+.+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------l~~~~~~~i~~~l~~~l~~lH~~~-- 127 (283)
T cd05080 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQICEGMAYLHSQH-- 127 (283)
T ss_pred HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcC----------CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 6789999999999987653 46889999999999999997543 899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++++|++|
T Consensus 128 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg 206 (283)
T cd05080 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH 206 (283)
T ss_pred -eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhC
Confidence 9999999999999999999999999987654322111 11122345569999999888899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
..||........ ................+..+.......+...+..+.+++.+||+.+|.+|||++++++.|+.+.
T Consensus 207 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 207 CDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCcchhh-hhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 999864432111 1111111111112222233333333344556678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=248.83 Aligned_cols=212 Identities=26% Similarity=0.414 Sum_probs=166.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCC-CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA-QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++||||+++++++..+...+++|||+.+++|.+++......... .....+++..+..++.|++.||.|||+.+
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 139 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--- 139 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 56789999999999999999999999999999999998754322111 11223788899999999999999999998
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||+++...............++..|.|||.+.+..++.++|+||||+++|++++ |.
T Consensus 140 i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 219 (277)
T cd05032 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAE 219 (277)
T ss_pred ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCC
Confidence 99999999999999999999999999875543322212223345678999999988889999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
.||...... ...+.+........+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus 220 ~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 220 QPYQGLSNE----------------EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCccCCHH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 998643211 111111122222334445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=251.26 Aligned_cols=204 Identities=21% Similarity=0.285 Sum_probs=163.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++++++.+++..+++|||+.+|+|.+.+...... .+++..+..++.|++.||.|||+.+
T Consensus 53 il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--- 122 (285)
T cd05631 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-------GFDEQRAIFYAAELCCGLEDLQRER--- 122 (285)
T ss_pred HHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367889999999999999999999999999999998887643322 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++||||||+||+++.++.++|+|||++........ .....|+..|+|||.+.+..++.++||||+|+++|+|++|..
T Consensus 123 iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~ 199 (285)
T cd05631 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199 (285)
T ss_pred EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCC
Confidence 99999999999999999999999999876432211 123457899999999999899999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~~ 230 (247)
||.......... .+...+ .......+...+.++.+++.+||+.||.+||| ++++++.
T Consensus 200 pf~~~~~~~~~~------------~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 200 PFRKRKERVKRE------------EVDRRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCCCCCcchhHH------------HHHHHh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 997543321110 011100 01112234455678999999999999999997 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=254.15 Aligned_cols=196 Identities=21% Similarity=0.293 Sum_probs=161.3
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 54 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~--- 121 (291)
T cd05612 54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---------FSNSTGLFYASEIVCALEYLHSKE--- 121 (291)
T ss_pred HHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999875432 888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++||||||+||+++.++.++|+|||++...... .....|+..|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 122 i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~ 196 (291)
T cd05612 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196 (291)
T ss_pred eeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998754321 123457889999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~~ 230 (247)
||...... .......... ...+...+..+.+++++||+.||.+||+ ++++++.
T Consensus 197 pf~~~~~~---------------~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 197 PFFDDNPF---------------GIYEKILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCCCCHH---------------HHHHHHHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 99643211 1111111111 1233344667999999999999999995 8998874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=254.24 Aligned_cols=214 Identities=21% Similarity=0.342 Sum_probs=162.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-CCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~-~~~ 79 (247)
+|++++||||+++++++..+...++||||+.+++|.+++..... +++..+..++.|++.||.|||+. +
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~~-- 124 (331)
T cd06649 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---------IPEEILGKVSIAVLRGLAYLREKHQ-- 124 (331)
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHhhcCC--
Confidence 36789999999999999999999999999999999999976432 88999999999999999999985 5
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 125 -ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 199 (331)
T cd06649 125 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199 (331)
T ss_pred -EEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987543221 12345788999999999888999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhh------------cc---------------ccCCcc---hhhhhcccccCCC-CCHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTW------------AT---------------PKLSED---KVRQCVDARLGGD-YPPKAVAKMAA 208 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~------------~~---------------~~~~~~---~~~~~~~~~~~~~-~~~~~~~~l~~ 208 (247)
.||...+.......... .. ...... .....+....... .....+.++.+
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (331)
T cd06649 200 YPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQE 279 (331)
T ss_pred CCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHH
Confidence 99964432110000000 00 000000 0000010101111 11235678999
Q ss_pred HHHhhcccCCCCCCCHHHHHHH
Q 025816 209 VAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 209 li~~cl~~~p~~Rps~~~il~~ 230 (247)
++.+||+.||++|||++++++.
T Consensus 280 li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 280 FVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred HHHHHccCCcccCCCHHHHhcC
Confidence 9999999999999999999984
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=254.74 Aligned_cols=203 Identities=22% Similarity=0.257 Sum_probs=161.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---i 122 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV---------LSEDHARFYMAEMFEAVDALHELG---Y 122 (333)
T ss_pred HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999975432 889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++..... ......|+..|+|||.+.+..++.++|||||||++|+|++|..|
T Consensus 123 vH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p 197 (333)
T cd05600 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197 (333)
T ss_pred cccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCC
Confidence 9999999999999999999999999875433 12334688899999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|.............. .................+.++.+++.+||..+|.+|||++++++.
T Consensus 198 f~~~~~~~~~~~i~~---------~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 198 FSGSTPNETWENLKY---------WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCHHHHHHHHHh---------ccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 975432111000000 000000000000012346679999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=244.50 Aligned_cols=212 Identities=31% Similarity=0.449 Sum_probs=169.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..+...+++|||+.+++|.+++...........+..+++..++.++.|++.||.+||+.+ +
T Consensus 50 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i 126 (262)
T cd00192 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---F 126 (262)
T ss_pred HhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---c
Confidence 5678999999999999999999999999999999999987632211111233999999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+................++..|+|||.+....++.++|+||+|+++|+|++ |..
T Consensus 127 ~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 127 VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred ccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987654332222233456778999999988889999999999999999999 699
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
||..... ..+.+.+........+...+.++.+++.+||..+|.+|||++++++.|+
T Consensus 207 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 207 PYPGLSN----------------EEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9865421 1112222222223344555778999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=252.01 Aligned_cols=216 Identities=19% Similarity=0.236 Sum_probs=159.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..+...++||||+.++.+..+..... .+++..+..++.|++.||.|||+.+
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~--- 120 (287)
T cd07848 53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHKND--- 120 (287)
T ss_pred HHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999998866654433221 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 121 i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~ 199 (287)
T cd07848 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199 (287)
T ss_pred eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCC
Confidence 999999999999999999999999998765322211 1123457889999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcc---------ccc------CCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVD---------ARL------GGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
||...................+......... +.. ........+.++.+++++||+.||.+|||++
T Consensus 200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~ 279 (287)
T cd07848 200 LFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTE 279 (287)
T ss_pred CCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHH
Confidence 9976443221111111111111111100000 000 0011122456799999999999999999999
Q ss_pred HHHH
Q 025816 226 IVVK 229 (247)
Q Consensus 226 ~il~ 229 (247)
++++
T Consensus 280 ~~l~ 283 (287)
T cd07848 280 QCLN 283 (287)
T ss_pred HHhc
Confidence 9986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=246.01 Aligned_cols=207 Identities=25% Similarity=0.403 Sum_probs=165.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++++.+..++..+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~l~~~l~~LH~~~--- 123 (261)
T cd05072 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGG-------KVLLPKLIDFSAQIAEGMAYIERKN--- 123 (261)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 357889999999999999999999999999999999998764332 2888999999999999999999998
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 124 i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~ 202 (261)
T cd05072 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK 202 (261)
T ss_pred eeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCC
Confidence 999999999999999999999999999765432211 1122234567999999988889999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
.||...... .....+............+..+.+++.+||..+|++|||++++++.|+.+
T Consensus 203 ~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 203 IPYPGMSNS----------------DVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHH----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 999643211 11111111111222234456799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=249.38 Aligned_cols=219 Identities=26% Similarity=0.447 Sum_probs=171.1
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++.+ +||||+++++++......+++|||+.+++|.+++....... ...+...+++..+..++.|++.||.||
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L 153 (304)
T cd05101 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL 153 (304)
T ss_pred HHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence 4566 89999999999999999999999999999999997643210 001223488899999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++|+||||+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|
T Consensus 154 H~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 230 (304)
T cd05101 154 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230 (304)
T ss_pred HHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHH
Confidence 9999 9999999999999999999999999987654332222222233456799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
++++ |..||.... ...+.+.+........+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 231 el~~~g~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 231 EIFTLGGSPYPGIP----------------VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred HHHcCCCCCcccCC----------------HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 9998 788875321 11122222222222334455678999999999999999999999999999
Q ss_pred HhHhcCC
Q 025816 233 PLLNARP 239 (247)
Q Consensus 233 ~~~~~~~ 239 (247)
+++....
T Consensus 295 ~~~~~~~ 301 (304)
T cd05101 295 RILTLTT 301 (304)
T ss_pred HHHHhhh
Confidence 9886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=253.14 Aligned_cols=197 Identities=24% Similarity=0.335 Sum_probs=159.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..++||||+.+++|...+.... +++..+..++.|++.||.|||+.+ +
T Consensus 56 ~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~al~~lH~~~---i 122 (324)
T cd05589 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV----------FSEPRAVFYAACVVLGLQYLHENK---I 122 (324)
T ss_pred ccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 467899999999999999999999999999999998886532 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 123 vHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~p 200 (324)
T cd05589 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200 (324)
T ss_pred EecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 9999999999999999999999998865322111 12334688899999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
|....... ....+... ....+...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 201 f~~~~~~~---------------~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 201 FPGDDEEE---------------VFDSIVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCHHH---------------HHHHHHhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 97543211 01111111 1123344567799999999999999999 57777763
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=252.13 Aligned_cols=215 Identities=20% Similarity=0.320 Sum_probs=159.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..+...++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~--- 123 (288)
T cd07871 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHKRK--- 123 (288)
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999975 99998865432 2788999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
|+||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.
T Consensus 124 ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~ 201 (288)
T cd07871 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201 (288)
T ss_pred cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875432211 1123457889999998875 56899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhh---------hhcccccCC----CCCHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVR---------QCVDARLGG----DYPPKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
.||.......................+. ....+.... ......+.++.+++++||+.||.+|||++|
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~ 281 (288)
T cd07871 202 PMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA 281 (288)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 9997654321111111111111111111 111010000 001123567899999999999999999999
Q ss_pred HHH
Q 025816 227 VVK 229 (247)
Q Consensus 227 il~ 229 (247)
+++
T Consensus 282 ~l~ 284 (288)
T cd07871 282 ALR 284 (288)
T ss_pred Hhc
Confidence 985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=254.77 Aligned_cols=199 Identities=22% Similarity=0.285 Sum_probs=161.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++......++||||+.+|+|.+.+.... .+++..++.++.|++.||.|||+.+
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~--- 115 (323)
T cd05595 48 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD--- 115 (323)
T ss_pred HHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678899999999999999999999999999999998886543 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 116 ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~ 193 (323)
T cd05595 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (323)
T ss_pred eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCC
Confidence 99999999999999999999999998874322111 1123458899999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
||...+... ......... ...+...+.++.+++.+||..||.+|| ++.++++.
T Consensus 194 Pf~~~~~~~---------------~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 194 PFYNQDHER---------------LFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHH---------------HHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 996432210 011111111 123344567799999999999999998 89998873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=247.10 Aligned_cols=212 Identities=23% Similarity=0.379 Sum_probs=162.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC-CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG-AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++||||+++++++..+...++||||+.+++|.+++........ ......+++..+..++.|++.||.|||+.+
T Consensus 63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--- 139 (277)
T cd05062 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--- 139 (277)
T ss_pred HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999999999999999999999999999865332110 111223678889999999999999999998
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 140 ~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~ 219 (277)
T cd05062 140 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219 (277)
T ss_pred cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999875433222111122334678999999988889999999999999999998 78
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
.||...... ...+..........+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 220 ~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 220 QPYQGMSNE----------------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCHH----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 888643211 111111111111223344567999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=247.32 Aligned_cols=212 Identities=25% Similarity=0.404 Sum_probs=164.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC------CCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK------GAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++|+||+++++++..+...+++|||+.+++|.+++....... .......+++..+..++.|++.|++|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 578899999999999999999999999999999999987543210 00111238899999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ ++|+||+|+||+++.++.++|+|||++................++..|.|||.+.+..++.++|+||||+++|+|
T Consensus 141 ~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 217 (280)
T cd05092 141 LH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217 (280)
T ss_pred CC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 99 999999999999999999999999998754322211112223346679999999988899999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
++ |..||..... ....+..........+..++..+.+++.+||+.||.+||++++|++.|+
T Consensus 218 ~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 218 FTYGKQPWYQLSN----------------TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCCCCCCccCCH----------------HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 98 8999853221 1111111122222233345567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=249.75 Aligned_cols=220 Identities=28% Similarity=0.454 Sum_probs=169.1
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++++ +||||+++++++..+...+++|||+.+|+|.+++....... .......+++..+..++.|++.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 150 (314)
T cd05099 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150 (314)
T ss_pred HHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence 4556 69999999999999899999999999999999997643210 001123488999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++|+||||+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|
T Consensus 151 H~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 227 (314)
T cd05099 151 ESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227 (314)
T ss_pred HHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHH
Confidence 9999 9999999999999999999999999997654322211111122345799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
++++ |..||..... ....+.+........+...+.++.+++.+||..+|.+|||+.++++.|+
T Consensus 228 el~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 228 EIFTLGGSPYPGIPV----------------EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred HHHhCCCCCCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 9998 8888854321 1111111122222233445567999999999999999999999999999
Q ss_pred HhHhcCCC
Q 025816 233 PLLNARPG 240 (247)
Q Consensus 233 ~~~~~~~~ 240 (247)
++......
T Consensus 292 ~~~~~~~~ 299 (314)
T cd05099 292 KVLAAVSE 299 (314)
T ss_pred HHHHHhcC
Confidence 98864433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=254.34 Aligned_cols=198 Identities=22% Similarity=0.312 Sum_probs=161.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++.+..+...++||||+.+++|.+.+..... +....+..++.|++.||.|||+.+
T Consensus 53 il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~--- 120 (323)
T cd05584 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI---------FMEDTACFYLSEISLALEHLHQQG--- 120 (323)
T ss_pred HHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999865432 788889999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 121 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 198 (323)
T cd05584 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198 (323)
T ss_pred eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCC
Confidence 99999999999999999999999999864322211 1223458899999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~ 229 (247)
||...... .......... ...+...+..+.+++.+||+.+|.+|| +++++++
T Consensus 199 pf~~~~~~---------------~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 199 PFTAENRK---------------KTIDKILKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCHH---------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 99754221 1111111111 123344566799999999999999999 8888877
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=255.16 Aligned_cols=196 Identities=21% Similarity=0.266 Sum_probs=161.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++.++||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 84 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~--- 151 (340)
T PTZ00426 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR---------FPNDVGCFYAAQIVLIFEYLQSLN--- 151 (340)
T ss_pred HHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36788999999999999999999999999999999999976532 889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++||||||+||+++.++.++|+|||++...... .....||..|+|||++.+..++.++|+||+||++|+|++|..
T Consensus 152 ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~ 226 (340)
T PTZ00426 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226 (340)
T ss_pred eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCC
Confidence 999999999999999999999999998754321 123468889999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
||...+... ......... ...+...+..+.+++++||+.||.+|+ |++++++.
T Consensus 227 Pf~~~~~~~---------------~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 227 PFYANEPLL---------------IYQKILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCHHH---------------HHHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 997543210 011111111 122334456789999999999999995 89999874
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=246.17 Aligned_cols=210 Identities=28% Similarity=0.429 Sum_probs=164.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++......+++|||+.+++|.+++....... .....+++..+..++.|++.||.|||+.+ +
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i 137 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRP--ERPSSLTMKDLLFCARDVAKGCKYLEENH---F 137 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 578999999999999999999999999999999999987654211 11224899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCC---ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-
Q 025816 82 IHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT- 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~- 157 (247)
+|+||+|+||+++.++ .++|+|||+++................+..|+|||.+.+..++.++||||||+++|+|++
T Consensus 138 vH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~ 217 (277)
T cd05036 138 IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217 (277)
T ss_pred eecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcC
Confidence 9999999999998765 589999999886532221111112223457999999998889999999999999999997
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
|..||..... ......+........+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 218 g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 218 GYMPYPGRTN----------------QEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 9999864321 1112222222223334555678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=243.47 Aligned_cols=207 Identities=26% Similarity=0.451 Sum_probs=164.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++. ....++||||+.+++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 48 ~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~--- 115 (257)
T cd05115 48 IMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLEGKN--- 115 (257)
T ss_pred HHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---
Confidence 367899999999999875 4578999999999999999864332 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus 116 i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g 195 (257)
T cd05115 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYG 195 (257)
T ss_pred eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999987543221111 1111223467999999988889999999999999999996 9
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
..||..... ..+...+........+..++.++.+++.+||..+|.+||++.+|.+.|+.++
T Consensus 196 ~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 196 QKPYKKMKG----------------PEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred CCCcCcCCH----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 999964321 1222333333334455566778999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=246.14 Aligned_cols=213 Identities=26% Similarity=0.357 Sum_probs=167.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+++++||||+++++++......++++||+.+++|.+++....... .......+++..+..++.|++.||.|||
T Consensus 62 ~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred HhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 567899999999999999999999999999999999985332110 0111234888899999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
+.+ ++||||||.||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+||||+++|+
T Consensus 142 ~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 218 (283)
T cd05091 142 SHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218 (283)
T ss_pred HcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 999 99999999999999999999999999876543322222223345678999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
|++ |..||..... ..+.+.+........+..++..+.+++.+||+.+|.+|||+++|+..|+.
T Consensus 219 l~~~g~~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 219 VFSYGLQPYCGYSN----------------QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCCCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 998 8888864321 11222222222233445667789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=243.27 Aligned_cols=203 Identities=27% Similarity=0.447 Sum_probs=161.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..+...+++|||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~--- 120 (256)
T cd05114 52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNS--- 120 (256)
T ss_pred HHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999875432 1889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||+|+++|++++ |+
T Consensus 121 i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~ 199 (256)
T cd05114 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199 (256)
T ss_pred ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence 999999999999999999999999988754322211 1112234557999999988889999999999999999999 89
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
.||...+.. ...+.+........+...+..+.+++.+||..+|.+|||++++++.|
T Consensus 200 ~p~~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 200 MPFEKKSNY----------------EVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCHH----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 998643211 11111111111112223456799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=249.29 Aligned_cols=218 Identities=29% Similarity=0.452 Sum_probs=169.6
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++.+ +||||+++++++..+...+++|||+.+++|.+++....... .......+++..++.++.|++.||.||
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 156 (307)
T cd05098 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156 (307)
T ss_pred HHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4456 79999999999999999999999999999999997643210 011223488999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|
T Consensus 157 H~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 233 (307)
T cd05098 157 ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 233 (307)
T ss_pred HHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHH
Confidence 9998 9999999999999999999999999987654322111111222346799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
+|++ |..||..... ..+.+.+........+...+.++.+++.+||..+|.+|||+.++++.|+
T Consensus 234 el~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 234 EIFTLGGSPYPGVPV----------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred HHHcCCCCCCCcCCH----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 9998 8888854321 1122222222222334455678999999999999999999999999999
Q ss_pred HhHhcC
Q 025816 233 PLLNAR 238 (247)
Q Consensus 233 ~~~~~~ 238 (247)
+++...
T Consensus 298 ~~~~~~ 303 (307)
T cd05098 298 RILALT 303 (307)
T ss_pred HHHHHh
Confidence 988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=255.63 Aligned_cols=199 Identities=26% Similarity=0.417 Sum_probs=168.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|.+++++||.++|+.+..+..++++||||.||++.++++...- +.+..+..++++++.|+.|||..+
T Consensus 64 ~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~---------~~E~~i~~ilre~l~~l~ylH~~~--- 131 (467)
T KOG0201|consen 64 VLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNI---------LDEFEIAVILREVLKGLDYLHSEK--- 131 (467)
T ss_pred HHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCC---------CccceeeeehHHHHHHhhhhhhcc---
Confidence 36789999999999999999999999999999999999987652 477888889999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
.+|||||+.||++...|.+||+|||++-........ ...+.||+.|+|||++....|+.++||||||++.++|++|.+
T Consensus 132 kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GeP 209 (467)
T KOG0201|consen 132 KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEP 209 (467)
T ss_pred eecccccccceeEeccCcEEEEecceeeeeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCC
Confidence 999999999999999999999999999876554433 366789999999999999899999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|+....+-- +.-.+-....+.....++..+.+++..||.+||+.|||+.++|+
T Consensus 210 P~s~~hPmr----------------vlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 210 PHSKLHPMR----------------VLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCcccCcce----------------EEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 997554311 11111111222223356677999999999999999999999997
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=248.56 Aligned_cols=225 Identities=20% Similarity=0.259 Sum_probs=181.5
Q ss_pred CcccccCCCccceeeEEeeCC-----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 1 MVSRLKHENFVQLLGYCVDGT-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+|+.+.|||||++.-+|.... ...+||||+.. +|.+++...... +..++.-.+.-...|+..||.|||+
T Consensus 70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~-----~~~mp~~~iKLYt~Qlfrgl~yLh~ 143 (364)
T KOG0658|consen 70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRA-----NQRMPLLEIKLYTYQLFRGLAYLHS 143 (364)
T ss_pred HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhc-----CCCCceeeeHHHHHHHHHHHHHHHh
Confidence 477899999999988775432 34699999986 999999853211 1127888888999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCC-CceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ 153 (247)
.+ |+||||||.|+|+|.+ |.+||+|||-|......... .....+..|+|||.+.| ..|+.+.||||.||++.
T Consensus 144 ~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~a 217 (364)
T KOG0658|consen 144 HG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMA 217 (364)
T ss_pred cC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHH
Confidence 98 9999999999999876 89999999999876543332 45678999999999987 47999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC------------CCHHHHHHHHHHHHhhcccCCCCC
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD------------YPPKAVAKMAAVAALCVQYEADFR 221 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~cl~~~p~~R 221 (247)
||+-|++.|.+....++-..+...-+..+.+++..+........ .....+.+..+++.++|..+|.+|
T Consensus 218 ELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R 297 (364)
T KOG0658|consen 218 ELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKR 297 (364)
T ss_pred HHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhc
Confidence 99999999999888888777777777777776666554422211 223456789999999999999999
Q ss_pred CCHHHHHH--HHHHhHhc
Q 025816 222 PNMSIVVK--ALQPLLNA 237 (247)
Q Consensus 222 ps~~~il~--~l~~~~~~ 237 (247)
.|+.+++. +++.+...
T Consensus 298 ~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 298 LSALEALAHPFFDELRDP 315 (364)
T ss_pred CCHHHHhcchhhHHhhCc
Confidence 99999997 55555543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=248.07 Aligned_cols=205 Identities=19% Similarity=0.245 Sum_probs=160.3
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..+...++||||+.+++|.+.+....... +.+..+..++.|++.||.|||+.+
T Consensus 46 il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~-------~~~~~~~~~~~qi~~al~~lH~~~--- 115 (277)
T cd05607 46 ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-------LEMERVIHYSAQITCGILHLHSMD--- 115 (277)
T ss_pred HHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccC-------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999999999998886543322 888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 116 ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~ 192 (277)
T cd05607 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRT 192 (277)
T ss_pred EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999876533221 123457889999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||.......... ........... .......+.++.+++.+||+.||.+|||++|+++.
T Consensus 193 p~~~~~~~~~~~-----------~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 193 PFKDHKEKVAKE-----------ELKRRTLEDEV-KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CCCCCcchhhHH-----------HHHHHhhcccc-ccccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 997543211100 00001111111 00112345679999999999999999999766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=243.23 Aligned_cols=203 Identities=27% Similarity=0.428 Sum_probs=161.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++......+++|||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 121 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQ---F 121 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 6789999999999999998899999999999999999875432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|.||+++.++.++|+|||.+......... ......++..|.|||...+..++.++|+||||+++|+|++ |..
T Consensus 122 ~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 200 (256)
T cd05113 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200 (256)
T ss_pred eccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999988754332211 1112234567999999988889999999999999999998 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
||..... ..+...+........+...+..+.+++.+||+.+|.+|||+.+|++.++
T Consensus 201 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 201 PYERFNN----------------SETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CcCcCCH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 9864321 1111111111222222334577999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=257.83 Aligned_cols=217 Identities=23% Similarity=0.374 Sum_probs=168.0
Q ss_pred ccccc-CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC---------------------------------
Q 025816 2 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG--------------------------------- 47 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--------------------------------- 47 (247)
|+++. ||||+++++++......++||||+.+|+|.+++........
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 94 MTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred HHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 56675 99999999999999999999999999999998865321000
Q ss_pred ------------------------------------------------------CCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 48 ------------------------------------------------------AQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 48 ------------------------------------------------------~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
......+++..+..++.|++.||.||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 00112478888999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|
T Consensus 254 H~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ 330 (400)
T cd05105 254 ASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330 (400)
T ss_pred HhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHH
Confidence 9999 9999999999999999999999999987543322222222334567899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
+|++ |..||...... ......+........+...+.++.+++.+||+.||.+|||+.+|.+.|+
T Consensus 331 ellt~g~~P~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 331 EIFSLGGTPYPGMIVD---------------STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHHCCCCCCcccchh---------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 9997 88998643111 1111111222222334455678999999999999999999999999999
Q ss_pred HhHh
Q 025816 233 PLLN 236 (247)
Q Consensus 233 ~~~~ 236 (247)
++++
T Consensus 396 ~l~~ 399 (400)
T cd05105 396 SLLP 399 (400)
T ss_pred HHcC
Confidence 8765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=250.82 Aligned_cols=218 Identities=24% Similarity=0.407 Sum_probs=166.4
Q ss_pred cccc-cCCCccceeeEEee-CCeeeEEEecCCCCChhhhhcCCCCCCC--------------------------------
Q 025816 2 VSRL-KHENFVQLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKG-------------------------------- 47 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~-------------------------------- 47 (247)
++++ +|+||+++++++.. +...+++|||+.+++|.+++........
T Consensus 64 ~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (337)
T cd05054 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSA 143 (337)
T ss_pred HHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccc
Confidence 4566 79999999998865 4578899999999999999864321100
Q ss_pred --------------------CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeecccccc
Q 025816 48 --------------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 107 (247)
Q Consensus 48 --------------------~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~ 107 (247)
......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a 220 (337)
T cd05054 144 SSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLA 220 (337)
T ss_pred ccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccc
Confidence 000124889999999999999999999999 999999999999999999999999998
Q ss_pred CCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchh
Q 025816 108 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKV 186 (247)
Q Consensus 108 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 186 (247)
................++..|+|||.+.+..++.++|+|||||++++|++ |..||...... +..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---------------~~~ 285 (337)
T cd05054 221 RDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---------------EEF 285 (337)
T ss_pred hhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---------------HHH
Confidence 76533222222223345667999999999999999999999999999998 99998643211 111
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 187 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
...+........+...+.++.+++.+||+.+|.+|||++++++.|+++++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 286 CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111112222222334456799999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=246.21 Aligned_cols=214 Identities=26% Similarity=0.389 Sum_probs=166.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC--------CCCCCCCcCHHHHHHHHHHHHHHHHH
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK--------GAQPGPVLSWQQRVKIAVGAAKGLEY 72 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~--------~~~~~~~l~~~~~~~~~~~~~~~l~~ 72 (247)
++++++||||+++++++..+...+++|||+.+++|.+++....... .......+++..+..++.|++.||.|
T Consensus 60 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 139 (283)
T cd05090 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEY 139 (283)
T ss_pred HHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 3678999999999999999999999999999999999985432110 00011237889999999999999999
Q ss_pred hhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHH
Q 025816 73 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL 152 (247)
Q Consensus 73 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 152 (247)
||+++ ++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++
T Consensus 140 lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 216 (283)
T cd05090 140 LSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL 216 (283)
T ss_pred HHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHH
Confidence 99999 999999999999999999999999998765332221112223346679999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 153 LELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 153 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
++|++ |..||..... ..+.+.+........+..++..+.+++.+||..+|.+||++.+|++.|
T Consensus 217 ~el~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 217 WEIFSFGLQPYYGFSN----------------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHHHcCCCCCCCCCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 99998 9889864321 112222222222233344566799999999999999999999999988
Q ss_pred HH
Q 025816 232 QP 233 (247)
Q Consensus 232 ~~ 233 (247)
+.
T Consensus 281 ~~ 282 (283)
T cd05090 281 RS 282 (283)
T ss_pred hc
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=255.27 Aligned_cols=223 Identities=20% Similarity=0.290 Sum_probs=160.2
Q ss_pred CcccccCCCccceeeEEeeC-----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 1 MVSRLKHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
++++++||||+++++++... ...++||||+. ++|.+++..... +++..+..++.|+++||.|||+
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~ 121 (338)
T cd07859 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------LTPEHHQFFLYQLLRALKYIHT 121 (338)
T ss_pred HHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhccc---------CCHHHHHHHHHHHHHHHHHHHH
Confidence 36789999999999988543 24799999995 599998875432 8999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhc--CCCCccccchhhhHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVL 152 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l 152 (247)
.+ ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+ ..++.++||||+||++
T Consensus 122 ~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl 198 (338)
T cd07859 122 AN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 198 (338)
T ss_pred CC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHH
Confidence 99 999999999999999999999999998754322111 11123468889999999876 5789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhh--------hhcccccCC---C---CCHHHHHHHHHHHHhhcccCC
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR--------QCVDARLGG---D---YPPKAVAKMAAVAALCVQYEA 218 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~---~---~~~~~~~~l~~li~~cl~~~p 218 (247)
|+|++|+.||......................... +........ . .....+..+.+++.+||+.||
T Consensus 199 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 278 (338)
T cd07859 199 AEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDP 278 (338)
T ss_pred HHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCc
Confidence 99999999997543221111111111111111110 000000000 0 001234568899999999999
Q ss_pred CCCCCHHHHHH--HHHHhHh
Q 025816 219 DFRPNMSIVVK--ALQPLLN 236 (247)
Q Consensus 219 ~~Rps~~~il~--~l~~~~~ 236 (247)
.+|||++++++ +++.+.+
T Consensus 279 ~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 279 KDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred ccCCCHHHHhcCchhhhcCc
Confidence 99999999997 3554444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=242.85 Aligned_cols=213 Identities=28% Similarity=0.400 Sum_probs=164.5
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++++ +||||+++++++......+++|||+.+++|.+++........ ......+++..+..++.|++.||.||
T Consensus 49 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l 128 (270)
T cd05047 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128 (270)
T ss_pred HHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567 799999999999999999999999999999999875432110 11123488999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++|+||+|+||+++.++.++|+|||++........ ......+..|.|||.+.+..++.++|+||||++++
T Consensus 129 H~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 202 (270)
T cd05047 129 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202 (270)
T ss_pred HHCC---EeecccccceEEEcCCCeEEECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence 9998 99999999999999999999999999864322111 11122355799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
+|++ |..||...... ...+.+........+...+.++.+++.+||..+|.+|||+.++++.|+
T Consensus 203 el~~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 203 EIVSLGGTPYCGMTCA----------------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred HHHcCCCCCccccCHH----------------HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 9997 99999643211 111111111112223344567999999999999999999999999999
Q ss_pred HhHh
Q 025816 233 PLLN 236 (247)
Q Consensus 233 ~~~~ 236 (247)
++++
T Consensus 267 ~~~~ 270 (270)
T cd05047 267 RMLE 270 (270)
T ss_pred HhhC
Confidence 8763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=238.55 Aligned_cols=213 Identities=23% Similarity=0.325 Sum_probs=171.4
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
|+++ -||||+++.++++++...++|+|.+..|.|.|++..... ++++....+++|+.+++.|||.++
T Consensus 76 LRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt---------lSEK~tR~iMrqlfegVeylHa~~--- 143 (411)
T KOG0599|consen 76 LRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT---------LSEKETRRIMRQLFEGVEYLHARN--- 143 (411)
T ss_pred HHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee---------ecHHHHHHHHHHHHHHHHHHHHhh---
Confidence 4444 799999999999999999999999999999999987664 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh------cCCCCccccchhhhHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM------TGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~~l~~ 154 (247)
|+|||+||+|||++.+.+++|+|||.+......... ...+||++|+|||.+. ..+|+...|.|++|+++|-
T Consensus 144 IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyT 220 (411)
T KOG0599|consen 144 IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYT 220 (411)
T ss_pred hhhcccChhheeeccccceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHH
Confidence 999999999999999999999999999876543322 4568999999999884 2468899999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC--HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--H
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPNMSIVVK--A 230 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~ 230 (247)
++.|.+||-....-.- ++.+.+....-..+ .+.+.+..+||.+||+.||..|.|++|.|+ +
T Consensus 221 LLaGcpPFwHRkQmlM---------------LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 221 LLAGCPPFWHRKQMLM---------------LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred HHcCCCchhHHHHHHH---------------HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 9999999953211100 11111111111111 355678999999999999999999999998 6
Q ss_pred HHHhHhcCCCCCCC
Q 025816 231 LQPLLNARPGPAGE 244 (247)
Q Consensus 231 l~~~~~~~~~~~~~ 244 (247)
+.++.+.+.....|
T Consensus 286 f~q~~~~~~r~msP 299 (411)
T KOG0599|consen 286 FIQIAQQQARQMSP 299 (411)
T ss_pred HHHHHHhcccccCC
Confidence 66666655554444
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=251.52 Aligned_cols=197 Identities=21% Similarity=0.263 Sum_probs=158.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++.+..++..++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+ +
T Consensus 50 ~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~g---i 117 (323)
T cd05575 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSLN---I 117 (323)
T ss_pred HhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 467899999999999999999999999999999999887543 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 118 vH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p 195 (323)
T cd05575 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195 (323)
T ss_pred EeCCCCHHHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCC
Confidence 999999999999999999999999986532211 112334688999999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH----HHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS----IVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~----~il~ 229 (247)
|...+.. +.......... ..+...+..+.+++.+||+.||.+||++. ++++
T Consensus 196 f~~~~~~---------------~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~ 250 (323)
T cd05575 196 FYSRDTA---------------EMYDNILNKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKN 250 (323)
T ss_pred CCCCCHH---------------HHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHc
Confidence 9643211 11111111111 12233466799999999999999999984 5554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=233.03 Aligned_cols=214 Identities=24% Similarity=0.374 Sum_probs=167.6
Q ss_pred ccccCCCccceeeEEeeCC-----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 3 SRLKHENFVQLLGYCVDGT-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
++++|||+++++++...+. ..|++++|+..|+|.+.++..... +..+++.+.++++.++++||.+||+..
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~k-----g~~~sE~~iL~if~gic~gL~~lH~~~ 147 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIK-----GNFVSEAQILWIFLGICRGLEALHEKE 147 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhc-----CCccCHHHHHHHHHHHHHHHHHHhccC
Confidence 6789999999999875443 489999999999999999876632 344999999999999999999999986
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccc-------cceeccccccCchhhhc---CCCCccccchh
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-------TRVLGTFGYHAPEYAMT---GQLNAKSDVYS 147 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~---~~~~~~~Dvws 147 (247)
+++.||||||.||+++..+.++++|||.+....-.-..... .....|..|+|||.+.- ...++++||||
T Consensus 148 -~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWS 226 (302)
T KOG2345|consen 148 -PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWS 226 (302)
T ss_pred -CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhh
Confidence 46999999999999999999999999998766432211110 11246889999999864 35689999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 148 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
|||++|.|+.|..||+..-+++.....+ ...+...-.....+++.+.++|++|++.||.+||++.++
T Consensus 227 LGCtLYa~mf~~sPfe~~~~~GgSlaLA-------------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~l 293 (302)
T KOG2345|consen 227 LGCTLYAMMFGESPFERIYQQGGSLALA-------------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPEL 293 (302)
T ss_pred hhHHHHHHHHcCCcchHHhhcCCeEEEe-------------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHH
Confidence 9999999999999997543332221111 111122222233478889999999999999999999999
Q ss_pred HHHHHHhH
Q 025816 228 VKALQPLL 235 (247)
Q Consensus 228 l~~l~~~~ 235 (247)
+..++.+.
T Consensus 294 l~~~d~Li 301 (302)
T KOG2345|consen 294 LSKLDDLI 301 (302)
T ss_pred HHHHHhhc
Confidence 99998764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=243.69 Aligned_cols=204 Identities=25% Similarity=0.351 Sum_probs=171.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||+.+.||.++.+|+.|+.+...|++||||.||+|..++++..... +++..+...+..++.||.|||..|
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~-------fse~~aRFYaAEvl~ALEYLHmlG--- 199 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKR-------FSESAARFYAAEVLLALEYLHMLG--- 199 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCc-------cchhhHHHHHHHHHHHHHHHHhhc---
Confidence 5788999999999999999999999999999999999999877665 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchh--------------------------------h-h------------
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM--------------------------------A-A------------ 115 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~--------------------------------~-~------------ 115 (247)
|++||+||+|||+-++|.+-|+||+++....-. . .
T Consensus 200 ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~ 279 (459)
T KOG0610|consen 200 IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRS 279 (459)
T ss_pred eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccccc
Confidence 999999999999999999999999886433110 0 0
Q ss_pred ---------cccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchh
Q 025816 116 ---------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV 186 (247)
Q Consensus 116 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 186 (247)
..++..+.||-.|+|||++.|.+.+.+.|.|+||+++|||+.|..||.+.. ..+..
T Consensus 280 ~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~---------------~~~Tl 344 (459)
T KOG0610|consen 280 LPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN---------------NKETL 344 (459)
T ss_pred chhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC---------------chhhH
Confidence 011233568889999999999999999999999999999999999998653 33445
Q ss_pred hhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC----HHHHHH
Q 025816 187 RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN----MSIVVK 229 (247)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~il~ 229 (247)
..++.+.+.-....+.+..+.+||+++|.+||++|-- +.||=+
T Consensus 345 ~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 345 RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 5555555544444466788999999999999999999 666644
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=242.18 Aligned_cols=204 Identities=28% Similarity=0.453 Sum_probs=163.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++. +...+++|||+.+++|.+++.... .+++..+..++.|++.||.+||+++ +
T Consensus 50 l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---i 116 (257)
T cd05116 50 MQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLEETN---F 116 (257)
T ss_pred HHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 56789999999999875 456789999999999999986543 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
+|+||+|.||+++.++.++|+|||.+.......... ......++..|+|||.+....++.++|+||||+++|+|++ |.
T Consensus 117 ~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~ 196 (257)
T cd05116 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQ 196 (257)
T ss_pred eecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987654322111 1111223568999999988888999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
.||..... ..+.+.+........+...+.++.++|.+||+.||.+|||+.+|.+.|+..
T Consensus 197 ~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 197 KPYKGMKG----------------NEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCH----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 99964321 122222333333344455667899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=247.96 Aligned_cols=213 Identities=19% Similarity=0.284 Sum_probs=156.8
Q ss_pred ccccCCCccceeeEEee-----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 3 SRLKHENFVQLLGYCVD-----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
++++||||+++++++.. ....+++|||+. ++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~ 130 (290)
T cd07862 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHR 130 (290)
T ss_pred cccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45689999999998853 346899999996 5999998764432 2889999999999999999999999
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
++||||||+||+++.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 131 ---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 204 (290)
T cd07862 131 ---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 204 (290)
T ss_pred ---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHc
Confidence 999999999999999999999999998754322 11233457889999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhh-------hcccccC---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ-------CVDARLG---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
|.+||.......................+.+ ....... .......+..+.+++.+||+.||.+|||+.++
T Consensus 205 g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 284 (290)
T cd07862 205 RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 284 (290)
T ss_pred CCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHH
Confidence 9999976543211111110000000000000 0000000 00112345678899999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
++
T Consensus 285 l~ 286 (290)
T cd07862 285 LS 286 (290)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=253.34 Aligned_cols=195 Identities=23% Similarity=0.293 Sum_probs=158.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++..+...++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~--- 118 (318)
T cd05582 51 ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLG--- 118 (318)
T ss_pred HHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999999999999986543 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 119 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 196 (318)
T cd05582 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSL 196 (318)
T ss_pred EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCC
Confidence 99999999999999999999999999875433211 1123457889999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
||...+.. .....+... ....+...+.++.+++.+||+.||.+|||+.+
T Consensus 197 p~~~~~~~---------------~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 197 PFQGKDRK---------------ETMTMILKA--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHH---------------HHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 99643211 111111111 11233445677999999999999999999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=243.35 Aligned_cols=212 Identities=24% Similarity=0.359 Sum_probs=165.1
Q ss_pred cccccCCCccceeeEEeeCCe------eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDGTS------RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
++.++||||+++++++..... .+++|||+.+++|.+++....... ....+++..+..++.|++.||.|||+
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH~ 131 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLSN 131 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHh
Confidence 567899999999998866554 789999999999999985543211 11238999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ ++|+||||+||+++.++.++|+|||+++...............++..|.|||.+.+..++.++|+||+|+++|+|
T Consensus 132 ~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el 208 (273)
T cd05035 132 RN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208 (273)
T ss_pred CC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHH
Confidence 98 999999999999999999999999998765432222111223345679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
++ |..||..... ....+.+........+..++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 209 ~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 209 ATRGQTPYPGVEN----------------HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HhCCCCCCCCCCH----------------HHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99 8888864321 111122222222233445667899999999999999999999999999876
Q ss_pred H
Q 025816 235 L 235 (247)
Q Consensus 235 ~ 235 (247)
+
T Consensus 273 ~ 273 (273)
T cd05035 273 L 273 (273)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=253.18 Aligned_cols=198 Identities=21% Similarity=0.275 Sum_probs=159.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~ 80 (247)
+++++||||+++++++..+...++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+ .+
T Consensus 49 l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~~--- 116 (325)
T cd05594 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEKN--- 116 (325)
T ss_pred HHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---
Confidence 567899999999999999999999999999999998886543 28999999999999999999997 67
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++||||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 117 ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~ 194 (325)
T cd05594 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 194 (325)
T ss_pred EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCC
Confidence 99999999999999999999999999864322111 1123458899999999998899999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
||....... ..+.+.. .....+...+.++.+++.+||+.||.+|+ ++.++++.
T Consensus 195 Pf~~~~~~~----------------~~~~i~~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 195 PFYNQDHEK----------------LFELILM-EEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHH----------------HHHHHhc-CCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 996432110 0111000 01122334566799999999999999996 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=230.09 Aligned_cols=198 Identities=27% Similarity=0.368 Sum_probs=169.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
-+.|+||||+++|++|.++.+.||++||...|.++..+......+ +.+...+....|++.|+.|+|..+ +
T Consensus 76 qs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~-------f~e~~~a~Yi~q~A~Al~y~h~k~---V 145 (281)
T KOG0580|consen 76 QSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKR-------FDEQRAATYIKQLANALLYCHLKR---V 145 (281)
T ss_pred ecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhccccc-------ccccchhHHHHHHHHHHHHhccCC---c
Confidence 468999999999999999999999999999999999998665544 888899999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+|+|++..|.+|++|||++.... .......+||..|.+||+..+..++...|+|++|++-|+++.|.+|
T Consensus 146 IhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~pp 221 (281)
T KOG0580|consen 146 IHRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPP 221 (281)
T ss_pred ccCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCc
Confidence 999999999999999999999999987653 2233567899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|.... ..+...++.. .+...|...+.+..++|.+|+..+|.+|.+..|+++.
T Consensus 222 Fes~~---------------~~etYkrI~k--~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 222 FESQS---------------HSETYKRIRK--VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred hhhhh---------------hHHHHHHHHH--ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 97432 1122222221 2224556777889999999999999999999999863
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=242.43 Aligned_cols=202 Identities=28% Similarity=0.445 Sum_probs=162.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++......+++|||+.+++|.+++..... .+++..+..++.|++.|+.|||+.+ +
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i 121 (256)
T cd05059 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNG---F 121 (256)
T ss_pred HHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5789999999999999999999999999999999999875432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||+++........ ......++..|.|||.+.+..++.++|+||+|+++|++++ |..
T Consensus 122 ~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~ 200 (256)
T cd05059 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM 200 (256)
T ss_pred ccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCC
Confidence 99999999999999999999999998765322111 1111223457999999988889999999999999999998 899
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
||...... .....+........+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 201 p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 201 PYERFSNS----------------EVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHH----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 98643211 11111122222233344567899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=246.58 Aligned_cols=216 Identities=28% Similarity=0.401 Sum_probs=167.3
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++++ +|+||+++++++..++..+++|||+.+++|.+++........ ...+..+++..++.++.|++.||.||
T Consensus 61 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 140 (303)
T cd05088 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 140 (303)
T ss_pred HHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence 4567 899999999999999999999999999999999975432110 11223489999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++||||||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||++++
T Consensus 141 H~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 141 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred HhCC---ccccccchheEEecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 9999 99999999999999999999999999864321111 11122356799999998888899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
++++ |..||...... ...+.+........+...+..+.+++.+||+.+|.+|||++++++.+.
T Consensus 215 ellt~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 215 EIVSLGGTPYCGMTCA----------------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred HHHhcCCCCcccCChH----------------HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9998 99999643221 111111111122223334567899999999999999999999999999
Q ss_pred HhHhcCC
Q 025816 233 PLLNARP 239 (247)
Q Consensus 233 ~~~~~~~ 239 (247)
+++....
T Consensus 279 ~~~~~~~ 285 (303)
T cd05088 279 RMLEERK 285 (303)
T ss_pred HHHHhhh
Confidence 8876554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=254.22 Aligned_cols=215 Identities=19% Similarity=0.270 Sum_probs=159.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++|+||||+++++++..+...+++||++. ++|.+++..... +++..++.++.|++.||.|||+.+
T Consensus 136 il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~ylH~~~--- 202 (391)
T PHA03212 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRN---------IAICDILAIERSVLRAIQYLHENR--- 202 (391)
T ss_pred HHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4688999999999999999999999999996 589888865432 889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.++.++|+|||++......... ......||..|+|||++.+..++.++|+||+|+++|+|++|..
T Consensus 203 IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 281 (391)
T PHA03212 203 IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281 (391)
T ss_pred cccCCCChHhEEEcCCCCEEEEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999998653222111 1123468999999999998899999999999999999999998
Q ss_pred CCCCCCCCCCc----chhh---hccccCC-------cchhhhhc----ccccC--CCC-----CHHHHHHHHHHHHhhcc
Q 025816 161 PVDHTLPRGQQ----SLVT---WATPKLS-------EDKVRQCV----DARLG--GDY-----PPKAVAKMAAVAALCVQ 215 (247)
Q Consensus 161 pf~~~~~~~~~----~~~~---~~~~~~~-------~~~~~~~~----~~~~~--~~~-----~~~~~~~l~~li~~cl~ 215 (247)
||...+..... .... ......+ .....+.. ..... ... ....+.++.+++.+||+
T Consensus 282 p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~ 361 (391)
T PHA03212 282 SLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLA 361 (391)
T ss_pred CcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhc
Confidence 87543221110 0000 0000000 00000000 00000 000 11345679999999999
Q ss_pred cCCCCCCCHHHHHH
Q 025816 216 YEADFRPNMSIVVK 229 (247)
Q Consensus 216 ~~p~~Rps~~~il~ 229 (247)
.||.+|||++|+++
T Consensus 362 ~dP~~Rpta~elL~ 375 (391)
T PHA03212 362 FDAHHRPSAEALLD 375 (391)
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999997
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=251.35 Aligned_cols=212 Identities=22% Similarity=0.324 Sum_probs=159.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-CCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~-~~~~ 80 (247)
+++++||||+++++++..++..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+. +
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~~--- 124 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKHK--- 124 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---
Confidence 678999999999999999999999999999999999987543 288899999999999999999975 6
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+||++|++++|..
T Consensus 125 ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 200 (333)
T cd06650 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRY 200 (333)
T ss_pred EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999999987543221 123457889999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhh-cc------------------------ccCCcc---hhhhhcccccCCCC-CHHHHHHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTW-AT------------------------PKLSED---KVRQCVDARLGGDY-PPKAVAKMAAVAA 211 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~-~~------------------------~~~~~~---~~~~~~~~~~~~~~-~~~~~~~l~~li~ 211 (247)
||.............. .. ...+.. .....+........ ....+.++.+++.
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 280 (333)
T cd06650 201 PIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVN 280 (333)
T ss_pred CCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHH
Confidence 9975432111000000 00 000000 00000000000011 1124567999999
Q ss_pred hhcccCCCCCCCHHHHHH
Q 025816 212 LCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 212 ~cl~~~p~~Rps~~~il~ 229 (247)
+||+.||.+|||++++++
T Consensus 281 ~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 281 KCLIKNPAERADLKQLMV 298 (333)
T ss_pred HhccCCcccCcCHHHHhh
Confidence 999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=242.98 Aligned_cols=209 Identities=24% Similarity=0.385 Sum_probs=165.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++... ..+++++|+.+|+|.+++..... .+++..++.++.|++.||.|||+++ +
T Consensus 63 l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i 130 (279)
T cd05109 63 MAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEEVR---L 130 (279)
T ss_pred HHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999988754 56789999999999999876432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||||+||+++.++.++|+|||++................++..|+|||...+..++.++|+||||+++|++++ |..
T Consensus 131 iH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 210 (279)
T cd05109 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAK 210 (279)
T ss_pred eccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999876543222111122234567999999988889999999999999999998 899
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
||..... ......+........+...+.++.+++.+||..||.+|||+.++++.++.+...+
T Consensus 211 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 211 PYDGIPA----------------REIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CCCCCCH----------------HHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 9864321 1112222222222333445667999999999999999999999999998886554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=245.22 Aligned_cols=217 Identities=28% Similarity=0.385 Sum_probs=167.9
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++++ +||||+++++++......+++|||+.+++|.+++........ ......+++..++.++.|++.||.||
T Consensus 56 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 135 (297)
T cd05089 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL 135 (297)
T ss_pred HHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4566 799999999999999999999999999999999965432110 01113488999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++|+||||+||+++.++.++|+|||++........ ......+..|+|||...+..++.++||||||+++|
T Consensus 136 H~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 209 (297)
T cd05089 136 SEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW 209 (297)
T ss_pred HHCC---cccCcCCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence 9998 99999999999999999999999999864321111 11112345699999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
+|++ |..||...... .+.+.+........+...+..+.+++.+||..+|.+|||++++++.|.
T Consensus 210 el~t~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 210 EIVSLGGTPYCGMTCA----------------ELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred HHHcCCCCCCCCCCHH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9997 99999643211 111112222222333445677999999999999999999999999999
Q ss_pred HhHhcCCC
Q 025816 233 PLLNARPG 240 (247)
Q Consensus 233 ~~~~~~~~ 240 (247)
.+.+..-+
T Consensus 274 ~~~~~~~~ 281 (297)
T cd05089 274 RMLEARKA 281 (297)
T ss_pred HHHHhhcc
Confidence 98876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=240.50 Aligned_cols=201 Identities=26% Similarity=0.374 Sum_probs=163.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...+++|||+.+++|.+++...... .++...++.++.|++.||.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~~l~~al~~lH~~~---i 122 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-------PLPEDQVWRFFIQILLGLAHLHSKK---I 122 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 67899999999999999999999999999999999999765322 2889999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+......... .....++..|+|||...+..++.++|+||||+++++|++|..|
T Consensus 123 ~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 200 (256)
T cd08529 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200 (256)
T ss_pred ccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999988755332211 1233567889999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|..... ...............+...+..+.+++.+||+.+|++||++.++++.
T Consensus 201 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 201 FDANNQ----------------GALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCH----------------HHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 964431 11111111111222333556789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=241.66 Aligned_cols=211 Identities=28% Similarity=0.438 Sum_probs=165.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...+++|||+.+++|.+++....... .....+++..+..++.|++.||.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i 127 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVER--FGPPLLTLKELLDICLDVAKGCVYLEQMH---F 127 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcc--cCCccccHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 678899999999999999999999999999999999997543211 12223788999999999999999999998 9
Q ss_pred EeccCCCCceeecCCC-----ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDD-----VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 82 ~h~di~~~nil~~~~~-----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 156 (247)
+|+||+|+||+++.++ .++++|||++................++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 128 ~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 207 (269)
T cd05044 128 IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207 (269)
T ss_pred ccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHH
Confidence 9999999999999887 89999999987553322222222234567899999999888999999999999999999
Q ss_pred h-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 157 T-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 157 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
+ |..||..... ......+........+...+..+.+++.+||..+|.+|||+.++++.|++
T Consensus 208 t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 208 TLGQQPYPALNN----------------QEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HcCCCCCcccCH----------------HHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 8 9999863321 11111111112223334556789999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=240.53 Aligned_cols=219 Identities=22% Similarity=0.261 Sum_probs=172.6
Q ss_pred CcccccCCC-ccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 1 MVSRLKHEN-FVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 1 ~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
+|++|+|+| |+.+++++.+.+ ..++|+||.+. +|.+++....... ..++...+..++.|++.||.||
T Consensus 63 llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~ 136 (323)
T KOG0594|consen 63 LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFL 136 (323)
T ss_pred HHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHH
Confidence 478899999 999999999888 78999999975 9999998776321 1267789999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVL 152 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l 152 (247)
|+++ |+|||+||+|+++++.|.+||+|||+++-..-.... -....+|.+|+|||++.+. .|+...|+||+||++
T Consensus 137 H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIf 211 (323)
T KOG0594|consen 137 HSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIF 211 (323)
T ss_pred HhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHH
Confidence 9999 999999999999999999999999999855422222 1334679999999999986 789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccc-----ccCCCC-C-------HHHHHHHHHHHHhhcccCCC
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-----RLGGDY-P-------PKAVAKMAAVAALCVQYEAD 219 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~-~-------~~~~~~l~~li~~cl~~~p~ 219 (247)
.||+++...|.+..+..+...+-...+...+..+.....- ...... + +....+..+++.+||+.+|.
T Consensus 212 aEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~ 291 (323)
T KOG0594|consen 212 AEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPA 291 (323)
T ss_pred HHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcc
Confidence 9999999999988776665544444444444333332211 111111 1 11124789999999999999
Q ss_pred CCCCHHHHHHH
Q 025816 220 FRPNMSIVVKA 230 (247)
Q Consensus 220 ~Rps~~~il~~ 230 (247)
+|.|++.+++.
T Consensus 292 ~R~Sa~~al~h 302 (323)
T KOG0594|consen 292 KRISAKGALTH 302 (323)
T ss_pred cCcCHHHHhcC
Confidence 99999999985
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=258.63 Aligned_cols=210 Identities=26% Similarity=0.409 Sum_probs=188.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|+.++|||+|+++|+|+..-..|||.||+..|+|.+++.+..... ++.-..+.++.||.+|+.||.+++
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~e-------v~avvLlyMAtQIsSaMeYLEkkn--- 385 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSE-------VPAVVLLYMATQISSAMEYLEKKN--- 385 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhh-------cchhHHHHHHHHHHHHHHHHHHhh---
Confidence 5788999999999999999999999999999999999998876543 777888999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|||+..+|+|+..+..+|+.|||+++.+....... .........|.|||.+.+..++.++|||+||+++|++.| |-
T Consensus 386 FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGM 464 (1157)
T KOG4278|consen 386 FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGM 464 (1157)
T ss_pred hhhhhhhhhhccccccceEEeeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999999886554432 223345678999999999999999999999999999999 88
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
.||.+. ....+..+++.+.+.+.+..|+..+++||..||+++|.+||+++|+.+.++.++++
T Consensus 465 sPYPGi----------------dlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 465 SPYPGI----------------DLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCCCCc----------------cHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 998644 35678888999999999999999999999999999999999999999999988764
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=252.22 Aligned_cols=196 Identities=20% Similarity=0.236 Sum_probs=157.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++..++..++||||+.+++|.+++..... +....+..++.|++.||.|||+.+ +
T Consensus 50 l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~g---i 117 (325)
T cd05602 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---I 117 (325)
T ss_pred HHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 4678999999999999999999999999999999999875432 788888999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 118 iHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 195 (325)
T cd05602 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred EecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCC
Confidence 9999999999999999999999999875322111 12334688999999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
|...... .......... .......+..+.+++.+||+.+|.+||++.+.+
T Consensus 196 f~~~~~~---------------~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 196 FYSRNTA---------------EMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHH---------------HHHHHHHhCC--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 9643211 0111111111 122334566799999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=241.60 Aligned_cols=207 Identities=25% Similarity=0.399 Sum_probs=164.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++......+++|||+.+++|.+++..... .+++..+..++.|++.|+.|||+.+ +
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~~~---i 128 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLSDMN---Y 128 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 6788999999999999999999999999999999999865432 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccc-cceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
+|+||+|+||+++.++.++++|||++............ .....+..|+|||.+.+..++.++|+||+|+++|++++ |.
T Consensus 129 ~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~ 208 (268)
T cd05063 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208 (268)
T ss_pred eccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998755432211111 11122446999999988889999999999999999987 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
.||..... ......+........+...+..+.+++.+||..+|.+||++.++++.|++++
T Consensus 209 ~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 209 RPYWDMSN----------------HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCCcCCH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 99854321 1111112222222233345667999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=240.04 Aligned_cols=208 Identities=24% Similarity=0.373 Sum_probs=159.9
Q ss_pred cccccCCCccceeeEEe-eCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++.++||||+++++++. .+...+++|||+.+++|.+++...... +.+..+..++.|+++||.|||+.+
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~--- 118 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN--------PTVKDLIGFGLQVAKGMEYLASKK--- 118 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 67899999999999775 455688999999999999998754321 677788899999999999999998
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc--ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|+||+++.++.++|+|||+++........ .......++..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 119 i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 198 (262)
T cd05058 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 198 (262)
T ss_pred ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcC
Confidence 999999999999999999999999998754321111 111123356679999999888899999999999999999994
Q ss_pred -CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 159 -RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 159 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
.+||...... .....+........+...+..+.+++.+||..+|.+|||+.++++.|+.++.
T Consensus 199 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 199 GAPPYPDVDSF----------------DITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCCCCHH----------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 5666432111 1111111111112222345679999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=249.00 Aligned_cols=220 Identities=28% Similarity=0.450 Sum_probs=170.2
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++++ +||||+++++++..+...+++|||+.+|+|.+++....... ...+...+++..+..++.|++.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred HHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4567 79999999999999999999999999999999987543110 001223488899999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+||||+++|
T Consensus 151 H~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 227 (334)
T cd05100 151 ASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227 (334)
T ss_pred HHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHH
Confidence 9999 9999999999999999999999999987654322211112223345799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
+|++ |..||..... ......+........+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 228 el~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 228 EIFTLGGSPYPGIPV----------------EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred HHHhcCCCCCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 9998 8888854321 1111222222222333445667999999999999999999999999999
Q ss_pred HhHhcCCC
Q 025816 233 PLLNARPG 240 (247)
Q Consensus 233 ~~~~~~~~ 240 (247)
.++...+.
T Consensus 292 ~~~~~~~~ 299 (334)
T cd05100 292 RVLTVTST 299 (334)
T ss_pred HHhhhcCC
Confidence 99865543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=240.03 Aligned_cols=204 Identities=27% Similarity=0.434 Sum_probs=162.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++++.|+||+++++++. .+..+++|||+.+++|.+++.... .+++..+..++.|++.|+.+||..+ +
T Consensus 50 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lh~~~---i 116 (257)
T cd05060 50 MAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR---------EIPVSDLKELAHQVAMGMAYLESKH---F 116 (257)
T ss_pred HHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHhhcC---e
Confidence 67889999999999776 456799999999999999997654 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhccc-ccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
+|+||+|+||+++.++.++|+|||.+........... .....++..|+|||...+..++.++|+||||+++|++++ |.
T Consensus 117 ~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~ 196 (257)
T cd05060 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGA 196 (257)
T ss_pred eccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999876533221111 111223457999999988889999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
.||...+. ..+.+.+........+...+..+.+++.+||..+|.+|||+.++++.|+.+
T Consensus 197 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 197 KPYGEMKG----------------AEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCcccCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 99964321 111122222222234445566799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=246.91 Aligned_cols=195 Identities=23% Similarity=0.285 Sum_probs=157.4
Q ss_pred cccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 025816 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 83 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h 83 (247)
..+||||+++++++..+...++||||+.+|+|.+++..... ++...+..++.|++.||.|||+.+ |+|
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivH 119 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---------FDEARARFYAAEIICGLQFLHKKG---IIY 119 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 35899999999999999999999999999999998865432 889999999999999999999999 999
Q ss_pred ccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCC
Q 025816 84 RDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163 (247)
Q Consensus 84 ~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 163 (247)
|||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|+||+||++|+|++|..||.
T Consensus 120 ~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~ 197 (316)
T cd05592 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987532222 11233468999999999998889999999999999999999999997
Q ss_pred CCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 025816 164 HTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS-IVVK 229 (247)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~il~ 229 (247)
+.+... ....+.. .....+...+.++.+++.+||+.||.+||++. ++++
T Consensus 198 ~~~~~~---------------~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 198 GEDEDE---------------LFDSILN--DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCHHH---------------HHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 542110 0011100 11223344566789999999999999999975 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=241.86 Aligned_cols=202 Identities=24% Similarity=0.331 Sum_probs=162.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++++||+.+++|.+.+..... ++...+..++.|++.||.+||+.+ +
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~---i 125 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---------LTETVTRKYTRQILEGVEYLHSNM---I 125 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 6789999999999999999999999999999999999875432 888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhccc-ccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||+|+++|++++|+.
T Consensus 126 ~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 205 (263)
T cd06625 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205 (263)
T ss_pred ecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999875432211110 022346778999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||...... ...............+...+..+.+++.+||..+|.+|||++++++.
T Consensus 206 p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 206 PWAEFEAM---------------AAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CccccchH---------------HHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 98643211 11111111112223444566789999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=241.93 Aligned_cols=211 Identities=25% Similarity=0.350 Sum_probs=161.1
Q ss_pred cccccCCCccceeeEEeeC------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDG------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++|+||+++++++... ...+++|||+.+|+|.+++...... .....+++..+..++.|++.||.|||+
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~ 130 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG---DCPQYLPTQMLVKFMTDIASGMEYLSS 130 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhccc---CCcccCCHHHHHHHHHHHHHHHHHHHH
Confidence 5788999999999987432 2468999999999999887432211 112238899999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ ++|+||||+||+++.++.++|+|||++................++..|.|||...+..++.++|+||||+++|++
T Consensus 131 ~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el 207 (272)
T cd05075 131 KS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207 (272)
T ss_pred CC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHH
Confidence 98 999999999999999999999999998865432221111223356679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
++ |..||...... .+.+.+........+...+..+.+++.+||..+|.+|||+.++++.|+.+
T Consensus 208 ~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 208 ATRGQTPYPGVENS----------------EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCCCCCCCCCHH----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99 88898643211 11111111111122334556799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=239.86 Aligned_cols=203 Identities=30% Similarity=0.476 Sum_probs=161.8
Q ss_pred CcccccCCCccceeeEEe-eCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
++++++|+|++++++++. .++..+++|||+.+++|.+++...... .+++..++.++.|++.||.|||+++
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~-- 122 (256)
T cd05082 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEANN-- 122 (256)
T ss_pred HHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 367899999999999764 456789999999999999998765432 2888999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
++|+||+|+||+++.++.++|+|||.+....... .....+..|+|||.+.+..++.++|+||+|+++|+|++ |
T Consensus 123 -i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g 196 (256)
T cd05082 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196 (256)
T ss_pred -EeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCC
Confidence 9999999999999999999999999887543221 12234557999999988889999999999999999997 9
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
..||..... ..+...+........+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 197 ~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 197 RVPYPRIPL----------------KDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 999863321 111111122222233345567799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=241.30 Aligned_cols=210 Identities=26% Similarity=0.393 Sum_probs=167.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.. ...+++|||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 63 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---i 130 (279)
T cd05057 63 MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEKR---L 130 (279)
T ss_pred HHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 578899999999999887 788999999999999999876432 2899999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++................++..|+|||.+....++.++|+||+|++++++++ |..
T Consensus 131 ~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 210 (279)
T cd05057 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210 (279)
T ss_pred EecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999876543222111111223457999999988889999999999999999998 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 239 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~ 239 (247)
||..... ..+.+.+........+..++.++.+++.+||..+|.+|||+.++++.++.+.+.++
T Consensus 211 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 211 PYEGIPA----------------VEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred CCCCCCH----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 9964321 11222222222223333455679999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=239.70 Aligned_cols=206 Identities=31% Similarity=0.483 Sum_probs=163.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++.+. ....+++|||+.+++|.+++...... .+++..+..++.|++.||.+||+.+ +
T Consensus 55 l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~~~---i 123 (262)
T cd05071 55 MKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGK-------YLRLPQLVDMAAQIASGMAYVERMN---Y 123 (262)
T ss_pred HHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhcccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 56789999999999774 45678999999999999999754322 2789999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|.||+++.++.++|+|||.+......... ......++..|+|||...+..++.++|+||||+++|++++ |..
T Consensus 124 ~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~ 202 (262)
T cd05071 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 202 (262)
T ss_pred cccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998755332211 1122335667999999988889999999999999999999 888
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
||...... .....+........+...+..+.+++.+||+.+|.+|||+.++++.|+..+
T Consensus 203 p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 203 PYPGMVNR----------------EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCCChH----------------HHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 88643211 111111111122233456678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=241.36 Aligned_cols=216 Identities=28% Similarity=0.399 Sum_probs=168.0
Q ss_pred cccccCCCccceeeEEee-CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++|+||+++++++.. +...+++++|+.+++|.+++....... ...+..+++..++.++.|++.||.|||+.+
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--- 137 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGE-ANNPQALSTQQLVHMAIQIACGMSYLHKRG--- 137 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccc-cccccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 577899999999998766 467889999999999999987653221 112234899999999999999999999998
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||++++++++ |.
T Consensus 138 i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 138 VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence 99999999999999999999999999875533222111122334667999999988889999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
.||...++. .+...+........+..++..+.+++.+||..+|++|||+.++++.|+++.+.
T Consensus 218 ~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 218 TPYVEIDPF----------------EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCcCcCCHH----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 999643221 11111212222222334456799999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=254.24 Aligned_cols=214 Identities=27% Similarity=0.449 Sum_probs=169.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++-+|.||+-+.|+|..+.. .+|.-+|+|.+|+.++...... |.+...+.|+.|++.|+.|||.++
T Consensus 441 ~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etk--------fdm~~~idIAqQiaqGM~YLHAK~--- 508 (678)
T KOG0193|consen 441 VLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETK--------FDMNTTIDIAQQIAQGMDYLHAKN--- 508 (678)
T ss_pred HHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhh--------hhHHHHHHHHHHHHHhhhhhhhhh---
Confidence 4788999999999999998877 8999999999999999876532 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc---CCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+|+|+|..||++.++++|||+|||++................|...|+|||++.. .+|++++||||+|+++|||++
T Consensus 509 IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELlt 588 (678)
T KOG0193|consen 509 IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLT 588 (678)
T ss_pred hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHh
Confidence 99999999999999999999999999875443322222233457789999999974 368999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
|..||..... .+.+.+..++....+ .......++.++.+|+..||.+++++||++.+|+..|+.+..+
T Consensus 589 g~lPysi~~~--dqIifmVGrG~l~pd----------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 589 GELPYSIQNR--DQIIFMVGRGYLMPD----------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred CcCCcCCCCh--hheEEEecccccCcc----------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 9999972211 111111111110000 0012246677899999999999999999999999999988875
Q ss_pred C
Q 025816 238 R 238 (247)
Q Consensus 238 ~ 238 (247)
.
T Consensus 657 ~ 657 (678)
T KOG0193|consen 657 L 657 (678)
T ss_pred c
Confidence 3
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=239.99 Aligned_cols=203 Identities=31% Similarity=0.495 Sum_probs=165.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++++++......+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 53 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh~~~--- 122 (256)
T cd05039 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLEEKN--- 122 (256)
T ss_pred HHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367889999999999999999999999999999999999765432 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||.++....... ....+..|.|||.+.+..++.++|+||+|++++++++ |.
T Consensus 123 i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~ 197 (256)
T cd05039 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197 (256)
T ss_pred ccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999886532111 2234557999999988889999999999999999997 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
.||..... ..+.+.+........+...+..+.+++.+||..+|.+|||++++++.|+.+
T Consensus 198 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 198 VPYPRIPL----------------KDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCCCH----------------HHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 99863321 112222222222233344567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=240.10 Aligned_cols=210 Identities=22% Similarity=0.319 Sum_probs=166.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++...+..++++||+.+++|.+++...... ...++...+..++.|++.||.|||+.+
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~--- 126 (267)
T cd08228 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMHSRR--- 126 (267)
T ss_pred HHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---
Confidence 367889999999999999999999999999999999988643211 123788999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||+|+++++|++|..
T Consensus 127 i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 204 (267)
T cd08228 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204 (267)
T ss_pred eeCCCCCHHHEEEcCCCCEEECccccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999988765432221 122356778999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCC-CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG-DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
||....... ..+.+.+...... ......+..+.+++.+||..+|.+|||++++++.++++
T Consensus 205 p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 205 PFYGDKMNL--------------FSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCccccccH--------------HHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 986432110 0111111111111 12234567799999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=249.48 Aligned_cols=194 Identities=21% Similarity=0.290 Sum_probs=156.9
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
.+||||+++++++...+..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ ++||
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~---------l~~~~~~~~~~ql~~~L~~lH~~~---ivH~ 120 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEITSALMFLHDKG---IIYR 120 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeC
Confidence 4799999999999999999999999999999998875432 889999999999999999999999 9999
Q ss_pred cCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCC
Q 025816 85 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164 (247)
Q Consensus 85 di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 164 (247)
||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 121 dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (320)
T cd05590 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198 (320)
T ss_pred CCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999875322111 12234688999999999988899999999999999999999999975
Q ss_pred CCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH------HHHHH
Q 025816 165 TLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM------SIVVK 229 (247)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~~il~ 229 (247)
..... ....+.... ...+...+.++.+++.+||+.||.+||++ +++++
T Consensus 199 ~~~~~---------------~~~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 199 ENEDD---------------LFEAILNDE--VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred CCHHH---------------HHHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 42211 011111110 12233456679999999999999999998 66665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=239.88 Aligned_cols=201 Identities=22% Similarity=0.326 Sum_probs=162.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++.+..+...+++|||+.+++|.+++...... .++...++.++.|++.||.+||+.+ +
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~~~---i 121 (255)
T cd08219 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGK-------LFPEDTILQWFVQMCLGVQHIHEKR---V 121 (255)
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHhhCC---c
Confidence 57889999999999999999999999999999999988654332 2888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 122 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p 199 (255)
T cd08219 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199 (255)
T ss_pred ccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCC
Confidence 9999999999999999999999999875533221 11234577889999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|...... ..... +........+...+..+.+++.+||..||.+|||+.+++..
T Consensus 200 ~~~~~~~---------------~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 200 FQANSWK---------------NLILK-VCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCHH---------------HHHHH-HhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 9643211 00111 11111122334455679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=242.87 Aligned_cols=216 Identities=24% Similarity=0.395 Sum_probs=165.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCC-CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA-QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++||||+++++++......+++|||+.+|+|.+++......... .....++...+..++.|++.||.|||+.+
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--- 139 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--- 139 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 57789999999999999999999999999999999999754321111 11133677888999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+||+|+++|+|++ |.
T Consensus 140 i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~ 219 (288)
T cd05061 140 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 219 (288)
T ss_pred CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999875433222111122234567999999988889999999999999999998 78
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
.||...... .+...+........+...+..+.+++.+||+.+|.+|||+.++++.++..+.
T Consensus 220 ~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 220 QPYQGLSNE----------------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CCCCCCCHH----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 888643211 1111111111112223345679999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=240.10 Aligned_cols=206 Identities=25% Similarity=0.415 Sum_probs=163.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..+++|||+.+++|.+++..... .+++..+..++.|++.||.+||+.+ +
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i 127 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLSDMG---Y 127 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5778999999999999999999999999999999999975432 2888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhccc-ccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
+|+||+|+||+++.++.++++|||++........... .....++..|+|||.+.+..++.++|+||+|++++++++ |.
T Consensus 128 ~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~ 207 (267)
T cd05066 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207 (267)
T ss_pred eehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999886543222111 111123457999999998889999999999999999886 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
.||....... ....+....+...+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 208 ~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 208 RPYWEMSNQD----------------VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCcccCCHHH----------------HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 9986432211 1111111111122334456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=248.49 Aligned_cols=204 Identities=21% Similarity=0.286 Sum_probs=158.3
Q ss_pred ccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 3 SRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 3 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++ +||||+++++++..++..++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+ +
T Consensus 50 ~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i 117 (329)
T cd05588 50 ETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNFLHERG---I 117 (329)
T ss_pred HhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 344 79999999999999999999999999999998886543 2999999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 118 vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~P 195 (329)
T cd05588 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred EecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCC
Confidence 999999999999999999999999886422111 112334688999999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchh-hhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC------HHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKV-RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN------MSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps------~~~il~ 229 (247)
|........... ...... ....... ...+...+..+.+++.+||+.||.+|+| ++++++
T Consensus 196 f~~~~~~~~~~~-------~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 196 FDIVGMSDNPDQ-------NTEDYLFQVILEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred cccccccccccc-------cchHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 964321110000 000001 1111111 1234445667999999999999999997 677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=243.89 Aligned_cols=204 Identities=21% Similarity=0.304 Sum_probs=162.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++.+..++..++||||+.+|+|.+.+...... .+++..+..++.|++.||.|||+.+
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--- 122 (285)
T cd05605 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-------GFDEERAVFYAAEITCGLEDLHRER--- 122 (285)
T ss_pred HHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 367889999999999999999999999999999999887643322 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus 123 ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~ 199 (285)
T cd05605 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199 (285)
T ss_pred cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCC
Confidence 99999999999999999999999999876432221 123457889999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
||......... ..+...+.. .....+...+..+.+++.+||..||.+|| +++++++.
T Consensus 200 pf~~~~~~~~~------------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 200 PFRQRKEKVKR------------EEVERRVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CCCCCchhhHH------------HHHHHHhhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 99754321100 111111111 11223445677899999999999999999 89999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=246.96 Aligned_cols=202 Identities=29% Similarity=0.386 Sum_probs=159.7
Q ss_pred CcccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCC-cCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 1 MVSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV-LSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
||++|+|||||+++.+..+. +.+|||+|||..|.+...-.. ++ +.+.++++++++++.||.|||.+|
T Consensus 161 ilKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d----------~~els~~~Ar~ylrDvv~GLEYLH~Qg 230 (576)
T KOG0585|consen 161 ILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD----------KPELSEQQARKYLRDVVLGLEYLHYQG 230 (576)
T ss_pred HHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC----------cccccHHHHHHHHHHHHHHHHHHHhcC
Confidence 58999999999999988664 589999999988777444322 22 899999999999999999999999
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcc---cccceeccccccCchhhhcCC---C-CccccchhhhH
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL---HSTRVLGTFGYHAPEYAMTGQ---L-NAKSDVYSFGV 150 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~---~-~~~~DvwslG~ 150 (247)
|+||||||.|+|++.+|.+||+|||.+..+....... .-....||+.|+|||...++. + +.+.||||+|+
T Consensus 231 ---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 231 ---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred ---eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 9999999999999999999999999998662221100 012256999999999987732 2 56899999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|-|+.|+.||.+.. ..+....+++..+.-...++...++.+||+++|.+||..|.+..+|-..
T Consensus 308 TLYCllfG~~PF~~~~---------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFDDF---------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred hHHHhhhccCCcccch---------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 9999999999997442 1222333444444333334667889999999999999999999998654
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=237.88 Aligned_cols=205 Identities=27% Similarity=0.471 Sum_probs=163.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++++++......+++|||+.+++|.+++..... .++...+..++.+++.+|.+||+++
T Consensus 45 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~--- 113 (251)
T cd05041 45 ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKN--- 113 (251)
T ss_pred HHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999999999999865432 2788999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+||||++++++++ |.
T Consensus 114 i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~ 193 (251)
T cd05041 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGD 193 (251)
T ss_pred EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccC
Confidence 99999999999999999999999999875432111111112223556999999988889999999999999999998 88
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
.||...... ...+.+........+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus 194 ~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 194 TPYPGMSNQ----------------QTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCccCCHH----------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 888644221 111222222222233445667999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=239.97 Aligned_cols=206 Identities=25% Similarity=0.425 Sum_probs=162.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...+++|||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~g---~ 127 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEMN---Y 127 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5788999999999999999999999999999999999875432 1889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccc-e--eccccccCchhhhcCCCCccccchhhhHHHHHHHh-
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-V--LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT- 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~-~--~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~- 157 (247)
+|+||+|+||+++.++.++|+|||.+.............. . ..+..|+|||.+.+..++.++|+||+|+++|++++
T Consensus 128 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~ 207 (269)
T cd05065 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 207 (269)
T ss_pred eecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcC
Confidence 9999999999999999999999998875433221111011 1 12346999999988889999999999999999886
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
|..||...... ...+.+........+..++..+.+++.+||..+|.+||++++++..|+.+
T Consensus 208 g~~p~~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 208 GERPYWDMSNQ----------------DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCCCCCCHH----------------HHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99998643211 11111111122223344566799999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=239.33 Aligned_cols=205 Identities=31% Similarity=0.484 Sum_probs=164.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..+...+++|||+.+++|.+++....... +++..+..++.+++.|+.|||+++ +
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~-------~~~~~~~~~~~~i~~al~~lh~~~---i 124 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-------LRLPQLVDMAAQIAEGMAYLESRN---Y 124 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCC-------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 578999999999999999899999999999999999997654322 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+......... .......+..|+|||.+.+..++.++|+||+|++++++++ |+.
T Consensus 125 ~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 203 (261)
T cd05034 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203 (261)
T ss_pred ccCCcchheEEEcCCCCEEECccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432111 1112234567999999998889999999999999999998 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
||..... ....+.+........+...+.++.+++.+||..+|.+|||++++++.|+.
T Consensus 204 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 204 PYPGMTN----------------REVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 9864321 11111111222222333446679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=251.34 Aligned_cols=199 Identities=27% Similarity=0.339 Sum_probs=154.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++++++..+...++||||+.+++|.+... .....+..++.|++.||.|||+.+
T Consensus 125 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------------~~~~~~~~i~~qi~~aL~~LH~~~--- 188 (353)
T PLN00034 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI-------------ADEQFLADVARQILSGIAYLHRRH--- 188 (353)
T ss_pred HHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccccc-------------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999999999865321 566778899999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----CCCCccccchhhhHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l 155 (247)
++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.. ...+.++|||||||++|+|
T Consensus 189 ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el 266 (353)
T PLN00034 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266 (353)
T ss_pred EeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHH
Confidence 99999999999999999999999999876532211 1133468899999998743 2234689999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|..||........... ...+........+...+.++.++|.+||+.||.+|||+.|+++.
T Consensus 267 ~~g~~pf~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 267 YLGRFPFGVGRQGDWASL-------------MCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HhCCCCCCCCCCccHHHH-------------HHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999973221111000 00011111122334556779999999999999999999999984
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=243.19 Aligned_cols=207 Identities=21% Similarity=0.293 Sum_probs=162.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++.+++..+...++||||+.+|+|.+.+..... ....+++..+..++.|++.||.|||+.+
T Consensus 46 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~--- 117 (280)
T cd05608 46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDE-----ENPGFPEPRACFYTAQIISGLEHLHQRR--- 117 (280)
T ss_pred HHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999887743221 1123899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++||||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 118 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~ 195 (280)
T cd05608 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARG 195 (280)
T ss_pred cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998754332211 123457889999999999899999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
||.......... ......... ....+...+..+.+++.+||+.||.+|| |++++++.
T Consensus 196 pf~~~~~~~~~~-----------~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 196 PFRARGEKVENK-----------ELKQRILND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCCCCCcchhHH-----------HHHHhhccc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 997543211100 000011111 1123344567799999999999999999 78888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=249.49 Aligned_cols=193 Identities=20% Similarity=0.243 Sum_probs=156.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++.+.+..++||||+.+++|...+.... .++...+..++.|++.||.|||+.+ +
T Consensus 50 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---i 117 (321)
T cd05603 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER---------CFLEPRARFYAAEVASAIGYLHSLN---I 117 (321)
T ss_pred HHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999988886533 2888899999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus 118 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 195 (321)
T cd05603 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195 (321)
T ss_pred EeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCC
Confidence 9999999999999999999999999875322111 12334688899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
|...+... ........ ....+...+..+.+++.+||+.+|.+||++.
T Consensus 196 f~~~~~~~---------------~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 196 FYSRDVSQ---------------MYDNILHK--PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHH---------------HHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 96532110 01111111 1123344566799999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=253.07 Aligned_cols=201 Identities=22% Similarity=0.291 Sum_probs=161.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++.+++..++||||+.+++|.+++.... .++...+..++.|++.||.|||+.+ +
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---i 122 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHKLG---F 122 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999999997652 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhh---------------------------hcccccceeccccccCchhh
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA---------------------------ARLHSTRVLGTFGYHAPEYA 134 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~ 134 (247)
+||||||+||+++.++.++|+|||++....... .........|+..|+|||.+
T Consensus 123 iH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (350)
T cd05573 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL 202 (350)
T ss_pred eccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 999999999999999999999999987654322 00112234588999999999
Q ss_pred hcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcc--cccCCCCCHHHHHHHHHHHHh
Q 025816 135 MTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD--ARLGGDYPPKAVAKMAAVAAL 212 (247)
Q Consensus 135 ~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~ 212 (247)
.+..++.++|||||||++|+|++|..||....... ....+.. ...........+.++.++|.+
T Consensus 203 ~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~---------------~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ 267 (350)
T cd05573 203 RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE---------------TYNKIINWKESLRFPPDPPVSPEAIDLICR 267 (350)
T ss_pred cCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH---------------HHHHHhccCCcccCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999999997543111 1111111 111111111246779999999
Q ss_pred hcccCCCCCCC-HHHHHHH
Q 025816 213 CVQYEADFRPN-MSIVVKA 230 (247)
Q Consensus 213 cl~~~p~~Rps-~~~il~~ 230 (247)
|+. +|.+||+ ++++++.
T Consensus 268 ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 268 LLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred Hcc-ChhhcCCCHHHHhcC
Confidence 997 9999999 9999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=238.28 Aligned_cols=205 Identities=27% Similarity=0.384 Sum_probs=162.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.. ...+++|||+.+++|.+.+..... ..+++..++.++.|++.||.+||+.+ +
T Consensus 50 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i 118 (257)
T cd05040 50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESKR---F 118 (257)
T ss_pred HhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 678999999999999988 889999999999999999976542 12899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
+|+||+|+||+++.++.++|+|||++.......... ......++..|.|||.+.+..++.++|+||||+++++|++ |.
T Consensus 119 ~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~ 198 (257)
T cd05040 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGE 198 (257)
T ss_pred cccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999999988654322111 1122345678999999988889999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
.||....... ..............+...+..+.+++.+||..+|.+|||+.++++.|.
T Consensus 199 ~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 199 EPWAGLSGSQ---------------ILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCCCCHHH---------------HHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 9985332111 000000011111223344567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=238.11 Aligned_cols=205 Identities=31% Similarity=0.481 Sum_probs=161.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+|++++++++. ....+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~~~--- 122 (260)
T cd05069 54 IMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGK-------YLKLPQLVDMAAQIADGMAYIERMN--- 122 (260)
T ss_pred HHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367889999999998875 45688999999999999999764322 2789999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||...+..++.++|+||||+++|++++ |.
T Consensus 123 i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~ 201 (260)
T cd05069 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201 (260)
T ss_pred EeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998754322111 1122235567999999988889999999999999999999 89
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
.||...... ...+.+........+...+..+.+++.+||..+|.+|||++++++.|++
T Consensus 202 ~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 202 VPYPGMVNR----------------EVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCCHH----------------HHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 998643211 1111111111222334456779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=247.52 Aligned_cols=195 Identities=18% Similarity=0.258 Sum_probs=158.1
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
.+||||+++++++..++..++||||+.+++|.+.+..... +++..+..++.|++.||.|||+.+ ++||
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHr 120 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK---------FDEPRSRFYAAEVTLALMFLHRHG---VIYR 120 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 4899999999999999999999999999999988865432 888999999999999999999999 9999
Q ss_pred cCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCC
Q 025816 85 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164 (247)
Q Consensus 85 di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 164 (247)
||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 121 Dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred CCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence 9999999999999999999999875322111 12334588999999999988999999999999999999999999975
Q ss_pred CCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-------CHHHHHHH
Q 025816 165 TLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-------NMSIVVKA 230 (247)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-------s~~~il~~ 230 (247)
..... ....+.... ...+...+.++.+++.+||+.||.+|| +++++++.
T Consensus 199 ~~~~~---------------~~~~i~~~~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 199 DNEDD---------------LFESILHDD--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCHHH---------------HHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 43211 111111111 112333456799999999999999999 88888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=237.86 Aligned_cols=210 Identities=23% Similarity=0.341 Sum_probs=167.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+|++++++++..++..+++|||+.+++|.+++...... +..++...++.++.+++.||.+||+.+ +
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i 127 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMHSKR---I 127 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 57889999999999999999999999999999999998653211 123889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+......... .....++..|.|||.+.+..++.++|+||+|++++++++|..|
T Consensus 128 ~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p 205 (267)
T cd08224 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred ecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999998754332211 1223577789999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCH-HHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP-KAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
|....... ....+.+........+. ..+..+.+++.+||..+|.+|||+.+|++.++.+.
T Consensus 206 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 206 FYGDKMNL--------------YSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cccCCccH--------------HHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 86432110 01111111111222222 55668999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=238.56 Aligned_cols=205 Identities=30% Similarity=0.462 Sum_probs=162.3
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+|++++++++. ....+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 54 ~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~~~--- 122 (260)
T cd05070 54 IMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGR-------ALKLPNLVDMAAQVAAGMAYIERMN--- 122 (260)
T ss_pred HHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 367899999999999875 45688999999999999999764322 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||...+..++.++|+||||+++|++++ |.
T Consensus 123 i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~ 201 (260)
T cd05070 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201 (260)
T ss_pred cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCC
Confidence 999999999999999999999999998764332211 1112234567999999988889999999999999999999 88
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
.||...... ...+.+........+...+..+.+++.+||..+|.+|||++++.+.|++
T Consensus 202 ~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 202 VPYPGMNNR----------------EVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCHH----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 998643211 1111122222223344556679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=252.32 Aligned_cols=201 Identities=19% Similarity=0.251 Sum_probs=160.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++.++||||+++++++.+++..++||||+.+|+|.+++.... ++...+..++.|++.||.|||+.+
T Consensus 96 il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~--- 162 (370)
T cd05596 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSMG--- 162 (370)
T ss_pred HHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3578899999999999999999999999999999999987543 888899999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC----CCCccccchhhhHHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----QLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~~l~~l~ 156 (247)
|+||||||+||+++.++.++|+|||++........ .......|+..|+|||.+.+. .++.++|+|||||++|+|+
T Consensus 163 ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyell 241 (370)
T cd05596 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241 (370)
T ss_pred eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHH
Confidence 99999999999999999999999999875432211 112234689999999998653 3788999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC--HHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADF--RPNMSIVVKA 230 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--Rps~~~il~~ 230 (247)
+|..||...... .....+.........+ ...+.++.++|.+||..+|.+ |+|++++++.
T Consensus 242 tG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 242 VGDTPFYADSLV---------------GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred hCCCCcCCCCHH---------------HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 999999754321 1111111111111112 234678999999999999988 9999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=247.60 Aligned_cols=204 Identities=22% Similarity=0.283 Sum_probs=157.9
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
.+||||+++++++..++..++||||+.+|+|...+.... .+++..+..++.|++.||.|||+.+ ++||
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 120 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERG---IIYR 120 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeC
Confidence 489999999999999999999999999999998886543 2899999999999999999999999 9999
Q ss_pred cCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCC
Q 025816 85 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164 (247)
Q Consensus 85 di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 164 (247)
||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 121 Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 9999999999999999999999875322111 12334688999999999998999999999999999999999999963
Q ss_pred CCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 025816 165 TLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM------SIVVKA 230 (247)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~~il~~ 230 (247)
......... .....+.+.+.. .....+...+..+.+++.+||+.||.+|||+ +++++.
T Consensus 199 ~~~~~~~~~-------~~~~~~~~~i~~-~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 199 VGSSDNPDQ-------NTEDYLFQVILE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCcCCccc-------ccHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 221110000 000011111100 1123444556779999999999999999994 676653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=236.57 Aligned_cols=203 Identities=30% Similarity=0.469 Sum_probs=162.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++......+++|||+.+++|.+++..... .+.+..+..++.+++.+|.|+|+.+ +
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---~ 114 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKN---C 114 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999999999999999999999999865432 1789999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||+|+++|++++ |..
T Consensus 115 ~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~ 193 (250)
T cd05085 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVC 193 (250)
T ss_pred eecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999988654322111 1112233557999999988889999999999999999998 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
||...... .....+........+...+..+.+++.+||..+|++|||+.++++.|.
T Consensus 194 p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 194 PYPGMTNQ----------------QAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHH----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 98643211 111111122222333445678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=246.78 Aligned_cols=194 Identities=22% Similarity=0.280 Sum_probs=156.2
Q ss_pred cccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 025816 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 83 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h 83 (247)
.++||||+++++++.+++..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ ++|
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivH 119 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---------FDLYRATFYAAEIVCGLQFLHSKG---IIY 119 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEe
Confidence 45899999999999999999999999999999998865432 889999999999999999999999 999
Q ss_pred ccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCC
Q 025816 84 RDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163 (247)
Q Consensus 84 ~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 163 (247)
|||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.
T Consensus 120 rDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred cCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 99999999999999999999998864321111 1233458899999999999899999999999999999999999997
Q ss_pred CCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH-HHH
Q 025816 164 HTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS-IVV 228 (247)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~il 228 (247)
..+.. ...+.+.. .....+...+.++.+++.+||+.||.+||++. +++
T Consensus 198 ~~~~~----------------~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 198 GDDED----------------ELFESIRV-DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHH----------------HHHHHHHh-CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 54321 01111100 01122334556799999999999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=248.84 Aligned_cols=203 Identities=22% Similarity=0.262 Sum_probs=159.3
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++ +||||+++++++..+...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~--- 125 (332)
T cd05614 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN---------FSEDEVRFYSGEIILALEHLHKLG--- 125 (332)
T ss_pred HHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4556 589999999999999999999999999999999865432 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++||||||+||+++.++.++|+|||++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|.
T Consensus 126 ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 204 (332)
T cd05614 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA 204 (332)
T ss_pred cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence 999999999999999999999999998754322211 12234689999999998865 4788999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
.||.......... .+...+. ......+...+..+.+++.+||+.||.+|| +++++++.
T Consensus 205 ~pf~~~~~~~~~~------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 205 SPFTLEGERNTQS------------EVSRRIL-KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCCCCCHH------------HHHHHHh-cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 9996443221111 0100000 011223344566799999999999999999 78888763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=247.79 Aligned_cols=194 Identities=22% Similarity=0.288 Sum_probs=157.7
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
+||||+++++++......++||||+.+|+|.+.+..... +++..+..++.|++.||.|||+.+ ++|+|
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~d 121 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---------FDEPRARFYAAEIVLGLQFLHERG---IIYRD 121 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEccC
Confidence 799999999999999999999999999999988875432 899999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 165 (247)
|||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus 122 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 122 LKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred CCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999998864321111 112345888999999999989999999999999999999999999643
Q ss_pred CCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHHH
Q 025816 166 LPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM-----SIVVKA 230 (247)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~il~~ 230 (247)
.... ........ ....+...+..+.+++.+||+.||.+|||+ .++++.
T Consensus 200 ~~~~---------------~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 200 DEDE---------------LFQSILED--EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CHHH---------------HHHHHHcC--CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2110 00111111 112333456779999999999999999999 888763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=242.27 Aligned_cols=213 Identities=27% Similarity=0.401 Sum_probs=163.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC-------------CCCCCCcCHHHHHHHHHHHHH
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG-------------AQPGPVLSWQQRVKIAVGAAK 68 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-------------~~~~~~l~~~~~~~~~~~~~~ 68 (247)
+++++||||+++++++..+...+++|||+.+++|.+++........ ......+++..++.++.|++.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 5678999999999999999999999999999999999975432110 011123788999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhh
Q 025816 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSF 148 (247)
Q Consensus 69 ~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 148 (247)
||.|||..+ ++|+||+|+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+|||
T Consensus 142 aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (288)
T cd05050 142 GMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218 (288)
T ss_pred HHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHH
Confidence 999999998 99999999999999999999999998875432221111122234567999999988889999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 149 GVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 149 G~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
|+++|+|++ |..||.+.... .+...+........+...+..+.+++.+||+.+|.+|||++|+
T Consensus 219 G~il~el~~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el 282 (288)
T cd05050 219 GVVLWEIFSYGMQPYYGMAHE----------------EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCHH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 999999997 87888533211 1111111111112233456779999999999999999999999
Q ss_pred HHHHHH
Q 025816 228 VKALQP 233 (247)
Q Consensus 228 l~~l~~ 233 (247)
++.|++
T Consensus 283 ~~~l~~ 288 (288)
T cd05050 283 NRILQR 288 (288)
T ss_pred HHHhhC
Confidence 998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=253.29 Aligned_cols=217 Identities=18% Similarity=0.260 Sum_probs=162.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++......+++||++. ++|.+++.... .+++..++.++.|++.||.|||+.+
T Consensus 139 il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~g--- 205 (392)
T PHA03207 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRG--- 205 (392)
T ss_pred HHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4678999999999999999999999999996 58998884332 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.++.++|+|||++................|+..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 206 ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~ 285 (392)
T PHA03207 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285 (392)
T ss_pred ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999876543322222234568999999999998899999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhcccc-------CCc---chhhhh---cccccCCCCC-------HHHHHHHHHHHHhhcccCCCC
Q 025816 161 PVDHTLPRGQQSLVTWATPK-------LSE---DKVRQC---VDARLGGDYP-------PKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~-------~~~---~~~~~~---~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~ 220 (247)
||.+................ ... ..+.+. .....+.... ...+.++.++|.+||..||++
T Consensus 286 pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 365 (392)
T PHA03207 286 TLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEF 365 (392)
T ss_pred CCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhh
Confidence 99765432111100000000 000 000000 0000111110 123457889999999999999
Q ss_pred CCCHHHHHHH
Q 025816 221 RPNMSIVVKA 230 (247)
Q Consensus 221 Rps~~~il~~ 230 (247)
|||+.+++..
T Consensus 366 Rpsa~e~l~~ 375 (392)
T PHA03207 366 RPSAQDILSL 375 (392)
T ss_pred CCCHHHHhhC
Confidence 9999999985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=245.95 Aligned_cols=215 Identities=21% Similarity=0.273 Sum_probs=155.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.++...++||||+. ++|.+++..... .++...+..++.|++.||.|||+.+
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~--- 123 (303)
T cd07869 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQRY--- 123 (303)
T ss_pred HHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999996 588888865432 2888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++||||||+||+++.++.++|+|||++........ ......++..|+|||++.+ ..++.++|+||+||++|+|++|.
T Consensus 124 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 201 (303)
T cd07869 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV 201 (303)
T ss_pred eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999864322111 1123457889999999875 45788999999999999999999
Q ss_pred CCCCCCCCCCCcc-hhhhccccCCcchhhh------hcccccCCCCC---------HHHHHHHHHHHHhhcccCCCCCCC
Q 025816 160 KPVDHTLPRGQQS-LVTWATPKLSEDKVRQ------CVDARLGGDYP---------PKAVAKMAAVAALCVQYEADFRPN 223 (247)
Q Consensus 160 ~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rps 223 (247)
.||.......... .............+.. ..........+ ...+.++.+++.+||+.||.+|||
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s 281 (303)
T cd07869 202 AAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS 281 (303)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC
Confidence 9997543211000 0000000000000000 00000000000 012356889999999999999999
Q ss_pred HHHHHH
Q 025816 224 MSIVVK 229 (247)
Q Consensus 224 ~~~il~ 229 (247)
++++++
T Consensus 282 ~~~~l~ 287 (303)
T cd07869 282 AQAALS 287 (303)
T ss_pred HHHHhc
Confidence 999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=250.29 Aligned_cols=194 Identities=22% Similarity=0.253 Sum_probs=156.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++..++..++||||+.+|+|...+.... .+++..+..++.|++.||.|||+.| +
T Consensus 50 l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~g---i 117 (325)
T cd05604 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSIN---I 117 (325)
T ss_pred HHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999998886543 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 118 vH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~p 195 (325)
T cd05604 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred eecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCC
Confidence 9999999999999999999999999875322111 12334688999999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
|...+.. ........... ......+..+.+++.+|+..+|.+||++++
T Consensus 196 f~~~~~~---------------~~~~~~~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 196 FYCRDVA---------------EMYDNILHKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCHH---------------HHHHHHHcCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 9744211 11111111111 122234567889999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=238.53 Aligned_cols=208 Identities=25% Similarity=0.387 Sum_probs=164.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.. ...+++|||+.+++|.+++..... .+++..+..++.+++.||.|||+.+ +
T Consensus 61 l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---~ 128 (270)
T cd05056 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLESKR---F 128 (270)
T ss_pred HHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 578899999999998875 457899999999999999975432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+.......... .....++..|+|||.+....++.++|+||||++++++++ |..
T Consensus 129 ~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 207 (270)
T cd05056 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207 (270)
T ss_pred eccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999987654332211 112223457999999988889999999999999999986 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
||....... ....+........+...+..+.+++.+|+..+|.+|||+.++++.|+.+.+.+
T Consensus 208 pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 208 PFQGVKNND----------------VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred CCCCCCHHH----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 996443211 01111111122233445667999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=252.45 Aligned_cols=207 Identities=27% Similarity=0.438 Sum_probs=186.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|+++.||||++++|+|.+ +..++|||.+.-|-|..+++.+... ++.......+.|++.|+.|||+..
T Consensus 444 iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~s--------L~l~tL~ly~~Qi~talaYLeSkr--- 511 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDS--------LPLRTLTLYCYQICTALAYLESKR--- 511 (974)
T ss_pred HHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhcccc--------chHHHHHHHHHHHHHHHHHHHhhc---
Confidence 5789999999999998865 4789999999999999999988754 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++||||..+|||+.++.-+||+|||+++.......+..+ ...-...|+|||.++...|+.++|||.||+++||++. |.
T Consensus 512 fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGv 590 (974)
T KOG4257|consen 512 FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGV 590 (974)
T ss_pred hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcC
Confidence 999999999999999999999999999998776655433 3345678999999999999999999999999999988 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
.||.+ ..+.++.-.++++-+...|+.|+..++.++.+||.++|.+||++.+|-+.|.++.+
T Consensus 591 kPfqg----------------vkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 591 KPFQG----------------VKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred Ccccc----------------ccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99963 45667777888999999999999999999999999999999999999999987776
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=240.55 Aligned_cols=222 Identities=24% Similarity=0.400 Sum_probs=163.8
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++... ...+++|||+.+++|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~g-- 129 (284)
T cd05079 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGSRQ-- 129 (284)
T ss_pred HHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 6789999999999998775 568899999999999999865432 2889999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|+||+++.++.++|+|||++......... .......++..|.|||.+.+..++.++|+||||+++++++++
T Consensus 130 -i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~ 208 (284)
T cd05079 130 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY 208 (284)
T ss_pred -eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcC
Confidence 999999999999999999999999998765432211 111223456679999999888899999999999999999997
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
..|.......-...... .............+........+..++..+.+++.+||+.+|.+|||+.++++.++.++
T Consensus 209 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 209 CDSESSPMTLFLKMIGP-THGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred CCCCccccchhhhhccc-ccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 76643211100000000 00000001111111122222233445678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=243.09 Aligned_cols=209 Identities=26% Similarity=0.410 Sum_probs=164.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++... ..+++++|+.+|+|.+++..... .+++..+..++.|++.||.|||+++ +
T Consensus 63 ~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---i 130 (303)
T cd05110 63 MASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERR---L 130 (303)
T ss_pred HHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcC---e
Confidence 5778999999999988754 46789999999999999876432 2888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|++++ |..
T Consensus 131 vH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~ 210 (303)
T cd05110 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 210 (303)
T ss_pred eccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986543222212222335668999999988889999999999999999997 889
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
||..... ....+.+........+..++.++.+++.+||..+|.+|||++++++.+..+.+..
T Consensus 211 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 211 PYDGIPT----------------REIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCCCCH----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 9864321 1111222222222223334567999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=237.91 Aligned_cols=210 Identities=20% Similarity=0.323 Sum_probs=166.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...+++|||+.+++|.+++...... +..+++..++.++.|++.|+.|||+.+ +
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i 127 (267)
T cd08229 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMHSRR---V 127 (267)
T ss_pred HHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 57789999999999999999999999999999999988643211 123899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 128 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p 205 (267)
T cd08229 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred ecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999988755332211 1234577889999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhccc-ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
|........ ...+.+.. ..........+..+.+++.+||..+|.+|||+.+|++.++++.
T Consensus 206 ~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 206 FYGDKMNLY--------------SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cccccchHH--------------HHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 864322100 00001111 1111112345678999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=244.57 Aligned_cols=195 Identities=24% Similarity=0.308 Sum_probs=156.9
Q ss_pred cccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 025816 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 83 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h 83 (247)
.++||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ ++|
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivH 119 (316)
T cd05619 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---------FDLPRATFYAAEIICGLQFLHSKG---IVY 119 (316)
T ss_pred ccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEe
Confidence 35899999999999999999999999999999999875432 888999999999999999999999 999
Q ss_pred ccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCC
Q 025816 84 RDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163 (247)
Q Consensus 84 ~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 163 (247)
|||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||+||++|+|++|..||.
T Consensus 120 rdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999998864321111 1133458889999999998889999999999999999999999997
Q ss_pred CCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 025816 164 HTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS-IVVK 229 (247)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~il~ 229 (247)
..+.. ...+.+.. .....+...+.++.+++.+||+.||.+||++. +++.
T Consensus 198 ~~~~~----------------~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 198 GHDEE----------------ELFQSIRM-DNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCHH----------------HHHHHHHh-CCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 43211 01111100 01122334556789999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=240.71 Aligned_cols=222 Identities=25% Similarity=0.351 Sum_probs=161.8
Q ss_pred cccccCCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++.. ....+++|||+.+++|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~~-- 128 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGSKR-- 128 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 678999999999998754 3468899999999999999865432 2889999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhccc-ccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||||+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++++|++|
T Consensus 129 -i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 207 (284)
T cd05081 129 -YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 207 (284)
T ss_pred -ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhc
Confidence 99999999999999999999999999886543221111 1111233458999999888899999999999999999998
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
..++.......................+.+.+........+...+.++.+++.+||..+|.+|||+.+|++.|+.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 208 SDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 7765432211000000000000000111122222222233344567799999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=242.34 Aligned_cols=219 Identities=26% Similarity=0.379 Sum_probs=164.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCC--CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA--QPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~--~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++..+...+++||++.+++|.+++......... .....+++..++.++.|++.||.|||+.+
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-- 150 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-- 150 (296)
T ss_pred HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--
Confidence 67899999999999999999999999999999999998765421111 11224899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh--
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-- 157 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-- 157 (247)
++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|++++
T Consensus 151 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 151 -FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred -ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 99999999999999999999999999875433222222233345678999999988889999999999999999988
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
+..||...... ............ .........+...+.++.+++.+||+.+|.+|||+.+|++.|+
T Consensus 230 ~~~p~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 230 REQPYEHLTDQ---QVIENAGHFFRD------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCCcChH---HHHHHHHhcccc------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 66777532210 011100000000 0011111223344567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=239.83 Aligned_cols=220 Identities=23% Similarity=0.337 Sum_probs=163.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC--CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG--AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++|+||+++++++..+...+++|||+.+++|.+++........ ......+++..+..++.|++.||.|||+.+
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-- 150 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-- 150 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5788999999999999999999999999999999999876542211 122234888899999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh--
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-- 157 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-- 157 (247)
++|+||||+||+++.++.++|+|||.+............+...++..|++||...+..++.++|+||||+++|+|++
T Consensus 151 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 151 -FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred -eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999875433221111222334567999999888889999999999999999998
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
|..||....... ..... ...............+..++..+.+++.+||+.||.+|||+.+|++.|++
T Consensus 230 ~~~p~~~~~~~~---~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 230 KEQPYSQLSDEQ---VIENT------GEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCCCccccChHH---HHHHH------HHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 677875332110 00000 00000000000111223445679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=245.04 Aligned_cols=197 Identities=22% Similarity=0.342 Sum_probs=167.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|+-++|||||++|.+..+...+|||+|.=++|+|++++-++... +.+..+.+.+.||+.||.|+|+.. +
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~G--------l~E~La~kYF~QI~~AI~YCHqLH---V 139 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEG--------LNEDLAKKYFAQIVHAISYCHQLH---V 139 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhcc--------ccHHHHHHHHHHHHHHHHHHhhhh---h
Confidence 56789999999999999999999999999999999999887753 999999999999999999999998 9
Q ss_pred EeccCCCCceee-cCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCC-ccccchhhhHHHHHHHhCC
Q 025816 82 IHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN-AKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 82 ~h~di~~~nil~-~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~ 159 (247)
+|||+||+|+.+ .+-|-+||+|||.+..+..... -...+|+..|.|||++.|..|+ ++.||||||+++|.+.+|+
T Consensus 140 VHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq 216 (864)
T KOG4717|consen 140 VHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQ 216 (864)
T ss_pred hcccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCC
Confidence 999999999877 5678899999999887654332 2456789999999999999986 5789999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+||+... ..+.+..+++ .....|...+.++.+||.+||..||.+|.|.++|..
T Consensus 217 ~PFqeAN---------------DSETLTmImD--CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 217 PPFQEAN---------------DSETLTMIMD--CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred Ccccccc---------------chhhhhhhhc--ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 9997432 1222233332 223567788999999999999999999999999875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=249.82 Aligned_cols=200 Identities=19% Similarity=0.262 Sum_probs=158.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++.++...++||||+.+|+|.+++.... ++...+..++.|++.||.|||+.+ |
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~~---I 163 (370)
T cd05621 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSMG---L 163 (370)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999999997543 888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC----CCccccchhhhHHHHHHHh
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~~l~~ 157 (247)
+||||||+||+++.++.+||+|||++........ .......||..|+|||++.+.. ++.++|+||+||++|+|++
T Consensus 164 vHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~ 242 (370)
T cd05621 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 242 (370)
T ss_pred EecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh
Confidence 9999999999999999999999999876432211 1123456899999999997643 7889999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC--HHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADF--RPNMSIVVKA 230 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--Rps~~~il~~ 230 (247)
|..||...... ....++.........+ ...+..+.+++.+|+..++.+ |+|++++++.
T Consensus 243 G~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 243 GDTPFYADSLV---------------GTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCCCCCCHH---------------HHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 99999754221 1112222211111112 234667899999999865544 8999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=250.21 Aligned_cols=216 Identities=28% Similarity=0.454 Sum_probs=167.7
Q ss_pred ccccc-CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC----------------------------------
Q 025816 2 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---------------------------------- 46 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------------------------------- 46 (247)
|.++. ||||+++++++......++||||+.+|+|.+++.......
T Consensus 94 l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (401)
T cd05107 94 MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173 (401)
T ss_pred HHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhc
Confidence 55676 9999999999999999999999999999999997543210
Q ss_pred -------------------------------------------------------CCCCCCCcCHHHHHHHHHHHHHHHH
Q 025816 47 -------------------------------------------------------GAQPGPVLSWQQRVKIAVGAAKGLE 71 (247)
Q Consensus 47 -------------------------------------------------------~~~~~~~l~~~~~~~~~~~~~~~l~ 71 (247)
.......+++..++.++.|++.||.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 253 (401)
T cd05107 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGME 253 (401)
T ss_pred cCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 0012234788889999999999999
Q ss_pred HhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHH
Q 025816 72 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV 151 (247)
Q Consensus 72 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~ 151 (247)
|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||+|++
T Consensus 254 ~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvi 330 (401)
T cd05107 254 FLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGIL 330 (401)
T ss_pred HHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHH
Confidence 999998 99999999999999999999999999875432221111222345678999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 152 LLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 152 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
+++|++ |..||..... .+...+.+....+...+...+.++.+++.+||..+|.+|||+++|++.
T Consensus 331 l~e~l~~g~~P~~~~~~---------------~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 331 LWEIFTLGGTPYPELPM---------------NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHcCCCCCCCCCc---------------hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999998 8889853311 111112222222233344556789999999999999999999999999
Q ss_pred HHHhH
Q 025816 231 LQPLL 235 (247)
Q Consensus 231 l~~~~ 235 (247)
|+.++
T Consensus 396 L~~~~ 400 (401)
T cd05107 396 VGDLL 400 (401)
T ss_pred HHHHh
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=252.45 Aligned_cols=210 Identities=24% Similarity=0.269 Sum_probs=165.5
Q ss_pred CCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 025816 8 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 87 (247)
Q Consensus 8 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~ 87 (247)
-|+|+++++|...+++|||+|.+.. +|+++++.+.... ++...++.++.||+.||.+||+.+ |||+|||
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~n~f~G-------lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLK 316 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELLST-NLYELLKNNKFRG-------LSLPLVRKFAQQILTALLFLHELG---IIHCDLK 316 (586)
T ss_pred eeEEEeeeccccccceeeeehhhhh-hHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCC
Confidence 3899999999999999999999965 9999999887654 999999999999999999999999 9999999
Q ss_pred CCceeecCCC--ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 025816 88 SSNVLIFDDD--VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165 (247)
Q Consensus 88 ~~nil~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 165 (247)
|+|||+...+ .+||+|||.+....... .....+..|+|||++.|.+|+.++|+|||||+++||++|.+.|.+.
T Consensus 317 PENILL~~~~r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 317 PENILLKDPKRSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred hhheeeccCCcCceeEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 9999996544 69999999988654322 2455678899999999999999999999999999999999999988
Q ss_pred CCCCCcchhhhccccCCcch----------------------------------hhhh----cccccCC--------CCC
Q 025816 166 LPRGQQSLVTWATPKLSEDK----------------------------------VRQC----VDARLGG--------DYP 199 (247)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~----~~~~~~~--------~~~ 199 (247)
.+.++-..+....+..+..- .... ....... ...
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 87766444433333222100 0000 0000000 011
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHH
Q 025816 200 PKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQP 233 (247)
Q Consensus 200 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~ 233 (247)
......+.+++++||.+||.+|+|+.+.++ +++.
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 234556899999999999999999999998 5553
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=236.43 Aligned_cols=205 Identities=27% Similarity=0.439 Sum_probs=162.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++++++. +...+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~al~~LH~~~--- 122 (260)
T cd05067 54 LMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGI-------KLTINKLIDMAAQIAEGMAFIERKN--- 122 (260)
T ss_pred HHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHhcCC---
Confidence 367899999999999864 55789999999999999998654432 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||++++++++ |.
T Consensus 123 i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~ 201 (260)
T cd05067 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201 (260)
T ss_pred eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998765421111 1122334668999999988889999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
.||..... ....+.+........+...+..+.+++.+||..+|++|||++++++.|+.
T Consensus 202 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 202 IPYPGMTN----------------PEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCh----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 99964321 11111122222223334445679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=247.06 Aligned_cols=202 Identities=20% Similarity=0.257 Sum_probs=155.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++.+.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ |
T Consensus 55 l~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~g---i 122 (363)
T cd05628 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT---------LTEEETQFYIAETVLAIDSIHQLG---F 122 (363)
T ss_pred HHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999999999999999999999999975432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhc---------------------------------ccccceeccccc
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR---------------------------------LHSTRVLGTFGY 128 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~---------------------------------~~~~~~~~~~~y 128 (247)
+||||||+||+++.++.++|+|||++......... .......||..|
T Consensus 123 vHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y 202 (363)
T cd05628 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDY 202 (363)
T ss_pred EecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccc
Confidence 99999999999999999999999998754221000 001124689999
Q ss_pred cCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC--HHHHHHH
Q 025816 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKM 206 (247)
Q Consensus 129 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 206 (247)
+|||++.+..++.++|+|||||++|+|++|..||....... ....+.........+ ...+.++
T Consensus 203 ~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~---------------~~~~i~~~~~~~~~p~~~~~s~~~ 267 (363)
T cd05628 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE---------------TYKKVMNWKETLIFPPEVPISEKA 267 (363)
T ss_pred cCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHH---------------HHHHHHcCcCcccCCCcCCCCHHH
Confidence 99999999899999999999999999999999997543211 011111100000111 1234567
Q ss_pred HHHHHhhcc--cCCCCCCCHHHHHHH
Q 025816 207 AAVAALCVQ--YEADFRPNMSIVVKA 230 (247)
Q Consensus 207 ~~li~~cl~--~~p~~Rps~~~il~~ 230 (247)
.+++.+++. .++..||++++|++.
T Consensus 268 ~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 268 KDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 888887553 233457999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=249.18 Aligned_cols=200 Identities=22% Similarity=0.236 Sum_probs=158.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++|+||+++++++.+++..++||||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~~---i 123 (330)
T cd05601 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQMG---Y 123 (330)
T ss_pred HHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999976532 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh------cCCCCccccchhhhHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM------TGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~~l~~l 155 (247)
+||||||+||+++.++.++|+|||++......... ......++..|+|||.+. ...++.++||||||+++|+|
T Consensus 124 ~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el 202 (330)
T cd05601 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202 (330)
T ss_pred EcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeee
Confidence 99999999999999999999999998754332211 112345788999999986 44678899999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccc--cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR--LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
++|..||...... .....+.... .........+.++.+++.+||. +|.+|||++++++
T Consensus 203 ~~g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 203 IYGRSPFHEGTSA---------------KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCCCCCCCCCHH---------------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 9999999643211 0111111111 0011112345679999999998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=228.02 Aligned_cols=197 Identities=22% Similarity=0.291 Sum_probs=160.3
Q ss_pred ccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 025816 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII 82 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~ 82 (247)
+.|+|||||++.+.+......++|+|+++|++|..-+-++. .+++..+...+.||+++|.|+|.++ |+
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n~---Iv 132 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSNG---IV 132 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhcC---ce
Confidence 56899999999999999999999999999999877665543 2888899999999999999999999 99
Q ss_pred eccCCCCceeecCC---CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 83 HRDIKSSNVLIFDD---DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 83 h~di~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
|||+||+|+++.+. .-+||+|||++..... ...-..+.||+.|+|||++...+|+..+|||+.|+++|-++.|.
T Consensus 133 HRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~ 209 (355)
T KOG0033|consen 133 HRDLKPENLLLASKAKGAAVKLADFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 209 (355)
T ss_pred eccCChhheeeeeccCCCceeecccceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCC
Confidence 99999999999643 3599999999987652 22235678999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+||.+.+... ..++++.....-. .=...+.+..+|+++||..||.+|.|+.|.|+
T Consensus 210 ~PF~~~~~~r---------------lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 210 PPFWDEDQHR---------------LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCCCCccHHH---------------HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 9997643211 1111111111111 11344667999999999999999999999886
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=244.46 Aligned_cols=220 Identities=20% Similarity=0.317 Sum_probs=161.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+ +|.+++..... .++...+..++.|++.||.|||+.+ +
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---i 125 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHRRK---V 125 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5789999999999999999999999999975 88888765432 2788999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+||||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+ ..++.++|+||+|+++++|++|..
T Consensus 126 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~ 203 (309)
T cd07872 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203 (309)
T ss_pred ecCCCCHHHEEECCCCCEEECccccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998754322111 122356788999998865 457899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcc---------cccCC----CCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVD---------ARLGG----DYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
||...+...................+..+.. ..... ......+.++.+++.+||+.||.+|||++|+
T Consensus 204 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 283 (309)
T cd07872 204 LFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA 283 (309)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH
Confidence 9976543222111111111111111100000 00000 0112345678999999999999999999999
Q ss_pred HH--HHHHhH
Q 025816 228 VK--ALQPLL 235 (247)
Q Consensus 228 l~--~l~~~~ 235 (247)
++ .++.+-
T Consensus 284 l~h~~~~~~~ 293 (309)
T cd07872 284 MKHAYFRSLG 293 (309)
T ss_pred hcChhhhhcc
Confidence 98 555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=249.58 Aligned_cols=203 Identities=21% Similarity=0.237 Sum_probs=156.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 54 il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~~LH~~g--- 121 (381)
T cd05626 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV---------FPEVLARFYIAELTLAIESVHKMG--- 121 (381)
T ss_pred HHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36788999999999999999999999999999999999876432 888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc--------------------------------------------
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-------------------------------------------- 116 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-------------------------------------------- 116 (247)
|+||||||+||+++.++.++|+|||++.........
T Consensus 122 ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (381)
T cd05626 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQ 201 (381)
T ss_pred eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccc
Confidence 999999999999999999999999987532110000
Q ss_pred -ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccc--c
Q 025816 117 -LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--R 193 (247)
Q Consensus 117 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 193 (247)
.......||..|+|||.+.+..++.++|||||||++|+|++|..||........ ....... .
T Consensus 202 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~---------------~~~i~~~~~~ 266 (381)
T cd05626 202 RCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET---------------QLKVINWENT 266 (381)
T ss_pred ccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHH---------------HHHHHccccc
Confidence 001124589999999999988899999999999999999999999975432111 0111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHh--hcccCCCCCCCHHHHHHH
Q 025816 194 LGGDYPPKAVAKMAAVAAL--CVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 194 ~~~~~~~~~~~~l~~li~~--cl~~~p~~Rps~~~il~~ 230 (247)
.........+.++.+++.+ |+..++..|||++++++.
T Consensus 267 ~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 267 LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111112345678889988 445666679999999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=250.70 Aligned_cols=202 Identities=22% Similarity=0.249 Sum_probs=156.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.++...++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+
T Consensus 54 il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~g--- 121 (377)
T cd05629 54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVHKLG--- 121 (377)
T ss_pred HHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3577899999999999999999999999999999999987543 2888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc------------c-------------------------------
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR------------L------------------------------- 117 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~------------~------------------------------- 117 (247)
|+||||||+||+++.++.++|+|||+++........ .
T Consensus 122 ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (377)
T cd05629 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNR 201 (377)
T ss_pred eeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc
Confidence 999999999999999999999999998633210000 0
Q ss_pred --cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC
Q 025816 118 --HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG 195 (247)
Q Consensus 118 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (247)
......||..|+|||.+.+..++.++|+|||||++|+|++|..||........ ...+......
T Consensus 202 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---------------~~~i~~~~~~ 266 (377)
T cd05629 202 RLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHET---------------YRKIINWRET 266 (377)
T ss_pred cccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHH---------------HHHHHccCCc
Confidence 00123588999999999988999999999999999999999999965432110 0111100000
Q ss_pred CCCC--HHHHHHHHHHHHhhcccCCCCC---CCHHHHHHH
Q 025816 196 GDYP--PKAVAKMAAVAALCVQYEADFR---PNMSIVVKA 230 (247)
Q Consensus 196 ~~~~--~~~~~~l~~li~~cl~~~p~~R---ps~~~il~~ 230 (247)
...+ ...+.++.+++.+|+. +|.+| +|+.++++.
T Consensus 267 ~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 267 LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 1111 1245679999999997 66664 699999884
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=239.18 Aligned_cols=221 Identities=26% Similarity=0.410 Sum_probs=167.8
Q ss_pred cccccCCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++|+||+++++++.. +...+++|||+.+++|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~-- 129 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQR-- 129 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 578899999999999877 5678999999999999999976542 2899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|.||+++.++.++|+|||.+.......... ......++..|.|||...+..++.++|+||||+++++|++|
T Consensus 130 -i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg 208 (284)
T cd05038 130 -YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208 (284)
T ss_pred -eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeecc
Confidence 9999999999999999999999999988764222111 11122345569999999888899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
..|+............. .........+.+.+........+..++..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus 209 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 209 GDPSQSPPAEFLRMIGI-AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCCcccccchhcccccc-ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 99986432211110000 0001111222223333333333445567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=251.70 Aligned_cols=198 Identities=24% Similarity=0.382 Sum_probs=164.4
Q ss_pred CcccccCCCccceeeEEeeCCe--eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTS--RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
||+.|+||||+++|+++.+... ..+|.|.+..|+|..++.+... +..+.+..|++||++||.|||++ +
T Consensus 94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~-~ 163 (632)
T KOG0584|consen 94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQ-D 163 (632)
T ss_pred HHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcC-C
Confidence 5899999999999999987665 7899999999999999998875 88899999999999999999998 5
Q ss_pred CCeEeccCCCCceeecCC-CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 79 PHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+|+|||||-+||+++.+ |.|||+|+|+|....... .....||+.|+|||++. ..|.+..||||||+++.||+|
T Consensus 164 PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 164 PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred CCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHh
Confidence 789999999999999765 789999999998654322 24478999999999887 789999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCH-HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP-KAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+..||.-.. ....+.+.+.++..+.... -...+++++|.+||.. ..+|||+.|+|+
T Consensus 239 ~eYPYsEC~---------------n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 239 SEYPYSECT---------------NPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ccCChhhhC---------------CHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 999996332 2233344444444332211 1134699999999999 999999999998
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=256.38 Aligned_cols=205 Identities=22% Similarity=0.320 Sum_probs=160.8
Q ss_pred cccccCCCccceeeEEeeCC--------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRLKHENFVQLLGYCVDGT--------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++.++|+||+++.+.+.... ..++||||+.+|+|.+++..... ....+++..+..++.|++.||.||
T Consensus 85 l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-----~~~~l~e~~~~~i~~qll~aL~~l 159 (496)
T PTZ00283 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK-----TNRTFREHEAGLLFIQVLLAVHHV 159 (496)
T ss_pred HhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhc-----cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 56789999999988765432 36799999999999999865432 112389999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++||||||+||+++.++.++|+|||+++...............|+..|+|||.+.+..++.++||||||+++|
T Consensus 160 H~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvily 236 (496)
T PTZ00283 160 HSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLY 236 (496)
T ss_pred HhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 9999 9999999999999999999999999987654322222223456899999999999989999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
+|++|..||...... ..+.... .......+...+.++.+++.+||+.||.+|||+.++++.
T Consensus 237 eLltG~~Pf~~~~~~---------------~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 237 ELLTLKRPFDGENME---------------EVMHKTL-AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHCCCCCCCCCHH---------------HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 999999999643210 0111111 111122344556789999999999999999999999873
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=239.96 Aligned_cols=220 Identities=25% Similarity=0.352 Sum_probs=162.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC---CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG---AQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+++++|+|++++++++..+...++||||+.+++|.+++........ ......+++..+..++.|++.||.|||+.+
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 149 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN- 149 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 6789999999999999999999999999999999999865431110 011123788899999999999999999999
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT- 157 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~- 157 (247)
++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++++|++
T Consensus 150 --i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 150 --FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred --eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 99999999999999999999999999875432221111222334668999999988889999999999999999988
Q ss_pred -CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 158 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 158 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
+..||....... ......... ...........+...+..+.+++.+||..+|.+|||+++|++.|++
T Consensus 228 ~~~~p~~~~~~~~---~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 228 CKEQPYSLLSDEQ---VIENTGEFF------RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCCCCCcccChHH---HHHHHHHhh------hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 566765322100 000000000 0000011111223345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=234.88 Aligned_cols=205 Identities=25% Similarity=0.433 Sum_probs=163.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++++++.. ...+++|||+.+++|.+++....... +++..+..++.|++.||.+||+.+
T Consensus 54 ~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~~~~~l~~aL~~lH~~~--- 122 (260)
T cd05073 54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSK-------QPLPKLIDFSAQIAEGMAFIEQRN--- 122 (260)
T ss_pred HHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccc-------cCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678999999999998877 77899999999999999997644322 788899999999999999999998
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||++++++++ |.
T Consensus 123 i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~ 201 (260)
T cd05073 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201 (260)
T ss_pred ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCC
Confidence 999999999999999999999999988754322111 1122234567999999988888999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
.||...+.. ...+.+........+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 202 ~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 202 IPYPGMSNP----------------EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCCHH----------------HHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999643211 1111122222223334456679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=240.35 Aligned_cols=199 Identities=24% Similarity=0.371 Sum_probs=160.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.+.|+||+++++.+..+...++||||+.+++|.+++.... +++..+..++.|++.||.|||+.+ +
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~i~~ql~~aL~~LH~~g---i 137 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---V 137 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999999999999999999999999999986543 788999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 138 ~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~p 215 (296)
T cd06654 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215 (296)
T ss_pred ccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999988754322111 1223577889999999888889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|....+..... ... .........+...+..+.+++.+||..+|.+|||++++++
T Consensus 216 f~~~~~~~~~~--~~~------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 216 YLNENPLRALY--LIA------------TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCHHHhHH--HHh------------cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 96543211110 000 0000011123345567999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=249.36 Aligned_cols=201 Identities=20% Similarity=0.265 Sum_probs=158.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|+.++||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~~--- 121 (364)
T cd05599 54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT---------FTEEETRFYIAETILAIDSIHKLG--- 121 (364)
T ss_pred HHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36788999999999999999999999999999999999875432 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcc------------------------------------cccceec
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL------------------------------------HSTRVLG 124 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~------------------------------------~~~~~~~ 124 (247)
++||||||+||+++.++.++|+|||++.......... ......|
T Consensus 122 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 201 (364)
T cd05599 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVG 201 (364)
T ss_pred eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccccc
Confidence 9999999999999999999999999986432111000 0012358
Q ss_pred cccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccc--cCCCCCHHH
Q 025816 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR--LGGDYPPKA 202 (247)
Q Consensus 125 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 202 (247)
|..|+|||++.+..++.++|+|||||++|+|++|..||........ ........ .........
T Consensus 202 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~---------------~~~i~~~~~~~~~~~~~~~ 266 (364)
T cd05599 202 TPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET---------------YRKIINWKETLQFPDEVPL 266 (364)
T ss_pred CccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH---------------HHHHHcCCCccCCCCCCCC
Confidence 9999999999988999999999999999999999999975432110 01111000 000111133
Q ss_pred HHHHHHHHHhhcccCCCCCCC---HHHHHH
Q 025816 203 VAKMAAVAALCVQYEADFRPN---MSIVVK 229 (247)
Q Consensus 203 ~~~l~~li~~cl~~~p~~Rps---~~~il~ 229 (247)
+.++.++|.+|+. +|.+|++ ++++++
T Consensus 267 s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 267 SPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 5678999999996 9999998 999887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=234.76 Aligned_cols=195 Identities=22% Similarity=0.429 Sum_probs=153.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...+++|||+.+++|..++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i 126 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLEDKD---L 126 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhhhCC---e
Confidence 5678999999999999999899999999999999888765332 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCc-------eeeccccccCCcchhhhcccccceeccccccCchhhh-cCCCCccccchhhhHHHH
Q 025816 82 IHRDIKSSNVLIFDDDV-------AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~-------~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~ 153 (247)
+||||+|+||+++.++. ++++|||++...... ....++..|+|||.+. +..++.++||||||+++|
T Consensus 127 vH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 200 (262)
T cd05077 127 VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLW 200 (262)
T ss_pred ECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHH
Confidence 99999999999987664 899999988654221 2234677899999886 466899999999999999
Q ss_pred HHH-hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 154 ELL-TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 154 ~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
+|+ .|..||....... ......... ........++.+++.+||+.||.+||++.+|++.+
T Consensus 201 el~~~~~~p~~~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 201 EICYNGEIPLKDKTLAE----------------KERFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHhCCCCCCCCcchhH----------------HHHHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 997 4888875432111 000011111 11112345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=260.53 Aligned_cols=212 Identities=25% Similarity=0.427 Sum_probs=192.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||-+..||||+++-|+++..+...+|.||+++|+|..|+.++.++ +++-+...+++.|+.|++||-+.+
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq--------ftviQLVgMLrGIAsGMkYLsdm~--- 751 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIASGMKYLSDMN--- 751 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc--------eEeehHHHHHHHHHHHhHHHhhcC---
Confidence 578899999999999999999999999999999999999998865 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
+|||||..+|||++.+-.+|++|||+++...+..+. ..+..-.-..+|.|||.+...+++.++||||+|+++||.++ |
T Consensus 752 YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 752 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 999999999999999999999999999976554422 22222234568999999999999999999999999999988 9
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
..||- .+++.++.+.++.+.+...|.+++..|..|+..||++|-.+||.+.+|+..|++++..+
T Consensus 832 ERPYW----------------dmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 832 ERPYW----------------DMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCccc----------------ccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 99983 46788999999999999999999999999999999999999999999999999998765
Q ss_pred C
Q 025816 239 P 239 (247)
Q Consensus 239 ~ 239 (247)
.
T Consensus 896 ~ 896 (996)
T KOG0196|consen 896 N 896 (996)
T ss_pred h
Confidence 4
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=236.55 Aligned_cols=201 Identities=25% Similarity=0.410 Sum_probs=162.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++......+++|||+.+++|.+++..... ++...+..++.|++.||.+||+.+
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~l~~~l~~lH~~~--- 126 (267)
T cd06628 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA---------FEETLVRNFVRQILKGLNYLHNRG--- 126 (267)
T ss_pred HHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccC---------ccHHHHHHHHHHHHHHHHHHHhcC---
Confidence 36789999999999999999999999999999999999975432 888899999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc----ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 156 (247)
++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+..++.++|+||+|+++++++
T Consensus 127 ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206 (267)
T ss_pred cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHh
Confidence 999999999999999999999999998765421111 0111234678899999998888899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||...... ..+.... .......+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 207 ~g~~p~~~~~~~---------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 207 TGKHPFPDCTQL---------------QAIFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hCCCCCCCccHH---------------HHHHHHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 999999643211 1111111 11222334455678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=239.88 Aligned_cols=213 Identities=22% Similarity=0.276 Sum_probs=155.6
Q ss_pred ccccCCCccceeeEEeeC-----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 3 SRLKHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
++++||||+++++++... ...+++||++.+ +|.+++....... +++..+..++.|++.||.|||+.+
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~-------~~~~~~~~~~~qi~~al~~lH~~~ 128 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPG-------LPAETIKDLMRQFLRGLDFLHANC 128 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345799999999988642 457999999975 8988887644322 899999999999999999999999
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
++|+||||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 129 ---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 202 (288)
T cd07863 129 ---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 202 (288)
T ss_pred ---eecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHh
Confidence 99999999999999999999999999876532211 123456888999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhh-------ccccc---CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC-------VDARL---GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
|.+||.......................+... ..... ........+..+.+++.+||+.||.+|||+.++
T Consensus 203 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~ 282 (288)
T cd07863 203 RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA 282 (288)
T ss_pred CCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH
Confidence 99999654322111100000000000000000 00000 001112345678999999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
+.
T Consensus 283 l~ 284 (288)
T cd07863 283 LQ 284 (288)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=233.93 Aligned_cols=200 Identities=29% Similarity=0.499 Sum_probs=160.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|||++++++++..+ ..+++|||+.+++|.+++....... +++..++.++.|++.||.|||+.+ +
T Consensus 53 l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~al~~lH~~~---~ 121 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRAL-------VSVIQLLQFSLDVAEGMEYLESKK---L 121 (254)
T ss_pred HHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCC-------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5788999999999988654 5799999999999999997654322 889999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+||||+|+||+++.++.++|+|||.+....... .....+..|.|||.+.+..++.++|+||||+++++|++ |..
T Consensus 122 ~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 196 (254)
T cd05083 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRA 196 (254)
T ss_pred eccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999887542211 11223457999999988889999999999999999997 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
||..... ....+.+........+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 197 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 197 PYPKMSL----------------KEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCccCCH----------------HHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 9864321 11122222222223334456779999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=243.95 Aligned_cols=203 Identities=22% Similarity=0.275 Sum_probs=157.7
Q ss_pred ccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 3 SRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 3 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++ +||||+++++.+...+..++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+ +
T Consensus 50 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---i 117 (327)
T cd05617 50 EQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLHERG---I 117 (327)
T ss_pred HhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 344 69999999999999999999999999999998886543 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 118 vHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~p 195 (327)
T cd05617 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195 (327)
T ss_pred eccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCC
Confidence 9999999999999999999999998874322111 12334688999999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH------HHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM------SIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~~il~ 229 (247)
|........... .....+.+.. .....+...+..+.+++.+||..||.+|+++ +++++
T Consensus 196 f~~~~~~~~~~~---------~~~~~~~~~~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 196 FDIITDNPDMNT---------EDYLFQVILE-KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred CCccCCCccccc---------HHHHHHHHHh-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 964322111100 0001111100 1112344455678999999999999999984 56655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=240.67 Aligned_cols=162 Identities=23% Similarity=0.361 Sum_probs=128.7
Q ss_pred CcccccCCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+|++++||||+++++++.. +...+++|||+. ++|.+++..............++...+..++.|++.||.|||+.+
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 128 (317)
T cd07868 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 128 (317)
T ss_pred HHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678999999999998854 456889999986 499888765433222222234899999999999999999999999
Q ss_pred CCeEeccCCCCceee----cCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhc-CCCCccccchhhhHHH
Q 025816 79 PHIIHRDIKSSNVLI----FDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVL 152 (247)
Q Consensus 79 ~~i~h~di~~~nil~----~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l 152 (247)
++||||||+||++ +..+.+||+|||+++........ .......+|..|+|||.+.+ ..++.++|+||+||++
T Consensus 129 --ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (317)
T cd07868 129 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred --EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHH
Confidence 9999999999999 45678999999999765332111 11223467889999999877 4589999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 025816 153 LELLTGRKPVDHTL 166 (247)
Q Consensus 153 ~~l~~g~~pf~~~~ 166 (247)
++|++|.+||....
T Consensus 207 ~el~~g~~~f~~~~ 220 (317)
T cd07868 207 AELLTSEPIFHCRQ 220 (317)
T ss_pred HHHHhCCCCccCCc
Confidence 99999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=255.95 Aligned_cols=224 Identities=20% Similarity=0.257 Sum_probs=159.5
Q ss_pred CcccccCCCccceeeEEeeC--------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHH
Q 025816 1 MVSRLKHENFVQLLGYCVDG--------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 72 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 72 (247)
+|++++||||+++++++... ..+++||||+.+ +|.+++..... .+..+++..+..++.|++.||.|
T Consensus 112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~gL~y 185 (440)
T PTZ00036 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYAR-----NNHALPLFLVKLYSYQLCRALAY 185 (440)
T ss_pred HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHH
Confidence 46789999999999887432 246799999975 88777753221 11238999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCceeecCCC-ceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhH
Q 025816 73 LHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGV 150 (247)
Q Consensus 73 lh~~~~~~i~h~di~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~ 150 (247)
||+.+ |+||||||+||+++.++ .+||+|||++........ .....++..|+|||++.+. .++.++||||+||
T Consensus 186 LH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv 259 (440)
T PTZ00036 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGC 259 (440)
T ss_pred HHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHH
Confidence 99999 99999999999998665 699999999976532221 1234578899999998764 6899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhh------------cccccCCCCCHHHHHHHHHHHHhhcccCC
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC------------VDARLGGDYPPKAVAKMAAVAALCVQYEA 218 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p 218 (247)
++|+|++|.+||.+...................+.+... ....+...++...+.++.+++.+||.+||
T Consensus 260 il~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP 339 (440)
T PTZ00036 260 IIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339 (440)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCCh
Confidence 999999999999765432211111111111111111110 00001111223345679999999999999
Q ss_pred CCCCCHHHHHH--HHHHhHh
Q 025816 219 DFRPNMSIVVK--ALQPLLN 236 (247)
Q Consensus 219 ~~Rps~~~il~--~l~~~~~ 236 (247)
.+|||+.++++ +++.+..
T Consensus 340 ~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 340 LKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hHCcCHHHHhCChhHHhhhc
Confidence 99999999996 5665544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=251.38 Aligned_cols=185 Identities=24% Similarity=0.352 Sum_probs=162.2
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
+||.++.++..|.+.+++|+||||+.||++....+... +++..+.-.+..++.||+|||++| |++||
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~~----------F~e~rarfyaAev~l~L~fLH~~~---IIYRD 493 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTDV----------FSEPRARFYAAEVVLGLQFLHENG---IIYRD 493 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEeccc----------ccHHHHHHHHHHHHHHHHHHHhcC---ceeee
Confidence 79999999999999999999999999999766665444 999999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 165 (247)
+|.+|||+|..|.+||+|||++...-... ..+...+||+.|+|||++.+..|+.+.|.|+||+++|+|+.|..||.++
T Consensus 494 lKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd 571 (694)
T KOG0694|consen 494 LKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD 571 (694)
T ss_pred cchhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999998653322 2456788999999999999999999999999999999999999999866
Q ss_pred CCCCCcchhhhccccCCcchhhhhcccccCC--CCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 025816 166 LPRGQQSLVTWATPKLSEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNM 224 (247)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~ 224 (247)
++ .++.++.+.+ .+|...+.+...+++++|.+||.+|--+
T Consensus 572 dE-------------------ee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 572 DE-------------------EEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CH-------------------HHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 43 2333333333 4677888999999999999999999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=244.13 Aligned_cols=195 Identities=22% Similarity=0.266 Sum_probs=157.3
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||....+|.||++|-.|.+...+||||||..||++..++..... |++..+...+.+++.||..+|+.|
T Consensus 194 iL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~---------L~e~~arfYiaE~vlAI~~iH~~g--- 261 (550)
T KOG0605|consen 194 ILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDT---------LTEDWARFYIAETVLAIESIHQLG--- 261 (550)
T ss_pred HhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCc---------CchHHHHHHHHHHHHHHHHHHHcC---
Confidence 34557889999999999999999999999999999999987663 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchh----------------------hhcc----c----------------
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM----------------------AARL----H---------------- 118 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~----------------------~~~~----~---------------- 118 (247)
++||||||+|+||+..|++||+|||++.-.... .... .
T Consensus 262 yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nr 341 (550)
T KOG0605|consen 262 YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNR 341 (550)
T ss_pred cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhh
Confidence 999999999999999999999999998422110 0000 0
Q ss_pred ---ccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC
Q 025816 119 ---STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG 195 (247)
Q Consensus 119 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (247)
.....||+.|+|||++.+.+|...+|.|||||++|||+.|.+||.+.++... .+.++.-...
T Consensus 342 r~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T---------------~rkI~nwr~~ 406 (550)
T KOG0605|consen 342 RQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQET---------------YRKIVNWRET 406 (550)
T ss_pred hhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHHHhhh
Confidence 0123599999999999999999999999999999999999999987654322 2222222211
Q ss_pred CC--CCHHHHHHHHHHHHhhcccCCCCCCC
Q 025816 196 GD--YPPKAVAKMAAVAALCVQYEADFRPN 223 (247)
Q Consensus 196 ~~--~~~~~~~~l~~li~~cl~~~p~~Rps 223 (247)
.. .....+.+..+||.+|+. ||..|--
T Consensus 407 l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 407 LKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred ccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 11 122344789999999999 9999986
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=241.08 Aligned_cols=220 Identities=20% Similarity=0.275 Sum_probs=158.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++..++..++||||+.+|+|.+++....... +++..++.++.|++.||.|||+.+ +
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~-------l~~~~~~~i~~qi~~~L~~LH~~~---i 122 (327)
T cd08227 53 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-------MSELAIAYILQGVLKALDYIHHMG---Y 122 (327)
T ss_pred HHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCC-------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 567899999999999999999999999999999999996543222 889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhc-----ccccceeccccccCchhhhc--CCCCccccchhhhHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~ 154 (247)
+||||||+||+++.++.+++.||+........... .......++..|+|||.+.+ ..++.++|+||+||++++
T Consensus 123 iH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~e 202 (327)
T cd08227 123 VHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 202 (327)
T ss_pred ecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHH
Confidence 99999999999999999999999764432111100 00112235667999999876 458899999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccC---------Ccchhh-------------h---------hcccccCCCCCHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKL---------SEDKVR-------------Q---------CVDARLGGDYPPKAV 203 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~~~-------------~---------~~~~~~~~~~~~~~~ 203 (247)
|++|..||........ ......... ..+... . ..............+
T Consensus 203 l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (327)
T cd08227 203 LANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFS 280 (327)
T ss_pred HHHCCCCCCCcchhHH--HHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccC
Confidence 9999999964321100 000000000 000000 0 000000011222445
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHH--HHHH
Q 025816 204 AKMAAVAALCVQYEADFRPNMSIVVK--ALQP 233 (247)
Q Consensus 204 ~~l~~li~~cl~~~p~~Rps~~~il~--~l~~ 233 (247)
..+.+++.+||+.||.+|||++++++ ++++
T Consensus 281 ~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 281 PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred HHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 67999999999999999999999997 4544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=249.79 Aligned_cols=218 Identities=20% Similarity=0.260 Sum_probs=157.7
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++|+|+||+++++++..+...+++||++. ++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 213 iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g--- 280 (461)
T PHA03211 213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGEG--- 280 (461)
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4678999999999999999999999999995 599888865432 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.++.++|+|||+++...............||..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 281 IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~ 360 (461)
T PHA03211 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360 (461)
T ss_pred EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999875433221111123458999999999999899999999999999999999776
Q ss_pred CCCCCC-CCCC----cchh---hhcc---ccCC---cchhhhhccc----ccCCCCC-------HHHHHHHHHHHHhhcc
Q 025816 161 PVDHTL-PRGQ----QSLV---TWAT---PKLS---EDKVRQCVDA----RLGGDYP-------PKAVAKMAAVAALCVQ 215 (247)
Q Consensus 161 pf~~~~-~~~~----~~~~---~~~~---~~~~---~~~~~~~~~~----~~~~~~~-------~~~~~~l~~li~~cl~ 215 (247)
++.... .... ..+. .... .... ...+...... ....... ...+.++.+||.+||+
T Consensus 361 ~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 440 (461)
T PHA03211 361 SLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALT 440 (461)
T ss_pred CcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcc
Confidence 543221 1100 0000 0000 0000 0000000000 0000000 1223478999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 025816 216 YEADFRPNMSIVVKA 230 (247)
Q Consensus 216 ~~p~~Rps~~~il~~ 230 (247)
.||.+|||+.|+|+.
T Consensus 441 ~DP~~RPsa~elL~h 455 (461)
T PHA03211 441 FDGARRPSAAELLRL 455 (461)
T ss_pred cChhhCcCHHHHhhC
Confidence 999999999999974
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=233.50 Aligned_cols=203 Identities=30% Similarity=0.469 Sum_probs=163.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++.+.+..+++|||+.+++|.+++....... +++..+..++.|++.||.+||+.+ +
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~ql~~~l~~lh~~~---~ 124 (258)
T smart00219 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKE-------LSLSDLLSFALQIARGMEYLESKN---F 124 (258)
T ss_pred HHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhcc-------CCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 567899999999999999999999999999999999997654322 889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++........... ....++..|+|||.+.+..++.++|+||+|+++++|++ |..
T Consensus 125 ~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~ 203 (258)
T smart00219 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGES 203 (258)
T ss_pred eecccccceEEEccCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876654322211 12235678999999988889999999999999999998 788
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
||..... ....+.+........+...+..+.+++.+||..+|.+|||+.++++.|
T Consensus 204 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 204 PYPGMSN----------------EEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCH----------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 8864211 111111222222233334567799999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=239.02 Aligned_cols=203 Identities=21% Similarity=0.305 Sum_probs=161.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+.+++.+..++..+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~~--- 122 (285)
T cd05630 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-------GFEEGRAVFYAAEICCGLEDLHQER--- 122 (285)
T ss_pred HHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367899999999999999999999999999999999988644322 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||++........ .....|+..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 123 iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 199 (285)
T cd05630 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199 (285)
T ss_pred EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998865432211 123357889999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~ 229 (247)
||.......... ...... .......+...+.++.+++.+||+.||.+||| ++++++
T Consensus 200 Pf~~~~~~~~~~------------~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 200 PFQQRKKKIKRE------------EVERLV-KEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCCCCCccchHH------------HHHhhh-hhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 997542211100 001100 00111223344567999999999999999999 889988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=250.08 Aligned_cols=204 Identities=22% Similarity=0.243 Sum_probs=157.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++.+.+++..++||||+.+|+|.+++..... ++...+..++.|++.||.|||+.+
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~--- 121 (376)
T cd05598 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI---------FEEDLARFYIAELTCAIESVHKMG--- 121 (376)
T ss_pred HHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999976432 888899999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhh-----------------------------------------hcccc
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA-----------------------------------------ARLHS 119 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~-----------------------------------------~~~~~ 119 (247)
|+||||||+||+++.++.++|+|||++....... .....
T Consensus 122 ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (376)
T cd05598 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLA 201 (376)
T ss_pred eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccc
Confidence 9999999999999999999999999874221000 00001
Q ss_pred cceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC
Q 025816 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP 199 (247)
Q Consensus 120 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (247)
....||..|+|||++.+..++.++|||||||++|+|++|..||............ ..+ .........
T Consensus 202 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------------~~~-~~~~~~~~~ 268 (376)
T cd05598 202 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV------------INW-ETTLHIPSQ 268 (376)
T ss_pred cccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHH------------hcc-CccccCCCC
Confidence 1245889999999999989999999999999999999999999754321110000 000 000111111
Q ss_pred HHHHHHHHHHHHhhcccCCCCCC---CHHHHHHH
Q 025816 200 PKAVAKMAAVAALCVQYEADFRP---NMSIVVKA 230 (247)
Q Consensus 200 ~~~~~~l~~li~~cl~~~p~~Rp---s~~~il~~ 230 (247)
...+..+.+++.+|+ .+|.+|+ |+.++++.
T Consensus 269 ~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 269 AKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 234556888888876 5999999 89999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=246.07 Aligned_cols=211 Identities=21% Similarity=0.240 Sum_probs=154.4
Q ss_pred cccccCCCccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++||||+++++++.... ..+++|||+.+ +|.+.+... ++...+..++.|++.||.|||+
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~~L~~LH~ 141 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHME-----------LDHERMSYLLYQMLCGIKHLHS 141 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhcc-----------CCHHHHHHHHHHHHHHHHHHHh
Confidence 57889999999999986543 47999999975 777766421 7888899999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ |+||||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 142 ~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 215 (359)
T cd07876 142 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215 (359)
T ss_pred CC---cccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHH
Confidence 99 9999999999999999999999999987542211 11234578899999999998999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccC----------------------Ccchhhhhccccc---CCCCCHHHHHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKL----------------------SEDKVRQCVDARL---GGDYPPKAVAKMAAVA 210 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~---~~~~~~~~~~~l~~li 210 (247)
++|..||...+............... ......+...... ........+..+.+++
T Consensus 216 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (359)
T cd07876 216 VKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLL 295 (359)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHH
Confidence 99999998654321110000000000 0000000000000 0001112345689999
Q ss_pred HhhcccCCCCCCCHHHHHHH
Q 025816 211 ALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 211 ~~cl~~~p~~Rps~~~il~~ 230 (247)
.+||..||.+|||+.|+++.
T Consensus 296 ~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 296 SKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHhccCcccCCCHHHHhcC
Confidence 99999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=235.78 Aligned_cols=213 Identities=26% Similarity=0.408 Sum_probs=164.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++++++......++||||+.+++|.+++..............+++..+..++.|++.||.|||+.+
T Consensus 61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--- 137 (275)
T cd05046 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--- 137 (275)
T ss_pred HHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---
Confidence 36789999999999999998999999999999999999976553322222224899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++++|||++........ .......++..|+|||.+.+..++.++|+||||++++++++ |.
T Consensus 138 i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 216 (275)
T cd05046 138 FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216 (275)
T ss_pred cccCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998764322111 11122345667999999988888999999999999999998 78
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
.||....... .+............+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 217 ~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 217 LPFYGLSDEE---------------VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCccccchHH---------------HHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 8886432111 011111111111123345567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=234.58 Aligned_cols=198 Identities=25% Similarity=0.389 Sum_probs=162.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++++.|+||+++++++..+...++||||+.+++|.+++.... ++...+..++.|++.|+.+||+.+ +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----------l~~~~~~~~~~~l~~~l~~lh~~~---i 122 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP----------FDEFQIATMLKEILKGLDYLHSEK---K 122 (277)
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 577899999999999999999999999999999999986533 888899999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++++|||++........ ......++..|.|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 123 vH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06640 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred cCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999875433221 11233567789999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|....+... ................+.++.+++.+||..+|.+|||+++++..
T Consensus 201 ~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 201 NSDMHPMRV----------------LFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCcChHhH----------------hhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 964432111 11111111223445667889999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=232.88 Aligned_cols=202 Identities=25% Similarity=0.394 Sum_probs=163.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++++++.+....+++|||+.+++|.+++...... .+++..+..++.|++.++.|||+.+
T Consensus 52 ~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~--- 121 (256)
T cd08221 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ-------LFEEEMVLWYLFQIVSAVSYIHKAG--- 121 (256)
T ss_pred HHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367889999999999999999999999999999999999765322 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||.+........ ......++..|.|||.+.+..++.++|+||+|+++++|++|..
T Consensus 122 i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 199 (256)
T cd08221 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199 (256)
T ss_pred ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999875533221 1223457889999999988888999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||...... +...+...... ...+...+.++.+++.+||..+|.+|||++++++.
T Consensus 200 ~~~~~~~~---------------~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 200 TFDATNPL---------------NLVVKIVQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCCCCHH---------------HHHHHHHcCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 98643211 11111111111 11224456779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=232.48 Aligned_cols=204 Identities=27% Similarity=0.387 Sum_probs=160.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..+...+++|||+.+++|.+++..... .++...+..++.|++.|+.|||+.+
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~--- 121 (262)
T cd06613 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLHETG--- 121 (262)
T ss_pred HHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999999999998876421 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC---CCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~~l~~ 157 (247)
++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++++|++
T Consensus 122 i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~t 199 (262)
T cd06613 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE 199 (262)
T ss_pred ceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHh
Confidence 99999999999999999999999999876543221 11234567789999998776 78899999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||.......... ....... ...........+.++.+++.+||..+|.+|||+.++++
T Consensus 200 g~~p~~~~~~~~~~~--~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 200 LQPPMFDLHPMRALF--LISKSNF----------PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCCCCCCCHHHHHH--HHHhccC----------CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999996432111000 0000000 00011123345677999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=238.65 Aligned_cols=213 Identities=22% Similarity=0.347 Sum_probs=160.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~ 80 (247)
+++++||||+++++++..+...+++|||+.+++|.+++.... .+++..+..++.|+++||.|||+ .+
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~~--- 120 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLREKHK--- 120 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhhCC---
Confidence 678899999999999999999999999999999999997543 28899999999999999999997 47
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 121 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 196 (308)
T cd06615 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRY 196 (308)
T ss_pred EEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999886543221 123457889999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCc-----------------chhhhhccc---ccCCCCC-HHHHHHHHHHHHhhcccCCC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSE-----------------DKVRQCVDA---RLGGDYP-PKAVAKMAAVAALCVQYEAD 219 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~---~~~~~~~-~~~~~~l~~li~~cl~~~p~ 219 (247)
||...+................. ..+.+..+. ......+ ...+.++.+++.+||..+|.
T Consensus 197 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (308)
T cd06615 197 PIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPK 276 (308)
T ss_pred CCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChh
Confidence 98654322111111100000000 000000000 0001111 12456799999999999999
Q ss_pred CCCCHHHHHHH
Q 025816 220 FRPNMSIVVKA 230 (247)
Q Consensus 220 ~Rps~~~il~~ 230 (247)
+|||++++++.
T Consensus 277 ~Rpt~~~ll~~ 287 (308)
T cd06615 277 ERADLKELTKH 287 (308)
T ss_pred hCcCHHHHhcC
Confidence 99999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=248.09 Aligned_cols=201 Identities=21% Similarity=0.255 Sum_probs=155.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++.+.++...++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+
T Consensus 54 il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH~~~--- 121 (382)
T cd05625 54 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVHKMG--- 121 (382)
T ss_pred HHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678899999999999999999999999999999999987543 2888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhh---------------------------------------------
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA--------------------------------------------- 115 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~--------------------------------------------- 115 (247)
|+||||||+|||++.++.++|+|||++........
T Consensus 122 ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (382)
T cd05625 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQ 201 (382)
T ss_pred eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccc
Confidence 99999999999999999999999999753210000
Q ss_pred cccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcc--cc
Q 025816 116 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD--AR 193 (247)
Q Consensus 116 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 193 (247)
........||..|+|||++.+..++.++|+||+||++|+|++|..||...++.. ....... ..
T Consensus 202 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---------------~~~~i~~~~~~ 266 (382)
T cd05625 202 RCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE---------------TQMKVINWQTS 266 (382)
T ss_pred cccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHH---------------HHHHHHccCCC
Confidence 000112358899999999999899999999999999999999999997543211 0111111 00
Q ss_pred cCCCCCHHHHHHHHHHHHhhcccCCCCCCC---HHHHHH
Q 025816 194 LGGDYPPKAVAKMAAVAALCVQYEADFRPN---MSIVVK 229 (247)
Q Consensus 194 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~il~ 229 (247)
.........+.++.+++.+|+ .+|.+|++ ++++++
T Consensus 267 ~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 267 LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 111111233556888888875 59999997 888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=233.78 Aligned_cols=204 Identities=26% Similarity=0.490 Sum_probs=161.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|||++++++++......+++|||+.+++|.+++..... .+++..++.++.|++.++.+||+.+
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~--- 120 (256)
T cd05112 52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN--- 120 (256)
T ss_pred HHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36788999999999999999999999999999999999865432 2788999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||+|+++|++++ |.
T Consensus 121 i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 199 (256)
T cd05112 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred ccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999988754322111 1112234567999999988889999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
.||..... ..+.+.+....+...+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 200 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 200 TPYENRSN----------------SEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCcCCH----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 99864321 1111111111111122234567999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=236.13 Aligned_cols=197 Identities=26% Similarity=0.386 Sum_probs=160.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++.+..++..++||||+.+++|.+++.... +++..+..++.|++.|+.|||+.+ +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~~---i 122 (277)
T cd06642 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP----------LEETYIATILREILKGLDYLHSER---K 122 (277)
T ss_pred HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 578899999999999999999999999999999999886532 888999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 123 vH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06642 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred eccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875433221 11223467789999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|....+... ...+............+.++.+++.+||..+|.+|||+.++++
T Consensus 201 ~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 201 NSDLHPMRV----------------LFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CcccchhhH----------------HhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 864322110 0011111111223345667999999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=235.01 Aligned_cols=212 Identities=24% Similarity=0.332 Sum_probs=155.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++|+||+++++.+......+++|||+.+|+|.+++....... .....+..+..++.|++.||.|||+.+ +
T Consensus 49 ~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 121 (269)
T cd05042 49 YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMV----AQMAQKDVLQRMACEVASGLLWLHQAD---F 121 (269)
T ss_pred HHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccc----cccccHHHHHHHHHHHHHHHHHHHhcC---E
Confidence 467899999999999999999999999999999999997654321 112567788899999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-------CCCCccccchhhhHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-------GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~ 154 (247)
+||||||+||+++.++.++|+|||++................++..|+|||.+.. ..++.++|+||+|+++|+
T Consensus 122 vH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 201 (269)
T cd05042 122 IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE 201 (269)
T ss_pred ecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHH
Confidence 9999999999999999999999999865322211111122335667999998753 346789999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
|++ |..||........ .... +.+..........+...+..+.+++..|| .||.+|||+++|++.+.
T Consensus 202 l~~~~~~p~~~~~~~~~---~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 202 LFTAADQPYPDLSDEQV---LKQV--------VREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHhCCCCCCCcCCHHHH---HHHH--------hhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 999 7788864321100 0000 00000000011122345566888999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=240.45 Aligned_cols=214 Identities=21% Similarity=0.312 Sum_probs=158.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..++||||+. ++|.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---i 125 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHRRK---V 125 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 578999999999999999999999999997 599888865432 2888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..
T Consensus 126 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 203 (301)
T cd07873 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203 (301)
T ss_pred eCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998754322111 1223467789999988753 57889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcc---------cccCC----CCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVD---------ARLGG----DYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
||...+...................+..+.. +.... ......+..+.++|.+||+.||.+|||++++
T Consensus 204 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei 283 (301)
T cd07873 204 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA 283 (301)
T ss_pred CCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 9976543211111111110111111111100 00000 0112345578999999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
++
T Consensus 284 l~ 285 (301)
T cd07873 284 MK 285 (301)
T ss_pred hc
Confidence 87
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=235.32 Aligned_cols=212 Identities=24% Similarity=0.329 Sum_probs=155.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+....++||||+.+|+|.+++....... ....++..+..++.|++.|+.|||+.+ +
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i 121 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKNN---F 121 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 578899999999999999999999999999999999986543211 112667788899999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-------CCCccccchhhhHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-------QLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~~l~~ 154 (247)
+|+||||+||+++.++.++|+|||.+................++..|+|||.+.+. .++.++|+||+|+++++
T Consensus 122 ~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 201 (269)
T cd05087 122 IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE 201 (269)
T ss_pred eccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHH
Confidence 99999999999999999999999998654322221122233466789999988542 35789999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
|++ |..||........ ..... ........ ........+..+.+++.+|| .+|.+|||+++|+..|+
T Consensus 202 l~~~g~~p~~~~~~~~~---~~~~~----~~~~~~~~----~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 202 LFELGSQPYRHLSDEQV---LTYTV----REQQLKLP----KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHhCCCCCCCCCChHHH---HHHHh----hcccCCCC----CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 996 9999964322110 00000 00000000 01111233456888999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=242.32 Aligned_cols=218 Identities=27% Similarity=0.398 Sum_probs=163.4
Q ss_pred cccc-cCCCccceeeEEeeC-CeeeEEEecCCCCChhhhhcCCCCCCC--------------------------------
Q 025816 2 VSRL-KHENFVQLLGYCVDG-TSRVLAYEFASNGSLHDILHGRKGVKG-------------------------------- 47 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~-------------------------------- 47 (247)
|+++ +||||+++++++... ...+++|||+.+|+|.+++........
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (343)
T cd05103 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITS 143 (343)
T ss_pred HHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccc
Confidence 4566 689999999988654 467899999999999999865321000
Q ss_pred --------------------------CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceee
Q 025816 48 --------------------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 101 (247)
Q Consensus 48 --------------------------~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l 101 (247)
......+++..+..++.|+++||.|||+.+ ++||||||.||+++.++.++|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl 220 (343)
T cd05103 144 SQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKI 220 (343)
T ss_pred ccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEE
Confidence 001123788889999999999999999999 999999999999999999999
Q ss_pred ccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCCCcchhhhcccc
Q 025816 102 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180 (247)
Q Consensus 102 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 180 (247)
+|||++................++..|+|||.+.+..++.++|+||+|++++++++ |..||......
T Consensus 221 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------ 288 (343)
T cd05103 221 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------------ 288 (343)
T ss_pred EecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------------
Confidence 99999876432222111222334567999999988889999999999999999997 89998643211
Q ss_pred CCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
......+........+...+.++.+++.+||+.+|.+|||+.+|++.|+.++++
T Consensus 289 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 289 ---EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ---HHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 011111111111222223345689999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=233.36 Aligned_cols=211 Identities=20% Similarity=0.296 Sum_probs=154.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++.+......+++|||+.+|+|.+++...... ....+...+..++.|++.||.|||+.+ +
T Consensus 49 ~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~~---i 120 (268)
T cd05086 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWH-----RRNSQLLLLQRMACEIAAGVTHMHKHN---F 120 (268)
T ss_pred HhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 56789999999999999999999999999999999999764321 112677788899999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-------CCCCccccchhhhHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-------GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~ 154 (247)
+|+||||+||+++.++.++|+|||++................++..|+|||.+.. ..++.++|+||+|+++|+
T Consensus 121 ~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (268)
T cd05086 121 LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200 (268)
T ss_pred eccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHH
Confidence 9999999999999999999999998754222111111223456788999998743 235788999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
|++ +..||....... ...... .+.... ..........+..+.+++..|| .+|.+|||+++|++.|.
T Consensus 201 l~~~~~~p~~~~~~~~---~~~~~~----~~~~~~----~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 201 LFENAAQPYSHLSDRE---VLNHVI----KDQQVK----LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHhCCCCCCCCCCHHH---HHHHHH----hhcccc----cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 997 567875332110 000000 000000 0112222334567889999999 67999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=233.33 Aligned_cols=195 Identities=26% Similarity=0.471 Sum_probs=154.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 121 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKG---L 121 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999976542 2888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCc--------eeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHH
Q 025816 82 IHRDIKSSNVLIFDDDV--------AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVL 152 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~--------~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l 152 (247)
+||||||+||+++.++. ++++|||.+...... ....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 122 iH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 195 (258)
T cd05078 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTL 195 (258)
T ss_pred ecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence 99999999999987764 689999987654321 22346778999999876 4578999999999999
Q ss_pred HHHHhCC-CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 153 LELLTGR-KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 153 ~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
|++++|. .||...+.... ...... ....+.....++.+++.+||+.+|.+|||++++++.|
T Consensus 196 ~~l~~g~~~~~~~~~~~~~----------------~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 196 WEIFSGGDKPLSALDSQKK----------------LQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHcCCCCChhhccHHHH----------------HHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 9999985 55543221110 011111 1123333446799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=245.62 Aligned_cols=200 Identities=18% Similarity=0.213 Sum_probs=157.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++.+.++...++||||+.+|+|.+++.... ++...+..++.|++.||.|||+.+ |
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~---i 163 (371)
T cd05622 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---F 163 (371)
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 567899999999999999999999999999999999997543 888899999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC----CCccccchhhhHHHHHHHh
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~~l~~ 157 (247)
+||||||+||+++.++.++|+|||++........ .......||..|+|||++.+.. ++.++|+|||||++|+|++
T Consensus 164 vHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~ 242 (371)
T cd05622 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242 (371)
T ss_pred EeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh
Confidence 9999999999999999999999999876532211 1123456899999999987643 7889999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCC--CCCHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADF--RPNMSIVVKA 230 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~il~~ 230 (247)
|..||...... ....++....... ......+..+.++|.+|+..++.+ |++++++++.
T Consensus 243 G~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 243 GDTPFYADSLV---------------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCCCCCCCHH---------------HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 99999754321 1111111111111 112245667999999999854443 7899999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=234.67 Aligned_cols=195 Identities=25% Similarity=0.467 Sum_probs=152.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+|+|..++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i 138 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALSYLEDKN---L 138 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHcCC---c
Confidence 5789999999999999999999999999999999998865332 2889999999999999999999998 9
Q ss_pred EeccCCCCceeecCCC-------ceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHH
Q 025816 82 IHRDIKSSNVLIFDDD-------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 82 ~h~di~~~nil~~~~~-------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ 153 (247)
+||||||+||+++..+ .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|
T Consensus 139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~ 212 (274)
T cd05076 139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212 (274)
T ss_pred cCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHH
Confidence 9999999999997654 3799999987543211 12245677999998865 56899999999999999
Q ss_pred HHH-hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 154 ELL-TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 154 ~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
+++ +|..||........ ........ ..+.....++.+++.+||+.+|.+|||++++++.|
T Consensus 213 el~~~g~~p~~~~~~~~~----------------~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 213 EICFDGEVPLKERTPSEK----------------ERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHhCCCCCccccChHHH----------------HHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 985 68999864322111 01111100 11122234689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=240.63 Aligned_cols=225 Identities=19% Similarity=0.237 Sum_probs=155.7
Q ss_pred CcccccCCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
++++++||||+++++++.. +...+++|||+.+ +|.+++..............+++..+..++.|++.||.|||+.+
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~- 128 (317)
T cd07867 51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW- 128 (317)
T ss_pred HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678999999999998853 5678999999864 88888764432222222234889999999999999999999999
Q ss_pred CCeEeccCCCCceee----cCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhc-CCCCccccchhhhHHH
Q 025816 79 PHIIHRDIKSSNVLI----FDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVL 152 (247)
Q Consensus 79 ~~i~h~di~~~nil~----~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l 152 (247)
++||||||+||++ +.++.++|+|||+++........ .......++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 129 --ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 206 (317)
T cd07867 129 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred --EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHH
Confidence 9999999999999 45678999999999865432211 11223457889999999876 4578999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcch------h---hhccccCCcchhhhh------------cccc-c--------CCCCCHHH
Q 025816 153 LELLTGRKPVDHTLPRGQQSL------V---TWATPKLSEDKVRQC------------VDAR-L--------GGDYPPKA 202 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~------~---~~~~~~~~~~~~~~~------------~~~~-~--------~~~~~~~~ 202 (247)
|+|++|..||........... . ...........+... .... . ........
T Consensus 207 ~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (317)
T cd07867 207 AELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKP 286 (317)
T ss_pred HHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCC
Confidence 999999999975432211000 0 000000000000000 0000 0 00001122
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 203 VAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 203 ~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
...+.+++.+||+.||.+|||++|+++
T Consensus 287 ~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 287 DSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred ChHHHHHHHHHhccCcccccCHHHHhc
Confidence 346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=249.44 Aligned_cols=216 Identities=25% Similarity=0.315 Sum_probs=159.3
Q ss_pred CcccccCCCccceeeEEeeCC-----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 1 MVSRLKHENFVQLLGYCVDGT-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++.++||||+++++++.... ..++||||+. ++|.+.+.... .+++..+..++.|++.||.|||+
T Consensus 52 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~ 121 (372)
T cd07853 52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHS 121 (372)
T ss_pred HHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 367889999999999998776 7899999996 58888875433 28999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~ 154 (247)
.+ ++||||||+||+++.++.++|+|||++......... ......++..|+|||.+.+. .++.++|+||+||++++
T Consensus 122 ~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e 197 (372)
T cd07853 122 AG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAE 197 (372)
T ss_pred CC---eeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHH
Confidence 99 999999999999999999999999998754322211 11223567889999998874 47899999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhh-------hccc-ccCC-------CCCHHHHHHHHHHHHhhcccCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ-------CVDA-RLGG-------DYPPKAVAKMAAVAALCVQYEAD 219 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~~~-------~~~~~~~~~l~~li~~cl~~~p~ 219 (247)
|++|+.||.......+...+...........+.. .+.. .... ......+.++.+++.+||+.||.
T Consensus 198 l~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 277 (372)
T cd07853 198 LLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD 277 (372)
T ss_pred HHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChh
Confidence 9999999976544322221111111111111100 0000 0000 11123356789999999999999
Q ss_pred CCCCHHHHHHH
Q 025816 220 FRPNMSIVVKA 230 (247)
Q Consensus 220 ~Rps~~~il~~ 230 (247)
+|||+.++++.
T Consensus 278 ~R~t~~e~l~h 288 (372)
T cd07853 278 KRISAADALAH 288 (372)
T ss_pred hCcCHHHHhcC
Confidence 99999999973
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=247.40 Aligned_cols=208 Identities=27% Similarity=0.398 Sum_probs=173.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|.+|+||||+.++|+|..++.+++|+||++.|+|.+++.++.... +.....+.++.||++|++||.+.+
T Consensus 588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLes~n--- 657 (807)
T KOG1094|consen 588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLESLN--- 657 (807)
T ss_pred HHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHHhhc---
Confidence 4789999999999999999999999999999999999999886322 455667789999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh--C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~--g 158 (247)
++|||+.++|+|+++++++||+|||+++..-........+.......|+|+|.+..++++.++|+|++|+++||+++ .
T Consensus 658 fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~ 737 (807)
T KOG1094|consen 658 FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCR 737 (807)
T ss_pred hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHh
Confidence 99999999999999999999999999986544444444556667889999999999999999999999999999977 7
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccc-------cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR-------LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
..||... +.+.+.+..... .....|.-++..++++|.+||+.|-.+|||++++...|
T Consensus 738 e~Py~~l----------------t~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 738 EQPYSQL----------------TDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred hCchhhh----------------hHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 7788522 222222222222 22345677888999999999999999999999999998
Q ss_pred HHh
Q 025816 232 QPL 234 (247)
Q Consensus 232 ~~~ 234 (247)
++.
T Consensus 802 q~~ 804 (807)
T KOG1094|consen 802 QED 804 (807)
T ss_pred HHh
Confidence 864
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=242.29 Aligned_cols=196 Identities=22% Similarity=0.268 Sum_probs=155.3
Q ss_pred ccccC-CCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 3 SRLKH-ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 3 ~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+.++| ++|+.+++.+...+..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---i 122 (324)
T cd05587 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---------FKEPHAVFYAAEIAIGLFFLHSKG---I 122 (324)
T ss_pred HhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 45555 5688899999999999999999999999999865432 888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 123 vH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p 200 (324)
T cd05587 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200 (324)
T ss_pred EecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 9999999999999999999999998864321111 11234588999999999998899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM-----SIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~il~ 229 (247)
|...+.. .....+... ....+...+.++.+++.+||..||.+|++. +++++
T Consensus 201 f~~~~~~---------------~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 201 FDGEDED---------------ELFQSIMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCCCCHH---------------HHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9744321 011111111 112333456679999999999999999986 66665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=231.29 Aligned_cols=201 Identities=27% Similarity=0.413 Sum_probs=161.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..+...++++||+.+++|.+++..... .+++..+..++.|++.|+.|||+.+ +
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh~~~---i 120 (256)
T cd06612 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLHSNK---K 120 (256)
T ss_pred HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5778999999999999999999999999999999999864332 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+........ ......++..|.|||.+.+..++.++|+||+|+++++|++|..|
T Consensus 121 ~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p 198 (256)
T cd06612 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198 (256)
T ss_pred ccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543221 11234467889999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|....+........ . ........+...+..+.+++.+||+.+|.+|||++++++
T Consensus 199 ~~~~~~~~~~~~~~------------~--~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 199 YSDIHPMRAIFMIP------------N--KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCcchhhhhhhhc------------c--CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 97543221100000 0 000011122344567999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=243.79 Aligned_cols=194 Identities=19% Similarity=0.183 Sum_probs=153.3
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
+||||+++++.+..+...++||||+.+|+|.+.+..... +++..+..++.|++.||.|||+.+ |+|||
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qil~al~~LH~~~---ivHrD 121 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---------FSEDRAKFYIAELVLALEHLHKYD---IVYRD 121 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 799999999999999999999999999999988865432 899999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCCCCCC
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDH 164 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~ 164 (247)
|||+||+++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++||||+|+++|+|++|..||..
T Consensus 122 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 122 LKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred CCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 999999999999999999999875322111 12334688999999998764 478999999999999999999999964
Q ss_pred CCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC----CHHHHHH
Q 025816 165 TLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP----NMSIVVK 229 (247)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp----s~~~il~ 229 (247)
.+.. .....+....... .....+.++.+++.+||..||.+|| +++++++
T Consensus 200 ~~~~---------------~~~~~i~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 200 EDTQ---------------QMYRNIAFGKVRF-PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCHH---------------HHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 3211 0001111010100 0112456789999999999999998 5777766
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=231.84 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=159.7
Q ss_pred cccccCCCccceeeEEee-CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++|+|++++++.+.. +...+++|||+.+++|.+.+...... .+++..++.++.+++.+|.+||+.+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~-------~l~~~~~~~~~~~l~~~l~~lH~~~--- 122 (257)
T cd08223 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK-------LLPENQVVEWFVQIAMALQYLHEKH--- 122 (257)
T ss_pred HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 578899999999998764 44689999999999999998754322 3899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 123 i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08223 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH 200 (257)
T ss_pred eeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999875532211 1123456788999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||...+.. ....... .......+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 201 ~~~~~~~~---------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 201 AFNAKDMN---------------SLVYRII-EGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCCCHH---------------HHHHHHH-hcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 98643211 0011111 111122334566779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=245.20 Aligned_cols=201 Identities=21% Similarity=0.282 Sum_probs=156.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++.+.++...++||||+.+|+|.+++..... ++...+..++.|++.||.|||+.+ +
T Consensus 55 l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~~L~~lH~~g---i 122 (360)
T cd05627 55 LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT---------LSEEATQFYIAETVLAIDAIHQLG---F 122 (360)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999875432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhc---------------------------------ccccceeccccc
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR---------------------------------LHSTRVLGTFGY 128 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~---------------------------------~~~~~~~~~~~y 128 (247)
+||||||+||+++.++.++|+|||++......... .......||..|
T Consensus 123 vHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 202 (360)
T cd05627 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDY 202 (360)
T ss_pred EccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccc
Confidence 99999999999999999999999998643211000 001124589999
Q ss_pred cCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC--HHHHHHH
Q 025816 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKM 206 (247)
Q Consensus 129 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 206 (247)
+|||++.+..++.++|+|||||++|+|++|..||........ ...+.........+ ...+.++
T Consensus 203 ~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~---------------~~~i~~~~~~~~~p~~~~~s~~~ 267 (360)
T cd05627 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET---------------YRKVMNWKETLVFPPEVPISEKA 267 (360)
T ss_pred cCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHH---------------HHHHHcCCCceecCCCCCCCHHH
Confidence 999999999999999999999999999999999975432111 11111100000111 1235678
Q ss_pred HHHHHhhcccCCCCCCC---HHHHHHH
Q 025816 207 AAVAALCVQYEADFRPN---MSIVVKA 230 (247)
Q Consensus 207 ~~li~~cl~~~p~~Rps---~~~il~~ 230 (247)
.++|.+++ .||.+|++ ++++++.
T Consensus 268 ~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 268 KDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 88888876 49999985 6777764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=240.98 Aligned_cols=193 Identities=23% Similarity=0.285 Sum_probs=156.1
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
+|++|+++++.+...+..++||||+.+|+|.+.+..... +++..+..++.|++.||.|||+.+ ++|||
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 126 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRD 126 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEecC
Confidence 689999999999999999999999999999999865432 888999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 165 (247)
|||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||+||++|+|++|..||...
T Consensus 127 lkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 127 LKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999874322111 123345889999999999989999999999999999999999999754
Q ss_pred CCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 025816 166 LPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM-----SIVVK 229 (247)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~il~ 229 (247)
... .....+.... ...+...+.++.+++.+||+.+|.+|++. +++++
T Consensus 205 ~~~---------------~~~~~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 205 DED---------------ELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred CHH---------------HHHHHHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 221 1111111111 12334456779999999999999999985 66654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=234.63 Aligned_cols=201 Identities=24% Similarity=0.343 Sum_probs=157.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++..++..+++|||+.+++|..++..... .+++..+..++.|+++||.|||+.+ +
T Consensus 56 l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~~~---i 124 (282)
T cd06643 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--------PLTEPQIRVVCKQTLEALNYLHENK---I 124 (282)
T ss_pred HHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999888764321 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-----cCCCCccccchhhhHHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~~l~ 156 (247)
+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+. +..++.++|+||+|+++|+|+
T Consensus 125 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~ 202 (282)
T cd06643 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202 (282)
T ss_pred eecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc
Confidence 9999999999999999999999999875432211 122345788899999874 345778999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhccc-ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
+|..||....... ........ ......+...+.++.+++.+||+.+|.+|||++++++.
T Consensus 203 ~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 203 QIEPPHHELNPMR---------------VLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cCCCCccccCHHH---------------HHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999986432111 00010000 00111233445679999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=244.01 Aligned_cols=215 Identities=22% Similarity=0.322 Sum_probs=154.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..+...++|||++. ++|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 110 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~--- 177 (357)
T PHA03209 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLHAQR--- 177 (357)
T ss_pred HHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999996 589888865332 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.++.++|+|||.+....... ......|+..|+|||.+.+..++.++|+|||||++|+|+++..
T Consensus 178 ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~ 254 (357)
T PHA03209 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPS 254 (357)
T ss_pred eecCCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999987432211 1123457889999999998899999999999999999998544
Q ss_pred C-CCCCCCCCCcc-------hhhhcc--cc----CC---c-chhhhhcccc--cCCCC-------CHHHHHHHHHHHHhh
Q 025816 161 P-VDHTLPRGQQS-------LVTWAT--PK----LS---E-DKVRQCVDAR--LGGDY-------PPKAVAKMAAVAALC 213 (247)
Q Consensus 161 p-f~~~~~~~~~~-------~~~~~~--~~----~~---~-~~~~~~~~~~--~~~~~-------~~~~~~~l~~li~~c 213 (247)
+ |.......... +..... .. .. . ......+... .+... ....+.++.++|.+|
T Consensus 255 ~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 334 (357)
T PHA03209 255 TIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKM 334 (357)
T ss_pred ccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHH
Confidence 4 43321110000 000000 00 00 0 0000000000 00000 012344677899999
Q ss_pred cccCCCCCCCHHHHHHH
Q 025816 214 VQYEADFRPNMSIVVKA 230 (247)
Q Consensus 214 l~~~p~~Rps~~~il~~ 230 (247)
|+.||.+|||++|+++.
T Consensus 335 L~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 335 LTFDAAMRPSAEEILNY 351 (357)
T ss_pred HcCCcccCcCHHHHhcC
Confidence 99999999999999873
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=245.70 Aligned_cols=211 Identities=20% Similarity=0.237 Sum_probs=154.8
Q ss_pred cccccCCCccceeeEEeeC------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDG------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
++.++||||+++++++... ...+++|||+.+ ++.+.+... ++...+..++.|++.||.|||+
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~qi~~aL~~LH~ 137 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHS 137 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHh
Confidence 5678999999999988644 357999999975 777776431 7888999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ ++||||||+||+++.++.++|+|||+++...... ......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 138 ~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el 211 (355)
T cd07874 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211 (355)
T ss_pred CC---cccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHH
Confidence 99 9999999999999999999999999987643221 11234578899999999998999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCc-------chhhhhccc---------------cc---CCCCCHHHHHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSE-------DKVRQCVDA---------------RL---GGDYPPKAVAKMAAVA 210 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~---------------~~---~~~~~~~~~~~l~~li 210 (247)
++|..||.+.+................. ..+....+. .. ........+..+.+++
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 291 (355)
T cd07874 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291 (355)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHH
Confidence 9999999754321110000000000000 000000000 00 0011122345789999
Q ss_pred HhhcccCCCCCCCHHHHHHH
Q 025816 211 ALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 211 ~~cl~~~p~~Rps~~~il~~ 230 (247)
.+||..||.+|||+.++++.
T Consensus 292 ~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 292 SKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhcCCchhcCCHHHHhcC
Confidence 99999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=241.93 Aligned_cols=199 Identities=23% Similarity=0.290 Sum_probs=167.7
Q ss_pred Cccccc-CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
||++++ ||||+.++++|++....++|||+|.||.|.+.+.... +++..+..++.|++.+++|||+.|
T Consensus 88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~~----------~sE~da~~~~~~il~av~~lH~~g-- 155 (382)
T KOG0032|consen 88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKKH----------YSERDAAGIIRQILEAVKYLHSLG-- 155 (382)
T ss_pred HHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHcc----------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 477888 9999999999999999999999999999999998761 899999999999999999999999
Q ss_pred CeEeccCCCCceeecCC----CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 80 HIIHRDIKSSNVLIFDD----DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~----~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
++|||+||+|+|+... +.++++|||++..... ........||+.|+|||++....|+..+|+||+|+++|.|
T Consensus 156 -vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiL 231 (382)
T KOG0032|consen 156 -VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYIL 231 (382)
T ss_pred -ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHH
Confidence 9999999999999643 4799999999987655 2223557899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccc--ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|.+||.+........ ++... .+....-...+..+.++|+.|+..||..|+|+.++|+.
T Consensus 232 L~G~~PF~~~~~~~~~~---------------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 232 LSGVPPFWGETEFEIFL---------------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred hhCCCCCcCCChhHHHH---------------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 99999998654322111 11111 12223334557789999999999999999999999984
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=231.24 Aligned_cols=196 Identities=24% Similarity=0.467 Sum_probs=155.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.. ...+++|||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 54 ~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~--- 121 (259)
T cd05037 54 LMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKK--- 121 (259)
T ss_pred HHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCC---
Confidence 3678999999999999888 778999999999999999976542 2889999999999999999999998
Q ss_pred eEeccCCCCceeecCCC-------ceeeccccccCCcchhhhcccccceeccccccCchhhhcC--CCCccccchhhhHH
Q 025816 81 IIHRDIKSSNVLIFDDD-------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVV 151 (247)
Q Consensus 81 i~h~di~~~nil~~~~~-------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~ 151 (247)
++|+||||+||+++.++ .++|+|||++..... .....++..|+|||.+.+. .++.++|+||+|++
T Consensus 122 i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~ 195 (259)
T cd05037 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTT 195 (259)
T ss_pred eecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHH
Confidence 99999999999999887 799999999876433 1223355679999998876 78899999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 152 LLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 152 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++++++ |..||...+......... ... ..+......+.+++.+||..+|.+|||+.++++.
T Consensus 196 ~~~l~~~~~~p~~~~~~~~~~~~~~----------------~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 196 LLEICSNGEEPLSTLSSSEKERFYQ----------------DQH--RLPMPDCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred HHHHHhCCCCCcccCCchhHHHHHh----------------cCC--CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 999999 577775443211110000 000 0111112679999999999999999999999987
Q ss_pred HH
Q 025816 231 LQ 232 (247)
Q Consensus 231 l~ 232 (247)
|+
T Consensus 258 l~ 259 (259)
T cd05037 258 LN 259 (259)
T ss_pred cC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=233.69 Aligned_cols=204 Identities=27% Similarity=0.392 Sum_probs=157.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++.... .+++..+..++.|++.|+.|||+.+ +
T Consensus 60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i 127 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHSKG---K 127 (267)
T ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 577899999999999999999999999999999999886433 2889999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh---cCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+|++|+||+++.++.++|+|||.+........ ......++..|+|||.+. ...++.++|+||+|+++++|++|
T Consensus 128 ~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g 205 (267)
T cd06646 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred cccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999876532211 112345778899999874 34478899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
..||....+......... ..... ... ......+..+.+++.+||..+|.+|||++++++.+
T Consensus 206 ~~p~~~~~~~~~~~~~~~--~~~~~--------~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 206 QPPMFDLHPMRALFLMSK--SNFQP--------PKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCccccchhhhheeeec--CCCCC--------CCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 999854322111100000 00000 000 01123346799999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=233.63 Aligned_cols=197 Identities=26% Similarity=0.402 Sum_probs=160.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++.++...++++||+.+++|.+++.... +++..+..++.|++.|+.+||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lh~~~---i 119 (274)
T cd06609 53 LSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK----------LDETYIAFILREVLLGLEYLHEEG---K 119 (274)
T ss_pred HHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 577899999999999999999999999999999999987642 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 120 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p 197 (274)
T cd06609 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197 (274)
T ss_pred ccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876643321 11234567789999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHH-HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|...++.. ....+........+.. .+.++.+++.+||..+|.+|||++++++
T Consensus 198 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 198 LSDLHPMR----------------VLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cccCchHH----------------HHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 96543211 0000111111111112 4567999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=233.53 Aligned_cols=201 Identities=25% Similarity=0.369 Sum_probs=155.0
Q ss_pred cccc-cCCCccceeeEEeeC------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 2 VSRL-KHENFVQLLGYCVDG------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
++++ +|+||+++++++... ...+++|||+.+++|.+++....... +++..+..++.|++.|+.|||
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~-------l~~~~~~~~~~qi~~~l~~LH 128 (272)
T cd06637 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-------LKEEWIAYICREILRGLSHLH 128 (272)
T ss_pred HHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHH
Confidence 4455 799999999998753 45789999999999999987644322 889999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-----cCCCCccccchhhh
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFG 149 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG 149 (247)
+.+ ++|+|++|+||+++.++.++|+|||++........ ......++..|+|||.+. +..++.++|+||+|
T Consensus 129 ~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 203 (272)
T cd06637 129 QHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203 (272)
T ss_pred HCC---CccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHH
Confidence 999 99999999999999999999999999875432211 123345788899999886 33578899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+++|+|++|..||.......... ...............+..+.+++.+||..+|.+|||+.++++
T Consensus 204 v~l~el~~g~~p~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 204 ITAIEMAEGAPPLCDMHPMRALF---------------LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHHhCCCCccccCHHHHHH---------------HHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 99999999999996432211110 000001111112234567999999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=230.95 Aligned_cols=201 Identities=21% Similarity=0.334 Sum_probs=162.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..+++|||+.+++|.+.+....... +++..+..++.|++.|+.+||+.+ +
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~l~~~l~~lh~~~---i 122 (256)
T cd08218 53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-------FPEDQILDWFVQICLALKHVHDRK---I 122 (256)
T ss_pred HHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 678999999999999999999999999999999999987544322 788999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++++|||.+......... .....++..|.|||.+.+..++.++|+||+|++++++++|..|
T Consensus 123 ~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~ 200 (256)
T cd08218 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200 (256)
T ss_pred ecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998765432221 1223467789999999888889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|...+. .+.+.+... ......+...+.++.++|.+||+.+|.+||++.++++.
T Consensus 201 ~~~~~~---------------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 201 FEAGNM---------------KNLVLKIIR-GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ccCCCH---------------HHHHHHHhc-CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 863321 111111111 11122344556789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=236.95 Aligned_cols=198 Identities=24% Similarity=0.382 Sum_probs=160.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++|+||+.+++|.+++.... +++..+..++.|++.|+.+||+.+ +
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~~---i 136 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC----------MDEAQIAAVCRECLQALEFLHANQ---V 136 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 578899999999999999999999999999999999986543 889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 137 ~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~p 214 (296)
T cd06655 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (296)
T ss_pred ccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999988754322211 1233577889999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhccc-ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|...+...... ..... ......+...+..+.++|.+||..+|.+|||+.+++.
T Consensus 215 f~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 215 YLNENPLRALY---------------LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCCCCHHHHHH---------------HHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 96543211100 00000 0001123344567999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=232.13 Aligned_cols=202 Identities=29% Similarity=0.400 Sum_probs=156.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++..+...+++|||+.+++|.+++.... .+++..+..++.|++.|+.|||+.+ +
T Consensus 60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i 127 (267)
T cd06645 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLHSKG---K 127 (267)
T ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999999986543 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh---cCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+. ...++.++|+||+|+++|+|++|
T Consensus 128 ~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~ 205 (267)
T cd06645 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred ecCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcC
Confidence 9999999999999999999999999865432211 123345788999999874 34578899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||....+........ ........ . ......+..+.+++.+||..+|++|||++++++
T Consensus 206 ~~p~~~~~~~~~~~~~~--~~~~~~~~--------~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 206 QPPMFDLHPMRALFLMT--KSNFQPPK--------L--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCcccccchhhHHhhh--ccCCCCCc--------c--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 99986443211110000 00000000 0 001123456899999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=244.14 Aligned_cols=211 Identities=20% Similarity=0.225 Sum_probs=154.9
Q ss_pred cccccCCCccceeeEEeeC------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDG------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
++.++||||+++++++... ...++||||+.+ +|.+.+... ++...+..++.|++.||.|||+
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~ 144 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHS 144 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHhh
Confidence 5778999999999987543 357999999975 888777431 7888999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
++ |+||||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|
T Consensus 145 ~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 218 (364)
T cd07875 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218 (364)
T ss_pred CC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHH
Confidence 99 9999999999999999999999999997643221 11234578899999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCC----------------------cchhhhhccccc---CCCCCHHHHHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLS----------------------EDKVRQCVDARL---GGDYPPKAVAKMAAVA 210 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~---~~~~~~~~~~~l~~li 210 (247)
++|..||...+................ .....+...... ...........+.+++
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298 (364)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHH
Confidence 999999976543211111000000000 000000000000 0011112345689999
Q ss_pred HhhcccCCCCCCCHHHHHHH
Q 025816 211 ALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 211 ~~cl~~~p~~Rps~~~il~~ 230 (247)
.+||+.||.+|||+.++++.
T Consensus 299 ~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 299 SKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhcCcCcccCCCHHHHhcC
Confidence 99999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=237.55 Aligned_cols=203 Identities=22% Similarity=0.302 Sum_probs=161.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++.+..+...+++|||+.+++|.+++....... +++..+..++.|++.||.|||+.+ +
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------l~~~~~~~~~~qi~~~l~~lH~~~---i 124 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC-------LSEEVARFYAAEVLLALEYLHLLG---I 124 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCc-------cCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 568899999999999999999999999999999999987654322 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhc---------------------------ccccceeccccccCchhh
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR---------------------------LHSTRVLGTFGYHAPEYA 134 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~ 134 (247)
+|+||||+||+++.++.++|+|||++......... .......|+..|+|||.+
T Consensus 125 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 204 (316)
T cd05574 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI 204 (316)
T ss_pred eccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH
Confidence 99999999999999999999999987654321110 001123567889999999
Q ss_pred hcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhc
Q 025816 135 MTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCV 214 (247)
Q Consensus 135 ~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 214 (247)
.+..++.++|+||||+++|++++|..||...+.. ....+..............+..+.+++.+||
T Consensus 205 ~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 269 (316)
T cd05574 205 SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD---------------ETFSNILKKEVTFPGSPPVSSSARDLIRKLL 269 (316)
T ss_pred cCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH---------------HHHHHHhcCCccCCCccccCHHHHHHHHHHc
Confidence 9888999999999999999999999999744321 1111111111111111225678999999999
Q ss_pred ccCCCCCCC----HHHHHH
Q 025816 215 QYEADFRPN----MSIVVK 229 (247)
Q Consensus 215 ~~~p~~Rps----~~~il~ 229 (247)
..+|.+||| +++++.
T Consensus 270 ~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 270 VKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred cCCHhHCCCchhhHHHHHc
Confidence 999999999 888887
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=236.71 Aligned_cols=200 Identities=24% Similarity=0.421 Sum_probs=159.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++.+..++..+++|||+.+++|.+++.... +++..+..++.|++.|+.|||+.+ +
T Consensus 73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~~---i 139 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIATVCLSVLRALSYLHNQG---V 139 (292)
T ss_pred HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 567899999999999999999999999999999999885432 888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 140 vH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p 217 (292)
T cd06658 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217 (292)
T ss_pred eecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875432221 12334578899999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|...+.... . ..+......... .....+..+.+++.+||..+|.+|||++++++.
T Consensus 218 ~~~~~~~~~--~----------~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 218 YFNEPPLQA--M----------RRIRDNLPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCCCHHHH--H----------HHHHhcCCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 964322110 0 000111111110 112345578999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=236.19 Aligned_cols=199 Identities=24% Similarity=0.383 Sum_probs=160.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++|+||+++++++..+...++||||+.+++|.+++.... +++..+..++.|++.+|.|||+.+ +
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~l~~~L~~LH~~~---i 136 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALDFLHSNQ---V 136 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999999999999999999999999999986543 888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 137 ~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~p 214 (297)
T cd06656 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (297)
T ss_pred ccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998875432221 11233577789999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|...++........ .........+...+..+.+++.+||..+|.+|||++++++
T Consensus 215 f~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 215 YLNENPLRALYLIA--------------TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCcchheeeec--------------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 96543321111000 0000001123344567899999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=233.65 Aligned_cols=204 Identities=19% Similarity=0.273 Sum_probs=161.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|+||+.+++.+..++..+++|||+.+++|.+.+...... .+++..+..++.|++.||.|||+.+
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~~--- 122 (285)
T cd05632 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-------GFEEERALFYAAEILCGLEDLHREN--- 122 (285)
T ss_pred HHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367899999999999999999999999999999999888643322 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus 123 iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 199 (285)
T cd05632 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199 (285)
T ss_pred eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998865432211 123457889999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~~ 230 (247)
||.......... .+...+.. .....+...+..+.+++.+||+.||.+||| +.++++.
T Consensus 200 P~~~~~~~~~~~------------~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 200 PFRGRKEKVKRE------------EVDRRVLE-TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CCCCCCHHHHHH------------HHHHhhhc-cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 997432211000 00000000 011223345567899999999999999999 7788774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=230.88 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=159.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|||++++++++...+..++||||+.+++|.+++.... .++...+..++.|++.||.+||+.+ +
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i 129 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSKG---I 129 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 678899999999999999999999999999999999987652 2888999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC--CCccccchhhhHHHHHHHhCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~ 159 (247)
+|+||+|+||+++.++.++++|||++................++..|+|||.+.... ++.++|+||+|++++++++|.
T Consensus 130 ~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 209 (272)
T cd06629 130 LHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209 (272)
T ss_pred eecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCC
Confidence 999999999999999999999999987654322221122345778899999987654 789999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhccccc----CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL----GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
.||...+... ...+...... ........+..+.+++.+||..+|.+|||++++++.
T Consensus 210 ~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 210 RPWSDEEAIA---------------AMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCCcCcchHH---------------HHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 9986332110 0000000111 111223446789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=257.37 Aligned_cols=223 Identities=20% Similarity=0.249 Sum_probs=167.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCC--CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA--QPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~--~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++.+++..+++|||+.|++|.+++......... .....+++..++.++.|++.||.|||+.+
T Consensus 56 Ls~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-- 133 (932)
T PRK13184 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-- 133 (932)
T ss_pred HHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 57889999999999999999999999999999999998643211110 11123667788999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhh----------------cccccceeccccccCchhhhcCCCCccc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA----------------RLHSTRVLGTFGYHAPEYAMTGQLNAKS 143 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 143 (247)
++||||||+||+++.++.++|+|||++........ ........||..|+|||.+.+..++.++
T Consensus 134 -IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kS 212 (932)
T PRK13184 134 -VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST 212 (932)
T ss_pred -ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHh
Confidence 99999999999999999999999999875521100 0001224589999999999998999999
Q ss_pred cchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-
Q 025816 144 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP- 222 (247)
Q Consensus 144 DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp- 222 (247)
|+||+||++++|++|..||...+..... . ................+..+.+++.+||..||.+||
T Consensus 213 DIWSLGVILyELLTG~~PF~~~~~~ki~---~-----------~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 213 DIYALGVILYQMLTLSFPYRRKKGRKIS---Y-----------RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred HHHHHHHHHHHHHHCCCCCCCcchhhhh---h-----------hhhccChhhccccccCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999999653221100 0 000000000001123456689999999999999996
Q ss_pred CHHHHHHHHHHhHhcCCCC
Q 025816 223 NMSIVVKALQPLLNARPGP 241 (247)
Q Consensus 223 s~~~il~~l~~~~~~~~~~ 241 (247)
+++++++.|+..++..+.+
T Consensus 279 s~eeLl~~Le~~lq~~p~w 297 (932)
T PRK13184 279 SVQELKQDLEPHLQGSPEW 297 (932)
T ss_pred HHHHHHHHHHHHHhcCccc
Confidence 5778888899888776654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=235.11 Aligned_cols=216 Identities=19% Similarity=0.221 Sum_probs=157.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+. ++|.+++..... +..++...+..++.|++.||.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i 122 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSRR---V 122 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 577899999999999999999999999997 589888865432 123899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 123 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 200 (285)
T cd07861 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200 (285)
T ss_pred eecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999999875432211 11223457789999988654 57889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCc---------chhhhhccc---ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSE---------DKVRQCVDA---RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
||..................... ......... ..........+.++.++|.+||..||.+|||+++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll 280 (285)
T cd07861 201 LFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280 (285)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 99754321110000000000000 000000000 000011123456789999999999999999999998
Q ss_pred H
Q 025816 229 K 229 (247)
Q Consensus 229 ~ 229 (247)
+
T Consensus 281 ~ 281 (285)
T cd07861 281 N 281 (285)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=233.02 Aligned_cols=200 Identities=25% Similarity=0.340 Sum_probs=156.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..+++|||+.+++|..+.. +++..+..++.|++.|+.|||+.+ +
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~qi~~~l~~lH~~~---i 116 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRK-------------IPEHVLGRIAVAVVKGLTYLWSLK---I 116 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhhc-------------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 577899999999999999999999999999988865421 778889999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 117 ~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 192 (279)
T cd06619 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192 (279)
T ss_pred eeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987543221 1234578899999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCC-CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD-YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|.......... .. ....+......... .....+.++.+++.+||+.+|.+||+++++++.
T Consensus 193 f~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 193 YPQIQKNQGSL--------MP-LQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred chhhccccccc--------ch-HHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 96432111100 00 01111111111111 112345578999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=231.11 Aligned_cols=200 Identities=22% Similarity=0.290 Sum_probs=163.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+++..+++|||+.+++|.+++..... ++...+..++.|++.||.|||+.+ +
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~i~~~l~~lH~~~---~ 114 (262)
T cd05572 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL---------FDEYTARFYIACVVLAFEYLHNRG---I 114 (262)
T ss_pred HHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhCC---c
Confidence 5788999999999999999999999999999999999976432 888999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||+|+++|++++|..|
T Consensus 115 ~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p 191 (262)
T cd05572 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191 (262)
T ss_pred ccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999987654332 11233567789999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~ 229 (247)
|....... .....+..........+...+.++.+++.+||+.+|.+||| ++++++
T Consensus 192 ~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 192 FGEDDEDP-------------MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCCCCCCH-------------HHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 97553210 11112222222233344445778999999999999999999 888877
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=233.43 Aligned_cols=200 Identities=25% Similarity=0.331 Sum_probs=156.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++.+..+...++||||+.+++|..++.+... .+++..+..++.|++.++.+||+.+ +
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---i 131 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLHSMK---I 131 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 5788999999999999999999999999999999888754332 2889999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-----cCCCCccccchhhhHHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~~l~ 156 (247)
+|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+. ...++.++|+||||+++|+|+
T Consensus 132 ~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~ 209 (292)
T cd06644 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 209 (292)
T ss_pred eecCCCcceEEEcCCCCEEEccCccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHh
Confidence 9999999999999999999999998765322211 112345677899999874 344678999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||....... ...+...... ....+...+.++.+++.+||..+|.+||+++++++
T Consensus 210 ~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 210 QIEPPHHELNPMR---------------VLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCCccccHHH---------------HHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 9999986432110 0011100000 01122344567999999999999999999999987
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=229.34 Aligned_cols=201 Identities=22% Similarity=0.357 Sum_probs=160.7
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|||++++++.+..++..++||||+.+++|.+++...... .+++..+..++.+++.++.+||+++
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~--- 121 (256)
T cd08220 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-------LLDEDTILHFFVQILLALHHVHTKL--- 121 (256)
T ss_pred HHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367889999999999999999999999999999999999765432 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCC-ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++|+||+|+||+++.++ .++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++|.
T Consensus 122 i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~ 198 (256)
T cd08220 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLK 198 (256)
T ss_pred eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCC
Confidence 99999999999998654 579999999876533221 12245677899999998888899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
.||...+... ...+.. .......+...+.++.+++.+||..+|.+|||++++++.
T Consensus 199 ~~~~~~~~~~---------------~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 199 RAFEAANLPA---------------LVLKIM-SGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCcccCchHH---------------HHHHHH-hcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 9986432211 111111 111112233456679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=230.50 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=157.1
Q ss_pred CcccccCCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
++++++||||+++++++.. +...++++||+.+++|.+.+..... ++....+.++.|++.||.+||+.+
T Consensus 57 ~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~- 126 (266)
T cd06651 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---------LTESVTRKYTRQILEGMSYLHSNM- 126 (266)
T ss_pred HHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678899999999998875 3578899999999999999865432 788899999999999999999998
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+||+|+++|++++
T Consensus 127 --i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~ 204 (266)
T cd06651 127 --IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT 204 (266)
T ss_pred --eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHH
Confidence 9999999999999999999999999987543221111 1122346788999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||...+. ...+............+......+.+++ +||..+|.+|||+++|++
T Consensus 205 g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 205 EKPPWAEYEA---------------MAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCccccch---------------HHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 9999964321 1111122222222334445566678888 688899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=235.33 Aligned_cols=202 Identities=30% Similarity=0.459 Sum_probs=158.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...+++||++.+++|.+++.... .+++..+..++.|++.||.+||+.+ +
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh~~~---i 119 (260)
T PF00069_consen 52 LRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLHSKG---I 119 (260)
T ss_dssp HHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---------ccccccccccccccccccccccccc---c
Confidence 467899999999999999999999999999889999998222 2999999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-cCCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+....... .......++..|.|||.+. +..++.++|+||||+++++|++|..
T Consensus 120 ~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 197 (260)
T PF00069_consen 120 VHRDIKPENILLDENGEVKLIDFGSSVKLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKL 197 (260)
T ss_dssp EESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSS
T ss_pred ccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999987531111 1123455788999999998 7889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||.......... ...+......... ........+.+++.+||+.||.+|||++++++
T Consensus 198 p~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 198 PFEESNSDDQLE------------IIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SSTTSSHHHHHH------------HHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccchhhhh------------hhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 997441000000 0000000000000 00111267999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=231.56 Aligned_cols=201 Identities=26% Similarity=0.379 Sum_probs=160.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..+...++++||+.+++|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 123 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP---------LPEPVFCKYTKQILDGVAYLHNNC---V 123 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5788999999999999999999999999999999999965431 788999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhh----cccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA----RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
+|+||+|+||+++.++.++|+|||.+........ ........++..|.|||.+.+..++.++|+||||++++++++
T Consensus 124 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 203 (265)
T cd06631 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT 203 (265)
T ss_pred ccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999998875422111 111122357888999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhccc-ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||...+..... ...... ......+...+.++.+++.+||..+|.+|||+.++++
T Consensus 204 g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 204 GKPPLASMDRLAAM---------------FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCccccCChHHHH---------------HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99999643221110 000000 1112233445677999999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=268.04 Aligned_cols=203 Identities=25% Similarity=0.343 Sum_probs=168.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|..++|||+|++||+-.+++..+|.||||++|+|.++++.... ..+........|++.|+.|||+.|
T Consensus 1287 vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH~~g--- 1354 (1509)
T KOG4645|consen 1287 VLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLHEHG--- 1354 (1509)
T ss_pred HHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHHhcC---
Confidence 36679999999999999999999999999999999999987653 666677778889999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc--ccccceeccccccCchhhhcC---CCCccccchhhhHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~~l 155 (247)
||||||||.||+++.+|.+|++|||.+....+.... ..-....||+.|+|||++.+. +-..+.|||||||++.||
T Consensus 1355 IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM 1434 (1509)
T KOG4645|consen 1355 IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEM 1434 (1509)
T ss_pred ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEe
Confidence 999999999999999999999999999877554211 112356799999999999764 356689999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
+||+.||...+ .+-.+.=.+..+-.++.|...+.+-++++..||..||..|+++.++++.
T Consensus 1435 ~tGkrPW~~~d---------------ne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1435 ATGKRPWAELD---------------NEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ecCCCchhhcc---------------chhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 99999996322 1222222333444566777888899999999999999999999998874
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=230.97 Aligned_cols=197 Identities=20% Similarity=0.291 Sum_probs=158.3
Q ss_pred cccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 025816 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 83 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h 83 (247)
..+||||+.+++++..++..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivH 120 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHNRF---VVY 120 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCC
Confidence 4579999999999999999999999999999999886543 2899999999999999999999999 999
Q ss_pred ccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-cCCCCccccchhhhHHHHHHHhCCCCC
Q 025816 84 RDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKPV 162 (247)
Q Consensus 84 ~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf 162 (247)
+||||+||+++.++.++|+|||++....... .....++..|+|||.+. +..++.++|+||+|+++++|++|..||
T Consensus 121 ~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 196 (279)
T cd05633 121 RDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196 (279)
T ss_pred CCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 9999999999999999999999986543221 12235788999999886 456889999999999999999999999
Q ss_pred CCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 163 DHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
.......... +.+ .........+...+.++.+++.+||..||.+|| |++++++.
T Consensus 197 ~~~~~~~~~~-------------~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 197 RQHKTKDKHE-------------IDR-MTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCCCCcCHHH-------------HHH-HhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 7543211110 000 011112234445667899999999999999999 69999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=234.10 Aligned_cols=200 Identities=25% Similarity=0.346 Sum_probs=154.0
Q ss_pred ccc-cCCCccceeeEEee------CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 3 SRL-KHENFVQLLGYCVD------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 3 ~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++ +|+||+++++++.. ....+++|||+.+|+|.+++....... +++..+..++.|+++|+.|||+
T Consensus 67 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~~~~qi~~al~~LH~ 139 (282)
T cd06636 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA-------LKEDWIAYICREILRGLAHLHA 139 (282)
T ss_pred HHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCC-------CCHHHHHHHHHHHHHHHHHHHH
Confidence 445 69999999999853 457899999999999999997644322 7888899999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-----cCCCCccccchhhhH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGV 150 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~ 150 (247)
.+ ++|+|++|+||+++.++.++|+|||++........ ......++..|+|||.+. ...++.++|+||||+
T Consensus 140 ~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~ 214 (282)
T cd06636 140 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGI 214 (282)
T ss_pred CC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHH
Confidence 99 99999999999999999999999999875432111 112345788899999875 345788999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
++|+|++|..||....+.... ................+.++.++|.+||+.||.+|||+.+|++
T Consensus 215 ~l~el~~g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 215 TAIEMAEGAPPLCDMHPMRAL---------------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHHHHHhCCCCccccCHHhhh---------------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 999999999999643221110 0000111111112234567999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=234.51 Aligned_cols=229 Identities=24% Similarity=0.320 Sum_probs=165.7
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++++++.+.+..++||||+ +++|.+++..... .+++..++.++.|+++||.|||+.+
T Consensus 55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~--- 122 (298)
T cd07841 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSI--------VLTPADIKSYMLMTLRGLEYLHSNW--- 122 (298)
T ss_pred HHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367889999999999999999999999999 7899999975431 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++|+||+|+||+++.++.++|+|||++......... .....++..|.|||.+.+ ..++.++|+||+|+++++|++|.
T Consensus 123 i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~ 200 (298)
T cd07841 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200 (298)
T ss_pred eeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999998765432211 122345678999998865 45788999999999999999998
Q ss_pred CCCCCCCCCCCcchhhhccccCCcch------hhhhcccccCCC-----CCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDK------VRQCVDARLGGD-----YPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
++|....................... ............ .....+..+.+++.+||+.+|.+|||+.+++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l 280 (298)
T cd07841 201 PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280 (298)
T ss_pred ccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 88765432211000000000000000 000000000001 1123356799999999999999999999999
Q ss_pred HHHHHhHhcCCCCCCCC
Q 025816 229 KALQPLLNARPGPAGES 245 (247)
Q Consensus 229 ~~l~~~~~~~~~~~~~~ 245 (247)
+ ...++..+.|.++.
T Consensus 281 ~--~~~~~~~~~~~~~~ 295 (298)
T cd07841 281 E--HPYFSNDPAPTPPS 295 (298)
T ss_pred h--CccccCCCCCCCCC
Confidence 9 45555555555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=229.69 Aligned_cols=212 Identities=22% Similarity=0.339 Sum_probs=160.2
Q ss_pred CcccccCCCccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
++++++||||+++++++.... ..+++++|+.+|+|.+++....... ....++...+..++.|++.||.|||
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH 130 (273)
T cd05074 54 CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE---EPFTLPLQTLVRFMIDIASGMEYLS 130 (273)
T ss_pred HHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 367899999999999886542 2468899999999988875332111 0113788999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
+.+ ++|+||||+||+++.++.++++|||.++...............++..|++||.+.+..++.++|+||||+++|+
T Consensus 131 ~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~e 207 (273)
T cd05074 131 SKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWE 207 (273)
T ss_pred hCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHH
Confidence 998 99999999999999999999999999886533221111122234567999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
+++ |..||...+... ....+........+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 208 l~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 208 IMTRGQTPYAGVENSE----------------IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred HhhCCCCCCCCCCHHH----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 998 889986443211 111111111112223445679999999999999999999999999987
Q ss_pred h
Q 025816 234 L 234 (247)
Q Consensus 234 ~ 234 (247)
+
T Consensus 272 ~ 272 (273)
T cd05074 272 I 272 (273)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=230.83 Aligned_cols=204 Identities=24% Similarity=0.360 Sum_probs=160.6
Q ss_pred ccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCCe
Q 025816 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHI 81 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~i 81 (247)
++++||||+++++++..+...+++|||+.+++|.+++...... +..++...++.++.|++.++.+||+ .+ +
T Consensus 64 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i 135 (269)
T cd08528 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLHKEKR---I 135 (269)
T ss_pred hcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhccCCc---e
Confidence 3579999999999999999999999999999999987542211 1238899999999999999999996 66 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|++++|..|
T Consensus 136 ~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 136 VHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 999999999999999999999999987654332 12334577889999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
|...+.. .......+...........+..+.+++.+||+.||.+|||+.++.+.+.
T Consensus 213 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 213 FYSTNML---------------SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccccCHH---------------HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 8643211 0011111111111111234567999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=229.90 Aligned_cols=204 Identities=25% Similarity=0.405 Sum_probs=163.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++.+.+..+++|||+.+++|.+++.... ++++..+..++.|++.||.+||+++ +
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~~---i 124 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHENQ---I 124 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 577899999999999999999999999999999999987543 2888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCC-ceeeccccccCCcchhhhc--ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|.||+++.++ .++|+|||.+......... .......++..|+|||.+.+..++.++|+||+|++++++++|
T Consensus 125 ~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 204 (268)
T cd06630 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA 204 (268)
T ss_pred ecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhC
Confidence 9999999999998776 5999999998765432111 111234567889999999888889999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||......... ..+.+..........+...+.++.+++.+||..+|.+|||+.++++
T Consensus 205 ~~p~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 205 KPPWNAEKHSNHL------------ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCCCCCcchH------------HHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 9999644321111 1111111122223455566788999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=233.52 Aligned_cols=221 Identities=20% Similarity=0.294 Sum_probs=162.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..+...+++|||+.+++|.+++....... +++..+..++.|++.||.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~-------~~~~~~~~~~~~l~~~L~~LH~~~---i 122 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-------LPELAIAFILKDVLNALDYIHSKG---F 122 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccC-------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 578899999999999999999999999999999999997654322 888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhc-----ccccceeccccccCchhhhc--CCCCccccchhhhHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~ 154 (247)
+|+||+|+||+++.++.++++|||.+......... .......++..|+|||.+.. ..++.++|+||+|+++++
T Consensus 123 vH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~e 202 (314)
T cd08216 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACE 202 (314)
T ss_pred ecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHH
Confidence 99999999999999999999999987644321111 01122346678999999875 358889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccC-----------Ccchhh--------hhcccccCCCCCHHHHHHHHHHHHhhcc
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKL-----------SEDKVR--------QCVDARLGGDYPPKAVAKMAAVAALCVQ 215 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~ 215 (247)
|++|..||....... .......... ...... ...............+.++.+++.+||.
T Consensus 203 l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 280 (314)
T cd08216 203 LANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280 (314)
T ss_pred HHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhh
Confidence 999999997543211 0000000000 000000 0000111112334556789999999999
Q ss_pred cCCCCCCCHHHHHH--HHHHh
Q 025816 216 YEADFRPNMSIVVK--ALQPL 234 (247)
Q Consensus 216 ~~p~~Rps~~~il~--~l~~~ 234 (247)
.||.+|||++++++ .++.+
T Consensus 281 ~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 281 RDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cCCCcCcCHHHHhcCchHhhh
Confidence 99999999999998 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=235.52 Aligned_cols=188 Identities=23% Similarity=0.297 Sum_probs=152.0
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
+|++|+++++.+.+.+..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ ++|||
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~---ivHrD 126 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---------FKEPQAVFYAAEISVGLFFLHRRG---IIYRD 126 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 568888999999999999999999999999999865432 899999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 165 (247)
|||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus 127 ikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 127 LKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred CCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875322111 122345889999999999888999999999999999999999999754
Q ss_pred CCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 025816 166 LPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM 224 (247)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 224 (247)
... .....+.... ...+...+.++.+++.+||+.+|.+|++.
T Consensus 205 ~~~---------------~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 205 DED---------------ELFQSIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CHH---------------HHHHHHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 221 1111111111 12334456678999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=231.71 Aligned_cols=202 Identities=25% Similarity=0.358 Sum_probs=159.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..+...++||||+.+++|.+++..... .+++..+..++.|++.|+.|||+.+
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~--- 123 (280)
T cd06611 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLHSHK--- 123 (280)
T ss_pred HHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999875432 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----CCCCccccchhhhHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l 155 (247)
++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.. ..++.++|+||+|+++|+|
T Consensus 124 i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l 201 (280)
T cd06611 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201 (280)
T ss_pred cccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHH
Confidence 99999999999999999999999998765432221 1223457888999998753 3467799999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccc-cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR-LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|..||...+... .+....... .....+...+.++.+++.+||..+|.+|||++++++.
T Consensus 202 ~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 202 AQMEPPHHELNPMR---------------VLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HhCCCCcccCCHHH---------------HHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 99999997542211 000100000 0011223445679999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=228.83 Aligned_cols=198 Identities=25% Similarity=0.384 Sum_probs=160.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..+...++++||+.+++|.+++.... .+++..+..++.|++.|+.+||+.+ +
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i 123 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHDRN---T 123 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 578899999999999999999999999999999999987543 2888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC-CCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++....... ......++..|++||.+.... ++.++|+||+|++++++++|..
T Consensus 124 ~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~ 200 (258)
T cd06632 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200 (258)
T ss_pred ccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999999887643322 112345778899999987766 8999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||...... ...............+...+.++.+++.+||..+|.+|||+++++.
T Consensus 201 pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 201 PWSQLEGV---------------AAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcccCcHH---------------HHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 99643211 1111111111112234445677999999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=235.54 Aligned_cols=200 Identities=22% Similarity=0.333 Sum_probs=159.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..+++|||+.+++|.+++.... +++..++.++.|++.||.+||+.+ +
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---i 138 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG---V 138 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567899999999999999999999999999999999875532 889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||+|+++++|++|..|
T Consensus 139 vH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 216 (297)
T cd06659 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216 (297)
T ss_pred ecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999988654322211 1234578899999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|........... ...... .........+..+.+++.+||+.+|.+|||++++++.
T Consensus 217 ~~~~~~~~~~~~---~~~~~~-----------~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 217 YFSDSPVQAMKR---LRDSPP-----------PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCCHHHHHHH---HhccCC-----------CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 964332111000 000000 0001112334568999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=221.67 Aligned_cols=199 Identities=20% Similarity=0.283 Sum_probs=160.7
Q ss_pred ccCCCccceeeEEeeC----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 5 LKHENFVQLLGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
-.|||||.+++++++. ..+.+|||.++||.|.+.++.+.... +++..+..+..||..|+.|||+.+
T Consensus 112 s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~a-------fTErea~eI~~qI~~Av~~lH~~n--- 181 (400)
T KOG0604|consen 112 SGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQA-------FTEREASEIMKQIGLAVRYLHSMN--- 181 (400)
T ss_pred cCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccccc-------chHHHHHHHHHHHHHHHHHHHhcc---
Confidence 3699999999998653 45789999999999999998876544 999999999999999999999999
Q ss_pred eEeccCCCCceeecCC---CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDD---DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
|.|||+||+|+|++.. ..+||+|||.+........ -...+.|+.|.|||++...+|+...|+||+|+++|-|++
T Consensus 182 IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC 258 (400)
T KOG0604|consen 182 IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258 (400)
T ss_pred hhhccCChhheeeecCCCCcceEecccccccccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhc
Confidence 9999999999999654 4699999999987543221 234567999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|.+||....... .+.+-...+..... .+| .+.+++..++|+.+|..+|.+|-|.+++++
T Consensus 259 GyPPFYS~hg~a-----------ispgMk~rI~~gqy--~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 259 GYPPFYSNHGLA-----------ISPGMKRRIRTGQY--EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCCcccccCCcc-----------CChhHHhHhhccCc--cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 999997554321 11111122221211 122 356888999999999999999999999987
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=235.97 Aligned_cols=202 Identities=16% Similarity=0.196 Sum_probs=155.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++|+||+++++.+.+....++||||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~~---i 123 (332)
T cd05623 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQLH---Y 123 (332)
T ss_pred HhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 4678999999999999999999999999999999999976332 2888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----CCCCccccchhhhHHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~ 156 (247)
+||||||+||+++.++.++|+|||++........ .......|+..|+|||++.. ..++.++|+||||+++|+|+
T Consensus 124 iHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell 202 (332)
T cd05623 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202 (332)
T ss_pred EecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHh
Confidence 9999999999999999999999999865322111 11123468999999999863 45788999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC---CCCCHHHHHHHHHHHHhhcccCCC--CCCCHHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG---GDYPPKAVAKMAAVAALCVQYEAD--FRPNMSIVVKA 230 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~--~Rps~~~il~~ 230 (247)
+|..||...... .....+.....+ .......+.++.+++.+|+..++. .|++++++++.
T Consensus 203 ~g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 203 YGETPFYAESLV---------------ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCCCCCCCHH---------------HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 999999643211 011111111111 111123466799999998865444 47899999886
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=230.52 Aligned_cols=203 Identities=21% Similarity=0.282 Sum_probs=160.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++......++||||+.+++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 46 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~~--- 115 (277)
T cd05577 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP-------GFPEARAIFYAAQIICGLEHLHQRR--- 115 (277)
T ss_pred HHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367889999999999999999999999999999999998755422 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||.+....... ......++..|.|||.+.+..++.++|+||+|+++++|++|..
T Consensus 116 i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~ 192 (277)
T cd05577 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192 (277)
T ss_pred cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCC
Confidence 9999999999999999999999999887543211 1122346778999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~ 229 (247)
||.......... .+.+... ......+...+..+.+++.+||+.+|.+|| ++.++++
T Consensus 193 p~~~~~~~~~~~------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 193 PFRQRKEKVEKE------------ELKRRTL-EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCCCCcccccHH------------HHHhccc-cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 996543211111 0111000 011123344567799999999999999999 7777875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=233.55 Aligned_cols=214 Identities=20% Similarity=0.241 Sum_probs=154.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+....++++||+. ++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~~---i 120 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCHSHN---V 120 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 577899999999999999999999999997 488887764322 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..
T Consensus 121 ~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~ 198 (284)
T cd07839 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198 (284)
T ss_pred ecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999998754322111 1223467789999998764 46899999999999999999888
Q ss_pred CCCCCCCCCCc-chhhhccccCCcc---hhhhhcccccC---------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 161 PVDHTLPRGQQ-SLVTWATPKLSED---KVRQCVDARLG---------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 161 pf~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
|+......... ............. .+.+..+.... .......+.++.+++.+||+.||.+|||++++
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i 278 (284)
T cd07839 199 PLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278 (284)
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence 86432211000 0000000000000 00000000000 11122345678999999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
++
T Consensus 279 l~ 280 (284)
T cd07839 279 LQ 280 (284)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=263.30 Aligned_cols=216 Identities=29% Similarity=0.536 Sum_probs=167.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+++|+|.+++.. +++..+..++.|++.|+.|||....+++
T Consensus 737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~i 804 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAV 804 (968)
T ss_pred HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 6789999999999999999999999999999999999952 8889999999999999999995533449
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|||+||+||+++.++..++. ++....... .....++..|+|||.+.+..++.++||||+|+++|||++|+.|
T Consensus 805 iH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred ecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 999999999999988877764 444332111 1123567899999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCC--CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
|...... ......+............++++.... ..+.+...++.+++.+||+.+|.+|||++++++.|+++.+.
T Consensus 878 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 878 ADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 9533221 122223332222233334444444432 23446667789999999999999999999999999998763
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=228.66 Aligned_cols=204 Identities=27% Similarity=0.374 Sum_probs=157.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..++..++++||+.+++|.+++...... ...+...+..++.|++.||.|||+.+ +
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---i 129 (268)
T cd06624 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLHDNQ---I 129 (268)
T ss_pred HHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 57889999999999999999999999999999999998754211 00277888899999999999999999 9
Q ss_pred EeccCCCCceeecC-CCceeeccccccCCcchhhhcccccceeccccccCchhhhcC--CCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||+++. ++.++|+|||.+......... .....++..|.|||.+... .++.++|+||+|++++++++|
T Consensus 130 ~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g 207 (268)
T cd06624 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207 (268)
T ss_pred eecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhC
Confidence 99999999999976 678999999998754322211 1223467889999998654 378899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..||......... .............+...+.++.+++.+||..+|.+|||+.++++.
T Consensus 208 ~~p~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 208 KPPFIELGEPQAA--------------MFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCCccccChhhh--------------HhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 9998643211100 000000111223344556779999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=228.56 Aligned_cols=202 Identities=29% Similarity=0.426 Sum_probs=161.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~ 80 (247)
+++++||||+++++.+..++..++++||+.+++|.+++..... .++...+..++.|++.++.+||+ .+
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~~--- 121 (265)
T cd06605 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQG--------RIPERILGKIAVAVLKGLTYLHEKHK--- 121 (265)
T ss_pred HHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHcCCCC---
Confidence 5678999999999999999999999999998999999976531 28899999999999999999999 88
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 122 i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 197 (265)
T cd06605 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRF 197 (265)
T ss_pred eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998865532221 11457778999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHH-HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||...+...... ...+..... ......+.. .+..+.++|.+||..+|.+|||+.++++
T Consensus 198 p~~~~~~~~~~~----------~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 198 PYPPENDPPDGI----------FELLQYIVN-EPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCccccccccH----------HHHHHHHhc-CCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 996543211100 001111111 111122222 5677999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=241.35 Aligned_cols=211 Identities=26% Similarity=0.312 Sum_probs=153.6
Q ss_pred CcccccCCCccceeeEEeeC------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVDG------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+|++++||||+++++++... ...+++++++ +++|.+++.... ++...+..++.|++.||.|||
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH 135 (343)
T cd07878 67 LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQK----------LSDEHVQFLIYQLLRGLKYIH 135 (343)
T ss_pred HHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHH
Confidence 36789999999999987543 3468999988 579998886433 899999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ 153 (247)
+.+ |+||||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|
T Consensus 136 ~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 207 (343)
T cd07878 136 SAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 207 (343)
T ss_pred HCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHH
Confidence 999 999999999999999999999999998764321 123457889999999876 56889999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCc--------chhhhhcccccCCC------CCHHHHHHHHHHHHhhcccCCC
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSE--------DKVRQCVDARLGGD------YPPKAVAKMAAVAALCVQYEAD 219 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~ 219 (247)
+|++|..||...+................. .............. ........+.+++.+||..||.
T Consensus 208 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~ 287 (343)
T cd07878 208 ELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSD 287 (343)
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChh
Confidence 999999999754321110000000000000 00000000000000 0011234578999999999999
Q ss_pred CCCCHHHHHHH
Q 025816 220 FRPNMSIVVKA 230 (247)
Q Consensus 220 ~Rps~~~il~~ 230 (247)
+|||+.++++.
T Consensus 288 ~R~s~~ell~h 298 (343)
T cd07878 288 KRISASEALAH 298 (343)
T ss_pred hCCCHHHHhcC
Confidence 99999999973
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=230.83 Aligned_cols=215 Identities=22% Similarity=0.285 Sum_probs=157.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+|++++++++..+...+++|||+.+++|..+..... .+++..+..++.|++.+|.|||+.+
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH~~~--- 120 (286)
T cd07847 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCHKHN--- 120 (286)
T ss_pred HHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3578899999999999999999999999999877777764432 1899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+ ..++.++|+||+|+++++|++|.
T Consensus 121 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~ 198 (286)
T cd07847 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198 (286)
T ss_pred ceecCCChhhEEEcCCCcEEECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC
Confidence 999999999999999999999999998765432211 122346778999999876 45788999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCc--------ch-hhhhcccccCCC-----CCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSE--------DK-VRQCVDARLGGD-----YPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
.||..................... .. ......+..... .....+..+.+++.+||..+|.+|||+.
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 278 (286)
T cd07847 199 PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCE 278 (286)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHH
Confidence 999754432111100000000000 00 000000000000 0112356799999999999999999999
Q ss_pred HHHH
Q 025816 226 IVVK 229 (247)
Q Consensus 226 ~il~ 229 (247)
+++.
T Consensus 279 eil~ 282 (286)
T cd07847 279 ELLE 282 (286)
T ss_pred HHhc
Confidence 9885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=231.18 Aligned_cols=194 Identities=22% Similarity=0.330 Sum_probs=159.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...+++|||+.+++|.+++..... ++...+..++.|++.||.+||+.+ +
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qil~~l~~lH~~~---i 122 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR---------FPEPVARFYAAQVVLALEYLHSLD---I 122 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 6788999999999999999999999999999999999876532 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|.||+++.++.++|+|||++...... .....++..|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 123 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 197 (290)
T cd05580 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197 (290)
T ss_pred ecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765433 1233577889999999888889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~ 229 (247)
|...... ......... ....+...+..+.+++.+||..||.+|+ +++++++
T Consensus 198 ~~~~~~~---------------~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 198 FFDDNPI---------------QIYEKILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCCCCHH---------------HHHHHHhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 9644310 001111111 1122334467799999999999999999 7888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=230.48 Aligned_cols=206 Identities=24% Similarity=0.361 Sum_probs=161.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~ 80 (247)
++.++||||+++++++......++||||+.+++|.+++.... .+++..+..++.+++.+|.|||+ .+
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~~--- 124 (284)
T cd06620 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVHR--- 124 (284)
T ss_pred HHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhcC---
Confidence 567899999999999999999999999999999999886543 28899999999999999999997 46
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 125 i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~ 200 (284)
T cd06620 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKF 200 (284)
T ss_pred eeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876542221 123457889999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhccccc---CCCCC-HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL---GGDYP-PKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
||.......... .....+.+...... ....+ ...+.++.+++.+||..||.+|||+.++++..
T Consensus 201 p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 201 PFAFSNIDDDGQ--------DDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCcccchhhhhh--------hhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 997543221100 00001111111111 01111 23556799999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=228.77 Aligned_cols=198 Identities=27% Similarity=0.406 Sum_probs=160.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++.... +++..+..++.|++.++.+||+.+ +
T Consensus 56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~----------~~~~~~~~~~~~l~~~l~~lh~~~---i 122 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---K 122 (277)
T ss_pred HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHccCC---e
Confidence 568899999999999999999999999999999999986532 889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++++|||++......... .....++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 123 ~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 200 (277)
T cd06641 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred ecCCCCHHhEEECCCCCEEEeecccceecccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999988654332211 1223467789999999888889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|...... .....+........+...+.++.+++.+||..+|.+||++.++++.
T Consensus 201 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 201 HSELHPM----------------KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCccchH----------------HHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 8643211 0111111111122333456779999999999999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=231.10 Aligned_cols=202 Identities=24% Similarity=0.361 Sum_probs=158.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~ 80 (247)
+++++|+||+++++.+..++..+++|||+.+++|.+++..... ...+++..+..++.|++.||.|||+ .+
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~--- 123 (286)
T cd06622 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123 (286)
T ss_pred HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---
Confidence 5678999999999999999999999999999999998875421 1138999999999999999999996 47
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC------CCccccchhhhHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ------LNAKSDVYSFGVVLLE 154 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~~l~~ 154 (247)
++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+.. ++.++|+||+|+++|+
T Consensus 124 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~ 199 (286)
T cd06622 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199 (286)
T ss_pred EeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHH
Confidence 99999999999999999999999999875432211 2234677899999885543 4789999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|++|..||......... ..+.... .......+...+.++.+++.+||..+|.+||++++++.
T Consensus 200 l~~g~~pf~~~~~~~~~------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 200 MALGRYPYPPETYANIF------------AQLSAIV-DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHhCCCCCCCcchhhHH------------HHHHHHh-hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 99999999643211000 0011111 11122344557788999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=227.75 Aligned_cols=203 Identities=20% Similarity=0.289 Sum_probs=162.4
Q ss_pred cccccCCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh-----
Q 025816 2 VSRLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH----- 74 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh----- 74 (247)
+++++|+||+++++++.. +...+++|||+.+++|.+++..... ....+++..++.++.|++.||.+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~ 127 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKK-----ERKYIEEEFIWRILTQLLLALYECHNRSDP 127 (265)
T ss_pred HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHhcCccc
Confidence 678899999999998754 4568999999999999999875421 1223899999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
+.+ ++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++++
T Consensus 128 ~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~ 202 (265)
T cd08217 128 GNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE 202 (265)
T ss_pred cCc---ceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHH
Confidence 777 999999999999999999999999998865433211 123357888999999988889999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|++|..||...+. ..+.+.+........+...+..+.+++.+||..+|.+|||+++|++.
T Consensus 203 l~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 203 LCALSPPFTARNQ----------------LQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHCCCcccCcCH----------------HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 9999999975431 11122222222233445666789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=226.92 Aligned_cols=200 Identities=25% Similarity=0.327 Sum_probs=158.0
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++.+. ...+++|||+.+++|.+++..... ++...+..++.|++.||.+||+.+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~-- 126 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---------LTENVTRKYTRQILEGVSYLHSNM-- 126 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5788999999999988764 467899999999999999875431 788889999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus 127 -i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g 205 (265)
T cd06652 127 -IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTE 205 (265)
T ss_pred -EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhC
Confidence 9999999999999999999999999987543221111 11223477889999999888899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||...... ..+.+..........+...+..+.+++.+|+. +|.+|||++++++
T Consensus 206 ~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 206 KPPWAEFEAM---------------AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCccchH---------------HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 9999633111 11112221222233455667789999999995 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=229.73 Aligned_cols=199 Identities=22% Similarity=0.392 Sum_probs=158.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..++++||+.+++|.+++.... ++...+..++.|++.|+.+||+.+ +
T Consensus 70 l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~~---i 136 (285)
T cd06648 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIATVCLAVLKALSFLHAQG---V 136 (285)
T ss_pred HHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567899999999999999999999999999999999987632 888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 137 ~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p 214 (285)
T cd06648 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214 (285)
T ss_pred ecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987654322211 1234578889999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|...++..... . +....... ...+...+..+.+++.+||+.+|.+|||++++++
T Consensus 215 ~~~~~~~~~~~---~---------~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 215 YFNEPPLQAMK---R---------IRDNLPPK--LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CcCCCHHHHHH---H---------HHhcCCCC--CcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 86432210000 0 00000000 0111224567999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=234.29 Aligned_cols=202 Identities=17% Similarity=0.178 Sum_probs=154.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++|+||+++++++.++...++||||+.+|+|.+++..... .+++..+..++.|++.||.|||+++ +
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 123 (331)
T cd05597 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVHQLG---Y 123 (331)
T ss_pred HHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4568999999999999999999999999999999999975322 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----CCCCccccchhhhHHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~ 156 (247)
+||||||+||+++.++.++|+|||++......... ......|+..|+|||++.. ..++.++|+||+||++|+|+
T Consensus 124 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (331)
T cd05597 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202 (331)
T ss_pred EECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHh
Confidence 99999999999999999999999998654322111 1122458899999999863 35688999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC---CCCCHHHHHHHHHHHHhhcccCC--CCCCCHHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG---GDYPPKAVAKMAAVAALCVQYEA--DFRPNMSIVVKA 230 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p--~~Rps~~~il~~ 230 (247)
+|..||....... ....+...... .......+..+.+++.+|+..++ ..|++++++++.
T Consensus 203 ~g~~Pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 203 YGETPFYAESLVE---------------TYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred hCCCCCCCCCHHH---------------HHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999996432110 00011100000 01112346678999999886544 348899999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=234.31 Aligned_cols=202 Identities=17% Similarity=0.171 Sum_probs=155.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++|+||+++++++..++..++||||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+ |
T Consensus 55 l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~~~---i 123 (331)
T cd05624 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQLH---Y 123 (331)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 4678999999999999999999999999999999999976332 2888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----CCCCccccchhhhHHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~ 156 (247)
+||||||+||+++.++.++|+|||++......... ......|+..|+|||.+.+ ..++.++|+||+|+++|+|+
T Consensus 124 iHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell 202 (331)
T cd05624 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202 (331)
T ss_pred eeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhh
Confidence 99999999999999999999999998754332211 1123458899999999875 45788999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCC---CCCHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG---DYPPKAVAKMAAVAALCVQYEADF--RPNMSIVVKA 230 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~il~~ 230 (247)
+|..||....... ....+.....+. ......+.++.+++.+|+...+++ |++++++++.
T Consensus 203 ~g~~Pf~~~~~~~---------------~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 203 YGETPFYAESLVE---------------TYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred hCCCCccCCCHHH---------------HHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9999996432110 011111111001 111233567999999999866544 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=232.23 Aligned_cols=204 Identities=21% Similarity=0.248 Sum_probs=157.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++.+..+...+++|||+.+++|.+++.... .+++..+..++.|++.|+.|||+.+ +
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i 122 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNYG---I 122 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 577899999999999999999999999999999999996543 2888999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhh-------------cccccceeccccccCchhhhcCCCCccccchhh
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-------------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSF 148 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 148 (247)
+|+||+|.||+++.++.++|+|||++........ ........++..|+|||.+.+..++.++|+|||
T Consensus 123 ~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (305)
T cd05609 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202 (305)
T ss_pred cccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHH
Confidence 9999999999999999999999998763211000 000112346778999999988889999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
|+++|++++|..||.+.... +.......... ........+.++.+++.+||+.+|.+|||+.++
T Consensus 203 G~vl~el~~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 267 (305)
T cd05609 203 GIILYEFLVGCVPFFGDTPE---------------ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGA 267 (305)
T ss_pred HHHHHHHHhCCCCCCCCCHH---------------HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCH
Confidence 99999999999999643211 00111111100 011112356679999999999999999996655
Q ss_pred HHHHH
Q 025816 228 VKALQ 232 (247)
Q Consensus 228 l~~l~ 232 (247)
++.++
T Consensus 268 ~~ll~ 272 (305)
T cd05609 268 FEVKQ 272 (305)
T ss_pred HHHHh
Confidence 55554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=228.42 Aligned_cols=200 Identities=26% Similarity=0.400 Sum_probs=160.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+|++++++.+..+...++++||+.+++|.+++.... ..+++..+..++.|++.||.+||+.+ +
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~g---i 137 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHSQN---V 137 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 578899999999999999999999999999999999998754 12899999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+|++|+||+++.++.++|+|||.+........ ......++..|++||.+.+..++.++|+||+|+++|++++|..|
T Consensus 138 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p 215 (286)
T cd06614 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215 (286)
T ss_pred eeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998765432211 11223467789999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCC-CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG-DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|....... ............ ......+..+.+++.+||+.+|.+|||+.++++
T Consensus 216 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 216 YLREPPLR---------------ALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCCCHHH---------------HHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 86432210 001111111100 111224567999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=230.66 Aligned_cols=215 Identities=22% Similarity=0.290 Sum_probs=158.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..++..+++|||+.++.+..+..... .++...+..++.|++.|+.|||+.+ +
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i 121 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHSHN---I 121 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 578899999999999999999999999998766655544322 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+|++|+||+++.++.++|+|||.+......... ......++..|+|||.+.+. .++.++|+||+|++++++++|..
T Consensus 122 ~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 200 (288)
T cd07833 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200 (288)
T ss_pred ecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765433221 11234567889999999887 78999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCc---------c-----hhhhhccc-ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSE---------D-----KVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~---------~-----~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
||..................... . ...+.... ......+...+.++.++|++||..+|.+|||++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 280 (288)
T cd07833 201 LFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCD 280 (288)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHH
Confidence 99754322110000000000000 0 00000000 000012223467899999999999999999999
Q ss_pred HHHH
Q 025816 226 IVVK 229 (247)
Q Consensus 226 ~il~ 229 (247)
++++
T Consensus 281 ~il~ 284 (288)
T cd07833 281 ELLQ 284 (288)
T ss_pred HHhc
Confidence 9985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=227.48 Aligned_cols=203 Identities=27% Similarity=0.415 Sum_probs=154.9
Q ss_pred cccc-cCCCccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 2 VSRL-KHENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
++++ +|+||+++++++.... ..+++|||+.+++|.+++..... .+..+++..+..++.|++.||.|||
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~ql~~al~~lH 130 (275)
T cd06608 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK-----KGKRLKEEWIAYILRETLRGLAYLH 130 (275)
T ss_pred HHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 4556 7999999999987644 48999999999999999865331 0123899999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----CCCCccccchhhh
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFG 149 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG 149 (247)
+.+ ++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.. ..++.++|+||||
T Consensus 131 ~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 205 (275)
T cd06608 131 ENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG 205 (275)
T ss_pred cCC---cccCCCCHHHEEEccCCeEEECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhH
Confidence 999 999999999999999999999999988754332211 123457888999998753 2467889999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
++++++++|..||....... ...+...... ....+...+.++.+++.+||..||++|||+++++
T Consensus 206 ~il~~l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 206 ITAIELADGKPPLCDMHPMR---------------ALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred HHHHHHHhCCCCccccchHH---------------HHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 99999999999996432110 0011111000 1112233566899999999999999999999998
Q ss_pred H
Q 025816 229 K 229 (247)
Q Consensus 229 ~ 229 (247)
+
T Consensus 271 ~ 271 (275)
T cd06608 271 E 271 (275)
T ss_pred c
Confidence 6
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=243.82 Aligned_cols=204 Identities=25% Similarity=0.396 Sum_probs=176.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|.+|+|+|++++||++.+ ....||||.+..|+|.+.+.+.... .|.....-..+.||+.|+.||.+++
T Consensus 164 ~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~-------~llv~~Lcdya~QiA~aM~YLeskr--- 232 (1039)
T KOG0199|consen 164 HMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKA-------ILLVSRLCDYAMQIAKAMQYLESKR--- 232 (1039)
T ss_pred HHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhcccc-------ceeHHHHHHHHHHHHHHHHHHhhhh---
Confidence 3678999999999999987 6778999999999999999873322 2888889999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
+||||+..+|+++.....+||+|||+++-.+..... .......-...|.|||.+....|+.++|+|++|+++|||++ |
T Consensus 233 lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyG 312 (1039)
T KOG0199|consen 233 LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYG 312 (1039)
T ss_pred hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccC
Confidence 999999999999999999999999999866543332 22233344567999999999999999999999999999999 8
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
..||.+. ....+.+.++.+.+...+..|+++++++++.||..+|++|||+.+|.+.+
T Consensus 313 EePW~G~----------------~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 313 EEPWVGC----------------RGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCCC----------------CHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 9999643 45667788888888899999999999999999999999999999998543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=229.97 Aligned_cols=215 Identities=21% Similarity=0.300 Sum_probs=155.3
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++|+||+++++++.++...++||||+.+ +|.+++..... .+++..+..++.|+++||.|||+.+
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~--- 123 (291)
T cd07844 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRR--- 123 (291)
T ss_pred HHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999975 99998875432 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++|+||+|+||+++.++.++|+|||+++........ .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|.
T Consensus 124 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~ 201 (291)
T cd07844 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201 (291)
T ss_pred eecccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998653221111 112235778999998875 45789999999999999999999
Q ss_pred CCCCCCCCCCCcc-hhhhccccCCcchhhhhcc--------------cccCCCC-CHHHHHHHHHHHHhhcccCCCCCCC
Q 025816 160 KPVDHTLPRGQQS-LVTWATPKLSEDKVRQCVD--------------ARLGGDY-PPKAVAKMAAVAALCVQYEADFRPN 223 (247)
Q Consensus 160 ~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--------------~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps 223 (247)
.||.......... ................... ....... ......++.+++.+||+.+|.+|||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps 281 (291)
T cd07844 202 PLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281 (291)
T ss_pred CCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC
Confidence 9996543211100 0000000000000000000 0000000 0011257889999999999999999
Q ss_pred HHHHHH
Q 025816 224 MSIVVK 229 (247)
Q Consensus 224 ~~~il~ 229 (247)
+.++++
T Consensus 282 ~~e~l~ 287 (291)
T cd07844 282 AAEAMK 287 (291)
T ss_pred HHHHhc
Confidence 999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=255.16 Aligned_cols=205 Identities=21% Similarity=0.310 Sum_probs=154.2
Q ss_pred CcccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+|++|+||||++++++|... ..+++||||+.+++|.+++...... ...+++..++.++.||+.||.|||+.+.
T Consensus 65 IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~ 139 (1021)
T PTZ00266 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKD 139 (1021)
T ss_pred HHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhccc
Confidence 46789999999999988543 5689999999999999998753211 1128999999999999999999998431
Q ss_pred ----CCeEeccCCCCceeecC-----------------CCceeeccccccCCcchhhhcccccceeccccccCchhhhc-
Q 025816 79 ----PHIIHRDIKSSNVLIFD-----------------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT- 136 (247)
Q Consensus 79 ----~~i~h~di~~~nil~~~-----------------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 136 (247)
.+|+|+||||+|||++. .+.++|+|||++........ .....+++.|+|||++.+
T Consensus 140 ~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge 216 (1021)
T PTZ00266 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHE 216 (1021)
T ss_pred ccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhcc
Confidence 23999999999999964 23489999999876532211 133468999999999864
Q ss_pred -CCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcc
Q 025816 137 -GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQ 215 (247)
Q Consensus 137 -~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 215 (247)
..++.++|||||||++|+|++|..||....... .+...+..... ......+.++.+||..||.
T Consensus 217 ~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~---------------qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~ 280 (1021)
T PTZ00266 217 TKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS---------------QLISELKRGPD-LPIKGKSKELNILIKNLLN 280 (1021)
T ss_pred CCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH---------------HHHHHHhcCCC-CCcCCCCHHHHHHHHHHhc
Confidence 357899999999999999999999996432110 01111111000 0112235679999999999
Q ss_pred cCCCCCCCHHHHHH
Q 025816 216 YEADFRPNMSIVVK 229 (247)
Q Consensus 216 ~~p~~Rps~~~il~ 229 (247)
.+|.+|||+.++|.
T Consensus 281 ~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 281 LSAKERPSALQCLG 294 (1021)
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999995
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=225.09 Aligned_cols=202 Identities=25% Similarity=0.353 Sum_probs=163.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~ 80 (247)
+++++|+||+++++++..+...+++|||+.+++|.+++.... .++...++.++.|++.++.+||+ .+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~--- 120 (264)
T cd06623 53 LRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRH--- 120 (264)
T ss_pred HHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCC---
Confidence 567899999999999999999999999999999999997642 28999999999999999999999 98
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++|..
T Consensus 121 ~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~ 198 (264)
T cd06623 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKF 198 (264)
T ss_pred CccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999988765432221 123456788999999988888999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHH-HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||.......... ...... .......+.. .+..+.+++.+||..+|.+|||++++++.
T Consensus 199 p~~~~~~~~~~~------------~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 199 PFLPPGQPSFFE------------LMQAIC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCccccccCHHH------------HHHHHh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 997543211100 111111 1111222233 56789999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=229.51 Aligned_cols=216 Identities=24% Similarity=0.317 Sum_probs=158.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+ +++|.+++..... ++++..++.++.|++.+|.|||+.+ +
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 120 (286)
T cd07832 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEER--------PLPEAQVKSYMRMLLKGVAYMHANG---I 120 (286)
T ss_pred HHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 57889999999999999999999999999 8899999865431 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+. .++.++|+||+|+++++|++|.+
T Consensus 121 ~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 199 (286)
T cd07832 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSP 199 (286)
T ss_pred ecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCc
Confidence 99999999999999999999999998765432211 11234578889999988654 46889999999999999999988
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhh------hh--cccccC-----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVR------QC--VDARLG-----GDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~--~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
+|.......................+. .+ +..... .+...+.+..+.+++.+||..+|++|||++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 279 (286)
T cd07832 200 LFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA 279 (286)
T ss_pred CcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHH
Confidence 886543211100000000000000000 00 000000 00112335789999999999999999999999
Q ss_pred HHH
Q 025816 228 VKA 230 (247)
Q Consensus 228 l~~ 230 (247)
++.
T Consensus 280 l~h 282 (286)
T cd07832 280 LRH 282 (286)
T ss_pred hhC
Confidence 863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=228.82 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=160.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..++|+||+.+++|.+++.... +++..+..++.|++.|+.+||+.+ +
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~g---i 136 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---V 136 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 578899999999999999999999999999999999987543 788899999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+|++|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 137 ~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~p 214 (293)
T cd06647 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (293)
T ss_pred eeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998765433221 11233577789999999888889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|............. . ........+...+..+.+++.+||..+|.+||++++++..
T Consensus 215 f~~~~~~~~~~~~~--~------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 215 YLNENPLRALYLIA--T------------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCChhhheeehh--c------------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 97543321111000 0 0000011222345679999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=235.50 Aligned_cols=197 Identities=21% Similarity=0.331 Sum_probs=158.4
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
.|.+|+++|+|-..+..+|||||+=+ .+|.+.+++.... .+...+..+..|++.|+.+.|..| |||.|
T Consensus 418 g~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~g---IVHSD 485 (677)
T KOG0596|consen 418 GHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQHG---IVHSD 485 (677)
T ss_pred CCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHhc---eeecC
Confidence 46899999999999999999999764 5999999987753 332378888899999999999999 99999
Q ss_pred CCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC-----------CCccccchhhhHHHHH
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-----------LNAKSDVYSFGVVLLE 154 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~DvwslG~~l~~ 154 (247)
+||.|+++- .|.+||+|||++................||..|++||.+.... .+.++|||||||++|+
T Consensus 486 LKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYq 564 (677)
T KOG0596|consen 486 LKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQ 564 (677)
T ss_pred CCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHH
Confidence 999999995 4689999999999887777666667789999999999886433 4568999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHH-HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPK-AVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|+.|++||+... .....+..+.++...-+++.- ...++.++++.||.+||.+|||..++|+
T Consensus 565 MvYgktPf~~~~--------------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 565 MVYGKTPFGQII--------------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHhcCCchHHHH--------------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 999999996331 011234444444443333321 1223999999999999999999999987
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=227.11 Aligned_cols=199 Identities=25% Similarity=0.303 Sum_probs=161.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++.+.++...++|+||+.+++|.+++.... +++...+..++.|+++||.|||+.+ +
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~---i 121 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSKG---I 121 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 578999999999999999999999999999999999997652 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 122 ~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 198 (258)
T cd05578 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198 (258)
T ss_pred eccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCC
Confidence 999999999999999999999999987654322 11234567789999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH--HHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM--SIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~--~~il~ 229 (247)
|...+..... ...+.... .....+...+..+.+++.+||..||.+||++ +++++
T Consensus 199 ~~~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 199 YRGHSRTIRD-------------QIRAKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred CCCCCccHHH-------------HHHHHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 9755432111 11111111 2223444556889999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=225.92 Aligned_cols=194 Identities=22% Similarity=0.265 Sum_probs=154.6
Q ss_pred ccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 025816 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII 82 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~ 82 (247)
++.+|+|++++++++..++..++++||+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---i~ 119 (260)
T cd05611 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLHQRG---II 119 (260)
T ss_pred hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 45689999999999999999999999999999999987543 2889999999999999999999999 99
Q ss_pred eccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCC
Q 025816 83 HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 162 (247)
Q Consensus 83 h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 162 (247)
|+||+|.||+++.++.++|+|||.+..... .....++..|+|||.+.+..++.++|+||+|+++|++++|..||
T Consensus 120 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 193 (260)
T cd05611 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPF 193 (260)
T ss_pred cCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999998875332 12334677899999998877899999999999999999999999
Q ss_pred CCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 163 DHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
....... .......... ........+..+.+++.+||+.+|.+|||+..+.+
T Consensus 194 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 194 HAETPDA---------------VFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred CCCCHHH---------------HHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 6432110 0001101110 11122245677999999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=225.33 Aligned_cols=201 Identities=25% Similarity=0.425 Sum_probs=160.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++.+..+...++++||+.+++|.+++...... .+++..+..++.|++.||.|||+.+ +
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~---i 122 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGV-------LFSEDQILSWFVQISLGLKHIHDRK---I 122 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 57889999999999999999999999999999999999765432 2789999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCc-eeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDV-AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~-~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++. ++++|||.+......... .....++..|.|||...+..++.++|+||+|++++++++|..
T Consensus 123 ~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08225 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKH 200 (257)
T ss_pred ccccCCHHHEEEcCCCCeEEecccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999998864 699999988765432211 122347788999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||...... ..+.+...... .......+.++.+++.+||..+|.+|||+.++++.
T Consensus 201 p~~~~~~~---------------~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 201 PFEGNNLH---------------QLVLKICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCccHH---------------HHHHHHhcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 98643211 11111111111 12223445679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=224.69 Aligned_cols=208 Identities=30% Similarity=0.390 Sum_probs=161.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++.+..++..+++||++.+++|.+++..... ...+++..+..++.|++.|+.+||+.+ +
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lh~~~---i 123 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP------RGGLDEAIIATVLKEVLKGLEYLHSNG---Q 123 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5779999999999999999999999999999999999975432 012889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcc--cccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+... .++.++|+||+|+++++|++|
T Consensus 124 ~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g 203 (267)
T cd06610 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203 (267)
T ss_pred ecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhC
Confidence 999999999999999999999999886554322211 11233578889999998876 789999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCC-CHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY-PPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..||....... ......... ........ ....+..+.+++.+||..||.+|||++++++.
T Consensus 204 ~~p~~~~~~~~--~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 204 AAPYSKYPPMK--VLMLTLQND----------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCccccChhh--hHHHHhcCC----------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 99997543211 111100000 00000000 12445679999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=227.61 Aligned_cols=201 Identities=29% Similarity=0.378 Sum_probs=155.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-CCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~-~~~~ 80 (247)
++.++||||+++++++..+...+++|||+. ++|.+++...... ...+++..++.++.|++.||.|||++ +
T Consensus 54 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~--- 124 (283)
T cd06617 54 MRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLHSKLS--- 124 (283)
T ss_pred HHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---
Confidence 456789999999999999999999999997 5888887643211 12389999999999999999999987 7
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc----CCCCccccchhhhHHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT----GQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~l~ 156 (247)
++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||+|+++|+|+
T Consensus 125 i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~ 201 (283)
T cd06617 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELA 201 (283)
T ss_pred eecCCCCHHHEEECCCCCEEEeecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHH
Confidence 99999999999999999999999999876532211 122356778999998865 45688999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCC-CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY-PPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||...... .+.+...... ..... ....+.++.+++.+||..+|.+|||++++++
T Consensus 202 ~g~~p~~~~~~~--------------~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 202 TGRFPYDSWKTP--------------FQQLKQVVEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred hCCCCCCccccC--------------HHHHHHHHhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999998532110 0111111111 11111 1234667999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=233.32 Aligned_cols=210 Identities=20% Similarity=0.227 Sum_probs=155.2
Q ss_pred cccccCCCccceeeEEeeC------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDG------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++||||+++++++... ...++||||+. ++|.+.+... ++...+..++.|++.||.|||+
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~ 136 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHS 136 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHh
Confidence 5788999999999988644 35799999996 4888887532 7788899999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ ++|+||||+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++++|
T Consensus 137 ~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 210 (353)
T cd07850 137 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210 (353)
T ss_pred CC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHH
Confidence 99 99999999999999999999999999876533211 1223567889999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccC----------------------Ccchhhhhccccc----CCCCCHHHHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKL----------------------SEDKVRQCVDARL----GGDYPPKAVAKMAAV 209 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~----~~~~~~~~~~~l~~l 209 (247)
++|..||...+............... ......+...... ....+...+..+.++
T Consensus 211 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (353)
T cd07850 211 IRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290 (353)
T ss_pred HHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHH
Confidence 99999997554211100000000000 0000011111100 011122345678999
Q ss_pred HHhhcccCCCCCCCHHHHHH
Q 025816 210 AALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 210 i~~cl~~~p~~Rps~~~il~ 229 (247)
+.+||+.||++|||+.++|+
T Consensus 291 i~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 291 LSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHcCCChhhCcCHHHHhc
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=228.03 Aligned_cols=205 Identities=25% Similarity=0.347 Sum_probs=153.9
Q ss_pred cccc-cCCCccceeeEEe-----eCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRL-KHENFVQLLGYCV-----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
++++ +||||+++++++. .+...+++|||+.+++|.+++...... +..+++..+..++.|++.||.|||+
T Consensus 68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~ 142 (286)
T cd06638 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHV 142 (286)
T ss_pred HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHh
Confidence 4566 6999999999874 345789999999999999987532211 1238889999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----CCCCccccchhhhH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGV 150 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~ 150 (247)
.+ ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.. ..++.++|+||+|+
T Consensus 143 ~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv 217 (286)
T cd06638 143 NK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217 (286)
T ss_pred CC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHH
Confidence 98 99999999999999999999999999875432211 1123457889999998753 34788999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|+|++|..||.......... .... .. ......+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 218 i~~el~~g~~p~~~~~~~~~~~--~~~~----------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 218 TAIELGDGDPPLADLHPMRALF--KIPR----------NP--PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHHHHhcCCCCCCCCchhHHHh--hccc----------cC--CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 9999999999986543211100 0000 00 00001112234569999999999999999999999975
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=222.49 Aligned_cols=225 Identities=20% Similarity=0.246 Sum_probs=168.3
Q ss_pred CcccccCCCccceeeEEee-CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++.++|||++.+..+|.+ +...++++||.+. +|+..+.-+..... .-++...+..++.||++|+.|||++=
T Consensus 80 L~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH~NW-- 152 (438)
T KOG0666|consen 80 LLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLHSNW-- 152 (438)
T ss_pred HHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHhhhh--
Confidence 3578999999999999877 8899999999987 99999987665443 24999999999999999999999998
Q ss_pred CeEeccCCCCceeecCC----CceeeccccccCCcchhhhcc-cccceeccccccCchhhhcC-CCCccccchhhhHHHH
Q 025816 80 HIIHRDIKSSNVLIFDD----DVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLL 153 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~----~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ 153 (247)
|+|||+||.|||+..+ |.+||+|+|+++.+.+.-... ......-|.+|+|||.+.|. -|+.+.|+|++||++.
T Consensus 153 -vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfa 231 (438)
T KOG0666|consen 153 -VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFA 231 (438)
T ss_pred -eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHH
Confidence 9999999999999888 899999999999886544332 33456789999999999985 5899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcc---------hhhhccccCCcchhhhh------------cccccCCCCCH--------HHHH
Q 025816 154 ELLTGRKPVDHTLPRGQQS---------LVTWATPKLSEDKVRQC------------VDARLGGDYPP--------KAVA 204 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~--------~~~~ 204 (247)
||++..+.|.+..+..... .+..+.+..+...+..+ +.......... .-+.
T Consensus 232 ElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~ 311 (438)
T KOG0666|consen 232 ELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDP 311 (438)
T ss_pred HHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCc
Confidence 9999999987654322211 11111111111111000 00000111100 0122
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 205 KMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 205 ~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
...+|+.++|..||.+|.|+++.++..=.
T Consensus 312 ~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 312 SALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred hHHHHHHHHhccCchhhccHHHHhccccc
Confidence 38899999999999999999999986543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=225.47 Aligned_cols=193 Identities=21% Similarity=0.346 Sum_probs=154.3
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
.|||++++++++..+...+++|||+.+++|.+++.... +++..++.++.|++.++.|||+.+ ++|+|
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~---i~H~d 126 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----------IAEKYISVIIREVLVALKYIHKVG---VIHRD 126 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHccC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 49999999999999999999999999999999986542 899999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCCCCCCC
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDH 164 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~ 164 (247)
|+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||..
T Consensus 127 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 127 IKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred cCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998765433211 123357788999998865 4568899999999999999999999975
Q ss_pred CCCCCCcchhhhccccCCcchhhhhcccccCCCCCH-HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 165 TLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP-KAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
.......... ........+. ..+.++.+++.+||..||.+|||+.++++
T Consensus 205 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 205 VDAFRAMMLI----------------PKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CChhhhhhcc----------------ccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 4321111000 0000001111 14567999999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=223.75 Aligned_cols=201 Identities=26% Similarity=0.401 Sum_probs=164.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..+...+++|||+.+++|.+++..... .+..+++..++.++.|++.||.+||+.+ +
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~al~~lh~~~---i 124 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKK-----KRKLIPEQEIWRIFIQLLRGLQALHEQK---I 124 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhCC---c
Confidence 5788999999999999999999999999999999999866321 1123889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|.||+++.++.++|+|||++....... .....++..|.+||.+.+..++.++|+||+|++++++++|+.|
T Consensus 125 ~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p 200 (256)
T cd08530 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200 (256)
T ss_pred ccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987654431 1224467789999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|...+. ...............+...+.++.+++.+||+.+|.+|||+.++++.
T Consensus 201 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 201 FEARSM----------------QDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCH----------------HHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 964321 11111122222233444667789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=223.04 Aligned_cols=201 Identities=26% Similarity=0.419 Sum_probs=158.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++...+..++++||+.+++|.+++.... .+++..+..++.+++.|+.|||+.+ +
T Consensus 53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~---i 120 (264)
T cd06626 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLHSHG---I 120 (264)
T ss_pred HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHHHCC---c
Confidence 578899999999999999999999999999999999987543 2788899999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhccc--ccceeccccccCchhhhcCC---CCccccchhhhHHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH--STRVLGTFGYHAPEYAMTGQ---LNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~~l~ 156 (247)
+|+||+|+||+++.++.++|+|||.+........... .....++..|+|||.+.+.. ++.++|+||+|+++++++
T Consensus 121 ~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~ 200 (264)
T cd06626 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200 (264)
T ss_pred ccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHH
Confidence 9999999999999999999999999876543222111 11234677899999988765 789999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCH--HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP--KAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||...+.... .............+. ..+..+.+++.+||+.+|.+|||+++++.
T Consensus 201 ~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 201 TGKRPWSELDNEFQ---------------IMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred hCCCCccCCcchHH---------------HHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 99999964321100 000000011111222 23667899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=223.66 Aligned_cols=193 Identities=23% Similarity=0.316 Sum_probs=156.6
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
+||||+++++.+..++..++||||+.+++|.+++.... .+++..+..++.|+++||.+||+.+ ++|+|
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 134 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHKHN---IIHND 134 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCC
Confidence 69999999999999999999999999999999997653 2899999999999999999999999 99999
Q ss_pred CCCCceeecCCC-ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCC
Q 025816 86 IKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164 (247)
Q Consensus 86 i~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 164 (247)
|+|+||+++.++ .++|+|||.+...... ....++..|+|||.+.+..++.++|+||+|+++++|++|..||..
T Consensus 135 l~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 208 (267)
T PHA03390 135 IKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208 (267)
T ss_pred CCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999998 9999999988754321 223567889999999988899999999999999999999999974
Q ss_pred CCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-HHHHHH
Q 025816 165 TLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-MSIVVK 229 (247)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~il~ 229 (247)
....... ...+..... .....+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus 209 ~~~~~~~-----------~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 209 DEDEELD-----------LESLLKRQQ--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CCcchhh-----------HHHHHHhhc--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 3221100 011111110 111233356678999999999999999996 598885
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=231.66 Aligned_cols=225 Identities=23% Similarity=0.312 Sum_probs=160.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||++++++|..+...+++|||+.+++|.+++....... +++..+..++.|++.||.|||+.+ +
T Consensus 53 ~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~-------~~~~~~~~~~~qi~~aL~~lH~~~---i 122 (328)
T cd08226 53 SHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-------MSEALIGNILFGALRGLNYLHQNG---Y 122 (328)
T ss_pred HHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccC-------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 456899999999999999999999999999999999987654322 888999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcc-----cccceeccccccCchhhhcC--CCCccccchhhhHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~ 154 (247)
+||||||+||+++.++.++++||+.+.......... ......++..|+|||.+.+. .++.++|+||+|+++++
T Consensus 123 vHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~e 202 (328)
T cd08226 123 IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202 (328)
T ss_pred ecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHH
Confidence 999999999999999999999997653321111000 00112245569999998763 47899999999999999
Q ss_pred HHhCCCCCCCCCCCCCcc-hhh------hccccCC------------------cchhh-----hhcccccCCCCCHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQS-LVT------WATPKLS------------------EDKVR-----QCVDARLGGDYPPKAVA 204 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~-~~~------~~~~~~~------------------~~~~~-----~~~~~~~~~~~~~~~~~ 204 (247)
|++|..||.......... ... +.....+ ..... ..............++.
T Consensus 203 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (328)
T cd08226 203 LATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSP 282 (328)
T ss_pred HHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhH
Confidence 999999997543211000 000 0000000 00000 00011111222345677
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHH--HHHHhHh
Q 025816 205 KMAAVAALCVQYEADFRPNMSIVVK--ALQPLLN 236 (247)
Q Consensus 205 ~l~~li~~cl~~~p~~Rps~~~il~--~l~~~~~ 236 (247)
.+.+++.+||..||.+|||++++++ .++.+.+
T Consensus 283 ~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 283 AFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 8999999999999999999999986 4444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=223.68 Aligned_cols=203 Identities=27% Similarity=0.423 Sum_probs=170.3
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||++++.|++|++||.+.....+++|||||..|++.+.+..+. +++++..+..++...++||+|||...
T Consensus 81 IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~--------K~L~E~EIs~iL~~TLKGL~YLH~~~--- 149 (502)
T KOG0574|consen 81 IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR--------KPLSEQEISAVLRDTLKGLQYLHDLK--- 149 (502)
T ss_pred HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhc--------CCccHHHHHHHHHHHHhHHHHHHHHH---
Confidence 5788999999999999999999999999999999999998665 34999999999999999999999998
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
-+|||||..|||++.+|..||.|||++-...+.... .+...||+.|+|||++...+|..++||||||++..+|..|++
T Consensus 150 KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 150 KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred HHHhhcccccEEEcccchhhhhhccccchhhhhHHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCC
Confidence 999999999999999999999999999876654443 356789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||....+--.-..+ +..+... -..|..-+.++-+++++||.++|++|-|+.++++.
T Consensus 228 PYsDIHPMRAIFMI----PT~PPPT----------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 228 PYSDIHPMRAIFMI----PTKPPPT----------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CcccccccceeEec----cCCCCCC----------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 99754321111100 0111100 12345667889999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=236.64 Aligned_cols=192 Identities=20% Similarity=0.254 Sum_probs=159.2
Q ss_pred ccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 025816 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII 82 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~ 82 (247)
+.-+||||+++.+.+.++.+.++|||.+.|+-+.+.+.... .....+..|+.+|+.|+.|||.+| ++
T Consensus 371 ~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~----------~~~~e~~~w~~~lv~Av~~LH~~g---vv 437 (612)
T KOG0603|consen 371 LVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP----------EFCSEASQWAAELVSAVDYLHEQG---VV 437 (612)
T ss_pred hhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc----------hhHHHHHHHHHHHHHHHHHHHhcC---ee
Confidence 34589999999999999999999999999987777776544 333788899999999999999999 99
Q ss_pred eccCCCCceee-cCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 83 HRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 83 h~di~~~nil~-~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
|||+||+|||+ +..+.++|+|||.+...... .....-|..|.|||++...+|++++|+||||+++|+|++|..|
T Consensus 438 hRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp 512 (612)
T KOG0603|consen 438 HRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTL 512 (612)
T ss_pred ecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCc
Confidence 99999999999 68899999999998876544 1233567889999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|.... .+ .++........+....++...+|+.+||+.||.+||++.++...
T Consensus 513 ~~~~P----------------~~--~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 513 FAAHP----------------AG--IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cccCC----------------ch--HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 97432 11 22222222233346778889999999999999999999999873
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=240.97 Aligned_cols=212 Identities=17% Similarity=0.205 Sum_probs=152.4
Q ss_pred cCCCccceeeEEeeC-CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCCeEe
Q 025816 6 KHENFVQLLGYCVDG-TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIH 83 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~i~h 83 (247)
.|.+++.+++++..+ .+.++||+++ +++|.+++.... .+++..+..++.|++.||.|||+ .+ |+|
T Consensus 189 ~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~~g---IiH 255 (467)
T PTZ00284 189 DRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHTELH---LMH 255 (467)
T ss_pred cCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---eec
Confidence 456688999988765 4789999988 568998886543 28999999999999999999997 58 999
Q ss_pred ccCCCCceeecCCC----------------ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchh
Q 025816 84 RDIKSSNVLIFDDD----------------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 147 (247)
Q Consensus 84 ~di~~~nil~~~~~----------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 147 (247)
|||||+|||++.++ .+||+|||.+..... ......||..|+|||++.+..++.++||||
T Consensus 256 rDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 330 (467)
T PTZ00284 256 TDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330 (467)
T ss_pred CCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHH
Confidence 99999999998765 499999998754321 123456899999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcc--------hhhhhccccc--CCC---------------CCHHH
Q 025816 148 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED--------KVRQCVDARL--GGD---------------YPPKA 202 (247)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~--~~~---------------~~~~~ 202 (247)
|||++|+|++|+.||...+.......+.......+.. ....+..... ... .....
T Consensus 331 lGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (467)
T PTZ00284 331 MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR 410 (467)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhc
Confidence 9999999999999997654322111111111111100 0000000000 000 00012
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhH
Q 025816 203 VAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLL 235 (247)
Q Consensus 203 ~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~~~ 235 (247)
...+.+||.+||++||.+|||++|+|+ +++...
T Consensus 411 ~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 411 DDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred hHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 346889999999999999999999998 555544
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=224.75 Aligned_cols=198 Identities=21% Similarity=0.303 Sum_probs=158.2
Q ss_pred ccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 025816 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII 82 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~ 82 (247)
+...||||+++++++......++||||+.+++|.+++.... .+++..+..++.|++.|+.|||+.+ ++
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~ 119 (278)
T cd05606 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRF---VV 119 (278)
T ss_pred HhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 34579999999999999999999999999999999886543 2899999999999999999999999 99
Q ss_pred eccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCCC
Q 025816 83 HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 83 h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..|
T Consensus 120 H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p 195 (278)
T cd05606 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195 (278)
T ss_pred cCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCC
Confidence 99999999999999999999999987543221 1234578899999998754 689999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
|.......... .... ........+...+..+.+++.+||..+|.+|| ++.++++.
T Consensus 196 ~~~~~~~~~~~-------------~~~~-~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 196 FRQHKTKDKHE-------------IDRM-TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCccchHH-------------HHHH-hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 97542221111 0000 00111223334467899999999999999999 99999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=222.06 Aligned_cols=202 Identities=26% Similarity=0.371 Sum_probs=164.2
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++|+||+++++.+... ...++++|++.+++|.+++.... .+++..++.++.|++.+|.|||+.+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~-- 121 (260)
T cd06606 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHSNG-- 121 (260)
T ss_pred HHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5788999999999999988 88999999999999999997654 2899999999999999999999998
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++|+|++|+||+++.++.++|+|||.+................++..|.|||.+.+..++.++|+||||++++++++|.
T Consensus 122 -~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 200 (260)
T cd06606 122 -IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200 (260)
T ss_pred -ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987665433211123345778899999998888999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
.||...+.. ................+...+..+.+++.+|+..+|.+|||+.+++.
T Consensus 201 ~p~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 201 PPWSELGNP--------------MAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCCCCCch--------------HHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 999754310 01111111112222344455778999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=226.21 Aligned_cols=207 Identities=29% Similarity=0.358 Sum_probs=157.1
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++... ...+++|||+.+++|.+++...... ...++...+..++.|++.||.|||+.+
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~-- 125 (287)
T cd06621 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLHSRK-- 125 (287)
T ss_pred HHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 6789999999999988654 4689999999999999887542211 122888999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++|+||+|+||+++.++.++|+|||++........ ....++..|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 126 -i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 200 (287)
T cd06621 126 -IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200 (287)
T ss_pred -cccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999865432211 1234677899999998888999999999999999999999
Q ss_pred CCCCCCCCCCCc--chhhhccccCCcchhhhhcccccCCCCC--HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 160 KPVDHTLPRGQQ--SLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 160 ~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
.||......... ....+.... .......... ...+..+.+++.+||..+|.+|||+.|+++
T Consensus 201 ~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 201 FPFPPEGEPPLGPIELLSYIVNM---------PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCcccCCCCChHHHHHHHhcC---------CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 999755321110 011110000 0000100111 124567999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=237.93 Aligned_cols=202 Identities=23% Similarity=0.326 Sum_probs=164.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||..+.||+||++++.|+.++.++++.|||.||.+...+-.... .|++.++..++.|++.||.|||+++
T Consensus 82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r--------~LtE~QIqvvc~q~ldALn~LHs~~--- 150 (1187)
T KOG0579|consen 82 ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR--------VLTEDQIQVVCYQVLDALNWLHSQN--- 150 (1187)
T ss_pred hhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhcc--------ccchHHHHHHHHHHHHHHHHHhhcc---
Confidence 57889999999999999999999999999999999888876543 3999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-----cCCCCccccchhhhHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~~l 155 (247)
|+|||+|..|||++-+|.++|.|||++..... .......+.||+.|+|||++. ..+|+.++||||||+++.+|
T Consensus 151 iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEM 228 (1187)
T KOG0579|consen 151 IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEM 228 (1187)
T ss_pred hhhhhccccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHH
Confidence 99999999999999999999999999875432 223346788999999999875 35789999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..+.+|-..-. +...+..+..+.- ..-.|..-+..+.+++++||.+||..||++.++++.
T Consensus 229 AqiEPPHheln---------------pMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 229 AQIEPPHHELN---------------PMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hccCCCccccc---------------hHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 99999964211 1111111110000 012344556789999999999999999999999873
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=228.76 Aligned_cols=214 Identities=21% Similarity=0.282 Sum_probs=157.6
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++..+ ...+++|||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~-- 126 (293)
T cd07843 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNW-- 126 (293)
T ss_pred HHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5688999999999998877 889999999974 99998876432 2899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|+||+|+++++|++|
T Consensus 127 -i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 203 (293)
T cd07843 127 -ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203 (293)
T ss_pred -eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876544321 11233467789999988764 468899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCc--------------chhhhhcccccCCCCCHH-HHHHHHHHHHhhcccCCCCCCC
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSE--------------DKVRQCVDARLGGDYPPK-AVAKMAAVAALCVQYEADFRPN 223 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps 223 (247)
..||..................... ...............+.. .+..+.++|.+||+.+|++|||
T Consensus 204 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t 283 (293)
T cd07843 204 KPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283 (293)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC
Confidence 9999754321110000000000000 000000001111112222 4667999999999999999999
Q ss_pred HHHHHH
Q 025816 224 MSIVVK 229 (247)
Q Consensus 224 ~~~il~ 229 (247)
+.|+++
T Consensus 284 ~~ell~ 289 (293)
T cd07843 284 AEDALK 289 (293)
T ss_pred HHHHhc
Confidence 999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=220.24 Aligned_cols=199 Identities=31% Similarity=0.462 Sum_probs=160.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+|++++++++..+...++++||+.+++|.+++..... .+++..+..++.|++.+|.+||..+ +
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lh~~~---i 119 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--------TLTESQIAYVCKELLKGLEYLHSNG---I 119 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHhhcCC---E
Confidence 5678999999999999999999999999998999999876531 2899999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+........ .....++..|++||.+.+..++.++|+||+|++++++++|..|
T Consensus 120 ~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 196 (253)
T cd05122 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196 (253)
T ss_pred ecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876544321 2344577889999999888889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCC--CHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY--PPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|...+.... ..... ....... ....+..+.+++.+||..||.+|||+.++++.
T Consensus 197 ~~~~~~~~~---------------~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 197 YSELPPMKA---------------LFKIA-TNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCCCchHHH---------------HHHHH-hcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 864321100 00000 0000111 11225679999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=235.31 Aligned_cols=228 Identities=22% Similarity=0.292 Sum_probs=162.4
Q ss_pred cccccCCCccceeeEEeeC-----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 2 VSRLKHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+++++|+||+++++++... ...++++||+.+ +|.+.+.... +++..+..++.|++.||.+||+.
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------l~~~~~~~i~~ql~~aL~~LH~~ 125 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH----------LSNDHIQYFLYQILRGLKYIHSA 125 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhC
Confidence 5788999999999987654 357999999964 8888876543 89999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
+ ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+ ..++.++|+||+|+++++
T Consensus 126 ~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~e 202 (336)
T cd07849 126 N---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAE 202 (336)
T ss_pred C---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHH
Confidence 9 9999999999999999999999999987653322111 1122457888999998754 468899999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc---------CCC-----CCHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL---------GGD-----YPPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~-----~~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|+.||...+.................+....+..... ... .....+..+.+++.+||+.+|.+
T Consensus 203 l~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 282 (336)
T cd07849 203 MLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHK 282 (336)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhh
Confidence 9999999965432111110111011111111111111000 000 01123567999999999999999
Q ss_pred CCCHHHHHHH--HHHhHhcCCCCCC
Q 025816 221 RPNMSIVVKA--LQPLLNARPGPAG 243 (247)
Q Consensus 221 Rps~~~il~~--l~~~~~~~~~~~~ 243 (247)
|||+.++++. ++......+.|..
T Consensus 283 Rpt~~e~l~hp~~~~~~~~~~~~~~ 307 (336)
T cd07849 283 RITVEEALAHPYLEQYHDPSDEPVA 307 (336)
T ss_pred CcCHHHHhcCccccccCCCCCcccC
Confidence 9999999995 7766654344333
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=241.23 Aligned_cols=200 Identities=28% Similarity=0.389 Sum_probs=165.3
Q ss_pred ccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCc--CHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL--SWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++|+|.|||+++|.+..+...-+.||-..||+|.+++....+- + .+........||++||.|||.+.
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGP--------lKDNEstm~fYtkQILeGLkYLHen~--- 695 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGP--------LKDNESTMNFYTKQILEGLKYLHENK--- 695 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCC--------CccchhHHHHHHHHHHHHhhhhhhcc---
Confidence 5799999999999999988888999999999999999877652 4 45667778899999999999999
Q ss_pred eEeccCCCCceeec-CCCceeeccccccCCcchhhhcccccceeccccccCchhhhc--CCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+|||||-+|+|++ -.|.+||+|||-+.+...... .+..+.||.-|+|||++.. .+|..++|||||||++.+|.|
T Consensus 696 IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT 773 (1226)
T KOG4279|consen 696 IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT 773 (1226)
T ss_pred eeeccccCCcEEEeeccceEEecccccchhhccCCc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc
Confidence 99999999999996 568999999999886644332 3456779999999999975 479999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|++||..-. .+...+-+..--......|.+.+.+...+|.+|+..+|.+||++.++|+
T Consensus 774 GrPPF~Elg--------------spqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 774 GRPPFVELG--------------SPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCCeeecC--------------ChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 999995211 0111122222223345678899999999999999999999999999997
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=231.86 Aligned_cols=222 Identities=23% Similarity=0.329 Sum_probs=159.7
Q ss_pred cccc-cCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
++++ +||||+++++++... ...++||||+. ++|.+++.... +.+..+..++.|++.||.|||+.+
T Consensus 60 l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~- 127 (337)
T cd07852 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRANI----------LEDVHKRYIMYQLLKALKYIHSGN- 127 (337)
T ss_pred HHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5678 999999999998654 46899999997 49999887542 888899999999999999999998
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhc---ccccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR---LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+ ..++.++|+||+|+++|+
T Consensus 128 --i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~e 205 (337)
T cd07852 128 --VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGE 205 (337)
T ss_pred --eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHH
Confidence 999999999999999999999999998755432211 11123457888999998765 457889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhh--------hhcccccC------CCCCHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR--------QCVDARLG------GDYPPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|..||.......................+. ..++.... .......+..+.++|.+||+.+|.+
T Consensus 206 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~ 285 (337)
T cd07852 206 MLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNK 285 (337)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccc
Confidence 999999997543322111111111111110000 00100000 0111224667999999999999999
Q ss_pred CCCHHHHHHH--HHHhHhc
Q 025816 221 RPNMSIVVKA--LQPLLNA 237 (247)
Q Consensus 221 Rps~~~il~~--l~~~~~~ 237 (247)
|||+.++++. ++.+...
T Consensus 286 Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 286 RLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred ccCHHHHhhChhhhhhccC
Confidence 9999999984 5555433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=226.34 Aligned_cols=199 Identities=23% Similarity=0.393 Sum_probs=157.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++.+..++..+++|||+.+++|.+++.... +++..+..++.|++.+++|||+.+ +
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~g---i 137 (292)
T cd06657 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG---V 137 (292)
T ss_pred HHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 577899999999999999999999999999999999875432 788999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 138 vH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p 215 (292)
T cd06657 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215 (292)
T ss_pred ecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998765432211 11234577889999998888889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|......... .. +........ ......+..+.+++.+||..+|.+||+++++++
T Consensus 216 ~~~~~~~~~~---~~---------~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 216 YFNEPPLKAM---KM---------IRDNLPPKL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCCCCHHHHH---HH---------HHhhCCccc--CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 9643221000 00 000000000 011233556899999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=227.12 Aligned_cols=201 Identities=27% Similarity=0.375 Sum_probs=157.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|||++++++++..+...++||||+.+ ++.+.+..... ++++..+..++.|++.|+.|||+.+ +
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~---i 146 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---M 146 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5778999999999999999999999999974 88887754332 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh---cCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||+++.++.++|+|||++...... ....++..|+|||.+. ...++.++|+||+|+++++|++|
T Consensus 147 ~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g 220 (317)
T cd06635 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 220 (317)
T ss_pred ccCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999987654321 2235677899999874 34678899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
..||...+.. ...................+..+.+++.+||+.+|.+|||+.++++..-.+.
T Consensus 221 ~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 221 KPPLFNMNAM---------------SALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCCCCCccHH---------------HHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 9998643211 1111111111111122344567999999999999999999999998655433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=228.72 Aligned_cols=215 Identities=25% Similarity=0.289 Sum_probs=156.1
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++|+||+++++++... +..++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~~~-- 128 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT--------PFSESQVKCLMLQLLRGLQYLHENF-- 128 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5789999999999998765 468999999974 89888875431 2899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|
T Consensus 129 -i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 205 (309)
T cd07845 129 -IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205 (309)
T ss_pred -eecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765432211 122234678999998865 4578999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhh--------cc-cccCC----CCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQC--------VD-ARLGG----DYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
..||...+....................... .. ..... ......+..+.++|.+||+.||++|||++
T Consensus 206 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ 285 (309)
T cd07845 206 KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE 285 (309)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHH
Confidence 9999755432221111110000000000000 00 00000 00112356788999999999999999999
Q ss_pred HHHHH
Q 025816 226 IVVKA 230 (247)
Q Consensus 226 ~il~~ 230 (247)
++++.
T Consensus 286 ~il~h 290 (309)
T cd07845 286 EALES 290 (309)
T ss_pred HHhcC
Confidence 99974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=224.66 Aligned_cols=212 Identities=25% Similarity=0.322 Sum_probs=154.7
Q ss_pred cccc-cCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
++++ +|+|++++++++.++ ...++||||+. ++|.+.+..... .+++..+..++.|++.||.|||+.+
T Consensus 51 l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~- 120 (282)
T cd07831 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMHRNG- 120 (282)
T ss_pred HhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3455 499999999999887 88999999997 488888765332 2899999999999999999999999
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHh
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~ 157 (247)
++|+||+|+||+++. +.++|+|||++......... ....++..|+|||.+.. ..++.++|+||+|+++++|++
T Consensus 121 --i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 121 --IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred --ceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 999999999999999 99999999998765332211 22346788999997754 456889999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc--C-----------CCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--G-----------GDYPPKAVAKMAAVAALCVQYEADFRPNM 224 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 224 (247)
|..||...+................. .+.+...... . .......+..+.++|.+||+.+|.+|||+
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 273 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDA-EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCH-HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH
Confidence 99999765432111100000000000 0000000000 0 00112346789999999999999999999
Q ss_pred HHHHHH
Q 025816 225 SIVVKA 230 (247)
Q Consensus 225 ~~il~~ 230 (247)
+++++.
T Consensus 274 ~~~l~~ 279 (282)
T cd07831 274 KQALRH 279 (282)
T ss_pred HHHhhC
Confidence 999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=225.81 Aligned_cols=204 Identities=26% Similarity=0.368 Sum_probs=153.9
Q ss_pred cccc-cCCCccceeeEEeeC-----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRL-KHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
++++ +|||++++++++... ...++||||+.+++|.+++..... .+..+++..++.++.|++.||.+||+
T Consensus 72 l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~ 146 (291)
T cd06639 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI-----CGQRLDEAMISYILYGALLGLQHLHN 146 (291)
T ss_pred HHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3455 799999999998654 358999999999999998864321 11238899999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-----CCCccccchhhhH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----QLNAKSDVYSFGV 150 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~ 150 (247)
.+ ++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+... .++.++|+||+|+
T Consensus 147 ~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGv 221 (291)
T cd06639 147 NR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGI 221 (291)
T ss_pred CC---eeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHH
Confidence 98 999999999999999999999999998764332211 1223567889999987543 3688999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccc-ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
++|+|++|..||........ . ...... ......+......+.++|.+||+.+|.+|||+.++++
T Consensus 222 i~~el~~g~~p~~~~~~~~~--~-------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 222 TAIELGDGDPPLFDMHPVKT--L-------------FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHhhCCCCCCCCcHHHH--H-------------HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 99999999999964432110 0 000000 0000112234457999999999999999999999986
Q ss_pred H
Q 025816 230 A 230 (247)
Q Consensus 230 ~ 230 (247)
.
T Consensus 287 ~ 287 (291)
T cd06639 287 H 287 (291)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=229.32 Aligned_cols=214 Identities=20% Similarity=0.265 Sum_probs=155.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...+++|||+. ++|.+++....... +++..+..++.|++.||.|||+.+ +
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~-------l~~~~~~~~~~~i~~~l~~lh~~~---i 121 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSG-------IPLPLIKSYLFQLLQGLAFCHSHR---V 121 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 678899999999999999999999999996 58988886544322 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC-CCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+.. ++.++|+||||+++|++++|..
T Consensus 122 ~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 199 (284)
T cd07860 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199 (284)
T ss_pred ecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999998754322111 12234577899999886644 5888999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcc-------------hhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSED-------------KVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
||...................... ....+..... .......+.++.++|.+||+.||.+|||++++
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 278 (284)
T cd07860 200 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278 (284)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence 997543211100000000000000 0000000000 00111234568899999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
++
T Consensus 279 l~ 280 (284)
T cd07860 279 LA 280 (284)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=220.71 Aligned_cols=203 Identities=24% Similarity=0.384 Sum_probs=163.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+|++++++.+..+...++++|++.+++|.+.+..... .+..+++..+..++.+++.||.+||+.+ +
T Consensus 53 l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~ 124 (258)
T cd08215 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLHSRK---I 124 (258)
T ss_pred HHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 5678999999999999999999999999999999999876531 1123999999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+........ ......++..|+|||...+..++.++|+||+|+++++|++|..|
T Consensus 125 ~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 202 (258)
T cd08215 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202 (258)
T ss_pred ecccCChHHeEEcCCCcEEECCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999876544321 12334577889999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|...... .+............+...+..+.+++.+||..+|.+|||++++++.
T Consensus 203 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 203 FEGENLL----------------ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCcHH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 8643211 1111111111222333556779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=228.70 Aligned_cols=214 Identities=24% Similarity=0.334 Sum_probs=156.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i 121 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCHSHN---I 121 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999999999999999999999888887765432 1889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+|++|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||+|+++++|++|.+
T Consensus 122 ~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~ 199 (286)
T cd07846 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199 (286)
T ss_pred cccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999875433221 1122346788999998875 346889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCc--------chh-hhhcccccC-----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSE--------DKV-RQCVDARLG-----GDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
||..................... ..+ .....+... .......+..+.+++.+||..+|.+|||+.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 279 (286)
T cd07846 200 LFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279 (286)
T ss_pred CCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHH
Confidence 99654321110000000000000 000 000000000 0011234677999999999999999999999
Q ss_pred HHH
Q 025816 227 VVK 229 (247)
Q Consensus 227 il~ 229 (247)
+++
T Consensus 280 il~ 282 (286)
T cd07846 280 LLH 282 (286)
T ss_pred Hhc
Confidence 986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=227.19 Aligned_cols=221 Identities=21% Similarity=0.290 Sum_probs=157.4
Q ss_pred CcccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
++++++||||+++++++... ...++||||+.+ ++.+++....... ...++...++.++.|++.||.|||+.+
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~- 128 (316)
T cd07842 55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLLWQILNGVHYLHSNW- 128 (316)
T ss_pred HHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCC----CcCcCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 35788999999999999888 789999999975 7887775433211 123889999999999999999999999
Q ss_pred CCeEeccCCCCceeecC----CCceeeccccccCCcchhhh-cccccceeccccccCchhhhcC-CCCccccchhhhHHH
Q 025816 79 PHIIHRDIKSSNVLIFD----DDVAKIADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVL 152 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~----~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l 152 (247)
++|+||+|+||+++. ++.++|+|||++........ ........++..|+|||.+.+. .++.++|+||||+++
T Consensus 129 --i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 206 (316)
T cd07842 129 --VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIF 206 (316)
T ss_pred --EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 999999999999999 89999999999886543222 1112234567889999988764 578999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchh------hhc---cccCCc---------chhhhhcccccCCCCC---------H--HHH
Q 025816 153 LELLTGRKPVDHTLPRGQQSLV------TWA---TPKLSE---------DKVRQCVDARLGGDYP---------P--KAV 203 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~------~~~---~~~~~~---------~~~~~~~~~~~~~~~~---------~--~~~ 203 (247)
++|++|..||............ ... ...... ...............+ . ..+
T Consensus 207 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (316)
T cd07842 207 AELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD 286 (316)
T ss_pred HHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCC
Confidence 9999999999765443210000 000 000000 0000000000000011 0 234
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 204 AKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 204 ~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..+.+++.+||+.||.+|||+.++++
T Consensus 287 ~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 287 SQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 56899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=240.36 Aligned_cols=220 Identities=18% Similarity=0.217 Sum_probs=154.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++......+++++++. ++|.+++....... ........+..++.|++.||.|||+.+
T Consensus 216 il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~----~~~~~~~~~~~i~~ql~~aL~yLH~~g--- 287 (501)
T PHA03210 216 ALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCAVEYIHDKK--- 287 (501)
T ss_pred HHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccc----cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678999999999999999999999999996 48888775433111 111446678889999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.++.+||+|||++......... ......|+..|+|||.+.+..++.++|||||||++|+|++|..
T Consensus 288 IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~ 366 (501)
T PHA03210 288 LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366 (501)
T ss_pred eecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999999765432211 1123468999999999999899999999999999999999775
Q ss_pred -CCCCCCCCCCcchhhhcc--cc----CC--cchhhhhcccccCCCC----C-----HHHHHHHHHHHHhhcccCCCCCC
Q 025816 161 -PVDHTLPRGQQSLVTWAT--PK----LS--EDKVRQCVDARLGGDY----P-----PKAVAKMAAVAALCVQYEADFRP 222 (247)
Q Consensus 161 -pf~~~~~~~~~~~~~~~~--~~----~~--~~~~~~~~~~~~~~~~----~-----~~~~~~l~~li~~cl~~~p~~Rp 222 (247)
|+..........+..... .. .+ ...+...+........ + ...+.++.+++.+||++||.+||
T Consensus 367 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp 446 (501)
T PHA03210 367 CPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP 446 (501)
T ss_pred CCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc
Confidence 443222111111110000 00 00 0001111111000000 0 11234678889999999999999
Q ss_pred CHHHHHH
Q 025816 223 NMSIVVK 229 (247)
Q Consensus 223 s~~~il~ 229 (247)
|+.|+++
T Consensus 447 sa~elL~ 453 (501)
T PHA03210 447 GAAELLA 453 (501)
T ss_pred CHHHHhh
Confidence 9999987
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=232.51 Aligned_cols=221 Identities=23% Similarity=0.309 Sum_probs=160.1
Q ss_pred cccccCCCccceeeEEeeC-----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 2 VSRLKHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
++.++|+||+++++++... ...++++||+. ++|.+++.... .+++..+..++.|++.||.|||+.
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~ 127 (337)
T cd07858 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIHSA 127 (337)
T ss_pred HHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5678999999999988654 34799999996 59998886543 289999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l 155 (247)
+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.. ..++.++|+||||+++|+|
T Consensus 128 ~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 202 (337)
T cd07858 128 N---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202 (337)
T ss_pred C---EecCCCCHHHEEEcCCCCEEECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHH
Confidence 9 99999999999999999999999999876543211 1123356788999998865 4688999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccC--------Ccchhhhhccccc---C---CCCCHHHHHHHHHHHHhhcccCCCCC
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKL--------SEDKVRQCVDARL---G---GDYPPKAVAKMAAVAALCVQYEADFR 221 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~---~---~~~~~~~~~~l~~li~~cl~~~p~~R 221 (247)
++|..||...+............... ............. . .......+.++.+++.+||+.+|.+|
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 282 (337)
T cd07858 203 LGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282 (337)
T ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhc
Confidence 99999997543211110000000000 0001111110000 0 00112346678999999999999999
Q ss_pred CCHHHHHHH--HHHhHhc
Q 025816 222 PNMSIVVKA--LQPLLNA 237 (247)
Q Consensus 222 ps~~~il~~--l~~~~~~ 237 (247)
||++++++. +..+...
T Consensus 283 ps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 283 ITVEEALAHPYLASLHDP 300 (337)
T ss_pred cCHHHHHcCcchhhhcCc
Confidence 999999985 6655433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=226.33 Aligned_cols=196 Identities=27% Similarity=0.383 Sum_probs=154.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++..+...++||||+. |++.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH~~~---i 136 (307)
T cd06607 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKK--------PLQEVEIAAICHGALQGLAYLHSHE---R 136 (307)
T ss_pred HHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 577999999999999999999999999997 588887754332 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh---cCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||+++.++.++|+|||++...... ....++..|+|||.+. ...++.++||||+|+++|++++|
T Consensus 137 ~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg 210 (307)
T cd06607 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (307)
T ss_pred eecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcC
Confidence 99999999999999999999999988654221 2234677899999874 34678899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..||...+.... .............+...+..+.+++.+||+.+|.+|||+.+++..
T Consensus 211 ~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 211 KPPLFNMNAMSA---------------LYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCCccHHHH---------------HHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 999864321110 000000000011122356679999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=227.65 Aligned_cols=216 Identities=22% Similarity=0.317 Sum_probs=153.8
Q ss_pred cccccCCCccceeeEEeeCC--------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRLKHENFVQLLGYCVDGT--------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
+++++||||+++++++.... ..+++|||+.+ +|.+.+..... .+++..++.++.|+++||.||
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~l 135 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYI 135 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHH
Confidence 57889999999999986653 45999999964 88888765431 289999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc--ccccceeccccccCchhhhcC-CCCccccchhhhH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGV 150 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~ 150 (247)
|+.+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+. .++.++|+||+|+
T Consensus 136 H~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 212 (310)
T cd07865 136 HRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGC 212 (310)
T ss_pred HHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHH
Confidence 9999 999999999999999999999999998765432211 111223467789999988664 4688999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhh-----ccc-ccCCCC---------CHHHHHHHHHHHHhhcc
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC-----VDA-RLGGDY---------PPKAVAKMAAVAALCVQ 215 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~-~~~~~~---------~~~~~~~l~~li~~cl~ 215 (247)
++|+|++|..||...................+.+..... .+. ...... .......+.++|.+||.
T Consensus 213 ~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~ 292 (310)
T cd07865 213 IMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV 292 (310)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhc
Confidence 999999999999765432221111111111111000000 000 000000 00123457899999999
Q ss_pred cCCCCCCCHHHHHH
Q 025816 216 YEADFRPNMSIVVK 229 (247)
Q Consensus 216 ~~p~~Rps~~~il~ 229 (247)
.||.+|||++++++
T Consensus 293 ~~P~~R~t~~e~l~ 306 (310)
T cd07865 293 LDPAKRIDADTALN 306 (310)
T ss_pred CChhhccCHHHHhc
Confidence 99999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=223.96 Aligned_cols=200 Identities=23% Similarity=0.327 Sum_probs=157.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++.+..+...+++|||+.+++|.+++.... .+++..+..++.|++.||.+||+.+ +
T Consensus 47 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~~---i 114 (265)
T cd05579 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG---------SLDEDVARIYIAEIVLALEYLHSNG---I 114 (265)
T ss_pred HHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---e
Confidence 567899999999999999999999999999999999987543 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhh------cccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
+|+||+|+||+++.++.++|+|||++........ ........++..|+|||......++.++|+||||++++++
T Consensus 115 ~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l 194 (265)
T cd05579 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEF 194 (265)
T ss_pred ecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHH
Confidence 9999999999999999999999998875432211 0011234467789999999888889999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHH--HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPK--AVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|..||....... ......... ...+.. .+..+.+++.+||+.+|.+|||+..+.+.
T Consensus 195 ~~g~~p~~~~~~~~---------------~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 195 LVGIPPFHGETPEE---------------IFQNILNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred HhCCCCCCCCCHHH---------------HHHHHhcCC--cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence 99999996443110 011111101 111112 26779999999999999999999444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=226.82 Aligned_cols=214 Identities=21% Similarity=0.275 Sum_probs=159.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..+...++++||+.+ +|.+++..... .+++..+..++.|++.||.+||+.+ +
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i 119 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCHSHG---I 119 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5788999999999999999999999999975 88888876432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+........ ......++..|.|||.+.+. .++.++|+||+|++++++++|+.
T Consensus 120 ~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 197 (283)
T cd05118 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197 (283)
T ss_pred eecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999998876543321 11223467789999998876 78999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcc----------cc---cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVD----------AR---LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
||............................. .. .........+..+.++|.+||..||.+||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l 277 (283)
T cd05118 198 LFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA 277 (283)
T ss_pred CCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence 9965432211111000000000000000000 00 0001123456789999999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
+.
T Consensus 278 l~ 279 (283)
T cd05118 278 LA 279 (283)
T ss_pred hh
Confidence 86
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=227.14 Aligned_cols=215 Identities=20% Similarity=0.240 Sum_probs=157.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|||++++++++.++...+++|||+. ++|.+++...... .+++..++.++.|++.||.|||+.+ +
T Consensus 52 l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~~L~~lH~~~---~ 120 (283)
T cd07835 52 LKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLT-------GLDPPLIKSYLYQLLQGIAYCHSHR---V 120 (283)
T ss_pred HHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999995 5999998765432 2899999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..
T Consensus 121 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 198 (283)
T cd07835 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198 (283)
T ss_pred eCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998754322111 1222457789999987654 56889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcc---------hhhhhcccc---cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSED---------KVRQCVDAR---LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
||...................... ......... .........+..+.+++.+||+.+|.+|||+++++
T Consensus 199 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 199 LFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 997543211100000000000000 000000000 00011223346799999999999999999999998
Q ss_pred H
Q 025816 229 K 229 (247)
Q Consensus 229 ~ 229 (247)
+
T Consensus 279 ~ 279 (283)
T cd07835 279 Q 279 (283)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=241.79 Aligned_cols=214 Identities=26% Similarity=0.393 Sum_probs=179.6
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCC-CCCCCCC----C--CCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK-GVKGAQP----G--PVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~----~--~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
-+|+||+.++|.|..+...++|+||+..|+|.+++.... ....... . ..++....+.++.||+.|+.||++..
T Consensus 359 g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~ 438 (609)
T KOG0200|consen 359 GKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP 438 (609)
T ss_pred cCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC
Confidence 379999999999999999999999999999999998776 1111111 1 34999999999999999999999998
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccc-cceeccccccCchhhhcCCCCccccchhhhHHHHHHH
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 156 (247)
++|||+..+|||++.+..+||+|||+++...+....... ....-...|+|||.+....|+.++||||+|+++||++
T Consensus 439 ---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eif 515 (609)
T KOG0200|consen 439 ---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIF 515 (609)
T ss_pred ---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHh
Confidence 999999999999999999999999999865444333211 1111355699999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 157 T-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 157 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
+ |..||.+. .....+.+.+.++.+...|..++.+++++++.||+.+|.+||++.++.+.+...+
T Consensus 516 sLG~~PYp~~---------------~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 516 TLGGTPYPGI---------------PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred hCCCCCCCCC---------------CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 9 99999631 1134446678888889999999999999999999999999999999999999865
Q ss_pred h
Q 025816 236 N 236 (247)
Q Consensus 236 ~ 236 (247)
+
T Consensus 581 ~ 581 (609)
T KOG0200|consen 581 Q 581 (609)
T ss_pred H
Confidence 4
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=231.47 Aligned_cols=216 Identities=22% Similarity=0.338 Sum_probs=157.4
Q ss_pred CcccccCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 1 MVSRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+|++++||||+++++++.. ....++||||+. ++|.+++..... +++..+..++.|++.||.|||+.
T Consensus 57 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~ 126 (334)
T cd07855 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQP---------LTEEHIRYFLYQLLRGLKYIHSA 126 (334)
T ss_pred HHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCC---------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 3678899999999998753 346899999996 599998865432 89999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc--ccccceeccccccCchhhhc-CCCCccccchhhhHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ 153 (247)
+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+ ..++.++|+||+|+++|
T Consensus 127 ~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~ 203 (334)
T cd07855 127 N---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFA 203 (334)
T ss_pred C---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHH
Confidence 9 999999999999999999999999998754332211 11123357888999998865 45789999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCc--------chhhhhccccc-CCCC-----CHHHHHHHHHHHHhhcccCCC
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSE--------DKVRQCVDARL-GGDY-----PPKAVAKMAAVAALCVQYEAD 219 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~~p~ 219 (247)
+|++|..||...+...............+. ..+.+...... .... ....+.++.+++.+||+.+|.
T Consensus 204 el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 283 (334)
T cd07855 204 EMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPE 283 (334)
T ss_pred HHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChh
Confidence 999999999754332111111111111111 11111111000 0011 123467799999999999999
Q ss_pred CCCCHHHHHH
Q 025816 220 FRPNMSIVVK 229 (247)
Q Consensus 220 ~Rps~~~il~ 229 (247)
+|||+++++.
T Consensus 284 ~Rpt~~~~l~ 293 (334)
T cd07855 284 ERITVEQALQ 293 (334)
T ss_pred hCcCHHHHHh
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=219.40 Aligned_cols=200 Identities=23% Similarity=0.306 Sum_probs=159.4
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++|+||+++++.+.+. ...++++||+.+++|.+++.... .+++..+..++.|+++||.|||+++
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~al~~LH~~~-- 126 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---------ALTENVTRRYTRQILQGVSYLHSNM-- 126 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 6788999999999998764 46889999999999999986543 2788899999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|+||+++.++.++|+|||+++......... ......++..|+|||.+.+..++.++|+||||++++++++|
T Consensus 127 -i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 205 (264)
T cd06653 127 -IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTE 205 (264)
T ss_pred -EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999988653221110 11223477889999999888889999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||..... ...+.+..........+...+..+.+++.+||. +|..|||+.+++.
T Consensus 206 ~~p~~~~~~---------------~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 206 KPPWAEYEA---------------MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCccCH---------------HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 999964311 112222222223344566677889999999999 5799999998876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=224.34 Aligned_cols=199 Identities=25% Similarity=0.381 Sum_probs=155.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+|++++++++..+...++||||+. |++.+.+..... .++...+..++.|++.|+.|||+.+ +
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH~~~---i 136 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---M 136 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 578899999999999999999999999996 588887754321 2888999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh---cCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||+++.++.++|+|||++...... ....++..|+|||.+. ...++.++|+||||++++++++|
T Consensus 137 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 210 (308)
T cd06634 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (308)
T ss_pred ccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcC
Confidence 99999999999999999999999988654221 2234677899999875 34578899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
..||...+... ..................+..+.++|.+||..+|.+|||++++++..-.
T Consensus 211 ~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 211 KPPLFNMNAMS---------------ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred CCCCccccHHH---------------HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 99985432110 0111111111111223455679999999999999999999999986433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=219.21 Aligned_cols=183 Identities=21% Similarity=0.237 Sum_probs=148.7
Q ss_pred cccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 025816 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 83 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h 83 (247)
...||||+++++++......+++|||+.+|+|.+++..... +++..+..++.|+++||.|||+.+ ++|
T Consensus 41 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~ql~~~l~~lH~~~---i~H 108 (237)
T cd05576 41 PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN---------IPEECVKRWAAEMVVALDALHREG---IVC 108 (237)
T ss_pred hcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC---------CCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 34699999999999999999999999999999999865432 899999999999999999999999 999
Q ss_pred ccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCC
Q 025816 84 RDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163 (247)
Q Consensus 84 ~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 163 (247)
+||||+||+++.++.++++|||.+....... ....++..|+|||...+..++.++|+||+|+++|++++|..|+.
T Consensus 109 ~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 109 RDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 9999999999999999999999876543221 12234567999999888888999999999999999999998874
Q ss_pred CCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 025816 164 HTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM 224 (247)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 224 (247)
...... ........+...+..+.+++.+||+.||.+|||+
T Consensus 184 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 184 CHPSGI---------------------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cCchhc---------------------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 221100 0000112333445679999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=217.66 Aligned_cols=198 Identities=29% Similarity=0.449 Sum_probs=160.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+|++++++++.+++..+++||++.+++|.+++.... .+++..+..++.|++.++.+||+.+ +
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---i 120 (254)
T cd06627 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQG---V 120 (254)
T ss_pred HHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---c
Confidence 578899999999999999999999999999999999987653 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+......... .....++..|.|||...+..++.++|+|++|++++++++|..|
T Consensus 121 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p 198 (254)
T cd06627 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198 (254)
T ss_pred ccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998865433221 1234567889999999887789999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|....... ..... ........+...+..+.+++.+||..+|.+|||+.+++.
T Consensus 199 ~~~~~~~~---------------~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 199 YYDLNPMA---------------ALFRI-VQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCccHHH---------------HHHHH-hccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 86432110 00000 011112233344667999999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=222.65 Aligned_cols=216 Identities=21% Similarity=0.265 Sum_probs=157.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..++..++||||+.+ +|.+++..... ...+++..+..++.|++.||.|||+.+ +
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 121 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGV------RGALDPNTVKSFTYQLLKGIAFCHENR---V 121 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCC------CCCcCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5788999999999999999999999999975 89888765431 123899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+. .++.++|+||+|++++++++|..
T Consensus 122 ~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (284)
T cd07836 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199 (284)
T ss_pred eeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999875432111 11223457789999988663 57889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcc-cccC-----------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVD-ARLG-----------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
||...+...................+..... +... .......+..+.+++.+||+.||.+|||+++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 279 (284)
T cd07836 200 LFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279 (284)
T ss_pred CCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence 9976543211111000000011111110000 0000 011123356789999999999999999999998
Q ss_pred H
Q 025816 229 K 229 (247)
Q Consensus 229 ~ 229 (247)
+
T Consensus 280 ~ 280 (284)
T cd07836 280 Q 280 (284)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=229.99 Aligned_cols=223 Identities=23% Similarity=0.297 Sum_probs=164.1
Q ss_pred cccccCCCccceeeEEeeCC-----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 2 VSRLKHENFVQLLGYCVDGT-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+++++|+||+++++++.... ..+++|||+. ++|.+++.... .+++..+..++.|++.||.+||+.
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~ 122 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSA 122 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 57789999999999988775 7899999997 48998886543 289999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcC-CCCccccchhhhHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~ 154 (247)
+ ++|+||+|.||+++.++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||+|+++++
T Consensus 123 g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~ 199 (330)
T cd07834 123 N---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAE 199 (330)
T ss_pred C---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHH
Confidence 9 999999999999999999999999998865443210 112234567889999999887 78999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCc--------chhhhhccccc-C-----CCCCHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSE--------DKVRQCVDARL-G-----GDYPPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~-----~~~~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|..||..................... ......+.... . .......+..+.+++.+||+.+|.+
T Consensus 200 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 279 (330)
T cd07834 200 LLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKK 279 (330)
T ss_pred HHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhh
Confidence 99999999765432111111110011110 00111111000 0 0011234667999999999999999
Q ss_pred CCCHHHHHH--HHHHhHhc
Q 025816 221 RPNMSIVVK--ALQPLLNA 237 (247)
Q Consensus 221 Rps~~~il~--~l~~~~~~ 237 (247)
|||+++++. +++.....
T Consensus 280 Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 280 RITADEALAHPYLAQLHDP 298 (330)
T ss_pred CCCHHHHHhCccHHhhccc
Confidence 999999998 46655543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=224.25 Aligned_cols=216 Identities=16% Similarity=0.208 Sum_probs=154.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..+...++||||+. ++|.+.+....... +.+..+..++.|++.||.|||+++
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~-------~~~~~~~~~~~qi~~aL~~LH~~~--- 122 (294)
T PLN00009 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFA-------KNPRLIKTYLYQILRGIAYCHSHR--- 122 (294)
T ss_pred HHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCC-------cCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678899999999999999999999999996 58888876544322 678888899999999999999999
Q ss_pred eEeccCCCCceeecC-CCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|+||+++. ++.++|+|||++......... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|
T Consensus 123 i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg 200 (294)
T PLN00009 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200 (294)
T ss_pred eeCCCCCcceEEEECCCCEEEEcccccccccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999985 457999999998754332111 122345778999998866 3578899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhh------hhc--ccccCC----CCCHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVR------QCV--DARLGG----DYPPKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
..||...+...................+. ... ...... ......+..+.+++.+||..+|.+||++.+
T Consensus 201 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~ 280 (294)
T PLN00009 201 KPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280 (294)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHH
Confidence 99997543221111000000000000000 000 000000 011233566899999999999999999999
Q ss_pred HHH
Q 025816 227 VVK 229 (247)
Q Consensus 227 il~ 229 (247)
+++
T Consensus 281 ~l~ 283 (294)
T PLN00009 281 ALE 283 (294)
T ss_pred Hhc
Confidence 997
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=218.18 Aligned_cols=213 Identities=22% Similarity=0.292 Sum_probs=156.1
Q ss_pred ccccCCCccceeeEEeeCCe-----eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 3 SRLKHENFVQLLGYCVDGTS-----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
++++|+|++++++++..... .+++|||+.+ +|.+++...... .+++..++.++.|++.||.+||+.+
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~~~ 127 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLHSHR 127 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45579999999999988776 8999999974 898888654322 2899999999999999999999999
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
++|+|++|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 128 ---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~ 201 (287)
T cd07838 128 ---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR 201 (287)
T ss_pred ---eeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHh
Confidence 99999999999999999999999999876533221 122346778999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhcccc-----CCcch--hhhhcccccC---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPK-----LSEDK--VRQCVDARLG---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
|.+||.................. +.... .......... .......+..+.+++.+||..||.+||+++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i 281 (287)
T cd07838 202 RRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281 (287)
T ss_pred CCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH
Confidence 99998754322110000000000 00000 0000000000 11122445678999999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
+.
T Consensus 282 l~ 283 (287)
T cd07838 282 LQ 283 (287)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=222.97 Aligned_cols=196 Identities=27% Similarity=0.404 Sum_probs=153.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|||++++++++.++...+++|||+. +++.+++..... ++++..+..++.|++.+|.|||+.+ +
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH~~g---i 142 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---M 142 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 578899999999999999999999999996 588888764332 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh---cCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||+++.++.++|+|||.+..... .....++..|+|||.+. ...++.++|+||+|+++++|++|
T Consensus 143 ~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred ecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999998764321 12345778899999874 34678899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..||...+..... ................+..+.+++.+||+.+|.+|||+.+++..
T Consensus 217 ~~p~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 217 KPPLFNMNAMSAL---------------YHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCCCChHHHH---------------HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9998644221110 00000000011122334568999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=218.37 Aligned_cols=194 Identities=25% Similarity=0.309 Sum_probs=157.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++.+..+...+++|||+.+++|.+++..... +++..+..++.|++.|+.+||+.+ +
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lh~~~---~ 114 (250)
T cd05123 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR---------FSEERARFYAAEIVLALEYLHSLG---I 114 (250)
T ss_pred HHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5788999999999999999999999999988999999976532 899999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+........ ......++..|++||...+...+.++|+|+||++++++++|..|
T Consensus 115 ~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p 192 (250)
T cd05123 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192 (250)
T ss_pred eecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999876533211 12334567789999999888889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
|...+.. ........ .....+...+..+.+++.+||..||.+|||+.+
T Consensus 193 ~~~~~~~---------------~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 193 FYAEDRK---------------EIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCHH---------------HHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 9644320 00111111 112233344677999999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=223.16 Aligned_cols=218 Identities=18% Similarity=0.213 Sum_probs=153.6
Q ss_pred cccc-cCCCccceeeEEeeCCe-----eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRL-KHENFVQLLGYCVDGTS-----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
++++ +||||+++++++..... .+++|||+.+ +|.+++...... .+..+++..++.++.|++.||.|||+
T Consensus 54 l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~ 128 (295)
T cd07837 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHK 128 (295)
T ss_pred HHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4556 46999999999887665 8999999985 898888654321 12348999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecC-CCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ 153 (247)
.+ ++|+||+|+||+++. ++.++|+|||++......... .....++..|.|||.+.+ ..++.++|+||+|+++|
T Consensus 129 ~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~ 203 (295)
T cd07837 129 HG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFA 203 (295)
T ss_pred CC---eeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHH
Confidence 99 999999999999998 889999999998754322111 122245778999998865 45789999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhc---c----cccC----CCCCHHHHHHHHHHHHhhcccCCCCCC
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV---D----ARLG----GDYPPKAVAKMAAVAALCVQYEADFRP 222 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~----~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rp 222 (247)
+|++|..||............................ . .... .......+..+.++|.+||..||.+||
T Consensus 204 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~ 283 (295)
T cd07837 204 EMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI 283 (295)
T ss_pred HHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC
Confidence 9999999997543221110000000000000000000 0 0000 001123456799999999999999999
Q ss_pred CHHHHHH
Q 025816 223 NMSIVVK 229 (247)
Q Consensus 223 s~~~il~ 229 (247)
|+++++.
T Consensus 284 ~~~eil~ 290 (295)
T cd07837 284 SAKAALT 290 (295)
T ss_pred CHHHHhc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=222.96 Aligned_cols=214 Identities=20% Similarity=0.227 Sum_probs=153.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..+...++||||+. +++.+.+..... .+++..+..++.|++.||.|||+.+ +
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i 124 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIHGQH---I 124 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 578899999999999999999999999996 588777654332 1778888999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+ ..++.++|+||||++++++++|..
T Consensus 125 ~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 202 (291)
T cd07870 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202 (291)
T ss_pred ccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999988754322111 122346788999998875 357889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhcccc-CCcch----------hhhhcccccCCC-----CCHHHHHHHHHHHHhhcccCCCCCCCH
Q 025816 161 PVDHTLPRGQQSLVTWATPK-LSEDK----------VRQCVDARLGGD-----YPPKAVAKMAAVAALCVQYEADFRPNM 224 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~ 224 (247)
||.............+.... ..... ............ .....+..+.+++.+|+..||.+|||+
T Consensus 203 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~ 282 (291)
T cd07870 203 AFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA 282 (291)
T ss_pred CCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH
Confidence 99754321110000000000 00000 000000000000 000124568899999999999999999
Q ss_pred HHHHH
Q 025816 225 SIVVK 229 (247)
Q Consensus 225 ~~il~ 229 (247)
.+++.
T Consensus 283 ~~~l~ 287 (291)
T cd07870 283 QDALL 287 (291)
T ss_pred HHHhc
Confidence 99875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=214.67 Aligned_cols=198 Identities=26% Similarity=0.373 Sum_probs=154.4
Q ss_pred cccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 025816 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 83 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h 83 (247)
.-..|+||+.||+|..+...++.||.+.. .+.+++.+... ++++..+-++...+++||.||..+. +|+|
T Consensus 147 s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKeKH--~viH 215 (391)
T KOG0983|consen 147 SHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKEKH--GVIH 215 (391)
T ss_pred ccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHHhc--ceee
Confidence 33469999999999999999999998853 66666665442 3999999999999999999998764 4999
Q ss_pred ccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc---CCCCccccchhhhHHHHHHHhCCC
Q 025816 84 RDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 84 ~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
||+||+|||++..|.+|++|||++-...+.... ....|-..|+|||.+.- ..|+.++||||||++++++.||..
T Consensus 216 RDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~y 292 (391)
T KOG0983|consen 216 RDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQY 292 (391)
T ss_pred cccCccceEEccCCCEEeecccccceeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccC
Confidence 999999999999999999999998766544433 33457778999999864 468999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||.+.+.. .+.+..+++..- .......++.++.+++..||++|+++||...++++
T Consensus 293 Py~~c~td--------------Fe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 293 PYKGCKTD--------------FEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCCCcc--------------HHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 99764321 111111111000 00111236788999999999999999999999887
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=220.02 Aligned_cols=202 Identities=21% Similarity=0.330 Sum_probs=158.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++......+++|||+.+++|.+++..... .+..+++..++.++.|++.|+.|||+.+ +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i 127 (260)
T cd08222 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKH-----TGKTLSENQVCEWFIQLLLGVHYMHQRR---I 127 (260)
T ss_pred HHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhh-----cccccCHHHHHHHHHHHHHHHHHHHHcC---c
Confidence 5678999999999999999999999999999999998864221 1123899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+|++|+||+++. +.++|+|||.+......... .....++..|.|||...+..++.++|+||+|++++++++|..|
T Consensus 128 ~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~ 204 (260)
T cd08222 128 LHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA 204 (260)
T ss_pred cccCCChhheEeec-CCEeecccCceeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999975 56999999988754332211 1233467789999999888889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|...... ..... .........+...+.++.++|.+||..+|.+||++.++++.
T Consensus 205 ~~~~~~~---------------~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 205 FEGQNFL---------------SVVLR-IVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCccHH---------------HHHHH-HHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 8532110 00011 11111223345667789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=227.49 Aligned_cols=215 Identities=24% Similarity=0.285 Sum_probs=156.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..++..+++|||+. ++|.+++..... ++......++.|++.||.+||+.+ +
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~ql~~aL~~LH~~~---i 140 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR---------LTESQVKCILLQILNGLNVLHKWY---F 140 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 578999999999999999999999999997 599999865432 889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhh------------cccccceeccccccCchhhhcC-CCCccccchhh
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA------------RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSF 148 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvwsl 148 (247)
+|+||+|+||+++.++.++|+|||.+........ ........++..|+|||.+.+. .++.++|+|||
T Consensus 141 ~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 220 (335)
T PTZ00024 141 MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220 (335)
T ss_pred ecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence 9999999999999999999999999876541110 0011122357789999988764 46889999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcc--------cccC---CCCCHHHHHHHHHHHHhhcccC
Q 025816 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD--------ARLG---GDYPPKAVAKMAAVAALCVQYE 217 (247)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~l~~li~~cl~~~ 217 (247)
|+++++|++|..||...+...................+.+... .... .......+..+.+++.+||+.+
T Consensus 221 G~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 300 (335)
T PTZ00024 221 GCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLN 300 (335)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCC
Confidence 9999999999999976543211110000000000000000000 0000 0011223567899999999999
Q ss_pred CCCCCCHHHHHH
Q 025816 218 ADFRPNMSIVVK 229 (247)
Q Consensus 218 p~~Rps~~~il~ 229 (247)
|.+|||+++++.
T Consensus 301 P~~R~s~~~~l~ 312 (335)
T PTZ00024 301 PLERISAKEALK 312 (335)
T ss_pred chhccCHHHHhc
Confidence 999999999997
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=223.39 Aligned_cols=214 Identities=22% Similarity=0.280 Sum_probs=154.3
Q ss_pred cccccCCCccceeeEEeeCC----------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHH
Q 025816 2 VSRLKHENFVQLLGYCVDGT----------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 71 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 71 (247)
+++++||||+++++++.+.. ..++++||+.+ ++.+.+..... .+++..++.++.|++.||+
T Consensus 60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~ 130 (302)
T cd07864 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLV--------HFSEDHIKSFMKQLLEGLN 130 (302)
T ss_pred HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHH
Confidence 57889999999999987655 78999999975 78887765421 2899999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhH
Q 025816 72 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGV 150 (247)
Q Consensus 72 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~ 150 (247)
|||+.+ ++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+ ..++.++|+||+|+
T Consensus 131 ~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 206 (302)
T cd07864 131 YCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 206 (302)
T ss_pred HHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHH
Confidence 999999 999999999999999999999999998765432211 1122335667999998865 35688999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcc--------------cccCCCCCHHHHHHHHHHHHhhccc
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD--------------ARLGGDYPPKAVAKMAAVAALCVQY 216 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~ 216 (247)
++++|++|+.||............................. ...+.. ....+..+.+++.+||+.
T Consensus 207 ~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~ 285 (302)
T cd07864 207 ILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTL 285 (302)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccC
Confidence 99999999999975432211111111100000000000000 000000 112356799999999999
Q ss_pred CCCCCCCHHHHHH
Q 025816 217 EADFRPNMSIVVK 229 (247)
Q Consensus 217 ~p~~Rps~~~il~ 229 (247)
+|.+|||++++++
T Consensus 286 ~P~~Rp~~~~il~ 298 (302)
T cd07864 286 DPSKRCTAEEALN 298 (302)
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=222.22 Aligned_cols=199 Identities=24% Similarity=0.344 Sum_probs=160.6
Q ss_pred ccccc-CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++ |+||+++++++..++..+++||++.+++|.+++.... .+++..++.++.|++.||.+||+.+
T Consensus 55 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~~--- 122 (280)
T cd05581 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSKG--- 122 (280)
T ss_pred HHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 45677 9999999999999999999999999999999997653 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc------------------ccccceeccccccCchhhhcCCCCcc
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR------------------LHSTRVLGTFGYHAPEYAMTGQLNAK 142 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 142 (247)
++|+||+|+||+++.++.++++|||++......... .......++..|+|||......++.+
T Consensus 123 ~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~ 202 (280)
T cd05581 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS 202 (280)
T ss_pred eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh
Confidence 999999999999999999999999998765433221 11123346788999999988888999
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC
Q 025816 143 SDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP 222 (247)
Q Consensus 143 ~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 222 (247)
+|+||||++++++++|..||...... ....... ......+...+..+.+++.+||+.+|.+||
T Consensus 203 ~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 265 (280)
T cd05581 203 SDLWALGCIIYQMLTGKPPFRGSNEY---------------LTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265 (280)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCccHH---------------HHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCC
Confidence 99999999999999999999744310 0011111 111223344467799999999999999999
Q ss_pred CH----HHHHH
Q 025816 223 NM----SIVVK 229 (247)
Q Consensus 223 s~----~~il~ 229 (247)
|+ +++++
T Consensus 266 ~~~~~~~~ll~ 276 (280)
T cd05581 266 GVNEGYDELKA 276 (280)
T ss_pred CcccCHHHHhc
Confidence 99 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=223.33 Aligned_cols=204 Identities=29% Similarity=0.373 Sum_probs=152.2
Q ss_pred ccccc-CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-CCC
Q 025816 2 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADP 79 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~-~~~ 79 (247)
++++. |+||+++++++..+...+++|||+.. ++.++....... ....+++..+..++.|++.||.|||+. +
T Consensus 56 l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-- 128 (288)
T cd06616 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEV----LKSVIPEEILGKIAVATVKALNYLKEELK-- 128 (288)
T ss_pred HHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhcCC--
Confidence 34554 99999999999999999999999864 666544321100 011289999999999999999999975 7
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC---CCCccccchhhhHHHHHHH
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~~l~ 156 (247)
++||||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+|+++++++
T Consensus 129 -i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 204 (288)
T cd06616 129 -IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVA 204 (288)
T ss_pred -eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHH
Confidence 99999999999999999999999999865432211 1223467789999998765 6889999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcc---cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD---ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
+|..||..... .. ..+.+... +......+...+..+.+++.+||+.+|.+|||+++|++.
T Consensus 205 ~g~~p~~~~~~-----~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 205 TGKFPYPKWNS-----VF---------DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hCCCCchhcch-----HH---------HHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999964321 00 00011000 111112223456679999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=219.12 Aligned_cols=207 Identities=16% Similarity=0.180 Sum_probs=152.5
Q ss_pred ccccCCCccceeeEEeeCC----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 3 SRLKHENFVQLLGYCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+.+.|+|++.+++.+.... ..+++++++. .++.+.+..... .++..+..++.|++.||.|||+.+
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~- 146 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKC---------KNKKLIKNIMKDMLTTLEYIHEHG- 146 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhcc---------CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4678999999998765543 3478888875 377777654321 567788999999999999999999
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhc-----ccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
++||||||+||+++.++.++|+|||+++........ .......||..|+|||...+..++.++||||+|++++
T Consensus 147 --iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~ 224 (294)
T PHA02882 147 --ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCML 224 (294)
T ss_pred --eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 999999999999999999999999998765321111 1112245899999999999989999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
+|++|..||............. ..+.+.+...... ....++..+.+++..||..+|.+||++.++++.+
T Consensus 225 el~~g~~P~~~~~~~~~~~~~~------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 225 KWAGIKLPWKGFGHNGNLIHAA------KCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhCCCCCCccccchHHHHHh------HHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9999999997542211100000 0000111111111 1123357799999999999999999999999876
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=221.49 Aligned_cols=215 Identities=22% Similarity=0.302 Sum_probs=157.0
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++|+|++++++++... ...++||||+.+ +|.+++..... .+++..++.++.|+++|+.+||+.+
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~i~~al~~LH~~~-- 120 (287)
T cd07840 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEV--------KFTESQIKCYMKQLLEGLQYLHSNG-- 120 (287)
T ss_pred HHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5678999999999999888 789999999975 89988865421 2899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+ ..++.++|+||||+++++|++|
T Consensus 121 -~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 121 -ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred -ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765433211 1122345778999997765 4578999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhh--------------cccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQC--------------VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM 224 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 224 (247)
..||.......................+... ............++..+.+++.+||..+|.+|||+
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 278 (287)
T cd07840 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278 (287)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 9999755432111111000000000000000 00000000111125679999999999999999999
Q ss_pred HHHHH
Q 025816 225 SIVVK 229 (247)
Q Consensus 225 ~~il~ 229 (247)
+++++
T Consensus 279 ~~~l~ 283 (287)
T cd07840 279 DQALQ 283 (287)
T ss_pred HHHhh
Confidence 99986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=219.74 Aligned_cols=214 Identities=22% Similarity=0.324 Sum_probs=156.4
Q ss_pred ccccc-CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++ |+|++++++++..+...++||||+ +++|.+.+...... .+++..+..++.|++.+|.|||+++
T Consensus 51 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~Lh~~~--- 119 (283)
T cd07830 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK-------PFSESVIRSIIYQILQGLAHIHKHG--- 119 (283)
T ss_pred HHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 45677 999999999999999999999999 67999988765422 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-cCCCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+. +..++.++|+||+|++++++++|.
T Consensus 120 i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~ 196 (283)
T cd07830 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196 (283)
T ss_pred cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCC
Confidence 999999999999999999999999998755332211 2234677899999875 345789999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcc----------hhhhhcccccC---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSED----------KVRQCVDARLG---GDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
.||...................... .+......... .......+.++.+++.+||+.+|.+|||+++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 276 (283)
T cd07830 197 PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276 (283)
T ss_pred CccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence 9996553321111000000000000 00000000000 0001112467999999999999999999999
Q ss_pred HHH
Q 025816 227 VVK 229 (247)
Q Consensus 227 il~ 229 (247)
+++
T Consensus 277 i~~ 279 (283)
T cd07830 277 ALQ 279 (283)
T ss_pred Hhh
Confidence 986
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=230.03 Aligned_cols=224 Identities=23% Similarity=0.328 Sum_probs=164.1
Q ss_pred CcccccCCCccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+|++|+|+|||+++++-++.. ...++||||.||||...++.-.+.. | |++...+.++.++..|+.|||
T Consensus 64 ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~----G--LpE~e~l~lL~d~~~al~~Lr 137 (732)
T KOG4250|consen 64 ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAY----G--LPESEFLDLLSDLVSALRHLR 137 (732)
T ss_pred HHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCccccc----C--CCHHHHHHHHHHHHHHHHHHH
Confidence 578999999999999866544 4689999999999999998766543 2 889999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCC--C--ceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhh
Q 025816 75 EKADPHIIHRDIKSSNVLIFDD--D--VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFG 149 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~--~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG 149 (247)
++| |+||||||.||++-.. | ..||+|||.|+...... ......||..|++||.+.. ..|+...|.||+|
T Consensus 138 En~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~G 211 (732)
T KOG4250|consen 138 ENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFG 211 (732)
T ss_pred HcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhh
Confidence 999 9999999999999432 3 58999999999765443 3456789999999999984 7899999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhcccc-CCcchhh---hhccccc----CCCCC----HHHHHHHHHHHHhhcccC
Q 025816 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPK-LSEDKVR---QCVDARL----GGDYP----PKAVAKMAAVAALCVQYE 217 (247)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~----~~~~~----~~~~~~l~~li~~cl~~~ 217 (247)
|++|+++||..||..........-.+|..-+ .+.+.+. +.-+..+ ...++ ......+...+..+|..+
T Consensus 212 vtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~ 291 (732)
T KOG4250|consen 212 VTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWN 291 (732)
T ss_pred hHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhh
Confidence 9999999999999765443211111111111 1111000 0000000 01112 222334666777789999
Q ss_pred CCCCC--CHHHHHHHHHHhHh
Q 025816 218 ADFRP--NMSIVVKALQPLLN 236 (247)
Q Consensus 218 p~~Rp--s~~~il~~l~~~~~ 236 (247)
|++|. .+.+..+.+..+++
T Consensus 292 ~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 292 PRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred HHHhCCCCcchHHHHHHHHHh
Confidence 99999 77777777777664
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-33 Score=229.43 Aligned_cols=197 Identities=24% Similarity=0.325 Sum_probs=165.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|+.|+|||||++|.+......+|+||||+.+|.+.+++..+.. .....+...+.|+++|+.|||+++
T Consensus 108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~--- 175 (596)
T KOG0586|consen 108 IMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKN--- 175 (596)
T ss_pred HHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcc---
Confidence 47899999999999999999999999999999999999988764 566888999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~ 159 (247)
|+|||||.+|++++.+.++||+|||.+..+.... .....+|++-|.|||++.+.+| .+.+|+|++|+++|-++.|.
T Consensus 176 ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~Gs 252 (596)
T KOG0586|consen 176 IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGS 252 (596)
T ss_pred eeccccchhhcccccccceeeeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecc
Confidence 9999999999999999999999999988765322 2355679999999999999887 57899999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
.||.+..-. +--...+.... ..+.-.+.++.++|+++|..+|.+|++.+++-+
T Consensus 253 LPFDG~~lk---------------~Lr~rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 253 LPFDGQNLK---------------ELRPRVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cccCCcccc---------------cccchheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 999754211 00111111111 234455678999999999999999999999876
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=219.18 Aligned_cols=205 Identities=22% Similarity=0.266 Sum_probs=157.8
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++ +||||+++++.+..+...++||||+.+++|.+.+.... .+++..+..++.|++.+|.+||+.+
T Consensus 58 l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~~--- 125 (288)
T cd05583 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQLG--- 125 (288)
T ss_pred HHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4566 59999999999999999999999999999999986532 2888999999999999999999998
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC--CCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|.||+++.++.++|+|||++......... ......++..|.|||.+.+.. .+.++|+||+|+++++|++|
T Consensus 126 ~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg 204 (288)
T cd05583 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204 (288)
T ss_pred eeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhC
Confidence 999999999999999999999999998754332211 112234678899999987654 78899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
..||......... .......... ....+...+..+.+++.+||+.+|.+|||+.++.+.++
T Consensus 205 ~~p~~~~~~~~~~-----------~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 205 ASPFTVDGEQNSQ-----------SEISRRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCCcccCcccchH-----------HHHHHHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 9999643221100 0000111111 12233445667999999999999999999877766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-33 Score=221.71 Aligned_cols=199 Identities=21% Similarity=0.288 Sum_probs=165.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||++++.+.||.+--.|++.+.+|+||..+.||+|.-.+...... -++++.++..+.+|+.||.+||..+
T Consensus 238 iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~-------gF~e~ra~FYAAEi~cGLehlH~~~--- 307 (591)
T KOG0986|consen 238 ILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNP-------GFDEQRARFYAAEIICGLEHLHRRR--- 307 (591)
T ss_pred HHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCC-------CCchHHHHHHHHHHHhhHHHHHhcc---
Confidence 567888999999988899999999999999999998888766532 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
||+||+||+|||+|+.|++.|+|+|+|..+...... ....||.+|+|||++.+..|+.+.|.|+|||++|+|+.|+.
T Consensus 308 iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~s 384 (591)
T KOG0986|consen 308 IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHS 384 (591)
T ss_pred eeeccCChhheeeccCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccC
Confidence 999999999999999999999999999977654433 44589999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
||....+... .+++.+.+ ......++..++++..++++.+|.+||.+|--.+
T Consensus 385 PFr~~KeKvk------------~eEvdrr~-~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 385 PFRQRKEKVK------------REEVDRRT-LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred chhhhhhhhh------------HHHHHHHH-hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 9974432221 11111111 0112346678888999999999999999987544
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=225.48 Aligned_cols=218 Identities=24% Similarity=0.317 Sum_probs=158.1
Q ss_pred CcccccCCCccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+|++++||||+++++++..+. ..++||||+ +++|.+++.... +++..+..++.|++.||.|||
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~al~~LH 135 (343)
T cd07880 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK----------LSEDRIQFLVYQMLKGLKYIH 135 (343)
T ss_pred HHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHH
Confidence 367899999999999987654 358999998 669988886432 899999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ 153 (247)
+.+ ++|+||+|+||+++.++.++|+|||++....... ....++..|+|||.+.+ ..++.++|+||+|++++
T Consensus 136 ~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~ 207 (343)
T cd07880 136 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA 207 (343)
T ss_pred hCC---eecCCCCHHHEEEcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence 999 9999999999999999999999999987543211 22346778999999876 45788999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCcc--------hhhhhcccc--cC----CCCCHHHHHHHHHHHHhhcccCCC
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSED--------KVRQCVDAR--LG----GDYPPKAVAKMAAVAALCVQYEAD 219 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--~~----~~~~~~~~~~l~~li~~cl~~~p~ 219 (247)
++++|..||...+.................. ......... .. .......+..+.+++.+|+..||.
T Consensus 208 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 287 (343)
T cd07880 208 EMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAE 287 (343)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChh
Confidence 9999999997543211110000000000000 000000000 00 001123345689999999999999
Q ss_pred CCCCHHHHHH--HHHHhHhc
Q 025816 220 FRPNMSIVVK--ALQPLLNA 237 (247)
Q Consensus 220 ~Rps~~~il~--~l~~~~~~ 237 (247)
+|||+.++++ +++.....
T Consensus 288 ~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 288 SRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hCCCHHHHhcCccHhhhcCc
Confidence 9999999995 66655443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=228.61 Aligned_cols=217 Identities=25% Similarity=0.328 Sum_probs=158.4
Q ss_pred cccccCCCccceeeEEeeCCe------eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDGTS------RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++||||+++.+++..+.. .++|+||+ +++|.+++.... +++..+..++.|++.||.+||+
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~ql~~aL~~LH~ 136 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK----------LSDDHIQFLVYQILRGLKYIHS 136 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 577899999999998866554 89999998 569999987532 8999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
.+ ++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++++
T Consensus 137 ~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~e 208 (343)
T cd07851 137 AG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208 (343)
T ss_pred CC---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHH
Confidence 99 999999999999999999999999998865332 122356778999998865 467899999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCc--------chhhhhccccc---CCCC---CHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSE--------DKVRQCVDARL---GGDY---PPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~---~~~~---~~~~~~~l~~li~~cl~~~p~~ 220 (247)
+++|..||..................... ......+.... .... ....+..+.+++.+||..+|.+
T Consensus 209 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~ 288 (343)
T cd07851 209 LLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDK 288 (343)
T ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhh
Confidence 99999999754332111111110011110 00000000000 0000 0123567999999999999999
Q ss_pred CCCHHHHHH--HHHHhHhc
Q 025816 221 RPNMSIVVK--ALQPLLNA 237 (247)
Q Consensus 221 Rps~~~il~--~l~~~~~~ 237 (247)
|||+.+|++ .++.....
T Consensus 289 Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 289 RITAAEALAHPYLAEYHDP 307 (343)
T ss_pred CCCHHHHhcCCCccccCCC
Confidence 999999988 45544433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=225.68 Aligned_cols=220 Identities=24% Similarity=0.309 Sum_probs=157.5
Q ss_pred cccccCCCccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++||||+++++++.... ..++++||+.. +|.+.+.. .+++..+..++.|++.||.|||+
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~ 135 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIHS 135 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999987543 46899999864 77766531 18889999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
.+ ++||||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||+|+++++
T Consensus 136 ~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~e 207 (342)
T cd07879 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAE 207 (342)
T ss_pred CC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHH
Confidence 99 999999999999999999999999998754221 122356778999999876 468889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccc---------c---cCCCC---CHHHHHHHHHHHHhhcccCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA---------R---LGGDY---PPKAVAKMAAVAALCVQYEAD 219 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~---~~~~~---~~~~~~~l~~li~~cl~~~p~ 219 (247)
|++|+.||.+.+............+... ....+.... . ..... .+..+..+.+++.+||+.||.
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 286 (342)
T cd07879 208 MLTGKTLFKGKDYLDQLTQILKVTGVPG-PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVD 286 (342)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCC-HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChh
Confidence 9999999975432111111011000000 000000000 0 00000 012345688999999999999
Q ss_pred CCCCHHHHHH--HHHHhHhcCCCCC
Q 025816 220 FRPNMSIVVK--ALQPLLNARPGPA 242 (247)
Q Consensus 220 ~Rps~~~il~--~l~~~~~~~~~~~ 242 (247)
+|||+++++. .++.+.+..+.+.
T Consensus 287 ~R~~~~e~l~h~~f~~~~~~~~~~~ 311 (342)
T cd07879 287 KRLTATEALEHPYFDSFRDADEETE 311 (342)
T ss_pred hCcCHHHHhcCcchhhcccccccCC
Confidence 9999999995 5877766544443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=229.60 Aligned_cols=196 Identities=26% Similarity=0.375 Sum_probs=158.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++|+|||++.+-|.|-.+...+||||||-| +-.|++.-.. +++-+..+..++.+.+.||+|||+.+ .
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhk--------KplqEvEIAAi~~gaL~gLaYLHS~~---~ 147 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHN---R 147 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHh--------ccchHHHHHHHHHHHHHHHHHHHHhh---H
Confidence 6789999999999999888999999999975 8888887655 23888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh---cCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|||||..|||++..|.|||+|||.+.... ..+.+.||+.|+|||++. .+.|+.++||||||++-.++...
T Consensus 148 IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAER 221 (948)
T KOG0577|consen 148 IHRDIKAGNILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 221 (948)
T ss_pred HhhhccccceEecCCCeeeeccccchhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhc
Confidence 999999999999999999999999876532 235678999999999985 35799999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|+..... ...+..+..+....-...+-++.++.++..||++-|++|||.+++++.
T Consensus 222 kPPlFnMNA---------------MSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 222 KPPLFNMNA---------------MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCccCchH---------------HHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 999642211 011111111100001134567789999999999999999999999874
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=218.24 Aligned_cols=196 Identities=26% Similarity=0.405 Sum_probs=150.0
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCCeEec
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHR 84 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~i~h~ 84 (247)
.||||+++++++..+...+++|||+. +++.+++..... .+++..+..++.|++.|+.|||+ .+ ++|+
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~ 139 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKHG---VIHR 139 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EecC
Confidence 59999999999999999999999985 478877765332 28899999999999999999997 47 9999
Q ss_pred cCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC----CCccccchhhhHHHHHHHhCCC
Q 025816 85 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 85 di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~~l~~g~~ 160 (247)
||+|+||+++.++.++|+|||++......... ....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..
T Consensus 140 dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (296)
T cd06618 140 DVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF 216 (296)
T ss_pred CCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999998754322211 2224667899999987543 7889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||...... . +.......... .......++..+.+++.+||..||.+|||++++++.
T Consensus 217 p~~~~~~~-~-------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 217 PYKNCKTE-F-------------EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCcchhH-H-------------HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99642111 0 00001111100 001111345679999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=220.48 Aligned_cols=216 Identities=24% Similarity=0.320 Sum_probs=152.2
Q ss_pred cccccCCCccceeeEEeeCC--------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRLKHENFVQLLGYCVDGT--------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
+++++||||+++++++.... ..+++|||+.+ ++.+.+..... .+++..+..++.|+++||.||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~l~~al~~l 131 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSV--------KLTESQIKCYMLQLLEGINYL 131 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHH
Confidence 67889999999999875433 46999999865 78777764321 289999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhccc---------ccceeccccccCchhhhcC-CCCccc
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH---------STRVLGTFGYHAPEYAMTG-QLNAKS 143 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~-~~~~~~ 143 (247)
|+.+ ++|+|++|+||+++.++.++|+|||++........... .....++..|+|||.+.+. .++.++
T Consensus 132 H~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 208 (311)
T cd07866 132 HENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV 208 (311)
T ss_pred HhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchh
Confidence 9999 99999999999999999999999999875433221111 1123457789999988653 578999
Q ss_pred cchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchh------hhhcccccCCCCC-------HHHHHHHHHHH
Q 025816 144 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV------RQCVDARLGGDYP-------PKAVAKMAAVA 210 (247)
Q Consensus 144 DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~l~~li 210 (247)
|+||+|+++|+|++|.+||.+...................... ............+ .....++.+++
T Consensus 209 Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 288 (311)
T cd07866 209 DIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLL 288 (311)
T ss_pred HhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHH
Confidence 9999999999999999999754432211111100000000000 0000000000000 12235689999
Q ss_pred HhhcccCCCCCCCHHHHHH
Q 025816 211 ALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 211 ~~cl~~~p~~Rps~~~il~ 229 (247)
.+||..+|.+|||+.+++.
T Consensus 289 ~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 289 SKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHcccCcccCcCHHHHhc
Confidence 9999999999999999885
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=216.23 Aligned_cols=214 Identities=25% Similarity=0.305 Sum_probs=157.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+|++++++++......+++|||+. ++|.+++..... .+++..+..++.|++.||.+||+.+ +
T Consensus 52 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i 119 (282)
T cd07829 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPG--------PLSPNLIKSIMYQLLRGLAYCHSHR---I 119 (282)
T ss_pred HHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999999999999999999997 599999986531 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+. .++.++|+||+|++++++++|..
T Consensus 120 ~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 197 (282)
T cd07829 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197 (282)
T ss_pred ccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765332211 1223346679999998766 78899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhh------------cccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQC------------VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
||.......................+... .............+..+.+++.+||..+|.+||++++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 277 (282)
T cd07829 198 LFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277 (282)
T ss_pred CCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence 99754321110000000000000000000 000000011112356799999999999999999999998
Q ss_pred H
Q 025816 229 K 229 (247)
Q Consensus 229 ~ 229 (247)
.
T Consensus 278 ~ 278 (282)
T cd07829 278 K 278 (282)
T ss_pred h
Confidence 6
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=225.22 Aligned_cols=219 Identities=21% Similarity=0.281 Sum_probs=152.6
Q ss_pred CcccccCCCccceeeEEeeC--------------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHH
Q 025816 1 MVSRLKHENFVQLLGYCVDG--------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 66 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 66 (247)
++++++||||+++++.+... ...+++|||+. ++|.+++.... +++..+..++.|+
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------l~~~~~~~~~~qi 123 (342)
T cd07854 55 IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGP----------LSEEHARLFMYQL 123 (342)
T ss_pred HHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcCC----------CCHHHHHHHHHHH
Confidence 36788999999999876543 35789999997 59988886433 8899999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCceeecC-CCceeeccccccCCcchhhhcc-cccceeccccccCchhhhc-CCCCccc
Q 025816 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMT-GQLNAKS 143 (247)
Q Consensus 67 ~~~l~~lh~~~~~~i~h~di~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~ 143 (247)
++||.|||+.+ ++|+||+|+||+++. ++.++++|||.+.......... ......++..|.|||.+.. ..++.++
T Consensus 124 ~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 200 (342)
T cd07854 124 LRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200 (342)
T ss_pred HHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchh
Confidence 99999999999 999999999999975 4578999999987543211111 1122346778999998764 4578899
Q ss_pred cchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhh-------hcc-cccCCC-----CCHHHHHHHHHHH
Q 025816 144 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ-------CVD-ARLGGD-----YPPKAVAKMAAVA 210 (247)
Q Consensus 144 DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~-~~~~~~-----~~~~~~~~l~~li 210 (247)
|+|||||++++|++|..||....+...........+......... ... ...... .....+.++.+++
T Consensus 201 DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 280 (342)
T cd07854 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFL 280 (342)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHH
Confidence 999999999999999999975432111110000000000000000 000 000000 1123456789999
Q ss_pred HhhcccCCCCCCCHHHHHH--HHHH
Q 025816 211 ALCVQYEADFRPNMSIVVK--ALQP 233 (247)
Q Consensus 211 ~~cl~~~p~~Rps~~~il~--~l~~ 233 (247)
.+||..||.+|||++++++ .++.
T Consensus 281 ~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 281 EQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHhCCCchhccCHHHHhCCCcccc
Confidence 9999999999999999996 4543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=234.89 Aligned_cols=210 Identities=26% Similarity=0.407 Sum_probs=187.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|.+|.|||++++++++..+. +-||.+|+.+|+|.++++.+... +..+..+.|..||++|+.|||++.
T Consensus 751 ~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~--------igsq~lLnw~~QIAkgM~YLe~qr--- 818 (1177)
T KOG1025|consen 751 RMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDN--------IGSQDLLNWCYQIAKGMKYLEEQR--- 818 (1177)
T ss_pred HHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhcc--------ccHHHHHHHHHHHHHHHHHHHhcc---
Confidence 378999999999999998776 77899999999999999986643 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++||||..+|||+.+...+|+.|||+++...............-.+.|+|-|.+....|+.++||||+|+++||++| |.
T Consensus 819 lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa 898 (1177)
T KOG1025|consen 819 LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGA 898 (1177)
T ss_pred hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCC
Confidence 99999999999999999999999999998766555444444445667999999999999999999999999999999 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
.|+.+ .+.+++...++.+.+.+.|+.++.++..++.+||..|+..||+++++.+.+.++.+.+
T Consensus 899 ~Py~g----------------i~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 899 KPYDG----------------IPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CccCC----------------CCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 99863 3567788888899999999999999999999999999999999999999999887665
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=223.74 Aligned_cols=210 Identities=26% Similarity=0.335 Sum_probs=152.5
Q ss_pred cccccCCCccceeeEEeeC------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDG------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++||||+++++++... ...+++++++ +++|.+++.... +++..+..++.|++.||.|||+
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~ 138 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHS 138 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 6788999999999988643 3467888887 679998886543 8899999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
.+ ++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||+|+++++
T Consensus 139 ~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e 210 (345)
T cd07877 139 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 210 (345)
T ss_pred CC---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHH
Confidence 99 999999999999999999999999998754321 123456788999998876 467889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccc--------cCCcchhhhhc---ccccCC---CCCHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATP--------KLSEDKVRQCV---DARLGG---DYPPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|..||...+............. ..........+ ...... ......+..+.++|.+|++.||.+
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 290 (345)
T cd07877 211 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 290 (345)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhh
Confidence 9999999965432111000000000 00000000100 000000 000123456899999999999999
Q ss_pred CCCHHHHHHH
Q 025816 221 RPNMSIVVKA 230 (247)
Q Consensus 221 Rps~~~il~~ 230 (247)
|||+.++++.
T Consensus 291 R~t~~e~l~h 300 (345)
T cd07877 291 RITAAQALAH 300 (345)
T ss_pred cCCHHHHhcC
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=223.12 Aligned_cols=211 Identities=23% Similarity=0.320 Sum_probs=154.2
Q ss_pred CcccccCCCccceeeEEee-CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
++++++||||+++++++.. +...++++||+. ++|.+++.... ++...+..++.|+++||.|||+.+
T Consensus 62 ~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~ql~~aL~~LH~~~-- 128 (328)
T cd07856 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLLTSRP----------LEKQFIQYFLYQILRGLKYVHSAG-- 128 (328)
T ss_pred HHHhcCCCCeeeEeeeEecCCCcEEEEeehhc-cCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 3578899999999998865 567899999984 69998886543 788889999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|.||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||+|++++++++|
T Consensus 129 -iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg 202 (328)
T cd07856 129 -VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202 (328)
T ss_pred -cccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999998753221 122345778999998765 5689999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcc--------c-ccCCCCC-----HHHHHHHHHHHHhhcccCCCCCCCH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD--------A-RLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNM 224 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~-~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~ 224 (247)
..||...................+.+....... . ......+ ...+..+.++|.+||+.+|.+|||+
T Consensus 203 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 282 (328)
T cd07856 203 KPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA 282 (328)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH
Confidence 999975432111111111001111111100000 0 0001111 1235679999999999999999999
Q ss_pred HHHHHH
Q 025816 225 SIVVKA 230 (247)
Q Consensus 225 ~~il~~ 230 (247)
++++..
T Consensus 283 ~ell~~ 288 (328)
T cd07856 283 AEALAH 288 (328)
T ss_pred HHHhcC
Confidence 999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=215.37 Aligned_cols=203 Identities=23% Similarity=0.288 Sum_probs=156.1
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++ +|+||+++++.+..+...++||||+.+++|.+++.... .++...+..++.|++.||.|||+.+
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~--- 125 (290)
T cd05613 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLHKLG--- 125 (290)
T ss_pred HHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4566 58999999999999999999999999999999987543 2888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC--CCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+... .++.++|+||+|+++|++++|
T Consensus 126 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g 204 (290)
T cd05613 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204 (290)
T ss_pred eeccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcC
Confidence 999999999999999999999999998764322111 11234577889999998753 467899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
..||......... ..+.+.+.. .....+...+..+.+++.+||..+|.+|| +++++++.
T Consensus 205 ~~p~~~~~~~~~~------------~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 205 ASPFTVDGEKNSQ------------AEISRRILK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCCCcCCccccH------------HHHHHHhhc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 9998643211110 011111100 01123344566799999999999999997 77888763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=214.92 Aligned_cols=205 Identities=15% Similarity=0.231 Sum_probs=155.7
Q ss_pred ccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 025816 10 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 89 (247)
Q Consensus 10 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~ 89 (247)
++++.++|...++.|+|+|.+ |-|+++++..+.... ++..++..++.|+++++++||+.+ ++|.|+||+
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~-------fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPE 221 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIP-------FPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPE 221 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccc-------cchHHHHHHHHHHHHHHHHHHhcc---eeecCCChh
Confidence 567788899999999999998 459999999887654 999999999999999999999999 999999999
Q ss_pred ceeecC--------------------CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhh
Q 025816 90 NVLIFD--------------------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFG 149 (247)
Q Consensus 90 nil~~~--------------------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 149 (247)
||++.+ +..++++|||-++...... .....|..|+|||++.+.+++.++||||+|
T Consensus 222 NILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiG 296 (415)
T KOG0671|consen 222 NILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIG 296 (415)
T ss_pred eEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeee
Confidence 999942 2347999999887643322 345678899999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhh-----cccc----------------cC--------CCCCH
Q 025816 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC-----VDAR----------------LG--------GDYPP 200 (247)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~----------------~~--------~~~~~ 200 (247)
|++.|+.+|...|+..+.......++.+.+..+..-+... ...+ .+ .....
T Consensus 297 CIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d 376 (415)
T KOG0671|consen 297 CILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDD 376 (415)
T ss_pred eEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCc
Confidence 9999999999999876521111111122221111111111 0000 00 01223
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 201 KAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 201 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
.....|++|+++||.+||.+|+|+.|+|..
T Consensus 377 ~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 377 LEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 556679999999999999999999999873
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=214.48 Aligned_cols=232 Identities=30% Similarity=0.420 Sum_probs=184.6
Q ss_pred cccCCCccceeeEEeeCC----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC--
Q 025816 4 RLKHENFVQLLGYCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-- 77 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~-- 77 (247)
.++|+||+++++.-.... .++||++|...|+|.+++..+. ++|.....++..++.||+|||+.-
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~ 329 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPR 329 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCc
Confidence 579999999999876554 7899999999999999999887 999999999999999999999652
Q ss_pred ----CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCC-----ccccchh
Q 025816 78 ----DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLN-----AKSDVYS 147 (247)
Q Consensus 78 ----~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~-----~~~Dvws 147 (247)
.++|+|||||.+|||+.+++...|+|||++................||.+|+|||++.+. ++. .+.||||
T Consensus 330 ~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYa 409 (534)
T KOG3653|consen 330 GDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYA 409 (534)
T ss_pred CCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHH
Confidence 567999999999999999999999999999877654444434457899999999999874 333 3689999
Q ss_pred hhHHHHHHHhCCCCCC-CCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCH-----HHHHHHHHHHHhhcccCCCC
Q 025816 148 FGVVLLELLTGRKPVD-HTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPP-----KAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 148 lG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~l~~li~~cl~~~p~~ 220 (247)
+|.++||+++.-.-+. +.-+..+.-+...+....+.+++++.+-... +...+. ....-+.+.+..||..||.-
T Consensus 410 mgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeA 489 (534)
T KOG3653|consen 410 MGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEA 489 (534)
T ss_pred HHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhh
Confidence 9999999999666554 3333444444455556666666666554433 222222 34556999999999999999
Q ss_pred CCCHHHHHHHHHHhHhcCCCCCCCC
Q 025816 221 RPNMSIVVKALQPLLNARPGPAGES 245 (247)
Q Consensus 221 Rps~~~il~~l~~~~~~~~~~~~~~ 245 (247)
|-|+.=+-+.+.++....+.+.+++
T Consensus 490 RLTA~Cv~eR~~~l~~~~~~~~~~s 514 (534)
T KOG3653|consen 490 RLTAGCVEERMAELMMLWEDSSGES 514 (534)
T ss_pred hhhhHHHHHHHHHHhccCCccCCcc
Confidence 9999999999999998887644443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=220.53 Aligned_cols=215 Identities=20% Similarity=0.236 Sum_probs=151.8
Q ss_pred cccc-cCCCccceeeEEeeC----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 2 VSRL-KHENFVQLLGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
++++ +||||+++++.+... ...+++++++. ++|.+.+.... .+++..+..++.|++.||.|||+.
T Consensus 55 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~ 124 (332)
T cd07857 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHSA 124 (332)
T ss_pred HHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3455 599999999875432 45788899886 59999886543 289999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc--ccccceeccccccCchhhhc-CCCCccccchhhhHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ 153 (247)
+ ++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+ ..++.++|+||+|++++
T Consensus 125 g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~ 201 (332)
T cd07857 125 N---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILA 201 (332)
T ss_pred C---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHH
Confidence 9 999999999999999999999999998754322111 11123457888999998765 46889999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcc-----------cccCC---CCCHHHHHHHHHHHHhhcccCCC
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD-----------ARLGG---DYPPKAVAKMAAVAALCVQYEAD 219 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~---~~~~~~~~~l~~li~~cl~~~p~ 219 (247)
++++|..||...+.................+....+.. ..... ......+..+.+++.+||+.||.
T Consensus 202 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 281 (332)
T cd07857 202 ELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT 281 (332)
T ss_pred HHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcc
Confidence 99999999975432111000000000000000000000 00000 01112346799999999999999
Q ss_pred CCCCHHHHHH
Q 025816 220 FRPNMSIVVK 229 (247)
Q Consensus 220 ~Rps~~~il~ 229 (247)
+|||+.++++
T Consensus 282 ~R~t~~~ll~ 291 (332)
T cd07857 282 KRISVEEALE 291 (332)
T ss_pred cCCCHHHHhc
Confidence 9999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=195.71 Aligned_cols=216 Identities=21% Similarity=0.275 Sum_probs=169.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|+.|+|+|||++++....++.+-+|+|||+. +|.++.....+. +..+.+..++.|++.|+.++|+.+
T Consensus 54 llkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~--------~d~~~~rsfmlqllrgl~fchshn--- 121 (292)
T KOG0662|consen 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGD--------LDPEIVRSFMLQLLRGLGFCHSHN--- 121 (292)
T ss_pred HHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCc--------CCHHHHHHHHHHHHhhhhhhhhhh---
Confidence 46789999999999999999999999999975 999998876654 889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHh-C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~-g 158 (247)
+.|||+||+|.+|+.+|.+|+.|||+++-++-...-. .....|.+|++|+++.+. -|+.+.|+||.||++.++.. |
T Consensus 122 vlhrdlkpqnllin~ngelkladfglarafgipvrcy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanag 199 (292)
T KOG0662|consen 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_pred hhhccCCcceEEeccCCcEEecccchhhhcCCceEee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcC
Confidence 9999999999999999999999999998764322111 223468899999999885 48999999999999999988 7
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhccc---ccCCCCC---------HHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA---RLGGDYP---------PKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
.+.|.+.+-.++...+-+.....+++.+..+..- ..-..++ +.....-++++.+.+.-+|..|.++++
T Consensus 200 rplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaea 279 (292)
T KOG0662|consen 200 RPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEA 279 (292)
T ss_pred CCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHH
Confidence 7778877766654444444444444433322111 1111111 233345688999999999999999998
Q ss_pred HHHH
Q 025816 227 VVKA 230 (247)
Q Consensus 227 il~~ 230 (247)
.++.
T Consensus 280 alqh 283 (292)
T KOG0662|consen 280 ALQH 283 (292)
T ss_pred HhcC
Confidence 8763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=206.16 Aligned_cols=198 Identities=30% Similarity=0.390 Sum_probs=160.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+||+++++++..+...++++|++.+++|.+++..... ++...++.++.+++.++.+||+.+ +
T Consensus 41 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lh~~~---i 108 (244)
T smart00220 41 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR---------LSEDEARFYARQILSALEYLHSNG---I 108 (244)
T ss_pred HHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHHcC---e
Confidence 4678999999999999999999999999998899999876442 788999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|.||+++.++.++++|||.+....... ......++..|++||...+..++.++|+|++|++++++++|..|
T Consensus 109 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 185 (244)
T smart00220 109 IHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPP 185 (244)
T ss_pred ecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999988764432 12334567789999999888889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHH--HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPK--AVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..... ...+.+............. .+.++.+++.+||..+|.+||++.++++
T Consensus 186 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 186 FPGDDQ---------------LLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCCc---------------HHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 864211 1111111111111111111 5567999999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=204.13 Aligned_cols=218 Identities=24% Similarity=0.381 Sum_probs=164.2
Q ss_pred CcccccCCCccceeeEEeeC--------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHH
Q 025816 1 MVSRLKHENFVQLLGYCVDG--------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 72 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 72 (247)
||..|+|+|++.++.+|... ..+++||.+|++ +|.-++...... ++...+.++..++++||.|
T Consensus 69 iL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr--------~sls~Ikk~Mk~Lm~GL~~ 139 (376)
T KOG0669|consen 69 ILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVR--------FSLSEIKKVMKGLMNGLYY 139 (376)
T ss_pred HHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCcccc--------ccHHHHHHHHHHHHHHHHH
Confidence 46789999999999888542 347999999987 999998766432 8999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc--ccccceeccccccCchhhhc-CCCCccccchhhh
Q 025816 73 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFG 149 (247)
Q Consensus 73 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG 149 (247)
+|.+. |+|||+|+.|+||+++|.++|.|||+++.+...... ..-..+..|.+|++||.+.| ..|+.+.|+|..|
T Consensus 140 iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAg 216 (376)
T KOG0669|consen 140 IHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAG 216 (376)
T ss_pred HHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence 99999 999999999999999999999999999765433221 11234556999999999987 5799999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcc--------hhhhhcccc-cC-CC--------CCHHHHHHHHHHHH
Q 025816 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED--------KVRQCVDAR-LG-GD--------YPPKAVAKMAAVAA 211 (247)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~-~~-~~--------~~~~~~~~l~~li~ 211 (247)
|++.+|+++.+.+.+..++.+-..+....+..+.+ .+.+.++.. +. .. .+.--.++..+++.
T Consensus 217 CimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle 296 (376)
T KOG0669|consen 217 CIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLE 296 (376)
T ss_pred HHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHH
Confidence 99999999999998876655433333222222211 111212100 00 00 01111347889999
Q ss_pred hhcccCCCCCCCHHHHHHH
Q 025816 212 LCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 212 ~cl~~~p~~Rps~~~il~~ 230 (247)
+++..||.+|+++.+++..
T Consensus 297 ~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 297 KLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHhccCcccCcchHhhhch
Confidence 9999999999999999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=206.38 Aligned_cols=216 Identities=23% Similarity=0.301 Sum_probs=181.6
Q ss_pred cccccCCCccceeeEEeeC-CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG-TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+..+.|||+.++.+++..+ ...+.++++...|+|..++..-.+.. ......++..+...++.|++.|+.|||+.+
T Consensus 341 ly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~-~~~aqtvtt~qlV~masQla~am~hlh~~~--- 416 (563)
T KOG1024|consen 341 LYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDD-PSYAQTVTTIQLVLMASQLAMAMEHLHNHG--- 416 (563)
T ss_pred HhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCC-CccccchhHHHHHHHHHHHHHHHHHHHhcC---
Confidence 4567899999999997654 57888999998899999998333221 122234888899999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|.||..+|++|++.-.+||+|-.+++..-..+.......-.....|++||.+.+..|+.++|+||||+++|||++ |+
T Consensus 417 ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~ 496 (563)
T KOG1024|consen 417 VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGK 496 (563)
T ss_pred cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999886544443333333345678999999999999999999999999999999 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
.|+... ...++...+..+.+...|.+++++++.++--||...|++||+++++..-|.++...
T Consensus 497 ~PyaeI----------------DPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 497 LPYAEI----------------DPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred CCcccc----------------CHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 998633 35677888888999999999999999999999999999999999999988887643
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=205.27 Aligned_cols=208 Identities=23% Similarity=0.348 Sum_probs=158.2
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
-|+||++++++|+++.+.|||||.+.||+|...++++.. +.+..+..+..+|+.||.+||.+| |.|||
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~kg---IAHRD 201 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH---------FNEREASRVVKDIASALDFLHTKG---IAHRD 201 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhcC---ccccc
Confidence 589999999999999999999999999999999988764 999999999999999999999999 99999
Q ss_pred CCCCceeecCCCc---eeeccccccCCcchhhh--cccc---cceeccccccCchhhhc-----CCCCccccchhhhHHH
Q 025816 86 IKSSNVLIFDDDV---AKIADFDLSNQAPDMAA--RLHS---TRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVL 152 (247)
Q Consensus 86 i~~~nil~~~~~~---~~l~d~g~~~~~~~~~~--~~~~---~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l 152 (247)
+||+|||.....+ +||+||++..-...... ...+ ....|+..|+|||++.- ..|+.+.|.||||+++
T Consensus 202 lKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIl 281 (463)
T KOG0607|consen 202 LKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVIL 281 (463)
T ss_pred CCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHH
Confidence 9999999977665 79999988654322111 1111 23457889999998742 2578999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC--CCCCH----HHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG--GDYPP----KAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
|-|++|.+||.+....+-. |.+...=..--..++++... -++|. ..+.+..+++..++..++..|-++.+
T Consensus 282 YImLsGYpPFvG~Cg~dCG----WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~ 357 (463)
T KOG0607|consen 282 YIMLSGYPPFVGHCGADCG----WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQ 357 (463)
T ss_pred HHHHhCCCCccCccCCcCC----ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhh
Confidence 9999999999876554321 11111110000111111111 12332 44678999999999999999999999
Q ss_pred HHH
Q 025816 227 VVK 229 (247)
Q Consensus 227 il~ 229 (247)
++.
T Consensus 358 vln 360 (463)
T KOG0607|consen 358 VLN 360 (463)
T ss_pred ccC
Confidence 987
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=208.01 Aligned_cols=212 Identities=19% Similarity=0.213 Sum_probs=167.4
Q ss_pred CcccccCCCccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
++..++|+||++++.+|+-.. ..|+|||+++. +|...+... +.=+.+..++.|++.|++|||
T Consensus 68 l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lh 135 (369)
T KOG0665|consen 68 LMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILME-----------LDHETISYILYQMLCGIKHLH 135 (369)
T ss_pred hhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHH
Confidence 356789999999999997654 46899999964 999999833 555788999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
+.+ |+|||+||+||++..+..+||.|||+++..... ........+..|+|||++-+.++.+.+||||+||++.+
T Consensus 136 s~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gE 209 (369)
T KOG0665|consen 136 SAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209 (369)
T ss_pred hcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHH
Confidence 999 999999999999999999999999999865332 22345567889999999999889999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccc------------------cC-------CCCCHHHHHHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR------------------LG-------GDYPPKAVAKMAAV 209 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~-------~~~~~~~~~~l~~l 209 (247)
|++|...|.+.+..++...+....+......+.++.... +. .+.+.-....+.++
T Consensus 210 li~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardl 289 (369)
T KOG0665|consen 210 LILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDL 289 (369)
T ss_pred HhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHH
Confidence 999999999888877765555544444432222211110 00 01111223458899
Q ss_pred HHhhcccCCCCCCCHHHHHHH
Q 025816 210 AALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 210 i~~cl~~~p~~Rps~~~il~~ 230 (247)
+.+||..||++|-|++++|..
T Consensus 290 l~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 290 LSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhccChhhcccHHHHhcC
Confidence 999999999999999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=220.99 Aligned_cols=193 Identities=21% Similarity=0.286 Sum_probs=164.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||..++.|.||++|-.|.++...|++||-|-||.||..+..+.. +....+..++..+++|+.|||..+
T Consensus 473 Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k~--- 540 (732)
T KOG0614|consen 473 IMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRKG--- 540 (732)
T ss_pred HHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhcC---
Confidence 46677899999999999999999999999999999999987654 788888889999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|++||+||+|++++.+|-+||.|||.+....... .+-.++||+.|.|||++.+.+.+.++|.||||+++|++++|.+
T Consensus 541 iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~p 617 (732)
T KOG0614|consen 541 IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSP 617 (732)
T ss_pred ceeccCChhheeeccCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999998765433 2345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 223 (247)
||.+.++-.... .++...-....|...+....++|+++...+|.+|--
T Consensus 618 PFs~~dpmktYn---------------~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 618 PFSGVDPMKTYN---------------LILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred CCCCCchHHHHH---------------HHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 998766432221 122222223466677778999999999999999976
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=209.85 Aligned_cols=187 Identities=25% Similarity=0.322 Sum_probs=158.1
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
+-|.++++...|.+-+++|+||||+.||+|--.+++... +.+..+...+..|+-||-+||++| |++||
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~kg---IiYRD 475 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSKG---IIYRD 475 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcCC---eeeee
Confidence 456777777778888899999999999999998887653 888899999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 165 (247)
+|.+|||++.+|.+||.|||++...- .....+...+||+.|+|||++.+.+|+.+.|.||+|+++|+|+.|++||.+.
T Consensus 476 LKLDNvmLd~eGHiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 476 LKLDNVMLDSEGHIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred ccccceEeccCCceEeeecccccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999997532 2223345678999999999999999999999999999999999999999876
Q ss_pred CCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC
Q 025816 166 LPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223 (247)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 223 (247)
++. +..+.+.+... .+|...+.+..++++..|.++|.+|--
T Consensus 554 DE~---------------elF~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 554 DED---------------ELFQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CHH---------------HHHHHHHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 532 22333333332 577788889999999999999999854
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=205.25 Aligned_cols=192 Identities=21% Similarity=0.263 Sum_probs=159.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++.+||.+..+--.|....++|+||||..||.|.-.+++... +++......-..|++||-|||+++
T Consensus 221 VL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~---------FsE~RtRFYGaEIvsAL~YLHs~~--- 288 (516)
T KOG0690|consen 221 VLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERV---------FSEDRTRFYGAEIVSALGYLHSRN--- 288 (516)
T ss_pred HHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhc---------ccchhhhhhhHHHHHHhhhhhhCC---
Confidence 46788999999998889999999999999999999888876543 888888888999999999999998
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|++||+|.+|.+++++|.+||+|||++...-. .......++||+.|+|||++....|..+.|.|.+|+++|+|++|+.
T Consensus 289 ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRL 366 (516)
T KOG0690|consen 289 IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRL 366 (516)
T ss_pred eeeeechhhhheeccCCceEeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccC
Confidence 99999999999999999999999999986422 2223456789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 223 (247)
||...+....-.++. .....+|...+.+...|+..+|.+||.+|--
T Consensus 367 PFyn~dh~kLFeLIl-----------------~ed~kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 367 PFYNKDHEKLFELIL-----------------MEDLKFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred cccccchhHHHHHHH-----------------hhhccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 997544322111111 0112356666778999999999999999964
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=205.53 Aligned_cols=223 Identities=26% Similarity=0.353 Sum_probs=166.1
Q ss_pred cccCCCccceeeEEeeCC----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc----
Q 025816 4 RLKHENFVQLLGYCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE---- 75 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~---- 75 (247)
-|+|+||+.+++.-..++ .++||.+|.+.|||+|++.+.. ++.+..++++..+++||++||.
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~G 330 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVG 330 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhc
Confidence 379999999998876554 5799999999999999999865 9999999999999999999994
Q ss_pred -CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhh--cccccceeccccccCchhhhcC-C---C--Cccccch
Q 025816 76 -KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTG-Q---L--NAKSDVY 146 (247)
Q Consensus 76 -~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~---~--~~~~Dvw 146 (247)
+|.|.|.|||||+.|||+.++|.+-|+|+|++........ ....+...||.+|+|||++... + | =..+|||
T Consensus 331 TqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIY 410 (513)
T KOG2052|consen 331 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIY 410 (513)
T ss_pred CCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHH
Confidence 4688899999999999999999999999999976544322 2234567899999999998653 1 1 1368999
Q ss_pred hhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhh-hcccccCCCCC-----HHHHHHHHHHHHhhcccCCCC
Q 025816 147 SFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ-CVDARLGGDYP-----PKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 147 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~ 220 (247)
|+|.++||++-.-.. .+.-++.+.....++....+.+++.+ .....+++..| .+....+.++|+.||..||.-
T Consensus 411 afgLVlWEiarRc~~-ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~a 489 (513)
T KOG2052|consen 411 AFGLVLWEIARRCES-GGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAA 489 (513)
T ss_pred HHHHHHHHHHHHhhc-CCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchh
Confidence 999999999752211 11111111112222222223333322 23344444433 356667999999999999999
Q ss_pred CCCHHHHHHHHHHhHhc
Q 025816 221 RPNMSIVVKALQPLLNA 237 (247)
Q Consensus 221 Rps~~~il~~l~~~~~~ 237 (247)
|-|+--|=+.|.++.++
T Consensus 490 RltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 490 RLTALRIKKTLAKLSNS 506 (513)
T ss_pred hhHHHHHHHHHHHHhcC
Confidence 99999999999988864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=224.20 Aligned_cols=200 Identities=26% Similarity=0.355 Sum_probs=151.8
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
=+||||+++|+.-.++...|+..|.|. .+|.++++.. +.. ... ..--..+.++.|+++||++||+.+ |+||
T Consensus 560 D~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~-~~d-~~~---~~~i~~~~~l~q~~~GlaHLHsl~---iVHR 630 (903)
T KOG1027|consen 560 DEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESS-GLD-VEM---QSDIDPISVLSQIASGLAHLHSLK---IVHR 630 (903)
T ss_pred cCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhcc-ccc-hhh---cccccHHHHHHHHHHHHHHHHhcc---cccc
Confidence 379999999998899999999999997 5999999874 110 000 111446788899999999999999 9999
Q ss_pred cCCCCceeecCC-----CceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-
Q 025816 85 DIKSSNVLIFDD-----DVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT- 157 (247)
Q Consensus 85 di~~~nil~~~~-----~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~- 157 (247)
|+||+||||+.. ..++|+|||++.......... ......||.+|+|||++.....+.++||||+||++|+.++
T Consensus 631 DLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 631 DLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred cCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecC
Confidence 999999999762 368999999998776544332 2344569999999999999888889999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||+.........+. .+. .........++ +..+||.+|++.+|..|||+.+||.
T Consensus 711 G~HpFGd~~~R~~NIl~-------~~~-------~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 711 GSHPFGDSLERQANILT-------GNY-------TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred CccCCCchHHhhhhhhc-------Ccc-------ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 59999855332111100 000 00011111222 7899999999999999999999985
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=235.00 Aligned_cols=198 Identities=20% Similarity=0.204 Sum_probs=140.4
Q ss_pred cccccC-CCccceeeEE-------eeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRLKH-ENFVQLLGYC-------VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
.++++| +||+.++++| ......+.++|++ +++|.+++..... .++...++.++.||+.||.||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~l 96 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR--------SVDAFECFHVFRQIVEIVNAA 96 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc--------cccHHHHHHHHHHHHHHHHHH
Confidence 356788 7999999988 2334567778887 4699999974321 289999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCC-------------------CceeeccccccCCcchhhh--------c------cccc
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDD-------------------DVAKIADFDLSNQAPDMAA--------R------LHST 120 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~-------------------~~~~l~d~g~~~~~~~~~~--------~------~~~~ 120 (247)
|+++ |+||||||+|||++.. +.+|++|||+++....... . ....
T Consensus 97 H~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (793)
T PLN00181 97 HSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQI 173 (793)
T ss_pred HhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccc
Confidence 9999 9999999999999654 4456666666653211000 0 0001
Q ss_pred ceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCH
Q 025816 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP 200 (247)
Q Consensus 121 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (247)
...+|..|+|||.+.+..++.++|||||||++|||++|..|+..... . +........ .....
T Consensus 174 ~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~------------~~~~~~~~~-~~~~~ 235 (793)
T PLN00181 174 LAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----T------------MSSLRHRVL-PPQIL 235 (793)
T ss_pred ccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----H------------HHHHHHhhc-Chhhh
Confidence 13478889999999998999999999999999999998887642110 0 000000000 00011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 201 KAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 201 ~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
........++.+||+.+|.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 236 LNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 11234668889999999999999999987
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-32 Score=203.97 Aligned_cols=205 Identities=25% Similarity=0.290 Sum_probs=154.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++-+.||||++||.+..+...++.||.++. ||..+-..--..+ ...++++-+-+++...+.||.||...- .|
T Consensus 117 mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq----~~~ipE~Ilg~ItvatV~AL~yLK~~l--ki 189 (361)
T KOG1006|consen 117 MKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQ----KSRIPENILGHITVATVDALDYLKEEL--KI 189 (361)
T ss_pred HhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHH----hccCcHhhhhheeeeehhHHHHHHHHh--hh
Confidence 5667889999999999999999999999964 7665542211110 112898999999999999999998774 49
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc--CCCCccccchhhhHHHHHHHhCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
+|||+||+|||++..|.+||+|||++-...+.-.. ..-.|-.-|+|||.+.. .+|+.++|+||||+++||+.||.
T Consensus 190 IHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~ 266 (361)
T KOG1006|consen 190 IHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGN 266 (361)
T ss_pred hhccCChhheEEecCCCEeeecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCC
Confidence 99999999999999999999999998765443322 22346668999999964 46999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccc---c-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR---L-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
.|+.+.+..- +.+.+..... + ......+++..+..+|..|+.+|..+||.+.++.++
T Consensus 267 fPyr~w~svf--------------eql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 267 FPYRKWDSVF--------------EQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCcchHHHHH--------------HHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 9997543210 1111111100 0 011113467789999999999999999999999873
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=216.62 Aligned_cols=199 Identities=27% Similarity=0.402 Sum_probs=160.9
Q ss_pred ccCCCccceeeEEee-----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 5 LKHENFVQLLGYCVD-----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 5 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
-.|||++.+|++|.- ++.++||||||.+|+..|+++...+.. +.+..+..+++.++.|+.+||.+.
T Consensus 73 ~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~r-------l~E~~IaYI~re~lrgl~HLH~nk-- 143 (953)
T KOG0587|consen 73 SHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNR-------LKEEWIAYILREILRGLAHLHNNK-- 143 (953)
T ss_pred cCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccc-------hhhHHHHHHHHHHHHHHHHHhhcc--
Confidence 479999999999853 568999999999999999999877544 999999999999999999999998
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----CCCCccccchhhhHHHHH
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~ 154 (247)
++|||||-.|||++.+|.|||+|||++...... ....+...||+.|+|||++.- ..|+..+|+||||++..+
T Consensus 144 -viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIE 220 (953)
T KOG0587|consen 144 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIE 220 (953)
T ss_pred -eeeecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeeh
Confidence 999999999999999999999999998764322 223456789999999999864 247789999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|.-|.+|+...-+.-....+. -.+....-.+..-++.+-++|..||.+|...||+..++++
T Consensus 221 ladG~PPl~DmHPmraLF~Ip--------------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 221 MAEGAPPLCDMHPMRALFLIP--------------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hcCCCCCccCcchhhhhccCC--------------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 999999986443321111110 0011112234455678999999999999999999999987
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=221.78 Aligned_cols=95 Identities=31% Similarity=0.410 Sum_probs=87.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++.+......++||||+.+++|.+++..... +++..++.++.|++.||.|||..+ |
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~---------l~~~~~~~i~~qil~aL~yLH~~g---I 125 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY---------FDEEMAVKYISEVALALDYLHRHG---I 125 (669)
T ss_pred HHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 5678999999999999999999999999999999999975432 888999999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSN 108 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~ 108 (247)
+||||||+|||++.++.++|+|||+++
T Consensus 126 iHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 126 IHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=203.28 Aligned_cols=207 Identities=27% Similarity=0.414 Sum_probs=157.8
Q ss_pred cccccCCCccceeeEEeeCC-eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
-+.|.||.||++|++|.-++ ..|-|+|||+|.+|.=+++.+.. ++++.+..++.||+.||.||.+.. ++
T Consensus 521 HKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl---------mSEKEARSIiMQiVnAL~YLNEik-pP 590 (775)
T KOG1151|consen 521 HKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL---------MSEKEARSIIMQIVNALKYLNEIK-PP 590 (775)
T ss_pred hhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhh---------hhHHHHHHHHHHHHHHHHHHhccC-CC
Confidence 36789999999999997665 67899999999899888887764 899999999999999999999884 67
Q ss_pred eEeccCCCCceeec---CCCceeeccccccCCcchhhhccc-----ccceeccccccCchhhhcC----CCCccccchhh
Q 025816 81 IIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLH-----STRVLGTFGYHAPEYAMTG----QLNAKSDVYSF 148 (247)
Q Consensus 81 i~h~di~~~nil~~---~~~~~~l~d~g~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~----~~~~~~Dvwsl 148 (247)
|+|.|+||.|||+- ..|.+||+|||++..+........ +....||.+|++||.+..+ +.+.+.||||+
T Consensus 591 IIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 591 IIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred eeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 99999999999994 457899999999988765433211 2234689999999998643 46889999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
|+++|+++.|+.||+....+ +.+..+ ..+....+-.+ ..-+-.+.+..++|++||++-.++|..+-++.
T Consensus 671 GVIFyQClYGrKPFGhnqsQ--QdILqe-------NTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 671 GVIFYQCLYGRKPFGHNQSQ--QDILQE-------NTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ehhhhhhhccCCCCCCchhH--HHHHhh-------hchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 99999999999999754221 111111 11111110000 11123455689999999999999999888876
Q ss_pred H
Q 025816 229 K 229 (247)
Q Consensus 229 ~ 229 (247)
.
T Consensus 740 ~ 740 (775)
T KOG1151|consen 740 C 740 (775)
T ss_pred c
Confidence 5
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=220.44 Aligned_cols=211 Identities=21% Similarity=0.272 Sum_probs=160.5
Q ss_pred CCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 025816 8 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 87 (247)
Q Consensus 8 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~ 87 (247)
+=|+.+.-.|.+++++|+||+|+.||+|..++..... +++..+...+..++.||..+|+.| +||||||
T Consensus 135 ~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~---------~pE~~ArFY~aEiVlAldslH~mg---yVHRDiK 202 (1317)
T KOG0612|consen 135 EWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDR---------LPEDWARFYTAEIVLALDSLHSMG---YVHRDIK 202 (1317)
T ss_pred HHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCC---------ChHHHHHHHHHHHHHHHHHHHhcc---ceeccCC
Confidence 4466666678899999999999999999999988762 999999999999999999999999 9999999
Q ss_pred CCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----CCCCccccchhhhHHHHHHHhCCCCC
Q 025816 88 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPV 162 (247)
Q Consensus 88 ~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~pf 162 (247)
|+|||++..|+++|.|||-+-.+..... ..+....||+.|.+||++.. +.|+..+|.||+|+++|+|+.|..||
T Consensus 203 PDNvLld~~GHikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 203 PDNVLLDKSGHIKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred cceeEecccCcEeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 9999999999999999999877653332 22345679999999999952 45889999999999999999999999
Q ss_pred CCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC--HHHHHHHHHHHHhhcccCCCCCCC---HHHHHHHH------
Q 025816 163 DHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPN---MSIVVKAL------ 231 (247)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps---~~~il~~l------ 231 (247)
..+.-. +....+++=.-...+| ...+....+||.+.+. +|..|-. ++++-..-
T Consensus 282 Yadslv---------------eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 282 YADSLV---------------ETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred hHHHHH---------------HHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 744211 1111122111112333 4467789999998765 5667776 77775522
Q ss_pred -HHhHhcCCCCCCCCCC
Q 025816 232 -QPLLNARPGPAGESAS 247 (247)
Q Consensus 232 -~~~~~~~~~~~~~~~~ 247 (247)
..+.++.||=.|..+|
T Consensus 346 W~~iR~~~pP~vPevss 362 (1317)
T KOG0612|consen 346 WDNIRESVPPVVPEVSS 362 (1317)
T ss_pred hhhhhhcCCCCCCcCCC
Confidence 4555665555555443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=197.25 Aligned_cols=217 Identities=22% Similarity=0.314 Sum_probs=173.0
Q ss_pred CcccccCCCccceeeEEeeCC-----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 1 MVSRLKHENFVQLLGYCVDGT-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
||...+|.|++..+++....+ .+|++.|.+.. +|.+.+-.-.. ++...+..++.||+.||+|||+
T Consensus 105 mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~---------Ls~DHvKVFlYQILRGLKYLHs 174 (449)
T KOG0664|consen 105 MLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQA---------LTPDHVKVFVYQILRGLKYLHT 174 (449)
T ss_pred HHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCC---------CCcchhhhhHHHHHhhhHHHhh
Confidence 355679999999998876543 45788888864 89888865432 8889999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~ 154 (247)
.+ |+||||||.|.++++|-.+||+|||+++.......... ....-|..|+|||+++|. .|+.+.||||+||++.|
T Consensus 175 A~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaE 250 (449)
T KOG0664|consen 175 AN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 250 (449)
T ss_pred cc---hhhccCCCccEEeccCceEEecccccccccchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHH
Confidence 99 99999999999999999999999999997655443322 223457789999999985 69999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC---------C--------CCCHHHHHHHHHHHHhhcccC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG---------G--------DYPPKAVAKMAAVAALCVQYE 217 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~--------~~~~~~~~~l~~li~~cl~~~ 217 (247)
++..+..|+...+..+..++....+..+.+.++-..+.... . ..+.....+...+...++.+|
T Consensus 251 LLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d 330 (449)
T KOG0664|consen 251 LLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFD 330 (449)
T ss_pred HHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCC
Confidence 99999999988888887788877777777666655554221 1 111233456778888999999
Q ss_pred CCCCCCHHHHHHHH
Q 025816 218 ADFRPNMSIVVKAL 231 (247)
Q Consensus 218 p~~Rps~~~il~~l 231 (247)
|..|.+.++.+...
T Consensus 331 ~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 331 PDKRISVEEALQHR 344 (449)
T ss_pred CcccccHhhhcccc
Confidence 99999999887644
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=181.73 Aligned_cols=164 Identities=21% Similarity=0.205 Sum_probs=124.7
Q ss_pred CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcch
Q 025816 33 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 112 (247)
Q Consensus 33 ~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~ 112 (247)
|+|.+++..... .+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+.....
T Consensus 1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence 588888875332 2999999999999999999999885 999999999999998 998775432
Q ss_pred hhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccc
Q 025816 113 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA 192 (247)
Q Consensus 113 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (247)
. ...++..|+|||++.+..++.++||||+|+++|+|++|..||........ ........
T Consensus 62 ~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--------------~~~~~~~~ 120 (176)
T smart00750 62 E-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--------------ILEILLNG 120 (176)
T ss_pred c-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--------------HHHHHHHH
Confidence 1 12578899999999999999999999999999999999999964322110 00111100
Q ss_pred ccCC-----CCCHHHHH--HHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 193 RLGG-----DYPPKAVA--KMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 193 ~~~~-----~~~~~~~~--~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
.... ..+..... .+.+++.+||..+|.+|||+.++++.+..+..
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 121 MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0000 11122233 69999999999999999999999998876653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=217.83 Aligned_cols=181 Identities=24% Similarity=0.386 Sum_probs=132.7
Q ss_pred CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCcee
Q 025816 21 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 100 (247)
Q Consensus 21 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~ 100 (247)
..+||-||||+..++.+++..+... -....+|.++++|++||.|+|++| ++||||||.||+++.++.||
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VK 737 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVK 737 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCee
Confidence 3568889999987777777665521 136789999999999999999999 99999999999999999999
Q ss_pred eccccccCCcc---hh-----------h--hcccccceeccccccCchhhhcC---CCCccccchhhhHHHHHHHhCCCC
Q 025816 101 IADFDLSNQAP---DM-----------A--ARLHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 101 l~d~g~~~~~~---~~-----------~--~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
|+|||++.... .. . .....+...||..|.|||++.+. .|+.|+|+||||++++||+. |
T Consensus 738 IGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---P 814 (1351)
T KOG1035|consen 738 IGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---P 814 (1351)
T ss_pred ecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---c
Confidence 99999998721 00 0 00112346799999999999765 49999999999999999974 3
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|...-+.. ..+..+.+..+. ..+.......-..+|.++++.||.+|||+.|+|.
T Consensus 815 F~TsMERa--------------~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 815 FGTSMERA--------------SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred CCchHHHH--------------HHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 64321110 001111111110 1122334455788999999999999999999986
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=203.84 Aligned_cols=200 Identities=21% Similarity=0.264 Sum_probs=161.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
||.+++||.||.+-..|++.++.++|||.+. |+....+-...... +++.....++.||+.||+|||-++
T Consensus 616 ILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILSsEkgR-------L~er~TkFlvtQIL~ALr~LH~kn--- 684 (888)
T KOG4236|consen 616 ILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILSSEKGR-------LPERITKFLVTQILVALRYLHFKN--- 684 (888)
T ss_pred HHHhcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHHhhccc-------chHHHHHHHHHHHHHHHHHhhhcc---
Confidence 5789999999999999999999999999996 57777765443322 998988999999999999999999
Q ss_pred eEeccCCCCceeecCCC---ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+|+|+||+|||+.... .+||+|||.++..+... ......||+.|+|||++...+|....|+||+|+++|.-++
T Consensus 685 IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLS 761 (888)
T KOG4236|consen 685 IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLS 761 (888)
T ss_pred eeeccCCchheeeccCCCCCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEec
Confidence 99999999999997654 58999999999876544 3456789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||+.+.....+ ++...-.++...+ .+.+....++|..+|+..=++|-|.+.-+.
T Consensus 762 GTFPFNEdEdIndQ--IQNAaFMyPp~PW-------------~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 762 GTFPFNEDEDINDQ--IQNAAFMYPPNPW-------------SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ccccCCCccchhHH--hhccccccCCCch-------------hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 99999755332221 1111111221111 244567899999999999999999887664
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=199.53 Aligned_cols=153 Identities=25% Similarity=0.305 Sum_probs=131.0
Q ss_pred cccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 025816 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 83 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h 83 (247)
.-..+-||++|-.|.+++.+|+||+|+.||++-.++.+..- |.+..+...+..+..||.+.|+.| ++|
T Consensus 685 EADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgI---------FeE~LARFYIAEltcAiesVHkmG---FIH 752 (1034)
T KOG0608|consen 685 EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI---------FEEDLARFYIAELTCAIESVHKMG---FIH 752 (1034)
T ss_pred hcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhcc---------CHHHHHHHHHHHHHHHHHHHHhcc---cee
Confidence 34567799999999999999999999999999999987652 888889999999999999999999 999
Q ss_pred ccCCCCceeecCCCceeeccccccCCcchhh--hcc--------------------------------------ccccee
Q 025816 84 RDIKSSNVLIFDDDVAKIADFDLSNQAPDMA--ARL--------------------------------------HSTRVL 123 (247)
Q Consensus 84 ~di~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~--------------------------------------~~~~~~ 123 (247)
|||||+|||||.+|.+||+|||++.-+.+.. .+. ......
T Consensus 753 RDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslv 832 (1034)
T KOG0608|consen 753 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLV 832 (1034)
T ss_pred cccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhc
Confidence 9999999999999999999999986432210 000 011235
Q ss_pred ccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCC
Q 025816 124 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 168 (247)
Q Consensus 124 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~ 168 (247)
||..|+|||++...+|+..+|.||.|+++|+|+.|+.||..+.+-
T Consensus 833 gt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 833 GTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred CCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCC
Confidence 899999999999999999999999999999999999999866543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=187.95 Aligned_cols=195 Identities=21% Similarity=0.296 Sum_probs=155.3
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
-+||.+|-+...|.+..++++|.||..||+|-=.+++... ++++.+......|+.||.|||++| |++|
T Consensus 308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~rg---iiyr 375 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHERG---IIYR 375 (593)
T ss_pred cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhcC---eeee
Confidence 3789999999889999999999999999999766665442 999999999999999999999999 9999
Q ss_pred cCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCC
Q 025816 85 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164 (247)
Q Consensus 85 di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 164 (247)
|+|.+|++++..|.+||+|+|++..... ....+..++||+.|.|||++.+..|..+.|.|+||+++++|+.|+.||..
T Consensus 376 dlkldnvlldaeghikltdygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 376 DLKLDNVLLDAEGHIKLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred eccccceEEccCCceeecccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 9999999999999999999999986433 22234567899999999999999999999999999999999999999963
Q ss_pred CCCCCCcchhhhccccCCcchh-hhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC
Q 025816 165 TLPRGQQSLVTWATPKLSEDKV-RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223 (247)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 223 (247)
-.-+ .....+++-+ +-+++... ..|...+.....+++.-|.+||.+|--
T Consensus 454 vgm~--------n~d~ntedylfqvilekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 454 VGMD--------NPDMNTEDYLFQVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ecCC--------CcccchhHHHHHHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 2100 0011122222 22223322 234445556778899999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=204.85 Aligned_cols=206 Identities=17% Similarity=0.171 Sum_probs=131.5
Q ss_pred eeCCeeeEEEecCCCCChhhhhcCCCCCC-----------CCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 025816 18 VDGTSRVLAYEFASNGSLHDILHGRKGVK-----------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI 86 (247)
Q Consensus 18 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-----------~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di 86 (247)
..+...++|+||+.+++|.+++....... ....+.......+..++.|++.||.|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 34567899999999999999987543100 0001111223456689999999999999999 999999
Q ss_pred CCCceeecC-CCceeeccccccCCcchhhhcccccceeccccccCchhhhcC----------------------CCCccc
Q 025816 87 KSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----------------------QLNAKS 143 (247)
Q Consensus 87 ~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~ 143 (247)
||+|||++. ++.+||+|||++........ .......+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 57899999999975432211 112345678899999976432 233456
Q ss_pred cchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC------CCHHHHHHHHHHHHhhcccC
Q 025816 144 DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD------YPPKAVAKMAAVAALCVQYE 217 (247)
Q Consensus 144 DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~ 217 (247)
||||+||++|+|+++..++...... ..............+..........+ ..........+|+.+||+.|
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQ---FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHH---HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 9999999999999876654321000 00000000001111111111111000 00111234568999999999
Q ss_pred CCCCCCHHHHHHH
Q 025816 218 ADFRPNMSIVVKA 230 (247)
Q Consensus 218 p~~Rps~~~il~~ 230 (247)
|++|||++++++.
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999984
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=177.33 Aligned_cols=223 Identities=16% Similarity=0.224 Sum_probs=160.7
Q ss_pred Cccccc-CCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 1 MVSRLK-HENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 1 ~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
||..|+ ||||++++++..+. ....|++||+.+.+...+... ++...+...+.++++||.|+|+.|
T Consensus 85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCHS~G 152 (338)
T KOG0668|consen 85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCHSMG 152 (338)
T ss_pred HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHHhcC
Confidence 356676 99999999998765 467899999988777776554 777889999999999999999999
Q ss_pred CCCeEeccCCCCceeecCC-CceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHH
Q 025816 78 DPHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l 155 (247)
|.|||+||.|++|+.. -+++|+|+|++......... +-+..+..|..||.+.. ..|+-+.|+|||||++..|
T Consensus 153 ---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~m 226 (338)
T KOG0668|consen 153 ---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 226 (338)
T ss_pred ---cccccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHH
Confidence 9999999999999854 57999999999877554443 33456777889998875 5688999999999999999
Q ss_pred HhCCCCCC-CCCCCCCcchhhhccccCC------------cchhhhhcccccCC--------CCCHHHHHHHHHHHHhhc
Q 025816 156 LTGRKPVD-HTLPRGQQSLVTWATPKLS------------EDKVRQCVDARLGG--------DYPPKAVAKMAAVAALCV 214 (247)
Q Consensus 156 ~~g~~pf~-~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl 214 (247)
+..+.||. +.+-.+|...++.+.+... ......++....+. +...-.+.+..+++.++|
T Consensus 227 iFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklL 306 (338)
T KOG0668|consen 227 IFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLL 306 (338)
T ss_pred HhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHH
Confidence 99998875 3333333222222111110 01111111111111 111112467899999999
Q ss_pred ccCCCCCCCHHHHHH--HHHHhHhcCCCC
Q 025816 215 QYEADFRPNMSIVVK--ALQPLLNARPGP 241 (247)
Q Consensus 215 ~~~p~~Rps~~~il~--~l~~~~~~~~~~ 241 (247)
..|.++|+|+.|..+ .+..+.+++..+
T Consensus 307 rYDHqeRlTakEam~HpyF~~~~~~~~~~ 335 (338)
T KOG0668|consen 307 RYDHQERLTAKEAMAHPYFAPVREAESSR 335 (338)
T ss_pred hhccccccchHHHhcCchHHHHHHHhhcc
Confidence 999999999999987 455555555444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=176.72 Aligned_cols=168 Identities=33% Similarity=0.545 Sum_probs=146.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++|++++++++++......++++|++.+++|.+++..... .++...+..++.+++.++.+||+.+ +
T Consensus 45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~~---~ 113 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLHSNG---I 113 (215)
T ss_pred HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999999999999999998899999986531 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecC-CCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCC
Q 025816 82 IHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~ 159 (247)
+|+||+|.||+++. ++.++|+|||.+........ ......+...|.+||..... .++.+.|+|++|++++++
T Consensus 114 ~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---- 187 (215)
T cd00180 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---- 187 (215)
T ss_pred eccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----
Confidence 99999999999999 89999999999876543321 11224467789999998877 788999999999999998
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..+.+++.+|+..+|.+||+++++++.
T Consensus 188 --------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 459999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=174.60 Aligned_cols=153 Identities=31% Similarity=0.384 Sum_probs=126.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++....|.+|.+||........++.||.++. ||..+-.+--. .+..+++..+-+++..++.|+.|||++- .+
T Consensus 99 ~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~-----~g~~ipE~vlGkIa~Svv~al~~L~~kL--~v 170 (282)
T KOG0984|consen 99 MRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLK-----KGGTIPEDVLGKIAVSVVHALEFLHSKL--SV 170 (282)
T ss_pred ccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHh-----cCCcCchHHhhHhHHHHHHHHHHHHHHh--hh
Confidence 4566789999999999999999999999975 88877654322 2334899999999999999999999985 49
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc----CCCCccccchhhhHHHHHHHh
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT----GQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~~l~~ 157 (247)
+|||+||.|||++..|.+|++|||++-...+.... ....|-.-|+|||.+.. .+|+.++||||||+++.||.+
T Consensus 171 IHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~ 247 (282)
T KOG0984|consen 171 IHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI 247 (282)
T ss_pred hhccCCcceEEEccCCcEEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh
Confidence 99999999999999999999999998776554332 22235557999998864 378999999999999999999
Q ss_pred CCCCCCCC
Q 025816 158 GRKPVDHT 165 (247)
Q Consensus 158 g~~pf~~~ 165 (247)
++.||...
T Consensus 248 lr~PY~~w 255 (282)
T KOG0984|consen 248 LRFPYESW 255 (282)
T ss_pred cccccccc
Confidence 99998643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-28 Score=196.78 Aligned_cols=208 Identities=21% Similarity=0.225 Sum_probs=154.0
Q ss_pred CccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 025816 9 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 88 (247)
Q Consensus 9 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~ 88 (247)
|.++++-.|...+++|||+|.+.- +|.+++.+.... .-|....+...+.|+..||..|-.+| |+|.||||
T Consensus 495 Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~n------vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKP 564 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRN------VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKP 564 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcc------cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCc
Confidence 678889999999999999999864 999999875432 12778899999999999999999999 99999999
Q ss_pred CceeecCC-CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCC
Q 025816 89 SNVLIFDD-DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 167 (247)
Q Consensus 89 ~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~ 167 (247)
.|||++.. ..+||||||-|........ ..+..+..|+|||++.|..|+...|+||+||+||++.||+..|.+..-
T Consensus 565 DNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 565 DNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 99999865 4689999998876543322 223345679999999999999999999999999999999999976543
Q ss_pred CCCcchhhhccccCCc-----------------------------chhhhh-------------cccccC-CCCCHHHHH
Q 025816 168 RGQQSLVTWATPKLSE-----------------------------DKVRQC-------------VDARLG-GDYPPKAVA 204 (247)
Q Consensus 168 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~-------------~~~~~~-~~~~~~~~~ 204 (247)
-.-..+.+...++.+. ...... +-...+ ..-.....+
T Consensus 641 N~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~ 720 (752)
T KOG0670|consen 641 NQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQ 720 (752)
T ss_pred HHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHH
Confidence 2222222222222222 110000 000000 011123345
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 205 KMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 205 ~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
.+.+|+.+||..||++|.|..+.|+.
T Consensus 721 ~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 721 QLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHHHHhccChhhcCCHHHHhcC
Confidence 69999999999999999999999873
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=196.32 Aligned_cols=147 Identities=24% Similarity=0.403 Sum_probs=130.3
Q ss_pred Cccccc---CCCccceeeEEeeCCeeeEEEecC-CCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 1 MVSRLK---HENFVQLLGYCVDGTSRVLAYEFA-SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 1 ~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
||..|+ |+||++++++|+++...||+||.. +|.+|.+++...+. +.+..+..++.|++.|+++||++
T Consensus 619 Ila~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~ 689 (772)
T KOG1152|consen 619 ILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQ 689 (772)
T ss_pred HHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc---------cchHHHHHHHHHHHhcccccccc
Confidence 355666 999999999999999999999985 45699999998775 99999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLEL 155 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l 155 (247)
| |+|||||-+|+.++.+|.+||+|||-+.+..... -..+.||..|.|||++.|.+| ...-|||+||+++|-+
T Consensus 690 ~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillyti 762 (772)
T KOG1152|consen 690 G---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTI 762 (772)
T ss_pred C---ceecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEE
Confidence 9 9999999999999999999999999887654433 245679999999999999888 4567999999999999
Q ss_pred HhCCCCCC
Q 025816 156 LTGRKPVD 163 (247)
Q Consensus 156 ~~g~~pf~ 163 (247)
+....||.
T Consensus 763 vykenpyy 770 (772)
T KOG1152|consen 763 VYKENPYY 770 (772)
T ss_pred EeccCCCc
Confidence 98888874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=192.70 Aligned_cols=213 Identities=21% Similarity=0.234 Sum_probs=140.1
Q ss_pred ccceeeEEee--------CCeeeEEEecCCCCChhhhhcCCCCCC---------------CCCCCCCcCHHHHHHHHHHH
Q 025816 10 FVQLLGYCVD--------GTSRVLAYEFASNGSLHDILHGRKGVK---------------GAQPGPVLSWQQRVKIAVGA 66 (247)
Q Consensus 10 i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~---------------~~~~~~~l~~~~~~~~~~~~ 66 (247)
+++++++|.. +...++||||+.+++|.+++....... .......+.+..+..++.|+
T Consensus 239 ~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql 318 (507)
T PLN03224 239 CAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQV 318 (507)
T ss_pred hhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHH
Confidence 3566777653 346799999999999999987532110 00111235678899999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC--------
Q 025816 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-------- 138 (247)
Q Consensus 67 ~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------- 138 (247)
+.+|.|||+.+ ++||||||+||+++.++.++|+|||++........ .......+++.|.|||.+....
T Consensus 319 ~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~ 394 (507)
T PLN03224 319 LTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVMPQSCPRAPAP 394 (507)
T ss_pred HHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcCCCCCCccchh
Confidence 99999999999 99999999999999999999999999865432111 1111223477899999875422
Q ss_pred --------------CCccccchhhhHHHHHHHhCCC-CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHH
Q 025816 139 --------------LNAKSDVYSFGVVLLELLTGRK-PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAV 203 (247)
Q Consensus 139 --------------~~~~~DvwslG~~l~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (247)
...+.|+||+||++++|+++.. ||......... ...+ ......++........-......+
T Consensus 395 ~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~~---~~~~~~~r~~~~~~~~~~~~d~~s 470 (507)
T PLN03224 395 AMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQY---DNDLNRWRMYKGQKYDFSLLDRNK 470 (507)
T ss_pred hhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhhc---cchHHHHHhhcccCCCcccccccC
Confidence 1234699999999999999875 66422111000 0000 000011111111111112233456
Q ss_pred HHHHHHHHhhcccCC---CCCCCHHHHHHH
Q 025816 204 AKMAAVAALCVQYEA---DFRPNMSIVVKA 230 (247)
Q Consensus 204 ~~l~~li~~cl~~~p---~~Rps~~~il~~ 230 (247)
....+++.++|..+| .+|+|++|+|+.
T Consensus 471 ~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 471 EAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 779999999999766 689999999873
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=190.46 Aligned_cols=200 Identities=26% Similarity=0.352 Sum_probs=158.7
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
|++-.+||||+.+++.+.....+++.||||.+|+|.+.-.-.- ++++-++..+.+..+.+++|||+.+
T Consensus 65 ~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylhs~g--- 132 (829)
T KOG0576|consen 65 MLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLHSQG--- 132 (829)
T ss_pred eeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhhcCC---
Confidence 4678899999999999999999999999999999988866543 3999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh---cCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~ 157 (247)
-+|||||-.||+++..|.+|+.|||.+......-. ....+.||+.|+|||+.. ..+|...+|+|++|++..++..
T Consensus 133 k~hRdiKGanilltd~gDvklaDfgvsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e 210 (829)
T KOG0576|consen 133 KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE 210 (829)
T ss_pred cccccccccceeecccCceeecccCchhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh
Confidence 99999999999999999999999999877654333 235678999999999875 3478899999999999999988
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC---CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
-++|-..-- +.+...-...+..... -...-+..+.++++.|+.++|.+|||++.+|.
T Consensus 211 Lqpplfdlh---------------pmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 211 LQPPLFDLH---------------PMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCcccccc---------------hHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 777743211 1111111111111111 11233456999999999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=173.81 Aligned_cols=79 Identities=28% Similarity=0.394 Sum_probs=70.1
Q ss_pred cCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 6 KHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 6 ~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
.-.+||++++.|.. +.++|||+|+. |.+|..+|.....+. ++...+.+++.||+.||.|||... +|
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrG-------lpl~~VK~I~~qvL~GLdYLH~ec--gI 209 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-------LPLSCVKEICRQVLTGLDYLHREC--GI 209 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCC-------CcHHHHHHHHHHHHHHHHHHHHhc--Cc
Confidence 34689999999964 56899999999 569999999887765 999999999999999999999885 59
Q ss_pred EeccCCCCceeec
Q 025816 82 IHRDIKSSNVLIF 94 (247)
Q Consensus 82 ~h~di~~~nil~~ 94 (247)
+|.||||+|||+.
T Consensus 210 IHTDlKPENvLl~ 222 (590)
T KOG1290|consen 210 IHTDLKPENVLLC 222 (590)
T ss_pred cccCCCcceeeee
Confidence 9999999999994
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=164.44 Aligned_cols=194 Identities=22% Similarity=0.329 Sum_probs=141.6
Q ss_pred cCCCccceeeE-EeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 6 KHENFVQLLGY-CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 6 ~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
.|.||+.-|+. |.+.+..++++||+.-|+|.+-+.... +.+.....++.|+++||.|+|+.+ ++||
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHskn---lVHR 145 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSKN---LVHR 145 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhccc---hhhc
Confidence 57899998876 666678889999999999999887643 899999999999999999999999 9999
Q ss_pred cCCCCceeecCC--CceeeccccccCCcchhhhcccccceeccccccCchhhhc---CC--CCccccchhhhHHHHHHHh
Q 025816 85 DIKSSNVLIFDD--DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQ--LNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 85 di~~~nil~~~~--~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~--~~~~~DvwslG~~l~~l~~ 157 (247)
|||.+|||+-.. -++||+|||..+..+..... .....-|.+||.... +. ..+.+|+|.||++++.+++
T Consensus 146 dlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~clt 220 (378)
T KOG1345|consen 146 DLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLT 220 (378)
T ss_pred ccccceEEEecCCccEEEeeecccccccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeec
Confidence 999999999543 37999999998865433221 223446889997643 22 3568999999999999999
Q ss_pred CCCCCCCCCCCCC--cchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCC---CCHHHHH
Q 025816 158 GRKPVDHTLPRGQ--QSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFR---PNMSIVV 228 (247)
Q Consensus 158 g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---ps~~~il 228 (247)
|..||+.....++ .+..+|...+.. .+ +..-..++..++.+.++-|..++.+| .++...-
T Consensus 221 G~~PWQka~~~d~~Y~~~~~w~~rk~~----------~~-P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 221 GKFPWQKASIMDKPYWEWEQWLKRKNP----------AL-PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred CCCcchhhhccCchHHHHHHHhcccCc----------cC-chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 9999984322111 111222222211 01 11112445668889999999999999 5554443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=161.77 Aligned_cols=151 Identities=35% Similarity=0.470 Sum_probs=129.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|+|++++++++..+...++++|++.+++|.+++...... +++..+..++.+++.++.+||+.+ +
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lh~~~---i 119 (225)
T smart00221 51 LKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK--------LSEEEARFYLRQILEALEYLHSLG---I 119 (225)
T ss_pred HHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 45779999999999999999999999999988999999765421 678899999999999999999998 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhh-hcCCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA-MTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+|+++.|++++.++.++|+|||.+......... ......++..|++||.. ....++.++|+|++|++++++++|+.
T Consensus 120 ~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~ 198 (225)
T smart00221 120 VHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPE 198 (225)
T ss_pred ecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999998866443211 11234567789999998 66677889999999999999999999
Q ss_pred CCCC
Q 025816 161 PVDH 164 (247)
Q Consensus 161 pf~~ 164 (247)
||..
T Consensus 199 pf~~ 202 (225)
T smart00221 199 PFSG 202 (225)
T ss_pred Cccc
Confidence 9953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=187.25 Aligned_cols=205 Identities=18% Similarity=0.256 Sum_probs=158.5
Q ss_pred ccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 025816 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII 82 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~ 82 (247)
++++|+|++.....+.+.....-.||||.. +|+.++..... +....+..++.|++.|++|+|+.| +.
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~---------~~~~e~~c~fKqL~~Gv~y~h~~G---ia 442 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGK---------LTPLEADCFFKQLLRGVKYLHSMG---LA 442 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccc---------cchhhhhHHHHHHHHHHHHHHhcC---ce
Confidence 578999998888777666555555999998 99999987621 888899999999999999999999 99
Q ss_pred eccCCCCceeecCCCceeeccccccCCcchhhhc--ccccceeccccccCchhhhcCCCCc-cccchhhhHHHHHHHhCC
Q 025816 83 HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 83 h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~~l~~g~ 159 (247)
|||+|++|++++.+|.+||+|||.+..+....+. .......|+..|.|||.+.+..|.. ..||||.|+++..|.+|+
T Consensus 443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 9999999999999999999999998766543333 3345567889999999999998865 689999999999999999
Q ss_pred CCCCCCCCCCCcc-hhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 160 KPVDHTLPRGQQS-LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 160 ~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
.||......+... ...+........ -........+.....+|.++|+.||.+|.|+++|++
T Consensus 523 ~~Wk~a~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKTNNYSDQRNIFE---------GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred Cccccccccccchhhhcccccccccc---------ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 9997655443332 000000000000 000112344667889999999999999999999987
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=166.92 Aligned_cols=210 Identities=21% Similarity=0.298 Sum_probs=149.9
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
-+.||+++.+.+...+..++||||+++....++... ++...+...++.++.||.++|++| |+|||
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRD 157 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRD 157 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccC---ccccC
Confidence 467999999999999999999999999899888865 788899999999999999999999 99999
Q ss_pred CCCCceeecC-CCceeeccccccCCcchhh------h-------c--------------------c---------cccce
Q 025816 86 IKSSNVLIFD-DDVAKIADFDLSNQAPDMA------A-------R--------------------L---------HSTRV 122 (247)
Q Consensus 86 i~~~nil~~~-~~~~~l~d~g~~~~~~~~~------~-------~--------------------~---------~~~~~ 122 (247)
|||.|++++. .++-.|+|||++....... . . . ..-.+
T Consensus 158 iKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anr 237 (418)
T KOG1167|consen 158 IKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANR 237 (418)
T ss_pred CCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceeccc
Confidence 9999999975 4678999999987211000 0 0 0 00123
Q ss_pred eccccccCchhhhc-CCCCccccchhhhHHHHHHHhCCCCCCCCCC-CCC----------cch--h--------hhcccc
Q 025816 123 LGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQ----------QSL--V--------TWATPK 180 (247)
Q Consensus 123 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~----------~~~--~--------~~~~~~ 180 (247)
.||++|+|||++.. ...+.++|+||.|+++.-++++..||..... .+. ... . .|....
T Consensus 238 AGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn 317 (418)
T KOG1167|consen 238 AGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSN 317 (418)
T ss_pred CCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecccc
Confidence 48999999999976 4678999999999999999999999864322 111 000 0 010000
Q ss_pred -CCcchhhhhcccc-----cC--------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 181 -LSEDKVRQCVDAR-----LG--------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 181 -~~~~~~~~~~~~~-----~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
....+.....+.. .. .......+..+++++.+|+..||.+|.|+++.|+.
T Consensus 318 ~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 318 IPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0000111111110 00 11112334579999999999999999999999873
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=161.09 Aligned_cols=199 Identities=20% Similarity=0.245 Sum_probs=145.4
Q ss_pred cCCCccceeeEEee---------------------------CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHH
Q 025816 6 KHENFVQLLGYCVD---------------------------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58 (247)
Q Consensus 6 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~ 58 (247)
+|||||+++++|.+ ...+|+||..++. +|..++-.+. .+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----------~s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----------RSYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----------CchHH
Confidence 79999999998854 2457999999975 9999997765 77788
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeec--CC--CceeeccccccCCcch--hhhcc--cccceeccccccC
Q 025816 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF--DD--DVAKIADFDLSNQAPD--MAARL--HSTRVLGTFGYHA 130 (247)
Q Consensus 59 ~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~--~~--~~~~l~d~g~~~~~~~--~~~~~--~~~~~~~~~~y~a 130 (247)
...++.|+++|+.|||++| +.|||+|++||++. .+ ..+++.|||.+--... ..... ..-...|...-+|
T Consensus 343 ~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 8899999999999999999 99999999999993 22 2489999998753322 11111 1122346777899
Q ss_pred chhhhcCC--C----CccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHH
Q 025816 131 PEYAMTGQ--L----NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVA 204 (247)
Q Consensus 131 PE~~~~~~--~----~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (247)
||+....+ . -.++|.|+.|.+.||+++...||.+.-+- . ......++ ..-...+..++.
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~----------L~~r~Yqe----~qLPalp~~vpp 484 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-L----------LDTRTYQE----SQLPALPSRVPP 484 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-e----------echhhhhh----hhCCCCcccCCh
Confidence 99886422 1 24789999999999999999999762111 0 11111111 111234556677
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 205 KMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 205 ~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
.+.+++...|+.||.+|++..-....++-
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence 79999999999999999998777666653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-22 Score=165.06 Aligned_cols=216 Identities=25% Similarity=0.365 Sum_probs=162.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|+++.|.|+.+++|.+.++...+.|.+||.-|+|.|.+...... +.+.....+.+++++|+.|+|... -.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~--------~d~~F~~s~~rdi~~Gl~ylh~s~--i~ 70 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIK--------LDYFFILSFIRDISKGLAYLHNSP--IG 70 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccC--------ccHHHHHHHHHHHHHHHHHHhcCc--ce
Confidence 68899999999999999999999999999999999999874432 888999999999999999999886 13
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC-------CCccccchhhhHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-------LNAKSDVYSFGVVLLE 154 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~~l~~ 154 (247)
+|+.++..|++++....+|++|||+.................-...|.|||.+.+.. .+.+.|+||+|+++++
T Consensus 71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 999999999999999999999999987654311111112222455799999987642 3567999999999999
Q ss_pred HHhCCCCCCCCCCCCC-cchhhhccccCCcchhhhhcccccCCCCC--HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQ-QSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
+++...||........ ..+...+.. ...+..++... .+...++..++..||..+|.+||+++.+-..+
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~~---------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~ 221 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVKK---------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKL 221 (484)
T ss_pred HHhccCccccccccCChHHHHHHHHh---------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence 9999999974321111 111111111 01111122211 14444799999999999999999999999888
Q ss_pred HHhHh
Q 025816 232 QPLLN 236 (247)
Q Consensus 232 ~~~~~ 236 (247)
+.+..
T Consensus 222 ~~~~~ 226 (484)
T KOG1023|consen 222 LTINK 226 (484)
T ss_pred hhhcc
Confidence 77664
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-20 Score=153.66 Aligned_cols=209 Identities=20% Similarity=0.252 Sum_probs=157.4
Q ss_pred CCccceeeEE-eeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 025816 8 ENFVQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI 86 (247)
Q Consensus 8 ~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di 86 (247)
+|+..+++.. ..+...++||+.+ |.+|.++........ ++...+..++.|++.+|.++|+.| ++||||
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~-------fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDi 148 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGR-------FSRKTVLRIAIQNLNALEDLHSKG---FIHRDI 148 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCC-------cCHhHHHHHHHHHHHHHHHHHhcC---cccCCc
Confidence 6889999988 4777889999988 679999997665333 999999999999999999999999 999999
Q ss_pred CCCceeecCC-----CceeeccccccCCcc--hhhh-----ccc-ccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 87 KSSNVLIFDD-----DVAKIADFDLSNQAP--DMAA-----RLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 87 ~~~nil~~~~-----~~~~l~d~g~~~~~~--~~~~-----~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
||.|+++... ..+.+.|||+++... .... ... .....||..|.++....+...+.+.|+||++.++.
T Consensus 149 Kp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~ 228 (322)
T KOG1164|consen 149 KPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLL 228 (322)
T ss_pred CHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHH
Confidence 9999999765 358999999998332 2111 111 12355999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
++..|..||.......... .+.+..............+..+.++...+-..+..++|....+.+.++.
T Consensus 229 el~~g~LPW~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 229 ELLKGSLPWEALEMTDLKS------------KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred HHhcCCCCCccccccchHH------------HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 9999999996543221111 1111111111111222334456666666667899999999999999999
Q ss_pred hHhcCC
Q 025816 234 LLNARP 239 (247)
Q Consensus 234 ~~~~~~ 239 (247)
.+.+..
T Consensus 297 ~~~~~~ 302 (322)
T KOG1164|consen 297 VFDSEG 302 (322)
T ss_pred HHHhcC
Confidence 887763
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7e-20 Score=143.03 Aligned_cols=214 Identities=19% Similarity=0.232 Sum_probs=166.3
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
..+.|...|-+...+.+-.||||.. |.+|.|+....... ++.+.+..++.|++.-+.++|+.. +|.||
T Consensus 82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~--------FSvKTV~miA~Qmi~rie~vH~k~---LIYRD 149 (449)
T KOG1165|consen 82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRR--------FSVKTVAMIAKQMITRIEYVHEKD---LIYRD 149 (449)
T ss_pred CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCc--------ccHHhHHHHHHHHHHHHHHHHhcc---eeecc
Confidence 3478888887778888889999988 67999999865432 999999999999999999999998 99999
Q ss_pred CCCCceeecCCC-----ceeeccccccCCcchhhhcc-----cccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 86 IKSSNVLIFDDD-----VAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 86 i~~~nil~~~~~-----~~~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
|||+|+||...+ .+.++|||++..+.+..... ......||..|++--...|.+.+.+.|+-|||.+++++
T Consensus 150 IKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYF 229 (449)
T KOG1165|consen 150 IKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 229 (449)
T ss_pred cCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhh
Confidence 999999997654 58999999998776544332 22345699999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
+-|..||++-.....+...+.+..+-....+.++++ .++.++...+...=..+-.+-|..+.+...+++++
T Consensus 230 LRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~---------g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 230 LRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCE---------GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred ccCCCccccccCcchHHHHHHhccccccCCHHHHHh---------cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 999999998766555544443333333223333221 23455666666666667778899999999988888
Q ss_pred hcCCC
Q 025816 236 NARPG 240 (247)
Q Consensus 236 ~~~~~ 240 (247)
.....
T Consensus 301 dr~g~ 305 (449)
T KOG1165|consen 301 DRLGE 305 (449)
T ss_pred HhcCC
Confidence 76543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-20 Score=141.79 Aligned_cols=204 Identities=23% Similarity=0.363 Sum_probs=157.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|+-..||||+++++.|.....+.++..|+..|+|+.++.+.... .+.-.++..++.+++.|++|||+.. +-|
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~v-------vvd~sqav~faldiargmaflhsle-p~i 312 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHSLE-PMI 312 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhhcc-hhh
Confidence 45568999999999999999999999999999999999887643 3777899999999999999999985 334
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC---CccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL---NAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~~l~~l~~g 158 (247)
..--++...++++.+...+|.- +-.. .........-.+.|++||.+...+- -.++|+||+.+++|++.|.
T Consensus 313 pr~~lns~hvmidedltarism-ad~k------fsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tr 385 (448)
T KOG0195|consen 313 PRFYLNSKHVMIDEDLTARISM-ADTK------FSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTR 385 (448)
T ss_pred hhhhcccceEEecchhhhheec-ccce------eeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcc
Confidence 4556889999999887766631 1111 1111122334668999999876543 3578999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
..||..-. +.+.-.++.-.+++...|+..+..+..+++-|+.-||.+||.+..|+-.|+.+.
T Consensus 386 evpfadls---------------pmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 386 EVPFADLS---------------PMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCC---------------chhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99996321 112222333456666778888889999999999999999999999998888763
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-21 Score=168.15 Aligned_cols=200 Identities=21% Similarity=0.248 Sum_probs=145.8
Q ss_pred ccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 025816 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII 82 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~ 82 (247)
+.++|||.+++..+...+...|||-+|..+ +|+|.+..++. +..-....++.|+++||..+|+.| |+
T Consensus 76 ~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPF---------L~~iEKkWiaFQLL~al~qcH~~g---Vc 142 (1431)
T KOG1240|consen 76 ALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPF---------LVLIEKKWIAFQLLKALSQCHKLG---VC 142 (1431)
T ss_pred HhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchH---------HHHHHHHHHHHHHHHHHHHHHHcC---cc
Confidence 356899999998887778888999999976 99999988774 777788899999999999999999 99
Q ss_pred eccCCCCceeecCCCceeeccccccCCc--chhhhcccc---cceeccccccCchhhhcCC-----------CCccccch
Q 025816 83 HRDIKSSNVLIFDDDVAKIADFDLSNQA--PDMAARLHS---TRVLGTFGYHAPEYAMTGQ-----------LNAKSDVY 146 (247)
Q Consensus 83 h~di~~~nil~~~~~~~~l~d~g~~~~~--~~~~~~~~~---~~~~~~~~y~aPE~~~~~~-----------~~~~~Dvw 146 (247)
|||||.+|||++.=.=+.|+||.-..-. +...+.... .....-.+|.|||.+.... .+++=|||
T Consensus 143 HGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIF 222 (1431)
T KOG1240|consen 143 HGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIF 222 (1431)
T ss_pred ccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhh
Confidence 9999999999998877999999765322 111111110 1111233799999986421 35677999
Q ss_pred hhhHHHHHHHh-CCCCCCCCCCCCCcchhhhccc-cCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 025816 147 SFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP-KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM 224 (247)
Q Consensus 147 slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 224 (247)
|+||++.|+++ |.++|.-. .+..+... ....+...+.++ ...+++++..|++.||..|-|+
T Consensus 223 S~GCViaELf~Eg~PlF~LS------QL~aYr~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSA 285 (1431)
T KOG1240|consen 223 SAGCVIAELFLEGRPLFTLS------QLLAYRSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSA 285 (1431)
T ss_pred hhhHHHHHHHhcCCCcccHH------HHHhHhccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCH
Confidence 99999999998 78888621 11111111 111111111111 1259999999999999999999
Q ss_pred HHHHHHHH
Q 025816 225 SIVVKALQ 232 (247)
Q Consensus 225 ~~il~~l~ 232 (247)
++.|+..+
T Consensus 286 edyL~~yr 293 (1431)
T KOG1240|consen 286 EDYLQKYR 293 (1431)
T ss_pred HHHHHhhh
Confidence 99998843
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-19 Score=145.90 Aligned_cols=208 Identities=29% Similarity=0.393 Sum_probs=157.1
Q ss_pred cccccCC-CccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHE-NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++.+.|+ +|+++++.+......+++++++.++++.+++...... ..+.......++.|++.++.++|+.+
T Consensus 51 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~--- 121 (384)
T COG0515 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKG--- 121 (384)
T ss_pred HHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4567887 7999999997777789999999999999777655321 12888999999999999999999999
Q ss_pred eEeccCCCCceeecCCC-ceeeccccccCCcchhhhcc----cccceeccccccCchhhhc---CCCCccccchhhhHHH
Q 025816 81 IIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARL----HSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVL 152 (247)
Q Consensus 81 i~h~di~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l 152 (247)
++|||+||+|++++..+ .+++.|||.+.......... ......++..|.+||.+.+ ..++...|+|++|+++
T Consensus 122 ~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~ 201 (384)
T COG0515 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201 (384)
T ss_pred eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHH
Confidence 99999999999999998 79999999987544332211 1245678999999999987 5788899999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc----CCCCC----HHHHHHHHHHHHhhcccCCCCCCCH
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL----GGDYP----PKAVAKMAAVAALCVQYEADFRPNM 224 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~ 224 (247)
+++++|..||....... ........+.... ..... ......+.+++..|+..+|..|.+.
T Consensus 202 ~~~~~~~~p~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~ 269 (384)
T COG0515 202 YELLTGLPPFEGEKNSS------------ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269 (384)
T ss_pred HHHHhCCCCCCCCCccc------------cHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCH
Confidence 99999999976443210 0000111111111 00111 1223568999999999999999999
Q ss_pred HHHHHH
Q 025816 225 SIVVKA 230 (247)
Q Consensus 225 ~~il~~ 230 (247)
.+....
T Consensus 270 ~~~~~~ 275 (384)
T COG0515 270 SSDLSH 275 (384)
T ss_pred HHHhhc
Confidence 887764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.6e-20 Score=144.75 Aligned_cols=167 Identities=20% Similarity=0.245 Sum_probs=110.1
Q ss_pred eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeec
Q 025816 23 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 102 (247)
Q Consensus 23 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~ 102 (247)
.+++|+-.. +||.+++..-...... ...+.......+..|++..+++||..| ++|+||+|+|++++.+|.+.|+
T Consensus 114 ~~~l~P~~~-~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg 187 (288)
T PF14531_consen 114 RFLLMPRAQ-GDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLG 187 (288)
T ss_dssp EEEEEE--S-EEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE-
T ss_pred hhhccchhh-hcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEc
Confidence 367888775 5888886532111100 122556667788899999999999999 9999999999999999999999
Q ss_pred cccccCCcchhhhcccccceeccccccCchhhhcC--------CCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchh
Q 025816 103 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--------QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174 (247)
Q Consensus 103 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 174 (247)
||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.++++..||...........
T Consensus 188 ~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~- 261 (288)
T PF14531_consen 188 DFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW- 261 (288)
T ss_dssp -GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-
T ss_pred ChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-
Confidence 99877655432221 2334668899977442 478899999999999999999999975422111100
Q ss_pred hhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCC
Q 025816 175 TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFR 221 (247)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 221 (247)
....+. +.++.+..||..+|++||.+|
T Consensus 262 -------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 -------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred -------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 122445 778889999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-19 Score=149.18 Aligned_cols=185 Identities=25% Similarity=0.276 Sum_probs=152.5
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
+||.++++.-.+..+...++++++..+|.|...+..... +.+.........++.++.++|+.+ ++++|
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~---------f~~~~~~~~~aelaLald~lh~l~---iiyrd 122 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM---------FDELDVAFYLAELALALDHLHKLG---IAYRD 122 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc---------hHHHHHHHHHHHHHHHHhhcchhH---HHHhc
Confidence 389999999999999999999999999999888877664 777777788888999999999999 99999
Q ss_pred CCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 165 (247)
+|++||+++.+|.+++.|||..+..-.... .+||..|+|||++. +...++|.||+|++.++|++|..||..
T Consensus 123 ~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~- 193 (612)
T KOG0603|consen 123 YKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG- 193 (612)
T ss_pred ccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-
Confidence 999999999999999999999876533222 27899999999998 567889999999999999999999963
Q ss_pred CCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH--HHHHHHH
Q 025816 166 LPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM--SIVVKAL 231 (247)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~--~~il~~l 231 (247)
+.+..+.. .....|.+......+++..++..+|.+|--. ..+.+..
T Consensus 194 ------------------~~~~~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 194 ------------------DTMKRILK--AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred ------------------HHHHHHhh--hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 12222221 2235677888889999999999999999876 3444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.5e-19 Score=131.78 Aligned_cols=209 Identities=19% Similarity=0.245 Sum_probs=153.8
Q ss_pred CCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 025816 8 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 87 (247)
Q Consensus 8 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~ 87 (247)
..|..+..+..+...-.+||+.. |.+|.++.+-.... ++.+.++.++-|++.-|.|+|.++ ++|||||
T Consensus 71 ~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~--------ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIK 138 (341)
T KOG1163|consen 71 VGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRR--------FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIK 138 (341)
T ss_pred CCCchhhhhccccccceeeeecc-CccHHHHHHHHhhh--------hhHHhHHHHHHHHHHHHHHHHhhc---cccccCC
Confidence 45666677778888889999988 67999999865433 999999999999999999999999 9999999
Q ss_pred CCceeecCC---CceeeccccccCCcchhhhccc-----ccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 88 SSNVLIFDD---DVAKIADFDLSNQAPDMAARLH-----STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 88 ~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
|+|+|..-+ .++.++|||++..+.+...... .....||..|.+--...+...+...|+-|+|.++.++--|.
T Consensus 139 PdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~ 218 (341)
T KOG1163|consen 139 PDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGS 218 (341)
T ss_pred ccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCC
Confidence 999999644 4689999999987755433221 22345888998887777778889999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
.||++.....++.....+..+-..-.+... - ..++.++.-.+..|=..--.+-|....+-+.++-++..
T Consensus 219 LPWQglka~tk~QKyEkI~EkK~s~~ie~L-----C----~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 219 LPWQGLKAATKKQKYEKISEKKMSTPIEVL-----C----KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred CcccccchhhHHHHHHHHHHhhcCCCHHHH-----h----CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 999987655443332222211111111111 1 13345577777778777777788888777766655544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-18 Score=143.73 Aligned_cols=169 Identities=28% Similarity=0.392 Sum_probs=125.9
Q ss_pred eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceee
Q 025816 22 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 101 (247)
Q Consensus 22 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l 101 (247)
.+++.|++|...+|.+.+..... +...++.....++.|++.++.| ++ .+|+|+||.||++..+..++|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~------~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT------GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc------ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhh
Confidence 47899999999999999975442 1236777889999999999999 66 999999999999999999999
Q ss_pred ccccccCCcchhh----hcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCCCcchhhh
Q 025816 102 ADFDLSNQAPDMA----ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 176 (247)
Q Consensus 102 ~d~g~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 176 (247)
+|||+........ .........||.+|++||.+.+..|+.++|||+||+++++++. -...+.-
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------ 465 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------ 465 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------------
Confidence 9999987654433 1222344579999999999999999999999999999999986 2233210
Q ss_pred ccccCCcchhhhhcccccCCCCCHHHH---HHHHHHHHhhcccCCCCCCCH
Q 025816 177 ATPKLSEDKVRQCVDARLGGDYPPKAV---AKMAAVAALCVQYEADFRPNM 224 (247)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~li~~cl~~~p~~Rps~ 224 (247)
...+........|+... ..-..++.+++...|.+||++
T Consensus 466 ----------~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 466 ----------IATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred ----------HHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchH
Confidence 00000111112222111 235688999999999999943
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=4e-17 Score=133.85 Aligned_cols=113 Identities=22% Similarity=0.208 Sum_probs=84.0
Q ss_pred CcccccCCCccc-eeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQ-LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+|++++|+|+++ +++ ....++||||+.|++|... . . .. ...++.+++++|.|||+.|
T Consensus 74 iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~--~----------~~---~~~~~~~i~~aL~~lH~~g-- 131 (365)
T PRK09188 74 ALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-R--P----------HG---DPAWFRSAHRALRDLHRAG-- 131 (365)
T ss_pred HHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-C--c----------cc---hHHHHHHHHHHHHHHHHCC--
Confidence 467899999986 443 2457999999999888632 1 0 11 1357889999999999999
Q ss_pred CeEeccC-CCCceeecCCCceeeccccccCCcchhhhccc------ccceeccccccCchhhhc
Q 025816 80 HIIHRDI-KSSNVLIFDDDVAKIADFDLSNQAPDMAARLH------STRVLGTFGYHAPEYAMT 136 (247)
Q Consensus 80 ~i~h~di-~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~ 136 (247)
|+|||| ||+||+++.++.++|+|||++........... .....++..|.|||.+..
T Consensus 132 -IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 132 -ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred -CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999 99999999999999999999986543221111 023346677889997754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.5e-17 Score=120.90 Aligned_cols=142 Identities=16% Similarity=0.167 Sum_probs=103.7
Q ss_pred CcccccC-CCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKH-ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+|++|+| +++++++++ +..+++|+|+.|.+|.+.... ....++.|++.+|.++|..|
T Consensus 54 iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~G-- 111 (218)
T PRK12274 54 ALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRCG-- 111 (218)
T ss_pred HHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHCc--
Confidence 3677854 889999886 456899999998888654321 11346788999999999999
Q ss_pred CeEeccC-CCCceeecCCCceeeccccccCCcchhhhc----cc-------ccceeccccccCchhhhcC-CCC-ccccc
Q 025816 80 HIIHRDI-KSSNVLIFDDDVAKIADFDLSNQAPDMAAR----LH-------STRVLGTFGYHAPEYAMTG-QLN-AKSDV 145 (247)
Q Consensus 80 ~i~h~di-~~~nil~~~~~~~~l~d~g~~~~~~~~~~~----~~-------~~~~~~~~~y~aPE~~~~~-~~~-~~~Dv 145 (247)
|+|||| ||.||+++.++.++|+|||++......... .. ......++.|++|+..... ..+ ...+.
T Consensus 112 -IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w 190 (218)
T PRK12274 112 -VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELW 190 (218)
T ss_pred -CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHH
Confidence 999999 799999999999999999999855432211 00 1122356678888866543 344 34566
Q ss_pred hhhhHHHHHHHhCCCCCCCC
Q 025816 146 YSFGVVLLELLTGRKPVDHT 165 (247)
Q Consensus 146 wslG~~l~~l~~g~~pf~~~ 165 (247)
++.|+-+|.++|+..++-.+
T Consensus 191 ~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 191 FATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHhcchHHHHHhccCCcccc
Confidence 79999999999988886433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.6e-17 Score=124.21 Aligned_cols=120 Identities=16% Similarity=0.295 Sum_probs=91.3
Q ss_pred cccccCCCccceeeEEeeC--------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRLKHENFVQLLGYCVDG--------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
+.+++|++|..+.+++... ...+++|||++|.+|.+... ++. ....+++.++..+
T Consensus 89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~l 151 (232)
T PRK10359 89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESL 151 (232)
T ss_pred HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHH
Confidence 4678999999999886543 35789999999989988732 332 2455889999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|..| ++|+|++|.|++++.+| ++|+|||........... . ..+....|..++|+|+||+++.
T Consensus 152 H~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~---d-----------~~vler~y~~~~di~~lg~~~~ 213 (232)
T PRK10359 152 HQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK---D-----------RIDLERHYGIKNEIKDLGYYLL 213 (232)
T ss_pred HHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH---H-----------HHHHHhHhcccccccceeEeeh
Confidence 9999 99999999999999988 999999987654221110 0 0233445667899999999987
Q ss_pred HHH
Q 025816 154 ELL 156 (247)
Q Consensus 154 ~l~ 156 (247)
.+.
T Consensus 214 ~~~ 216 (232)
T PRK10359 214 IYK 216 (232)
T ss_pred HHH
Confidence 654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.7e-16 Score=137.46 Aligned_cols=146 Identities=24% Similarity=0.308 Sum_probs=107.1
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc-------------ccccceeccccccCch
Q 025816 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-------------LHSTRVLGTFGYHAPE 132 (247)
Q Consensus 66 ~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE 132 (247)
++.++.|||+.+ |+|||+||+|.+|+.-|++|++|||+.......... ......+||+.|+|||
T Consensus 152 mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 152 MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 378899999999 999999999999999999999999987644221110 0112357999999999
Q ss_pred hhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHh
Q 025816 133 YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAAL 212 (247)
Q Consensus 133 ~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 212 (247)
++.-.+|....|.|++|+++|+++-|..||.++.+........ .+..++. +.....+.+.+++|.+
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi--------sd~i~wp------E~dea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI--------SDDIEWP------EEDEALPPEAQDLIEQ 294 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh--------hhhcccc------ccCcCCCHHHHHHHHH
Confidence 9999999999999999999999999999998764322111100 0011111 1122334569999999
Q ss_pred hcccCCCCCCCHHHHH
Q 025816 213 CVQYEADFRPNMSIVV 228 (247)
Q Consensus 213 cl~~~p~~Rps~~~il 228 (247)
+|+.+|.+|--....+
T Consensus 295 LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 295 LLRQNPLCRLGTGGAL 310 (1205)
T ss_pred HHHhChHhhcccchhh
Confidence 9999999996544333
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.9e-16 Score=122.23 Aligned_cols=202 Identities=22% Similarity=0.314 Sum_probs=138.0
Q ss_pred ccccCCCccceeeEEeeC-----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 3 SRLKHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
-++-|.|||++..|+.+. .+..++.||...|++.+++++..... +.+....-.+|+-||++||.|||+.
T Consensus 122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-----~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-----KALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-----hhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 356799999999888654 35788999999999999998776433 3477888889999999999999998
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCc---chhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA---PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~---~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
+|+++|+++.-+.|++..+|-+|+.- +..... .............+-.+|.+||.=...+.+.++|||++|....+
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 47799999999999999999888743 221111 11111111112235567889986655667789999999999999
Q ss_pred HHhCCCCC-CCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 155 LLTGRKPV-DHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 155 l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
|..+..-- ............. .+....+. ..-+.++.+|+...|+.||++++++...
T Consensus 275 mailEiq~tnseS~~~~ee~ia---------~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIA---------NVIIGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHheeccCCCcceeehhhhhh---------hheeeccC-----------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 97765432 1111100000000 00000111 1145678889999999999999988654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.8e-15 Score=134.02 Aligned_cols=137 Identities=21% Similarity=0.207 Sum_probs=113.2
Q ss_pred eeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCcee
Q 025816 13 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL 92 (247)
Q Consensus 13 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil 92 (247)
+.......+..++|++|...|+|.++++... ...+.....++.|++..|.+||..+ |||+||||+|++
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfl 826 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFL 826 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeE
Confidence 3333445567789999999999999999443 2888899999999999999999999 999999999999
Q ss_pred ecC-------CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 93 IFD-------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 93 ~~~-------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+.. +..++|+|||.+--+........-...++|-.+--+|+..|..++.++|.|.|+.+++-|+.|+..
T Consensus 827 l~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 827 LRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 942 345899999998765444433233456678889999999999999999999999999999998765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-15 Score=114.55 Aligned_cols=94 Identities=19% Similarity=0.176 Sum_probs=70.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHh-hcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL-HEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l-h~~~~~~ 80 (247)
|+++.++++.....+.. . ..++||||+.++++........ .++...+..++.|++.+|.++ |+.|
T Consensus 73 l~~l~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~g--- 138 (190)
T cd05147 73 LKRLVTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDCR--- 138 (190)
T ss_pred HHHHHHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34556666644333222 2 2389999998876655432221 288899999999999999999 6888
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCc
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
++||||||+||+++ ++.++|+|||++...
T Consensus 139 iiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 139 LVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 99999999999998 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3e-16 Score=136.68 Aligned_cols=198 Identities=24% Similarity=0.269 Sum_probs=152.4
Q ss_pred CCCccceeeEEeeCCeeeEEEecCCCCChhhhhc-CCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh-cCCCCCeEec
Q 025816 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH-GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH-EKADPHIIHR 84 (247)
Q Consensus 7 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh-~~~~~~i~h~ 84 (247)
|+|++.+++.....+..++.+++..|+++.+.+. .... ..+...+...+.|+..++.|+| ..+ +.|+
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~--------~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~ 148 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDST--------GTSSSSASRYLPQLNSGLSYLHPENG---VTHR 148 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCcc--------CCCCcchhhhhhhhccCccccCcccc---cccC
Confidence 9999999999999999999999999999999884 3221 1555667778899999999999 888 9999
Q ss_pred cCCCCceeecCCC-ceeeccccccCCcch-hhhcccccceec-cccccCchhhhcCCC-CccccchhhhHHHHHHHhCCC
Q 025816 85 DIKSSNVLIFDDD-VAKIADFDLSNQAPD-MAARLHSTRVLG-TFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 85 di~~~nil~~~~~-~~~l~d~g~~~~~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~ 160 (247)
|++|+|.+++.++ .+++.|||++..... ...........| +..|.|||...+..+ ....|+||+|+++.-+++|..
T Consensus 149 ~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~ 228 (601)
T KOG0590|consen 149 DIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGEL 228 (601)
T ss_pred CCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCC
Confidence 9999999999999 999999999987766 333333344567 899999999888544 678899999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|+.......... ..+.+... .............+++.+++..+|..|.+.+++-.
T Consensus 229 p~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 229 PWDFPSRKDGRY--------------SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred Cccccccccccc--------------eeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 997554433211 11111111 11122334456888899999999999999887643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.1e-15 Score=112.43 Aligned_cols=88 Identities=15% Similarity=0.138 Sum_probs=69.2
Q ss_pred cCCCccceeeEEeeCC---eee-EEEec--CCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHH-HHhhcCCC
Q 025816 6 KHENFVQLLGYCVDGT---SRV-LAYEF--ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL-EYLHEKAD 78 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l-~~lh~~~~ 78 (247)
.||||+++|+++.++. ..+ +|+|| +.+++|.+++.+.. +++. ..++.+++.++ .|||+.+
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~- 125 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNR- 125 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCC-
Confidence 6899999999998875 333 78999 45789999997632 4444 35577777777 9999999
Q ss_pred CCeEeccCCCCceeecCC----CceeeccccccC
Q 025816 79 PHIIHRDIKSSNVLIFDD----DVAKIADFDLSN 108 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~----~~~~l~d~g~~~ 108 (247)
|+||||||+||+++.. +.++|+|++.+.
T Consensus 126 --IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 126 --IVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred --EeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 9999999999999743 379999954443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.5e-15 Score=111.02 Aligned_cols=93 Identities=17% Similarity=0.193 Sum_probs=71.6
Q ss_pred ccccCCCccceeeEEeeCCeeeEEEecCCCCChhhh-hcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCC
Q 025816 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPH 80 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~ 80 (247)
.++.|+++.....+... ..++||||+.|+++... +.... ++......++.|++.++.++|+ .|
T Consensus 74 ~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~g--- 138 (190)
T cd05145 74 KRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVP----------LEEEEAEELYEQVVEQMRRLYQEAG--- 138 (190)
T ss_pred HHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhcc----------CCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 45667776544433332 24899999988754333 33221 7778899999999999999999 88
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcc
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 111 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~ 111 (247)
++|+||||+||+++ ++.++|+|||++....
T Consensus 139 ivHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 139 LVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999999998 8899999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=116.81 Aligned_cols=137 Identities=18% Similarity=0.297 Sum_probs=108.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|+.|+||+|+++++.+..+...|+|.|.+. .|..++++ ++.......+.||+.||.+||..+ ++
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------------l~~~~v~~Gl~qIl~AL~FL~~d~--~l 126 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------------LGKEEVCLGLFQILAALSFLNDDC--NL 126 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------------hHHHHHHHHHHHHHHHHHHHhccC--Ce
Confidence 678999999999999999999999999985 88888876 555667778889999999998554 49
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|++++-.+|+++..|..||++|.++........ ........-.|..|+.+.... ...|.|.|||++++++.|
T Consensus 127 vHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 127 VHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 9999999999999999999999998866543332 111122223456666443222 457999999999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.4e-13 Score=104.45 Aligned_cols=91 Identities=21% Similarity=0.364 Sum_probs=78.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++|+++.....++......+++|||+.|++|.+++.... . .+..++.+++.++.++|+.+ +
T Consensus 53 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~------------~-~~~~i~~~i~~~l~~lH~~~---i 116 (211)
T PRK14879 53 MSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG------------M-EELELSREIGRLVGKLHSAG---I 116 (211)
T ss_pred HHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc------------H-HHHHHHHHHHHHHHHHHhCC---c
Confidence 456778888877777777788899999999999999986421 2 77889999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
+|+|++|.||+++ ++.++++|||.+..
T Consensus 117 ~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 117 IHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred ccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999999 78899999998765
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.39 E-value=5e-13 Score=116.44 Aligned_cols=88 Identities=23% Similarity=0.395 Sum_probs=77.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|++++....++......++||||+++++|.+++. ....++.+++.+|.+||+.+ +
T Consensus 390 l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~g---i 449 (535)
T PRK09605 390 LSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAG---I 449 (535)
T ss_pred HHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCC---C
Confidence 567899999988777777778899999999999988874 24578889999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCc
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
+|||+||+||++ .++.++|+|||+++..
T Consensus 450 iHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 450 VHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999999 6788999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.39 E-value=6e-13 Score=101.35 Aligned_cols=89 Identities=22% Similarity=0.395 Sum_probs=73.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++|+++.....++......+++|||+.|++|.+++.... . .++.+++.+|.+||+.+ +
T Consensus 51 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~g---i 111 (199)
T TIGR03724 51 LSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKAG---I 111 (199)
T ss_pred HHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHCC---e
Confidence 345677776665555666677789999999999998875421 1 77889999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCc
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
+|+|++|.||+++ ++.++++|||.+...
T Consensus 112 ~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 112 VHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999999999 789999999987653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.5e-13 Score=103.42 Aligned_cols=93 Identities=17% Similarity=0.192 Sum_probs=72.0
Q ss_pred cccccCCCc--cceeeEEeeCC----eeeEEEecCCC-CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 2 VSRLKHENF--VQLLGYCVDGT----SRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 2 l~~l~h~~i--~~~~~~~~~~~----~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+++|+|++| +..+++...+. ..++|||++.| .+|.+++.... ++.. .+.+++.+|.+||
T Consensus 94 l~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH 159 (239)
T PRK01723 94 LAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFH 159 (239)
T ss_pred HHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHH
Confidence 456777775 66676644332 23599999987 68988876432 4443 3568899999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcc
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 111 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~ 111 (247)
..| |+|+||||.|||++.++.++|+|||.+....
T Consensus 160 ~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 160 DAG---VYHADLNAHNILLDPDGKFWLIDFDRGELRT 193 (239)
T ss_pred HCC---CCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence 999 9999999999999998999999999887643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.5e-12 Score=100.29 Aligned_cols=77 Identities=18% Similarity=0.219 Sum_probs=62.6
Q ss_pred eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceee
Q 025816 22 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 101 (247)
Q Consensus 22 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l 101 (247)
..++||||+.+.+|........ .+....+..++.|++.++.+||+.+ .++|+||+|+||+++ ++.++|
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~L 189 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVI 189 (237)
T ss_pred CceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEE
Confidence 3589999999877766542221 1555667889999999999999885 499999999999999 889999
Q ss_pred ccccccCCc
Q 025816 102 ADFDLSNQA 110 (247)
Q Consensus 102 ~d~g~~~~~ 110 (247)
+|||.+...
T Consensus 190 iDFg~a~~~ 198 (237)
T smart00090 190 IDVSQSVEL 198 (237)
T ss_pred EEChhhhcc
Confidence 999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.2e-12 Score=106.40 Aligned_cols=195 Identities=21% Similarity=0.202 Sum_probs=144.3
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHH----HHHHhhcCCCCCe
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK----GLEYLHEKADPHI 81 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~----~l~~lh~~~~~~i 81 (247)
.|++.++.+..+..+...++-.|+|. .+|.++....... ++...++..+.+... |+.++|+.+ +
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~--------~p~~~l~~~~~~~~~~~~~al~~~hs~~---~ 243 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNF--------LPDNLLWNSLRDWLSRDVTALSHLHSNN---I 243 (524)
T ss_pred ccccccccCcccccCCcceeeecccc-chhHHhhhccccc--------CCchhhhhHHhhhhhcccccccccCCCc---c
Confidence 58888888888999999999999996 5888887765543 777888888888888 999999998 9
Q ss_pred EeccCCCCceeecCC-CceeeccccccCCcchhhhcccc---cceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 82 IHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMAARLHS---TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
+|.|++|.|++...+ ...+++|||+...+......... ....+...|.+||...+ .++...|++++|.++.+...
T Consensus 244 ~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l 322 (524)
T KOG0601|consen 244 VHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAIL 322 (524)
T ss_pred cccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHh
Confidence 999999999999999 78999999998877654422111 12257778999997655 67889999999999999988
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+..+..... ...+.+.-......++-...+.++...+..++..+|..|++++.+.+
T Consensus 323 ~~~~~~~g~----------------~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 323 GSHLPSVGK----------------NSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hcccccCCC----------------CCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 766543210 00011110001111222223445666999999999999999988765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=8.6e-12 Score=94.95 Aligned_cols=72 Identities=17% Similarity=0.192 Sum_probs=60.8
Q ss_pred CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCcee
Q 025816 21 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 100 (247)
Q Consensus 21 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~ 100 (247)
...+++|||+.|++|.+.... .....++.+++.++.++|..+ ++|+||+|.||+++.++.++
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEE
Confidence 355899999999888765321 234578889999999999998 99999999999999999999
Q ss_pred eccccccCCc
Q 025816 101 IADFDLSNQA 110 (247)
Q Consensus 101 l~d~g~~~~~ 110 (247)
|+|||.+...
T Consensus 166 liDfg~~~~~ 175 (198)
T cd05144 166 IIDWPQMVST 175 (198)
T ss_pred EEECCccccC
Confidence 9999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.3e-09 Score=87.59 Aligned_cols=201 Identities=19% Similarity=0.221 Sum_probs=129.8
Q ss_pred eeEEEecCCCC-ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceee
Q 025816 23 RVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 101 (247)
Q Consensus 23 ~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l 101 (247)
..++|+.+.+- .+..+.......+.. +-..|..++.+++.++.+.+.||..| .+-+|++++|+|++.+++++|
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~---P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~L 158 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSY---PHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVL 158 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccC---CccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEE
Confidence 56788877653 344444333322222 23789999999999999999999999 999999999999999999999
Q ss_pred ccccccCCcchhhhcccccceeccccccCchhhhc-----CCCCccccchhhhHHHHHHHhC-CCCCCCCCCCC-Ccc--
Q 025816 102 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTG-RKPVDHTLPRG-QQS-- 172 (247)
Q Consensus 102 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g-~~pf~~~~~~~-~~~-- 172 (247)
.|-+-.....+... .-...|...|++||.-.- ..-+...|.|.||+++++++.| ..||.+.-... ...
T Consensus 159 VdsDsfqi~~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~ 235 (637)
T COG4248 159 VDSDSFQINANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL 235 (637)
T ss_pred EcccceeeccCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence 98654333211111 123457888999997652 2346689999999999999885 89997542111 000
Q ss_pred --hhhhccccCCcchhhhhcccccC---CCCC-HHHHHHHHHHHHhhccc--CCCCCCCHHHHHHHHHHhHhc
Q 025816 173 --LVTWATPKLSEDKVRQCVDARLG---GDYP-PKAVAKMAAVAALCVQY--EADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 173 --~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~l~~li~~cl~~--~p~~Rps~~~il~~l~~~~~~ 237 (247)
-+....-....+ + ..+.+ .+.+ .-.+.++..+..+|+.. ++.-|||++..+..|..+.++
T Consensus 236 E~~Ia~g~f~ya~~--~---~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 236 ETDIAHGRFAYASD--Q---RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hhhhhcceeeechh--c---cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 000000000000 0 00000 0111 12355688888899854 478999999999998877654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.15 E-value=9e-11 Score=84.83 Aligned_cols=92 Identities=21% Similarity=0.246 Sum_probs=74.0
Q ss_pred ccccC--CCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 3 SRLKH--ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 3 ~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+.++| .+++++++++..++..+++|||+.++.+..+ +......++.+++.++..+|.....+
T Consensus 46 ~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~ 109 (155)
T cd05120 46 QLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLV 109 (155)
T ss_pred HHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----------------CHHHHHHHHHHHHHHHHHHhCCCceE
Confidence 44555 5888888888888889999999988766544 22455677889999999999853234
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCc
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
++|+|++|.|++++..+.++++|||.+...
T Consensus 110 i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred EEecCCCcceEEEECCcEEEEEecccccCC
Confidence 999999999999999899999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2e-10 Score=102.50 Aligned_cols=193 Identities=22% Similarity=0.233 Sum_probs=135.3
Q ss_pred CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 025816 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI 86 (247)
Q Consensus 7 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di 86 (247)
+|-++..+-.+.-....+|+++|..+++|...++.... ...+-+...+..+..+..+||... +.|+|+
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~~---r~h~~~ 930 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSSL---RKHRDL 930 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccch---hhcccc
Confidence 34444444334455678899999999999998876542 333334445556678899999997 899999
Q ss_pred CCCceeecCCCceeeccccccCCcchhh-----------------------------hcccccceeccccccCchhhhcC
Q 025816 87 KSSNVLIFDDDVAKIADFDLSNQAPDMA-----------------------------ARLHSTRVLGTFGYHAPEYAMTG 137 (247)
Q Consensus 87 ~~~nil~~~~~~~~l~d~g~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~ 137 (247)
+|.|.+...++..++.||+......... .........+|..|.+||...+.
T Consensus 931 ~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~ 1010 (1205)
T KOG0606|consen 931 KPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR 1010 (1205)
T ss_pred cccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc
Confidence 9999999999999999987433221110 00111234588999999999999
Q ss_pred CCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccC
Q 025816 138 QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYE 217 (247)
Q Consensus 138 ~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 217 (247)
.....+|.|++|+++++.++|.+||....++.....+......+ ...+...+.+..+++...+..+
T Consensus 1011 ~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~--------------p~g~~~~s~~aq~~~~~ll~~~ 1076 (1205)
T KOG0606|consen 1011 RHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPW--------------PEGPEEGSYEAQDLINRLLTEE 1076 (1205)
T ss_pred cCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCC--------------CCCccccChhhhhhhhhhhccC
Confidence 99999999999999999999999998654432221111111111 1233455567888889999999
Q ss_pred CCCCCCHH
Q 025816 218 ADFRPNMS 225 (247)
Q Consensus 218 p~~Rps~~ 225 (247)
|..|-.+.
T Consensus 1077 ~~qr~~a~ 1084 (1205)
T KOG0606|consen 1077 PTQRLGAK 1084 (1205)
T ss_pred chhccCcc
Confidence 98888766
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-09 Score=89.56 Aligned_cols=185 Identities=12% Similarity=0.136 Sum_probs=131.9
Q ss_pred CcccccCCCccceeeEEe----eCCeeeEEEecCCC-CChhhhhcCCCCCC------CCCCCCCcCHHHHHHHHHHHHHH
Q 025816 1 MVSRLKHENFVQLLGYCV----DGTSRVLAYEFASN-GSLHDILHGRKGVK------GAQPGPVLSWQQRVKIAVGAAKG 69 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~ 69 (247)
+++++.|.|+|++-++|. .+..+++|++|+.+ ++|.++.-...... ....+..+++..+|..+.|++.|
T Consensus 326 ~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaa 405 (655)
T KOG3741|consen 326 AWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAA 405 (655)
T ss_pred HHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHH
Confidence 367899999999998886 34578999999754 57877764433222 12334448889999999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhh
Q 025816 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFG 149 (247)
Q Consensus 70 l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 149 (247)
|.++|+.| +.-+-+.+.+|+++++.+++|..+|......... . +.+.+ ..+.|.-.||
T Consensus 406 L~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--------------~--~~le~---~Qq~D~~~lG 463 (655)
T KOG3741|consen 406 LYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--------------T--EPLES---QQQNDLRDLG 463 (655)
T ss_pred HHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCC--------------C--cchhH---HhhhhHHHHH
Confidence 99999999 9999999999999999999999888765432211 0 11111 2356899999
Q ss_pred HHHHHHHhCCCC-CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 150 VVLLELLTGRKP-VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 150 ~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
.++..+.+|..- +..+ ..++. -.......++.++++++......++++ -+..+++
T Consensus 464 ~ll~aLAt~~~ns~~~d-------------------~~~~s----~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 464 LLLLALATGTENSNRTD-------------------STQSS----HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred HHHHHHhhccccccccc-------------------chHHH----HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 999999987442 1100 00000 001233566788999999999988887 7888887
Q ss_pred HHH
Q 025816 229 KAL 231 (247)
Q Consensus 229 ~~l 231 (247)
..+
T Consensus 520 p~~ 522 (655)
T KOG3741|consen 520 PMI 522 (655)
T ss_pred HHH
Confidence 754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.3e-10 Score=98.27 Aligned_cols=159 Identities=16% Similarity=0.256 Sum_probs=108.8
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhccc-------ccceeccccc
Q 025816 56 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-------STRVLGTFGY 128 (247)
Q Consensus 56 ~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~-------~~~~~~~~~y 128 (247)
.+....=+.+++.|+.++|... ++||++|.|++|.++.++..||+.|+.+........... .........|
T Consensus 98 Te~~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f 175 (700)
T KOG2137|consen 98 TEDGFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNF 175 (700)
T ss_pred ccHhhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccc
Confidence 3444555567779999999875 599999999999999999999999998765543211111 0112345679
Q ss_pred cCchhhhcCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHH
Q 025816 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMA 207 (247)
Q Consensus 129 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 207 (247)
.|||.+.+..-+.++|+||+|+++|.+.. |+.-+........ .......+......+..+.+.++.
T Consensus 176 ~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-------------~~~~~~~~~~~~~~~s~~~p~el~ 242 (700)
T KOG2137|consen 176 LAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-------------YSFSRNLLNAGAFGYSNNLPSELR 242 (700)
T ss_pred ccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcch-------------hhhhhcccccccccccccCcHHHH
Confidence 99999998778899999999999999984 5555543211111 011111111111123345567799
Q ss_pred HHHHhhcccCCCCCCCHHHHHH
Q 025816 208 AVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 208 ~li~~cl~~~p~~Rps~~~il~ 229 (247)
+-+.+++..+..-||++.+++.
T Consensus 243 ~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 243 ESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHHhcCCcccCcchhhhhc
Confidence 9999999999999997766643
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.98 E-value=7e-10 Score=83.56 Aligned_cols=75 Identities=19% Similarity=0.237 Sum_probs=58.7
Q ss_pred eeeEEEecCCCCChhhh-hcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCceeecCCCce
Q 025816 22 SRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVA 99 (247)
Q Consensus 22 ~~~lv~e~~~~~~L~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~i~h~di~~~nil~~~~~~~ 99 (247)
..+++|||+.++++... +.... .. ..+..++.+++.++.++|. .+ ++|+||+|+||+++ ++.+
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~----------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR----------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh----------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcE
Confidence 45899999988543221 11110 11 5678899999999999999 88 99999999999999 8899
Q ss_pred eeccccccCCcc
Q 025816 100 KIADFDLSNQAP 111 (247)
Q Consensus 100 ~l~d~g~~~~~~ 111 (247)
+++|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.7e-10 Score=93.49 Aligned_cols=196 Identities=17% Similarity=0.145 Sum_probs=136.8
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
.|.|++..+..+....+.++=.|||+++++...+.... . +.+...+.+..|++.++.++|+.. ++|+|
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~--~-------~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d 391 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQ--M-------LDEDPRLRLTAQILTALNVIHSKL---FVHLD 391 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhHHHH--h-------cCcchhhhhHHHHHhccccccchh---hhccc
Confidence 57888888888888888888999999887776662221 1 667778899999999999999999 99999
Q ss_pred CCCCceeecCC-CceeeccccccCCcchhhhcccccceeccccc-cCchhhhcCCCCccccchhhhHHHHHHHhCCCCCC
Q 025816 86 IKSSNVLIFDD-DVAKIADFDLSNQAPDMAARLHSTRVLGTFGY-HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163 (247)
Q Consensus 86 i~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 163 (247)
++|.||++..+ +..+++|||......-... .....+..| .++.......+-.+.|+++||..+.+.+++...-.
T Consensus 392 ~~psni~i~~~~~~~~~~~~~~~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 392 VKPSNILISNDGFFSKLGDFGCWTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred ccccceeeccchhhhhccccccccccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 99999999886 7788999998764211110 111122233 34555555677889999999999999988765422
Q ss_pred CCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 164 HTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
. ...+..+... .-...+ ...+.+..+.+.++..++..||++.++..........
T Consensus 468 ~------------------~~~~~~i~~~-~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 468 S------------------GVQSLTIRSG-DTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred c------------------cccceeeecc-cccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 1 1111111111 111122 2236788889999999999999999887766554433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.7e-09 Score=79.52 Aligned_cols=85 Identities=18% Similarity=0.199 Sum_probs=61.6
Q ss_pred CccceeeEEeeCCeeeEEEecCCCCChhh-hhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHh-hcCCCCCeEeccC
Q 025816 9 NFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL-HEKADPHIIHRDI 86 (247)
Q Consensus 9 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l-h~~~~~~i~h~di 86 (247)
+++..+++ ...++||||+.++.+.. .+.... ++......+..+++.++..+ |+.+ ++|+|+
T Consensus 89 ~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~----------~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 89 PCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAK----------LNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred CCCeEEEe----cCCEEEEEEcCCCCccchhhhccc----------cCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 34445543 45679999997643321 122111 45556677889999999988 8888 999999
Q ss_pred CCCceeecCCCceeeccccccCCcc
Q 025816 87 KSSNVLIFDDDVAKIADFDLSNQAP 111 (247)
Q Consensus 87 ~~~nil~~~~~~~~l~d~g~~~~~~ 111 (247)
++.||++. ++.++++|||.+-...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.79 E-value=7.6e-09 Score=87.83 Aligned_cols=79 Identities=23% Similarity=0.343 Sum_probs=60.3
Q ss_pred CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHH-HHHHhhcCCCCCeEeccCCCCceeecCCCc
Q 025816 20 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK-GLEYLHEKADPHIIHRDIKSSNVLIFDDDV 98 (247)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~l~~lh~~~~~~i~h~di~~~nil~~~~~~ 98 (247)
....+++|||++|++|.++....... .. ...++..++. .+..+|..| ++|+|++|.||+++.++.
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~--------~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~ 295 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAG--------LD---RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGK 295 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcC--------CC---HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCc
Confidence 34568999999999998876432110 21 2345555555 467889998 999999999999999999
Q ss_pred eeeccccccCCcch
Q 025816 99 AKIADFDLSNQAPD 112 (247)
Q Consensus 99 ~~l~d~g~~~~~~~ 112 (247)
++++|||++.....
T Consensus 296 i~liDfG~~~~l~~ 309 (437)
T TIGR01982 296 IIALDFGIVGRLSE 309 (437)
T ss_pred EEEEeCCCeeECCH
Confidence 99999999876654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=4e-08 Score=77.88 Aligned_cols=79 Identities=16% Similarity=0.084 Sum_probs=63.8
Q ss_pred CeeeEEEecCCCC-ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecC----
Q 025816 21 TSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---- 95 (247)
Q Consensus 21 ~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~---- 95 (247)
...++|+|++.+. +|.+++...... .........++.+++..+.-||..| ++|+|+++.|||++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~ 177 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG 177 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC
Confidence 3578999999875 798887532111 1455677789999999999999999 999999999999975
Q ss_pred ---CCceeeccccccCC
Q 025816 96 ---DDVAKIADFDLSNQ 109 (247)
Q Consensus 96 ---~~~~~l~d~g~~~~ 109 (247)
++.+.++||+.+..
T Consensus 178 ~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 178 REEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCceEEEEECCcccc
Confidence 46799999998753
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.5e-08 Score=75.03 Aligned_cols=80 Identities=24% Similarity=0.223 Sum_probs=58.0
Q ss_pred cceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC--CCCeEeccCCC
Q 025816 11 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--DPHIIHRDIKS 88 (247)
Q Consensus 11 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~--~~~i~h~di~~ 88 (247)
.+++.+. ....++||||++|.++.+. . .. ....+.+++.+++.||..+ ...++|+|++|
T Consensus 56 P~~~~~~--~~~~~lv~e~i~G~~l~~~----~----------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~ 116 (170)
T cd05151 56 PKLYYFD--PETGVLITEFIEGSELLTE----D----------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLP 116 (170)
T ss_pred CceEEEe--CCCCeEEEEecCCCccccc----c----------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCc
Confidence 4455433 3345799999998877543 0 11 1234568899999999987 22359999999
Q ss_pred CceeecCCCceeeccccccCCc
Q 025816 89 SNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 89 ~nil~~~~~~~~l~d~g~~~~~ 110 (247)
.||+++ ++.++++||+.+...
T Consensus 117 ~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 117 GNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred CcEEEE-CCeEEEEecccccCC
Confidence 999999 668999999987753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.9e-08 Score=72.80 Aligned_cols=74 Identities=23% Similarity=0.371 Sum_probs=59.8
Q ss_pred EeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCC
Q 025816 17 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 96 (247)
Q Consensus 17 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~ 96 (247)
..+.....++|||+.|..|.+.+... ...++..+-.-+.-||..| |+|+|+.++|+++.+.
T Consensus 68 dvD~~~~~I~me~I~G~~lkd~l~~~----------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~ 128 (204)
T COG3642 68 DVDPDNGLIVMEYIEGELLKDALEEA----------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG 128 (204)
T ss_pred EEcCCCCEEEEEEeCChhHHHHHHhc----------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCC
Confidence 44555667999999998888888754 1345666777788999999 9999999999999776
Q ss_pred CceeeccccccCCc
Q 025816 97 DVAKIADFDLSNQA 110 (247)
Q Consensus 97 ~~~~l~d~g~~~~~ 110 (247)
+ +.++|||++...
T Consensus 129 ~-i~~IDfGLg~~s 141 (204)
T COG3642 129 R-IYFIDFGLGEFS 141 (204)
T ss_pred c-EEEEECCccccc
Confidence 5 889999998754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=9.6e-08 Score=73.09 Aligned_cols=89 Identities=25% Similarity=0.272 Sum_probs=70.5
Q ss_pred ccceeeEEeeC----CeeeEEEecCCCC-ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 10 FVQLLGYCVDG----TSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 10 i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
.++.+++.... ...++|+|++++. +|.+++..... ........++.+++..+.-||..| ++|+
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll~~l~~~i~~lH~~g---i~H~ 142 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELLRALARLIAKLHDAG---IYHG 142 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHHHHHHHHHHHHHHCc---CCCC
Confidence 34455555543 2458999999874 79999876432 445667889999999999999999 9999
Q ss_pred cCCCCceeecCCC---ceeeccccccCCc
Q 025816 85 DIKSSNVLIFDDD---VAKIADFDLSNQA 110 (247)
Q Consensus 85 di~~~nil~~~~~---~~~l~d~g~~~~~ 110 (247)
|+++.|||++.++ .+.++||+.++..
T Consensus 143 Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 143 DLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred CCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999887 8999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.1e-07 Score=69.63 Aligned_cols=85 Identities=22% Similarity=0.326 Sum_probs=65.7
Q ss_pred EEeeCCeeeEEEecCCC-CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeec
Q 025816 16 YCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF 94 (247)
Q Consensus 16 ~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~ 94 (247)
++.+.+.-.++|||++| .++.+++....... ...+....++..+-..|.-||.++ ++|+|+..+||++.
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~ 147 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLR 147 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEe
Confidence 35566677799999975 38888887655432 222334788889999999999999 99999999999996
Q ss_pred CCC---ceeeccccccCCc
Q 025816 95 DDD---VAKIADFDLSNQA 110 (247)
Q Consensus 95 ~~~---~~~l~d~g~~~~~ 110 (247)
..+ .+.++|||++...
T Consensus 148 ~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 148 SDGNQITPILIDFGLSSVS 166 (229)
T ss_pred cCCCcCceEEEeecchhcc
Confidence 655 3589999988754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.4e-07 Score=70.73 Aligned_cols=83 Identities=20% Similarity=0.273 Sum_probs=52.0
Q ss_pred CccceeeEEeeCCeeeEEEecCC--CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHH-hhcCCCCCeEecc
Q 025816 9 NFVQLLGYCVDGTSRVLAYEFAS--NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY-LHEKADPHIIHRD 85 (247)
Q Consensus 9 ~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~-lh~~~~~~i~h~d 85 (247)
++.+.+++- ..++||||+. |..+..+.... +.......++.+++..+.. +|..| ++|+|
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGD 132 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILEEIIKMLHKAG---IVHGD 132 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHHHHHHHHHhcC---ceecC
Confidence 345555432 3469999998 65554444322 2234456677777774444 57888 99999
Q ss_pred CCCCceeecCCCceeeccccccCCc
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
+++.||+++.+ .+.++|||.+...
T Consensus 133 Ls~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 133 LSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp -STTSEEEETT-CEEE--GTTEEET
T ss_pred CChhhEEeecc-eEEEEecCcceec
Confidence 99999999887 8999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.46 E-value=6e-07 Score=67.50 Aligned_cols=95 Identities=32% Similarity=0.370 Sum_probs=74.8
Q ss_pred cccccC-CCccceeeEEeeCCeeeEEEecCCCCChhhh---hcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 2 VSRLKH-ENFVQLLGYCVDGTSRVLAYEFASNGSLHDI---LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 2 l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
|+.+++ +++++++|+|- .+++.||...++++.. +.... .-+|..+.+++.++++.+.+|+...
T Consensus 13 l~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~---------~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 13 LQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFL---------QSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred HHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccccc---------ccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 445566 59999999983 3578999876666532 11111 1789999999999999999999865
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCC
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
...+..+|++++|+.++.+|++|++|.+.+..
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 44599999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-06 Score=67.87 Aligned_cols=92 Identities=26% Similarity=0.369 Sum_probs=65.7
Q ss_pred CccceeeEEeeCC---eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC--------
Q 025816 9 NFVQLLGYCVDGT---SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-------- 77 (247)
Q Consensus 9 ~i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~-------- 77 (247)
++.+++.+..... ..++||||+.|.++.+.+.... ++......++.+++.+|..||+..
T Consensus 58 ~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ 127 (223)
T cd05154 58 PVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLRPE----------LSPEERRALARALADTLAALHSVDPAAVGLGD 127 (223)
T ss_pred CCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCCCC----------CCHHHHHHHHHHHHHHHHHHhCCChhhcCCcc
Confidence 4566777665532 5689999999988877654211 555666666677777777776421
Q ss_pred ---------------------------------------------CCCeEeccCCCCceeecC--CCceeeccccccCCc
Q 025816 78 ---------------------------------------------DPHIIHRDIKSSNVLIFD--DDVAKIADFDLSNQA 110 (247)
Q Consensus 78 ---------------------------------------------~~~i~h~di~~~nil~~~--~~~~~l~d~g~~~~~ 110 (247)
...++|+|+.+.||+++. ++.+.++||+.+...
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 128 LGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred cCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 134799999999999988 566889999987653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.4e-07 Score=78.48 Aligned_cols=80 Identities=14% Similarity=0.116 Sum_probs=53.1
Q ss_pred CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCC--
Q 025816 20 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-- 97 (247)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~-- 97 (247)
....+|||||+.|+.+.++-.-.... . ....+....+..++.|+ ...| ++|+|++|.||+++.+|
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g--~-d~~~la~~~v~~~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~ 299 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAG--T-DMKLLAERGVEVFFTQV-------FRDG---FFHADMHPGNIFVSYDPPE 299 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcC--C-CHHHHHHHHHHHHHHHH-------HhCC---eeeCCCChHHeEEecCCCC
Confidence 34667999999999998752211100 0 00013333333334443 3466 99999999999999888
Q ss_pred --ceeeccccccCCcch
Q 025816 98 --VAKIADFDLSNQAPD 112 (247)
Q Consensus 98 --~~~l~d~g~~~~~~~ 112 (247)
.++++|||++.....
T Consensus 300 ~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 300 NPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCeEEEEecceEEECCH
Confidence 999999999876644
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.4e-06 Score=65.04 Aligned_cols=68 Identities=24% Similarity=0.330 Sum_probs=52.7
Q ss_pred CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCcee
Q 025816 21 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 100 (247)
Q Consensus 21 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~ 100 (247)
...+++|||++|..|.+... +.. .+...+.+++.-+|+.| ++|+|..|.|++++.++ ++
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EE
Confidence 34568999999988876643 332 23456677899999999 99999999999998655 88
Q ss_pred eccccccCC
Q 025816 101 IADFDLSNQ 109 (247)
Q Consensus 101 l~d~g~~~~ 109 (247)
++|++..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.6e-06 Score=65.61 Aligned_cols=73 Identities=15% Similarity=0.215 Sum_probs=57.0
Q ss_pred CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCcee
Q 025816 21 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 100 (247)
Q Consensus 21 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~ 100 (247)
++..+|||+++|-.|.... +..++...++..|+..+.-+-..| ++|+|+++-||+++.+|.++
T Consensus 180 nRHaVvMe~ieG~eL~~~r--------------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLR--------------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred ccceeeeehcccceeeccc--------------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEE
Confidence 5678999999986665554 223445566667777777666777 99999999999999999999
Q ss_pred eccccccCCc
Q 025816 101 IADFDLSNQA 110 (247)
Q Consensus 101 l~d~g~~~~~ 110 (247)
++||-.+...
T Consensus 243 vIDwPQ~v~~ 252 (304)
T COG0478 243 VIDWPQAVPI 252 (304)
T ss_pred EEeCcccccC
Confidence 9999877643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.1e-05 Score=61.24 Aligned_cols=79 Identities=15% Similarity=0.080 Sum_probs=63.7
Q ss_pred eeeEEEecCCC-CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCc--
Q 025816 22 SRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-- 98 (247)
Q Consensus 22 ~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~-- 98 (247)
+-+||+|-+.+ .+|.+++....... .+......++.+++.+|+-||..| +.|+|+.+.||+++.+|.
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~-------~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~ 168 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSP-------YSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAE 168 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCC-------cchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCee
Confidence 46799997653 48888876543211 566777899999999999999999 999999999999987777
Q ss_pred eeeccccccCCc
Q 025816 99 AKIADFDLSNQA 110 (247)
Q Consensus 99 ~~l~d~g~~~~~ 110 (247)
+.++||.-++..
T Consensus 169 v~lIDlEk~r~~ 180 (216)
T PRK09902 169 AGFLDLEKSRRR 180 (216)
T ss_pred EEEEEhhccchh
Confidence 999999876643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.80 E-value=6.3e-05 Score=69.30 Aligned_cols=189 Identities=19% Similarity=0.252 Sum_probs=126.1
Q ss_pred cccccCCCccceeeEEeeCCee----eEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
+...+|+|++.++.+-..+... .+..++|..-++.+.++.... ++....+.+..+..+|+.++|+..
T Consensus 236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---------i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---------IPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---------cCHHHHHHHHHHHhhhHHHHHHhc
Confidence 4567999999999886554332 344667777778777765542 888999999999999999999986
Q ss_pred CCCeEeccCCCC---ceeecCCCceeec--cccccCCcchhhhcccccceeccccccCchhhhcCCCCc--cccchhhhH
Q 025816 78 DPHIIHRDIKSS---NVLIFDDDVAKIA--DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA--KSDVYSFGV 150 (247)
Q Consensus 78 ~~~i~h~di~~~---nil~~~~~~~~l~--d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~DvwslG~ 150 (247)
..|.-+... +.-.+..+.+..+ ||+.+......... .....+..+.++|......++. ..|+|.+|.
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 666655554 3444555556655 77776655433221 2223344567888776655444 479999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
....+..|..+-... ......++ ........+...+|+..++++|+++.++++.
T Consensus 381 l~~~~~~~~~i~~~~------------------~~~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS------------------AVPVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCcccccc------------------cchhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 999998766543211 00011110 0111157788889999999999999999985
Q ss_pred H
Q 025816 231 L 231 (247)
Q Consensus 231 l 231 (247)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=7.6e-06 Score=70.74 Aligned_cols=144 Identities=21% Similarity=0.218 Sum_probs=103.7
Q ss_pred CcccccCCC-ccceeeEEeeCCeeeEEEecCCCC-ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHEN-FVQLLGYCVDGTSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+|.+++||| .+..++.+..+....+.|+++.++ +.........- .+...+.....+.-+++++++|+..
T Consensus 286 LLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~--------~~~~~~~~~~~r~et~~l~~l~~~~- 356 (829)
T KOG0576|consen 286 LLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEI--------ALEQYQFAYPLRKETRPLAELHSSY- 356 (829)
T ss_pred HHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhH--------hhhhhhhhhhhhhhccccccccccc-
Confidence 467899999 777777777777889999999876 33322222111 1444555666777788999999875
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
-+|+| ||+.++ +..+..+++......... ......++..++|||......+....|+|+++.--.++.-|
T Consensus 357 --~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~ 426 (829)
T KOG0576|consen 357 --KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPG 426 (829)
T ss_pred --ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCC
Confidence 58887 666544 678899999877554332 22445688899999999998999999999999876677667
Q ss_pred CCCCC
Q 025816 159 RKPVD 163 (247)
Q Consensus 159 ~~pf~ 163 (247)
.+|-.
T Consensus 427 ~pPr~ 431 (829)
T KOG0576|consen 427 LPPRS 431 (829)
T ss_pred CCCCC
Confidence 76643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.001 Score=51.69 Aligned_cols=31 Identities=13% Similarity=0.146 Sum_probs=26.7
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
+.++|+|+.|.|++++.++ +.++||+.+...
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 3489999999999999888 999999987653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00083 Score=50.89 Aligned_cols=87 Identities=17% Similarity=0.242 Sum_probs=62.9
Q ss_pred cccCCCccceeeEEeeCCeeeEEEecCCC------CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 4 RLKHENFVQLLGYCVDGTSRVLAYEFASN------GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
...+.+|.++||+.+++....+|+|.+.+ -+|.+++.... ++. ...+.+. .-..+|-...
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~~~~L~---~f~~~l~~~~ 138 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-ELRQALD---EFKRYLLDHH 138 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HHHHHHH---HHHHHHHHcC
Confidence 34578999999999999999999998532 27888885443 554 3444444 4456667776
Q ss_pred CCCeEeccCCCCceeecCCC----ceeecc-cccc
Q 025816 78 DPHIIHRDIKSSNVLIFDDD----VAKIAD-FDLS 107 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~----~~~l~d-~g~~ 107 (247)
|+.+|++|.||++...+ .++|+| ||-.
T Consensus 139 ---Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 139 ---IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ---CeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence 99999999999995433 577877 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.00014 Score=61.80 Aligned_cols=42 Identities=26% Similarity=0.415 Sum_probs=34.2
Q ss_pred CcccccCCCccceeeEEeeC-CeeeEEEecCCCCChhhhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDG-TSRVLAYEFASNGSLHDILHGRK 43 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~ 43 (247)
+++.++|+|...++++.... .+..+|||++.. ||++.+..+.
T Consensus 35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~ 77 (725)
T KOG1093|consen 35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN 77 (725)
T ss_pred HHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc
Confidence 46889999999999877554 467889999964 9999987765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00096 Score=51.78 Aligned_cols=53 Identities=15% Similarity=0.229 Sum_probs=43.3
Q ss_pred CHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCceeecCCCceeeccccccCCcc
Q 025816 55 SWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 111 (247)
Q Consensus 55 ~~~~~~~~~~~~~~~l~~lh~-~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~ 111 (247)
....+..+..+++..+.-|-. .+ ++|+|++.-|||+. ++.+.++|++.+....
T Consensus 164 e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 164 ELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 333566777788888888777 66 99999999999999 8889999999887554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.002 Score=50.61 Aligned_cols=31 Identities=13% Similarity=0.137 Sum_probs=26.9
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCC
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
+.++|+|+.|.||++++++.+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 4599999999999999977788999997754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00093 Score=57.87 Aligned_cols=81 Identities=22% Similarity=0.284 Sum_probs=55.3
Q ss_pred CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCce
Q 025816 20 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 99 (247)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~ 99 (247)
.....|+|||++|..+.+...-.... +..+.+.....++ -+..+-..| ++|.|..|.|++++.+|++
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~~g--------~d~k~ia~~~~~~--f~~q~~~dg---ffHaDpHpGNi~v~~~g~i 304 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKSAG--------IDRKELAELLVRA--FLRQLLRDG---FFHADPHPGNILVRSDGRI 304 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHhcC--------CCHHHHHHHHHHH--HHHHHHhcC---ccccCCCccceEEecCCcE
Confidence 45678999999998888885322211 3323322222221 223333356 9999999999999999999
Q ss_pred eeccccccCCcchh
Q 025816 100 KIADFDLSNQAPDM 113 (247)
Q Consensus 100 ~l~d~g~~~~~~~~ 113 (247)
.+.|||+.......
T Consensus 305 ~~lDfGi~g~l~~~ 318 (517)
T COG0661 305 VLLDFGIVGRLDPK 318 (517)
T ss_pred EEEcCcceecCCHH
Confidence 99999998776543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.89 E-value=4.8e-05 Score=72.04 Aligned_cols=153 Identities=11% Similarity=-0.052 Sum_probs=106.0
Q ss_pred cccCCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC--CC
Q 025816 4 RLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--DP 79 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~--~~ 79 (247)
..+|+++...+.=... +...+..++++.+|.+.+.+-+....... +...-+.-.-.+.+....-+|... ..
T Consensus 1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~-----ld~~~v~~~~kvsvl~~~~~ls~tnlg~ 1359 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPD-----LDRSPVHLRHKVSVLNRNVILSLTNLGN 1359 (2724)
T ss_pred hhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCc-----chhchHHHHHHHHHhccchhhhcccCCc
Confidence 3567777666544432 23457889999999999999766543211 222222222223255555555442 44
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
.-+|+++++.|.+|..+-.+++.++|+.+...+.. ...+...+++.|+++++...-+++.++|+|..|+-+|....|.
T Consensus 1360 T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1360 TNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred cchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 58899999999999999999999999988322211 1234456777889999988889999999999999999988888
Q ss_pred CCCC
Q 025816 160 KPVD 163 (247)
Q Consensus 160 ~pf~ 163 (247)
.+|.
T Consensus 1438 ~~fi 1441 (2724)
T KOG1826|consen 1438 AYFI 1441 (2724)
T ss_pred HHHH
Confidence 7763
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0036 Score=54.29 Aligned_cols=82 Identities=22% Similarity=0.235 Sum_probs=53.9
Q ss_pred CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecC----
Q 025816 20 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---- 95 (247)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~---- 95 (247)
.....|+|||++|..+.|+-.-.... +....+..-+.+... ..+-..| ++|+|=.|.||++..
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i~~~g--------i~~~~i~~~l~~~~~--~qIf~~G---ffHaDPHPGNilv~~~~~~ 340 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAIDKRG--------ISPHDILNKLVEAYL--EQIFKTG---FFHADPHPGNILVRPNPEG 340 (538)
T ss_pred CcceEEEEEecCCccCCCHHHHHHcC--------CCHHHHHHHHHHHHH--HHHHhcC---CccCCCCCCcEEEecCCCC
Confidence 34678999999998666653222111 555544444433322 2222345 999999999999984
Q ss_pred CCceeeccccccCCcchhh
Q 025816 96 DDVAKIADFDLSNQAPDMA 114 (247)
Q Consensus 96 ~~~~~l~d~g~~~~~~~~~ 114 (247)
++.+++.|+|+.....+..
T Consensus 341 ~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 341 DEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred CccEEEEcccccccccHHH
Confidence 5679999999988765443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0071 Score=56.03 Aligned_cols=32 Identities=28% Similarity=0.467 Sum_probs=25.2
Q ss_pred CeEeccCCCCceeecCC-Cc-eeeccccccCCcc
Q 025816 80 HIIHRDIKSSNVLIFDD-DV-AKIADFDLSNQAP 111 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~-~~-~~l~d~g~~~~~~ 111 (247)
.++|+|+++.|++++.. +. .-|.||.++....
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 49999999999999753 33 5788998876653
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0089 Score=49.22 Aligned_cols=72 Identities=19% Similarity=0.205 Sum_probs=56.7
Q ss_pred eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceee
Q 025816 22 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 101 (247)
Q Consensus 22 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l 101 (247)
..|++|++. |+++.-.-. ..++++..++++.+..+.-+.+.- +.-||++...||+|+ +|.+.|
T Consensus 300 y~yl~~kdh-gt~is~ik~-------------~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtL 362 (488)
T COG5072 300 YLYLHFKDH-GTPISIIKA-------------DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTL 362 (488)
T ss_pred EEEEEEecC-Cceeeeeec-------------ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEE
Confidence 456777765 445533221 567889999999999888888764 589999999999999 999999
Q ss_pred ccccccCCc
Q 025816 102 ADFDLSNQA 110 (247)
Q Consensus 102 ~d~g~~~~~ 110 (247)
+||-+++..
T Consensus 363 IDfklsRl~ 371 (488)
T COG5072 363 IDFKLSRLS 371 (488)
T ss_pred EEeeeeecc
Confidence 999999853
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.0042 Score=50.36 Aligned_cols=75 Identities=17% Similarity=0.231 Sum_probs=57.4
Q ss_pred CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCce
Q 025816 20 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 99 (247)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~ 99 (247)
-++.++|||++.|-.|.+..+-. ....+...++.-|.-|-..| ++|+|++--||++..++++
T Consensus 180 ~~RH~Vvmelv~g~Pl~~v~~v~---------------d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 180 HNRHCVVMELVDGYPLRQVRHVE---------------DPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred ccceeeHHHhhcccceeeeeecC---------------ChHHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCE
Confidence 35678999999988887765432 23345555666677788888 9999999999999999999
Q ss_pred eeccccccCCcch
Q 025816 100 KIADFDLSNQAPD 112 (247)
Q Consensus 100 ~l~d~g~~~~~~~ 112 (247)
+++||-.+-...+
T Consensus 242 ~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 242 VVIDFPQMVSTSH 254 (465)
T ss_pred EEeechHhhccCC
Confidence 9999977654443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.093 Score=42.58 Aligned_cols=29 Identities=14% Similarity=0.155 Sum_probs=22.8
Q ss_pred CCCeEeccCCCCceeecCC-Cc-eeeccccc
Q 025816 78 DPHIIHRDIKSSNVLIFDD-DV-AKIADFDL 106 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~-~~-~~l~d~g~ 106 (247)
.+.++|+|+.+.|++++.. +. +.++|...
T Consensus 192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa~ 222 (297)
T PRK10593 192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPGL 222 (297)
T ss_pred CCeeEeCCCCcccEEECCCCCceEEEECchH
Confidence 4569999999999999865 43 67777663
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.042 Score=44.78 Aligned_cols=32 Identities=19% Similarity=0.395 Sum_probs=28.7
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 111 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~ 111 (247)
.++|+|+.+.|++++..+.+-+.||+.+....
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 59999999999999998889999999887654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.05 Score=41.88 Aligned_cols=39 Identities=23% Similarity=0.250 Sum_probs=32.5
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccc
Q 025816 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 106 (247)
Q Consensus 67 ~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~ 106 (247)
+++|.-.|+.. .+.+|+|..|+||+-++.|.+||.|-+.
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 36677888542 3599999999999999999999999764
|
The function of this family is unknown. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.05 Score=44.13 Aligned_cols=31 Identities=19% Similarity=0.450 Sum_probs=27.1
Q ss_pred CCeEeccCCCCceeecCC----CceeeccccccCC
Q 025816 79 PHIIHRDIKSSNVLIFDD----DVAKIADFDLSNQ 109 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~----~~~~l~d~g~~~~ 109 (247)
..++|+|+.+.||+++.+ +.+.++||.++..
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 359999999999999985 8899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.04 Score=42.86 Aligned_cols=30 Identities=20% Similarity=0.427 Sum_probs=26.3
Q ss_pred CeEeccCCCCceeecC-CCceeeccccccCC
Q 025816 80 HIIHRDIKSSNVLIFD-DDVAKIADFDLSNQ 109 (247)
Q Consensus 80 ~i~h~di~~~nil~~~-~~~~~l~d~g~~~~ 109 (247)
.++|+|+.+.||+++. ++.+.++||..+..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 4999999999999998 57799999987754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.044 Score=43.73 Aligned_cols=49 Identities=18% Similarity=0.230 Sum_probs=36.2
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 61 ~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
..+..+-.++.-.+..- -.++|+|+.|.|++.+..+.++|+||.++...
T Consensus 136 ~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 136 KKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN 184 (269)
T ss_pred HHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence 34444445555555440 13999999999999999999999999988654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.033 Score=43.44 Aligned_cols=33 Identities=24% Similarity=0.446 Sum_probs=26.9
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
...++|+|+.+.|++++.++..-|+||+.+...
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 344999999999999987665679999977653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.091 Score=42.71 Aligned_cols=29 Identities=28% Similarity=0.441 Sum_probs=25.2
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
+++|+|+.+.|++++. +.+.++||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 4999999999999987 6788999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.064 Score=43.67 Aligned_cols=32 Identities=31% Similarity=0.443 Sum_probs=27.5
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
.+++|+|+.+.|++++.++.+.|+||+.+...
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~ 218 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACTD 218 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccCc
Confidence 34999999999999998887789999987643
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.026 Score=43.24 Aligned_cols=30 Identities=30% Similarity=0.534 Sum_probs=21.4
Q ss_pred CeEeccCCCCceee-cCCCceeeccccccCC
Q 025816 80 HIIHRDIKSSNVLI-FDDDVAKIADFDLSNQ 109 (247)
Q Consensus 80 ~i~h~di~~~nil~-~~~~~~~l~d~g~~~~ 109 (247)
.++|+|+.+.||++ +.++.++++||.++..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 38999999999999 8889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.051 Score=41.83 Aligned_cols=31 Identities=32% Similarity=0.534 Sum_probs=21.1
Q ss_pred CCeEeccCCCCceeec-CCCceeeccccccCC
Q 025816 79 PHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQ 109 (247)
Q Consensus 79 ~~i~h~di~~~nil~~-~~~~~~l~d~g~~~~ 109 (247)
..++|+|+.+.||+++ .++.+.|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 3499999999999999 666667999986653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.041 Score=41.22 Aligned_cols=30 Identities=13% Similarity=0.376 Sum_probs=25.9
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
..+|+|+.|.|++++.++ ++++||+.+...
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 379999999999998777 889999988654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.91 E-value=0.047 Score=43.17 Aligned_cols=30 Identities=17% Similarity=0.427 Sum_probs=26.1
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
.++|+|+.+.||+++.++ +.++||+.+...
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence 489999999999999877 789999987654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.097 Score=42.26 Aligned_cols=31 Identities=29% Similarity=0.483 Sum_probs=27.0
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
.++|+|+.|.|++++.++.+.|+||+.+...
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 4999999999999998877789999877653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.05 Score=44.47 Aligned_cols=31 Identities=29% Similarity=0.442 Sum_probs=26.2
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
+++|+|+.+.||+++.+...-++||+.+...
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 4999999999999987655689999987653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.05 E-value=0.16 Score=41.44 Aligned_cols=31 Identities=16% Similarity=0.236 Sum_probs=28.0
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
+++|+|+.+.|++++.++.+.++||..+...
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 4999999999999999989999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.67 E-value=0.2 Score=41.57 Aligned_cols=30 Identities=20% Similarity=0.438 Sum_probs=25.9
Q ss_pred CeEeccCCCCceeecC-CCceeeccccccCC
Q 025816 80 HIIHRDIKSSNVLIFD-DDVAKIADFDLSNQ 109 (247)
Q Consensus 80 ~i~h~di~~~nil~~~-~~~~~l~d~g~~~~ 109 (247)
.++|+|+++.||+++. ++.+.++||.++..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 4999999999999986 46799999987764
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.23 E-value=0.13 Score=38.94 Aligned_cols=31 Identities=29% Similarity=0.438 Sum_probs=25.8
Q ss_pred CeEeccCCCCceeecCCC-----ceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDD-----VAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~-----~~~l~d~g~~~~~ 110 (247)
.++|||+.+.|+++..++ .+.++||..+...
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g 156 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYG 156 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCcC
Confidence 499999999999997543 5889999987754
|
subfamily of choline kinases |
| >PRK14559 putative protein serine/threonine phosphatase; Provisional | Back alignment and domain information |
|---|
Probab=92.10 E-value=0.49 Score=42.55 Aligned_cols=86 Identities=14% Similarity=0.069 Sum_probs=67.0
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCC-CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFAS-NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
++.||.++|+++..++..++++|+.. ..+|.+.+.... ++..+.+.|+.||+.-..-|...+ +...
T Consensus 178 ~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~~~----------~~~l~~l~Wl~q~~~LW~~l~~~~---~~~s 244 (645)
T PRK14559 178 FPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQDQT----------LPTLQILYWLNQMTQLWKALEPWG---CCQS 244 (645)
T ss_pred ccccCcchheeecCCCCcEEEeCCCCCCchHHHHhhhcC----------CcHHHHHHHHHHHHHHHHHHHhcC---eehh
Confidence 44569999999999888888999853 235555555432 667889999999999999999998 8888
Q ss_pred cCCCCceeecCCCceeeccc
Q 025816 85 DIKSSNVLIFDDDVAKIADF 104 (247)
Q Consensus 85 di~~~nil~~~~~~~~l~d~ 104 (247)
=+.++|+-++.+..+.|..+
T Consensus 245 ll~~~nlrv~~~~~~~l~~l 264 (645)
T PRK14559 245 LLELENLRVDEDQTLGLQQL 264 (645)
T ss_pred ccchhheeeCCCceehHhhh
Confidence 89999999986655555443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=91.60 E-value=0.16 Score=40.75 Aligned_cols=32 Identities=19% Similarity=0.404 Sum_probs=26.3
Q ss_pred CCeEeccCCCCceeecCCCc-eeeccccccCCc
Q 025816 79 PHIIHRDIKSSNVLIFDDDV-AKIADFDLSNQA 110 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~-~~l~d~g~~~~~ 110 (247)
+.++|+|+.+.|++++.++. .-|+||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 34999999999999987555 569999987754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.48 E-value=0.55 Score=38.69 Aligned_cols=30 Identities=40% Similarity=0.546 Sum_probs=26.1
Q ss_pred eEeccCCCCceeecCCCc-eeeccccccCCc
Q 025816 81 IIHRDIKSSNVLIFDDDV-AKIADFDLSNQA 110 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~-~~l~d~g~~~~~ 110 (247)
+||+|+.|.||+++.+.. ..++||+-+...
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~~ 229 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGYG 229 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccccc
Confidence 899999999999998874 889999977643
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.23 E-value=0.36 Score=39.62 Aligned_cols=40 Identities=28% Similarity=0.267 Sum_probs=25.5
Q ss_pred HHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCceeecCC
Q 025816 57 QQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDD 96 (247)
Q Consensus 57 ~~~~~~~~~~~~~l~~lh~~-~~~~i~h~di~~~nil~~~~ 96 (247)
+-+..++.|++.-.-...+. +-...+|.||||+|||+-.+
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 34556777876654333222 12239999999999999543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=91.22 E-value=0.17 Score=41.72 Aligned_cols=30 Identities=20% Similarity=0.393 Sum_probs=25.8
Q ss_pred CeEeccCCCCceeecC-CCceeeccccccCC
Q 025816 80 HIIHRDIKSSNVLIFD-DDVAKIADFDLSNQ 109 (247)
Q Consensus 80 ~i~h~di~~~nil~~~-~~~~~l~d~g~~~~ 109 (247)
-++|+|+.+.||+++. ++.++++||.++..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3899999999999975 56899999998764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.95 E-value=0.91 Score=38.00 Aligned_cols=76 Identities=22% Similarity=0.251 Sum_probs=54.0
Q ss_pred eeEEEecCCCCChhhh--hcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCcee
Q 025816 23 RVLAYEFASNGSLHDI--LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 100 (247)
Q Consensus 23 ~~lv~e~~~~~~L~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~ 100 (247)
..|||+++.. +=+-. +... .++...+..+-.+++.-+.-|.+.+ .+||.||+--|+|+- +|++.
T Consensus 239 hVLVM~FlGr-dgw~aPkLKd~----------~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG~ly 304 (520)
T KOG2270|consen 239 HVLVMEFLGR-DGWAAPKLKDA----------SLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DGKLY 304 (520)
T ss_pred ceEeeeeccC-CCCcCcccccc----------cCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CCEEE
Confidence 4689999853 22221 1111 1777788888888888888777654 499999999999984 56799
Q ss_pred eccccccCCcch
Q 025816 101 IADFDLSNQAPD 112 (247)
Q Consensus 101 l~d~g~~~~~~~ 112 (247)
++|.+.+....+
T Consensus 305 iIDVSQSVE~DH 316 (520)
T KOG2270|consen 305 IIDVSQSVEHDH 316 (520)
T ss_pred EEEccccccCCC
Confidence 999887765433
|
|
| >PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria | Back alignment and domain information |
|---|
Probab=89.15 E-value=1.9 Score=35.88 Aligned_cols=86 Identities=12% Similarity=0.156 Sum_probs=45.3
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCC-CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 83 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h 83 (247)
..||++++. .+-.+++.+.+.++.-.. -++..+.. ++...++.++.+| .+|...... -+|
T Consensus 20 ~~~~~f~~~-~i~~~ed~~~~~y~~~~~~~~f~~i~~-------------~~~~eklr~~~ni-~~l~~~~~~----~~~ 80 (359)
T PF10140_consen 20 EHDPYFLPQ-EIEEDEDELTFTYQIPESYQSFEEIKK-------------LDKSEKLRLLINI-AALKEHLNS----RYT 80 (359)
T ss_dssp S--TTB--E-EEEE-SSEEEEEE---TTSEEGGGGGG-------------S-HHHHHHHHHHG-GGGGGGGGS----SEE
T ss_pred ccCcccCCc-eEEEeCCEEEEEEEcCcccCcHHHHHh-------------cCHHHHHHHHHHH-HHHHHHhcC----cee
Confidence 468888884 455666665555554432 24433322 6777888888884 444433222 688
Q ss_pred ccCCCCceeecCCCceeeccccccCC
Q 025816 84 RDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 84 ~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
--++|+|++++.++.+++.-.|+-..
T Consensus 81 f~l~P~Nl~fd~~~~p~i~hrGi~~~ 106 (359)
T PF10140_consen 81 FILHPENLVFDKNLMPKILHRGIKEI 106 (359)
T ss_dssp ---SGGGEEE-TTS-EEES--EETTT
T ss_pred EEEechheEEcCCCCEEEEEcCCcCC
Confidence 89999999999999999987776543
|
This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=88.88 E-value=0.59 Score=38.58 Aligned_cols=54 Identities=30% Similarity=0.334 Sum_probs=32.6
Q ss_pred HHHHHHHHHHHHHHHHhhcC-CCCCeEeccCCCCceeecCCC------------------ceeeccccccCCc
Q 025816 57 QQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDD------------------VAKIADFDLSNQA 110 (247)
Q Consensus 57 ~~~~~~~~~~~~~l~~lh~~-~~~~i~h~di~~~nil~~~~~------------------~~~l~d~g~~~~~ 110 (247)
+-+..++.|++.-.--..+. +-...+|.||||+|||+-.+. +.+|.||+.++..
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 34556666765543112111 112399999999999994332 3577787777654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.79 E-value=0.69 Score=44.19 Aligned_cols=31 Identities=35% Similarity=0.552 Sum_probs=25.8
Q ss_pred eEeccCCCCceeecCCC--ce-eeccccccCCcc
Q 025816 81 IIHRDIKSSNVLIFDDD--VA-KIADFDLSNQAP 111 (247)
Q Consensus 81 i~h~di~~~nil~~~~~--~~-~l~d~g~~~~~~ 111 (247)
++|+|+++.||+++.++ .+ -|+|||-+....
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~~ 238 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAVHAP 238 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECccccccc
Confidence 99999999999998775 44 499999877653
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=87.56 E-value=3.2 Score=32.49 Aligned_cols=37 Identities=24% Similarity=0.310 Sum_probs=26.9
Q ss_pred HHHHHHhhcCC--CCCeEeccCCCCceeecCCCceeeccc
Q 025816 67 AKGLEYLHEKA--DPHIIHRDIKSSNVLIFDDDVAKIADF 104 (247)
Q Consensus 67 ~~~l~~lh~~~--~~~i~h~di~~~nil~~~~~~~~l~d~ 104 (247)
++.|..+-..- .|.++|+|+-..|+++..+| .++.|-
T Consensus 173 ~~~v~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fDP 211 (286)
T COG3001 173 VEKIQELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFDP 211 (286)
T ss_pred HHHHHHHHhcCCCCcceeecccccccccccCCC-Ceeecc
Confidence 34444443332 47799999999999999999 777664
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.87 E-value=1.4 Score=36.21 Aligned_cols=29 Identities=24% Similarity=0.302 Sum_probs=24.2
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
+++|+|+.+.||+++ + .+.++||+-+...
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~~g 225 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDARMG 225 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCCCC
Confidence 489999999999995 3 5788999977654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=85.53 E-value=1.6 Score=36.99 Aligned_cols=30 Identities=13% Similarity=0.431 Sum_probs=25.4
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
.++|||+.+.||++..+ .++++|+..+...
T Consensus 224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~~G 253 (401)
T PRK09550 224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAFYG 253 (401)
T ss_pred ceeeccCCcccEEeeCC-CcEEEeccccccC
Confidence 49999999999999776 5889999877654
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=85.52 E-value=5.6 Score=33.10 Aligned_cols=82 Identities=12% Similarity=0.120 Sum_probs=55.6
Q ss_pred cCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchh
Q 025816 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 133 (247)
Q Consensus 54 l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 133 (247)
......+.++.+.+..|..+... -.|-=+.|+||+++.++.+.+..+|+-..... .=+.||.
T Consensus 82 ~~k~~Klr~a~~~I~~l~e~~~t----r~~~~laPeNilf~~~l~p~~vH~Glk~~lpP--------------ye~tee~ 143 (434)
T COG4499 82 KEKTRKLRLALQNIATLSELNNT----RYTFFLAPENILFDGGLTPFFVHRGLKNSLPP--------------YEMTEER 143 (434)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcc----ceeEEecchheEEcCCCceEEEecchhccCCC--------------CCCCHHH
Confidence 44455666677777777766544 56777889999999999999888886543211 1134554
Q ss_pred hhcCCCCccccchhhhHHHHHHHhCCCCCC
Q 025816 134 AMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163 (247)
Q Consensus 134 ~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 163 (247)
+.. .+-+++..++.|..+|.
T Consensus 144 f~~----------~ykA~~~~~fn~k~~Fe 163 (434)
T COG4499 144 FLK----------EYKALAIYAFNGKFSFE 163 (434)
T ss_pred HHH----------HHHHHHHHHHcCCccHH
Confidence 432 56677777888888885
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 247 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-38 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-33 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-118
Identities = 90/237 (37%), Positives = 136/237 (57%), Gaps = 10/237 (4%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+S +H + V L+G+C + +L Y++ NG+L L+G P +SW+QR+
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL-----PTMSMSWEQRL 142
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-S 119
+I +GAA+GL YLH +A IIHRD+KS N+L+ ++ V KI DF +S + ++ + H S
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD-QTHLS 198
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
T V GT GY PEY + G+L KSDVYSFGVVL E+L R + +LPR +L WA
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 180 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236
+ ++ Q VD L P+++ K A C+ ++ RP+M V+ L+ L
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-116
Identities = 90/234 (38%), Positives = 133/234 (56%), Gaps = 10/234 (4%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M+S H N ++L G+C+ T R+L Y + +NGS+ L R + P L W +R
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQ 134
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-S 119
+IA+G+A+GL YLH+ DP IIHRD+K++N+L+ ++ A + DF L+ H +
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVT 192
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS--LVTWA 177
T V GT G+ APEY TG+ + K+DV+ +GV+LLEL+TG++ D L+ W
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 178 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231
L E K+ VD L G+Y + V ++ VA LC Q RP MS VV+ L
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-113
Identities = 91/238 (38%), Positives = 136/238 (57%), Gaps = 14/238 (5%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++++ +HEN V+LLG+ DG L Y + NGSL D L G P LSW R
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG------TPPLSWHMRC 136
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KIA GAA G+ +LHE H IHRDIKS+N+L+ + AKI+DF L+ + A + ++
Sbjct: 137 KIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
R++GT Y APE + G++ KSD+YSFGVVLLE++TG VD R Q L+
Sbjct: 194 RIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLDIKEEI 250
Query: 181 LSEDK-VRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
E+K + +D ++ D +V M +VA+ C+ + + RP++ V + LQ + +
Sbjct: 251 EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 9e-71
Identities = 64/256 (25%), Positives = 98/256 (38%), Gaps = 32/256 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 56
+ +KHEN +Q +G G L F GSL D L V+SW
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VVSW 120
Query: 57 QQRVKIAVGAAKGLEYLHEKAD-------PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109
+ IA A+GL YLHE P I HRDIKS NVL+ ++ A IADF L+ +
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 110 APDMAARLHSTRVLGTFGYHAPEYAMTG-----QLNAKSDVYSFGVVLLELLTGRKPVDH 164
+ + +GT Y APE + D+Y+ G+VL EL + D
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 165 TLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAV------AKMAAVAALCVQYEA 218
+ S + +++ V + A + C ++A
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 219 DFRPNMSIVVKALQPL 234
+ R + V + + +
Sbjct: 301 EARLSAGCVGERITQM 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-55
Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 28/242 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+SR+ H N V+L G C++ V+ E+A GSL+++LHG + P P + +
Sbjct: 54 QLSRVNHPNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAE------PLPYYTAAHAM 105
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHS 119
+ ++G+ YLH +IHRD+K N+L+ V KI DF + H
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HM 160
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
T G+ + APE + K DV+S+G++L E++T RKP D + + WA
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVH 218
Query: 180 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 239
R + ++ C + RP+M +VK + L+ P
Sbjct: 219 N----------GTRP--PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266
Query: 240 GP 241
G
Sbjct: 267 GA 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-52
Identities = 74/246 (30%), Positives = 113/246 (45%), Gaps = 24/246 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ RL+H N V +G + + E+ S GSL+ +LH L ++R+
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG------AREQLDERRRL 140
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+A AKG+ YLH + +P I+HR++KS N+L+ K+ DF LS S
Sbjct: 141 SMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
GT + APE N KSDVYSFGV+L EL T ++P + L Q V A
Sbjct: 200 A--GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQ---VVAAV-- 251
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
+ RL + P ++AA+ C E RP+ + ++ L+PL+ +
Sbjct: 252 -----GFK--CKRL--EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302
Query: 241 PAGESA 246
P S
Sbjct: 303 PPNRSD 308
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-51
Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 38/242 (15%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++S L H N V+L G + V+ EF G L+ L + + W ++
Sbjct: 76 IMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP--------IKWSVKL 125
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFDLSNQAPDMAA 115
++ + A G+EY+ + +P I+HRD++S N+ + D AK+ADF LS Q+
Sbjct: 126 RLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQL---NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 172
+ +LG F + APE + + K+D YSF ++L +LTG P D G+
Sbjct: 183 ---VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-YSYGKIK 237
Query: 173 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
+ + R P ++ V LC + RP+ S +VK L
Sbjct: 238 FINMIREE----------GLRP--TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
Query: 233 PL 234
L
Sbjct: 286 EL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-51
Identities = 53/243 (21%), Positives = 95/243 (39%), Gaps = 43/243 (17%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
H N + +LG C + + GSL+++LH V+ Q V
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQSQAV 114
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
K A+ A+G+ +LH +P I + S +V+I +D A+I+ D+ S
Sbjct: 115 KFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSP 166
Query: 121 RVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 176
+ + APE A+ + +D++SF V+L EL+T P
Sbjct: 167 GRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD------------ 213
Query: 177 ATPKLSEDKVRQCV---DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233
LS ++ V R PP ++ + +C+ + RP ++V L+
Sbjct: 214 ----LSNMEIGMKVALEGLRP--TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
Query: 234 LLN 236
+ +
Sbjct: 268 MQD 270
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 9e-51
Identities = 53/274 (19%), Positives = 90/274 (32%), Gaps = 43/274 (15%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV-----LAYEFASNGSLHDILHGRKGVKGAQPGPVLS 55
V ++H+N + + T+ L E+ NGSL L
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------SD 109
Query: 56 WQQRVKIAVGAAKGLEYLHE------KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-- 107
W ++A +GL YLH P I HRD+ S NVL+ +D I+DF LS
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 108 ----NQAPDMAARLHSTRVLGTFGYHAPEYAM-------TGQLNAKSDVYSFGVVLLELL 156
+ +GT Y APE + D+Y+ G++ E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 157 TGRKPVDH--TLPRGQQSLVTWATPKLSEDKVRQCVDAR-----LGGDYP--PKAVAKMA 207
+ ++P Q + T + + ++ V + AV +
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 208 AVAALCVQYEADFRPNMSIVVKALQPLLNARPGP 241
C +A+ R + + L+
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-49
Identities = 56/252 (22%), Positives = 89/252 (35%), Gaps = 37/252 (14%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
L+H N ++ +G E+ G+L I+ W QRV
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--------YPWSQRVSF 113
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS------------NQA 110
A A G+ YLH +IIHRD+ S N L+ ++ +ADF L+ ++
Sbjct: 114 AKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 111 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 170
R V+G + APE + K DV+SFG+VL E++ LPR
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 171 QSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230
+ + + PP + C + + RP+ +
Sbjct: 231 DFGLNV------RGFLDRYC--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276
Query: 231 LQPLLNARPGPA 242
L+ L G
Sbjct: 277 LETLRMHLAGHL 288
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-49
Identities = 58/169 (34%), Positives = 83/169 (49%), Gaps = 22/169 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ + LKH N + L G C+ + L EFA G L+ +L G++ + V
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILV 108
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI--------FDDDVAKIADFDLSNQAPD 112
AV A+G+ YLH++A IIHRD+KSSN+LI + + KI DF L+
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---- 164
Query: 113 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
R G + + APE + SDV+S+GV+L ELLTG P
Sbjct: 165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-48
Identities = 57/261 (21%), Positives = 96/261 (36%), Gaps = 36/261 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSW 56
++HEN + + + GT ++ NGSL+D L L
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----------LDA 133
Query: 57 QQRVKIAVGAAKGLEYLHEKAD-----PHIIHRDIKSSNVLIFDDDVAKIADFDLS--NQ 109
+ +K+A + GL +LH + P I HRD+KS N+L+ + IAD L+
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193
Query: 110 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNA-------KSDVYSFGVVLLELLTGRKPV 162
+ + +GT Y PE + LN +D+YSFG++L E+ R
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVS 251
Query: 163 DHTLPRGQQSLVTWATPKLSEDKVRQCV---DARL---GGDYPPKAVAKMAAVAALCVQY 216
+ Q S + +R+ V R + + +M + C +
Sbjct: 252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311
Query: 217 EADFRPNMSIVVKALQPLLNA 237
R V K L + +
Sbjct: 312 NPASRLTALRVKKTLAKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-48
Identities = 54/258 (20%), Positives = 93/258 (36%), Gaps = 36/258 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSW 56
L+HEN + + + + GSL+D L L
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDT 104
Query: 57 QQRVKIAVGAAKGLEYLHE-----KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---N 108
++I + A GL +LH + P I HRD+KS N+L+ + IAD L+ +
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 109 QAPDMAARLHSTRVLGTFGYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKPV 162
Q+ + ++ RV GT Y APE + D+++FG+VL E+ R
Sbjct: 165 QSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVS 222
Query: 163 DHTLPRGQQSLVTWATPKLSEDKVRQCV---DARL---GGDYPPKAVAKMAAVAALCVQY 216
+ + + S + +R+ V R + + +A + C
Sbjct: 223 NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ 282
Query: 217 EADFRPNMSIVVKALQPL 234
R + K L +
Sbjct: 283 NPSARLTALRIKKTLTKI 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 6e-48
Identities = 60/240 (25%), Positives = 114/240 (47%), Gaps = 30/240 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
++ + +H N + +GY T+ LA ++ SL+ LH + ++
Sbjct: 73 VLRKTRHVNILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHASE--------TKFEMKK 121
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
+ IA A+G++YLH K IIHRD+KS+N+ + +D+ KI DF L+ + +
Sbjct: 122 LIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 119 STRVLGTFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 175
++ G+ + APE + + +SDVY+FG+VL EL+TG+ P + R Q +
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---II 235
Query: 176 WATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235
+ +++ + P +M + A C++ + D RP+ ++ ++ L
Sbjct: 236 EMVGR----GSLSPDLSKVRSNCPK----RMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-47
Identities = 52/256 (20%), Positives = 85/256 (33%), Gaps = 49/256 (19%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+ +HEN V +G C+ + +L+ ++ K VL + +I
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQI 135
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHS 119
A KG+ YLH K I+H+D+KS NV D+ I DF L
Sbjct: 136 AQEIVKGMGYLHAK---GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKL 191
Query: 120 TRVLGTFGYHAPEYAMTGQLNA---------KSDVYSFGVVLLELLTGRKPVDHTLPRGQ 170
G + APE + SDV++ G + EL P P
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEA 250
Query: 171 QSLVTWAT-----PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225
+ W P LS+ +++ + C +E + RP +
Sbjct: 251 ---IIWQMGTGMKPNLSQI------------GMGK----EISDILLFCWAFEQEERPTFT 291
Query: 226 IVVKALQPLLNARPGP 241
++ L+ L
Sbjct: 292 KLMDMLEKLPKRNRRL 307
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-46
Identities = 59/260 (22%), Positives = 98/260 (37%), Gaps = 38/260 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSW 56
L+HEN + + ++ +GSL D L+ ++
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTV 138
Query: 57 QQRVKIAVGAAKGLEYLHEKAD-----PHIIHRDIKSSNVLIFDDDVAKIADFDLS---N 108
+ +K+A+ A GL +LH + P I HRD+KS N+L+ + IAD L+ +
Sbjct: 139 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198
Query: 109 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA-------KSDVYSFGVVLLELLTGRKP 161
A D + RV GT Y APE + +N ++D+Y+ G+V E+ R
Sbjct: 199 SATDTIDIAPNHRV-GTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCS 255
Query: 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCV---DARL---GGDYPPKAVAKMAAVAALCVQ 215
+ Q S +++R+ V R +A+ MA + C
Sbjct: 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 315
Query: 216 YEADFRPNMSIVVKALQPLL 235
R + K L L
Sbjct: 316 ANGAARLTALRIKKTLSQLS 335
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 62/248 (25%), Positives = 95/248 (38%), Gaps = 58/248 (23%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+ H N V+L+G C + E G L G L + +++
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTLLQMV 219
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
AA G+EYL K IHRD+ + N L+ + +V KI+DF +S R
Sbjct: 220 GDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMS-------------REE 263
Query: 124 GTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRG 169
Y APE G+ +++SDV+SFG++L E + G P
Sbjct: 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY------- 316
Query: 170 QQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227
P LS + R+ V+ RL P + + C YE RP+ S +
Sbjct: 317 ---------PNLSNQQTREFVEKGGRL--PCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365
Query: 228 VKALQPLL 235
+ LQ +
Sbjct: 366 YQELQSIR 373
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 58/239 (24%), Positives = 101/239 (42%), Gaps = 36/239 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+KH N VQLLG C + EF + G+L D L +S + +A
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMA 324
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
+ +EYL +K + IHR++ + N L+ ++ + K+ADF LS ++
Sbjct: 325 TQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAG 378
Query: 124 GTFGYH--APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180
F APE + + KSDV++FGV+L E+ T G P P
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------------PG 422
Query: 181 LSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
+ +V + ++ R+ + P K+ + C Q+ RP+ + + +A + +
Sbjct: 423 IDLSQVYELLEKDYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
S+L H+N V ++ + L E+ +L + + GP LS +
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAIN 115
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
G+++ H+ I+HRDIK N+LI + KI DF ++ +A + +
Sbjct: 116 FTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNH 171
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
VLGT Y +PE A + +D+YS G+VL E+L G P
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 47/241 (19%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+L+H N VQLLG V+ + Y E+ + GSL D L R VL +
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGL--YIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLL 292
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHS 119
K ++ + +EYL + +HRD+ + NVL+ +D+VAK++DF L + S
Sbjct: 293 KFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASS 341
Query: 120 TRVLGTFGYH--APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 176
T+ G APE + + KSDV+SFG++L E+ + GR P
Sbjct: 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-------------- 387
Query: 177 ATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234
P++ V V+ ++ D P + V C +A RP + + L+ +
Sbjct: 388 --PRIPLKDVVPRVEKGYKM--DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
Query: 235 L 235
Sbjct: 444 R 444
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-31
Identities = 55/250 (22%), Positives = 102/250 (40%), Gaps = 57/250 (22%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+L H VQL G C++ L EF +G L D L ++G+ + + + +
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--------FAAETLLGM 109
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
+ +G+ YL E +IHRD+ + N L+ ++ V K++DF ++ R
Sbjct: 110 CLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT-------------RF 153
Query: 123 LGTFGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRG 169
+ Y +PE + ++KSDV+SFGV++ E+ + G+ P
Sbjct: 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY------- 206
Query: 170 QQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227
S +V + + RL P A + + C + + RP S +
Sbjct: 207 ---------ENRSNSEVVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPAFSRL 255
Query: 228 VKALQPLLNA 237
++ L + +
Sbjct: 256 LRQLAEIAES 265
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-31
Identities = 66/262 (25%), Positives = 108/262 (41%), Gaps = 57/262 (21%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPV 53
+++ L+HE+ V+ G C DG ++ +E+ +G L+ L + Q
Sbjct: 70 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
L Q + IA A G+ YL + H +HRD+ + N L+ + + KI DF +S
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS------ 180
Query: 114 AARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159
R + + Y+ PE M + +SDV+SFGV+L E+ T G+
Sbjct: 181 -------RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 233
Query: 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYE 217
+P +LS +V +C+ L + P ++ V C Q E
Sbjct: 234 QPW----------------FQLSNTEVIECITQGRVL--ERPRVCPKEVYDVMLGCWQRE 275
Query: 218 ADFRPNMSIVVKALQPLLNARP 239
R N+ + K L L A P
Sbjct: 276 PQQRLNIKEIYKILHALGKATP 297
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 17/165 (10%)
Query: 2 VSRLKHENFVQLLGY-CVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQ 57
+ L H V + + + L Y E+ +L DI+H GP ++ +
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTPK 116
Query: 58 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 117
+ +++ A + L + H+ IIHRD+K +N++I + K+ DF ++ D +
Sbjct: 117 RAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 118 HST-RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T V+GT Y +PE A ++A+SDVYS G VL E+LTG P
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-30
Identities = 45/168 (26%), Positives = 68/168 (40%), Gaps = 24/168 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSR----VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVL 54
M+ L+H N V+ VL E ++G+L L +
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----------M 126
Query: 55 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDM 113
+ KGL++LH + P IIHRD+K N+ I KI D L+
Sbjct: 127 KIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
A+ V+GT + APE + + DVY+FG+ +LE+ T P
Sbjct: 186 FAK----AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-30
Identities = 54/254 (21%), Positives = 95/254 (37%), Gaps = 51/254 (20%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-GPVLSWQQR 59
++ + V+LLG G ++ E + G L L + P S +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
+++A A G+ YL+ +HRD+ + N ++ +D KI DF ++
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT------------ 185
Query: 120 TRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHT 165
R + Y+ +PE G SDV+SFGVVL E+ T +P
Sbjct: 186 -RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--- 241
Query: 166 LPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223
LS ++V + V L D P + + +C QY RP+
Sbjct: 242 -------------QGLSNEQVLRFVMEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPS 286
Query: 224 MSIVVKALQPLLNA 237
++ +++ +
Sbjct: 287 FLEIISSIKEEMEP 300
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-30
Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 33/237 (13%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L+HE VQL + ++ E+ S GSL D L G G L Q V +A
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETG-------KYLRLPQLVDMA 286
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
A G+ Y+ + +HRD++++N+L+ ++ V K+ADF L+ D
Sbjct: 287 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 124 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS 182
+ APE A+ G+ KSDV+SFG++L EL T GR P P +
Sbjct: 344 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----------------PGMV 386
Query: 183 EDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
+V V+ R+ PP+ + + C + E + RP + L+ +
Sbjct: 387 NREVLDQVERGYRM--PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-30
Identities = 66/248 (26%), Positives = 104/248 (41%), Gaps = 27/248 (10%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
L HE+ ++ G C D + L E+ GSL D L + Q
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASL-QLVMEYVPLGSLRDYLPRHS----------IGLAQL 136
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA--RL 117
+ A +G+ YLH + H IHRD+ + NVL+ +D + KI DF L+ P+ R+
Sbjct: 137 LLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 193
Query: 118 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 176
F Y APE + SDV+SFGV L ELLT + +
Sbjct: 194 REDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252
Query: 177 ATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234
+++ ++ + ++ RL P K A++ + C + EA FRP ++ L+ +
Sbjct: 253 --GQMTVLRLTELLERGERL--PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
Query: 235 LNARPGPA 242
G A
Sbjct: 309 HEKYQGQA 316
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 56/249 (22%), Positives = 98/249 (39%), Gaps = 57/249 (22%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
L HE VQL G C + E+ +NG L + L + QQ +++
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEM 125
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
+ +EYL K +HRD+ + N L+ D V K++DF LS R
Sbjct: 126 CKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS-------------RY 169
Query: 123 LGTFGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRG 169
+ Y PE M + ++KSD+++FGV++ E+ + G+ P
Sbjct: 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY------- 222
Query: 170 QQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227
+ + + + + RL P A K+ + C +AD RP I+
Sbjct: 223 ---------ERFTNSETAEHIAQGLRL--YRPHLASEKVYTIMYSCWHEKADERPTFKIL 271
Query: 228 VKALQPLLN 236
+ + +++
Sbjct: 272 LSNILDVMD 280
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-29
Identities = 57/257 (22%), Positives = 95/257 (36%), Gaps = 49/257 (19%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
L + V+ G + L E+ +G L D L + L + +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSL-RLVMEYLPSGCLRDFLQRHR--------ARLDASRLL 130
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ KG+EYL + +HRD+ + N+L+ + KIADF L+
Sbjct: 131 LYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA------------- 174
Query: 121 RVLGTFG--YH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHT 165
++L Y APE + +SDV+SFGVVL EL T K +
Sbjct: 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CS 232
Query: 166 LPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223
++ + ++ + ++ RL PP A++ + LC RP+
Sbjct: 233 PSAEFLRMMGCERDVPALSRLLELLEEGQRL--PAPPACPAEVHELMKLCWAPSPQDRPS 290
Query: 224 MSIVVKALQPLLNARPG 240
S + L L + G
Sbjct: 291 FSALGPQLDMLWSGSRG 307
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 60/249 (24%), Positives = 102/249 (40%), Gaps = 56/249 (22%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+KH N VQLLG C + EF + G+L D L +S + +A
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMA 117
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
+ +EYL +K + IHRD+ + N L+ ++ + K+ADF LS R++
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS-------------RLM 161
Query: 124 GTFGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQ 170
Y APE + + KSDV++FGV+L E+ T G P
Sbjct: 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-------- 213
Query: 171 QSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228
P + +V + ++ R+ + P K+ + C Q+ RP+ + +
Sbjct: 214 --------PGIDLSQVYELLEKDYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 263
Query: 229 KALQPLLNA 237
+A + +
Sbjct: 264 QAFETMFQE 272
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-29
Identities = 51/250 (20%), Positives = 91/250 (36%), Gaps = 57/250 (22%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+L H V+ G C + E+ SNG L + L G L Q +++
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQLLEM 109
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
+G+ +L IHRD+ + N L+ D K++DF ++ R
Sbjct: 110 CYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT-------------RY 153
Query: 123 LGTFGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRG 169
+ Y APE + ++KSDV++FG+++ E+ + G+ P
Sbjct: 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY------- 206
Query: 170 QQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227
+ +V V RL P A + + C + RP +
Sbjct: 207 ---------DLYTNSEVVLKVSQGHRL--YRPHLASDTIYQIMYSCWHELPEKRPTFQQL 255
Query: 228 VKALQPLLNA 237
+ +++PL
Sbjct: 256 LSSIEPLREK 265
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 33/237 (13%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L+HE VQL + ++ E+ S GSL D L G G L Q V +A
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETG-------KYLRLPQLVDMA 369
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
A G+ Y+ + +HRD++++N+L+ ++ V K+ADF L+ D
Sbjct: 370 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 426
Query: 124 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLS 182
+ APE A+ G+ KSDV+SFG++L EL T GR P P +
Sbjct: 427 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----------------PGMV 469
Query: 183 EDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
+V V+ R+ PP+ + + C + E + RP + L+ +
Sbjct: 470 NREVLDQVERGYRM--PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 57/245 (23%), Positives = 96/245 (39%), Gaps = 22/245 (8%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
L+H+N V+ G C R L E+ GSL D L K + +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------IDHIKL 147
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARL 117
++ KG+EYL K IHRD+ + N+L+ +++ KI DF L+ P ++
Sbjct: 148 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 204
Query: 118 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
F Y APE + + SDV+SFGVVL EL T + + +
Sbjct: 205 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263
Query: 178 TPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235
++ + + + RL P ++ + C + RP+ + + +
Sbjct: 264 QGQMIVFHLIELLKNNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
Query: 236 NARPG 240
+ G
Sbjct: 322 DQMAG 326
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-29
Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 43/240 (17%)
Query: 4 RLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+L+H N VQLLG V+ + + E+ + GSL D L R VL +K
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKF 122
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTR 121
++ + +EYL + +HRD+ + NVL+ +D+VAK++DF L + ST+
Sbjct: 123 SLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQ 171
Query: 122 VLGTFGYH--APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 178
G APE + + KSDV+SFG++L E+ + GR P
Sbjct: 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY---------------- 215
Query: 179 PKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236
P++ V V+ ++ D P + V C +A RP+ + + L+ +
Sbjct: 216 PRIPLKDVVPRVEKGYKM--DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-29
Identities = 60/251 (23%), Positives = 93/251 (37%), Gaps = 59/251 (23%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+ H N ++L G G ++ E+ NGSL L G + Q V +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGML 157
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
G G+ YL + +HRD+ + NVL+ + V K++DF LS RVL
Sbjct: 158 RGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLS-------------RVL 201
Query: 124 G--TFGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 168
+ APE ++ SDV+SFGVV+ E+L G +P
Sbjct: 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY------ 255
Query: 169 GQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226
++ V V+ RL P + + C + RP S
Sbjct: 256 ----------WNMTNRDVISSVEEGYRL--PAPMGCPHALHQLMLDCWHKDRAQRPRFSQ 303
Query: 227 VVKALQPLLNA 237
+V L L+ +
Sbjct: 304 IVSVLDALIRS 314
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-29
Identities = 56/257 (21%), Positives = 95/257 (36%), Gaps = 46/257 (17%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
L+H+N V+ G C R L E+ GSL D L K + +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------IDHIKL 116
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
++ KG+EYL K IHRD+ + N+L+ +++ KI DF L+
Sbjct: 117 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT------------ 161
Query: 120 TRVL--GTFGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165
+VL + APE + + SDV+SFGVVL EL T +
Sbjct: 162 -KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220
Query: 166 LPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223
+ + ++ + + + RL P ++ + C + RP+
Sbjct: 221 PAEFMRMIGNDKQGQMIVFHLIELLKNNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPS 278
Query: 224 MSIVVKALQPLLNARPG 240
+ + + + G
Sbjct: 279 FRDLALRVDQIRDNMAG 295
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-29
Identities = 61/253 (24%), Positives = 100/253 (39%), Gaps = 55/253 (21%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
S+ H+N V+ +G + R + E + G L L R+ L+ + +
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHV 145
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHS 119
A A G +YL E H IHRDI + N L+ VAKI DF ++
Sbjct: 146 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------------ 190
Query: 120 TRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHT 165
R + Y+ PE M G +K+D +SFGV+L E+ + G P
Sbjct: 191 -RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--- 246
Query: 166 LPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223
P S +V + V + R+ D P + + C Q++ + RPN
Sbjct: 247 -------------PSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPN 291
Query: 224 MSIVVKALQPLLN 236
+I+++ ++
Sbjct: 292 FAIILERIEYCTQ 304
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-29
Identities = 45/175 (25%), Positives = 69/175 (39%), Gaps = 29/175 (16%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY----------------EFASNGSLHDILHGRKGVK 46
++L H N V G EF G+L + R+G K
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 47 GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 106
L +++ KG++Y+H K +I+RD+K SN+ + D KI DF L
Sbjct: 119 -------LDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGL 168
Query: 107 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ R TR GT Y +PE + + D+Y+ G++L ELL
Sbjct: 169 VTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-29
Identities = 60/259 (23%), Positives = 94/259 (36%), Gaps = 57/259 (22%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPV 53
+ +RL+H N V LLG + + + S+G LH+ L R
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
L V + A G+EYL H++H+D+ + NVL++D KI+D L
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF------ 175
Query: 114 AARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159
R + Y+ APE M G+ + SD++S+GVVL E+ + G
Sbjct: 176 -------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228
Query: 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYE 217
+P S V + + L P A + A+ C
Sbjct: 229 QPY----------------CGYSNQDVVEMIRNRQVL--PCPDDCPAWVYALMIECWNEF 270
Query: 218 ADFRPNMSIVVKALQPLLN 236
RP + L+ N
Sbjct: 271 PSRRPRFKDIHSRLRAWGN 289
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-29
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 39/172 (22%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+ + + +LLG C+ T +++ + G L D + K + Q +
Sbjct: 73 SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWC 123
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
V AKG+ YL ++ ++HRD+ + NVL+ KI DF L+ ++L
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLL 167
Query: 124 GTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
G A E + +SDV+S+GV + EL+T G KP
Sbjct: 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-29
Identities = 62/253 (24%), Positives = 101/253 (39%), Gaps = 55/253 (21%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
S+ H+N V+ +G + R + E + G L L R+ L+ + +
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHV 186
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHS 119
A A G +YL E H IHRDI + N L+ VAKI DF ++
Sbjct: 187 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------------ 231
Query: 120 TRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHT 165
R + GY+ PE M G +K+D +SFGV+L E+ + G P
Sbjct: 232 -RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--- 287
Query: 166 LPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223
P S +V + V + R+ D P + + C Q++ + RPN
Sbjct: 288 -------------PSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPN 332
Query: 224 MSIVVKALQPLLN 236
+I+++ ++
Sbjct: 333 FAIILERIEYCTQ 345
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 41/241 (17%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+ H N ++L G ++ E+ NGSL L + Q V +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGM 152
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR- 121
G A G++YL + +HRD+ + N+LI + V K++DF L D ++TR
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 122 ----VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 176
+ T +PE + + SDV+S+G+VL E+++ G +P
Sbjct: 210 GKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------- 251
Query: 177 ATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234
++S V + VD RL P A + + C Q + + RP +V L L
Sbjct: 252 --WEMSNQDVIKAVDEGYRL--PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
Query: 235 L 235
+
Sbjct: 308 I 308
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 56/254 (22%), Positives = 96/254 (37%), Gaps = 51/254 (20%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLA-YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
++ H N + LLG C+ L + +G L + + + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--------HNPTVKDL 130
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LH 118
+ + AKG++YL K +HRD+ + N ++ + K+ADF L+ R ++
Sbjct: 131 IGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA--------RDMY 179
Query: 119 ST---RVLGTFGYH------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 168
V G A E T + KSDV+SFGV+L EL+T G P
Sbjct: 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------ 233
Query: 169 GQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226
P ++ + + RL P + V C +A+ RP+ S
Sbjct: 234 ----------PDVNTFDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 281
Query: 227 VVKALQPLLNARPG 240
+V + + + G
Sbjct: 282 LVSRISAIFSTFIG 295
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 18/162 (11%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+ +KH N VQ + S + ++ G L ++ +KGV Q +
Sbjct: 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-------FQEDQILDW 130
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHS 119
V L+++H++ I+HRDIKS N+ + D ++ DF ++ N ++A
Sbjct: 131 FVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA----R 183
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ GT Y +PE N KSD+++ G VL EL T +
Sbjct: 184 ACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 61/243 (25%), Positives = 103/243 (42%), Gaps = 41/243 (16%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+ H N ++L G ++ E+ NG+L L + G S Q V +
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGM 152
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR- 121
G A G++YL + +HRD+ + N+L+ + V K++DF LS D ++T
Sbjct: 153 LRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 122 ----VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 176
+ T APE + + SDV+SFG+V+ E++T G +P
Sbjct: 210 GKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPY-------------- 251
Query: 177 ATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234
+LS +V + ++ RL P + + + C Q E RP + +V L L
Sbjct: 252 --WELSNHEVMKAINDGFRL--PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
Query: 235 LNA 237
+ A
Sbjct: 308 IRA 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 59/253 (23%), Positives = 98/253 (38%), Gaps = 49/253 (19%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
L HEN V+ G C + + EF +GSL + L K ++ +Q+
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGI-KLIMEFLPSGSLKEYLPKNKNK--------INLKQQ 128
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
+K AV KG++YL + +HRD+ + NVL+ + KI DF L+
Sbjct: 129 LKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT------------ 173
Query: 120 TRVL--GTFGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDH 164
+ + Y APE M + SDV+SFGV L ELLT
Sbjct: 174 -KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232
Query: 165 TLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRP 222
+ T ++ + + RL PP ++ + C +++ R
Sbjct: 233 MALFLKMIGPTHGQMTVTR--LVNTLKEGKRL--PCPPNCPDEVYQLMRKCWEFQPSNRT 288
Query: 223 NMSIVVKALQPLL 235
+ +++ + LL
Sbjct: 289 SFQNLIEGFEALL 301
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 51/260 (19%), Positives = 94/260 (36%), Gaps = 59/260 (22%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY------EFASNGSLHDILHGRKGVKGAQPGPVLSW 56
H + +L+G + ++ F +G LH L + + L
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI---GENPFNLPL 136
Query: 57 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 116
Q V+ V A G+EYL + + IHRD+ + N ++ +D +ADF LS
Sbjct: 137 QTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS--------- 184
Query: 117 LHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPV 162
R + + Y+ A E SDV++FGV + E++T G+ P
Sbjct: 185 ----RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
Query: 163 DHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADF 220
+ ++ + RL PP+ + ++ + C +
Sbjct: 241 ----------------AGIENAEIYNYLIGGNRL--KQPPECMEEVYDLMYQCWSADPKQ 282
Query: 221 RPNMSIVVKALQPLLNARPG 240
RP+ + + L+ +L
Sbjct: 283 RPSFTCLRMELENILGHLSV 302
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 57/258 (22%), Positives = 99/258 (38%), Gaps = 58/258 (22%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY-----EFASNGSLHDILHGRKGVKGAQPGPVLSWQ 57
H N ++LLG C++ +S+ + F G LH L + + Q
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL---ETGPKHIPLQ 147
Query: 58 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 117
+K V A G+EYL + + +HRD+ + N ++ DD +ADF LS
Sbjct: 148 TLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS---------- 194
Query: 118 HSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 163
+ + + Y+ A E +KSDV++FGV + E+ T G P
Sbjct: 195 ---KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY- 250
Query: 164 HTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFR 221
P + ++ + RL P + ++ + C + + R
Sbjct: 251 ---------------PGVQNHEMYDYLLHGHRL--KQPEDCLDELYEIMYSCWRTDPLDR 293
Query: 222 PNMSIVVKALQPLLNARP 239
P S++ L+ LL + P
Sbjct: 294 PTFSVLRLQLEKLLESLP 311
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 13/160 (8%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
RL+ + V + + + + L +L + GP L+ + V
Sbjct: 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--------GP-LAPPRAVA 138
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
I L+ H HRD+K N+L+ DD A + DF ++ A
Sbjct: 139 IVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGN 194
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+GT Y APE ++D+Y+ VL E LTG P
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 63/261 (24%), Positives = 104/261 (39%), Gaps = 56/261 (21%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV------L 54
+++ L+H++ V+ G C +G ++ +E+ +G L+ L G L
Sbjct: 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 55 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 114
Q + +A A G+ YL H +HRD+ + N L+ V KI DF +S
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS------- 205
Query: 115 ARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160
R + + Y+ PE + + +SDV+SFGVVL E+ T G++
Sbjct: 206 ------RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259
Query: 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEA 218
P +LS + C+ L + P ++ A+ C Q E
Sbjct: 260 PW----------------YQLSNTEAIDCITQGREL--ERPRACPPEVYAIMRGCWQREP 301
Query: 219 DFRPNMSIVVKALQPLLNARP 239
R ++ V LQ L A P
Sbjct: 302 QQRHSIKDVHARLQALAQAPP 322
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 62/260 (23%), Positives = 103/260 (39%), Gaps = 57/260 (21%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPV 53
M KH+N + LLG C + E+AS G+L + L R+ P
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
++++ V A+G+EYL + IHRD+ + NVL+ +++V KIADF L+
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA------ 250
Query: 114 AARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159
R + Y+ APE +SDV+SFGV++ E+ T G
Sbjct: 251 -------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYE 217
P P + +++ + + R+ D P ++ + C
Sbjct: 304 SP----------------YPGIPVEELFKLLKEGHRM--DKPANCTNELYMMMRDCWHAV 345
Query: 218 ADFRPNMSIVVKALQPLLNA 237
RP +V+ L +L
Sbjct: 346 PSQRPTFKQLVEDLDRILTL 365
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-28
Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+L H N ++ ++ + E A G L ++ K + ++ + K
Sbjct: 87 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTVWKY 141
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
V LE++H + ++HRDIK +NV I V K+ D L HS +
Sbjct: 142 FVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--L 196
Query: 123 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+GT Y +PE N KSD++S G +L E+ + P
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-28
Identities = 62/264 (23%), Positives = 103/264 (39%), Gaps = 57/264 (21%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPV 53
M KH+N + LLG C + E+AS G+L + L R+ P
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
++++ V A+G+EYL + IHRD+ + NVL+ +++V KIADF L+
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA------ 204
Query: 114 AARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159
R + Y+ APE +SDV+SFGV++ E+ T G
Sbjct: 205 -------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257
Query: 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYE 217
P P + +++ + + R+ D P ++ + C
Sbjct: 258 SP----------------YPGIPVEELFKLLKEGHRM--DKPANCTNELYMMMRDCWHAV 299
Query: 218 ADFRPNMSIVVKALQPLLNARPGP 241
RP +V+ L +L
Sbjct: 300 PSQRPTFKQLVEDLDRILTLTTNE 323
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 57/239 (23%), Positives = 101/239 (42%), Gaps = 37/239 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
L+H+ V+L ++ EF + GSL D L +G + + +
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEG-------SKQPLPKLIDFS 290
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
A+G+ ++ ++ + IHRD++++N+L+ V KIADF L+ D ++ R
Sbjct: 291 AQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREG 344
Query: 124 GTFGYH--APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPK 180
F APE G KSDV+SFG++L+E++T GR P P
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY----------------PG 388
Query: 181 LSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
+S +V + ++ R+ P ++ + C + + RP + L A
Sbjct: 389 MSNPEVIRALERGYRM--PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-27
Identities = 41/177 (23%), Positives = 72/177 (40%), Gaps = 31/177 (17%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY------------EFASNGSLHDILHGRKGVKGAQP 50
++L+H V+ ++ + + +L D ++GR ++ +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 51 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF------ 104
L + A+ +E+LH K ++HRD+K SN+ DDV K+ DF
Sbjct: 118 SVCLHI------FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168
Query: 105 ----DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157
+ M A T +GT Y +PE + K D++S G++L ELL
Sbjct: 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 60/271 (22%), Positives = 104/271 (38%), Gaps = 65/271 (23%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK---------------GV 45
+++ + N V+LLG C G L +E+ + G L++ L
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 46 KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 105
+ P LS +++ IA A G+ YL E+ +HRD+ + N L+ ++ V KIADF
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFG 219
Query: 106 LSNQAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVL 152
LS R + + Y+ PE + +SDV+++GVVL
Sbjct: 220 LS-------------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
Query: 153 LELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAV 209
E+ + G +P ++ ++V V L P ++ +
Sbjct: 267 WEIFSYGLQPY----------------YGMAHEEVIYYVRDGNIL--ACPENCPLELYNL 308
Query: 210 AALCVQYEADFRPNMSIVVKALQPLLNARPG 240
LC RP+ + + LQ + G
Sbjct: 309 MRLCWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-27
Identities = 35/162 (21%), Positives = 66/162 (40%), Gaps = 11/162 (6%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+ +K+E + G + + YE+ N S+ + + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-CI 156
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
Y+H + +I HRD+K SN+L+ + K++DF S D ++ +R
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSR- 211
Query: 123 LGTFGYHAPEYAMTGQL---NAKSDVYSFGVVLLELLTGRKP 161
GT+ + PE + + AK D++S G+ L + P
Sbjct: 212 -GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-27
Identities = 45/187 (24%), Positives = 73/187 (39%), Gaps = 28/187 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSW 56
M H N ++L+ YC+ F G+L + + K G L+
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK-----DKGNFLTE 133
Query: 57 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 116
Q + + +G +GLE +H HRD+K +N+L+ D+ + D NQA
Sbjct: 134 DQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 117 LHSTRVL-------GTFGYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
L T Y APE + + + ++DV+S G VL ++ G P D
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYD 247
Query: 164 HTLPRGQ 170
+G
Sbjct: 248 MVFQKGD 254
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-27
Identities = 53/257 (20%), Positives = 92/257 (35%), Gaps = 61/257 (23%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLA-YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
L H N + L+G + + +G L + P + + +
Sbjct: 77 RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKDLIS 128
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
+ A+G+EYL E+ +HRD+ + N ++ + K+ADF L+ R
Sbjct: 129 FGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLA-------------R 172
Query: 122 VLGTFGYH---------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHT 165
+ Y+ A E T + KSDV+SFGV+L ELLT G P
Sbjct: 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY--- 229
Query: 166 LPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223
+ + + RL P + V C + + RP
Sbjct: 230 -------------RHIDPFDLTHFLAQGRRL--PQPEYCPDSLYQVMQQCWEADPAVRPT 274
Query: 224 MSIVVKALQPLLNARPG 240
++V ++ +++A G
Sbjct: 275 FRVLVGEVEQIVSALLG 291
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 44/254 (17%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPV 53
+ H N + LLG C LA E+A +G+L D L +
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
LS QQ + A A+G++YL +K IHRD+ + N+L+ ++ VAKIADF LS
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS------ 189
Query: 114 AARLHSTRVLGTFG-----YHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 167
R V T G + A E SDV+S+GV+L E+++ G P
Sbjct: 190 --RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY----- 242
Query: 168 RGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225
++ ++ + + RL + P ++ + C + + RP+ +
Sbjct: 243 -----------CGMTCAELYEKLPQGYRL--EKPLNCDDEVYDLMRQCWREKPYERPSFA 289
Query: 226 IVVKALQPLLNARP 239
++ +L +L R
Sbjct: 290 QILVSLNRMLEERK 303
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 67/260 (25%), Positives = 103/260 (39%), Gaps = 57/260 (21%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPV 53
M KH+N + LLG C + E+AS G+L + L R+ P
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
LS + V A A+G+EYL K IHRD+ + NVL+ +D+V KIADF L+
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA------ 238
Query: 114 AARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159
R + Y+ APE +SDV+SFGV+L E+ T G
Sbjct: 239 -------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
Query: 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYE 217
P P + +++ + + R+ D P ++ + C
Sbjct: 292 SP----------------YPGVPVEELFKLLKEGHRM--DKPSNCTNELYMMMRDCWHAV 333
Query: 218 ADFRPNMSIVVKALQPLLNA 237
RP +V+ L ++
Sbjct: 334 PSQRPTFKQLVEDLDRIVAL 353
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-27
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
LKH N V+ +D T+ L Y E+ G L ++ KG + L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVI-----TKGTKERQYLDEEFV 113
Query: 60 VKIAVGAAKGLEYLHEKADP--HIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMA 114
+++ L+ H ++D ++HRD+K +NV + K+ DF L+ N A
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 115 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T V GT Y +PE N KSD++S G +L EL P
Sbjct: 174 ----KTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 53/257 (20%), Positives = 92/257 (35%), Gaps = 61/257 (23%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
H N + LLG C+ L + +G L + + + + +
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--------HNPTVKDLIG 196
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
+ AKG+++L K +HRD+ + N ++ + K+ADF L+ R
Sbjct: 197 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA-------------R 240
Query: 122 VLGTFGYH---------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHT 165
+ + A E T + KSDV+SFGV+L EL+T G P
Sbjct: 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--- 297
Query: 166 LPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223
P ++ + + RL P + V C +A+ RP+
Sbjct: 298 -------------PDVNTFDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPS 342
Query: 224 MSIVVKALQPLLNARPG 240
S +V + + + G
Sbjct: 343 FSELVSRISAIFSTFIG 359
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 40/174 (22%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+L + V+L+G C + +L E A G LH L G++ + ++
Sbjct: 65 HQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAEL 115
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
+ G++YL EK + +HRD+ + NVL+ + AKI+DF LS +
Sbjct: 116 LHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLS-------------KA 159
Query: 123 LGT--FGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
LG Y APE + +++SDV+S+GV + E L+ G+KP
Sbjct: 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 39/172 (22%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
L H + V+LLG C + +++ ++ GSL D + +G L Q +
Sbjct: 71 SLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA--------LGPQLLLNWG 121
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
V AKG+ YL E ++HR++ + NVL+ ++ADF ++ +L
Sbjct: 122 VQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA-------------DLL 165
Query: 124 GTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
A E G+ +SDV+S+GV + EL+T G +P
Sbjct: 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 57/264 (21%), Positives = 98/264 (37%), Gaps = 63/264 (23%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
S+L H++ V G CV G +L EF GSL L K ++ ++++
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--------INILWKLEV 118
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD--------VAKIADFDLSNQAPDMA 114
A A + +L E +IH ++ + N+L+ ++ K++D +S
Sbjct: 119 AKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------- 168
Query: 115 ARLHSTRVLGTFGYH-------APEYAMTGQL-NAKSDVYSFGVVLLELLT-GRKPVDHT 165
+ PE + N +D +SFG L E+ + G KP+
Sbjct: 169 ------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--- 219
Query: 166 LPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPN 223
L + Q + +L PKA A++A + C+ YE D RP+
Sbjct: 220 -------------SALDSQRKLQFYEDRHQL---PAPKA-AELANLINNCMDYEPDHRPS 262
Query: 224 MSIVVKALQPLLNARPGPAGESAS 247
+++ L L P G
Sbjct: 263 FRAIIRDLNSLFTPDLVPRGSHHH 286
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 39/172 (22%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+ + + +LLG C+ T +++ + G L D + K + Q +
Sbjct: 73 SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWC 123
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
V AKG+ YL ++ ++HRD+ + NVL+ KI DF L+ ++L
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLL 167
Query: 124 GTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
G A E + +SDV+S+GV + EL+T G KP
Sbjct: 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-27
Identities = 49/173 (28%), Positives = 67/173 (38%), Gaps = 40/173 (23%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
L H N ++L G + + E A GSL D L +G + A
Sbjct: 77 SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYA 127
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
V A+G+ YL K IHRD+ + N+L+ D+ KI DF L R L
Sbjct: 128 VQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM-------------RAL 171
Query: 124 GTFG--YH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
Y APE T + SD + FGV L E+ T G++P
Sbjct: 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-27
Identities = 62/242 (25%), Positives = 106/242 (43%), Gaps = 43/242 (17%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+L+H+ V+L ++ Y E+ NGSL D L G L+ + +
Sbjct: 64 QLQHQRLVRLYAVV----TQEPIYIITEYMENGSLVDFLKTPSG-------IKLTINKLL 112
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+A A+G+ ++ E+ + IHRD++++N+L+ D KIADF L+ D ++
Sbjct: 113 DMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTA 166
Query: 121 RVLGTFGYH--APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWA 177
R F APE G KSDV+SFG++L E++T GR P
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY--------------- 211
Query: 178 TPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235
P ++ +V Q ++ R+ P ++ + LC + + RP + L+
Sbjct: 212 -PGMTNPEVIQNLERGYRM--VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
Query: 236 NA 237
A
Sbjct: 269 TA 270
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-27
Identities = 52/257 (20%), Positives = 85/257 (33%), Gaps = 58/257 (22%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
L H + V+L+G + + E G L L K L V
Sbjct: 68 KNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNS--------LKVLTLVLY 118
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
++ K + YL + +HRDI N+L+ + K+ DF LS R
Sbjct: 119 SLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS-------------RY 162
Query: 123 LGTFGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRG 169
+ Y+ +PE + SDV+ F V + E+L+ G++P
Sbjct: 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF------- 215
Query: 170 QQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227
L V ++ RL P + + C Y+ RP + +
Sbjct: 216 ---------FWLENKDVIGVLEKGDRL--PKPDLCPPVLYTLMTRCWDYDPSDRPRFTEL 264
Query: 228 VKALQPLLNARPGPAGE 244
V +L + A E
Sbjct: 265 VCSLSDVYQMEKDIAME 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-27
Identities = 50/161 (31%), Positives = 69/161 (42%), Gaps = 20/161 (12%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRV 60
S L+H N ++L GY D T L E+A G+++ L + Q+
Sbjct: 64 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----------FDEQRTA 112
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
A L Y H K +IHRDIK N+L+ KIADF S AP +
Sbjct: 113 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTD 166
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ GT Y PE + K D++S GV+ E L G+ P
Sbjct: 167 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-26
Identities = 49/163 (30%), Positives = 70/163 (42%), Gaps = 16/163 (9%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
LKH+N VQ LG + + E GSL +L + G +
Sbjct: 74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIG-----FY 127
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTR 121
+GL+YLH+ I+HRDIK NVLI V KI+DF S + + +
Sbjct: 128 TKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-- 182
Query: 122 VLGTFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT Y APE G +D++S G ++E+ TG+ P
Sbjct: 183 FTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGKPP 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 40/142 (28%), Positives = 63/142 (44%), Gaps = 21/142 (14%)
Query: 28 EFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGLEYLHEKADPHIIHRDI 86
+ +L D ++ R ++ + G L Q IA + +E+LH K ++HRD+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQ---IA----EAVEFLHSK---GLMHRDL 190
Query: 87 KSSNVLIFDDDVAKIADF----------DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 136
K SN+ DDV K+ DF + M A T +GT Y +PE
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250
Query: 137 GQLNAKSDVYSFGVVLLELLTG 158
+ K D++S G++L ELL
Sbjct: 251 NNYSHKVDIFSLGLILFELLYS 272
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-26
Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 41/173 (23%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L + V+++G C + S +L E A G L+ L + + + +++
Sbjct: 74 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELV 123
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
+ G++YL E + +HRD+ + NVL+ AKI+DF LS + L
Sbjct: 124 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-------------KAL 167
Query: 124 GTFG--YH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
Y APE + ++KSDV+SFGV++ E + G+KP
Sbjct: 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 36/175 (20%), Positives = 68/175 (38%), Gaps = 27/175 (15%)
Query: 3 SRLKHENF--VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++L+ + ++L Y + + E N L+ L +K + +R
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERK 111
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ + +H+ I+H D+K +N L D + K+ DF ++NQ +
Sbjct: 112 SYWKNMLEAVHTIHQH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKD 167
Query: 121 RVLGTFGYHAPE-----------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164
+GT Y PE +++ KSDV+S G +L + G+ P
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-26
Identities = 47/159 (29%), Positives = 68/159 (42%), Gaps = 13/159 (8%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+LKH + ++L Y D L E NG ++ L R S +
Sbjct: 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--------FSENEARHF 117
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
G+ YLH I+HRD+ SN+L+ + KIADF L+ Q + ++
Sbjct: 118 MHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-- 172
Query: 123 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT Y +PE A +SDV+S G + LL GR P
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-26
Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 33/179 (18%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-----GPVLS 55
M +HEN V LLG C G ++ E+ G L + L + V P S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 56 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 115
+ + + A+G+ +L K + IHRD+ + NVL+ + VAKI DF L A
Sbjct: 163 TRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL--------A 211
Query: 116 RLHSTRVLGTFGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
R ++ Y APE +SDV+S+G++L E+ + G P
Sbjct: 212 RD----IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 57/234 (24%), Positives = 87/234 (37%), Gaps = 34/234 (14%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
H + V+L+G + ++ E + G L L RK L + A
Sbjct: 448 FDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRK--------FSLDLASLILYAY 498
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
+ L YL K +HRDI + NVL+ +D K+ DF LS D S L
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 125 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSE 183
APE + + SDV+ FGV + E+L G KP +
Sbjct: 556 IKWM-APESINFRRFTSASDVWMFGVCMWEILMHGVKPF----------------QGVKN 598
Query: 184 DKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235
+ V ++ RL PP + ++ C Y+ RP + + L +L
Sbjct: 599 NDVIGRIENGERL--PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 36/175 (20%), Positives = 68/175 (38%), Gaps = 27/175 (15%)
Query: 3 SRLKHENF--VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++L+ + ++L Y + + E N L+ L +K + +R
Sbjct: 81 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERK 130
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ + +H+ I+H D+K +N L D + K+ DF ++NQ +
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKD 186
Query: 121 RVLGTFGYHAPE-----------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164
+GT Y PE +++ KSDV+S G +L + G+ P
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-26
Identities = 45/172 (26%), Positives = 67/172 (38%), Gaps = 38/172 (22%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+ H + V+L+G + ++ E + G L L RK L +
Sbjct: 71 RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASLILY 121
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
A + L YL K +HRDI + NVL+ +D K+ DF LS R
Sbjct: 122 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RY 165
Query: 123 LGTFGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ Y+ APE + + SDV+ FGV + E+L G KP
Sbjct: 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 43/184 (23%), Positives = 69/184 (37%), Gaps = 39/184 (21%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ---------PG 51
+ H N V LLG C G ++ E+ G L + L ++
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 52 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 111
L + + + AKG+ +L K + IHRD+ + N+L+ + KI DF L+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA---- 192
Query: 112 DMAARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT- 157
R + + APE +SDV+S+G+ L EL +
Sbjct: 193 ---------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 158 GRKP 161
G P
Sbjct: 244 GSSP 247
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-25
Identities = 55/197 (27%), Positives = 75/197 (38%), Gaps = 25/197 (12%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 66
V G + E + SL P +L KIAV
Sbjct: 65 CPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KIAVSI 118
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 126
K LE+LH K +IHRD+K SNVLI K+ DF +S D A+ G
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173
Query: 127 GYHAPE----YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP--RGQQSLVTWATPK 180
Y APE + KSD++S G+ ++EL R P D + + +V +P+
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233
Query: 181 LSEDK--------VRQC 189
L DK QC
Sbjct: 234 LPADKFSAEFVDFTSQC 250
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 58/251 (23%), Positives = 108/251 (43%), Gaps = 60/251 (23%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L + V+L+G C + +L E A G LH L G++ + ++
Sbjct: 392 QLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELL 442
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 123
+ G++YL EK + +HR++ + NVL+ + AKI+DF LS + L
Sbjct: 443 HQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS-------------KAL 486
Query: 124 GT--FGYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 168
G Y APE + +++SDV+S+GV + E L+ G+KP
Sbjct: 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY------ 540
Query: 169 GQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226
K+ +V ++ R+ + PP+ ++ A+ + C Y+ + RP+
Sbjct: 541 ----------KKMKGPEVMAFIEQGKRM--ECPPECPPELYALMSDCWIYKWEDRPDFLT 588
Query: 227 VVKALQPLLNA 237
V + ++ +
Sbjct: 589 VEQRMRACYYS 599
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 16/163 (9%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 62
+ L V L G +G + E GSL ++ ++ G P
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQM--GCLPEDRAL-----YY 155
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQ-APDMAARLHST 120
A +GLEYLH + I+H D+K+ NVL+ D A + DF + PD + T
Sbjct: 156 LGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 121 R--VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ GT + APE M +AK D++S ++L +L G P
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 48/209 (22%), Positives = 81/209 (38%), Gaps = 15/209 (7%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ V G + E GSL +L + P +L
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI----PEQILG----- 134
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
K+++ KGL YL EK I+HRD+K SN+L+ K+ DF +S Q D A +
Sbjct: 135 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---S 189
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
V GT Y +PE + +SD++S G+ L+E+ GR P+ + + +
Sbjct: 190 FV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAV 209
+ + + + A+
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAI 277
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 35/177 (19%), Positives = 68/177 (38%), Gaps = 31/177 (17%)
Query: 3 SRLKHENF--VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS--WQQ 58
++L+ + ++L Y + + E N L+ L +K + W+
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSI----DPWERKSYWKN 163
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
++ + +H+ I+H D+K +N L D + K+ DF ++NQ +
Sbjct: 164 MLE-------AVHTIHQH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVV 212
Query: 119 STRVLGTFGYHAPE-----------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164
+G Y PE +++ KSDV+S G +L + G+ P
Sbjct: 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 56/267 (20%), Positives = 100/267 (37%), Gaps = 65/267 (24%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ------------- 49
++ H + ++L G C +L E+A GSL L + V
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 50 --PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 107
L+ + A ++G++YL E ++HRD+ + N+L+ + KI+DF LS
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 108 NQAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLE 154
R + + A E +SDV+SFGV+L E
Sbjct: 198 -------------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAA 211
++T G P P + +++ + R+ + P +M +
Sbjct: 245 IVTLGGNP----------------YPGIPPERLFNLLKTGHRM--ERPDNCSEEMYRLML 286
Query: 212 LCVQYEADFRPNMSIVVKALQPLLNAR 238
C + E D RP + + K L+ ++ R
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKMMVKR 313
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 38/183 (20%)
Query: 1 MVSRLKHENFVQLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGP 52
++ H N V LLG C G ++ EF G+L L ++
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 53 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 112
L+ + + + AKG+E+L + IHRD+ + N+L+ + +V KI DF L+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA----- 195
Query: 113 MAARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-G 158
R + + APE +SDV+SFGV+L E+ + G
Sbjct: 196 --------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 159 RKP 161
P
Sbjct: 248 ASP 250
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-25
Identities = 52/161 (32%), Positives = 67/161 (41%), Gaps = 20/161 (12%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRV 60
S L+H N +++ Y D L EFA G L+ L HGR Q+
Sbjct: 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-----------FDEQRSA 117
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
A L Y HE+ +IHRDIK N+L+ KIADF S AP R +
Sbjct: 118 TFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTM 172
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT Y PE + K D++ GV+ E L G P
Sbjct: 173 --CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-24
Identities = 56/190 (29%), Positives = 77/190 (40%), Gaps = 18/190 (9%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ-PGPVLSWQQRVKIAV 64
VQ G + E + S V P +L KI +
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG-----KITL 132
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
K L +L E IIHRDIK SN+L+ K+ DF +S Q D A+ TR G
Sbjct: 133 ATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAG 187
Query: 125 TFGYHAPE----YAMTGQLNAKSDVYSFGVVLLELLTGRKPVD--HTLPRGQQSLVTWAT 178
Y APE A + +SDV+S G+ L EL TGR P +++ +V
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP 247
Query: 179 PKLSEDKVRQ 188
P+LS + R+
Sbjct: 248 PQLSNSEERE 257
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-24
Identities = 51/189 (26%), Positives = 78/189 (41%), Gaps = 44/189 (23%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--------------HGRKGVK 46
M HEN V LLG C L +E+ G L + L +K ++
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 47 GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 106
+ VL+++ + A AKG+E+L K +HRD+ + NVL+ V KI DF L
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 107 SNQAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLL 153
+ R + + + APE G KSDV+S+G++L
Sbjct: 219 A-------------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
Query: 154 ELLT-GRKP 161
E+ + G P
Sbjct: 266 EIFSLGVNP 274
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 8e-24
Identities = 32/176 (18%), Positives = 63/176 (35%), Gaps = 29/176 (16%)
Query: 2 VSRLKHENFVQLL--GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSW 56
++ + H + VQ+ D + Y E+ SL + L
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPV 181
Query: 57 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 116
+ + + L YLH +++ D+K N+++ ++ + K+ D +R
Sbjct: 182 AEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEEQL-KLIDLGA-------VSR 230
Query: 117 LHST-RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 171
++S + GT G+ APE +D+Y+ G L L + G
Sbjct: 231 INSFGYLYGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-24
Identities = 36/165 (21%), Positives = 64/165 (38%), Gaps = 21/165 (12%)
Query: 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 65
+H N ++ D + +A E + +L + + Q + + +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--------EQKDFAHLGLEPITLLQQ 126
Query: 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFDLSNQ-APDMAARLHS 119
GL +LH +I+HRD+K N+LI + A I+DF L + A +
Sbjct: 127 TTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 120 TRVLGTFGYHAPEY---AMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ V GT G+ APE D++S G V +++
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-23
Identities = 42/182 (23%), Positives = 69/182 (37%), Gaps = 37/182 (20%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAY-------------EFASNGSLHDILHGRKGVKGAQ 49
+ L H+ V+ ++ + V E+ NG+L+D++H
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN---- 112
Query: 50 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109
+ ++ + L Y+H + IIHRD+K N+ I + KI DF L+
Sbjct: 113 ----QQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 110 APDMAARLHS------------TRVLGTFGYHAPE-YAMTGQLNAKSDVYSFGVVLLELL 156
L T +GT Y A E TG N K D+YS G++ E++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 157 TG 158
Sbjct: 226 YP 227
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-23
Identities = 41/162 (25%), Positives = 64/162 (39%), Gaps = 16/162 (9%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV-K 61
L H++ V G+ D + E SL ++ RK + +
Sbjct: 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT----------EPEARY 119
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
G +YLH +IHRD+K N+ + +D KI DF L+ + R
Sbjct: 120 YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL- 175
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
GT Y APE + + DV+S G ++ LL G+ P +
Sbjct: 176 -CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-23
Identities = 35/161 (21%), Positives = 56/161 (34%), Gaps = 16/161 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+H V+L +G L E SL G L Q
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--------AWGASLPEAQVW 160
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
L +LH + ++H D+K +N+ + K+ DF L + A
Sbjct: 161 GYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EV 215
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ G Y APE + G +DV+S G+ +LE+ +
Sbjct: 216 QE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 6e-23
Identities = 43/170 (25%), Positives = 63/170 (37%), Gaps = 21/170 (12%)
Query: 4 RLKHENFVQLL------GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 57
+L H N V +LA E+ G L L+ + G L
Sbjct: 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG------LKEG 121
Query: 58 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMA 114
+ + L YLHE IIHRD+K N+++ + KI D + +
Sbjct: 122 PIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-- 176
Query: 115 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164
L + V GT Y APE + D +SFG + E +TG +P
Sbjct: 177 GELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-23
Identities = 41/160 (25%), Positives = 63/160 (39%), Gaps = 16/160 (10%)
Query: 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV-K 61
L H++ V G+ D + E SL ++ RK + +
Sbjct: 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT----------EPEARY 145
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
G +YLH +IHRD+K N+ + +D KI DF L+ + R
Sbjct: 146 YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL- 201
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT Y APE + + DV+S G ++ LL G+ P
Sbjct: 202 -CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-23
Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 15/161 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++S+ + G + T + E+ GS D+L +PGP L Q
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIA 122
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
I KGL+YLH + IHRDIK++NVL+ + K+ADF ++ Q D + ++
Sbjct: 123 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT- 178
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+GT + APE ++K+D++S G+ +EL G P
Sbjct: 179 -FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-23
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 13/161 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ + + V+ G T + E+ GS+ DI+ R L+ +
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--------LTEDEIA 128
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
I KGLEYLH IHRDIK+ N+L+ + AK+ADF ++ Q D A+ ++
Sbjct: 129 TILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT- 184
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
V+GT + APE N +D++S G+ +E+ G+ P
Sbjct: 185 -VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-22
Identities = 46/185 (24%), Positives = 73/185 (39%), Gaps = 27/185 (14%)
Query: 4 RLKHENFVQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
+L H+N V+L + T+R VL EF GSL+ +L G L + +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLI 116
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF----DDDVAKIADFDLSNQAPDMAARL 117
+ G+ +L E I+HR+IK N++ V K+ DF + + D +
Sbjct: 117 VLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQF 172
Query: 118 HSTRVLGTFGYHAPE--------YAMTGQLNAKSDVYSFGVVLLELLTGRKP-VDHTLPR 168
S + GT Y P+ + A D++S GV TG P PR
Sbjct: 173 VS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 169 GQQSL 173
+ +
Sbjct: 231 RNKEV 235
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-22
Identities = 48/192 (25%), Positives = 76/192 (39%), Gaps = 21/192 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ VQ G + T +A E + + + P +L
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI----PERILG----- 127
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
K+ V K L YL EK +IHRD+K SN+L+ + K+ DF +S + D A+
Sbjct: 128 KMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---D 182
Query: 121 RVLGTFGYHAPE-----YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP--RGQQSL 173
R G Y APE + ++DV+S G+ L+EL TG+ P + +
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
Query: 174 VTWATPKLSEDK 185
+ P L
Sbjct: 243 LQEEPPLLPGHM 254
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-22
Identities = 46/185 (24%), Positives = 73/185 (39%), Gaps = 27/185 (14%)
Query: 4 RLKHENFVQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
+L H+N V+L + T+R VL EF GSL+ +L G L + +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLI 116
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF----DDDVAKIADFDLSNQAPDMAARL 117
+ G+ +L E I+HR+IK N++ V K+ DF + + D +
Sbjct: 117 VLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQF 172
Query: 118 HSTRVLGTFGYHAPE--------YAMTGQLNAKSDVYSFGVVLLELLTGRKP-VDHTLPR 168
S + GT Y P+ + A D++S GV TG P PR
Sbjct: 173 VS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 169 GQQSL 173
+ +
Sbjct: 231 RNKEV 235
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 2e-22
Identities = 30/172 (17%), Positives = 54/172 (31%), Gaps = 18/172 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ F++ + VL E S G+L + ++ K P V+ +
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK----NTPEKVMPQGLVI 175
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA-----------KIADFDLSNQ 109
A+ +E +H+ IIH DIK N ++ + + + D S
Sbjct: 176 SFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 110 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T T G+ E N + D + + +L G
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-22
Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 16/184 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ K+ N V L + G + E+ + GSL D++ + Q
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIA 119
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ + LE+LH +IHRDIKS N+L+ D K+ DF Q ++ +
Sbjct: 120 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST- 175
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTWATP 179
++GT + APE K D++S G++ +E++ G P + P R + T TP
Sbjct: 176 -MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
Query: 180 KLSE 183
+L
Sbjct: 235 ELQN 238
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-21
Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 23/230 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+S+ H N V V L + S GS+ DI+ + G L
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDEST-- 122
Query: 61 KIAV---GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAAR 116
IA +GLEYLH+ IHRD+K+ N+L+ +D +IADF +S A
Sbjct: 123 -IATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178
Query: 117 LHSTR--VLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQS 172
+ R +GT + APE + + K+D++SFG+ +EL TG P P +
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238
Query: 173 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP 222
+ P L + + + G K+ KM +LC+Q + + RP
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYG-----KSFRKM---ISLCLQKDPEKRP 280
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 1e-21
Identities = 34/168 (20%), Positives = 57/168 (33%), Gaps = 17/168 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ H N V + + F + GS D++ ++
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI------CTHFMDG-MNELAIA 131
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
I G K L+Y+H +HR +K+S++LI D ++ + R
Sbjct: 132 YILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 121 RVL-----GTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKP 161
+ +PE +AKSD+YS G+ EL G P
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 7e-21
Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 15/161 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +H N V++ + G + EF G+L DI+ + L+ +Q
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----------LNEEQIA 144
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ + L YLH + +IHRDIKS ++L+ D K++DF Q + S
Sbjct: 145 TVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS- 200
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
++GT + APE + D++S G++++E++ G P
Sbjct: 201 -LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-21
Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 18/166 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+++ H V+LLG + EF G++ I+ L+ Q
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--------LTEPQIQ 120
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ + L +LH K IIHRD+K+ NVL+ + ++ADF +S + + S
Sbjct: 121 VVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS- 176
Query: 121 RVLGTFGYHAPEYAMTGQL-----NAKSDVYSFGVVLLELLTGRKP 161
+GT + APE M + + K+D++S G+ L+E+ P
Sbjct: 177 -FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 88.9 bits (220), Expect = 1e-20
Identities = 22/197 (11%), Positives = 60/197 (30%), Gaps = 25/197 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDGT--SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
+V + + +++ D SR Y +L G + + L
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTF--GEVLLSHSSTHKSLVHHA 207
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
R+++ + + L LH ++H ++ ++++ + F+ +
Sbjct: 208 RLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------A 258
Query: 119 STRVLGTFGYHAPEYAMT-----------GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 167
+ G+ PE + D ++ G+V+ + P+
Sbjct: 259 RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318
Query: 168 RGQQSLVTWATPKLSED 184
G + + + +
Sbjct: 319 LGGSEWIFRSCKNIPQP 335
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 2e-20
Identities = 15/166 (9%), Positives = 48/166 (28%), Gaps = 14/166 (8%)
Query: 24 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 83
+ ++ + ++L + L R+++ + + L LH ++H
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKS-----LVHHARLQLTLQVIRLLASLHHY---GLVH 234
Query: 84 RDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE-----YAMTGQ 138
++ ++++ + F+ +A R A
Sbjct: 235 TYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTL 293
Query: 139 LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED 184
+ D ++ G+ + + P G + + + +
Sbjct: 294 MTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQP 339
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-20
Identities = 53/173 (30%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 4 RLKHENFVQLLGYCV-DGTSRVLAY---EFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQ 58
+L H N V+L V D + Y E + G + ++ LS Q
Sbjct: 92 KLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-----------LSEDQ 138
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 118
KG+EYLH + IIHRDIK SN+L+ +D KIADF +SN+ A L
Sbjct: 139 ARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195
Query: 119 STRVLGTFGYHAPEYAMTGQLN---AKSDVYSFGVVLLELLTGRKP-VDHTLP 167
+T GT + APE + DV++ GV L + G+ P +D +
Sbjct: 196 NTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 3e-20
Identities = 18/153 (11%), Positives = 35/153 (22%), Gaps = 13/153 (8%)
Query: 22 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81
+ +L AS L + + + L K +
Sbjct: 162 NYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215
Query: 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--TGQL 139
+H N+ I D + D + Y E+ T
Sbjct: 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATF 270
Query: 140 NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 172
+ + G+ + + P P + S
Sbjct: 271 THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-20
Identities = 41/181 (22%), Positives = 61/181 (33%), Gaps = 27/181 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSR-------VLAYEFASNGSLHDILHGRKGVKGAQPGPV 53
M H N VQ G L G L + L +
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP------ 132
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF--------- 104
LS +KI + ++++H + P IIHRD+K N+L+ + K+ DF
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191
Query: 105 -DLSNQAPDMAARLHSTRVLGTFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRK 160
D S A A T Y PE + K D+++ G +L L +
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
Query: 161 P 161
P
Sbjct: 252 P 252
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 9e-20
Identities = 37/179 (20%), Positives = 66/179 (36%), Gaps = 28/179 (15%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
H N ++ +A E N +L D++ + + + + +
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN--VSDENLKLQKEYNPISLLR 122
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLI-------------FDDDVAKIADFDLSNQ-- 109
A G+ +LH IIHRD+K N+L+ ++ I+DF L +
Sbjct: 123 QIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 110 APDMAARLHSTRVLGTFGYHAPE-------YAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ + R + GT G+ APE +L D++S G V +L+ K
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-19
Identities = 28/177 (15%), Positives = 58/177 (32%), Gaps = 34/177 (19%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
+H + V+ + ++ E+ + GSL D + + L + +
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLLL 122
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD------------ 112
+GL Y+H ++H DIK SN+ I + A +
Sbjct: 123 QVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 113 MAARLHSTRVL-GTFGYHAPE-------YAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
R+ S +V G + A E + K+D+++ + ++
Sbjct: 180 HVTRISSPQVEEGDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPL 230
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-19
Identities = 50/195 (25%), Positives = 79/195 (40%), Gaps = 30/195 (15%)
Query: 6 KHENFVQLLG-YCVDGTSRVLAY-----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
H N G + + EF GS+ D++ KG L +
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-------LKEEW- 130
Query: 60 VKIAV---GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 116
IA +GL +LH+ +IHRDIK NVL+ ++ K+ DF +S Q R
Sbjct: 131 --IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 117 LHSTRVLGTFGYHAPEYAMTGQL-----NAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQ 170
++ +GT + APE + + KSD++S G+ +E+ G P+ P R
Sbjct: 186 RNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243
Query: 171 QSLVTWATPKLSEDK 185
+ P+L K
Sbjct: 244 FLIPRNPAPRLKSKK 258
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-19
Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 22/189 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ +L+H N +Q G + + L E+ GS D+L K L +
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--------LQEVEIA 157
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ GA +GL YLH ++IHRD+K+ N+L+ + + K+ DF ++ MA
Sbjct: 158 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI---MAPA---N 208
Query: 121 RVLGTFGYHAPEYAMTGQL---NAKSDVYSFGVVLLELLTGRKPVDHTLP-RGQQSLVTW 176
+GT + APE + + K DV+S G+ +EL + P+ + +
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 268
Query: 177 ATPKLSEDK 185
+P L
Sbjct: 269 ESPALQSGH 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-16
Identities = 55/171 (32%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQR 59
L H N V+L + V T + L E+AS G + D L HGR K A+ ++Q
Sbjct: 70 ILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS----KFRQI 123
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
V ++Y H+K I+HRD+K+ N+L+ D KIADF SN+
Sbjct: 124 VS-------AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLD 171
Query: 120 TRVLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKP-VDHTLP 167
G Y APE G+ + DV+S GV+L L++G P L
Sbjct: 172 AFC-GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 49/161 (30%), Positives = 68/161 (42%), Gaps = 19/161 (11%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
L H N ++L D L EF G L + + R I
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH---------KFDECDAANIM 152
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHST 120
G+ YLH+ +I+HRDIK N+L+ + + KI DF LS+ +L
Sbjct: 153 KQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKLRD- 207
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
LGT Y APE + + N K DV+S GV++ LL G P
Sbjct: 208 -RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-16
Identities = 47/161 (29%), Positives = 68/161 (42%), Gaps = 19/161 (11%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
L H N ++L + D + L E G L D + R + I
Sbjct: 92 LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM---------KFNEVDAAVII 142
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHST 120
G+ YLH+ +I+HRD+K N+L+ + + KI DF LS +
Sbjct: 143 KQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---K 196
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
LGT Y APE + + + K DV+S GV+L LL G P
Sbjct: 197 ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-16
Identities = 47/161 (29%), Positives = 68/161 (42%), Gaps = 19/161 (11%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L H N ++L + D L E + G L D + RK S +I
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---------RFSEVDAARII 132
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHST 120
G+ Y+H+ I+HRD+K N+L+ +I DF LS
Sbjct: 133 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---K 186
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+GT Y APE + G + K DV+S GV+L LL+G P
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-15
Identities = 45/195 (23%), Positives = 58/195 (29%), Gaps = 40/195 (20%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L H N +L D L E G L D L+ + + Q
Sbjct: 84 KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 64 VG------------------------AAK-------GLEYLHEKADPHIIHRDIKSSNVL 92
+ L YLH + I HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFL 200
Query: 93 IFDDDVA--KIADFDLSN--QAPDMAARLHSTRVLGTFGYHAPE--YAMTGQLNAKSDVY 146
+ K+ DF LS + T GT + APE K D +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 147 SFGVVLLELLTGRKP 161
S GV+L LL G P
Sbjct: 261 SAGVLLHLLLMGAVP 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-15
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 25/170 (14%)
Query: 4 RLKHENFVQLLGYCVDGTSR--VLAYEFASNGS--LHD-ILHGRKGVKGAQPGPVLSWQQ 58
RL+H+N +QL+ + + + E+ G + D + R V A + Q
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH----GYFCQ 117
Query: 59 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA--R 116
+ GLEYLH + I+H+DIK N+L+ KI+ ++ AA
Sbjct: 118 LID-------GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167
Query: 117 LHSTRVLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVDH 164
+++ G+ + PE A K D++S GV L + TG P +
Sbjct: 168 CRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 52/165 (31%), Positives = 72/165 (43%), Gaps = 21/165 (12%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVK 61
L HEN V+ G+ +G + L E+ S G L D + AQ + Q +
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----RFFHQLMA 116
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHST 120
G+ YLH I HRDIK N+L+ + D KI+DF L+ RL +
Sbjct: 117 -------GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 121 RVLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 163
GT Y APE + + DV+S G+VL +L G P D
Sbjct: 167 MC-GTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-15
Identities = 23/160 (14%), Positives = 39/160 (24%), Gaps = 43/160 (26%)
Query: 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 61
+SR+ ++L ++ E+ GSL ++ P P ++
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSP----VGAIR 133
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 121
A + H + S V + D
Sbjct: 134 AMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVV--------------------- 169
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
L N + D+ G L LL R P
Sbjct: 170 -LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWP 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 3e-15
Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 4/113 (3%)
Query: 50 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109
L+ + + + AKG+E+L + IHRD+ + N+L+ + +V KI DF L+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 110 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 161
+ + APE +SDV+SFGV+L E+ + G P
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-15
Identities = 54/173 (31%), Positives = 74/173 (42%), Gaps = 38/173 (21%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAY--EFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQR 59
L+H N V+ V T LA E+AS G L++ + GR A+ +QQ
Sbjct: 72 SLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR----FFFQQL 125
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAAR 116
+ G+ Y H I HRD+K N L+ D A KI DF S + ++
Sbjct: 126 LS-------GVSYCHSM---QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL-HSQ 173
Query: 117 LHSTRVLGTFGYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
ST +GT Y APE Y G +DV+S GV L +L G P +
Sbjct: 174 PKST--VGTPAYIAPEVLLRQEYD--G---KIADVWSCGVTLYVMLVGAYPFE 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-15
Identities = 52/169 (30%), Positives = 71/169 (42%), Gaps = 29/169 (17%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVK 61
L HEN V+ G+ +G + L E+ S G L D + AQ + Q +
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----RFFHQLMA 116
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHST 120
G+ YLH I HRDIK N+L+ + D KI+DF L+ RL +
Sbjct: 117 -------GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 121 RVLGTFGYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
GT Y APE + DV+S G+VL +L G P D
Sbjct: 167 MC-GTLPYVAPELLKRREFH--A---EPVDVWSCGIVLTAMLAGELPWD 209
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 7e-15
Identities = 53/166 (31%), Positives = 78/166 (46%), Gaps = 26/166 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQR 59
+H + ++L Y V T + E+ S G L D + HGR A +QQ
Sbjct: 67 LFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----RRLFQQI 120
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
+ ++Y H ++HRD+K NVL+ AKIADF LSN D L +
Sbjct: 121 LS-------AVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRT 169
Query: 120 TRVLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 163
+ G+ Y APE ++G+L + D++S GV+L LL G P D
Sbjct: 170 S--CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 19/161 (11%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L H N ++L D +S + E + G L D + RK S +I
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARII 127
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHST 120
G+ Y+H+ +I+HRD+K N+L+ + KI DF LS ++
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKD- 182
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+GT Y APE + G + K DV+S GV+L LL+G P
Sbjct: 183 -RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 16/160 (10%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
L+H V L D V+ YEF S G L + + +S + V+
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--------KMSEDEAVEYM 261
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIF--DDDVAKIADFDLSNQAPDMAARLHSTR 121
KGL ++HE + +H D+K N++ + K+ DF L+ + +
Sbjct: 262 RQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKV 315
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT + APE A + +D++S GV+ LL+G P
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 41/161 (25%), Positives = 63/161 (39%), Gaps = 15/161 (9%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
L H N +++ D + + E G L + + + LS ++
Sbjct: 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELM 130
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHST 120
L Y H + H++H+D+K N+L D KI DF L+ +
Sbjct: 131 KQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTN 185
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT Y APE + K D++S GVV+ LLTG P
Sbjct: 186 AA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-14
Identities = 45/178 (25%), Positives = 68/178 (38%), Gaps = 42/178 (23%)
Query: 5 LKHENFVQLLGYCVDGTSR--VLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSWQQR 59
LKH N + L + R L +++A HD I+ + K + L
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAA 115
+ G+ YLH ++HRD+K +N+L+ + KIAD A
Sbjct: 131 KSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------A 179
Query: 116 RL---------HSTRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 159
RL V+ TF Y APE L A+ D+++ G + ELLT
Sbjct: 180 RLFNSPLKPLADLDPVVVTFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 4e-14
Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQR 59
+H + ++L Y V T + E+ S G L D + +GR K + +QQ
Sbjct: 72 LFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES----RRLFQQI 125
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
+ G++Y H ++HRD+K NVL+ AKIADF LSN D L +
Sbjct: 126 LS-------GVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRT 174
Query: 120 TRVLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 163
+ G+ Y APE ++G+L + D++S GV+L LL G P D
Sbjct: 175 S--CGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-14
Identities = 44/165 (26%), Positives = 65/165 (39%), Gaps = 13/165 (7%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
LKH + V+LL + +EF L + VK A G V S
Sbjct: 82 MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAVASHYM 136
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHST 120
+ L Y H+ +IIHRD+K VL+ + + K+ F ++ Q +
Sbjct: 137 RQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG- 192
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165
+GT + APE DV+ GV+L LL+G P T
Sbjct: 193 -RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GLE++H + +++RD+K +N+L+ + +I+D L+ V GT GY
Sbjct: 304 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV-GTHGY 356
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE G S D +S G +L +LL G P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 36/100 (36%), Positives = 47/100 (47%), Gaps = 12/100 (12%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLG 124
++YLHE IIHRD+K NVL+ + + KI DF S + + L T G
Sbjct: 250 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLC-G 303
Query: 125 TFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T Y APE T N D +S GV+L L+G P
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-13
Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+++ H + ++HRDIK N+LI AK+ DF D GT
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDF--DGTRV 203
Query: 128 YHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDH 164
Y PE+ Q + V+S G++L +++ G P +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 42/161 (26%), Positives = 68/161 (42%), Gaps = 18/161 (11%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L H + L D VL EF S G L D + +S + +
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAEVINYM 155
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQA-PDMAARLHST 120
A +GL+++HE I+H DIK N++ + KI DF L+ + PD ++
Sbjct: 156 RQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--- 209
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T + APE + +D+++ GV+ LL+G P
Sbjct: 210 -TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-13
Identities = 31/97 (31%), Positives = 44/97 (45%), Gaps = 9/97 (9%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
+ YL K IIHRDIK N++I +D K+ DF + +L T GT Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYTFC-GTIEY 195
Query: 129 HAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 163
APE + G + +++S GV L L+ P
Sbjct: 196 CAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 9/97 (9%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
+EY H I+HRD+K N+L+ D+ KIADF LSN D L ++ G+ Y
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTS--CGSPNY 173
Query: 129 HAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 163
APE + G+L + DV+S G+VL +L GR P D
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L+YL + IIHRD+K N+L+ + I DF+++ P +T + GT Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPY 180
Query: 129 HAPE--YAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + G + + D +S GV ELL GR+P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 129
LEYLH K IIHRD+K N+L+ +D +I DF + + + + +GT Y
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 130 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+PE SD+++ G ++ +L+ G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-13
Identities = 25/98 (25%), Positives = 46/98 (46%), Gaps = 9/98 (9%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDV-AKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+ + H ++HRDIK N+LI + K+ DF D +++ GT
Sbjct: 161 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFD-GTRV 213
Query: 128 YHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVDH 164
Y PE+ + + + V+S G++L +++ G P +H
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-13
Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 23/163 (14%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVK 61
L H N ++L D T L E + G L + + A + +K
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMK 113
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLH 118
+ A + Y H+ ++ HRD+K N L D K+ DF L+ + ++
Sbjct: 114 DVLSA---VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMM 165
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T+V GT Y +P+ + G + D +S GV++ LL G P
Sbjct: 166 RTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 6e-13
Identities = 45/165 (27%), Positives = 68/165 (41%), Gaps = 29/165 (17%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIA 63
LKH+N V+L L +EF L G P V S+ Q +K
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLK-- 112
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN--QAPDMAARLHSTR 121
GL + H + +++HRD+K N+LI + K+A+F L+ P R +S
Sbjct: 113 -----GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAE 161
Query: 122 VLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 161
V+ T Y P+ AK D++S G + EL +P
Sbjct: 162 VV-TLWYRPPDVL----FGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 6e-13
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GLE+LH++ +II+RD+K NVL+ DD +I+D L+ + + GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYA-GTPGF 355
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + G+ S D ++ GV L E++ R P
Sbjct: 356 MAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-13
Identities = 44/166 (26%), Positives = 63/166 (37%), Gaps = 25/166 (15%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAV 64
H N +QL T L ++ G L D LS ++ KI
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----------LSEKETRKIMR 131
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
+ + LH+ +I+HRD+K N+L+ DD K+ DF S Q G
Sbjct: 132 ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVC-G 185
Query: 125 TFGYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164
T Y APE + D++S GV++ LL G P H
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 37/174 (21%)
Query: 4 RLKHENFVQLLGYCVDGTSRV--------LAYEFASNGSLHDILHGRKGVKG--AQPGPV 53
LKHEN V L+ C S L ++F HD+ G +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDL-------AGLLSNVLVK 120
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQA 110
+ + ++ GL Y+H I+HRD+K++NVLI D V K+ADF L+ + A
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 111 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 159
+ ++ RV+ T Y PE L + D++ G ++ E+ T
Sbjct: 178 KNSQPNRYTNRVV-TLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-12
Identities = 36/162 (22%), Positives = 65/162 (40%), Gaps = 20/162 (12%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKI 62
+H N + L V+ +EF S + + I L+ ++ V
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSY 107
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQ-APDMAARLHS 119
+ L++LH +I H DI+ N++ + KI +F + Q P RL
Sbjct: 108 VHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-- 162
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ Y+APE ++ +D++S G ++ LL+G P
Sbjct: 163 --LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-12
Identities = 47/162 (29%), Positives = 67/162 (41%), Gaps = 21/162 (12%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKI 62
++KHEN V L T L + S G L D IL +GV + + +
Sbjct: 62 KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGV--------YTEKDASLV 111
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHS 119
++YLHE I+HRD+K N+L ++ I DF LS + + +
Sbjct: 112 IQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMST 166
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT GY APE + D +S GV+ LL G P
Sbjct: 167 --ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-12
Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 24/164 (14%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASN--GSLHDILHGRKGVKGAQPGPVLSW-QQRV 60
LKHEN V+L L +EF N D +G + V + Q
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ-- 116
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+GL + HE I+HRD+K N+LI K+ DF L+ +A + S+
Sbjct: 117 -----LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVNTFSS 167
Query: 121 RVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 159
V+ T Y AP+ + +++ D++S G +L E++TG+
Sbjct: 168 EVV-TLWYRAPDVL----MGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-12
Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
G+++LH IIHRD+K SN+++ D KI DF L A T + T
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRY 191
Query: 128 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159
Y APE + D++S G ++ E++ G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-12
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GLE LH + I++RD+K N+L+ D +I+D L+ P+ + RV GT GY
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 351
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + + S D ++ G +L E++ G+ P
Sbjct: 352 MAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-12
Identities = 36/99 (36%), Positives = 46/99 (46%), Gaps = 12/99 (12%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGT 125
++YLHE IIHRD+K NVL+ + + KI DF S + L T GT
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC-GT 179
Query: 126 FGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
Y APE T N D +S GV+L L+G P
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 5e-12
Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 25/162 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKI 62
L H N V L+ L +EF L +L K G Q + + Q ++
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLR- 130
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 122
G+ + H+ I+HRD+K N+LI D K+ADF L+ +A + R ++ V
Sbjct: 131 ------GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTHEV 180
Query: 123 LGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 159
+ T Y AP+ + +K D++S G + E++TG+
Sbjct: 181 V-TLWYRAPDVL----MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-12
Identities = 50/162 (30%), Positives = 66/162 (40%), Gaps = 20/162 (12%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKI 62
RL H N ++L T L E + G L D I+ KG S +
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV--EKGY--------YSERDAADA 153
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHS 119
+ + YLHE I+HRD+K N+L D KIADF LS L
Sbjct: 154 VKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMK 208
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T GT GY APE + D++S G++ LL G +P
Sbjct: 209 TVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-12
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L+YLH + + +++RD+K N+++ D KI DF L + A + + GT Y
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + ++ D + GVV+ E++ GR P
Sbjct: 316 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-12
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
++ H N + L + T VL E S G L D L ++ LS ++
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFI 121
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLSNQAPDMAARLHS 119
G+ YLH K I H D+K N+++ D ++ K+ DF L+++ + +
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEF 175
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ GT + APE L ++D++S GV+ LL+G P
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-12
Identities = 43/165 (26%), Positives = 69/165 (41%), Gaps = 25/165 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
++ H N + L + T VL E S G L D L ++ LS ++
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFI 121
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAPDMAAR 116
G+ YLH K I H D+K N+++ D ++ K+ DF L+ +
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 117 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ GT + APE L ++D++S GV+ LL+G P
Sbjct: 176 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 8e-12
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 29/163 (17%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IA 63
LKH N V+L VL +E D+ K + G + S K
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLD----QDL----KKLLDVCEGGLESVT--AKSFL 106
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN--QAPDMAARLHSTR 121
+ G+ Y H++ ++HRD+K N+LI + KIADF L+ P R ++
Sbjct: 107 LQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHE 160
Query: 122 VLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 159
++ T Y AP+ + +K D++S G + E++ G
Sbjct: 161 IV-TLWYRAPDVL----MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-11
Identities = 49/163 (30%), Positives = 71/163 (43%), Gaps = 23/163 (14%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVK 61
+L H N ++L D +S + E + G L D I R S +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----------FSEHDAAR 125
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLH 118
I G+ Y+H+ +I+HRD+K N+L+ + KI DF LS
Sbjct: 126 IIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKM 180
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
R+ GT Y APE + G + K DV+S GV+L LL+G P
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
G+++LH IIHRD+K SN+++ D KI DF L+ A T + T
Sbjct: 175 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRY 228
Query: 128 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159
Y APE + D++S G ++ E++ +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-11
Identities = 39/169 (23%), Positives = 68/169 (40%), Gaps = 29/169 (17%)
Query: 1 MVSRLKHENFVQLL----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLS 55
+ +H N V+L D +++ L +E D+ P P +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDL----TTYLDKVPEPGVP 118
Query: 56 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 115
+ + +GL++LH ++HRD+K N+L+ K+ADF L A
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------A 167
Query: 116 RLHS-----TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159
R++S T V+ T Y APE + D++S G + E+ +
Sbjct: 168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 8/98 (8%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVL 123
+ ++H+ ++HRD+K N+L D++ KI DF + P L +
Sbjct: 116 VSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PC 170
Query: 124 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T Y APE + D++S GV+L +L+G+ P
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-11
Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 29/169 (17%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV-----LAYEFASNGSLHDILHGRKGVKGAQPGPVLS 55
+ +H N V+L+ C + L +E D+ + P P L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDL----RTYLDKAPPPGLP 118
Query: 56 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 115
+ + +GL++LH I+HRD+K N+L+ K+ADF L A
Sbjct: 119 AETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------A 167
Query: 116 RLHS-----TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159
R++S T V+ T Y APE + D++S G + E+ +
Sbjct: 168 RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 42/165 (25%), Positives = 66/165 (40%), Gaps = 26/165 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKI 62
+L H N +QL VL E+ G L D I+ L+ +
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII---------DESYNLTELDTILF 192
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF--DDDVAKIADFDLSNQAPDMAARLHST 120
+G+ ++H+ +I+H D+K N+L D KI DF L+ R
Sbjct: 193 MKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLA-------RRYKPR 242
Query: 121 RVL----GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
L GT + APE ++ +D++S GV+ LL+G P
Sbjct: 243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-11
Identities = 41/164 (25%), Positives = 65/164 (39%), Gaps = 31/164 (18%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSW-QQRV 60
LKH N V L S L +E+ D L V + Q +
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGN--IINMHNVKLFLFQLL 110
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ GL Y H + ++HRD+K N+LI + K+ADF L+ +A + + +
Sbjct: 111 R-------GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYDN 159
Query: 121 RVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 159
V+ T Y P+ L + D++ G + E+ TGR
Sbjct: 160 EVV-TLWYRPPDIL----LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 37/163 (22%), Positives = 62/163 (38%), Gaps = 25/163 (15%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAV 64
H + + L+ + L ++ G L D LS ++ I
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-----------LSEKETRSIMR 207
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 124
+ + +LH +I+HRD+K N+L+ D+ +++DF S G
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELC-G 261
Query: 125 TFGYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T GY APE + D+++ GV+L LL G P
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 40/167 (23%), Positives = 67/167 (40%), Gaps = 29/167 (17%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVK 61
++H N + L + T +L E + G L D L+ ++ +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----------LTEEEATE 118
Query: 62 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAPDMA 114
G+ YLH I H D+K N+++ D +V KI DF L+ + +
Sbjct: 119 FLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 115 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ GT + APE L ++D++S GV+ LL+G P
Sbjct: 175 -----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+GL+Y+H IIHRD+K SN+ + +D KI DF L+ D +TR
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 128 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
Y APE + ++ D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-11
Identities = 42/165 (25%), Positives = 69/165 (41%), Gaps = 25/165 (15%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
++H N + L + T VL E S G L D L ++ L+ + +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQFL 114
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAPDMAAR 116
G+ YLH K I H D+K N+++ D +V K+ DF ++ +
Sbjct: 115 KQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--- 168
Query: 117 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ GT + APE L ++D++S GV+ LL+G P
Sbjct: 169 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-11
Identities = 44/177 (24%), Positives = 72/177 (40%), Gaps = 18/177 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +H N + L DG + E G L D + +K S ++
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---------FFSEREAS 119
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAAR 116
+ K +EYLH + ++HRD+K SN+L D+ +I DF + Q
Sbjct: 120 AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 117 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 173
L T T + APE +A D++S GV+L +LTG P + + +
Sbjct: 177 LM-TPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-11
Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L++LH II+RD+K N+L+ ++ K+ DF LS ++ D + +S GT Y
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + + + +S D +SFGV++ E+LTG P
Sbjct: 193 MAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-11
Identities = 36/162 (22%), Positives = 62/162 (38%), Gaps = 19/162 (11%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKI 62
LKH N V+L + L ++ + G L + I+ + S
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AREY--------YSEADASHC 115
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHS 119
+ + + H+ ++HR++K N+L+ K+ADF L+ +
Sbjct: 116 IQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT GY +PE D+++ GV+L LL G P
Sbjct: 173 --FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-11
Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 35/167 (20%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSW-QQR 59
L H N + LL ++ L ++F D I+ V P + ++
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLT--PSHIKAYMLM- 120
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARL 117
+GLEYLH+ I+HRD+K +N+L+ ++ V K+ADF L+ +P+ R
Sbjct: 121 ------TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---RA 168
Query: 118 HSTRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 159
++ +V+ T Y APE A+ D+++ G +L ELL
Sbjct: 169 YTHQVV-TRWYRAPELL----FGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-11
Identities = 44/169 (26%), Positives = 69/169 (40%), Gaps = 27/169 (15%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 66
H N ++L+ + + L +E GS+ +H R+ + + +
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDV 120
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVA--KIADFDLS------NQAPDMAARL 117
A L++LH K I HRD+K N+L + V+ KI DFDL ++
Sbjct: 121 ASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 118 HSTRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 161
T G+ Y APE A D++S GV+L LL+G P
Sbjct: 178 LLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-11
Identities = 38/162 (23%), Positives = 66/162 (40%), Gaps = 20/162 (12%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKI 62
+L+H N V+L + + L ++ + G L + I+ + S
Sbjct: 84 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AREF--------YSEADASHC 133
Query: 63 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHS 119
+ + Y H I+HR++K N+L+ K+ADF L+ + D +
Sbjct: 134 IQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWH 188
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT GY +PE + D+++ GV+L LL G P
Sbjct: 189 GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-11
Identities = 32/123 (26%), Positives = 48/123 (39%), Gaps = 16/123 (13%)
Query: 51 GPVLSWQQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 102
G +++ + A+ L+ +H IHRD+K N+L+ K+A
Sbjct: 154 GDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA 210
Query: 103 DFDLSNQAPDMAARLHSTRVLGTFGYHAPE----YAMTGQLNAKSDVYSFGVVLLELLTG 158
DF + T V GT Y +PE G + D +S GV L E+L G
Sbjct: 211 DFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
Query: 159 RKP 161
P
Sbjct: 270 DTP 272
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-11
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 18/161 (11%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
+L+H N V+L + + L ++ + G L + + R+ S
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCI 111
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHST 120
+ + Y H I+HR++K N+L+ K+ADF L+ + D +
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 166
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
GT GY +PE + D+++ GV+L LL G P
Sbjct: 167 FA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARLHSTRVLGTF 126
KGL+Y+H ++HRD+K N+ + +D KI DF L+ + +M T + T
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTR 187
Query: 127 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
Y APE ++ ++ D++S G ++ E+LTG+
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 11/94 (11%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARLHSTRVLGTF 126
KGL Y+H IIHRD+K N+ + +D KI DF L+ +M T + T
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTR 189
Query: 127 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
Y APE + ++ D++S G ++ E++TG+
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-11
Identities = 23/100 (23%), Positives = 39/100 (39%), Gaps = 11/100 (11%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
++ +H +HRDIK N+L+ ++ADF + + S +GT Y
Sbjct: 174 AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSLVAVGTPDY 229
Query: 129 HAPEYAMTGQLNAKSDVY-------SFGVVLLELLTGRKP 161
+PE + Y + GV E+ G+ P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 7e-11
Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L +LH+K II+RD+K N+++ K+ DF L ++ H+ GT Y
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + + ++ D +S G ++ ++LTG P
Sbjct: 188 MAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-10
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 9/98 (9%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
++ +H+ H +HRDIK N+L+ + ++ADF + + S V GT Y
Sbjct: 187 AIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 242
Query: 129 HAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 161
+PE + D +S GV + E+L G P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-10
Identities = 27/98 (27%), Positives = 43/98 (43%), Gaps = 10/98 (10%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVL 123
+++LH +I HRD+K N+L + V K+ DF + + T
Sbjct: 138 GTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPC- 190
Query: 124 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T Y APE + + D++S GV++ LL G P
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-10
Identities = 25/99 (25%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLS---NQAPDMAARLHSTRVL 123
K L+Y H I+HRD+K NV+I + ++ D+ L+ + + R+ ++R
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRY- 195
Query: 124 GTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
+ PE + Q+ S D++S G +L ++ ++P
Sbjct: 196 ----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
LEYLH + +++RDIK N+++ D KI DF L + A + + GT Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + ++ D + GVV+ E++ GR P
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
GL LHE A ++HRD+ N+L+ D++ I DF+L+ + A + T +
Sbjct: 145 LGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLARED---TADANKTHYVTHRW 198
Query: 128 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
Y APE M + K D++S G V+ E+ +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-10
Identities = 43/167 (25%), Positives = 64/167 (38%), Gaps = 37/167 (22%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG-RKGVKGAQPGPVLSWQQRVKIA 63
LKH N V LL L +E+ H +LH + +G V S +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQT--- 111
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS---- 119
+ + + H+ + IHRD+K N+LI V K+ DF ARL +
Sbjct: 112 ---LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF--------ARLLTGPSD 157
Query: 120 --TRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 159
+ T Y +PE + DV++ G V ELL+G
Sbjct: 158 YYDDEVATRWYRSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 44/159 (27%), Positives = 67/159 (42%), Gaps = 21/159 (13%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIA 63
L+HEN V LL C L +EF + ++ D L G V + Q +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN--GLDYQVVQKYLFQII--- 134
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS--NQAPDMAARLHSTR 121
G+ + H +IIHRDIK N+L+ V K+ DF + AP ++
Sbjct: 135 ----NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---EVYDDE 184
Query: 122 VLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 159
V T Y APE + + DV++ G ++ E+ G
Sbjct: 185 VA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARLHSTRVLGTF 126
+GL+Y+H A+ ++HRD+K SN+L+ KI DF L+ PD T + T
Sbjct: 139 RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 127 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
Y APE + + KS D++S G +L E+L+ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L YLHE+ II+RD+K NVL+ + K+ D+ + + + GT Y
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 176
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 177 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-10
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L +LH+K II+RD+K NVL+ + K+ADF + + + + + GT Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDY 190
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + L + D ++ GV+L E+L G P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-10
Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L YLH +I++RD+K N+L+ + DF L + ++ ++ GT Y
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEY 205
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + Q ++ D + G VL E+L G P
Sbjct: 206 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-10
Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GL++LH K I++RD+K N+L+ D KIADF + + A+ ++ GT Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 184
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + GQ S D +SFGV+L E+L G+ P
Sbjct: 185 IAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-10
Identities = 30/95 (31%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLS-NQAPDMAARLHSTRVLGT 125
+GL+Y+H +++HRD+K +N+ I +D V KI DF L+ P + + H + L T
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 126 FGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
Y +P ++ K+ D+++ G + E+LTG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GL +L K II+RD+K NV++ + KIADF + + ++ + + GT Y
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDY 508
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 509 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-10
Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-GTFG 127
LE+LH+ II+RDIK N+L+ + + DF LS + +A GT
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETERAYDFCGTIE 225
Query: 128 YHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
Y AP+ +G A D +S GV++ ELLTG P
Sbjct: 226 YMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASP 261
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-10
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 12/101 (11%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
+ ++ LH ++ +IHRD+K SN+LI + K+ DF L+ + AA +
Sbjct: 123 RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 128 --------YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
Y APE +T +++ DV+S G +L EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-10
Identities = 35/162 (21%), Positives = 68/162 (41%), Gaps = 24/162 (14%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVG 65
+ L + + +L E+A+ G + L + ++S +++
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCL--------PELAEMVSENDVIRLIKQ 139
Query: 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLS---NQAPDMAARLHS 119
+G+ YLH+ +I+H D+K N+L+ KI DF +S A ++
Sbjct: 140 ILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL------ 190
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
++GT Y APE + +D+++ G++ LLT P
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-10
Identities = 45/184 (24%), Positives = 67/184 (36%), Gaps = 60/184 (32%)
Query: 4 RLKHENFVQLLGYCVDGTSRV-------LAYEFASNGSLHDILHGRKGVKGAQPGPVL-- 54
+L H N V+L Y + L ++ +++ + R + Q PV+
Sbjct: 103 KLDHCNIVRLR-YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA--RHYSRAKQTLPVIYV 158
Query: 55 ---SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQA 110
+Q + L Y+H I HRDIK N+L+ D V K+ DF
Sbjct: 159 KLYMYQ--------LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS---- 203
Query: 111 PDMAARLHS----------TRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLEL 155
A+ +R Y APE + A DV+S G VL EL
Sbjct: 204 ----AKQLVRGEPNVSYICSRY-----YRAPE-LI---FGATDYTSSIDVWSAGCVLAEL 250
Query: 156 LTGR 159
L G+
Sbjct: 251 LLGQ 254
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-10
Identities = 27/93 (29%), Positives = 42/93 (45%), Gaps = 10/93 (10%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-GTFGY 128
EYLH +I+RD+K N+LI ++ DF + + T L GT
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEA 204
Query: 129 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
APE ++ N D ++ GV++ E+ G P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-10
Identities = 36/167 (21%), Positives = 64/167 (38%), Gaps = 33/167 (19%)
Query: 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
L+H N ++L L +E+A N L + V + S+ ++
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDV---SMRVIKSFLYQL---- 141
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA-----KIADFDL--SNQAPDMAARL 117
G+ + H + +HRD+K N+L+ D + KI DF L + P R
Sbjct: 142 --INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI---RQ 193
Query: 118 HSTRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 159
+ ++ T Y PE L ++ D++S + E+L
Sbjct: 194 FTHEII-TLWYRPPEIL----LGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-10
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
L YLHE+ II+RD+K NVL+ + K+ D+ + + + GT Y
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 219
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 220 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 128
GL +L K II+RD+K NV++ + KIADF + + + GT Y
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 187
Query: 129 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 9/98 (9%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVL 123
+ ++YLH +I HRD+K N+L + K+ DF + + +T
Sbjct: 171 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPC- 224
Query: 124 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
T Y APE + + D++S GV++ LL G P
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 40/171 (23%), Positives = 62/171 (36%), Gaps = 34/171 (19%)
Query: 4 RLKHENFVQLLGYCVDGTSRV------LAYEFASNGSLHDILHGRKGVKGAQPGPVL--- 54
+KH N V L + + L E+ +++ R K Q P+L
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS--RHYAKLKQTMPMLLIK 144
Query: 55 --SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAP 111
+Q + L Y+H I HRDIK N+L+ V K+ DF +
Sbjct: 145 LYMYQ--------LLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
Query: 112 DMAARLH--STRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGR 159
+ +R Y APE D++S G V+ EL+ G+
Sbjct: 194 AGEPNVSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 25/96 (26%), Positives = 42/96 (43%), Gaps = 12/96 (12%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLH--STRVLG 124
+ + ++H I HRDIK N+L+ D+ K+ DF + + + +R
Sbjct: 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-- 206
Query: 125 TFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGR 159
Y APE + D++S G V EL+ G+
Sbjct: 207 ---YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 3e-09
Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 12/95 (12%)
Query: 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-GTFG 127
LEYLH K II+RD+K N+L+ + KI DF + PD+ T L GT
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPD 168
Query: 128 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
Y APE ++ + KS D +SFG+++ E+L G P
Sbjct: 169 YIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-09
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 10/96 (10%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLH--STRVLG 124
+ + LH + ++ HRDIK NVL+ + D K+ DF + + + +R
Sbjct: 140 RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-- 196
Query: 125 TFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 159
Y APE Q + D++S G + E++ G
Sbjct: 197 ---YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-09
Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA------KIADFDLSNQAPDMAARLHSTR 121
GL+Y+H + IIH DIK NVL+ D KIAD + + TR
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 122 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159
Y +PE + +D++S ++ EL+TG
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-08
Identities = 27/112 (24%), Positives = 48/112 (42%), Gaps = 23/112 (20%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLG 124
K ++YLH ++HRD+K SN+L+ + K+ADF LS + + +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 125 TFGYHAPEYAMTG------------QLNAKS-----DVYSFGVVLLELLTGR 159
T + + +T L + D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 28/115 (24%), Positives = 43/115 (37%), Gaps = 24/115 (20%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 127
G ++HE + IIHRD+K +N L+ D K+ DF L+ +
Sbjct: 140 LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 128 --------------------YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 161
Y APE + + KS D++S G + ELL +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 7e-07
Identities = 29/129 (22%), Positives = 48/129 (37%), Gaps = 29/129 (22%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---------NQAPDMAARLH 118
G++Y+H A I+HRD+K +N L+ D K+ DF L+ N ++ R
Sbjct: 167 VGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 119 STRVLGTFGYHAPEYAMTGQ------------LNAKS-----DVYSFGVVLLELLTGRKP 161
++ + +TG L ++ DV+S G + ELL K
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 162 VDHTLPRGQ 170
Sbjct: 284 NVAYHADRG 292
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 26/136 (19%), Positives = 41/136 (30%), Gaps = 46/136 (33%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV----- 122
+GL+YLH K IIH DIK N+L+ ++ + + A S
Sbjct: 157 QGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 123 ----------------------LGTFG-----------------YHAPEYAMTGQLNAKS 143
+ G Y + E + N +
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274
Query: 144 DVYSFGVVLLELLTGR 159
D++S + EL TG
Sbjct: 275 DIWSTACMAFELATGD 290
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 30/111 (27%), Positives = 46/111 (41%), Gaps = 13/111 (11%)
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK---IADFDLSNQAPDMAAR 116
+ +A +EY+H K + IHRD+K N L+ I DF L+ + D
Sbjct: 108 LLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
Query: 117 LH-----STRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 161
H + + GT Y A G + + + D+ S G VL+ G P
Sbjct: 165 QHIPYRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-06
Identities = 24/107 (22%), Positives = 43/107 (40%), Gaps = 26/107 (24%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLSNQAPDMAARLH-----STRV 122
LEY+HE +H DIK+SN+L+ + ++ D+ L+ +
Sbjct: 165 LEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 123 LGTFGYHAPEYAMTGQLNA--------KSDVYSFGVVLLELLTGRKP 161
GT E+ ++A + D+ G +++ LTG P
Sbjct: 222 DGT-----IEFT---SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 28/107 (26%), Positives = 45/107 (42%), Gaps = 26/107 (24%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLSNQAPDMAARLH----STRVL 123
LEY+HE +H DIK++N+L+ + ++ AD+ LS + +
Sbjct: 164 LEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 124 -GTFGYHAPEYAMTGQLNA--------KSDVYSFGVVLLELLTGRKP 161
GT E+ L+A +SDV G +L L G+ P
Sbjct: 221 NGT-----IEFT---SLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 26/94 (27%), Positives = 42/94 (44%), Gaps = 8/94 (8%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQAPDMAARLHSTRVLGT 125
L +L + IIH D+K N+L+ + + KI DF S Q +
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSR 222
Query: 126 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159
F Y +PE + + D++S G +L+E+ TG
Sbjct: 223 F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 29/94 (30%), Positives = 42/94 (44%), Gaps = 10/94 (10%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQAPDMAARLHSTRVLGT 125
+ L+ LH IIH D+K N+L+ + K+ DF S +R
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR---- 263
Query: 126 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159
F Y APE + + D++S G +L ELLTG
Sbjct: 264 F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-06
Identities = 24/103 (23%), Positives = 41/103 (39%), Gaps = 15/103 (14%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAK-----IADFDLSNQAPDMAARLH-----S 119
++ +HEK +++RDIK N LI + + DF + D + H
Sbjct: 119 VQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 120 TRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 161
+ GT Y G + + + D+ + G V + L G P
Sbjct: 176 KNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 7e-06
Identities = 27/176 (15%), Positives = 52/176 (29%), Gaps = 35/176 (19%)
Query: 6 KHENFVQLLG-YCVDGT---SRVLAYEF--ASNGSLHDILHGRKGVKG------------ 47
+ E F+ L +CV G+ + A++ ++ GS +D K +
Sbjct: 90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID 149
Query: 48 --AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 105
+ S I L HRD+ NVL+ + K+
Sbjct: 150 LEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTL 207
Query: 106 LSNQAPDMAARLHSTRVLGTFGYHAP--EYAMTGQLNAKSDVYSFGVVLLELLTGR 159
+ + + G +Y ++ V+ + +L TG
Sbjct: 208 NGK-----------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD 252
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-06
Identities = 21/107 (19%), Positives = 43/107 (40%), Gaps = 26/107 (24%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLSNQAPD----MAARLHSTRVL 123
LE+LHE +H ++ + N+ + +D +++ A + + + +A S
Sbjct: 172 LEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPH 228
Query: 124 -GTFGYHAPEYAMTGQLNA--------KSDVYSFGVVLLELLTGRKP 161
G E+ ++ +SD+ S G +L+ L G P
Sbjct: 229 EGD-----LEFI---SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-05
Identities = 24/98 (24%), Positives = 38/98 (38%), Gaps = 30/98 (30%)
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVL 123
+ ++YLH +I HRD+K N+L + K+ DF A +
Sbjct: 127 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE---------TT 171
Query: 124 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
G Y + D++S GV++ LL G P
Sbjct: 172 GE-KY-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 6e-05
Identities = 30/111 (27%), Positives = 48/111 (43%), Gaps = 13/111 (11%)
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAAR 116
+ +A +E++H K +HRDIK N L+ + I DF L+ + D +
Sbjct: 106 LMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
Query: 117 LH-----STRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 161
H + + GT Y A G + + + D+ S G VL+ L G P
Sbjct: 163 QHIPYRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-05
Identities = 27/103 (26%), Positives = 44/103 (42%), Gaps = 15/103 (14%)
Query: 70 LEYLHEKADPHIIHRDIKSSNVLI-----FDDDVAKIADFDLSNQAPDMAARLH-----S 119
+EY+H K ++I+RD+K N LI V I DF L+ + D + H
Sbjct: 118 MEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 120 TRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 161
+ GT Y G + + + D+ + G + + L G P
Sbjct: 175 KSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 29/117 (24%), Positives = 39/117 (33%), Gaps = 35/117 (29%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV---LG 124
K L YL + + H D+K N+L+ D K + L
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 125 TFG-----------------YHAPE------YAMTGQLNAKSDVYSFGVVLLELLTG 158
FG Y APE + + SD++SFG VL EL TG
Sbjct: 205 DFGCATFKSDYHGSIINTRQYRAPEVILNLGWDV------SSDMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 5e-04
Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 37/115 (32%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV-LGTF 126
L +LH + + H D+K N+L + + + + S + + +T + + F
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK----SVKNTSIRVADF 186
Query: 127 G-----------------YHAPE------YAMTGQLNAKSDVYSFGVVLLELLTG 158
G Y PE +A DV+S G +L E G
Sbjct: 187 GSATFDHEHHTTIVATRHYRPPEVILELGWAQ------PCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 7e-04
Identities = 24/112 (21%), Positives = 40/112 (35%), Gaps = 31/112 (27%)
Query: 68 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA---RL------- 117
K + +LH + H D+K N+L D + + + + ++
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 118 -----HSTRVLGTFGYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTG 158
HST V Y APE ++ DV+S G +L+E G
Sbjct: 186 YDDEHHSTLVSTRH-YRAPEVILALGWSQ------PCDVWSIGCILIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 247 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.67 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.42 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.19 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.76 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.6 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.55 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.79 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.51 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.99 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.52 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.57 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.11 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.44 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.05 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.67 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 91.26 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 90.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 90.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.1 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 89.01 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 88.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.78 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 88.26 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.33 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 83.9 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 82.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 81.13 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=339.40 Aligned_cols=221 Identities=26% Similarity=0.411 Sum_probs=175.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC------CCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG------AQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~------~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+|++|+|||||+++++|.++...+||||||.+|+|.+++........ .....++++..++.++.|++.||.|||
T Consensus 96 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 47899999999999999999999999999999999999976542210 111234999999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
+.+ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++||
T Consensus 176 ~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~E 252 (329)
T 4aoj_A 176 GLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252 (329)
T ss_dssp HTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHH
Confidence 999 99999999999999999999999999986644333333344568999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
|++ |+.||.... ..++...+..+.+...+..++.++.+++.+||+.||.+|||++||++.|+.
T Consensus 253 llt~G~~Pf~~~~----------------~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 253 IFTYGKQPWYQLS----------------NTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHTTSCCTTCSSC----------------HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHcCCCCCCCCCC----------------HHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 998 899996432 222333333444455666778889999999999999999999999999999
Q ss_pred hHhcCCC
Q 025816 234 LLNARPG 240 (247)
Q Consensus 234 ~~~~~~~ 240 (247)
+.+++|.
T Consensus 317 l~~~pp~ 323 (329)
T 4aoj_A 317 LAQAPPV 323 (329)
T ss_dssp HHHSCC-
T ss_pred HhhCCcc
Confidence 9988664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=337.43 Aligned_cols=221 Identities=27% Similarity=0.448 Sum_probs=183.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCC----CCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV----KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+|++|+|||||+++++|.+++..++|||||.+|+|.+++...... ........+++..++.++.|++.||.|||++
T Consensus 68 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 68 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 478999999999999999999999999999999999999754210 0011223499999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 156 (247)
+ |+||||||+|||++.++.+||+|||+++...............||..|+|||.+.+..|+.++|||||||++|||+
T Consensus 148 ~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell 224 (299)
T 4asz_A 148 H---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224 (299)
T ss_dssp T---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 9 9999999999999999999999999997654433333334456899999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 157 T-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 157 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
| |+.||.... ..++...+..+.....+..++.++.+++.+||+.||.+|||+++|++.|+.+.
T Consensus 225 t~G~~Pf~~~~----------------~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 225 TYGKQPWYQLS----------------NNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp TTTCCTTTTSC----------------HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCCCC----------------HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 8 899996432 22333334444445566777888999999999999999999999999999998
Q ss_pred hcCCC
Q 025816 236 NARPG 240 (247)
Q Consensus 236 ~~~~~ 240 (247)
++.|.
T Consensus 289 ~~~p~ 293 (299)
T 4asz_A 289 KASPV 293 (299)
T ss_dssp HHSCC
T ss_pred hcCCc
Confidence 87664
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=331.62 Aligned_cols=212 Identities=23% Similarity=0.264 Sum_probs=172.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++|+|||||++++++.++..+|||||||+||+|.+++.... .+++..+..++.|++.||.|||+++
T Consensus 103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~~~--- 170 (336)
T 4g3f_A 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---------CLPEDRALYYLGQALEGLEYLHTRR--- 170 (336)
T ss_dssp TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5789999999999999999999999999999999999997643 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCC-ceeeccccccCCcchhhhc---ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAAR---LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 81 i~h~di~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 156 (247)
|+||||||+|||++.+| .+||+|||+++........ .......||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 171 IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml 250 (336)
T 4g3f_A 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250 (336)
T ss_dssp EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999988 5999999999865432211 1123356999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
+|..||........... +..... ....+...+..+.++|.+||+.||.+|||+.|+++.+...+
T Consensus 251 tG~~Pf~~~~~~~~~~~---------------i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 251 NGCHPWTQYFRGPLCLK---------------IASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp HSSCSSTTTCCSCCHHH---------------HHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HCcCCCCCCCHHHHHHH---------------HHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 99999975433211111 110000 01234456678999999999999999999999999998887
Q ss_pred hcCC
Q 025816 236 NARP 239 (247)
Q Consensus 236 ~~~~ 239 (247)
+...
T Consensus 316 ~~~~ 319 (336)
T 4g3f_A 316 QEVG 319 (336)
T ss_dssp HHTT
T ss_pred hhhh
Confidence 6544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=329.02 Aligned_cols=212 Identities=28% Similarity=0.452 Sum_probs=167.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|||||++++++.. ...+||||||++|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 85 il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH~~~--- 152 (307)
T 3omv_A 85 VLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLHAKN--- 152 (307)
T ss_dssp HHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4789999999999998765 568999999999999999975432 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC---CCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+. .|+.++|||||||++|+|++
T Consensus 153 IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt 232 (307)
T 3omv_A 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232 (307)
T ss_dssp CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH
Confidence 999999999999999999999999999865443333333456799999999999743 58999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc----CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL----GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
|..||...... ..+...+.... ....+..++..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 233 g~~Pf~~~~~~---------------~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 233 GELPYSHINNR---------------DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp SSCTTTTCCCH---------------HHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCChH---------------HHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 99999743221 11111111111 112344567789999999999999999999999999998
Q ss_pred hHhcCC
Q 025816 234 LLNARP 239 (247)
Q Consensus 234 ~~~~~~ 239 (247)
+..+.|
T Consensus 298 l~~~lp 303 (307)
T 3omv_A 298 LQHSLP 303 (307)
T ss_dssp HHTTCC
T ss_pred HhccCC
Confidence 876554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=332.03 Aligned_cols=215 Identities=26% Similarity=0.373 Sum_probs=180.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
+|++++|||||+++|+|.++...++|||||.+|+|.+++........ ......+++..++.++.|++.|+.||
T Consensus 82 il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 161 (308)
T 4gt4_A 82 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 161 (308)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 36789999999999999999999999999999999999975432211 11123499999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+++ |+||||||+|||++.++.+||+|||+++...............||..|+|||.+.+..|+.++||||||+++|
T Consensus 162 H~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~ 238 (308)
T 4gt4_A 162 SSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 238 (308)
T ss_dssp HHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHH
Confidence 9999 9999999999999999999999999998665444333344567899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
||++ |..||.+.. ...+.+.+..+.....+..++..+.+++.+||+.||.+|||+++|++.|+
T Consensus 239 El~t~g~~Pf~~~~----------------~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 239 EVFSYGLQPYCGYS----------------NQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp HHHTTTCCTTTTCC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhCCCCCCCCCC----------------HHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9998 899996432 23333444444455667778888999999999999999999999999998
Q ss_pred Hh
Q 025816 233 PL 234 (247)
Q Consensus 233 ~~ 234 (247)
..
T Consensus 303 a~ 304 (308)
T 4gt4_A 303 AW 304 (308)
T ss_dssp TS
T ss_pred hc
Confidence 64
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=331.95 Aligned_cols=201 Identities=22% Similarity=0.350 Sum_probs=168.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++|+|||||++++++.+++..|+|||||.||+|.+++...... .+++..++.++.|++.||.|||+++
T Consensus 76 il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~-------~~~e~~~~~~~~qi~~aL~ylH~~~--- 145 (350)
T 4b9d_A 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALKHVHDRK--- 145 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 467899999999999999999999999999999999999754432 2789999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.+|.+||+|||+++........ .....||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus 146 IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~ 223 (350)
T 4b9d_A 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223 (350)
T ss_dssp CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH--HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eeeccCCHHHEEECCCCCEEEcccccceeecCCccc--ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999999876543221 234569999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||.+.... ..+..+... .....+...+.++.+||.+||+.||.+|||++|+++
T Consensus 224 PF~~~~~~---------------~~~~~i~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 224 AFEAGSMK---------------NLVLKIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp SCCCSSHH---------------HHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCcCHH---------------HHHHHHHcC-CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99754211 111111111 112234456678999999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=325.78 Aligned_cols=199 Identities=24% Similarity=0.330 Sum_probs=167.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++|+|||||+++++|.+++..|+|||||.||+|.+++.+... +++..+..++.|++.||.|||+++
T Consensus 85 il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~--- 152 (311)
T 4aw0_A 85 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG--- 152 (311)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 47899999999999999999999999999999999999976432 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.+|.+||+|||+++...............||+.|+|||++.+..|+.++|+|||||++|+|++|..
T Consensus 153 IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 232 (311)
T 4aw0_A 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232 (311)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999987654333333455689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
||.+.+.. .....+.... ...+...+.++.+||.+||..||.+|||++|++
T Consensus 233 PF~~~~~~---------------~~~~~i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 233 PFRAGNEG---------------LIFAKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp SSCCSSHH---------------HHHHHHHHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCCCCHH---------------HHHHHHHcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 99754211 1111111111 133445567899999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=327.19 Aligned_cols=199 Identities=22% Similarity=0.372 Sum_probs=166.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|||||+++++|.+++.+|||||||+||+|.+++.... +++..+..++.|++.||.|||+++
T Consensus 124 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~--- 190 (346)
T 4fih_A 124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG--- 190 (346)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4788999999999999999999999999999999999997643 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.+|.+||+|||++........ ......||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus 191 IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 268 (346)
T 4fih_A 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 268 (346)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999986543222 2245679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||.+..... ..+.+.... ........+.++.+||.+||..||.+|||++|+++.
T Consensus 269 PF~~~~~~~----------------~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 269 PYFNEPPLK----------------AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp TTTTSCHHH----------------HHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCcCHHH----------------HHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 997542211 111111111 112234556789999999999999999999999873
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=328.62 Aligned_cols=220 Identities=25% Similarity=0.382 Sum_probs=180.5
Q ss_pred cccccC-CCccceeeEEeeC-CeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHH
Q 025816 2 VSRLKH-ENFVQLLGYCVDG-TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEY 72 (247)
Q Consensus 2 l~~l~h-~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~ 72 (247)
|++++| ||||+++++|... +.+++|||||.+|+|.+++....... .......+++..+..++.|++.|+.|
T Consensus 121 l~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 566755 8999999999764 57899999999999999997543211 01112348999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHH
Q 025816 73 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL 152 (247)
Q Consensus 73 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 152 (247)
||+++ |+||||||+|||++.++.+||+|||+++...............||..|+|||++.+..|+.++|||||||++
T Consensus 201 LH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 201 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 99999 999999999999999999999999999866544333334556789999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 153 LELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 153 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
|||++ |..||.+.. ....+...+..+.+...+..++.++.++|.+||+.||.+|||+.+|++.|
T Consensus 278 ~El~t~G~~Pf~~~~---------------~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 278 WEIFSLGASPYPGVK---------------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp HHHTTTSCCSSTTCC---------------CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCCCCCCCC---------------HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 99998 999996432 12233444445555566677788899999999999999999999999999
Q ss_pred HHhHhcCC
Q 025816 232 QPLLNARP 239 (247)
Q Consensus 232 ~~~~~~~~ 239 (247)
+.++++..
T Consensus 343 ~~llq~~~ 350 (353)
T 4ase_A 343 GNLLQANA 350 (353)
T ss_dssp HHHHHHTC
T ss_pred HHHHHHhh
Confidence 99998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=317.74 Aligned_cols=198 Identities=22% Similarity=0.294 Sum_probs=164.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|||||++++++.+++..|+|||||.||+|.+++.+... +++..+..++.|++.||.|||+++
T Consensus 79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~--- 146 (304)
T 3ubd_A 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSLG--- 146 (304)
T ss_dssp CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 58899999999999999999999999999999999999976432 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+..|+.++||||+||++|+|++|..
T Consensus 147 IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 224 (304)
T 3ubd_A 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224 (304)
T ss_dssp CCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCC
Confidence 99999999999999999999999999986433222 2244679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~ 229 (247)
||.+.+.. +.+..+... ....+...+.++.++|.+||+.||.+||| ++|+++
T Consensus 225 PF~~~~~~---------------~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 225 PFQGKDRK---------------ETMTMILKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp SSCCSSHH---------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCcCHH---------------HHHHHHHcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 99754221 111111111 12344456678999999999999999999 477876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=315.26 Aligned_cols=226 Identities=23% Similarity=0.324 Sum_probs=169.3
Q ss_pred cccccCCCccceeeEEeeCC----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 2 VSRLKHENFVQLLGYCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
+++++|||||++++++..++ ..+|||||+++|+|.+++.... +++..+..++.|++.||.|||++.
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~ 120 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhh
Confidence 56899999999999998654 5799999999999999997654 999999999999999999999871
Q ss_pred -----CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcc--cccceeccccccCchhhhcC------CCCcccc
Q 025816 78 -----DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMTG------QLNAKSD 144 (247)
Q Consensus 78 -----~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~D 144 (247)
.++|+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|
T Consensus 121 ~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~D 200 (303)
T 3hmm_A 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200 (303)
T ss_dssp CSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHH
T ss_pred hhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHh
Confidence 1239999999999999999999999999997654332221 12345799999999999754 3678999
Q ss_pred chhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhh-hhcccccCCCCC-----HHHHHHHHHHHHhhcccCC
Q 025816 145 VYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR-QCVDARLGGDYP-----PKAVAKMAAVAALCVQYEA 218 (247)
Q Consensus 145 vwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p 218 (247)
||||||++|||++|..||......... .............+. .......+...+ .+.+..+.+++.+||+.||
T Consensus 201 VwS~Gvvl~El~tg~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP 279 (303)
T 3hmm_A 201 IYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSG
T ss_pred hhhHHHHHHHHHHCCCCCCcccccccc-chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCH
Confidence 999999999999999887643321111 001101111111121 222333444433 2466789999999999999
Q ss_pred CCCCCHHHHHHHHHHhHhcC
Q 025816 219 DFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 219 ~~Rps~~~il~~l~~~~~~~ 238 (247)
.+|||+.+|++.|+++.+.+
T Consensus 280 ~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 280 AARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp GGSCCHHHHHHHHHHHHHC-
T ss_pred hHCcCHHHHHHHHHHHHHHc
Confidence 99999999999999988765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=328.81 Aligned_cols=200 Identities=22% Similarity=0.361 Sum_probs=166.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++|+|||||+++++|.+++.+|||||||.||+|.+++.... +++..+..++.||+.||.|||+++
T Consensus 201 il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~~--- 267 (423)
T 4fie_A 201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG--- 267 (423)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4788999999999999999999999999999999999997543 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.+|.+||+|||++........ ......||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus 268 IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 345 (423)
T 4fie_A 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 345 (423)
T ss_dssp EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999986543222 2245679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccc-cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR-LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||.+...... +..+.... .........+.++.+||.+||..||.+|||++|+++.
T Consensus 346 PF~~~~~~~~---------------~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 346 PYFNEPPLKA---------------MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TTTTSCHHHH---------------HHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCcCHHHH---------------HHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 9975422111 11111110 0112223456779999999999999999999999883
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=315.27 Aligned_cols=199 Identities=25% Similarity=0.411 Sum_probs=157.8
Q ss_pred CcccccCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 1 MVSRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+|++|+|||||+++++|.+ +...+||||||.+|+|.+++.+... +++..+..++.|++.||.|||++
T Consensus 78 il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~ylH~~ 148 (290)
T 3fpq_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTR 148 (290)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 4688999999999999865 3468999999999999999976432 99999999999999999999987
Q ss_pred CCCCeEeccCCCCceeecC-CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
+ ++|+||||||+|||++. +|.+||+|||+++..... ......||+.|+|||++.+ .|+.++|||||||++|+|
T Consensus 149 ~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyel 222 (290)
T 3fpq_A 149 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 222 (290)
T ss_dssp S-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred C-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHH
Confidence 5 34999999999999985 789999999999754321 2244579999999998865 699999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG-GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
++|..||...... ..+...+..... ...+...+.++.++|.+||+.||.+|||++|+++
T Consensus 223 ltg~~Pf~~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 223 ATSEYPYSECQNA---------------AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHSSCTTTTCSSH---------------HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCCCCcH---------------HHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999999643211 111111111111 1112223456999999999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=310.80 Aligned_cols=196 Identities=24% Similarity=0.306 Sum_probs=154.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++||||| +|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~--- 132 (275)
T 3hyh_A 66 YLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDK---------MSEQEARRFFQQIISAVEYCHRHK--- 132 (275)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 367899999999999999999999999999 5799999876432 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~ 159 (247)
|+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus 133 IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~ 209 (275)
T 3hyh_A 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209 (275)
T ss_dssp CCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCC
Confidence 9999999999999999999999999998654322 1234679999999999998876 57999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
.||...... .....+... ....+...+.++.++|.+||+.||.+|||++|+++
T Consensus 210 ~PF~~~~~~---------------~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 210 LPFDDESIP---------------VLFKNISNG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CSSCCSSHH---------------HHHHHHHHT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHH---------------HHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999743211 001111111 11234455678999999999999999999999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=299.61 Aligned_cols=199 Identities=23% Similarity=0.373 Sum_probs=149.2
Q ss_pred CcccccCCCccceeeEEeeCC------------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHH
Q 025816 1 MVSRLKHENFVQLLGYCVDGT------------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 68 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 68 (247)
+|++|+|||||++++++.+.+ .+|+|||||.+|+|.+++...... .......++.++.|+++
T Consensus 56 il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~ 129 (299)
T 4g31_A 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI------EERERSVCLHIFLQIAE 129 (299)
T ss_dssp HHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSG------GGSCHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC------ChhHHHHHHHHHHHHHH
Confidence 478999999999999987544 368999999999999999865421 11455678899999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc----------ccccceeccccccCchhhhcCC
Q 025816 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR----------LHSTRVLGTFGYHAPEYAMTGQ 138 (247)
Q Consensus 69 ~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~ 138 (247)
||.|||+++ |+||||||+|||++.+|.+||+|||+++........ .......||+.|+|||++.+..
T Consensus 130 al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~ 206 (299)
T 4g31_A 130 AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206 (299)
T ss_dssp HHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC
T ss_pred HHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC
Confidence 999999999 999999999999999999999999999865432211 1122356999999999999999
Q ss_pred CCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCH---HHHHHHHHHHHhhcc
Q 025816 139 LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP---KAVAKMAAVAALCVQ 215 (247)
Q Consensus 139 ~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~ 215 (247)
|+.++|||||||++|+|++ ||.... .....+........+. ..+..+.++|.+||+
T Consensus 207 y~~~~DiwSlGvilyell~---Pf~~~~------------------~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~ 265 (299)
T 4g31_A 207 YSHKVDIFSLGLILFELLY---PFSTQM------------------ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLS 265 (299)
T ss_dssp CCTHHHHHHHHHHHHHHHS---CCSSHH------------------HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTC
T ss_pred CCCHHHHHHHHHHHHHHcc---CCCCcc------------------HHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcC
Confidence 9999999999999999996 764211 0001111111122232 334457889999999
Q ss_pred cCCCCCCCHHHHHH
Q 025816 216 YEADFRPNMSIVVK 229 (247)
Q Consensus 216 ~~p~~Rps~~~il~ 229 (247)
.||.+|||+.|+++
T Consensus 266 ~dP~~Rps~~eil~ 279 (299)
T 4g31_A 266 PSPMERPEAINIIE 279 (299)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=286.92 Aligned_cols=231 Identities=39% Similarity=0.677 Sum_probs=190.7
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..++..++||||+.+|+|.+++..... ....+++..++.++.|++.||.|||+.+
T Consensus 88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~--- 159 (321)
T 2qkw_B 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL-----PTMSMSWEQRLEICIGAARGLHYLHTRA--- 159 (321)
T ss_dssp GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCC-----CSCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCC-----CccccCHHHHHHHHHHHHHHHHHhcCCC---
Confidence 46889999999999999999999999999999999999976432 1223899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
++||||||+||+++.++.+||+|||++................|+..|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 160 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~ 239 (321)
T 2qkw_B 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239 (321)
T ss_dssp EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCT
T ss_pred eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCC
Confidence 99999999999999999999999999875433222222234468899999999999899999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 239 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~ 239 (247)
||....+........+.........+.+.+++......+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.+-
T Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp TCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 9987665544444433333333344455555666667778899999999999999999999999999999999887543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=303.38 Aligned_cols=221 Identities=21% Similarity=0.317 Sum_probs=164.2
Q ss_pred CcccccCCCccceeeEEee------CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVD------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+|++|+|||||++++++.. ...+|+|||||. |+|.+++..... +++..+..++.|++.||.|||
T Consensus 106 il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~---------l~~~~~~~~~~qil~al~ylH 175 (398)
T 4b99_A 106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQP---------LTLEHVRYFLYQLLRGLKYMH 175 (398)
T ss_dssp HHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSC---------CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHH
Confidence 4688999999999998764 357899999996 589999976542 999999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhh--cccccceeccccccCchhhhcC-CCCccccchhhhHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVV 151 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~ 151 (247)
+++ |+||||||+|||++.+|.+||+|||+++....... ........||+.|+|||++.+. .++.++||||+||+
T Consensus 176 ~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~i 252 (398)
T 4b99_A 176 SAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCI 252 (398)
T ss_dssp HTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred HCc---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHH
Confidence 999 99999999999999999999999999986543221 1223456799999999998875 46999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhh--------hccccc-CCCCC-----HHHHHHHHHHHHhhcccC
Q 025816 152 LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ--------CVDARL-GGDYP-----PKAVAKMAAVAALCVQYE 217 (247)
Q Consensus 152 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~~ 217 (247)
+|+|++|..||.+.+...+...+.......+...... .+.... ....+ ...+.++.+||.+||.+|
T Consensus 253 l~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d 332 (398)
T 4b99_A 253 FGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFE 332 (398)
T ss_dssp HHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSS
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCC
Confidence 9999999999987654333222222211111111110 000000 00011 123567899999999999
Q ss_pred CCCCCCHHHHHH--HHHHh
Q 025816 218 ADFRPNMSIVVK--ALQPL 234 (247)
Q Consensus 218 p~~Rps~~~il~--~l~~~ 234 (247)
|.+|||++|+|+ ++++.
T Consensus 333 P~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 333 PSARISAAAALRHPFLAKY 351 (398)
T ss_dssp TTTSCCHHHHTTSGGGTTT
T ss_pred hhHCcCHHHHhcCHhhCcC
Confidence 999999999998 45443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=293.94 Aligned_cols=213 Identities=20% Similarity=0.253 Sum_probs=155.9
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
|+++ +||||++++++|.++++.++||||+++|+|.+++.. +++..+..++.|++.||.|||++|
T Consensus 73 l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~------------l~~~~~~~~~~qll~al~ylH~~g--- 137 (361)
T 4f9c_A 73 LTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS------------LSFQEVREYMLNLFKALKRIHQFG--- 137 (361)
T ss_dssp HHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT------------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC------------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4455 699999999999999999999999999999999842 899999999999999999999999
Q ss_pred eEeccCCCCceeecCC-CceeeccccccCCcchhhhc--------------------------ccccceeccccccCchh
Q 025816 81 IIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMAAR--------------------------LHSTRVLGTFGYHAPEY 133 (247)
Q Consensus 81 i~h~di~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~ 133 (247)
|+||||||+|||++.+ +.+||+|||+++........ .......||+.|+|||+
T Consensus 138 IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~ 217 (361)
T 4f9c_A 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEV 217 (361)
T ss_dssp EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHH
T ss_pred eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHH
Confidence 9999999999999877 79999999999754321110 01123469999999999
Q ss_pred hhcC-CCCccccchhhhHHHHHHHhCCCCCCCCCCC-CCcchhhhccc-------------------cCCcchhhhhccc
Q 025816 134 AMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPR-GQQSLVTWATP-------------------KLSEDKVRQCVDA 192 (247)
Q Consensus 134 ~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~-------------------~~~~~~~~~~~~~ 192 (247)
+.+. .|+.++|+||+||++|+|++|+.||...... .+...+..... ..+........+.
T Consensus 218 l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 297 (361)
T 4f9c_A 218 LTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCER 297 (361)
T ss_dssp HTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHH
T ss_pred HcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHh
Confidence 9875 5899999999999999999999999643221 10000000000 0000000110000
Q ss_pred c------------------cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 193 R------------------LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 193 ~------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
. .........+.++.+|+.+||..||.+|||++|+|+
T Consensus 298 ~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 298 LRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 000111233567899999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=311.07 Aligned_cols=198 Identities=21% Similarity=0.284 Sum_probs=164.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++|||||+++++|.+++.+|+|||||.||+|.+++.+... +++..+..++.||+.||.|||+++ |
T Consensus 246 l~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~---------l~E~~a~~y~~qIl~aL~yLH~~g---I 313 (689)
T 3v5w_A 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---V 313 (689)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999976432 999999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-cCCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+||||||+|||++.+|.+||+|||++....... ....+||+.|+|||++. +..|+.++|+|||||++|+|++|..
T Consensus 314 iHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~ 389 (689)
T 3v5w_A 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389 (689)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999997654322 23467999999999996 4679999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~ 229 (247)
||.+........+ ...... .....+...+.++.+||.+||..||.+|++ ++||++
T Consensus 390 PF~~~~~~~~~~i------------~~~i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 390 PFRQHKTKDKHEI------------DRMTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TTCGGGCCCHHHH------------HHHHHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCCChHHHHHH------------HHhhcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 9975432211110 111111 112345556778999999999999999998 688876
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=307.27 Aligned_cols=200 Identities=22% Similarity=0.297 Sum_probs=164.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++|+||||++++++|.++..+++|||||.||+|.+++..... .+++..+..++.||+.||.|||+++
T Consensus 207 il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~--------~l~e~~~~~~~~qi~~al~ylH~~~--- 275 (573)
T 3uto_A 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN--- 275 (573)
T ss_dssp HHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTS--------CEEHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 46789999999999999999999999999999999999865432 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCC--CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIFDD--DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~--~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
|+||||||+|||++.+ +.+||+|||+++....... .....||+.|+|||++.+..|+.++|||||||++|+|++|
T Consensus 276 iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G 352 (573)
T 3uto_A 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352 (573)
T ss_dssp EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999999999854 8899999999986543222 2345799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||.+...... +..+..... ........+.++.+||.+||..||.+|||++|+++
T Consensus 353 ~~Pf~~~~~~~~---------------~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 353 LSPFGGENDDET---------------LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCSSCCSSHHHH---------------HHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCcCHHHH---------------HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999975432111 111111111 11111234567999999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=282.89 Aligned_cols=224 Identities=29% Similarity=0.360 Sum_probs=174.8
Q ss_pred CcccccCCCccceeeEEeeCC----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 1 MVSRLKHENFVQLLGYCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
++++++||||+++++++.... ..++||||+.+|+|.+++.... +++..++.++.|++.||.|||+.
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~ 140 (322)
T 3soc_A 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHED 140 (322)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhh
Confidence 478899999999999998754 4699999999999999997643 99999999999999999999998
Q ss_pred ----------CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-----CCCc
Q 025816 77 ----------ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----QLNA 141 (247)
Q Consensus 77 ----------~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~ 141 (247)
+ ++||||||+||+++.++.+||+|||++................||..|+|||.+.+. .++.
T Consensus 141 ~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 217 (322)
T 3soc_A 141 IPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217 (322)
T ss_dssp EEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHH
T ss_pred ccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCc
Confidence 8 999999999999999999999999999765443332223345689999999999863 4567
Q ss_pred cccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccc-ccCCCC-----CHHHHHHHHHHHHhhcc
Q 025816 142 KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-RLGGDY-----PPKAVAKMAAVAALCVQ 215 (247)
Q Consensus 142 ~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~ 215 (247)
++||||||+++|+|++|..||.+.....................+...... ...... ....+..+.++|.+||+
T Consensus 218 ~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (322)
T 3soc_A 218 RIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297 (322)
T ss_dssp HHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTC
T ss_pred cchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHcc
Confidence 889999999999999999999876544333332222222222222222211 111111 22456779999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhHhc
Q 025816 216 YEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 216 ~~p~~Rps~~~il~~l~~~~~~ 237 (247)
.||.+|||++++++.|+++.+.
T Consensus 298 ~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 298 HDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=283.01 Aligned_cols=220 Identities=32% Similarity=0.457 Sum_probs=165.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++......++||||+.+|+|.+++...... ..+++..++.++.|++.||.|||+.+ +++
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~-~~i 160 (309)
T 3p86_A 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHNRN-PPI 160 (309)
T ss_dssp HHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCC-CCE
Confidence 67889999999999999999999999999999999999864321 12889999999999999999999985 239
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 161 vH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P 238 (309)
T 3p86_A 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238 (309)
T ss_dssp CCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCT
T ss_pred ECCCCChhhEEEeCCCcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999875433221 12345689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCCCC
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPGP 241 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~~~ 241 (247)
|...... ...............+...+..+.++|.+||+.||.+|||++++++.|+.++++..+|
T Consensus 239 f~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 239 WGNLNPA---------------QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp TTTSCHH---------------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred CCCCCHH---------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 9643211 1111111122223445556678999999999999999999999999999999877666
Q ss_pred CCCC
Q 025816 242 AGES 245 (247)
Q Consensus 242 ~~~~ 245 (247)
+..+
T Consensus 304 ~~~~ 307 (309)
T 3p86_A 304 PNRS 307 (309)
T ss_dssp ----
T ss_pred CCcc
Confidence 5543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=282.37 Aligned_cols=216 Identities=26% Similarity=0.407 Sum_probs=174.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.+++..++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 103 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~--- 171 (325)
T 3kul_A 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYLSDLG--- 171 (325)
T ss_dssp HHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999975432 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
|+||||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 172 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g 251 (325)
T 3kul_A 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251 (325)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999998654332211 1222345678999999999899999999999999999999 9
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
..||.... ...+...+........+..++..+.+++.+||..||.+|||++++++.|+.++++.
T Consensus 252 ~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 252 ERPYWNMT----------------NRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCTTTTSC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCcccCC----------------HHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 99996432 22233333333444455566778999999999999999999999999999999887
Q ss_pred CCCCC
Q 025816 239 PGPAG 243 (247)
Q Consensus 239 ~~~~~ 243 (247)
....+
T Consensus 316 ~~~~~ 320 (325)
T 3kul_A 316 ESLRA 320 (325)
T ss_dssp C----
T ss_pred ccccc
Confidence 66544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=286.83 Aligned_cols=217 Identities=27% Similarity=0.444 Sum_probs=175.4
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
|+++ +||||+++++++..+...++||||+.+|+|.+++....... ...+...+++..++.++.|++.||.||
T Consensus 140 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 219 (370)
T 2psq_A 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219 (370)
T ss_dssp HHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 5667 89999999999999999999999999999999997653210 001123389999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ |+||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|
T Consensus 220 H~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 220 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred HhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHH
Confidence 9999 9999999999999999999999999997554333222223345678899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
+|++ |..||.... ...+...+........+..++..+.+++.+||+.||.+|||++++++.|+
T Consensus 297 ellt~g~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 297 EIFTLGGSPYPGIP----------------VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp HHHTTSCCSSTTCC----------------GGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHcCCCCCCCCCC----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999 999996432 12222233333334455566778999999999999999999999999999
Q ss_pred HhHhc
Q 025816 233 PLLNA 237 (247)
Q Consensus 233 ~~~~~ 237 (247)
.+++.
T Consensus 361 ~il~~ 365 (370)
T 2psq_A 361 RILTL 365 (370)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=289.14 Aligned_cols=210 Identities=26% Similarity=0.435 Sum_probs=174.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++..+...++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 165 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~--- 233 (377)
T 3cbl_A 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLESKC--- 233 (377)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999975432 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 234 ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~ 313 (377)
T 3cbl_A 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGA 313 (377)
T ss_dssp EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999875433222211222345678999999998899999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
.||.... ...+.+.+....+...+..++..+.++|.+||+.||.+|||++++++.|+.+.+.
T Consensus 314 ~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 314 SPYPNLS----------------NQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CSSTTSC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCC----------------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 9996432 2233334444444455566677899999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=276.61 Aligned_cols=225 Identities=39% Similarity=0.653 Sum_probs=187.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC---C
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK---A 77 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~---~ 77 (247)
++++++||||+++++++..+...++||||+.+|+|.+++...... ...+++..+..++.|++.||.|||+. +
T Consensus 80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ 154 (326)
T 3uim_A 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPK 154 (326)
T ss_dssp GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 467899999999999999999999999999999999999876532 23489999999999999999999999 7
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
++||||||+||+++.++.++|+|||++......... ......||..|+|||.+.+..++.++||||||+++|+|++
T Consensus 155 ---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 230 (326)
T 3uim_A 155 ---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230 (326)
T ss_dssp ---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH
T ss_pred ---eEeCCCchhhEEECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh
Confidence 999999999999999999999999999765432221 1233458999999999998889999999999999999999
Q ss_pred CCCCCCCCC--CCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 158 GRKPVDHTL--PRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 158 g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
|..||.... .........+..............+.......+...+..+.+++.+||+.||.+|||++++++.|+..
T Consensus 231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 231 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred CCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 999996321 12222333444444555566666667777778889999999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=278.62 Aligned_cols=215 Identities=27% Similarity=0.439 Sum_probs=171.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.++...++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 60 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~--- 128 (310)
T 3s95_A 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHSMN--- 128 (310)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999999999999986432 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcc------------cccceeccccccCchhhhcCCCCccccchhh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL------------HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSF 148 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 148 (247)
++|+||||+||+++.++.++|+|||++.......... ......||..|+|||.+.+..++.++|||||
T Consensus 129 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 208 (310)
T 3s95_A 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208 (310)
T ss_dssp EECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 9999999999999999999999999997654322211 0113468999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
|+++|+|++|..||........... ......... ..+..++..+.+++.+||+.||.+|||+++++
T Consensus 209 G~~l~el~~g~~~~~~~~~~~~~~~----------~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~ 274 (310)
T 3s95_A 209 GIVLCEIIGRVNADPDYLPRTMDFG----------LNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE 274 (310)
T ss_dssp HHHHHHHHHTCCSSTTTSCBCTTSS----------BCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHhcCCCCCcchhhhHHHHh----------hhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999999865432211110 011111111 12233445699999999999999999999999
Q ss_pred HHHHHhHhcCCC
Q 025816 229 KALQPLLNARPG 240 (247)
Q Consensus 229 ~~l~~~~~~~~~ 240 (247)
+.|+.+....++
T Consensus 275 ~~L~~l~~~~~~ 286 (310)
T 3s95_A 275 HWLETLRMHLAG 286 (310)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHhccC
Confidence 999988766443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=277.27 Aligned_cols=217 Identities=24% Similarity=0.409 Sum_probs=175.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC---------------CCCCCCCcCHHHHHHHHHHH
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---------------GAQPGPVLSWQQRVKIAVGA 66 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------------~~~~~~~l~~~~~~~~~~~~ 66 (247)
+++++||||+++++++..+...++||||+.+++|.+++....... .......+++..++.++.|+
T Consensus 80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 159 (314)
T 2ivs_A 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159 (314)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence 678999999999999999999999999999999999997654210 00112348999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccch
Q 025816 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY 146 (247)
Q Consensus 67 ~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 146 (247)
+.||.|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||
T Consensus 160 ~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 236 (314)
T 2ivs_A 160 SQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236 (314)
T ss_dssp HHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHH
Confidence 99999999999 999999999999999999999999998765443332223344567889999999998899999999
Q ss_pred hhhHHHHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 147 SFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 147 slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
|||+++|+|++ |..||..... ..+.+.+........+...+..+.+++.+||+.||.+|||+.
T Consensus 237 slG~il~el~t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 300 (314)
T 2ivs_A 237 SFGVLLWEIVTLGGNPYPGIPP----------------ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300 (314)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCG----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999 9999964422 122222333333344556677899999999999999999999
Q ss_pred HHHHHHHHhHhc
Q 025816 226 IVVKALQPLLNA 237 (247)
Q Consensus 226 ~il~~l~~~~~~ 237 (247)
++++.|+++++.
T Consensus 301 ~l~~~l~~~~~~ 312 (314)
T 2ivs_A 301 DISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHhh
Confidence 999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=283.63 Aligned_cols=222 Identities=28% Similarity=0.437 Sum_probs=181.0
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++++ +||||+++++++..+...++||||+.+|+|.+++....... .......+++..++.++.|++.||.||
T Consensus 128 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 207 (382)
T 3tt0_A 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207 (382)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4566 89999999999999999999999999999999997654210 111223499999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||++++
T Consensus 208 H~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 208 ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284 (382)
T ss_dssp HHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred HhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHH
Confidence 9999 9999999999999999999999999998665433322333445678899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
+|++ |..||.... ...+.+.+........+..++.++.+++.+||+.||.+|||++++++.|+
T Consensus 285 ellt~g~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 285 EIFTLGGSPYPGVP----------------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp HHHTTSCCSSTTCC----------------HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhCCCCCCCCCC----------------HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999 999996432 22233333333344455566778999999999999999999999999999
Q ss_pred HhHhcCCCCC
Q 025816 233 PLLNARPGPA 242 (247)
Q Consensus 233 ~~~~~~~~~~ 242 (247)
.++.......
T Consensus 349 ~~~~~~~~~~ 358 (382)
T 3tt0_A 349 RIVALTSNQE 358 (382)
T ss_dssp HHHHHSCSCC
T ss_pred HHHHHHhcCC
Confidence 9997765544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=287.04 Aligned_cols=216 Identities=25% Similarity=0.398 Sum_probs=174.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+|+|.+++....... .....+++..++.++.|++.||.|||+++ |
T Consensus 128 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 202 (367)
T 3l9p_A 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---F 202 (367)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhcccc--CccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567899999999999999999999999999999999997654221 12234899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCC---ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-
Q 025816 82 IHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT- 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~- 157 (247)
+||||||+||+++.++ .+||+|||++................+|..|+|||.+.+..++.++||||||+++|+|++
T Consensus 203 vHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~ 282 (367)
T 3l9p_A 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 282 (367)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999999655 499999999875433332223344567889999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
|..||.... ...+.+.+........+..++..+.+++.+||+.||.+|||+++|++.|+.+.+.
T Consensus 283 g~~pf~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 283 GYMPYPSKS----------------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp SCCSSTTCC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCCC----------------HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 999996432 2223333333333444555667899999999999999999999999999988754
Q ss_pred C
Q 025816 238 R 238 (247)
Q Consensus 238 ~ 238 (247)
.
T Consensus 347 ~ 347 (367)
T 3l9p_A 347 P 347 (367)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=269.76 Aligned_cols=208 Identities=25% Similarity=0.471 Sum_probs=172.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i 127 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---V 127 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 6789999999999999999999999999999999999976543 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||+|+++++|++ |..
T Consensus 128 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~ 206 (269)
T 4hcu_A 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 206 (269)
T ss_dssp CCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ecCCcchheEEEcCCCCEEeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999999865443322 1233446778999999999999999999999999999999 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
||..... ....+.+........+...+..+.+++.+||+.||.+|||++++++.|+++.++
T Consensus 207 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 207 PYENRSN----------------SEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TTTTCCH----------------HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCH----------------HHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 9964321 122222222233334445567799999999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=278.31 Aligned_cols=207 Identities=25% Similarity=0.395 Sum_probs=170.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+. .+++++++.+|+|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 71 l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---i 138 (327)
T 3poz_A 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---L 138 (327)
T ss_dssp HHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 57789999999999998764 7789999999999999976442 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 139 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 218 (327)
T 3poz_A 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218 (327)
T ss_dssp CCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred eCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCC
Confidence 9999999999999999999999999876543332222233456778999999999999999999999999999999 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
||.... ...+.+.+........+..++.++.+++.+||+.||.+|||++++++.|+.+.+
T Consensus 219 p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 219 PYDGIP----------------ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTTTCC----------------GGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CccCCC----------------HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 996432 223334444444445556667789999999999999999999999999998875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=279.58 Aligned_cols=208 Identities=26% Similarity=0.419 Sum_probs=168.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++. +...++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 69 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 136 (325)
T 3kex_A 69 IGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEEHG---M 136 (325)
T ss_dssp HHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHhCC---C
Confidence 56789999999999886 4568899999999999999976532 2888999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 137 vH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 216 (325)
T 3kex_A 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216 (325)
T ss_dssp CCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCC
Confidence 9999999999999999999999999987644333322344557789999999999999999999999999999999 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
||..... ..+.+.+........+..++.++.+++.+||..||.+|||++++++.|+.+...
T Consensus 217 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 217 PYAGLRL----------------AEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTTTSCT----------------THHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CccccCH----------------HHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9975422 222222333333334444556789999999999999999999999999988754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=274.14 Aligned_cols=198 Identities=24% Similarity=0.369 Sum_probs=164.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..++||||+.+|+|.+++.... +++..+..++.|++.||.|||+.+ +
T Consensus 71 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i 137 (297)
T 3fxz_A 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---V 137 (297)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 577899999999999999999999999999999999997653 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++........ ......||..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 138 ~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 215 (297)
T 3fxz_A 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215 (297)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543222 12345689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcc-cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVD-ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|........ ...... .......+...+..+.+++.+||+.||.+|||++++++
T Consensus 216 f~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 216 YLNENPLRA---------------LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp TTTSCHHHH---------------HHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCHHHH---------------HHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 965422110 001000 11112234455677999999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=278.20 Aligned_cols=221 Identities=26% Similarity=0.408 Sum_probs=174.6
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC--------------CCCCCCcCHHHHHHHHHHH
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG--------------AQPGPVLSWQQRVKIAVGA 66 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--------------~~~~~~l~~~~~~~~~~~~ 66 (247)
++++ +||||+++++++..+...++||||+.+|+|.+++........ ......+++..++.++.|+
T Consensus 102 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 5667 899999999999999999999999999999999987543110 0111238999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccch
Q 025816 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY 146 (247)
Q Consensus 67 ~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 146 (247)
+.||.|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||
T Consensus 182 ~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 258 (344)
T 1rjb_A 182 AKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258 (344)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHH
Confidence 99999999999 999999999999999999999999999866443332223445678889999999998999999999
Q ss_pred hhhHHHHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 147 SFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 147 slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
|||+++|+|++ |..||..... ...+...+........+...+..+.+++.+||+.||.+|||++
T Consensus 259 slG~il~el~t~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 323 (344)
T 1rjb_A 259 SYGILLWEIFSLGVNPYPGIPV---------------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 323 (344)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCC---------------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHcCCCCCcccCCc---------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 99999999998 9999965421 1122233333333444555677899999999999999999999
Q ss_pred HHHHHHHHhHhcCCC
Q 025816 226 IVVKALQPLLNARPG 240 (247)
Q Consensus 226 ~il~~l~~~~~~~~~ 240 (247)
++++.|+.+....+.
T Consensus 324 ~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 324 NLTSFLGCQLADAEE 338 (344)
T ss_dssp HHHHHHHHHC-----
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999998876554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=270.12 Aligned_cols=209 Identities=26% Similarity=0.445 Sum_probs=173.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+++..++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i 141 (283)
T 3gen_A 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---F 141 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5788999999999999999999999999999999999976432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||||+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus 142 ~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~ 220 (283)
T 3gen_A 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220 (283)
T ss_dssp CCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999865443322 1223346778999999999899999999999999999998 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
||.... .....+.+........+...+..+.+++.+||+.||.+|||++++++.|+++++.+
T Consensus 221 p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 221 PYERFT----------------NSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TTTTSC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CccccC----------------hhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 996432 12222222333333344445677999999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=281.53 Aligned_cols=211 Identities=25% Similarity=0.410 Sum_probs=164.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++..+...++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 99 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~--- 167 (373)
T 2qol_A 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMKYLSDMG--- 167 (373)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999976532 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
++||||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.++||||||+++|++++ |
T Consensus 168 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g 247 (373)
T 2qol_A 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247 (373)
T ss_dssp CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC
T ss_pred eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998654332211 1122234678999999999999999999999999999998 9
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
..||.... ...+.+.+........+..++..+.+++.+||+.||.+|||++++++.|+.+++..
T Consensus 248 ~~P~~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 248 ERPYWEMS----------------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -CTTTTCC----------------HHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCCCCCC----------------HHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 99996432 12223333333334445566778999999999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=275.08 Aligned_cols=219 Identities=21% Similarity=0.327 Sum_probs=163.2
Q ss_pred cccccCCCccceeeEEeeCCee------eEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++||||+++++++...... +++|||+.+|+|.+++....... ....+++..++.++.|++.||.|||+
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~ 155 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLPLQTLVRFMVDIACGMEYLSS 155 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccc---cccccCHHHHHHHHHHHHHHHHHHHc
Confidence 6789999999999999877655 89999999999999986543211 11238999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|
T Consensus 156 ~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (323)
T 3qup_A 156 RN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232 (323)
T ss_dssp TT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHH
Confidence 99 999999999999999999999999999865443332222334567789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
++ |..||..... ......+........+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 233 l~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 233 MTRGQTPYAGIEN----------------AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HTTSCCTTTTCCG----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCCccccCh----------------HHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99 9999975422 112222222222334455667899999999999999999999999999999
Q ss_pred HhcCCCCC
Q 025816 235 LNARPGPA 242 (247)
Q Consensus 235 ~~~~~~~~ 242 (247)
++.+....
T Consensus 297 l~~~~~~~ 304 (323)
T 3qup_A 297 LGHLSVLS 304 (323)
T ss_dssp HHC-----
T ss_pred HHHhhhcC
Confidence 87665433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=279.96 Aligned_cols=219 Identities=26% Similarity=0.380 Sum_probs=173.9
Q ss_pred cccc-cCCCccceeeEEeeCC-eeeEEEecCCCCChhhhhcCCCCCC---------------------------------
Q 025816 2 VSRL-KHENFVQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVK--------------------------------- 46 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~--------------------------------- 46 (247)
++++ +||||+++++++.... ..++||||+.+|+|.+++.......
T Consensus 79 l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (359)
T 3vhe_A 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITS 158 (359)
T ss_dssp HHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------
T ss_pred HHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCc
Confidence 4556 7899999999998765 4899999999999999998764310
Q ss_pred ------------------------CCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeec
Q 025816 47 ------------------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 102 (247)
Q Consensus 47 ------------------------~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~ 102 (247)
.......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~ 235 (359)
T 3vhe_A 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKIC 235 (359)
T ss_dssp -------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred cccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEE
Confidence 0001223899999999999999999999999 9999999999999999999999
Q ss_pred cccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCCCCCCCCCCCCcchhhhccccC
Q 025816 103 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKL 181 (247)
Q Consensus 103 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 181 (247)
|||++................+|..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 236 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------- 302 (359)
T 3vhe_A 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------------- 302 (359)
T ss_dssp CCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------------
T ss_pred eccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------------
Confidence 9999986544333323344567889999999999999999999999999999998 99999754221
Q ss_pred CcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 182 SEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
..+...+........+...+..+.+++.+||+.||.+|||++++++.|+.++++.
T Consensus 303 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 303 --EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp --HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 1222222333333444555677999999999999999999999999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=273.85 Aligned_cols=220 Identities=24% Similarity=0.384 Sum_probs=176.7
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC---------CCCCCCCcCHHHHHHHHHHHHHHHH
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---------GAQPGPVLSWQQRVKIAVGAAKGLE 71 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------~~~~~~~l~~~~~~~~~~~~~~~l~ 71 (247)
++++ +||||+++++++..+...++||||+.+|+|.+++....... .......+++..++.++.|++.||.
T Consensus 80 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 4567 89999999999999999999999999999999997654210 0111234899999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHH
Q 025816 72 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV 151 (247)
Q Consensus 72 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~ 151 (247)
|||+.+ ++|+||||+||+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||++
T Consensus 160 ~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 236 (313)
T 1t46_A 160 FLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (313)
T ss_dssp HHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHH
Confidence 999999 99999999999999999999999999987654433222334457788999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 152 LLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 152 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
+++|++ |..||...... ....+.+........+...+..+.+++.+||+.||.+|||++++++.
T Consensus 237 l~ellt~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPVD---------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHTTTCCSSTTCCSS---------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCCCcccch---------------hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 999998 99999754221 12222222333333344556789999999999999999999999999
Q ss_pred HHHhHhcCC
Q 025816 231 LQPLLNARP 239 (247)
Q Consensus 231 l~~~~~~~~ 239 (247)
|+++++..+
T Consensus 302 L~~~~~~~~ 310 (313)
T 1t46_A 302 IEKQISEST 310 (313)
T ss_dssp HHHHHHHTC
T ss_pred HHHHHHHhh
Confidence 999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=288.69 Aligned_cols=216 Identities=25% Similarity=0.419 Sum_probs=177.7
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++. +...++||||+.+|+|.+++....... +++..++.++.|++.||.|||+++
T Consensus 236 ~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~LH~~~--- 304 (454)
T 1qcf_A 236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK-------QPLPKLIDFSAQIAEGMAFIEQRN--- 304 (454)
T ss_dssp HHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHT-------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 368899999999999886 667899999999999999998653222 888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 305 ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~ 383 (454)
T 1qcf_A 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383 (454)
T ss_dssp CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCC
Confidence 999999999999999999999999999865433221 1223345778999999999899999999999999999999 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 239 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~ 239 (247)
.||.... ...+.+.+....+...+..++..+.++|.+||+.||.+|||+++|++.|+.+..+..
T Consensus 384 ~P~~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 384 IPYPGMS----------------NPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp CSSTTCC----------------HHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred CCCCCCC----------------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 9996432 222333333444445556677889999999999999999999999999999987766
Q ss_pred CCCCC
Q 025816 240 GPAGE 244 (247)
Q Consensus 240 ~~~~~ 244 (247)
....+
T Consensus 448 ~~~~~ 452 (454)
T 1qcf_A 448 SQYEE 452 (454)
T ss_dssp CSSBC
T ss_pred ccccc
Confidence 55433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=278.35 Aligned_cols=219 Identities=26% Similarity=0.389 Sum_probs=171.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC---------------CCCCCCCcCHHHHHHHHHHH
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---------------GAQPGPVLSWQQRVKIAVGA 66 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------------~~~~~~~l~~~~~~~~~~~~ 66 (247)
+++++||||+++++++.++...++||||+.+++|.+++....... .......+++..++.++.|+
T Consensus 104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 678899999999999999999999999999999999997643210 00111349999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccch
Q 025816 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY 146 (247)
Q Consensus 67 ~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 146 (247)
+.||.|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+|
T Consensus 184 ~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 260 (343)
T 1luf_A 184 AAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260 (343)
T ss_dssp HHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccH
Confidence 99999999999 999999999999999999999999998755433222222344578899999999998999999999
Q ss_pred hhhHHHHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 147 SFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 147 slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
|||+++|+|++ |..||..... ..+...+........+...+..+.+++.+||+.||.+|||+.
T Consensus 261 slG~il~el~t~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 324 (343)
T 1luf_A 261 AYGVVLWEIFSYGLQPYYGMAH----------------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC 324 (343)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCH----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHhcCCCcCCCCCh----------------HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 99999999999 9999964321 111122222222234455667899999999999999999999
Q ss_pred HHHHHHHHhHhcCC
Q 025816 226 IVVKALQPLLNARP 239 (247)
Q Consensus 226 ~il~~l~~~~~~~~ 239 (247)
++++.|+++.+...
T Consensus 325 ~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 325 SIHRILQRMCERAE 338 (343)
T ss_dssp HHHHHHHHTTC---
T ss_pred HHHHHHHHHHhhhh
Confidence 99999999886543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=277.26 Aligned_cols=227 Identities=22% Similarity=0.308 Sum_probs=169.9
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++... ...++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~-- 134 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR-- 134 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHhcCC--
Confidence 6789999999999998653 568999999999999999976543 2899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++++|++|
T Consensus 135 -ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 213 (295)
T 3ugc_A 135 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 213 (295)
T ss_dssp -CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred -cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999866433221 111223466779999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
..|+.........................+.+........+..++..+.+++.+||+.||.+|||++++++.|+.+.+.-
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 214 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 99986431110000000000000011222333333444556667788999999999999999999999999999998765
Q ss_pred C
Q 025816 239 P 239 (247)
Q Consensus 239 ~ 239 (247)
+
T Consensus 294 ~ 294 (295)
T 3ugc_A 294 A 294 (295)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=274.97 Aligned_cols=208 Identities=25% Similarity=0.392 Sum_probs=166.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+. .+++++++.+|+|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 71 l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---i 138 (327)
T 3lzb_A 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---L 138 (327)
T ss_dssp HTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---C
Confidence 67899999999999998765 7889999999999999976542 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 139 vH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 218 (327)
T 3lzb_A 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218 (327)
T ss_dssp CCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999987644333322333456778999999999999999999999999999999 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
||.... ...+.+.+........+...+.++.+++.+||+.||.+|||++++++.|+.+.+.
T Consensus 219 p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 219 PYDGIP----------------ASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTTTCC----------------GGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCC----------------HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 996432 2223333444444445556677899999999999999999999999999988743
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=273.95 Aligned_cols=203 Identities=26% Similarity=0.317 Sum_probs=164.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+++..++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 59 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~g---i 126 (323)
T 3tki_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGIG---I 126 (323)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999976542 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~ 160 (247)
+||||||+||+++.++.++|+|||++................||..|+|||.+.+..+ +.++||||||+++|+|++|..
T Consensus 127 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 206 (323)
T 3tki_A 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 206 (323)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999976543332222334578999999999988775 778999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||......... .................+..+.+++.+||+.||.+|||++|+++.
T Consensus 207 pf~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 207 PWDQPSDSCQE--------------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp SCSSSCTTSHH--------------HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCchHHHH--------------HHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 99754332111 111111111111223456678999999999999999999999873
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=284.12 Aligned_cols=207 Identities=29% Similarity=0.464 Sum_probs=171.6
Q ss_pred CcccccCCCccceeeEEeeCC-eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+|++++||||+++++++.... ..++||||+.+|+|.+++...... .++...++.++.|++.||.|||+++
T Consensus 239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~-- 309 (450)
T 1k9a_A 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN-- 309 (450)
T ss_dssp HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTT-------TCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 367899999999999987665 789999999999999999865322 2789999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
++||||||+||+++.++.+||+|||+++...... ....++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 310 -ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g 383 (450)
T 1k9a_A 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 383 (450)
T ss_dssp -EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTT
T ss_pred -eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987543211 12246788999999999999999999999999999998 9
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
..||..... ..+.+.+..+.+...+..++..+.++|.+||+.||.+|||++++++.|+.+.+..
T Consensus 384 ~~P~~~~~~----------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 384 RVPYPRIPL----------------KDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CCSSTTSCT----------------TTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCCCCCCH----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 999964321 2222333344444556677788999999999999999999999999999987653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=267.28 Aligned_cols=215 Identities=23% Similarity=0.343 Sum_probs=173.5
Q ss_pred cccccCCCccceeeEEeeCCee-eEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSR-VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++||||+++++++.+.+.. +++|||+.+++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~--- 144 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVARGMEYLAEQK--- 144 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5788999999999999876655 899999999999999976432 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc--ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||||+||+++.++.++|+|||.+......... .......++..|.|||.+.+..++.++||||||+++|+|++|
T Consensus 145 i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 224 (298)
T 3pls_A 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224 (298)
T ss_dssp CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHT
T ss_pred cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhC
Confidence 999999999999999999999999999865443321 112334578899999999998999999999999999999995
Q ss_pred CCC-CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 159 RKP-VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 159 ~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
..| |.... ...+...+........+...+..+.+++.+||+.||.+|||++++++.|++++++
T Consensus 225 ~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 225 GAPPYRHID----------------PFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp SCCTTTTSC----------------GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccCC----------------HHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 555 43222 1222222223333334445567899999999999999999999999999999988
Q ss_pred CCCCCC
Q 025816 238 RPGPAG 243 (247)
Q Consensus 238 ~~~~~~ 243 (247)
..+...
T Consensus 289 l~~~~~ 294 (298)
T 3pls_A 289 LLGDHY 294 (298)
T ss_dssp CCSCCB
T ss_pred Hhccch
Confidence 776554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=287.79 Aligned_cols=217 Identities=29% Similarity=0.457 Sum_probs=174.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.. ...++||||+.+|+|.+++...... .+++..++.++.|++.||.|||+++
T Consensus 232 ~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~--- 300 (452)
T 1fmk_A 232 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMN--- 300 (452)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678999999999998876 6789999999999999999753322 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 301 ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 379 (452)
T 1fmk_A 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379 (452)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCC
Confidence 999999999999999999999999999865432211 1223346778999999999999999999999999999999 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 239 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~ 239 (247)
.||.... ...+.+.+....+...+..++..+.++|.+||+.||.+|||++++++.|+.+..+..
T Consensus 380 ~P~~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 380 VPYPGMV----------------NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CSSTTCC----------------HHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCC----------------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 9996432 122333333444445566777889999999999999999999999999999998877
Q ss_pred CCCCCC
Q 025816 240 GPAGES 245 (247)
Q Consensus 240 ~~~~~~ 245 (247)
++..++
T Consensus 444 ~~~~~~ 449 (452)
T 1fmk_A 444 PQYQPG 449 (452)
T ss_dssp CCCCCS
T ss_pred cccccc
Confidence 766554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=289.02 Aligned_cols=210 Identities=26% Similarity=0.409 Sum_probs=176.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++..+...++||||+.+|+|.+++....... +++..++.++.|++.||.|||+++
T Consensus 269 ~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~--- 338 (495)
T 1opk_A 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAMEYLEKKN--- 338 (495)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTT-------SCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCC-------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678999999999999999999999999999999999997644322 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
|+||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 339 ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~ 417 (495)
T 1opk_A 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 417 (495)
T ss_dssp EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCChhhEEECCCCcEEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCC
Confidence 999999999999999999999999999865432211 1223345678999999999899999999999999999999 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
.||...+ ...+.+.+....+...+..++..+.++|.+||+.||.+|||+++|++.|+.+++.
T Consensus 418 ~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 418 SPYPGID----------------LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CSSTTCC----------------GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCC----------------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 9996432 2223344444445556667778899999999999999999999999999988754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=266.50 Aligned_cols=204 Identities=31% Similarity=0.508 Sum_probs=160.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++.... +++..++.++.|++.||.|||+.+..++
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~~~~i 129 (271)
T 3dtc_A 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHDEAIVPI 129 (271)
T ss_dssp HHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSSC----------CCHHHHHHHHHHHHHHHHHHHHSSSSCC
T ss_pred HHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence 567899999999999999999999999999999999986443 8999999999999999999999974458
Q ss_pred EeccCCCCceeecC--------CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 82 IHRDIKSSNVLIFD--------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 82 ~h~di~~~nil~~~--------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
+|+||||+||+++. ++.++|+|||.+........ ....++..|+|||.+.+..++.++|+||||++++
T Consensus 130 ~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 205 (271)
T 3dtc_A 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLW 205 (271)
T ss_dssp CCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHH
T ss_pred eecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHH
Confidence 89999999999986 67899999999876543222 2346889999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
+|++|..||...... ...............+...+..+.+++.+||+.||.+|||++++++.|+.
T Consensus 206 ~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 206 ELLTGEVPFRGIDGL---------------AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHCCCTTTTSCHH---------------HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHhCCCCCCCCCHH---------------HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 999999999743211 11111222222333445566789999999999999999999999999975
Q ss_pred h
Q 025816 234 L 234 (247)
Q Consensus 234 ~ 234 (247)
+
T Consensus 271 l 271 (271)
T 3dtc_A 271 I 271 (271)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=267.81 Aligned_cols=207 Identities=26% Similarity=0.404 Sum_probs=159.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++. ++..++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 70 l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 137 (281)
T 1mp8_A 70 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---F 137 (281)
T ss_dssp HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 57889999999999874 5678999999999999999975432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus 138 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~ 216 (281)
T 1mp8_A 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216 (281)
T ss_dssp CCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred ecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999865432221 1223346778999999999899999999999999999996 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
||...... .....+........+...+..+.+++.+||+.||.+|||+.++++.|+.+++.
T Consensus 217 pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 217 PFQGVKNN----------------DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TTTTCCGG----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcCCHH----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 99754221 11111222222334455667899999999999999999999999999998865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=266.84 Aligned_cols=207 Identities=24% Similarity=0.364 Sum_probs=169.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i 125 (268)
T 3sxs_A 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK--------GLEPSQLLEMCYDVCEGMAFLESHQ---F 125 (268)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999976432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||||+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++++|++ |..
T Consensus 126 ~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 204 (268)
T 3sxs_A 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204 (268)
T ss_dssp EESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCcCcceEEECCCCCEEEccCccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998765433222 1223345678999999999899999999999999999998 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
||..... ......+........+...+..+.+++.+||+.||.+|||++++++.|+.+.+
T Consensus 205 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 205 PYDLYTN----------------SEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTTTSCH----------------HHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CccccCh----------------HHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 9964321 11111122222223334446679999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=274.47 Aligned_cols=197 Identities=24% Similarity=0.322 Sum_probs=162.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++.+++..++||||+.+++|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---i 135 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR---------MKEKEARSKFRQIVSAVQYCHQKR---I 135 (328)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5788999999999999999999999999999999999865432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCC-ccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN-AKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~ 160 (247)
+||||||+||+++.++.+||+|||++........ .....||..|+|||.+.+..+. .++||||+|+++|+|++|..
T Consensus 136 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 212 (328)
T 3fe3_A 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212 (328)
T ss_dssp CCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSC
T ss_pred eccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence 9999999999999999999999999875433221 2345689999999999988775 78999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||.+.... ......... ....+...+.++.+++.+||..||.+|||++++++.
T Consensus 213 pf~~~~~~---------------~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 213 PFDGQNLK---------------ELRERVLRG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp SSCCSSHH---------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCHH---------------HHHHHHHhC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 99754211 111111111 112334456779999999999999999999999973
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=274.91 Aligned_cols=214 Identities=24% Similarity=0.375 Sum_probs=163.4
Q ss_pred CcccccCCCccceeeEEee-CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
++++++||||+++++++.. +...++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~-- 212 (373)
T 3c1x_A 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK-- 212 (373)
T ss_dssp TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5789999999999998754 4578999999999999999976432 2889999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcc--cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
++||||||+||+++.++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 213 -ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt 291 (373)
T 3c1x_A 213 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291 (373)
T ss_dssp -CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999998653322111 1123446778999999999999999999999999999999
Q ss_pred -CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 158 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 158 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
|.+||....... +...+........+..++..+.+++.+||+.||.+|||++++++.|+.++.
T Consensus 292 ~~~~p~~~~~~~~----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 292 RGAPPYPDVNTFD----------------ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp TSCCSCTTSCSSC----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCCCCCCCHHH----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 777876443211 111111122223344556779999999999999999999999999999998
Q ss_pred cCCCC
Q 025816 237 ARPGP 241 (247)
Q Consensus 237 ~~~~~ 241 (247)
+....
T Consensus 356 ~~~~~ 360 (373)
T 3c1x_A 356 TFIGE 360 (373)
T ss_dssp TCCSC
T ss_pred hcccc
Confidence 76654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=269.22 Aligned_cols=216 Identities=24% Similarity=0.351 Sum_probs=164.4
Q ss_pred cccccCCCccceeeEEeeCC-----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 2 VSRLKHENFVQLLGYCVDGT-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+++++||||+++++++.... ..++||||+.+++|.+++....... ....+++..++.++.|++.||.|||+.
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~ 166 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLSNR 166 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 57889999999999997765 3599999999999999985432111 122399999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 156 (247)
+ ++|+||||+||+++.++.++|+|||++................++..|.|||.+.+..++.++|+||||+++|+|+
T Consensus 167 ~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 243 (313)
T 3brb_A 167 N---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243 (313)
T ss_dssp T---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred C---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence 9 9999999999999999999999999987654332222223345678899999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 157 T-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 157 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
+ |..||...... .+...+........+...+..+.+++.+||..||.+|||++++++.|+.++
T Consensus 244 ~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 244 TRGMTPYPGVQNH----------------EMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp TTSCCSSTTCCGG----------------GHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCccCCHH----------------HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9 88998643221 111112222223334455677999999999999999999999999999999
Q ss_pred hcCC
Q 025816 236 NARP 239 (247)
Q Consensus 236 ~~~~ 239 (247)
+..|
T Consensus 308 ~~lp 311 (313)
T 3brb_A 308 ESLP 311 (313)
T ss_dssp HHC-
T ss_pred HhcC
Confidence 8765
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=266.74 Aligned_cols=213 Identities=26% Similarity=0.393 Sum_probs=165.1
Q ss_pred ccccCCCccceeeEEeeC----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC--
Q 025816 3 SRLKHENFVQLLGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-- 76 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~-- 76 (247)
..++||||+++++++... ...++||||+.+|+|.+++.... +++..++.++.|++.||.|||+.
T Consensus 86 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~ 155 (337)
T 3mdy_A 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIF 155 (337)
T ss_dssp TTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBC
T ss_pred HhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhh
Confidence 346999999999999887 78899999999999999997643 99999999999999999999998
Q ss_pred ------CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcc--cccceeccccccCchhhhcCCCCcc------
Q 025816 77 ------ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMTGQLNAK------ 142 (247)
Q Consensus 77 ------~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------ 142 (247)
+ ++||||||+||+++.++.+||+|||++.......... ......||..|+|||.+.+...+..
T Consensus 156 ~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 232 (337)
T 3mdy_A 156 STQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232 (337)
T ss_dssp STTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHH
T ss_pred hhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccc
Confidence 7 9999999999999999999999999987553322211 1123468999999999987766655
Q ss_pred ccchhhhHHHHHHHhCC----------CCCCCCCCCCCcchhhhccccCCcchhhhh-cccccCCCCC-----HHHHHHH
Q 025816 143 SDVYSFGVVLLELLTGR----------KPVDHTLPRGQQSLVTWATPKLSEDKVRQC-VDARLGGDYP-----PKAVAKM 206 (247)
Q Consensus 143 ~DvwslG~~l~~l~~g~----------~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~l 206 (247)
+||||||+++|+|++|. .||........ ........ .........+ ..++..+
T Consensus 233 ~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (337)
T 3mdy_A 233 ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP-----------SYEDMREIVCIKKLRPSFPNRWSSDECLRQM 301 (337)
T ss_dssp HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-----------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHH
T ss_pred cchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC-----------chhhhHHHHhhhccCccccccchhhHHHHHH
Confidence 99999999999999994 44432211111 01111111 1111222222 2678889
Q ss_pred HHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCC
Q 025816 207 AAVAALCVQYEADFRPNMSIVVKALQPLLNARP 239 (247)
Q Consensus 207 ~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~ 239 (247)
.+++.+||+.||.+|||+.++++.|+.+.++..
T Consensus 302 ~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 302 GKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred HHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=273.78 Aligned_cols=220 Identities=26% Similarity=0.432 Sum_probs=174.8
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++++ +||||+++++++..++..++||||+.+|+|.+++........ ......+++..++.++.|++.||.||
T Consensus 94 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 173 (334)
T 2pvf_A 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173 (334)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4566 899999999999999999999999999999999986542100 01122389999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++|+||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|
T Consensus 174 H~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 250 (334)
T 2pvf_A 174 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250 (334)
T ss_dssp HHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHH
Confidence 9999 9999999999999999999999999987654433222223345678899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
+|++ |..||.... ...+...+........+...+..+.+++.+||+.||.+|||++++++.|+
T Consensus 251 ellt~g~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 251 EIFTLGGSPYPGIP----------------VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp HHHTTSCCSSTTCC----------------HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhCCCCCcCcCC----------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9999 999996432 11222222222333444556678999999999999999999999999999
Q ss_pred HhHhcCCC
Q 025816 233 PLLNARPG 240 (247)
Q Consensus 233 ~~~~~~~~ 240 (247)
.++...+.
T Consensus 315 ~l~~~~~~ 322 (334)
T 2pvf_A 315 RILTLTTN 322 (334)
T ss_dssp HHHHHHC-
T ss_pred HHHhcccc
Confidence 99876543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=275.69 Aligned_cols=218 Identities=27% Similarity=0.421 Sum_probs=173.0
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCC-----CCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG-----AQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-----~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
++++ +||||+++++++..+...++||||+.+|+|.+++........ ......+++..++.++.|++.||.|||+
T Consensus 103 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 4567 899999999999999999999999999999999865321000 0001238999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|
T Consensus 183 ~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 183 KN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp TT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 99 999999999999999999999999999865443332223345567889999999998999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 156 LT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 156 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
++ |..||..... .....+..........+...+..+.+++.+||+.||.+|||++++++.|+++
T Consensus 260 ~t~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 260 FSLGLNPYPGILV---------------NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp TTTSCCSSTTCCS---------------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCCcccch---------------hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 98 9999964321 1122222333333333444567899999999999999999999999999987
Q ss_pred Hhc
Q 025816 235 LNA 237 (247)
Q Consensus 235 ~~~ 237 (247)
.+.
T Consensus 325 ~~~ 327 (333)
T 2i1m_A 325 AQE 327 (333)
T ss_dssp HHH
T ss_pred HHh
Confidence 754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=266.47 Aligned_cols=223 Identities=38% Similarity=0.612 Sum_probs=174.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...+++|||+.+++|.+++..... ...+++..++.++.|++.||.|||+.+ +
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i 154 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG------TPPLSWHMRCKIAQGAANGINFLHENH---H 154 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG------CCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 5778999999999999999999999999999999999975432 123899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++................|+..|+|||.+.+ .++.++|+||||+++|+|++|..|
T Consensus 155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999876543222222234568999999998865 578999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
|................ ......+...++... ...+...+..+.+++.+||+.||.+|||++++++.|+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 234 VDEHREPQLLLDIKEEI-EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BCTTBSSSBTTHHHHHH-HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cccCcchHHHHHHHHHh-hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 97654322111111000 011112223333322 34567788899999999999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=266.22 Aligned_cols=213 Identities=24% Similarity=0.376 Sum_probs=169.3
Q ss_pred cccccCCCccceeeEEe-eCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++||||+++++++. .+...+++|||+.+++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~ql~~~l~~lH~~~--- 148 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKYLASKK--- 148 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 67899999999999864 45678999999999999999975432 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcc--cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT- 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~- 157 (247)
++||||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+..++.++|+||||+++++|++
T Consensus 149 i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 228 (298)
T 3f66_A 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 228 (298)
T ss_dssp CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998664433211 1223456778999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
+.+||....... .............+...+..+.+++.+||+.||.+|||++++++.|+++++.
T Consensus 229 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 229 GAPPYPDVNTFD----------------ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp SCCSSTTSCTTT----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCccCCHHH----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 566665432211 1111111222223344556799999999999999999999999999999987
Q ss_pred CCCC
Q 025816 238 RPGP 241 (247)
Q Consensus 238 ~~~~ 241 (247)
..+.
T Consensus 293 ~~~~ 296 (298)
T 3f66_A 293 FIGE 296 (298)
T ss_dssp SCCS
T ss_pred hccC
Confidence 6654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=267.78 Aligned_cols=209 Identities=27% Similarity=0.414 Sum_probs=175.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+.+++|.+++....... +++..++.++.|++.||.|||+.+ +
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~---i 132 (288)
T 3kfa_A 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAMEYLEKKN---F 132 (288)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTT-------SCHHHHHHHHHHHHHHHHHHHHHT---C
T ss_pred HHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCC-------ccHhHHHHHHHHHHHHHHHHHHCC---c
Confidence 578899999999999999999999999999999999997654332 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||||+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus 133 ~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~ 211 (288)
T 3kfa_A 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211 (288)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCCcceEEEcCCCCEEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999865432221 1233456778999999999999999999999999999999 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
||...+. ..+.+.+........+...+..+.+++.+||..||.+|||++++++.|+.+++.
T Consensus 212 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 212 PYPGIDL----------------SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp SSTTCCG----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCH----------------HHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 9964321 222333333334445556677899999999999999999999999999988764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=267.29 Aligned_cols=214 Identities=25% Similarity=0.434 Sum_probs=174.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++ .....++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 64 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 131 (287)
T 1u59_A 64 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---F 131 (287)
T ss_dssp HHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCc--------cCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5678999999999998 55678999999999999999965432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
+|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 132 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 211 (287)
T 1u59_A 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211 (287)
T ss_dssp ECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred eeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999998765432221 11223346788999999998889999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 239 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~ 239 (247)
.||..... ..+.+.+........+...+..+.+++.+||..||.+|||+.++++.|+.++.+..
T Consensus 212 ~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 212 KPYKKMKG----------------PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp CTTTTCCT----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCcccCCH----------------HHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 99964321 12222223333344555667789999999999999999999999999999997766
Q ss_pred CCCC
Q 025816 240 GPAG 243 (247)
Q Consensus 240 ~~~~ 243 (247)
++..
T Consensus 276 ~~~~ 279 (287)
T 1u59_A 276 SKVE 279 (287)
T ss_dssp TTCS
T ss_pred Cccc
Confidence 5543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=276.19 Aligned_cols=228 Identities=28% Similarity=0.385 Sum_probs=177.6
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
|++++||||+++++++.+. ...++||||+.+++|.+++.... +++..++.++.|++.||.|||+.+
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~~-- 154 (318)
T 3lxp_A 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQH-- 154 (318)
T ss_dssp HHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5788999999999999874 67899999999999999997654 899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||||+||+++.++.++|+|||.+......... .......++..|+|||.+.+..++.++||||||+++++|++|
T Consensus 155 -ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g 233 (318)
T 3lxp_A 155 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233 (318)
T ss_dssp -EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred -ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999865443221 112334577789999999998999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
..||........ ..............+.+.+........+..++..+.+++.+||+.||.+|||++++++.|+.+.+.-
T Consensus 234 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 234 CDSSQSPPTKFL-ELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp TCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCcccccchhhh-hhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 999863211000 0000000111122334444445555566677788999999999999999999999999999998776
Q ss_pred CCCCC
Q 025816 239 PGPAG 243 (247)
Q Consensus 239 ~~~~~ 243 (247)
.++++
T Consensus 313 ~~~~p 317 (318)
T 3lxp_A 313 QGQAP 317 (318)
T ss_dssp HC---
T ss_pred ccCCC
Confidence 55544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=266.94 Aligned_cols=216 Identities=27% Similarity=0.434 Sum_probs=170.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++. ++..++||||+.+++|.+++....... +++..++.++.|++.||.|||+.+ +
T Consensus 62 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---i 130 (279)
T 1qpc_A 62 MKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN---Y 130 (279)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHT-------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 57889999999999876 456899999999999999997643212 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+......... ......++..|.|||.+.+..++.++|+||||+++++|++ |..
T Consensus 131 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 209 (279)
T 1qpc_A 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209 (279)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred eccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432211 1223346778999999998889999999999999999999 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCCC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~~ 240 (247)
||..... ....+.+........+...+..+.+++.+||+.||.+|||++++++.|+.++.+..+
T Consensus 210 p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 210 PYPGMTN----------------PEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp SSTTCCH----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CCcccCH----------------HHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 9964321 111222222222333445567899999999999999999999999999999988776
Q ss_pred CCCCC
Q 025816 241 PAGES 245 (247)
Q Consensus 241 ~~~~~ 245 (247)
+..++
T Consensus 274 ~~~~~ 278 (279)
T 1qpc_A 274 QYQPQ 278 (279)
T ss_dssp -----
T ss_pred CCCCC
Confidence 66554
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=269.85 Aligned_cols=217 Identities=23% Similarity=0.373 Sum_probs=171.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-CCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
++++++||||+++++++.++...++||||+.+|+|.+++....... .......+++..++.++.|++.||.|||+.+
T Consensus 81 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 158 (322)
T 1p4o_A 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 158 (322)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3678999999999999999999999999999999999987532100 0000112789999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 159 -i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 237 (322)
T 1p4o_A 159 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237 (322)
T ss_dssp -CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred -CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999986544332222334456888999999999899999999999999999999 8
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
..||..... ......+........+...+..+.+++.+||+.||.+|||+.++++.|++.+.
T Consensus 238 ~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 238 EQPYQGLSN----------------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCTTTTSCH----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCccccCCH----------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 999864321 11111111122223344556779999999999999999999999999987643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=289.31 Aligned_cols=213 Identities=25% Similarity=0.436 Sum_probs=172.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.. +..++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 389 il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~~--- 456 (613)
T 2ozo_A 389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN--- 456 (613)
T ss_dssp HHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4688999999999999876 568999999999999999965432 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
|+||||||+||+++.++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 457 iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G 536 (613)
T 2ozo_A 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 536 (613)
T ss_dssp CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999998654322211 1122335678999999999999999999999999999998 9
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
..||.... ...+.+.+....+...+..++..+.++|.+||..||.+|||+++|++.|+.++.+.
T Consensus 537 ~~Pf~~~~----------------~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 537 QKPYKKMK----------------GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CCTTTTCC----------------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCC----------------HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 99996432 22333444444455566677888999999999999999999999999999987654
Q ss_pred CCC
Q 025816 239 PGP 241 (247)
Q Consensus 239 ~~~ 241 (247)
...
T Consensus 601 ~~~ 603 (613)
T 2ozo_A 601 ASK 603 (613)
T ss_dssp SCS
T ss_pred ccc
Confidence 443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=262.96 Aligned_cols=208 Identities=25% Similarity=0.460 Sum_probs=171.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...+++|||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 125 (267)
T 3t9t_A 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---V 125 (267)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5788999999999999999999999999999999999976432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+......... ......++..|.|||.+.+..++.++|+||||+++|+|++ |..
T Consensus 126 ~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 204 (267)
T 3t9t_A 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204 (267)
T ss_dssp CCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCchheEEECCCCCEEEccccccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCC
Confidence 99999999999999999999999998765432221 1223346778999999998899999999999999999999 899
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
||..... ....+.+........+...+..+.+++.+||+.||.+|||++++++.|+++.++
T Consensus 205 p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 205 PYENRSN----------------SEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TTTTCCH----------------HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCH----------------HHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9964321 111111222222233444567799999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=269.15 Aligned_cols=218 Identities=28% Similarity=0.396 Sum_probs=173.1
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
++++ +||||+++++++.++...++||||+.+++|.+++....... .......+++..++.++.|++.||.||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 5678 89999999999999999999999999999999997653100 000112389999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++||||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|
T Consensus 159 H~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 159 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp HHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HhCC---ccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 9999 9999999999999999999999999987433211 122334677899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
+|++ |..||..... ..+.+.+........+...+..+.+++.+||..||.+|||++++++.|+
T Consensus 233 ellt~g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 233 EIVSLGGTPYCGMTC----------------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp HHHTTSCCTTTTCCH----------------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHcCCCCCCCCCcH----------------HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9998 9999964321 1122222222333444556678999999999999999999999999999
Q ss_pred HhHhcCCCC
Q 025816 233 PLLNARPGP 241 (247)
Q Consensus 233 ~~~~~~~~~ 241 (247)
.+++.....
T Consensus 297 ~~~~~~~~~ 305 (327)
T 1fvr_A 297 RMLEERKTY 305 (327)
T ss_dssp HHHHSSSCS
T ss_pred HHHHhhcCc
Confidence 998876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=271.07 Aligned_cols=211 Identities=26% Similarity=0.412 Sum_probs=166.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++......++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 100 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---i 168 (333)
T 1mqb_A 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---Y 168 (333)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5788999999999999999999999999999999999975432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
+|+||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 169 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 248 (333)
T 1mqb_A 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 248 (333)
T ss_dssp CCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 999999999999999999999999998654332211 1122345778999999998899999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 239 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~ 239 (247)
.||.... ...+.+.+........+...+..+.+++.+||+.||.+|||+.++++.|+.++++..
T Consensus 249 ~pf~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 249 RPYWELS----------------NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CTTTTCC----------------HHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCcccCC----------------HHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 9996432 112222222233333445566789999999999999999999999999999886543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=273.96 Aligned_cols=223 Identities=17% Similarity=0.216 Sum_probs=170.7
Q ss_pred cccccCCCccceeeEEeeC----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 2 VSRLKHENFVQLLGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
++.++||||+++++++... ...++||||+ +++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~~~ 172 (364)
T 3op5_A 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIHEHE 172 (364)
T ss_dssp HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4678999999999998765 4589999999 8899999976432 2999999999999999999999999
Q ss_pred CCCeEeccCCCCceeec--CCCceeeccccccCCcchhhhcc-----cccceeccccccCchhhhcCCCCccccchhhhH
Q 025816 78 DPHIIHRDIKSSNVLIF--DDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 150 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~--~~~~~~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 150 (247)
|+||||||+||+++ .++.+||+|||++.......... ......||..|+|||.+.+..++.++||||||+
T Consensus 173 ---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 249 (364)
T 3op5_A 173 ---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGY 249 (364)
T ss_dssp ---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHH
Confidence 99999999999999 88999999999997654332211 112344899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|+|++|..||........ ........ ....+.+.++..+. ....+.++.+++.+||+.+|.+|||+++|++.
T Consensus 250 ~l~el~~g~~Pf~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 250 CMIQWLTGHLPWEDNLKDPK--YVRDSKIR-YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHHSCCTTGGGTTCHH--HHHHHHHH-HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHhCCCCccccccCHH--HHHHHHHH-hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 99999999999974322111 00000000 00112222222211 12235679999999999999999999999999
Q ss_pred HHHhHhcCCCCC
Q 025816 231 LQPLLNARPGPA 242 (247)
Q Consensus 231 l~~~~~~~~~~~ 242 (247)
|+.+++......
T Consensus 324 l~~~~~~~~~~~ 335 (364)
T 3op5_A 324 LLQGLKAIGSKD 335 (364)
T ss_dssp HHHHHHHTTCCC
T ss_pred HHHHHHHcCCCc
Confidence 999998765543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=265.71 Aligned_cols=212 Identities=23% Similarity=0.368 Sum_probs=166.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ +
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i 132 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---------PLSVDTAINFTNQILDGIKHAHDMR---I 132 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 578999999999999999999999999999999999997643 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++......... ......||..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 133 ~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p 211 (294)
T 4eqm_A 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211 (294)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCCCHHHEEECCCCCEEEEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999865432221 12345689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhccccc---CCCCCHHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHHHHhHhc
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL---GGDYPPKAVAKMAAVAALCVQYEADFRP-NMSIVVKALQPLLNA 237 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~il~~l~~~~~~ 237 (247)
|....... .....+.... ........+..+.+++.+||+.||.+|| +++++.+.|+.++..
T Consensus 212 f~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 212 FNGETAVS---------------IAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SCSSCHHH---------------HHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred CCCCChHH---------------HHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 97542110 0000000000 0012233456799999999999999999 899999999988765
Q ss_pred CCCC
Q 025816 238 RPGP 241 (247)
Q Consensus 238 ~~~~ 241 (247)
....
T Consensus 277 ~~~~ 280 (294)
T 4eqm_A 277 NRAN 280 (294)
T ss_dssp SSTT
T ss_pred ccCC
Confidence 5443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=268.75 Aligned_cols=198 Identities=21% Similarity=0.271 Sum_probs=164.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++.+....++||||+.+|+|.+++..... +++..++.++.|++.||.|||+.+ |
T Consensus 59 l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---i 126 (337)
T 1o6l_A 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---V 126 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5788999999999999999999999999999999999875432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.+|.+||+|||++........ ......||..|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus 127 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 204 (337)
T 1o6l_A 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204 (337)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCC
Confidence 9999999999999999999999999875332211 22345789999999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~ 230 (247)
|...+.. .....+... ....+...+.++.++|.+||+.||.+|| +++++++.
T Consensus 205 f~~~~~~---------------~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 205 FYNQDHE---------------RLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp SCCSSHH---------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCHH---------------HHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 9643211 111111111 1123445567899999999999999999 89999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=266.17 Aligned_cols=208 Identities=26% Similarity=0.419 Sum_probs=170.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++ .....++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 72 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i 138 (291)
T 1xbb_A 72 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---F 138 (291)
T ss_dssp HHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcC---------CCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5788999999999998 56678999999999999999976432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
+|+||||+||+++.++.++|+|||++.......... ......++..|.|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 139 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 218 (291)
T 1xbb_A 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 218 (291)
T ss_dssp ECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred EcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCC
Confidence 999999999999999999999999987654322211 1122345678999999998889999999999999999999 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
.||..... ..+.+.+........+...+..+.+++.+||+.||.+|||+.++++.|+.++...
T Consensus 219 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 219 KPYRGMKG----------------SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CSSTTCCH----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 99964321 2223333333334455566778999999999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=272.24 Aligned_cols=197 Identities=24% Similarity=0.368 Sum_probs=161.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.++...++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+
T Consensus 68 il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g--- 135 (361)
T 2yab_A 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK--- 135 (361)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999999999999997643 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCC----ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 81 i~h~di~~~nil~~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 156 (247)
|+||||||+||+++.++ .++|+|||++....... ......||+.|+|||++.+..++.++|+||||+++|+|+
T Consensus 136 ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll 212 (361)
T 2yab_A 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212 (361)
T ss_dssp EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHH
Confidence 99999999999998777 79999999997654322 123456899999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||.+..... ....+.... ...+ ...+..+.++|.+||..||.+|||++++++
T Consensus 213 ~g~~Pf~~~~~~~---------------~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 213 SGASPFLGDTKQE---------------TLANITAVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HSCCSSCCSSHHH---------------HHHHHHTTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCCCCCCCCCHHH---------------HHHHHHhcC--CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999997542111 111111110 0111 123567999999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=269.75 Aligned_cols=199 Identities=19% Similarity=0.225 Sum_probs=162.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++.+....++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 55 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~g---i 123 (321)
T 1tki_A 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---I 123 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 5788999999999999999999999999999999999976432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecC--CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 82 IHRDIKSSNVLIFD--DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
+||||||+||+++. ++.++|+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 124 vH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 200 (321)
T 1tki_A 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp ECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999987 78999999999976543221 23456899999999999888899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
.||...... ..+..+........ .....+.++.+++.+||..||.+|||+.++++
T Consensus 201 ~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 201 NPFLAETNQ---------------QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CTTCCSSHH---------------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcCCCHH---------------HHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999653211 11111111111000 00133567999999999999999999999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=277.95 Aligned_cols=200 Identities=20% Similarity=0.245 Sum_probs=163.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.++...++||||+.+|+|.+.+..... +++..+..++.|++.||.|||+.+
T Consensus 63 il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~---------~~e~~~~~i~~qil~aL~~lH~~g--- 130 (444)
T 3soa_A 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---------YSEADASHCIQQILEAVLHCHQMG--- 130 (444)
T ss_dssp HHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999876542 899999999999999999999999
Q ss_pred eEeccCCCCceeec---CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+||+++ .++.+||+|||++......... .....||+.|+|||++.+..++.++||||+|+++|+|++
T Consensus 131 ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~ 208 (444)
T 3soa_A 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208 (444)
T ss_dssp CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh
Confidence 99999999999998 4578999999999765433221 234568999999999999899999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||...+.. .....+...... .......+.++.++|.+||+.||.+|||+.++++
T Consensus 209 G~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 209 GYPPFWDEDQH---------------RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp SSCSCCCSSHH---------------HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCccHH---------------HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999643211 111111111111 1111244567999999999999999999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=267.81 Aligned_cols=207 Identities=26% Similarity=0.463 Sum_probs=161.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---i 134 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEENT---L 134 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 6789999999999999999999999999999999999986542 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCc--------eeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHH
Q 025816 82 IHRDIKSSNVLIFDDDV--------AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVL 152 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~--------~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l 152 (247)
+||||||+||+++.++. ++|+|||.+....... ...++..|+|||.+.+ ..++.++||||||+++
T Consensus 135 vH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 208 (289)
T 4fvq_A 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208 (289)
T ss_dssp CCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHH
T ss_pred ECCCcCcceEEEecCCcccccccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHH
Confidence 99999999999998887 9999999987553322 2346788999999987 6789999999999999
Q ss_pred HHHHhCC-CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 153 LELLTGR-KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 153 ~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
|+|++|. .||...... ........ ....+...+.++.+++.+||+.||.+|||++++++.|
T Consensus 209 ~el~~g~~~~~~~~~~~----------------~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 209 WEICSGGDKPLSALDSQ----------------RKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp HHHHTTTCCTTTTSCHH----------------HHHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCccccchH----------------HHHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999955 444322111 01111111 1112222345689999999999999999999999999
Q ss_pred HHhHhcCCCCCC
Q 025816 232 QPLLNARPGPAG 243 (247)
Q Consensus 232 ~~~~~~~~~~~~ 243 (247)
+++++...+++.
T Consensus 271 ~~l~~p~~~~~~ 282 (289)
T 4fvq_A 271 NSLFTPDLVPRG 282 (289)
T ss_dssp HTCC--------
T ss_pred HHhcCCCCCCCC
Confidence 999987666554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=259.84 Aligned_cols=206 Identities=24% Similarity=0.373 Sum_probs=167.2
Q ss_pred CcccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
++++++||||+++++++.+. ...++||||+.+|+|.+++...... .+++..++.++.|++.||.|||+.+
T Consensus 60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~- 131 (271)
T 3kmu_A 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-------VVDQSQAVKFALDMARGMAFLHTLE- 131 (271)
T ss_dssp GGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSC-------CCCHHHHHHHHHHHHHHHHHHTTSS-
T ss_pred HHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 47889999999999999887 7789999999999999999875532 2899999999999999999999874
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCc---cccchhhhHHHHHH
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA---KSDVYSFGVVLLEL 155 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~~l~~l 155 (247)
+.++|+||||+||+++.++.+++.|||....... ....+|..|+|||.+.+..++. ++||||||+++|+|
T Consensus 132 ~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 204 (271)
T 3kmu_A 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWEL 204 (271)
T ss_dssp SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHH
T ss_pred CceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHH
Confidence 2399999999999999999999988887653211 2345788999999998765544 79999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
++|..||..... ................+...+..+.+++.+||+.||.+|||++++++.|+.+.
T Consensus 205 ~~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 205 VTREVPFADLSN---------------MEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHCSCTTTTSCH---------------HHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HhCCCCccccCh---------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 999999964321 11122222233334455566778999999999999999999999999999875
Q ss_pred h
Q 025816 236 N 236 (247)
Q Consensus 236 ~ 236 (247)
+
T Consensus 270 ~ 270 (271)
T 3kmu_A 270 D 270 (271)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=267.84 Aligned_cols=220 Identities=25% Similarity=0.375 Sum_probs=173.2
Q ss_pred cccc-cCCCccceeeEEeeCC-eeeEEEecCCCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHH
Q 025816 2 VSRL-KHENFVQLLGYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEY 72 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~l~~ 72 (247)
++++ +||||+++++++.... ..++||||+.+++|.+++........ ......+++..++.++.|++.||.|
T Consensus 84 l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 163 (316)
T 2xir_A 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163 (316)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHH
Confidence 4556 7899999999987765 58999999999999999987543110 0011238899999999999999999
Q ss_pred hhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHH
Q 025816 73 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL 152 (247)
Q Consensus 73 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 152 (247)
||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++
T Consensus 164 lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 240 (316)
T 2xir_A 164 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240 (316)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHH
Confidence 99999 999999999999999999999999999865443332233445678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 025816 153 LELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231 (247)
Q Consensus 153 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l 231 (247)
|+|++ |..||...... ..+...+........+...+..+.+++.+||+.||.+|||++++++.|
T Consensus 241 ~~l~t~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 241 WEIFSLGASPYPGVKID---------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp HHHHTTSCCSSTTCCCS---------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCCCCcccchh---------------HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99998 99999643211 111222222222333444566799999999999999999999999999
Q ss_pred HHhHhcCC
Q 025816 232 QPLLNARP 239 (247)
Q Consensus 232 ~~~~~~~~ 239 (247)
+.++++..
T Consensus 306 ~~~~~~~~ 313 (316)
T 2xir_A 306 GNLLQANA 313 (316)
T ss_dssp HHHHHHHC
T ss_pred HHHHhhhc
Confidence 99987643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=261.85 Aligned_cols=221 Identities=16% Similarity=0.179 Sum_probs=171.9
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++ +|+|++.+++++..+...++||||+ +++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 59 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~--- 126 (298)
T 1csn_A 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS--- 126 (298)
T ss_dssp HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred HHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 7999999999999999999999999 8899999985432 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCc-----eeeccccccCCcchhhhc-----ccccceeccccccCchhhhcCCCCccccchhhhH
Q 025816 81 IIHRDIKSSNVLIFDDDV-----AKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 150 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~-----~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 150 (247)
++||||||+||+++.++. ++|+|||.+......... .......||..|+|||.+.+..++.++||||||+
T Consensus 127 ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 206 (298)
T 1csn_A 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 206 (298)
T ss_dssp EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHH
Confidence 999999999999987776 999999999765433221 1123456899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|+|++|..||........................ .......+.++.+++.+||+.||.+|||+++|++.
T Consensus 207 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 207 VFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 999999999999764332211111110000000000 00111345679999999999999999999999999
Q ss_pred HHHhHhcCCCCCC
Q 025816 231 LQPLLNARPGPAG 243 (247)
Q Consensus 231 l~~~~~~~~~~~~ 243 (247)
|+++++.......
T Consensus 278 l~~~~~~~~~~~~ 290 (298)
T 1csn_A 278 FSKVLERLNTTED 290 (298)
T ss_dssp HHHHHHHTTCCSC
T ss_pred HHHHHHhcCCCCC
Confidence 9999987665443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=264.71 Aligned_cols=209 Identities=27% Similarity=0.506 Sum_probs=156.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++ .....++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 73 ~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~~~--- 140 (289)
T 3og7_A 73 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLHAKS--- 140 (289)
T ss_dssp HHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999955 55678999999999999999965442 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh---cCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~ 157 (247)
++|+||||+||+++.++.++|+|||++................|+..|+|||.+. +..++.++||||||+++++|++
T Consensus 141 i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 220 (289)
T 3og7_A 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220 (289)
T ss_dssp CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHH
T ss_pred cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHH
Confidence 9999999999999999999999999987654322222223456899999999986 5668889999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc----CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL----GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
|..||...... ..+.+.+.... .......++..+.+++.+||+.||.+|||++++++.|++
T Consensus 221 g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 285 (289)
T 3og7_A 221 GQLPYSNINNR---------------DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285 (289)
T ss_dssp SSCTTSSCCCH---------------HHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCccccchH---------------HHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 99999643221 11111111111 011223456779999999999999999999999999998
Q ss_pred hHh
Q 025816 234 LLN 236 (247)
Q Consensus 234 ~~~ 236 (247)
+.+
T Consensus 286 l~~ 288 (289)
T 3og7_A 286 LAR 288 (289)
T ss_dssp TTC
T ss_pred Hhh
Confidence 764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=288.52 Aligned_cols=216 Identities=29% Similarity=0.459 Sum_probs=177.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.. ...++||||+.+|+|.+++...... .+++..++.++.|++.||.|||+++
T Consensus 315 ~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~--- 383 (535)
T 2h8h_A 315 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMN--- 383 (535)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678999999999998876 6789999999999999999753322 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
|+||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 384 ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~ 462 (535)
T 2h8h_A 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462 (535)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTC
T ss_pred eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999876433221 1223346778999999999999999999999999999999 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARP 239 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~ 239 (247)
.||.... ...+.+.+....+...+..++..+.++|.+||+.||.+|||+++|++.|+.++.+..
T Consensus 463 ~P~~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 463 VPYPGMV----------------NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CSSTTCC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCCC----------------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 9996432 122333333344445556677889999999999999999999999999999988766
Q ss_pred CCCCC
Q 025816 240 GPAGE 244 (247)
Q Consensus 240 ~~~~~ 244 (247)
+...+
T Consensus 527 ~~~~~ 531 (535)
T 2h8h_A 527 PQYQP 531 (535)
T ss_dssp CSSCC
T ss_pred cccCc
Confidence 65544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=265.95 Aligned_cols=194 Identities=25% Similarity=0.382 Sum_probs=163.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+....++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ |
T Consensus 60 l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---i 127 (318)
T 1fot_A 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD---I 127 (318)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999976432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.+|.+||+|||++...... .....||..|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus 128 vHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 202 (318)
T 1fot_A 128 IYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202 (318)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred cccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 99999999999999999999999998764321 2345689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~ 229 (247)
|...... .....+.... ...+...+.++.+++.+||..||.+|| +++++++
T Consensus 203 f~~~~~~---------------~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 203 FYDSNTM---------------KTYEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TCCSSHH---------------HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHH---------------HHHHHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 9643211 1111222221 123445567899999999999999999 8999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=270.64 Aligned_cols=216 Identities=25% Similarity=0.395 Sum_probs=170.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++....... .....+++..++.++.|++.||.|||+.+ +
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i 161 (327)
T 2yfx_A 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---F 161 (327)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 567899999999999999999999999999999999998654321 11234899999999999999999999999 9
Q ss_pred EeccCCCCceeecCC---CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-
Q 025816 82 IHRDIKSSNVLIFDD---DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT- 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~- 157 (247)
+|+||||+||+++.+ ..++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 162 ~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 241 (327)
T 2yfx_A 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241 (327)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcC
Confidence 999999999999844 4699999999864432222222234457889999999999899999999999999999998
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
|..||..... ..+.+.+........+...+..+.+++.+||+.||.+|||+.++++.++.+.+.
T Consensus 242 g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 242 GYMPYPSKSN----------------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp SCCSSTTCCH----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCcCH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 9999964321 122222222223334445567899999999999999999999999999988754
Q ss_pred C
Q 025816 238 R 238 (247)
Q Consensus 238 ~ 238 (247)
+
T Consensus 306 ~ 306 (327)
T 2yfx_A 306 P 306 (327)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=264.36 Aligned_cols=211 Identities=29% Similarity=0.500 Sum_probs=162.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc---CCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE---KAD 78 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~---~~~ 78 (247)
+++++||||+++++++.+ ..++||||+.+++|.+++...... ..++...++.++.|++.||.|||+ .+
T Consensus 55 l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~- 125 (307)
T 2eva_A 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKA- 125 (307)
T ss_dssp HHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSC-
T ss_pred HhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCC-
Confidence 577899999999998773 478999999999999999765421 127888999999999999999999 66
Q ss_pred CCeEeccCCCCceeecCCCc-eeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 79 PHIIHRDIKSSNVLIFDDDV-AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~-~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
++||||||+||+++.++. +||+|||++....... ....|+..|+|||.+.+..++.++||||||+++|+|++
T Consensus 126 --ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 198 (307)
T 2eva_A 126 --LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT 198 (307)
T ss_dssp --CCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred --eecCCCChhHEEEeCCCCEEEEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999998886 7999999987543221 23358899999999999899999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
|..||........ .+................+..+.+++.+||+.||.+|||++++++.|+.+.+.
T Consensus 199 g~~p~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 199 RRKPFDEIGGPAF--------------RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp TCCTTTTTCSSHH--------------HHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred CCCCchhhCccHH--------------HHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 9999964322110 01111111122223344566799999999999999999999999999999876
Q ss_pred CCCCC
Q 025816 238 RPGPA 242 (247)
Q Consensus 238 ~~~~~ 242 (247)
.++..
T Consensus 265 ~~~~~ 269 (307)
T 2eva_A 265 FPGAD 269 (307)
T ss_dssp CCCTT
T ss_pred ccCCC
Confidence 65543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=270.63 Aligned_cols=199 Identities=21% Similarity=0.293 Sum_probs=161.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+.+|+|.+.+.... .+++..+..++.|++.||.|||+.+ |
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---i 149 (362)
T 2bdw_A 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSNG---I 149 (362)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 577899999999999999999999999999999999987653 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCC---ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+||||||+||+++.++ .+||+|||++........ .....||..|+|||++.+..++.++||||||+++|+|++|
T Consensus 150 vH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 226 (362)
T 2bdw_A 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226 (362)
T ss_dssp BCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999998654 599999999986543221 2335689999999999998999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..||...+.. .....+........ .....+.++.++|.+||..||.+|||+.++++.
T Consensus 227 ~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 227 YPPFWDEDQH---------------RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp SCSSCCSSHH---------------HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCHH---------------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999654211 01111111111111 112345679999999999999999999999873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=265.98 Aligned_cols=218 Identities=20% Similarity=0.307 Sum_probs=162.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..++||||+.+++|.+++...... +..++...++.++.|++.||.|||+.+ +
T Consensus 86 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i 157 (310)
T 2wqm_A 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMHSRR---V 157 (310)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---e
Confidence 57889999999999999999999999999999999998642211 122899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 158 ~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 235 (310)
T 2wqm_A 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235 (310)
T ss_dssp CCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432221 1234578899999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhccc-ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCCC
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~~ 240 (247)
|....... ..+...+.. ..........+.++.+++.+||..||.+|||++++++.|+++....++
T Consensus 236 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 236 FYGDKMNL--------------YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp TC---CCH--------------HHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CcccchhH--------------HHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 96432110 001111111 111111234456799999999999999999999999999999988887
Q ss_pred CCC
Q 025816 241 PAG 243 (247)
Q Consensus 241 ~~~ 243 (247)
|++
T Consensus 302 ~~~ 304 (310)
T 2wqm_A 302 SLE 304 (310)
T ss_dssp ---
T ss_pred hhh
Confidence 765
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=264.19 Aligned_cols=199 Identities=22% Similarity=0.344 Sum_probs=162.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++.... +++..+..++.|++.||.|||+.+ +
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------l~~~~~~~i~~qi~~~L~~LH~~~---i 162 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQG---V 162 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 678999999999999999999999999999999999987543 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.++|+|||++........ ......||..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 163 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 240 (321)
T 2c30_A 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240 (321)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543221 12345689999999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|........ ......... ........+..+.+++.+||+.||.+|||++++++.
T Consensus 241 f~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 241 YFSDSPVQA---------------MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TTTSCHHHH---------------HHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCHHHH---------------HHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 965422110 000000000 011122445679999999999999999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=266.82 Aligned_cols=196 Identities=21% Similarity=0.330 Sum_probs=160.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++.++...++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ +
T Consensus 68 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---i 135 (326)
T 2y0a_A 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQ---I 135 (326)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 578899999999999999999999999999999999997543 2999999999999999999999999 9
Q ss_pred EeccCCCCceeecCCC----ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 82 IHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
+||||||+||+++.++ .++|+|||++........ .....||..|+|||++.+..++.++|+||||+++|+|++
T Consensus 136 vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 212 (326)
T 2y0a_A 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212 (326)
T ss_dssp ECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred EcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH
Confidence 9999999999998887 799999999876543221 233568999999999998899999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||....... ........ ....+ ...+..+.+++.+||..||.+|||++++++
T Consensus 213 g~~pf~~~~~~~---------------~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 213 GASPFLGDTKQE---------------TLANVSAV--NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp SCCSSCCSSHHH---------------HHHHHHHT--CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCCCCCCCHHH---------------HHHHHHhc--CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999996542110 00000000 00111 123567899999999999999999999997
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=266.84 Aligned_cols=214 Identities=21% Similarity=0.264 Sum_probs=161.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+.+ +|.+.+..... .+++..++.++.|++.||.|||+.+ |
T Consensus 73 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---i 140 (311)
T 3niz_A 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQHR---I 140 (311)
T ss_dssp HHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5788999999999999999999999999975 88888876542 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+||||||+||+++.++.+||+|||++........ ......+|..|+|||.+.+ ..++.++||||||+++|+|++|..
T Consensus 141 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 218 (311)
T 3niz_A 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218 (311)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999976532211 1233467899999999876 568999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhh------cccccC--CC-----CCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQC------VDARLG--GD-----YPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~--~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
||.......................+... ...... .. .....+.++.+++.+||+.||.+|||++++
T Consensus 219 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 298 (311)
T 3niz_A 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298 (311)
T ss_dssp SCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 99865543322221111111111111100 000000 00 112335678999999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
++
T Consensus 299 l~ 300 (311)
T 3niz_A 299 MN 300 (311)
T ss_dssp HT
T ss_pred hc
Confidence 97
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=265.49 Aligned_cols=223 Identities=25% Similarity=0.394 Sum_probs=172.6
Q ss_pred cccccCCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++... +..++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~-- 146 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLGSRQ-- 146 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhhcCC--
Confidence 5788999999999999876 678999999999999999955432 2899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||||+||+++.++.++|+|||.+......... .......++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 147 -i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 225 (302)
T 4e5w_A 147 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225 (302)
T ss_dssp -EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred -cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHc
Confidence 999999999999999999999999999765443221 122334577789999999998999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
..|+......... .............+...+........+...+..+.+++.+||+.||.+|||++++++.|+.+++
T Consensus 226 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 226 CDSDSSPMALFLK-MIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp TCGGGSHHHHHHH-HHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred cCCCcchhhHHhh-ccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 9886422100000 0000001111222333333444445566677889999999999999999999999999998864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=264.01 Aligned_cols=198 Identities=26% Similarity=0.314 Sum_probs=156.9
Q ss_pred cccccCCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
|++++||||+++++++.+ +...++||||+.+++|.+++.... +++..++.++.|++.||.|||+.+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~-- 157 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP----------LSEDQARFYFQDLIKGIEYLHYQK-- 157 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSC----------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 678899999999999986 568899999999999988765432 999999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC---CCccccchhhhHHHHHHH
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ---LNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~~l~ 156 (247)
++||||||+||+++.++.+||+|||++......... .....||..|+|||.+.+.. ++.++||||||+++|+|+
T Consensus 158 -ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 158 -IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred -eeccCCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 999999999999999999999999998765432211 13346899999999987654 377899999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||...... ...................+.++.+++.+||+.||.+|||++++++
T Consensus 235 ~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 235 FGQCPFMDERIM---------------CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HSSCSSCCSSHH---------------HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HCCCCCCCccHH---------------HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 999999643211 0001111111111112234567999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=261.84 Aligned_cols=207 Identities=22% Similarity=0.334 Sum_probs=165.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.. ...++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 67 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 134 (281)
T 3cc6_A 67 MKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLESIN---C 134 (281)
T ss_dssp HHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 567899999999998765 456899999999999999975432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+|+||||+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus 135 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~ 213 (281)
T 3cc6_A 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213 (281)
T ss_dssp CCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998865432221 1223446778999999998899999999999999999998 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
||...... .....+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 214 p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 214 PFFWLENK----------------DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TTTTSCGG----------------GHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccCChH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 99643221 11122222222233444567799999999999999999999999999988764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=266.11 Aligned_cols=212 Identities=19% Similarity=0.241 Sum_probs=168.7
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++ +||||+++++++..+...++||||+ +++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 58 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~--- 125 (330)
T 2izr_A 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVHSKN--- 125 (330)
T ss_dssp HHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5667 9999999999999999999999999 8899999986422 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCc-----eeeccccccCCcchhhhcc-----cccceeccccccCchhhhcCCCCccccchhhhH
Q 025816 81 IIHRDIKSSNVLIFDDDV-----AKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 150 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~-----~~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 150 (247)
++||||||+||+++.++. ++|+|||++.......... ......||..|+|||.+.+..++.++||||||+
T Consensus 126 iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 205 (330)
T 2izr_A 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGH 205 (330)
T ss_dssp EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHH
Confidence 999999999999998887 9999999998654322211 123456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC---CCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
++|+|++|..||.............. +........ .....+ ++.+++.+||+.||.+|||+++|
T Consensus 206 il~ell~g~~Pf~~~~~~~~~~~~~~------------i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l 272 (330)
T 2izr_A 206 MFMYFLRGSLPWQGLKADTLKERYQK------------IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYL 272 (330)
T ss_dssp HHHHHHHSSCTTTTCCCSSHHHHHHH------------HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHH
T ss_pred HHHHHhcCCCCccccccccHHHHHHH------------HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHH
Confidence 99999999999976532221111110 000000000 001123 79999999999999999999999
Q ss_pred HHHHHHhHhcC
Q 025816 228 VKALQPLLNAR 238 (247)
Q Consensus 228 l~~l~~~~~~~ 238 (247)
.+.|+++.+..
T Consensus 273 ~~~l~~~~~~~ 283 (330)
T 2izr_A 273 RKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHHc
Confidence 99999988654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=271.02 Aligned_cols=200 Identities=24% Similarity=0.328 Sum_probs=163.3
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+....++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.|
T Consensus 68 il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g--- 135 (384)
T 4fr4_A 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH---------FKEETVKLFICELVMALDYLQNQR--- 135 (384)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999986532 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc---CCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+||+++.+|.++|+|||++....... ......||..|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 136 ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ellt 212 (384)
T 4fr4_A 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212 (384)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHH
T ss_pred ceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHh
Confidence 9999999999999999999999999997653322 2244578999999999864 458999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-HHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-MSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~il~ 229 (247)
|..||........... ...+. ......+...+..+.++|.+||+.||.+||+ ++++++
T Consensus 213 G~~Pf~~~~~~~~~~~-------------~~~~~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 213 GRRPYHIRSSTSSKEI-------------VHTFE-TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SSCSSCCCTTSCHHHH-------------HHHHH-HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCCCCCCCccHHHH-------------HHHHh-hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 9999975432211111 11111 1112344556678999999999999999999 777765
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=271.87 Aligned_cols=196 Identities=22% Similarity=0.296 Sum_probs=159.1
Q ss_pred ccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 3 SRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 3 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+.+ +||||+++++++.+....++||||+.+|+|.+++..... +++..++.++.|++.||.|||+.+ |
T Consensus 78 ~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---i 145 (353)
T 3txo_A 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEIISALMFLHDKG---I 145 (353)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 344 799999999999999999999999999999999976532 999999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus 146 vHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P 223 (353)
T 3txo_A 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223 (353)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCCHHHEEECCCCCEEEccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCC
Confidence 9999999999999999999999999875332221 22345689999999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH------HHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM------SIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~~il~ 229 (247)
|...... .....+.... ...+...+.++.+++.+||..||.+||++ +++++
T Consensus 224 f~~~~~~---------------~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 224 FEAENED---------------DLFEAILNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp SCCSSHH---------------HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCHH---------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 9754221 1111111111 12344566779999999999999999998 77876
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=260.85 Aligned_cols=207 Identities=26% Similarity=0.364 Sum_probs=160.2
Q ss_pred cccCCCccceeeEEeeC----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh-----
Q 025816 4 RLKHENFVQLLGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH----- 74 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh----- 74 (247)
+++||||+++++++... ...++||||+.+|+|.+++.... +++..++.++.|++.||.|||
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~ 127 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHIEIFG 127 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTCC----------BCHHHHHHHHHHHHHHHHHHHSCBCS
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhcc----------cCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 48999999999986543 45899999999999999996543 999999999999999999999
Q ss_pred ---cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcc--cccceeccccccCchhhhcC------CCCccc
Q 025816 75 ---EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMTG------QLNAKS 143 (247)
Q Consensus 75 ---~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~ 143 (247)
+.+ ++||||||+||+++.++.+||+|||++.......... ......||..|+|||.+.+. .++.++
T Consensus 128 ~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 204 (301)
T 3q4u_A 128 TQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204 (301)
T ss_dssp TTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHH
T ss_pred ccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchh
Confidence 888 9999999999999999999999999987544322211 12234689999999999876 455789
Q ss_pred cchhhhHHHHHHHhC----------CCCCCCCCCCCCcchhhhccccCCcchhhhhc-ccccCCCC-----CHHHHHHHH
Q 025816 144 DVYSFGVVLLELLTG----------RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV-DARLGGDY-----PPKAVAKMA 207 (247)
Q Consensus 144 DvwslG~~l~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~l~ 207 (247)
||||||+++|+|++| ..||.......... ..+.... ........ +...+..+.
T Consensus 205 DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 273 (301)
T 3q4u_A 205 DIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF-----------EDMRKVVCVDQQRPNIPNRWFSDPTLTSLA 273 (301)
T ss_dssp HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH-----------HHHHHHHTTSCCCCCCCGGGGGSHHHHHHH
T ss_pred hHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch-----------hhhhHHHhccCCCCCCChhhccCccHHHHH
Confidence 999999999999999 77775432221110 1111110 11111112 235678899
Q ss_pred HHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 208 AVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 208 ~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
+++.+||+.||.+|||++++++.|+++
T Consensus 274 ~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 274 KLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 999999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=288.57 Aligned_cols=208 Identities=26% Similarity=0.414 Sum_probs=170.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.. ...++||||+.+|+|.+++..... +++..++.++.|++.||.|||+.+
T Consensus 423 il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~yLH~~~--- 489 (635)
T 4fl3_A 423 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN--- 489 (635)
T ss_dssp HHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999998864 468899999999999999975432 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
|+||||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |
T Consensus 490 iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G 569 (635)
T 4fl3_A 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 569 (635)
T ss_dssp CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998755432221 11223346778999999999999999999999999999998 9
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
..||.... ...+.+.+........+..++.++.++|.+||+.||.+|||+++|++.|+.++..
T Consensus 570 ~~Pf~~~~----------------~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 570 QKPYRGMK----------------GSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCSSTTCC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCC----------------HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99996432 2334444445555556667788899999999999999999999999999988753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=269.29 Aligned_cols=214 Identities=20% Similarity=0.219 Sum_probs=164.5
Q ss_pred cccccCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 2 VSRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
+++++||||+++++++.. +...++||||+ +++|.+++.... .+++..++.++.|++.||.|||+.+
T Consensus 102 ~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ 171 (345)
T 2v62_A 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIHENE 171 (345)
T ss_dssp HHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 457899999999999988 67899999999 889999997654 2999999999999999999999999
Q ss_pred CCCeEeccCCCCceeecCCC--ceeeccccccCCcchhhhcc-----cccceeccccccCchhhhcCCCCccccchhhhH
Q 025816 78 DPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 150 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~--~~~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 150 (247)
++||||||+||+++.++ .++|+|||++.......... ......|+..|+|||.+.+..++.++||||||+
T Consensus 172 ---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 248 (345)
T 2v62_A 172 ---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGY 248 (345)
T ss_dssp ---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHH
T ss_pred ---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHH
Confidence 99999999999998887 99999999997654322111 113346899999999999988999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchh--hhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLV--TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
++|+|++|..||............ .......+ ..+... . .....+.++.+++.+||..||.+|||+++|+
T Consensus 249 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 320 (345)
T 2v62_A 249 CMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELP-QSVLKW----A---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALK 320 (345)
T ss_dssp HHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTT-HHHHHH----S---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHHHHhCCCCccccccccHHHHHHHHhhccccc-HHHHhh----c---cccccHHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999999999999632111100000 00000000 000000 0 0013455799999999999999999999999
Q ss_pred HHHHHhHh
Q 025816 229 KALQPLLN 236 (247)
Q Consensus 229 ~~l~~~~~ 236 (247)
+.|+.+.-
T Consensus 321 ~~L~~~~~ 328 (345)
T 2v62_A 321 KILNPHGI 328 (345)
T ss_dssp HHHCTTCC
T ss_pred HHHhccCC
Confidence 99987653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=271.49 Aligned_cols=226 Identities=23% Similarity=0.297 Sum_probs=173.7
Q ss_pred cccccCCCccceeeEEe--eCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCV--DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++. .....++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~-- 147 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLGSRR-- 147 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 67889999999999886 45678999999999999999976432 2899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||||+||+++.++.++|+|||.+......... .......++..|+|||.+.+..++.++||||||+++++|++|
T Consensus 148 -ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g 226 (327)
T 3lxl_A 148 -CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 226 (327)
T ss_dssp -EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred -ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999865433221 122334577889999999998899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
..||.......... ............+.+.+........+..++..+.+++.+||+.||.+|||++++++.|+.+....
T Consensus 227 ~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 227 CDKSCSPSAEFLRM-MGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp TCGGGSHHHHHHHH-CC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred CCCCccccchhhhh-cccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 99986432110000 00000111112333444444555566677788999999999999999999999999999887544
Q ss_pred C
Q 025816 239 P 239 (247)
Q Consensus 239 ~ 239 (247)
.
T Consensus 306 ~ 306 (327)
T 3lxl_A 306 R 306 (327)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=257.78 Aligned_cols=202 Identities=26% Similarity=0.302 Sum_probs=162.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+++..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ +
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i 126 (276)
T 2yex_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---I 126 (276)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567899999999999999999999999999999999987543 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+................++..|.|||.+.+..+ +.++|+||||+++++|++|..
T Consensus 127 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 206 (276)
T 2yex_A 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 206 (276)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred eccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876543222222234568899999999987665 778999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||......... ...+.............+..+.+++.+||+.||.+|||++++++
T Consensus 207 p~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 207 PWDQPSDSCQE--------------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp CCSCSCTTSHH--------------HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCchHHHH--------------HHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 99754322110 11111111111112344567999999999999999999999987
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=271.49 Aligned_cols=201 Identities=21% Similarity=0.303 Sum_probs=160.6
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
+||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ |+|||
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 178 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRD 178 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEecc
Confidence 899999999999999999999999999999999976432 999999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 165 (247)
|||+||+++.+|.+||+|||++....... .......||+.|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 179 LKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred CCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999997532221 1234467899999999999999999999999999999999999999643
Q ss_pred CCCCCcchhhhccccCCcchh-hhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH------HHHHH
Q 025816 166 LPRGQQSLVTWATPKLSEDKV-RQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM------SIVVK 229 (247)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~~il~ 229 (247)
....... ......+ ..+... ....+...+.++.++|.+||+.||.+||++ +++++
T Consensus 257 ~~~~~~~-------~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 257 GSSDNPD-------QNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp TC-------------CCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ccccccc-------hhhHHHHHHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 2211100 0000111 111111 123455567789999999999999999995 66665
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=270.54 Aligned_cols=201 Identities=22% Similarity=0.274 Sum_probs=162.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.++...++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 101 il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g--- 169 (387)
T 1kob_A 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS--- 169 (387)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999999999999875432 2899999999999999999999999
Q ss_pred eEeccCCCCceeecC--CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIFD--DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++||||||+||+++. .+.++|+|||++........ .....+|..|+|||++.+..++.++||||||+++|+|++|
T Consensus 170 ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 246 (387)
T 1kob_A 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246 (387)
T ss_dssp EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred eeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhC
Confidence 999999999999974 46799999999976543221 2334689999999999998899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhccc--ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA--RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..||....... ....+... ..........+.++.++|.+||..||.+|||++++++.
T Consensus 247 ~~Pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 247 LSPFAGEDDLE---------------TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCSSCCSSHHH---------------HHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCHHH---------------HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 99997542210 00111000 01112223456679999999999999999999999973
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=261.68 Aligned_cols=206 Identities=30% Similarity=0.469 Sum_probs=162.9
Q ss_pred cccccCCCccceeeEEeeC-CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDG-TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++||||+++++++... ...++||||+.+++|.+++...... .+++..++.++.|++.||.|||+.+
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~--- 137 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN--- 137 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6789999999999987554 4789999999999999999754321 2788899999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++|+||+|+||+++.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 138 i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 212 (278)
T 1byg_A 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212 (278)
T ss_dssp CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987543321 22346778999999999899999999999999999998 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
.||..... ..+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 213 ~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 213 VPYPRIPL----------------KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CSCTTSCG----------------GGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCCH----------------HHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 99964321 1122222222233444556678999999999999999999999999999987643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=266.42 Aligned_cols=196 Identities=26% Similarity=0.332 Sum_probs=160.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+ +|+|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---i 129 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR---------MTEDEGRRFFQQIICAIEYCHRHK---I 129 (336)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHT---C
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 67899999999999999999999999999 5799998865432 999999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~ 160 (247)
+||||||+||+++.++.+||+|||++........ .....|++.|+|||.+.+..+ +.++||||||+++|+|++|..
T Consensus 130 vH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 206 (336)
T 3h4j_B 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206 (336)
T ss_dssp CCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSC
T ss_pred EecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876543221 234568999999999988776 689999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||.......... .+.. .....+...+..+.+++.+||..||.+|||++++++.
T Consensus 207 Pf~~~~~~~~~~----------------~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 207 PFDDEFIPNLFK----------------KVNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SSBCSSSTTCBC----------------CCCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCCccHHHHHH----------------HHHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 997542211110 0000 0112334456679999999999999999999999983
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=261.99 Aligned_cols=223 Identities=20% Similarity=0.264 Sum_probs=169.9
Q ss_pred cccccCCCccceeeEEeeCC--eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGT--SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
|++++||||+++++++.... ..++||||+.+++|.+++...... ..+++..++.++.|++.||.|||+.+
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~-- 132 (319)
T 4euu_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG-- 132 (319)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 57889999999999988765 789999999999999999865421 12899999999999999999999999
Q ss_pred CeEeccCCCCceee----cCCCceeeccccccCCcchhhhcccccceeccccccCchhhh--------cCCCCccccchh
Q 025816 80 HIIHRDIKSSNVLI----FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--------TGQLNAKSDVYS 147 (247)
Q Consensus 80 ~i~h~di~~~nil~----~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dvws 147 (247)
++||||||+||++ +.++.+||+|||++........ .....++..|+|||.+. +..++.++||||
T Consensus 133 -ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diws 208 (319)
T 4euu_A 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS 208 (319)
T ss_dssp -EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHH
T ss_pred -EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHH
Confidence 9999999999999 7788899999999976543222 13346899999999986 467899999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCC-CcchhhhccccCCcchhhh---hc--------ccccCCCCCHHHHHHHHHHHHhhcc
Q 025816 148 FGVVLLELLTGRKPVDHTLPRG-QQSLVTWATPKLSEDKVRQ---CV--------DARLGGDYPPKAVAKMAAVAALCVQ 215 (247)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~---~~--------~~~~~~~~~~~~~~~l~~li~~cl~ 215 (247)
||+++|+|++|..||....... ............+...+.. .. ........+...+..+.+++.+||+
T Consensus 209 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~ 288 (319)
T 4euu_A 209 IGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288 (319)
T ss_dssp HHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhcc
Confidence 9999999999999997543221 1111111111111000000 00 0011124556888899999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhHh
Q 025816 216 YEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 216 ~~p~~Rps~~~il~~l~~~~~ 236 (247)
.||.+|||++|+++..++-..
T Consensus 289 ~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 289 ADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CCTTTSCCHHHHHHHHHHHTC
T ss_pred CChhhhccHHHhhhccHHHhh
Confidence 999999999999999886543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=270.67 Aligned_cols=218 Identities=19% Similarity=0.262 Sum_probs=161.3
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..++..++||||+.+|+|.+++....... +++..+..++.|++.||.|||+.+
T Consensus 79 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~LH~~~--- 148 (389)
T 3gni_B 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-------MNELAIAYILQGVLKALDYIHHMG--- 148 (389)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccC-------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678899999999999999999999999999999999997654322 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc-----ccccceeccccccCchhhhc--CCCCccccchhhhHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ 153 (247)
|+||||||+||+++.++.++|+|||.+......... .......|+..|+|||++.+ ..++.++|||||||++|
T Consensus 149 ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~ 228 (389)
T 3gni_B 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228 (389)
T ss_dssp EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHH
Confidence 999999999999999999999999987644322111 11122467888999999987 57899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCC---------cchh-------------hhhcc---------cccCCCCCHHH
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLS---------EDKV-------------RQCVD---------ARLGGDYPPKA 202 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~~-------------~~~~~---------~~~~~~~~~~~ 202 (247)
+|++|..||.......... ........ .... ..... .......+...
T Consensus 229 el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (389)
T 3gni_B 229 ELANGHVPFKDMPATQMLL--EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306 (389)
T ss_dssp HHHHSSCTTTTCCSTTHHH--HC--------------------------------------------------------C
T ss_pred HHHHCCCCCCCCCHHHHHH--HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccccc
Confidence 9999999997643322110 00000000 0000 00000 00000122344
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 203 VAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 203 ~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
+..+.++|.+||+.||.+|||++++++.
T Consensus 307 s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 307 SPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 5679999999999999999999999973
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=269.66 Aligned_cols=203 Identities=21% Similarity=0.284 Sum_probs=152.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+.+|+|.+++..... +++..++.++.|++.||.|||+.+ |
T Consensus 70 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~ql~~~L~~LH~~~---i 137 (361)
T 3uc3_A 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR---------FSEDEARFFFQQLLSGVSYCHSMQ---I 137 (361)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999865432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCc--eeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCcc-ccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDV--AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAK-SDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g 158 (247)
+||||||+||+++.++. +||+|||+++....... .....||..|+|||++.+..++.+ +||||||+++|+|++|
T Consensus 138 vH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 214 (361)
T 3uc3_A 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214 (361)
T ss_dssp CSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHS
T ss_pred ccCCCCHHHEEEcCCCCceEEEeecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhC
Confidence 99999999999987765 99999999874322211 233468999999999988887655 8999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..||.......... ..+................+..+.++|.+||+.||.+|||++++++.
T Consensus 215 ~~Pf~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 215 AYPFEDPEEPRDYR-----------KTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp SCSCC----CCCHH-----------HHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCCccHHHHH-----------HHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 99997543221111 11111111111111122345679999999999999999999999984
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=261.63 Aligned_cols=208 Identities=25% Similarity=0.376 Sum_probs=164.0
Q ss_pred cccccCCCccceeeEEee----------------CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHH
Q 025816 2 VSRLKHENFVQLLGYCVD----------------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 65 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 65 (247)
+++++||||+++++++.. ....++||||+.+++|.+++....... +++..++.++.|
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~i~~q 130 (284)
T 2a19_B 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-------LDKVLALELFEQ 130 (284)
T ss_dssp HHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSC-------CCHHHHHHHHHH
T ss_pred HHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCC-------CCHHHHHHHHHH
Confidence 577899999999998864 345799999999999999997543222 899999999999
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccc
Q 025816 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDV 145 (247)
Q Consensus 66 ~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 145 (247)
++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+
T Consensus 131 i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (284)
T 2a19_B 131 ITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDL 204 (284)
T ss_dssp HHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHH
T ss_pred HHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhh
Confidence 999999999999 99999999999999999999999999876543221 233458899999999999899999999
Q ss_pred hhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 146 YSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 146 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
||||+++|+|++|..|+.... ........ ...+...+..+.+++.+||+.||.+|||+.
T Consensus 205 ~slG~il~~l~~~~~~~~~~~-----------------~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 263 (284)
T 2a19_B 205 YALGLILAELLHVCDTAFETS-----------------KFFTDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTS 263 (284)
T ss_dssp HHHHHHHHHHHSCCSSHHHHH-----------------HHHHHHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHHhcCCcchhHH-----------------HHHHHhhc----ccccccCCHHHHHHHHHHccCChhhCcCHH
Confidence 999999999999988863110 00111111 112233456689999999999999999999
Q ss_pred HHHHHHHHhHhcCCCCCC
Q 025816 226 IVVKALQPLLNARPGPAG 243 (247)
Q Consensus 226 ~il~~l~~~~~~~~~~~~ 243 (247)
++++.+..+.++......
T Consensus 264 e~l~~l~~~~~~~~~~~~ 281 (284)
T 2a19_B 264 EILRTLTVWKKSPEKNER 281 (284)
T ss_dssp HHHHHHHHHTC-------
T ss_pred HHHHHHHHHhhCCCcccc
Confidence 999999998876654443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=267.40 Aligned_cols=195 Identities=19% Similarity=0.273 Sum_probs=163.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.++...++||||+.+|+|.+++..... +++..++.++.|++.||.|||+.+
T Consensus 94 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~--- 161 (350)
T 1rdq_E 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD--- 161 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999976432 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.+|.++|+|||++...... .....||..|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 162 ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (350)
T 1rdq_E 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236 (350)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCC
Confidence 999999999999999999999999998765322 234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~ 229 (247)
||...... .....+.... ...+...+.++.++|.+||+.||.+||+ +++|++
T Consensus 237 Pf~~~~~~---------------~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 237 PFFADQPI---------------QIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SSCCSSHH---------------HHHHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHH---------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 99744211 1111111111 2234455678999999999999999999 888886
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=270.13 Aligned_cols=196 Identities=20% Similarity=0.231 Sum_probs=161.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++.+.+..++||||+.+|+|.+++..... +++..++.++.|++.||.|||+.+ |
T Consensus 93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---i 160 (373)
T 2r5t_A 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---I 160 (373)
T ss_dssp BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5789999999999999999999999999999999999976432 889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.+|.+||+|||++....... .......||..|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus 161 vHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P 238 (373)
T 2r5t_A 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238 (373)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999987532211 122445789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
|...... .....+.... ...+...+..+.++|.+||+.||.+||++.+.+
T Consensus 239 f~~~~~~---------------~~~~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 239 FYSRNTA---------------EMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp TCCSBHH---------------HHHHHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred CCCCCHH---------------HHHHHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 9643211 1111222211 123344567799999999999999999985433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=274.09 Aligned_cols=200 Identities=24% Similarity=0.324 Sum_probs=164.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++.+....++||||+.+|+|.+++.... .+++..++.++.|++.||.|||+.+ |
T Consensus 70 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---i 137 (476)
T 2y94_A 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCHRHM---V 137 (476)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS---------SCCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 678999999999999999999999999999999999997543 2999999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~ 160 (247)
+||||||+||+++.++.+||+|||++........ .....|+..|+|||.+.+..+ +.++||||||+++|+|++|..
T Consensus 138 vHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~ 214 (476)
T 2y94_A 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTL 214 (476)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred CcccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCC
Confidence 9999999999999999999999999876543221 234568999999999988765 689999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQP 233 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~ 233 (247)
||...... .....+.... ...+...+.++.++|.+||..||.+|||++++++ .++.
T Consensus 215 Pf~~~~~~---------------~~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 215 PFDDDHVP---------------TLFKKICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp SSCCSSSH---------------HHHHHHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred CCCCCCHH---------------HHHHHHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 99743211 1111111111 1223344567999999999999999999999998 4443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=265.40 Aligned_cols=223 Identities=22% Similarity=0.311 Sum_probs=163.4
Q ss_pred cccccCCCccceeeEEee-----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 2 VSRLKHENFVQLLGYCVD-----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
++.++||||+++++.+.. ....++||||+.+|+|.+++.... .++..++.++.|++.||.|||+.
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~ 130 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTE 130 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhh
Confidence 456899999999986532 235789999999999999997654 78899999999999999999999
Q ss_pred ---------CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhh------cccccceeccccccCchhhhc-----
Q 025816 77 ---------ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA------RLHSTRVLGTFGYHAPEYAMT----- 136 (247)
Q Consensus 77 ---------~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~----- 136 (247)
+ |+||||||+||+++.++.+||+|||++........ ........||..|+|||++.+
T Consensus 131 ~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (336)
T 3g2f_A 131 LPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207 (336)
T ss_dssp BCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG
T ss_pred hccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc
Confidence 8 99999999999999999999999999976533211 111123458999999999976
Q ss_pred --CCCCccccchhhhHHHHHHHhCCCCCCCCCCCCC-cchhh-hccccCCcchhhhhcc-cccCCCC------CHHHHHH
Q 025816 137 --GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSLVT-WATPKLSEDKVRQCVD-ARLGGDY------PPKAVAK 205 (247)
Q Consensus 137 --~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~ 205 (247)
..++.++||||||+++|+|++|..||........ ..... ..........+..... ...+... ....+..
T Consensus 208 ~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
T 3g2f_A 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287 (336)
T ss_dssp GHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHH
T ss_pred cccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHH
Confidence 3566789999999999999999777643322211 11111 1111111111111111 1111111 2346778
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 206 MAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 206 l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
+.++|.+||+.||.+|||++++++.|++++..
T Consensus 288 l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 99999999999999999999999999998843
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=258.02 Aligned_cols=196 Identities=29% Similarity=0.418 Sum_probs=160.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---i 130 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR---V 130 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---C
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 6788999999999999999999999999999999999876432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++||||||+++++|++|..|
T Consensus 131 ~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 206 (279)
T 3fdn_A 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206 (279)
T ss_dssp EECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred ecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCC
Confidence 999999999999999999999999886543322 1334678999999999998899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|....... ...... ......+...+..+.+++.+||+.||.+|||++++++.
T Consensus 207 ~~~~~~~~---------------~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 207 FEANTYQE---------------TYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TCCSSHHH---------------HHHHHH--HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcHHH---------------HHHHHH--hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 96432110 001110 11122334456679999999999999999999999984
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=273.93 Aligned_cols=198 Identities=20% Similarity=0.267 Sum_probs=163.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~ 79 (247)
++++++||||+++++++...+..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+ .+
T Consensus 201 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~g-- 269 (446)
T 4ejn_A 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKN-- 269 (446)
T ss_dssp CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHHTC--
T ss_pred HHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHhhcCC--
Confidence 47889999999999999999999999999999999999976432 8999999999999999999998 88
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
|+||||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 270 -iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 346 (446)
T 4ejn_A 270 -VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346 (446)
T ss_dssp -CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred -EEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCC
Confidence 99999999999999999999999999975432222 123456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK 229 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~ 229 (247)
.||...+.. .....+... ....+...+.++.++|.+||+.||.+|| |++++++
T Consensus 347 ~Pf~~~~~~---------------~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 347 LPFYNQDHE---------------KLFELILME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CSSCCSSHH---------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCHH---------------HHHHHHHhC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 999643211 111111111 1123444567799999999999999999 9999997
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=262.06 Aligned_cols=216 Identities=26% Similarity=0.382 Sum_probs=158.8
Q ss_pred CcccccCCCccceeeEEeeCCe----eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTS----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
++++++||||+++++++..... .++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.
T Consensus 65 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~ 135 (311)
T 3ork_A 65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQN 135 (311)
T ss_dssp TCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4788999999999999876543 499999999999999997543 289999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
+ ++|+||||+||+++.++.++|+|||++......... .......|+..|+|||.+.+..++.++||||||+++|+|
T Consensus 136 ~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 212 (311)
T 3ork_A 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212 (311)
T ss_dssp T---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred C---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHH
Confidence 9 999999999999999999999999999865433221 122334689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCC--CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH-HHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVV-KALQ 232 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il-~~l~ 232 (247)
++|..||....... ...+........ ......+.++.+++.+||+.||.+||++.+++ ..+.
T Consensus 213 l~g~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 213 LTGEPPFTGDSPVS---------------VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp HHSSCSCCCSSHHH---------------HHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HhCCCCCCCCChHH---------------HHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 99999997543211 000111000000 00112456799999999999999999765555 4666
Q ss_pred HhHhcCCCCCC
Q 025816 233 PLLNARPGPAG 243 (247)
Q Consensus 233 ~~~~~~~~~~~ 243 (247)
......+++++
T Consensus 278 ~~~~~~~~~~~ 288 (311)
T 3ork_A 278 RVHNGEPPEAP 288 (311)
T ss_dssp HHHTTCCCSSC
T ss_pred HHhcCCCCCCC
Confidence 66655554443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=268.63 Aligned_cols=200 Identities=22% Similarity=0.270 Sum_probs=160.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+.+++|.+.+...... +..+++..++.++.|++.||.|||+++ |
T Consensus 80 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---i 151 (351)
T 3c0i_A 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDNN---I 151 (351)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 56789999999999999999999999999999998887643211 123899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCc---eeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDV---AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~---~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+||||||+||+++.++. ++|+|||++........ ......||..|+|||++.+..++.++||||||+++|+|++|
T Consensus 152 vHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (351)
T 3c0i_A 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229 (351)
T ss_dssp ECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred eeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHC
Confidence 99999999999987654 99999999976543221 12345689999999999998999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||..... .....+..... ..+ ...+.++.++|.+||..||.+|||+.++++
T Consensus 230 ~~pf~~~~~----------------~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 230 CLPFYGTKE----------------RLFEGIIKGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp SCSSCSSHH----------------HHHHHHHHTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCcHH----------------HHHHHHHcCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999975311 00111111111 011 123567999999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=260.93 Aligned_cols=215 Identities=20% Similarity=0.276 Sum_probs=158.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.++...++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~--- 120 (288)
T 1ob3_A 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCHDRR--- 120 (288)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 47889999999999999999999999999975 99999876432 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++||||||+||+++.++.+||+|||.+........ ......+|..|+|||.+.+. .++.++||||||+++|+|++|.
T Consensus 121 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 198 (288)
T 1ob3_A 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (288)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999865432111 11234578999999999764 5899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhh-----hcccccC-------CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQ-----CVDARLG-------GDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
.||.......................+.. ..+.... .......+.++.+++.+||+.||.+|||++++
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 278 (288)
T 1ob3_A 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278 (288)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 99975432211110000000000000000 0000000 01122345678999999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
++
T Consensus 279 l~ 280 (288)
T 1ob3_A 279 LE 280 (288)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=269.83 Aligned_cols=204 Identities=17% Similarity=0.243 Sum_probs=155.5
Q ss_pred ccccCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 3 SRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+..+||||+++++++.. +...++||||+.+|+|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 110 ~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~- 181 (400)
T 1nxk_A 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN- 181 (400)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 44689999999999876 56789999999999999999875432 2999999999999999999999999
Q ss_pred CCeEeccCCCCceeecC---CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 79 PHIIHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
|+||||||+||+++. ++.+||+|||++........ .....||..|+|||++.+..++.++||||||+++|+|
T Consensus 182 --ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 256 (400)
T 1nxk_A 182 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256 (400)
T ss_dssp --EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHH
T ss_pred --ccccCcCcceEEEecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHH
Confidence 999999999999987 78899999999875533221 2345679999999999988999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|..||.......... .....+...... .......+.++.++|.+||+.||.+|||++++++.
T Consensus 257 l~g~~pf~~~~~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 257 LCGYPPFYSNHGLAISP-----------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHSSCSCCCCTTCSSCC-----------SHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HhCCCCCCCCccccccH-----------HHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 99999997654322110 000111111111 01112456679999999999999999999999984
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=260.50 Aligned_cols=215 Identities=20% Similarity=0.244 Sum_probs=158.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.++...++||||+.+ ++.+.+..... .+++..++.++.|++.||.|||+.+
T Consensus 54 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~--- 121 (292)
T 3o0g_A 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHSRN--- 121 (292)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999975 67666654332 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC-CCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~ 159 (247)
++||||||+||+++.++.++|+|||.+........ ......+|..|+|||.+.+.. ++.++||||+|+++|+|++|.
T Consensus 122 ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~ 199 (292)
T 3o0g_A 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred eecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999976532211 123346789999999998765 799999999999999999988
Q ss_pred CCCCCCCC-CCCcchhhhccccCCcchhhhhc------------ccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 160 KPVDHTLP-RGQQSLVTWATPKLSEDKVRQCV------------DARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 160 ~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
.||..... ..................+.... ............+.++.+++.+||+.||.+|||++|
T Consensus 200 ~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 279 (292)
T 3o0g_A 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp CCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHH
Confidence 77532221 11100000000000100000000 000011122345677999999999999999999999
Q ss_pred HHH
Q 025816 227 VVK 229 (247)
Q Consensus 227 il~ 229 (247)
+++
T Consensus 280 ~l~ 282 (292)
T 3o0g_A 280 ALQ 282 (292)
T ss_dssp HHT
T ss_pred Hhc
Confidence 987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=260.67 Aligned_cols=212 Identities=21% Similarity=0.283 Sum_probs=160.2
Q ss_pred cccCCCccceeeEEeeCC-----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 4 RLKHENFVQLLGYCVDGT-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+++||||+++++++.... ..+++|||+. ++|.+++....... +++..++.++.|++.||.|||+.+
T Consensus 70 ~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~-------~~~~~~~~i~~qi~~al~~lH~~~- 140 (308)
T 3g33_A 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPG-------LPAETIKDLMRQFLRGLDFLHANC- 140 (308)
T ss_dssp HHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTC-------SCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCC-------CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 345999999999998765 5799999997 59999998765432 899999999999999999999999
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++||||||+||+++.++.++|+|||.+........ .....+|..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 141 --ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 215 (308)
T 3g33_A 141 --IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215 (308)
T ss_dssp --CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTS
T ss_pred --cccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999976533221 2345689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhc---ccccCC-------CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV---DARLGG-------DYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
..||.......................+.... ...... ....+.+..+.+++.+||+.||.+|||+++++
T Consensus 216 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 216 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 99997654322111111111111111000000 000000 01123456799999999999999999999998
Q ss_pred H
Q 025816 229 K 229 (247)
Q Consensus 229 ~ 229 (247)
+
T Consensus 296 ~ 296 (308)
T 3g33_A 296 Q 296 (308)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=264.52 Aligned_cols=197 Identities=23% Similarity=0.307 Sum_probs=159.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++..+...++||||+.+++|.+++..... +++..+..++.|++.||.|||+.+ |
T Consensus 75 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---i 142 (327)
T 3a62_A 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI---------FMEDTACFYLAEISMALGHLHQKG---I 142 (327)
T ss_dssp HHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 5778999999999999999999999999999999999975432 889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 143 vH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 220 (327)
T 3a62_A 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220 (327)
T ss_dssp CCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EcccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCC
Confidence 9999999999999999999999999875432221 12334689999999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~ 229 (247)
|...... ..+..+... ....+...+.++.+++.+||..||.+|| +++++++
T Consensus 221 f~~~~~~---------------~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 221 FTGENRK---------------KTIDKILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCCSSHH---------------HHHHHHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCHH---------------HHHHHHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 9753211 111111111 1123445567899999999999999999 7888887
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=265.04 Aligned_cols=199 Identities=24% Similarity=0.307 Sum_probs=153.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++..+...++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 102 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~L~~LH~~~---i 169 (349)
T 2w4o_A 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY---------YSERDAADAVKQILEAVAYLHENG---I 169 (349)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5788999999999999999999999999999999999976432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecC---CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+||||||+||+++. ++.++|+|||++........ .....|+..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 170 vH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 246 (349)
T 2w4o_A 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246 (349)
T ss_dssp CCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EecCCCcccEEEecCCCCCCEEEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 99999999999975 88999999999886543221 2335689999999999998999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||....... . ....+..... ........+.++.+++.+||..||.+|||+.++++
T Consensus 247 ~~pf~~~~~~~--~------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 247 FEPFYDERGDQ--F------------MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp SCTTCCTTCHH--H------------HHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccH--H------------HHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99996432210 0 0111111111 01112345667999999999999999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=268.32 Aligned_cols=200 Identities=22% Similarity=0.287 Sum_probs=161.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++..++..++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 139 ~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~--- 207 (373)
T 2x4f_A 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY--------NLTELDTILFMKQICEGIRHMHQMY--- 207 (373)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999998865432 2899999999999999999999999
Q ss_pred eEeccCCCCceee--cCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLI--FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~--~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
|+||||||+||++ +.++.++|+|||++........ .....||..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 208 ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 284 (373)
T 2x4f_A 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284 (373)
T ss_dssp EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHS
T ss_pred cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhC
Confidence 9999999999999 5677899999999986543222 2334689999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||....... .+.++...... .......+.++.++|.+||+.||.+|||++++++
T Consensus 285 ~~pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 285 LSPFLGDNDAE---------------TLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCTTCCSSHHH---------------HHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHH---------------HHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99997543211 11111111100 0111234567999999999999999999999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=264.28 Aligned_cols=221 Identities=22% Similarity=0.280 Sum_probs=164.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..++..++||||+. ++|.+++....... ....+++..+..++.|++.||.|||+.+
T Consensus 56 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~--- 128 (317)
T 2pmi_A 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHENK--- 128 (317)
T ss_dssp HHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999998 59999886543211 1123889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++||||||+||+++.++.+||+|||.+........ ......+|..|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 129 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 206 (317)
T 2pmi_A 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206 (317)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred eeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999876532211 1233467899999999976 46899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCC---------------------cchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLS---------------------EDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEA 218 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 218 (247)
.||.................... ...+.+.+.... ....+.++.+++.+||+.||
T Consensus 207 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP 282 (317)
T 2pmi_A 207 PLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNP 282 (317)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSG
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCc
Confidence 99976543211111110000000 000111111111 11234579999999999999
Q ss_pred CCCCCHHHHHH--HHHHh
Q 025816 219 DFRPNMSIVVK--ALQPL 234 (247)
Q Consensus 219 ~~Rps~~~il~--~l~~~ 234 (247)
.+|||++++++ ++++.
T Consensus 283 ~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 283 DMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp GGSCCHHHHTTSGGGGGG
T ss_pred ccCCCHHHHhCChhhhcc
Confidence 99999999997 34443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=266.34 Aligned_cols=221 Identities=20% Similarity=0.295 Sum_probs=161.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+. |+|.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---i 121 (324)
T 3mtl_A 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCHRQK---V 121 (324)
T ss_dssp HSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 678999999999999999999999999997 499998876432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+||||||+||+++.++.++|+|||++......... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..
T Consensus 122 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 199 (324)
T 3mtl_A 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199 (324)
T ss_dssp EESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCcCHHHEEECCCCCEEEccCcccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998754332221 233467899999999876 568999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhccc---------ccCC----CCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA---------RLGG----DYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
||.+.....................+...... .... ......+.++.+++.+||+.||.+|||++|+
T Consensus 200 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 279 (324)
T 3mtl_A 200 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279 (324)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH
Confidence 99765432221111111111111111111100 0000 0112345678999999999999999999999
Q ss_pred HH--HHHHhHh
Q 025816 228 VK--ALQPLLN 236 (247)
Q Consensus 228 l~--~l~~~~~ 236 (247)
++ ++..+..
T Consensus 280 l~hp~f~~~~~ 290 (324)
T 3mtl_A 280 MKHPFFLSLGE 290 (324)
T ss_dssp TTSGGGGGGCS
T ss_pred hcChhhhhccc
Confidence 98 5555443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=257.40 Aligned_cols=204 Identities=30% Similarity=0.518 Sum_probs=163.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+.. ++||||+.+++|.+.+..... .+++..++.++.|++.||.|||+.+ .++
T Consensus 77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~-~~i 145 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH--------PIKWSVKLRLMLDIALGIEYMQNQN-PPI 145 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccC--------CccHHHHHHHHHHHHHHHHHHHhCC-CCe
Confidence 67889999999999987665 699999999999998865442 2899999999999999999999985 239
Q ss_pred EeccCCCCceeecCCCc-----eeeccccccCCcchhhhcccccceeccccccCchhhh--cCCCCccccchhhhHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDV-----AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--TGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~-----~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~~ 154 (247)
+|+||||+||+++.++. ++|+|||++...... .....++..|+|||.+. ...++.++||||||+++|+
T Consensus 146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~ 220 (287)
T 4f0f_A 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT 220 (287)
T ss_dssp BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHH
Confidence 99999999999988776 999999998754331 23346889999999984 4457889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
|++|..||........ ...............+...+..+.+++.+||+.||.+|||++++++.|+++
T Consensus 221 l~~g~~pf~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 221 ILTGEGPFDEYSYGKI-------------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHSSCTTTTCCCCHH-------------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHcCCCCCccccccHH-------------HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 9999999964422111 111222223333344556677899999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=256.97 Aligned_cols=204 Identities=27% Similarity=0.386 Sum_probs=166.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 68 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 135 (284)
T 2vgo_A 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---------FDEQRSATFMEELADALHYCHERK---V 135 (284)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5788999999999999999999999999999999999976432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 136 ~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 211 (284)
T 2vgo_A 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211 (284)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred eecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCC
Confidence 999999999999999999999999886543221 2334688999999999998899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhHhcC
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLNAR 238 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~~~~~~ 238 (247)
|....... ........ ....+...+..+.+++.+||+.||.+|||++++++ +++......
T Consensus 212 f~~~~~~~---------------~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~ 273 (284)
T 2vgo_A 212 FDSPSHTE---------------THRRIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273 (284)
T ss_dssp TCCSSHHH---------------HHHHHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred CCCCCHhH---------------HHHHHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence 96432110 01111111 11233445677999999999999999999999998 555444333
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=262.52 Aligned_cols=214 Identities=22% Similarity=0.300 Sum_probs=159.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++......+++|||+.+++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~--- 150 (319)
T 2y4i_B 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--------VLDVNKTRQIAQEIVKGMGYLHAKG--- 150 (319)
T ss_dssp GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCC--------CCCSHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 46789999999999999999999999999999999999976432 2889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc---ccccceeccccccCchhhhc---------CCCCccccchhh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR---LHSTRVLGTFGYHAPEYAMT---------GQLNAKSDVYSF 148 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Dvwsl 148 (247)
++|+||+|+||+++ ++.++|+|||++......... .......|+..|+|||.+.+ ..++.++|||||
T Consensus 151 i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~sl 229 (319)
T 2y4i_B 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229 (319)
T ss_dssp CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHH
T ss_pred ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHH
Confidence 99999999999998 679999999998755322211 11223458889999999875 347889999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
|+++|+|++|..||....... ..................+..+.+++.+||..||.+|||+++++
T Consensus 230 G~il~el~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~ 294 (319)
T 2y4i_B 230 GTIWYELHAREWPFKTQPAEA---------------IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLM 294 (319)
T ss_dssp HHHHHHHHHSSCSSSSCCHHH---------------HHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHH---------------HHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 999999999999996432110 00011111111111123345699999999999999999999999
Q ss_pred HHHHHhHhcCCCC
Q 025816 229 KALQPLLNARPGP 241 (247)
Q Consensus 229 ~~l~~~~~~~~~~ 241 (247)
+.|+.+.+.....
T Consensus 295 ~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 295 DMLEKLPKRNRRL 307 (319)
T ss_dssp HHHTTC-------
T ss_pred HHHHHHHHhhccC
Confidence 9999888665443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=261.98 Aligned_cols=192 Identities=24% Similarity=0.293 Sum_probs=160.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCC-ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+|++++||||+++++++.++...++||||+.+| +|.+++..... +++..++.++.|++.||.|||+.+
T Consensus 82 ~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~-- 150 (335)
T 3dls_A 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---------LDEPLASYIFRQLVSAVGYLRLKD-- 150 (335)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCC---------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 367899999999999999999999999998766 99999986542 999999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g 158 (247)
++||||||+||+++.++.++|+|||++........ .....||..|+|||.+.+..+ +.++||||||+++|+|++|
T Consensus 151 -ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 226 (335)
T 3dls_A 151 -IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226 (335)
T ss_dssp -EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHS
T ss_pred -eEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhC
Confidence 99999999999999999999999999876543221 234568999999999988776 7899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..||...... .... ...+...+.++.+++.+||+.||.+|||++++++.
T Consensus 227 ~~pf~~~~~~---------------------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 227 ENPFCELEET---------------------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SCSCSSGGGG---------------------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CCchhhHHHH---------------------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999642110 0000 01122245679999999999999999999999984
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=272.85 Aligned_cols=200 Identities=18% Similarity=0.241 Sum_probs=162.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++.++...++||||+.+|+|.+++.... +++..+..++.|++.||.|||+.+ |
T Consensus 123 l~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~g---i 189 (410)
T 3v8s_A 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---F 189 (410)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 567899999999999999999999999999999999997643 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC----CCccccchhhhHHHHHHHh
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~~l~~ 157 (247)
+||||||+||+++.+|.+||+|||++........ .......||+.|+|||++.+.. ++.++|+||||+++|+|++
T Consensus 190 vHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~ 268 (410)
T 3v8s_A 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268 (410)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred EeccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence 9999999999999999999999999976543221 1223457999999999998765 7899999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC--HHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADF--RPNMSIVVKA 230 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--Rps~~~il~~ 230 (247)
|..||...+.. .....+.........+ ...+.++.++|.+||..+|.+ ||++++|++.
T Consensus 269 G~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 269 GDTPFYADSLV---------------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp SSCTTCCSSHH---------------HHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCCCCCCCChh---------------hHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 99999754321 1111222111111111 235677999999999999988 9999999983
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=262.16 Aligned_cols=214 Identities=21% Similarity=0.279 Sum_probs=157.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~i~~~l~~~l~~lH~~~---i 123 (311)
T 4agu_A 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG---------VPEHLVKSITWQTLQAVNFCHKHN---C 123 (311)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSC---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcC---------CCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 5778999999999999999999999999999899988875432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+ ..++.++|+||+|+++++|++|..
T Consensus 124 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 201 (311)
T 4agu_A 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201 (311)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999765432221 133467889999999986 568999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhh-----hccc----ccCCCC-----CHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQ-----CVDA----RLGGDY-----PPKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~----~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
||.......................... .... ...... ....+..+.+++.+||+.||.+|||+++
T Consensus 202 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 281 (311)
T 4agu_A 202 LWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281 (311)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHH
Confidence 9976543222111111100000000000 0000 000000 0234566999999999999999999999
Q ss_pred HHH
Q 025816 227 VVK 229 (247)
Q Consensus 227 il~ 229 (247)
+++
T Consensus 282 ll~ 284 (311)
T 4agu_A 282 LLH 284 (311)
T ss_dssp HHT
T ss_pred Hhc
Confidence 987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=268.47 Aligned_cols=225 Identities=23% Similarity=0.317 Sum_probs=170.0
Q ss_pred cccccCCCccceeeEEeeCC--eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGT--SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++.... ..++||||+.+++|.+++..... .+++..++.++.|++.||.+||+.+
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~-- 165 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR-- 165 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 67889999999999987654 78999999999999999976532 2899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++++|++|
T Consensus 166 -ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg 244 (326)
T 2w1i_A 166 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244 (326)
T ss_dssp -EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHT
T ss_pred -EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987654332211 12233467789999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
..||.......................+.+.+........+..++..+.++|.+||+.||.+|||++++++.|+.+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 245 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 9987532100000000000000001112233333333344556677899999999999999999999999999988754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=264.42 Aligned_cols=197 Identities=22% Similarity=0.266 Sum_probs=161.9
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
|+.+ +||||+++++++.+....++||||+.+|+|.+++..... +++..++.++.|++.||.|||+.+
T Consensus 74 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g--- 141 (353)
T 2i0e_A 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG--- 141 (353)
T ss_dssp HTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3445 899999999999999999999999999999999975432 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.+|.++|+|||++........ ......||..|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 142 ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 219 (353)
T 2i0e_A 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219 (353)
T ss_dssp CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCC
Confidence 99999999999999999999999999875332211 2234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~ 229 (247)
||...+.. .....+.... ...+...+.++.++|.+||..||.+||+ ++++++
T Consensus 220 Pf~~~~~~---------------~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 220 PFEGEDED---------------ELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp SSCCSSHH---------------HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCCHH---------------HHHHHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 99754211 1111111111 2334456678999999999999999995 577776
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=259.83 Aligned_cols=212 Identities=26% Similarity=0.396 Sum_probs=166.1
Q ss_pred cccCCCccceeeEEeeCC----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh-----
Q 025816 4 RLKHENFVQLLGYCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH----- 74 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh----- 74 (247)
+++||||+++++++.... ..++||||+.+|+|.+++.... +++..++.++.|++.||.|||
T Consensus 92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~ 161 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVG 161 (342)
T ss_dssp CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhh
Confidence 379999999999998876 7899999999999999997643 899999999999999999999
Q ss_pred ---cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcc--cccceeccccccCchhhhcC------CCCccc
Q 025816 75 ---EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMTG------QLNAKS 143 (247)
Q Consensus 75 ---~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~ 143 (247)
+.+ ++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+. .++.++
T Consensus 162 ~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 238 (342)
T 1b6c_B 162 TQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238 (342)
T ss_dssp TTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHH
T ss_pred hcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcc
Confidence 777 9999999999999999999999999987654332211 12344689999999999765 234689
Q ss_pred cchhhhHHHHHHHhC----------CCCCCCCCCCCCcchhhhccccCCcchhhh-hcccccCCCCC-----HHHHHHHH
Q 025816 144 DVYSFGVVLLELLTG----------RKPVDHTLPRGQQSLVTWATPKLSEDKVRQ-CVDARLGGDYP-----PKAVAKMA 207 (247)
Q Consensus 144 DvwslG~~l~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~ 207 (247)
||||||+++|+|++| ..||........ ....+.+ ..........+ ...+..+.
T Consensus 239 Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (342)
T 1b6c_B 239 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP-----------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 307 (342)
T ss_dssp HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-----------CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc-----------cHHHHHHHHHHHHhCCCCcccccchhHHHHHH
Confidence 999999999999999 566653322111 0111111 11222222222 36677899
Q ss_pred HHHHhhcccCCCCCCCHHHHHHHHHHhHhcCC
Q 025816 208 AVAALCVQYEADFRPNMSIVVKALQPLLNARP 239 (247)
Q Consensus 208 ~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~ 239 (247)
+++.+||+.||.+|||++++++.|+.+.+...
T Consensus 308 ~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 308 KIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred HHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999987653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=267.60 Aligned_cols=194 Identities=23% Similarity=0.300 Sum_probs=160.1
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
++||||+++++++.+....++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ |+||
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHr 142 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IVYR 142 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCC
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeC
Confidence 3899999999999999999999999999999999976432 899999999999999999999999 9999
Q ss_pred cCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCC
Q 025816 85 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164 (247)
Q Consensus 85 di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 164 (247)
||||+||+++.+|.++|+|||++........ ......||..|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus 143 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999875422111 22445789999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 025816 165 TLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS-IVVK 229 (247)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~il~ 229 (247)
.+.. .....+... ....+...+.++.++|.+||..||.+||++. ++++
T Consensus 221 ~~~~---------------~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 221 QDEE---------------ELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp SSHH---------------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCHH---------------HHHHHHHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 4221 111111111 1223444567899999999999999999997 6654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=263.99 Aligned_cols=204 Identities=21% Similarity=0.297 Sum_probs=161.0
Q ss_pred ccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 3 SRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 3 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++ +||||+++++++.++...++||||+.+|+|.+++..... +++..++.++.|++.||.|||+.+ |
T Consensus 64 ~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---i 131 (345)
T 3a8x_A 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---I 131 (345)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 444 899999999999999999999999999999999975432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 132 vHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 209 (345)
T 3a8x_A 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209 (345)
T ss_dssp BCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eecCCCHHHEEECCCCCEEEEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999975332211 22345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhh-hhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH------HHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVR-QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM------SIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~~il~ 229 (247)
|.......... ......+. .+... ....+...+.++.++|.+||+.||.+||++ +++++
T Consensus 210 f~~~~~~~~~~-------~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 210 FDIVGSSDNPD-------QNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp TTTTTC--------------CHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred cCCcccccccc-------cccHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 96432111000 00001111 11111 123444566789999999999999999995 67765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=255.47 Aligned_cols=198 Identities=27% Similarity=0.377 Sum_probs=142.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+++..++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 133 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--------PFSENEARHFMHQIITGMLYLHSHG---I 133 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5788999999999999999999999999999999999986532 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 134 ~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 211 (278)
T 3cok_A 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211 (278)
T ss_dssp ECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred ecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765432211 1234578899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|......... ...... ....+...+.++.+++.+||+.||.+|||++++++
T Consensus 212 ~~~~~~~~~~---------------~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 212 FDTDTVKNTL---------------NKVVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCCCSCC--------------------CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCChhHHHHH---------------HHHhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 9754321110 000000 01223344567999999999999999999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=265.33 Aligned_cols=201 Identities=21% Similarity=0.399 Sum_probs=156.4
Q ss_pred cccccC--CCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKH--ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
|++++| |||+++++++..+...++|||+ .+++|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 61 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~-- 128 (343)
T 3dbq_A 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG-- 128 (343)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCC---------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 456766 9999999999999999999995 56799999986542 899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----------CCCCccccchhh
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLNAKSDVYSF 148 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dvwsl 148 (247)
|+||||||+||+++ ++.+||+|||++................||..|+|||.+.+ ..++.++|||||
T Consensus 129 -iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diwsl 206 (343)
T 3dbq_A 129 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206 (343)
T ss_dssp -CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHH
T ss_pred -eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHH
Confidence 99999999999997 67899999999987654333322344568999999999875 568889999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
|+++|+|++|..||...... .......++.......+...+..+.+++.+||+.||.+|||+.+++
T Consensus 207 G~il~ell~g~~pf~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l 272 (343)
T 3dbq_A 207 GCILYYMTYGKTPFQQIINQ--------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272 (343)
T ss_dssp HHHHHHHHHSSCTTTTCCSH--------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHhCCCcchhhhhH--------------HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHH
Confidence 99999999999999642110 1122333333333344444556799999999999999999999999
Q ss_pred HH
Q 025816 229 KA 230 (247)
Q Consensus 229 ~~ 230 (247)
+.
T Consensus 273 ~h 274 (343)
T 3dbq_A 273 AH 274 (343)
T ss_dssp TS
T ss_pred hC
Confidence 74
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=254.14 Aligned_cols=216 Identities=19% Similarity=0.285 Sum_probs=168.1
Q ss_pred cccccCCCccceeeEE-eeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++|++++..+..+ ..+...+++|||+ +++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~--- 125 (296)
T 4hgt_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN--- 125 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4567888877776665 6677889999999 8899999974332 2899999999999999999999999
Q ss_pred eEeccCCCCceee---cCCCceeeccccccCCcchhhhc-----ccccceeccccccCchhhhcCCCCccccchhhhHHH
Q 025816 81 IIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL 152 (247)
Q Consensus 81 i~h~di~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 152 (247)
++||||||+||++ +.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++
T Consensus 126 ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 205 (296)
T 4hgt_A 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 205 (296)
T ss_dssp EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHH
Confidence 9999999999999 78899999999999765433221 112345689999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC---CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|+|++|..||.............. ......... .....+..+.+++.+||+.||.+|||++++++
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 206 MYFNLGSLPWQGLKAATKRQKYER------------ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHH------------HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHhcCCCCCcccchhhhhhhhhh------------hhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 999999999976543322221111 111111000 01123467999999999999999999999999
Q ss_pred HHHHhHhcCCCC
Q 025816 230 ALQPLLNARPGP 241 (247)
Q Consensus 230 ~l~~~~~~~~~~ 241 (247)
.|+.++++....
T Consensus 274 ~l~~~~~~~~~~ 285 (296)
T 4hgt_A 274 LFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHHHHHTCC
T ss_pred HHHHHHHHhCCC
Confidence 999999876543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=259.58 Aligned_cols=210 Identities=26% Similarity=0.360 Sum_probs=165.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+. .++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 75 l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 142 (291)
T 1u46_A 75 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---F 142 (291)
T ss_dssp HHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 56789999999999988765 8899999999999999976432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
+|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 143 ~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 222 (291)
T 1u46_A 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222 (291)
T ss_dssp ECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998765433221 11223456778999999998889999999999999999999 99
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
.||...... ...............+...+..+.+++.+||..||.+|||+.++++.|+++....
T Consensus 223 ~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 223 EPWIGLNGS---------------QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp CTTTTCCHH---------------HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCcccCCHH---------------HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 999644211 1111111122222333455678999999999999999999999999999886543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=254.41 Aligned_cols=203 Identities=19% Similarity=0.287 Sum_probs=163.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~---i 127 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV---------FRESDAARIMKDVLSAVAYCHKLN---V 127 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 6789999999999999999999999999999999998875432 899999999999999999999999 9
Q ss_pred EeccCCCCceee---cCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+ .++.++|+||||+++++|++|
T Consensus 128 ~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g 203 (277)
T 3f3z_A 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCG 203 (277)
T ss_dssp ECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHS
T ss_pred cCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHC
Confidence 999999999999 7888999999999876543221 234468999999998876 489999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCH----HHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQ 232 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~ 232 (247)
..||...... ........... ..+. ..+..+.+++.+||+.||.+|||+.++++ .++
T Consensus 204 ~~p~~~~~~~---------------~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 204 YPPFSAPTDS---------------EVMLKIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp SCSSCCSSHH---------------HHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred CCCCCCCCHH---------------HHHHHHHhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 9999643211 11111111111 1111 23567999999999999999999999997 566
Q ss_pred HhHhc
Q 025816 233 PLLNA 237 (247)
Q Consensus 233 ~~~~~ 237 (247)
+.+++
T Consensus 267 ~~~~~ 271 (277)
T 3f3z_A 267 KQLSS 271 (277)
T ss_dssp HHHCC
T ss_pred ccccc
Confidence 55543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=263.27 Aligned_cols=215 Identities=24% Similarity=0.244 Sum_probs=160.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------------------------------CCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------------------------------GAQP 50 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------------------------------~~~~ 50 (247)
+++++||||+++++++.++...++||||+.+|+|.+++....... ....
T Consensus 82 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (345)
T 3hko_A 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161 (345)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred HHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 577899999999999999999999999999999999986321100 0000
Q ss_pred CCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCC--ceeeccccccCCcchhhhc--ccccceeccc
Q 025816 51 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAPDMAAR--LHSTRVLGTF 126 (247)
Q Consensus 51 ~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~--~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~ 126 (247)
...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++......... .......|+.
T Consensus 162 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 238 (345)
T 3hko_A 162 DFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCG
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCc
Confidence 112567888999999999999999999 99999999999998776 8999999999754332211 1123456899
Q ss_pred cccCchhhhc--CCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCC--CHHH
Q 025816 127 GYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY--PPKA 202 (247)
Q Consensus 127 ~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 202 (247)
.|+|||.+.+ ..++.++||||||+++|+|++|..||...... ....+.......... ....
T Consensus 239 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~ 303 (345)
T 3hko_A 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA---------------DTISQVLNKKLCFENPNYNVL 303 (345)
T ss_dssp GGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------HHHHHHHHCCCCTTSGGGGGS
T ss_pred cccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH---------------HHHHHHHhcccccCCcccccC
Confidence 9999999975 57889999999999999999999999654221 111222222211111 1234
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHh
Q 025816 203 VAKMAAVAALCVQYEADFRPNMSIVVK--ALQPL 234 (247)
Q Consensus 203 ~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~~ 234 (247)
+..+.++|.+||..||.+|||+.++++ +++++
T Consensus 304 ~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 567999999999999999999999998 44443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=258.64 Aligned_cols=198 Identities=27% Similarity=0.402 Sum_probs=163.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++.... +++..++.++.|++.||.|||+.+ +
T Consensus 74 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i 140 (303)
T 3a7i_A 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---K 140 (303)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 567899999999999999999999999999999999997533 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 141 ~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (303)
T 3a7i_A 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218 (303)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCC
Confidence 9999999999999999999999999876543221 12345688899999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|...... .....+........+...+..+.+++.+||+.||.+|||++++++.
T Consensus 219 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 219 HSELHPM----------------KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp TTTSCHH----------------HHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCcCHH----------------HHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 9643211 1111111112222333455679999999999999999999999984
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=264.52 Aligned_cols=206 Identities=20% Similarity=0.265 Sum_probs=142.6
Q ss_pred ccccc-CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++ ||||+++++++.++...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 59 l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~--- 126 (325)
T 3kn6_A 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH---------FSETEASYIMRKLVSAVSHMHDVG--- 126 (325)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 44565 99999999999999999999999999999999976542 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCC---ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
++||||||+||+++.++ .++|+|||++......... .....+|..|+|||.+.+..++.++||||||+++|+|++
T Consensus 127 ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 204 (325)
T 3kn6_A 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS 204 (325)
T ss_dssp EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHh
Confidence 99999999999998766 7999999999754332221 233457899999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||............ ......+........ .....+.++.++|.+||+.||.+|||++++++
T Consensus 205 g~~pf~~~~~~~~~~~~--------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 205 GQVPFQSHDRSLTCTSA--------VEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SSCTTC-------CCCH--------HHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCCCCCCccccccccH--------HHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 99999765432110000 011111111111000 01234677999999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=259.86 Aligned_cols=212 Identities=21% Similarity=0.268 Sum_probs=158.6
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..+++|||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ +
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---i 155 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---------PLAPPRAVAIVRQIGSALDAAHAAG---A 155 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCc---C
Confidence 678999999999999999999999999999999999997543 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 156 ~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 234 (309)
T 2h34_A 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234 (309)
T ss_dssp CCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCS
T ss_pred CcCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999998765432211 12334688899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccC--CCCCHHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHHHHhHhcC
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRP-NMSIVVKALQPLLNAR 238 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~il~~l~~~~~~~ 238 (247)
|...... .+...+..... ...+...+..+.+++.+||+.||.+|| |++++++.|+.++...
T Consensus 235 f~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 235 YQGDQLS----------------VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp SCSCHHH----------------HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCCchHH----------------HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 9743211 01111111100 112234456799999999999999999 9999999999888665
Q ss_pred CCCC
Q 025816 239 PGPA 242 (247)
Q Consensus 239 ~~~~ 242 (247)
....
T Consensus 299 ~~~~ 302 (309)
T 2h34_A 299 DQDR 302 (309)
T ss_dssp ----
T ss_pred cccc
Confidence 5443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=270.51 Aligned_cols=219 Identities=21% Similarity=0.299 Sum_probs=160.1
Q ss_pred ccccc-CCCccceeeEEeeCC--eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 2 VSRLK-HENFVQLLGYCVDGT--SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
|++++ ||||+++++++..++ ..++||||+. ++|.+++.... ++...+..++.|++.||.|||+.+
T Consensus 62 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~- 129 (388)
T 3oz6_A 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANI----------LEPVHKQYVVYQLIKVIKYLHSGG- 129 (388)
T ss_dssp HHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHTC----------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45666 999999999997654 6899999997 59999997643 899999999999999999999999
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhh-------------------hcccccceeccccccCchhhhc-CC
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA-------------------ARLHSTRVLGTFGYHAPEYAMT-GQ 138 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~ 138 (247)
|+||||||+||+++.++.+||+|||+++...... .........||..|+|||++.+ ..
T Consensus 130 --ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 207 (388)
T 3oz6_A 130 --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK 207 (388)
T ss_dssp --EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCC
T ss_pred --EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCC
Confidence 9999999999999999999999999997543210 0111233568999999999986 67
Q ss_pred CCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcc------------------cccCC----
Q 025816 139 LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD------------------ARLGG---- 196 (247)
Q Consensus 139 ~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~---- 196 (247)
++.++|||||||++|+|++|..||.+.+...+...+...........+..... .....
T Consensus 208 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (388)
T 3oz6_A 208 YTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK 287 (388)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHH
T ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcc
Confidence 89999999999999999999999986543322222111111111111100000 00000
Q ss_pred --------CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH--HHHh
Q 025816 197 --------DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA--LQPL 234 (247)
Q Consensus 197 --------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~--l~~~ 234 (247)
......+.++.+++.+||..||.+|||++++++. ++.+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred hhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 0011335579999999999999999999999985 4444
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=252.37 Aligned_cols=218 Identities=19% Similarity=0.280 Sum_probs=169.0
Q ss_pred cccccCCCccceeeEE-eeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++|++++..+..+ ..+...++||||+ +++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~--- 125 (296)
T 3uzp_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN--- 125 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5677888877766665 5667889999999 7899999974332 2999999999999999999999999
Q ss_pred eEeccCCCCceee---cCCCceeeccccccCCcchhhhcc-----cccceeccccccCchhhhcCCCCccccchhhhHHH
Q 025816 81 IIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL 152 (247)
Q Consensus 81 i~h~di~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 152 (247)
++||||||+||++ +.++.++|+|||.+.......... ......++..|+|||.+.+..++.++||||||+++
T Consensus 126 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 205 (296)
T 3uzp_A 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 205 (296)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHH
Confidence 9999999999999 488899999999987654432211 12345689999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC---CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|+|++|..||.............. ......... .....+..+.+++.+||+.||.+|||++++++
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 206 MYFNLGSLPWQGLKAATKRQKYER------------ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHH------------HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhCCCCCCCcCchhhhhhhhh------------hcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 999999999986543322221111 111000000 11233567999999999999999999999999
Q ss_pred HHHHhHhcCCCCCC
Q 025816 230 ALQPLLNARPGPAG 243 (247)
Q Consensus 230 ~l~~~~~~~~~~~~ 243 (247)
.|+.+++....+..
T Consensus 274 ~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 274 LFRNLFHRQGFSYD 287 (296)
T ss_dssp HHHHHHHHTTCCSS
T ss_pred HHHHHHHhcCCccc
Confidence 99999988766544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=260.57 Aligned_cols=177 Identities=22% Similarity=0.336 Sum_probs=137.9
Q ss_pred eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeec
Q 025816 23 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 102 (247)
Q Consensus 23 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~ 102 (247)
.+++|||+.+++|.+++...... ....+..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~ 206 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRCSL------EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 206 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCCSG------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEEecCCCCHHHHHhcccCc------cchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEe
Confidence 79999999999999999875432 12566678999999999999999999 9999999999999999999999
Q ss_pred cccccCCcchhhhc----------ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcc
Q 025816 103 DFDLSNQAPDMAAR----------LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 172 (247)
Q Consensus 103 d~g~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 172 (247)
|||++......... .......||..|+|||.+.+..++.++||||||+++|+|++|..|+...
T Consensus 207 DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------- 279 (332)
T 3qd2_B 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------- 279 (332)
T ss_dssp CCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------
T ss_pred ecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------
Confidence 99998765433211 1123346899999999999999999999999999999999987664210
Q ss_pred hhhhccccCCcchhhhhcccccCCCCC---HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 173 LVTWATPKLSEDKVRQCVDARLGGDYP---PKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
.+..........+ ...+..+.+++.+||+.||.+|||++++++
T Consensus 280 --------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 280 --------------VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp --------------HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred --------------HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 0011111111222 344567899999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=266.23 Aligned_cols=209 Identities=20% Similarity=0.271 Sum_probs=158.3
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
+.||||+++++++......++||||+ +++|.+++....... +++..+..++.|++.||.|||+.+ |+||
T Consensus 93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~-------~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 161 (360)
T 3llt_A 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNG-------FHIEDIKLYCIEILKALNYLRKMS---LTHT 161 (360)
T ss_dssp TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---eeeC
Confidence 45999999999999999999999999 789999998765332 899999999999999999999999 9999
Q ss_pred cCCCCceeecC-------------------------CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC
Q 025816 85 DIKSSNVLIFD-------------------------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL 139 (247)
Q Consensus 85 di~~~nil~~~-------------------------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 139 (247)
||||+||+++. ++.+||+|||++...... .....||..|+|||++.+..+
T Consensus 162 Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 236 (360)
T 3llt_A 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGW 236 (360)
T ss_dssp CCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCC
T ss_pred CCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCC
Confidence 99999999975 788999999998753321 234568999999999999999
Q ss_pred CccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccc---------c----cCCC---------
Q 025816 140 NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA---------R----LGGD--------- 197 (247)
Q Consensus 140 ~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~----~~~~--------- 197 (247)
+.++|||||||++|+|++|..||...................+.....+.... . ....
T Consensus 237 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 316 (360)
T 3llt_A 237 DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316 (360)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHH
T ss_pred CCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhh
Confidence 99999999999999999999999765432211111111111111111000000 0 0000
Q ss_pred ----C---CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 198 ----Y---PPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 198 ----~---~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
. .......+.+++.+||+.||.+|||++++++
T Consensus 317 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0011256889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=263.47 Aligned_cols=198 Identities=23% Similarity=0.369 Sum_probs=157.9
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
+||||+++++++.++...++||||+.+|+|.+.+..... +++..+..++.|++.||.|||+.+ |+|||
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~g---ivHrD 141 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLHAQG---VVHRD 141 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEecc
Confidence 799999999999999999999999999999999976542 899999999999999999999999 99999
Q ss_pred CCCCceeecCC----CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 86 IKSSNVLIFDD----DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 86 i~~~nil~~~~----~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
|||+||++... +.+||+|||++........ ......+|..|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus 142 lkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 219 (342)
T 2qr7_A 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219 (342)
T ss_dssp CCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCC
Confidence 99999998543 3599999999876533221 12334679999999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|............ ..+..... ........+.++.++|.+||..||.+|||++++++
T Consensus 220 f~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 220 FANGPDDTPEEIL------------ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp SCSSTTSCHHHHH------------HHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCcCCHHHHH------------HHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9753221111111 11111111 11122345677999999999999999999999997
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=259.38 Aligned_cols=196 Identities=24% Similarity=0.364 Sum_probs=160.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ +
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---i 136 (321)
T 2a2a_A 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---I 136 (321)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567899999999999999999999999999999999997643 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCC----ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 82 IHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
+|+||+|+||+++.++ .++|+|||++........ .....|+..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 137 vH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 213 (321)
T 2a2a_A 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213 (321)
T ss_dssp ECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHH
Confidence 9999999999999888 799999999876543221 233468999999999998899999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||....... ....+.... ...+ ...+..+.+++.+||..||.+|||++++++
T Consensus 214 g~~pf~~~~~~~---------------~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 214 GASPFLGDTKQE---------------TLANITSVS--YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp SCCSSCCSSHHH---------------HHHHHHTTC--CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCHHH---------------HHHHHHhcc--cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 999996542110 001100000 0111 123456999999999999999999999997
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=267.09 Aligned_cols=201 Identities=21% Similarity=0.396 Sum_probs=156.3
Q ss_pred ccccc--CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLK--HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
|++++ ||||+++++++..+...++||| +.+++|.+++..... +++..++.++.|++.||.|||+.+
T Consensus 108 l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~-- 175 (390)
T 2zmd_A 108 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG-- 175 (390)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 45565 5999999999999999999999 557799999976542 888999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----------CCCCccccchhh
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLNAKSDVYSF 148 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dvwsl 148 (247)
|+||||||+||+++ ++.+||+|||++................||..|+|||++.+ ..++.++|||||
T Consensus 176 -ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl 253 (390)
T 2zmd_A 176 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253 (390)
T ss_dssp -CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred -eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence 99999999999995 58899999999987644332222334568999999999875 368889999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
|+++|+|++|..||...... ...+...++.......+...+.++.++|.+||..||.+|||+.+++
T Consensus 254 Gvil~ell~G~~Pf~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 319 (390)
T 2zmd_A 254 GCILYYMTYGKTPFQQIINQ--------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319 (390)
T ss_dssp HHHHHHHHHSSCTTTTCCCH--------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHCCCcchhhhHH--------------HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence 99999999999999643211 1122233333333334444456799999999999999999999999
Q ss_pred HH
Q 025816 229 KA 230 (247)
Q Consensus 229 ~~ 230 (247)
+.
T Consensus 320 ~h 321 (390)
T 2zmd_A 320 AH 321 (390)
T ss_dssp TS
T ss_pred hC
Confidence 74
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=270.96 Aligned_cols=201 Identities=17% Similarity=0.193 Sum_probs=161.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||++++++|.++...++||||+.+|+|.+++..... .+++..+..++.|++.||.|||+.+ |
T Consensus 128 l~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~--------~l~e~~~~~~~~qi~~aL~~LH~~g---i 196 (437)
T 4aw2_A 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED--------RLPEEMARFYLAEMVIAIDSVHQLH---Y 196 (437)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5678999999999999999999999999999999999986432 2999999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-----cCCCCccccchhhhHHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~~l~ 156 (247)
+||||||+|||++.++.+||+|||++......... ......||+.|+|||++. ...++.++|+||||+++|+|+
T Consensus 197 iHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ell 275 (437)
T 4aw2_A 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275 (437)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHH
T ss_pred EecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHH
Confidence 99999999999999999999999998754332221 123356899999999997 456899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC---CCHHHHHHHHHHHHhhcccCCCC--CCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD---YPPKAVAKMAAVAALCVQYEADF--RPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~--Rps~~~il~ 229 (247)
+|..||...... +....++....... .....+.++.++|++||..+|.+ ||+++++++
T Consensus 276 tG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 276 YGETPFYAESLV---------------ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HSSCTTCCSSHH---------------HHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hCCCCCCCCChh---------------HHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 999999754321 11111111111111 11235677999999999888888 999999988
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=276.45 Aligned_cols=203 Identities=20% Similarity=0.308 Sum_probs=166.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.++...++||||+.||+|.+++....... +++..++.++.|++.||.|||+.+
T Consensus 237 iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~-------l~e~~~~~i~~qIl~aL~yLH~~g--- 306 (576)
T 2acx_A 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-------FPEARAVFYAAEICCGLEDLHRER--- 306 (576)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCC-------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678899999999999999999999999999999999997654322 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.+|.+||+|||++........ .....||..|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 307 IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~ 383 (576)
T 2acx_A 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383 (576)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSC
T ss_pred EeccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999976543221 133468999999999999889999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~ 229 (247)
||......... ..+.+.+. ......+...+.++.++|.+||..||.+|| +++++++
T Consensus 384 PF~~~~~~~~~------------~~i~~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 384 PFQQRKKKIKR------------EEVERLVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp SSSCSSSCCCH------------HHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CCcccccchhH------------HHHHHHhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 99754322111 11111111 112234455667899999999999999999 7899986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=258.72 Aligned_cols=191 Identities=19% Similarity=0.228 Sum_probs=152.2
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
.+||||+++++++.++...++||||+ +++|.+++..... .+++..++.++.|++.||.|||+.+ |+||
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 181 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLHSQG---LVHL 181 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 48999999999999999999999999 5699998876432 2999999999999999999999999 9999
Q ss_pred cCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCC
Q 025816 85 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 164 (247)
Q Consensus 85 di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 164 (247)
||||+||+++.++.+||+|||++........ .....||..|+|||++.+ .++.++||||||+++++|++|..++..
T Consensus 182 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 182 DVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp CCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876543222 233458999999998876 789999999999999999999766542
Q ss_pred CCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 165 TLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
.. ..............+...+..+.+++.+||+.||.+|||++++++
T Consensus 258 ~~------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 258 GE------------------GWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HH------------------HHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc------------------HHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 111111111111111234567999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=262.28 Aligned_cols=219 Identities=26% Similarity=0.426 Sum_probs=165.5
Q ss_pred cccccCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 2 VSRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
+++++||||+++++++.. ....++||||+.+++|.+++...... +..+++..++.++.|++.||.|||+.+
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ 154 (317)
T 2buj_A 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAKG 154 (317)
T ss_dssp HHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578899999999999863 34789999999999999998753211 123899999999999999999999999
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc-------ccccceeccccccCchhhhcCC---CCccccchh
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-------LHSTRVLGTFGYHAPEYAMTGQ---LNAKSDVYS 147 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dvws 147 (247)
++|+||||+||+++.++.++|+|||.+......... .......|+..|+|||.+.+.. ++.++||||
T Consensus 155 ---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s 231 (317)
T 2buj_A 155 ---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWS 231 (317)
T ss_dssp ---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHH
T ss_pred ---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHH
Confidence 999999999999999999999999987654321110 0011234688999999987543 688999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 148 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
||+++|+|++|..||....... ...................+..+.+++.+||+.||.+|||++++
T Consensus 232 lG~il~el~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 297 (317)
T 2buj_A 232 LGCVLYAMMFGEGPYDMVFQKG--------------DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297 (317)
T ss_dssp HHHHHHHHHHSSCTTHHHHHTT--------------SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhCCCChhhhhccc--------------chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 9999999999999995321110 01111111122222234456679999999999999999999999
Q ss_pred HHHHHHhHhcCCCCC
Q 025816 228 VKALQPLLNARPGPA 242 (247)
Q Consensus 228 l~~l~~~~~~~~~~~ 242 (247)
++.|+.+....|++.
T Consensus 298 l~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 298 LSQLEALQPPAPGQH 312 (317)
T ss_dssp HHHHHHTCCCCCC--
T ss_pred HHHhhhcCCCCCCCC
Confidence 999998875555443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=254.90 Aligned_cols=198 Identities=21% Similarity=0.289 Sum_probs=160.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...+++|||+.+++|.+.+..... +++..+..++.|++.||.|||+.+ +
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i 126 (284)
T 3kk8_A 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSNG---I 126 (284)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5778999999999999999999999999999999988876532 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCc---eeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDV---AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~---~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||+++.++. ++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++++|++|
T Consensus 127 ~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 203 (284)
T 3kk8_A 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203 (284)
T ss_dssp ECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHC
Confidence 99999999999987665 99999999875543222 1335689999999999998999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||....... ........... .......+..+.+++.+||+.||.+|||++++++
T Consensus 204 ~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 204 YPPFWDEDQHR---------------LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp SCSSCCSSHHH---------------HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCchhH---------------HHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99996432111 01111111110 1111234567999999999999999999999998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=260.48 Aligned_cols=211 Identities=22% Similarity=0.309 Sum_probs=154.8
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
++||||+++++++.+++..++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ ++||
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 135 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLHNKG---IAHR 135 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ceeC
Confidence 5799999999999999999999999999999999976432 899999999999999999999999 9999
Q ss_pred cCCCCceeecCCCc---eeeccccccCCcchhhhc-----ccccceeccccccCchhhhc-----CCCCccccchhhhHH
Q 025816 85 DIKSSNVLIFDDDV---AKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVV 151 (247)
Q Consensus 85 di~~~nil~~~~~~---~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~ 151 (247)
||||+||+++.++. ++|+|||++......... .......|+..|+|||.+.+ ..++.++||||||++
T Consensus 136 dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 215 (316)
T 2ac3_A 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215 (316)
T ss_dssp CCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHH
T ss_pred CCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHH
Confidence 99999999988776 999999998754322110 11123458999999999875 457899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCH----HHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 152 LLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 152 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
+|+|++|..||................... ...+.+.+.... ...+. ..+..+.+++.+||+.||.+|||++++
T Consensus 216 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 293 (316)
T 2ac3_A 216 LYILLSGYPPFVGRCGSDCGWDRGEACPAC-QNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293 (316)
T ss_dssp HHHHHHSSCSCCCCCCSCSCC----CCHHH-HHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHHHCCCCCcccccccccccccccchhH-HHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHH
Confidence 999999999998654332111000000000 000111111110 11221 235679999999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
++
T Consensus 294 l~ 295 (316)
T 2ac3_A 294 LQ 295 (316)
T ss_dssp HH
T ss_pred hc
Confidence 98
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=262.48 Aligned_cols=214 Identities=17% Similarity=0.217 Sum_probs=154.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.++...++||||+.+ +|.+++..... +++..++.++.|++.||.|||+.+
T Consensus 86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~---------~~~~~~~~i~~ql~~~l~~LH~~~--- 152 (329)
T 3gbz_A 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD---------VSMRVIKSFLYQLINGVNFCHSRR--- 152 (329)
T ss_dssp HGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36789999999999999999999999999975 99999976542 899999999999999999999999
Q ss_pred eEeccCCCCceeec-----CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHH
Q 025816 81 IIHRDIKSSNVLIF-----DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 81 i~h~di~~~nil~~-----~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~ 154 (247)
|+||||||+||+++ ..+.++|+|||++........ ......+|..|+|||++.+. .++.++||||||+++|+
T Consensus 153 ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 230 (329)
T 3gbz_A 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAE 230 (329)
T ss_dssp CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999994 445699999999875432211 12334578999999999874 48999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhh------hcc--cccCCC-----CCHHHHHHHHHHHHhhcccCCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ------CVD--ARLGGD-----YPPKAVAKMAAVAALCVQYEADFR 221 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~--~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~R 221 (247)
|++|..||.......................+.. +.. ...... .+...+.++.+++.+||+.||.+|
T Consensus 231 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 310 (329)
T 3gbz_A 231 MLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKR 310 (329)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhC
Confidence 9999999976543211111110000000000000 000 000000 011245678999999999999999
Q ss_pred CCHHHHHH
Q 025816 222 PNMSIVVK 229 (247)
Q Consensus 222 ps~~~il~ 229 (247)
||++++++
T Consensus 311 ~t~~e~l~ 318 (329)
T 3gbz_A 311 ISAKNALE 318 (329)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhC
Confidence 99999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=264.75 Aligned_cols=224 Identities=17% Similarity=0.227 Sum_probs=168.5
Q ss_pred cccccCCCccc---------------eeeEEee-CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHH
Q 025816 2 VSRLKHENFVQ---------------LLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 65 (247)
Q Consensus 2 l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 65 (247)
+++++||||++ +++++.. +...++||||+ +++|.+++...... .+++..++.++.|
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~-------~l~~~~~~~i~~q 167 (352)
T 2jii_A 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH-------VLSERSVLQVACR 167 (352)
T ss_dssp HHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGG-------CCCHHHHHHHHHH
T ss_pred HHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcC-------CCCHHHHHHHHHH
Confidence 45677777776 6777776 67889999999 88999999865322 2999999999999
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCceeecCCC--ceeeccccccCCcchhhhcc-----cccceeccccccCchhhhcCC
Q 025816 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQ 138 (247)
Q Consensus 66 ~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~--~~~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~ 138 (247)
++.||.|||+.+ ++||||||+||+++.++ .++|+|||++.......... ......|+..|+|||.+.+..
T Consensus 168 i~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 244 (352)
T 2jii_A 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG 244 (352)
T ss_dssp HHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC
T ss_pred HHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC
Confidence 999999999999 99999999999999998 89999999998664432211 112346899999999999989
Q ss_pred CCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC-CCCCHHHHHHHHHHHHhhcccC
Q 025816 139 LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG-GDYPPKAVAKMAAVAALCVQYE 217 (247)
Q Consensus 139 ~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~ 217 (247)
++.++||||||+++|+|++|..||.......... ..... ........... .......+..+.+++.+||..|
T Consensus 245 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 317 (352)
T 2jii_A 245 PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI-MKQKQ------KFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALT 317 (352)
T ss_dssp CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH-HHHHH------HHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCC
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH-HHHHH------hccCChhhhhhhccccCCCcHHHHHHHHHHHhCC
Confidence 9999999999999999999999997543111100 00000 00000000000 0001123567999999999999
Q ss_pred CCCCCCHHHHHHHHHHhHhcCCCCCC
Q 025816 218 ADFRPNMSIVVKALQPLLNARPGPAG 243 (247)
Q Consensus 218 p~~Rps~~~il~~l~~~~~~~~~~~~ 243 (247)
|.+|||++++++.|+.+++.......
T Consensus 318 p~~Rps~~~l~~~L~~~~~~~~~~~~ 343 (352)
T 2jii_A 318 YEEKPPYAMLRNNLEALLQDLRVSPY 343 (352)
T ss_dssp TTCCCCHHHHHHHHHHHHHHTTCCTT
T ss_pred hhhCCCHHHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999987765543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=262.83 Aligned_cols=213 Identities=22% Similarity=0.326 Sum_probs=161.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-CCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~-~~~ 79 (247)
++++++||||+++++++..+...++||||+.+++|.+++..... +++..+..++.|++.||.|||+. +
T Consensus 84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~~-- 152 (360)
T 3eqc_A 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK-- 152 (360)
T ss_dssp GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC--
T ss_pred HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 46789999999999999999999999999999999999976432 89999999999999999999986 8
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
++|+||||+||+++.++.++|+|||++...... ......|+..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 153 -i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 227 (360)
T 3eqc_A 153 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227 (360)
T ss_dssp -CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTS
T ss_pred -EEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999988644222 123456899999999999989999999999999999999999
Q ss_pred CCCCCCCCCCCcchhh-----------------------hccccCCcc---h-hhhhcccccCCCCCHHHHHHHHHHHHh
Q 025816 160 KPVDHTLPRGQQSLVT-----------------------WATPKLSED---K-VRQCVDARLGGDYPPKAVAKMAAVAAL 212 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~-----------------------~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~l~~li~~ 212 (247)
.||............. ......... . .................+.++.+++.+
T Consensus 228 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 307 (360)
T 3eqc_A 228 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 307 (360)
T ss_dssp CCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHH
Confidence 9997543211000000 000000000 0 011111111111122346679999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 025816 213 CVQYEADFRPNMSIVVK 229 (247)
Q Consensus 213 cl~~~p~~Rps~~~il~ 229 (247)
||+.||.+|||++++++
T Consensus 308 ~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 308 CLIKNPAERADLKQLMV 324 (360)
T ss_dssp HHCSSTTTSCCHHHHHT
T ss_pred HhhcChhhCCCHHHHhh
Confidence 99999999999999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=262.80 Aligned_cols=196 Identities=26% Similarity=0.399 Sum_probs=158.4
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++..+...++||||+. |+|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 108 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---i 175 (348)
T 1u5q_A 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---M 175 (348)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 578899999999999999999999999997 588888854322 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh---cCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+||||||+||+++.++.+||+|||++...... ....||..|+|||++. ...++.++||||||+++++|++|
T Consensus 176 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g 249 (348)
T 1u5q_A 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249 (348)
T ss_dssp BCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred eeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999998765321 2346899999999985 45789999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..||...... ..+............+...+..+.++|.+||+.||.+|||++++++.
T Consensus 250 ~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 250 KPPLFNMNAM---------------SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp SCTTTTSCHH---------------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCChH---------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 9999643211 11111111111111223445679999999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=265.24 Aligned_cols=224 Identities=20% Similarity=0.260 Sum_probs=171.0
Q ss_pred cccccCCCccceeeEEeeCC--eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGT--SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
|++++||||+++++++.... ..++||||+.+|+|.+++...... ..+++..++.++.|++.||.|||+.+
T Consensus 61 l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~-- 132 (396)
T 4eut_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG-- 132 (396)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 57889999999999998765 779999999999999999765421 12899999999999999999999999
Q ss_pred CeEeccCCCCceee----cCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc--------CCCCccccchh
Q 025816 80 HIIHRDIKSSNVLI----FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--------GQLNAKSDVYS 147 (247)
Q Consensus 80 ~i~h~di~~~nil~----~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dvws 147 (247)
|+||||||+||++ +.++.+||+|||++........ .....|+..|+|||.+.+ ..++.++||||
T Consensus 133 -ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwS 208 (396)
T 4eut_A 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS 208 (396)
T ss_dssp -EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHH
T ss_pred -EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHH
Confidence 9999999999999 7778899999999976543322 123468999999999875 46788999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCC-CcchhhhccccCCcchhhhh---c--------ccccCCCCCHHHHHHHHHHHHhhcc
Q 025816 148 FGVVLLELLTGRKPVDHTLPRG-QQSLVTWATPKLSEDKVRQC---V--------DARLGGDYPPKAVAKMAAVAALCVQ 215 (247)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~--------~~~~~~~~~~~~~~~l~~li~~cl~ 215 (247)
||+++|+|++|..||....... ............+...+... . ............+..+.+++.+||.
T Consensus 209 lG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~ 288 (396)
T 4eut_A 209 IGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288 (396)
T ss_dssp HHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhc
Confidence 9999999999999997543321 11111111111111000000 0 0011123456788899999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhHhc
Q 025816 216 YEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 216 ~~p~~Rps~~~il~~l~~~~~~ 237 (247)
.||.+|||+.++++.++.+++.
T Consensus 289 ~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 289 ADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTTSCCHHHHHHHHHHHHTC
T ss_pred cChhhhccHHHHHHHHHHHhhc
Confidence 9999999999999999998864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=265.24 Aligned_cols=215 Identities=23% Similarity=0.289 Sum_probs=163.7
Q ss_pred cccccCCCccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
|++++||||+++++++..+. ..++||||+ +++|.+++.... +++..+..++.|++.||.|||+
T Consensus 78 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~ 146 (367)
T 1cm8_A 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHA 146 (367)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999997763 459999999 679999997643 8999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
.+ ++||||||+||+++.++.+||+|||+++..... .....+|..|+|||++.+ ..++.++|+||+||++++
T Consensus 147 ~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 218 (367)
T 1cm8_A 147 AG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218 (367)
T ss_dssp TT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHH
T ss_pred CC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHH
Confidence 99 999999999999999999999999999764321 233467999999999987 679999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhh--------hcccc---c---CCCCCHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ--------CVDAR---L---GGDYPPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~---~---~~~~~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|..||.+.+...+...+.......+.+.+.. .+... . ........+..+.+++.+||..||.+
T Consensus 219 ll~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~ 298 (367)
T 1cm8_A 219 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 298 (367)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhH
Confidence 9999999986543322221111111111111111 00000 0 00112334567999999999999999
Q ss_pred CCCHHHHHH--HHHHhH
Q 025816 221 RPNMSIVVK--ALQPLL 235 (247)
Q Consensus 221 Rps~~~il~--~l~~~~ 235 (247)
|||++++++ .++.+.
T Consensus 299 R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 299 RVTAGEALAHPYFESLH 315 (367)
T ss_dssp SCCHHHHHHSGGGTTTC
T ss_pred CCCHHHHhcChHHHhhc
Confidence 999999998 455443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=254.41 Aligned_cols=201 Identities=22% Similarity=0.321 Sum_probs=156.0
Q ss_pred cccccCCCccceeeEEe--eCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLKHENFVQLLGYCV--DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++||||+++++++. +....++||||+.++ |.+++...... .+++..++.++.|++.||.|||+.+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~-- 129 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEK-------RFPVCQAHGYFCQLIDGLEYLHSQG-- 129 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTC-------SCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCccc-------ccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 67899999999999984 456789999999864 77777654432 2899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC--CCccccchhhhHHHHHHHh
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~ 157 (247)
++|+||||+||+++.++.++|+|||.+................++..|+|||.+.+.. ++.++||||||+++|+|++
T Consensus 130 -i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 208 (305)
T 2wtk_C 130 -IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208 (305)
T ss_dssp -EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH
T ss_pred -eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999987654322222223456889999999998644 3779999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|..||...... ...+.+... ....+...+..+.+++.+||..||.+|||++++++.
T Consensus 209 g~~p~~~~~~~----------------~~~~~i~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 209 GLYPFEGDNIY----------------KLFENIGKG-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp SSCSCCCSSHH----------------HHHHHHHHC-CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCCCCCCchHH----------------HHHHHHhcC-CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999743211 011111111 112333456679999999999999999999999973
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.31 Aligned_cols=207 Identities=26% Similarity=0.405 Sum_probs=166.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++. ++..++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 445 l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g---i 512 (656)
T 2j0j_A 445 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLESKR---F 512 (656)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 56789999999999885 4578999999999999999975432 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~ 160 (247)
+||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 513 vHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~ 591 (656)
T 2j0j_A 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591 (656)
T ss_dssp CCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999876433221 1223346778999999999899999999999999999997 999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
||..... ..+...+........+..++..+.+++.+||..||.+|||+.++++.|+.+++.
T Consensus 592 Pf~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 592 PFQGVKN----------------NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TTTTCCH----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCH----------------HHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 9964321 112222222333344556677899999999999999999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=269.28 Aligned_cols=211 Identities=20% Similarity=0.225 Sum_probs=154.7
Q ss_pred cccccCCCccceeeEEeeC------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDG------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
|++++||||+++++++... ...++||||+.+ +|.+.+... +++..+..++.|++.||.|||+
T Consensus 115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~~-----------l~~~~~~~~~~qil~aL~~lH~ 182 (464)
T 3ttj_A 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHS 182 (464)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 6788999999999999655 357999999975 677777431 8899999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ |+||||||+||+++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|
T Consensus 183 ~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 256 (464)
T 3ttj_A 183 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256 (464)
T ss_dssp TT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred CC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHH
Confidence 99 9999999999999999999999999998653321 12345789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcc-------hhhhhccc---------------ccCCC---CCHHHHHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSED-------KVRQCVDA---------------RLGGD---YPPKAVAKMAAVA 210 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~---------------~~~~~---~~~~~~~~l~~li 210 (247)
++|..||.+.+...+...+.......... .....+.. ..... .....+.++.+|+
T Consensus 257 l~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 336 (464)
T 3ttj_A 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 336 (464)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHH
Confidence 99999998654322211111111111100 00111110 00000 0112266799999
Q ss_pred HhhcccCCCCCCCHHHHHHH
Q 025816 211 ALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 211 ~~cl~~~p~~Rps~~~il~~ 230 (247)
.+||..||.+|||++|+++.
T Consensus 337 ~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 337 SKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999983
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=254.58 Aligned_cols=198 Identities=23% Similarity=0.347 Sum_probs=162.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+++..++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---i 136 (294)
T 2rku_A 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNR---V 136 (294)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5788999999999999999999999999999999999875432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 137 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 214 (294)
T 2rku_A 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214 (294)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred cccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876532221 12334688899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|...... ......... ....+...+..+.+++.+||+.||.+|||++++++.
T Consensus 215 ~~~~~~~---------------~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 215 FETSCLK---------------ETYLRIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TCCSSHH---------------HHHHHHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCCCHH---------------HHHHHHhhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 9643211 001111111 112233445679999999999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=272.19 Aligned_cols=203 Identities=25% Similarity=0.348 Sum_probs=163.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++......++||||+.+++|.+.+..... +++..++.++.|++.||.|||+.+
T Consensus 79 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~--- 146 (484)
T 3nyv_A 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGITYMHKNK--- 146 (484)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC---------CBHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999876542 999999999999999999999999
Q ss_pred eEeccCCCCceee---cCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+||++ +.++.++|+|||++........ .....||+.|+|||++.+ .++.++||||+|+++|+|++
T Consensus 147 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~ 222 (484)
T 3nyv_A 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS 222 (484)
T ss_dssp CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHH
T ss_pred eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHH
Confidence 9999999999999 5678899999999875432221 123458999999999876 68999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQP 233 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~ 233 (247)
|..||....... ....+........ .....+..+.++|.+||+.||.+|||++++++ .++.
T Consensus 223 g~~pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 223 GCPPFNGANEYD---------------ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp SSCSSCCSSHHH---------------HHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred CCCCCCCCCHHH---------------HHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 999997543211 1111111111111 11244667999999999999999999999998 4554
Q ss_pred h
Q 025816 234 L 234 (247)
Q Consensus 234 ~ 234 (247)
.
T Consensus 288 ~ 288 (484)
T 3nyv_A 288 Y 288 (484)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=260.48 Aligned_cols=197 Identities=23% Similarity=0.350 Sum_probs=162.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+++..++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 95 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~~---i 162 (335)
T 2owb_A 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNR---V 162 (335)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 5788999999999999999999999999999999999875432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 163 vH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 240 (335)
T 2owb_A 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240 (335)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred EecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCC
Confidence 9999999999999999999999999876532221 12335688999999999998899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|...... ......... ....+...+..+.++|.+||+.||.+|||++++++
T Consensus 241 f~~~~~~---------------~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 241 FETSCLK---------------ETYLRIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TCCSSHH---------------HHHHHHHHT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCCHH---------------HHHHHHhcC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9643211 001111111 11223344567999999999999999999999998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=270.61 Aligned_cols=204 Identities=25% Similarity=0.352 Sum_probs=162.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+....++||||+.+|+|.+.+..... +++..++.++.|++.||.|||+.+
T Consensus 89 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~--- 156 (494)
T 3lij_A 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK---------FNEVDAAVIIKQVLSGVTYLHKHN--- 156 (494)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999998865432 899999999999999999999999
Q ss_pred eEeccCCCCceeecCC---CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDD---DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+||+++.. +.+||+|||++........ .....||..|+|||++. ..++.++||||+|+++|+|++
T Consensus 157 ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~ 232 (494)
T 3lij_A 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232 (494)
T ss_dssp EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH
T ss_pred ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh
Confidence 9999999999999764 4599999999876543221 23456899999999886 468999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCC--CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY--PPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQP 233 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~ 233 (247)
|..||....... ....+......... ....+..+.++|.+||+.||.+|||++++++ .++.
T Consensus 233 g~~pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 233 GYPPFGGQTDQE---------------ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp SSCSSCCSSHHH---------------HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred CCCCCCCCCHHH---------------HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 999997543211 11111111111010 1234567999999999999999999999997 4555
Q ss_pred hH
Q 025816 234 LL 235 (247)
Q Consensus 234 ~~ 235 (247)
..
T Consensus 298 ~~ 299 (494)
T 3lij_A 298 MC 299 (494)
T ss_dssp HH
T ss_pred Cc
Confidence 44
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=257.95 Aligned_cols=202 Identities=18% Similarity=0.273 Sum_probs=158.4
Q ss_pred ccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 3 SRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 3 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++ +||||+++++++..+...++||||+.+|+|.+++...... .+++..++.++.|++.||.|||+.+ +
T Consensus 83 ~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~ql~~~L~~LH~~g---i 152 (327)
T 3lm5_A 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE-------MVSENDVIRLIKQILEGVYYLHQNN---I 152 (327)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-C-------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 345 5699999999999999999999999999999998654332 2999999999999999999999999 9
Q ss_pred EeccCCCCceeecC---CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+||||||+||+++. ++.++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 153 vH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (327)
T 3lm5_A 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229 (327)
T ss_dssp ECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999987 78999999999986543222 1334689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..||.............. .............+..+.++|.+||+.||.+|||++++++.
T Consensus 230 ~~pf~~~~~~~~~~~i~~-------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 230 TSPFVGEDNQETYLNISQ-------------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp SCSSCCSSHHHHHHHHHH-------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCchHHHHHHHh-------------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 999965432111000000 00111112223456679999999999999999999999973
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=250.79 Aligned_cols=207 Identities=21% Similarity=0.341 Sum_probs=162.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ +
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i 129 (283)
T 3bhy_A 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGVHYLHSKR---I 129 (283)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 567899999999999999999999999999999999997543 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCC----ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 82 IHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 82 ~h~di~~~nil~~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
+|+||+|+||+++.++ .++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++++|++
T Consensus 130 ~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 206 (283)
T 3bhy_A 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206 (283)
T ss_dssp ECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHH
Confidence 9999999999998877 799999999876543221 123458889999999998899999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQP 233 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~ 233 (247)
|..||........ ......... ........+..+.+++.+||..||.+|||+.++++ .++.
T Consensus 207 g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 207 GASPFLGETKQET---------------LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp SSCTTCCSSHHHH---------------HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCCCCCCcchHHH---------------HHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 9999975421100 000000000 00001123456999999999999999999999998 5666
Q ss_pred hHhcC
Q 025816 234 LLNAR 238 (247)
Q Consensus 234 ~~~~~ 238 (247)
+....
T Consensus 272 ~~~~~ 276 (283)
T 3bhy_A 272 IRRRN 276 (283)
T ss_dssp HHHCC
T ss_pred HHHHh
Confidence 65543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=260.62 Aligned_cols=215 Identities=23% Similarity=0.268 Sum_probs=161.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++......++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ +
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i 133 (346)
T 1ua2_A 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL--------VLTPSHIKAYMLMTLQGLEYLHQHW---I 133 (346)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCS--------SCCSSHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5678999999999999999999999999985 89988876432 2888899999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+||||||+||+++.++.+||+|||++........ ......+|..|+|||.+.+. .++.++||||||+++|+|++|.+
T Consensus 134 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 211 (346)
T 1ua2_A 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211 (346)
T ss_dssp CCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999999999986543221 12334679999999999764 58899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhh------hhcccccCCCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVR------QCVDARLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||.+.....................+. +..........+ ...+.++.++|.+||..||.+|||++|+++
T Consensus 212 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 212 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 997653221111111000011111000 000000001111 233567999999999999999999999998
Q ss_pred H
Q 025816 230 A 230 (247)
Q Consensus 230 ~ 230 (247)
.
T Consensus 292 h 292 (346)
T 1ua2_A 292 M 292 (346)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=269.59 Aligned_cols=199 Identities=25% Similarity=0.350 Sum_probs=159.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+....++||||+.+++|.+.+..... +++..+..++.|++.||.|||+.+
T Consensus 74 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~--- 141 (486)
T 3mwu_A 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN--- 141 (486)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999998865432 899999999999999999999999
Q ss_pred eEeccCCCCceeec---CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+||+++ .++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+|+++|+|++
T Consensus 142 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~ 217 (486)
T 3mwu_A 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217 (486)
T ss_dssp CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHH
T ss_pred eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHh
Confidence 99999999999995 455799999999976543222 233468999999999876 58999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
|..||....... ....+........ .....+.++.++|.+||+.||.+|||+.++++.
T Consensus 218 g~~pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 218 GTPPFYGKNEYD---------------ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SSCSSCCSSHHH---------------HHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCCCCCHHH---------------HHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 999997542211 1111111111111 112346679999999999999999999999983
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=252.37 Aligned_cols=202 Identities=24% Similarity=0.314 Sum_probs=153.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++.+....++||||+.+++|.+.+...... +..+++..++.++.|++.||.|||+.+ +
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---i 145 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHSQH---V 145 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 67899999999999999999999999999999999988543210 112899999999999999999999999 9
Q ss_pred EeccCCCCceee---cCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||||+||++ +.++.++|+|||++........ .....++..|+|||.+. ..++.++|+||||+++++|++|
T Consensus 146 vH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g 221 (285)
T 3is5_A 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221 (285)
T ss_dssp CCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHS
T ss_pred EECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhC
Confidence 999999999999 4567899999999976543222 23456889999999876 4688999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||.............. ...... ......+..+.+++.+||+.||.+|||++++++
T Consensus 222 ~~pf~~~~~~~~~~~~~~-------------~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 222 CLPFTGTSLEEVQQKATY-------------KEPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp SCSSCCSSHHHHHHHHHH-------------CCCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCCCCCCCHHHHHhhhcc-------------CCcccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999975421110000000 000000 001113466899999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=261.06 Aligned_cols=214 Identities=24% Similarity=0.354 Sum_probs=157.3
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 78 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---i 145 (331)
T 4aaa_A 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---------LDYQVVQKYLFQIINGIGFCHSHN---I 145 (331)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5788999999999999999999999999999888887665432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+. .++.++||||||+++|+|++|..
T Consensus 146 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (331)
T 4aaa_A 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223 (331)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EccCcChheEEEcCCCcEEEEeCCCceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999765432221 2334688899999999875 68999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcch---------hhhhcccccCCCC-----CHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDK---------VRQCVDARLGGDY-----PPKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
||....................... ......+...... ....+..+.+++.+||+.||.+|||+++
T Consensus 224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 303 (331)
T 4aaa_A 224 LFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303 (331)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred CCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHH
Confidence 9976543211111110000000000 0000000000011 1234667999999999999999999999
Q ss_pred HHH
Q 025816 227 VVK 229 (247)
Q Consensus 227 il~ 229 (247)
+++
T Consensus 304 ll~ 306 (331)
T 4aaa_A 304 LLH 306 (331)
T ss_dssp GGG
T ss_pred Hhc
Confidence 987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=254.84 Aligned_cols=218 Identities=25% Similarity=0.337 Sum_probs=159.3
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++..++..++||||+.+++|.+++....... ......+++..++.++.|++.||.|||+.+
T Consensus 66 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--- 141 (303)
T 2vwi_A 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKG-EHKSGVLDESTIATILREVLEGLEYLHKNG--- 141 (303)
T ss_dssp CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTT-TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4788999999999999999999999999999999999986421110 011223899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhh---cccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA---RLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~ 156 (247)
++|+||+|+||+++.++.++|+|||.+........ ........++..|+|||.+.+ ..++.++|+||||+++|+|+
T Consensus 142 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 221 (303)
T 2vwi_A 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221 (303)
T ss_dssp CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999998865432211 111233468899999999876 56899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||.......... ......... .. ............+..+.+++.+||+.||.+|||++++++
T Consensus 222 ~g~~pf~~~~~~~~~~---~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 222 TGAAPYHKYPPMKVLM---LTLQNDPPS-LE---TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HSSCTTTTSCGGGHHH---HHHTSSCCC-TT---C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCCccCchhhHHH---HHhccCCCc-cc---cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 9999997543221100 000000000 00 000011122334567999999999999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=252.31 Aligned_cols=199 Identities=25% Similarity=0.400 Sum_probs=155.9
Q ss_pred CcccccCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 1 MVSRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
++++++||||+++++++.. +...++||||+.+++|.+++..... +++..++.++.|++.||.|||+.
T Consensus 78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~ 148 (290)
T 1t4h_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTR 148 (290)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccC---------CCHHHHHHHHHHHHHHHHHHHcC
Confidence 3678999999999999865 3568999999999999999976432 89999999999999999999988
Q ss_pred CCCCeEeccCCCCceeec-CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
+ .+++|+||||+||+++ .++.++|+|||++....... .....++..|+|||.+.+ .++.++|+||||+++++|
T Consensus 149 ~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l 222 (290)
T 1t4h_A 149 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 222 (290)
T ss_dssp S-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred C-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHH
Confidence 4 2399999999999997 78899999999986543221 233458899999998764 589999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccc-cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR-LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
++|..||....... .....+... .....+...+..+.+++.+||+.||.+|||++++++
T Consensus 223 ~~g~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 223 ATSEYPYSECQNAA---------------QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHSSCTTTTCSSHH---------------HHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCCCCCcCcHH---------------HHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 99999996432111 011111111 011112223356999999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=254.56 Aligned_cols=200 Identities=26% Similarity=0.372 Sum_probs=161.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i 146 (314)
T 3com_A 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK--------TLTEDEIATILQSTLKGLEYLHFMR---K 146 (314)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---C
Confidence 5788999999999999999999999999999999999863221 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+|+||+|+||+++.++.++|+|||.+........ ......++..|.|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 147 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 224 (314)
T 3com_A 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224 (314)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred cCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543221 12334688899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcc-cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVD-ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|........ ...... .......+...+..+.+++.+||..||.+|||+.++++
T Consensus 225 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 225 YADIHPMRA---------------IFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp TTTSCHHHH---------------HHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCChHHH---------------HHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 964321100 000000 00011123344667999999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=265.66 Aligned_cols=200 Identities=18% Similarity=0.164 Sum_probs=158.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.+++..++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+ |
T Consensus 115 l~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~g---i 183 (412)
T 2vd5_A 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVHRLG---Y 183 (412)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999999999999999999999999975321 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-------cCCCCccccchhhhHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-------TGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~~ 154 (247)
+||||||+||+++.++.+||+|||++......... ......||..|+|||++. +..++.++|+||||+++|+
T Consensus 184 iHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilye 262 (412)
T 2vd5_A 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262 (412)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHH
T ss_pred eecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHH
Confidence 99999999999999999999999998765432211 123357899999999997 3568999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC---CCCCHHHHHHHHHHHHhhcccCCCCC---CCHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG---GDYPPKAVAKMAAVAALCVQYEADFR---PNMSIVV 228 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~R---ps~~~il 228 (247)
|++|..||...... .....+...... .......+.++.++|.+||. +|.+| |++++++
T Consensus 263 lltG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~ 326 (412)
T 2vd5_A 263 MFYGQTPFYADSTA---------------ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR 326 (412)
T ss_dssp HHHSSCTTCCSSHH---------------HHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH
T ss_pred HHhCCCCCCCCCHH---------------HHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 99999999754221 111111111100 11123456679999999999 99998 6999998
Q ss_pred H
Q 025816 229 K 229 (247)
Q Consensus 229 ~ 229 (247)
+
T Consensus 327 ~ 327 (412)
T 2vd5_A 327 T 327 (412)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=257.03 Aligned_cols=208 Identities=20% Similarity=0.294 Sum_probs=160.8
Q ss_pred cccccCCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC--
Q 025816 2 VSRLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-- 77 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~-- 77 (247)
+++++||||+++++++.. +...++||||+.+++|.+++...... +..+++..++.++.|++.||.|||+.+
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 133 (279)
T 2w5a_A 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDG 133 (279)
T ss_dssp HHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHC--
T ss_pred HHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcccCC
Confidence 577899999999998754 56899999999999999999754321 123899999999999999999999975
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
..+++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 134 ~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 211 (279)
T 2w5a_A 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211 (279)
T ss_dssp ----CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHH
T ss_pred CCeeEEeccchhhEEEcCCCCEEEecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHH
Confidence 223999999999999999999999999998754332111 123457889999999999899999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
|..||..... ..+.+.+........+...+.++.+++.+||+.||.+|||++++++.+.
T Consensus 212 g~~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 212 LMPPFTAFSQ----------------KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp SSCSSCCSSH----------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred CCCCCcccCH----------------HHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 9999974421 1111112222222344456678999999999999999999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=252.71 Aligned_cols=209 Identities=26% Similarity=0.289 Sum_probs=154.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-CCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~-~~~~ 80 (247)
++.++||||+++++++..+...++||||+.+ +|.+++...... +..+++..++.++.|++.||.|||++ +
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~--- 130 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLHSKLS--- 130 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHSC---
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---
Confidence 5678999999999999999999999999974 888877542110 12399999999999999999999998 8
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhh----hcCCCCccccchhhhHHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA----MTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~~l~~l~ 156 (247)
++|+||||+||+++.++.++|+|||++........ .....++..|+|||.+ .+..++.++|+||+|+++++|+
T Consensus 131 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 207 (290)
T 3fme_A 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 207 (290)
T ss_dssp CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999876543222 2334688899999996 4567899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHh
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPL 234 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~~ 234 (247)
+|..||...... ...+.+..............+.++.+++.+||+.||.+|||++++++ .++..
T Consensus 208 ~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 208 ILRFPYDSWGTP--------------FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HTSCSSCCCSCH--------------HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HCCCCccccCch--------------HHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 999999642111 11122222222222222345667999999999999999999999998 55544
Q ss_pred Hh
Q 025816 235 LN 236 (247)
Q Consensus 235 ~~ 236 (247)
.+
T Consensus 274 ~~ 275 (290)
T 3fme_A 274 ES 275 (290)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=262.97 Aligned_cols=197 Identities=23% Similarity=0.336 Sum_probs=150.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++. ....++||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ +
T Consensus 194 l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i 260 (419)
T 3i6u_A 194 LKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR---------LKEATCKLYFYQMLLAVQYLHENG---I 260 (419)
T ss_dssp HHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 67889999999999875 4568999999999999999875432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCC---ceeeccccccCCcchhhhcccccceeccccccCchhhhc---CCCCccccchhhhHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 82 ~h~di~~~nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l 155 (247)
+||||||+||+++.++ .+||+|||++........ .....||..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 261 vHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~l 337 (419)
T 3i6u_A 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337 (419)
T ss_dssp CCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHH
T ss_pred cccCCChHhEEEecCCCcceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHH
Confidence 9999999999997654 499999999987643221 234568999999999853 5678899999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC---HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP---PKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
++|..||........ +.+.+........+ ...+..+.+++.+||+.||.+|||++++++
T Consensus 338 ltg~~pf~~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 338 LSGYPPFSEHRTQVS---------------LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHSSCSSCCCSSSCC---------------HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHCCCCCCCCcchHH---------------HHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 999999975432111 11111111100000 123567999999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=256.00 Aligned_cols=208 Identities=16% Similarity=0.153 Sum_probs=164.9
Q ss_pred cccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 025816 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 83 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h 83 (247)
...|+||+.+++++..++..++||||+.+|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+|
T Consensus 123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivH 195 (365)
T 3e7e_A 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT----PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIH 195 (365)
T ss_dssp GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTS----TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EEC
T ss_pred hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCC---eec
Confidence 445999999999999999999999999999999999743211 1123999999999999999999999999 999
Q ss_pred ccCCCCceeecC-----------CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHH
Q 025816 84 RDIKSSNVLIFD-----------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL 152 (247)
Q Consensus 84 ~di~~~nil~~~-----------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 152 (247)
|||||+||+++. ++.+||+|||++................||..|+|||++.+..++.++||||||+++
T Consensus 196 rDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 275 (365)
T 3e7e_A 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275 (365)
T ss_dssp CCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHH
T ss_pred CCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHH
Confidence 999999999998 899999999999754332222223445689999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCC-CCHHHHHHHH
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFR-PNMSIVVKAL 231 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-ps~~~il~~l 231 (247)
|+|++|..||....... .. ...... .. .....+.+++..|++.+|.+| |+++++.+.|
T Consensus 276 ~elltg~~pf~~~~~~~--------------~~----~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 276 YCMLFGTYMKVKNEGGE--------------CK----PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp HHHHHSSCCCEEEETTE--------------EE----ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred HHHHhCCCccccCCCCc--------------ee----echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 99999999985322110 00 000000 11 224568899999999999988 5688888899
Q ss_pred HHhHhcCC
Q 025816 232 QPLLNARP 239 (247)
Q Consensus 232 ~~~~~~~~ 239 (247)
+..+...+
T Consensus 335 ~~~l~~~~ 342 (365)
T 3e7e_A 335 KKVFQQHY 342 (365)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHhh
Confidence 88887644
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=263.87 Aligned_cols=223 Identities=17% Similarity=0.216 Sum_probs=159.9
Q ss_pred CcccccCCCccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+|++++||||+++++++.... ..++||||+.+ ++.+.+...... ...+++..++.++.|++.||.|||
T Consensus 85 il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH 158 (394)
T 4e7w_A 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL-----KQTMPMLLIKLYMYQLLRSLAYIH 158 (394)
T ss_dssp HHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 367899999999999986543 37899999986 554444321100 012899999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeec-CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVL 152 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l 152 (247)
+.+ |+||||||+||+++ .++.+||+|||++........ .....+|..|+|||.+.+. .++.++||||+||++
T Consensus 159 ~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 232 (394)
T 4e7w_A 159 SIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232 (394)
T ss_dssp HTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHH
Confidence 999 99999999999999 799999999999976533222 2345678999999998764 589999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC------------CCCCHHHHHHHHHHHHhhcccCCCC
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG------------GDYPPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|+|++|..||.+.....+...............+......... ...+...+.++.+++.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (394)
T 4e7w_A 233 AELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA 312 (394)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhh
Confidence 9999999999865433222211111111111111111100000 0012234567999999999999999
Q ss_pred CCCHHHHHH--HHHHhH
Q 025816 221 RPNMSIVVK--ALQPLL 235 (247)
Q Consensus 221 Rps~~~il~--~l~~~~ 235 (247)
|||+.++++ +++.+.
T Consensus 313 R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 313 RLTAIEALCHPFFDELR 329 (394)
T ss_dssp SCCHHHHHTSGGGSTTT
T ss_pred CCCHHHHhcChhhhhhc
Confidence 999999998 355544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=254.30 Aligned_cols=197 Identities=23% Similarity=0.317 Sum_probs=160.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++.++...++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ +
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i 127 (304)
T 2jam_A 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLHENG---I 127 (304)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 577899999999999999999999999999999999986543 2899999999999999999999999 9
Q ss_pred EeccCCCCceee---cCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||++ +.++.++|+|||.+....... .....++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 128 ~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 203 (304)
T 2jam_A 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203 (304)
T ss_dssp CCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHS
T ss_pred cccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999 778899999999987543221 1234578899999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||....... ....+..... ........+..+.+++.+||..||.+|||++++++
T Consensus 204 ~~pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 204 YPPFYEETESK---------------LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp SCTTTTSCHHH---------------HHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCHHH---------------HHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99996432110 0111111111 11222345677999999999999999999999997
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=270.09 Aligned_cols=205 Identities=20% Similarity=0.296 Sum_probs=164.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++.+....++||||+.||+|.+++...... ...+++..++.++.|++.||.|||+.+ |
T Consensus 239 L~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~g---I 310 (543)
T 3c4z_A 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQRN---I 310 (543)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHHcC---C
Confidence 57789999999999999999999999999999999998764321 123899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.+|.+||+|||++........ ......||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 311 vHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~P 388 (543)
T 3c4z_A 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388 (543)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCC
Confidence 9999999999999999999999999976543221 12334789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 025816 162 VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM-----SIVVK 229 (247)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~il~ 229 (247)
|.......... .....+... ....+...+..+.++|.+||+.||.+||++ ++|++
T Consensus 389 F~~~~~~~~~~-----------~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 389 FRARGEKVENK-----------ELKQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp SCCTTCCCCHH-----------HHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCCCccchhHH-----------HHHHHHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 97543221100 011111111 123445566789999999999999999964 67765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=258.57 Aligned_cols=226 Identities=21% Similarity=0.294 Sum_probs=162.6
Q ss_pred cccccCCCccceeeEEee--------CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRLKHENFVQLLGYCVD--------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
+++++||||+++++++.. ++..++||||+.+ +|.+.+..... .+++..++.++.|++.||.||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~L 140 (351)
T 3mi9_A 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYI 140 (351)
T ss_dssp HHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHH
Confidence 577899999999999987 3468999999975 88888765542 289999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc--ccccceeccccccCchhhhc-CCCCccccchhhhH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGV 150 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~ 150 (247)
|+.+ ++||||||+||+++.++.++|+|||++......... .......+|..|+|||.+.+ ..++.++||||||+
T Consensus 141 H~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 217 (351)
T 3mi9_A 141 HRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 217 (351)
T ss_dssp HHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred HHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHH
Confidence 9999 999999999999999999999999998765322111 11233467999999999876 45799999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhh--------cccccCCCCCH-------HHHHHHHHHHHhhcc
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC--------VDARLGGDYPP-------KAVAKMAAVAALCVQ 215 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~-------~~~~~l~~li~~cl~ 215 (247)
++|+|++|..||........................... ........... ..+..+.++|.+||+
T Consensus 218 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 297 (351)
T 3mi9_A 218 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 297 (351)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSC
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhc
Confidence 999999999999865432221111111111111110000 00000000110 013468899999999
Q ss_pred cCCCCCCCHHHHHHHHHHhHhcCCCC
Q 025816 216 YEADFRPNMSIVVKALQPLLNARPGP 241 (247)
Q Consensus 216 ~~p~~Rps~~~il~~l~~~~~~~~~~ 241 (247)
.||.+|||++|+++. ..+++.+.|
T Consensus 298 ~dP~~R~t~~e~l~h--p~f~~~~~~ 321 (351)
T 3mi9_A 298 LDPAQRIDSDDALNH--DFFWSDPMP 321 (351)
T ss_dssp SSGGGSCCHHHHHTS--GGGGSSSCC
T ss_pred CChhhCCCHHHHhCC--CCcCCCCCc
Confidence 999999999999984 344444433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=258.51 Aligned_cols=217 Identities=21% Similarity=0.285 Sum_probs=150.4
Q ss_pred ccccc-CCCccceeeEEe--------eCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHH
Q 025816 2 VSRLK-HENFVQLLGYCV--------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 72 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 72 (247)
+++++ ||||+++++++. .....+++|||+. |+|.+++...... ..+++..++.++.|++.||.|
T Consensus 79 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~ 151 (337)
T 3ll6_A 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQH 151 (337)
T ss_dssp HHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHH
Confidence 45564 999999999984 3345799999996 6999988652211 138999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcc----------cccceeccccccCchhh---hcCCC
Q 025816 73 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL----------HSTRVLGTFGYHAPEYA---MTGQL 139 (247)
Q Consensus 73 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~ 139 (247)
||+.+ ++++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+ .+..+
T Consensus 152 LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 230 (337)
T 3ll6_A 152 MHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230 (337)
T ss_dssp HHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCS
T ss_pred HHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC
Confidence 99874 239999999999999999999999999998654322211 01134588899999998 56678
Q ss_pred CccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCC
Q 025816 140 NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEAD 219 (247)
Q Consensus 140 ~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 219 (247)
+.++||||||+++|+|++|..||....... ..............+..+.+++.+||+.||.
T Consensus 231 ~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 291 (337)
T 3ll6_A 231 GEKQDIWALGCILYLLCFRQHPFEDGAKLR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPE 291 (337)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCCC-------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGG
T ss_pred ChHHhHHHHHHHHHHHHhCCCCCcchhHHH-------------------hhcCcccCCcccccchHHHHHHHHHccCChh
Confidence 899999999999999999999996432110 1111111111222234588999999999999
Q ss_pred CCCCHHHHHHHHHHhHhcCCCCCCCC
Q 025816 220 FRPNMSIVVKALQPLLNARPGPAGES 245 (247)
Q Consensus 220 ~Rps~~~il~~l~~~~~~~~~~~~~~ 245 (247)
+|||++++++.|+.+..+.+..+..+
T Consensus 292 ~Rps~~e~l~~l~~~~~~~~~~~~~~ 317 (337)
T 3ll6_A 292 ERLSIAEVVHQLQEIAAARNVNPKSP 317 (337)
T ss_dssp GSCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred hCcCHHHHHHHHHHHHhccCCCCCcc
Confidence 99999999999999998877665543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=270.36 Aligned_cols=198 Identities=26% Similarity=0.365 Sum_probs=159.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.++...++|||||.+|+|.+.+..... +++..++.++.|++.||.|||+.+
T Consensus 99 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~--- 166 (504)
T 3q5i_A 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---------FDECDAANIMKQILSGICYLHKHN--- 166 (504)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999998865432 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCC---ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+||+++.++ .++|+|||++........ .....||+.|+|||++.+ .++.++||||+|+++|+|++
T Consensus 167 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~ 242 (504)
T 3q5i_A 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLC 242 (504)
T ss_dssp EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHH
T ss_pred eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHh
Confidence 99999999999998776 699999999976543221 234568999999998874 68999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCC--CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY--PPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||....... .+..+......... ....+.++.++|.+||..||.+|||++++++
T Consensus 243 g~~pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 243 GYPPFGGQNDQD---------------IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp SSCSSCCSSHHH---------------HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCHHH---------------HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999997543211 11111111110000 0123567999999999999999999999997
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=251.99 Aligned_cols=203 Identities=28% Similarity=0.370 Sum_probs=160.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++......++||||+.+++|.+++...... ..+++..+..++.|++.||.|||+.+ +
T Consensus 73 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i 143 (295)
T 2clq_A 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHDNQ---I 143 (295)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 57889999999999999999999999999999999999764321 12678889999999999999999999 9
Q ss_pred EeccCCCCceeecC-CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC--CCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||+++. ++.++|+|||.+........ ......++..|+|||.+.+.. ++.++|+||||+++|+|++|
T Consensus 144 ~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 221 (295)
T 2clq_A 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221 (295)
T ss_dssp ECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHT
T ss_pred EccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999987 89999999999876543221 123346888999999997643 78999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||....... ...............+...+..+.+++.+||+.||.+|||++++++
T Consensus 222 ~~pf~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 222 KPPFYELGEPQ--------------AAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp SCTTGGGSSHH--------------HHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCCccCCCchh--------------HHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99995321110 0011111112223344556678999999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=249.58 Aligned_cols=194 Identities=16% Similarity=0.256 Sum_probs=154.2
Q ss_pred ccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 3 SRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 3 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++ +||||+++++++.++...++||||+.+++|.+++...... ...+++..++.++.|++.||.|||+.+ +
T Consensus 65 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---i 136 (289)
T 1x8b_A 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRI-----MSYFKEAELKDLLLQVGRGLRYIHSMS---L 136 (289)
T ss_dssp HHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhccc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 345 8999999999999999999999999999999999764211 012899999999999999999999999 9
Q ss_pred EeccCCCCceeecCC-------------------CceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCc
Q 025816 82 IHRDIKSSNVLIFDD-------------------DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNA 141 (247)
Q Consensus 82 ~h~di~~~nil~~~~-------------------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ 141 (247)
+|+||||+||+++.+ ..++|+|||.+...... ....++..|+|||.+.+. .++.
T Consensus 137 vH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~ 210 (289)
T 1x8b_A 137 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLP 210 (289)
T ss_dssp ECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHH
T ss_pred eecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCc
Confidence 999999999999844 47999999988764321 223588899999999865 5678
Q ss_pred cccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCC
Q 025816 142 KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFR 221 (247)
Q Consensus 142 ~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 221 (247)
++||||||+++++|++|.+++.... .... +........+...+..+.+++.+||+.||.+|
T Consensus 211 ~~Di~slG~il~~l~~~~~~~~~~~------------------~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 271 (289)
T 1x8b_A 211 KADIFALALTVVCAAGAEPLPRNGD------------------QWHE-IRQGRLPRIPQVLSQEFTELLKVMIHPDPERR 271 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCSSSH------------------HHHH-HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGS
T ss_pred hhhHHHHHHHHHHHhcCCCCCcchh------------------HHHH-HHcCCCCCCCcccCHHHHHHHHHHhCCCcccC
Confidence 9999999999999999988764221 1111 11111223344456779999999999999999
Q ss_pred CCHHHHHH
Q 025816 222 PNMSIVVK 229 (247)
Q Consensus 222 ps~~~il~ 229 (247)
||++++++
T Consensus 272 ps~~~ll~ 279 (289)
T 1x8b_A 272 PSAMALVK 279 (289)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=252.07 Aligned_cols=197 Identities=23% Similarity=0.308 Sum_probs=154.7
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++||||+++++++..+. .++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ +
T Consensus 69 l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i 135 (322)
T 2ycf_A 69 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---I 135 (322)
T ss_dssp HHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 56789999999999987655 899999999999999987543 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCc---eeeccccccCCcchhhhcccccceeccccccCchhhh---cCCCCccccchhhhHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDV---AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~---~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~~l 155 (247)
+|+||||+||+++.++. ++|+|||++........ .....++..|+|||.+. ...++.++||||||+++|+|
T Consensus 136 vH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l 212 (322)
T 2ycf_A 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212 (322)
T ss_dssp ECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHH
T ss_pred eccCCCHHHEEEecCCCCCeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHH
Confidence 99999999999987665 99999999876543221 12345788999999975 45688999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCC---CHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY---PPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
++|..||........ . ...+........ ....+..+.+++.+||..||.+|||++++++
T Consensus 213 ~~g~~pf~~~~~~~~--~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 213 LSGYPPFSEHRTQVS--L-------------KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHSSCSSCSTTCSSC--H-------------HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCCCCCcccchHHH--H-------------HHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 999999975432211 0 000100000000 1123567999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=255.67 Aligned_cols=201 Identities=25% Similarity=0.374 Sum_probs=152.5
Q ss_pred cccc-cCCCccceeeEEee------CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 2 VSRL-KHENFVQLLGYCVD------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
++++ +||||+++++++.. ....++||||+.+++|.+++....... ++...++.++.|++.||.|||
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~~l~~lH 146 (326)
T 2x7f_A 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-------LKEEWIAYICREILRGLSHLH 146 (326)
T ss_dssp HHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGC-------CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCC-------CCHHHHHHHHHHHHHHHHHHH
Confidence 4456 79999999999977 467899999999999999998654322 899999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-----cCCCCccccchhhh
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFG 149 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG 149 (247)
+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+. +..++.++||||||
T Consensus 147 ~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG 221 (326)
T 2x7f_A 147 QHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221 (326)
T ss_dssp HTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHH
T ss_pred HCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHH
Confidence 999 99999999999999999999999999876543221 123346889999999986 45688999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+++|+|++|..||....... ..................+..+.++|.+||..||.+|||++++++
T Consensus 222 ~il~~l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 222 ITAIEMAEGAPPLCDMHPMR---------------ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHHSSCTTTTSCHHH---------------HHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCCCCCCcHHH---------------HHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 99999999999996432110 000111111111112334567999999999999999999999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=257.90 Aligned_cols=204 Identities=23% Similarity=0.281 Sum_probs=161.3
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
|+++ +||||+++++++..+...++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+
T Consensus 112 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~--- 179 (355)
T 1vzo_A 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG--- 179 (355)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4456 699999999999999999999999999999999975432 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc--CCCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g 158 (247)
|+||||||+||+++.++.+||+|||++......... ......||..|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus 180 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g 258 (355)
T 1vzo_A 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258 (355)
T ss_dssp CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999999999998765432221 1233568999999999986 3478899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVKAL 231 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~~l 231 (247)
..||............ ...... .....+...+..+.++|.+||..||.+|| |++++++..
T Consensus 259 ~~pf~~~~~~~~~~~~-----------~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 259 ASPFTVDGEKNSQAEI-----------SRRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp SCTTSCTTSCCCHHHH-----------HHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCCccCCccchHHHH-----------HHHHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 9999754322111100 000100 11234445567799999999999999999 999999843
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=255.48 Aligned_cols=212 Identities=19% Similarity=0.247 Sum_probs=159.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhh------hcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI------LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++||||+++++++.+++..++||||+.+++|.++ +..... ..+++..++.++.|++.||.|||+
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~ 169 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT-------CFIPIQVIKCIIKSVLNSFSYIHN 169 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccc-------cCCCHHHHHHHHHHHHHHHHHHhc
Confidence 6789999999999999999999999999999999999 443222 239999999999999999999999
Q ss_pred -CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCc-cccchhhhHHH
Q 025816 76 -KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNA-KSDVYSFGVVL 152 (247)
Q Consensus 76 -~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslG~~l 152 (247)
.+ ++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+. .++. ++|+||||+++
T Consensus 170 ~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 242 (348)
T 2pml_X 170 EKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242 (348)
T ss_dssp TSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHH
T ss_pred cCC---EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHH
Confidence 88 999999999999999999999999998765332 12345688999999999876 5666 99999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccc---cCCc--chhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATP---KLSE--DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
++|++|..||....... ........ ..+. ...................+..+.+++.+||+.||.+|||++++
T Consensus 243 ~~l~~g~~pf~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~ 320 (348)
T 2pml_X 243 YVMFYNVVPFSLKISLV--ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320 (348)
T ss_dssp HHHHHSSCSSCCSSCSH--HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHHhCCCCCCCCCcHH--HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 99999999997553311 00000000 0000 00000000000001113456679999999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
++
T Consensus 321 l~ 322 (348)
T 2pml_X 321 LK 322 (348)
T ss_dssp HT
T ss_pred hc
Confidence 87
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=249.07 Aligned_cols=197 Identities=23% Similarity=0.304 Sum_probs=153.8
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++..... +++..++.++.|++.||.|||+.+ +
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i 132 (276)
T 2h6d_A 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR---------VEEMEARRLFQQILSAVDYCHRHM---V 132 (276)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHC---S
T ss_pred HhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 5688999999999999999999999999999999999975432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~ 160 (247)
+|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..+ +.++|+||||+++++|++|..
T Consensus 133 ~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 209 (276)
T 2h6d_A 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTL 209 (276)
T ss_dssp SCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876543221 123457889999999987665 689999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
||...... ...+.+... ....+...+..+.+++.+||+.||.+|||++++++.
T Consensus 210 p~~~~~~~----------------~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 210 PFDDEHVP----------------TLFKKIRGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp SSCCSSHH----------------HHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCCcHH----------------HHHHHhhcC-cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 99643210 111111111 112233445679999999999999999999999983
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=268.52 Aligned_cols=221 Identities=19% Similarity=0.282 Sum_probs=153.8
Q ss_pred CcccccCCCccceeeEEeeC-----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 1 MVSRLKHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+|++++||||+++++++... ...++||||+. ++|.+++..... +++..+..++.|++.||.|||+
T Consensus 105 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~ 174 (458)
T 3rp9_A 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVY---------LTELHIKTLLYNLLVGVKYVHS 174 (458)
T ss_dssp HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCC---------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCC---------CCHHHHHHHHHHHHHHHHHHHh
Confidence 36788999999999998443 57899999985 699999976432 9999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc-------------------------ccccceeccccccC
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-------------------------LHSTRVLGTFGYHA 130 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-------------------------~~~~~~~~~~~y~a 130 (247)
.+ |+||||||+|||++.++.+||+|||+++........ .......||..|+|
T Consensus 175 ~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 251 (458)
T 3rp9_A 175 AG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251 (458)
T ss_dssp TT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCC
T ss_pred CC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccC
Confidence 99 999999999999999999999999999865422110 11233467999999
Q ss_pred chhh-hcCCCCccccchhhhHHHHHHHh-----------CCCCCCCCCCCCCc--------------------chhhhcc
Q 025816 131 PEYA-MTGQLNAKSDVYSFGVVLLELLT-----------GRKPVDHTLPRGQQ--------------------SLVTWAT 178 (247)
Q Consensus 131 PE~~-~~~~~~~~~DvwslG~~l~~l~~-----------g~~pf~~~~~~~~~--------------------~~~~~~~ 178 (247)
||++ .+..++.++|||||||++|+|++ |.++|.+....... ..+....
T Consensus 252 PE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~ 331 (458)
T 3rp9_A 252 PELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL 331 (458)
T ss_dssp HHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHH
T ss_pred hHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHc
Confidence 9986 45679999999999999999998 55666543211000 0000000
Q ss_pred ccCCcchhh--------hhccc---ccC---CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHh
Q 025816 179 PKLSEDKVR--------QCVDA---RLG---GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPL 234 (247)
Q Consensus 179 ~~~~~~~~~--------~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~~ 234 (247)
.....+.+. ..+.. ... .......+.++.+|+.+||..||.+|||++|+++ +++.+
T Consensus 332 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 332 GTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp CCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 011111000 00000 000 0011233667999999999999999999999998 44443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=258.58 Aligned_cols=198 Identities=22% Similarity=0.359 Sum_probs=157.7
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++ +||||+++++++......++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.|
T Consensus 153 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~g--- 220 (365)
T 2y7j_A 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHANN--- 220 (365)
T ss_dssp HHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 79999999999999999999999999999999997543 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC------CCCccccchhhhHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG------QLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~~ 154 (247)
++|+||+|+||+++.++.++|+|||++........ .....||..|+|||.+.+. .++.++||||||+++|+
T Consensus 221 i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 297 (365)
T 2y7j_A 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297 (365)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHH
Confidence 99999999999999999999999999876543221 2345689999999998743 57889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC--HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|++|..||....... ....+.........+ ...+..+.+++.+||..||.+|||++++++
T Consensus 298 ll~g~~pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 298 LLAGSPPFWHRRQIL---------------MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHSSCSSCCSSHHH---------------HHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHCCCCCCCCCHHH---------------HHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999996432110 001111111100000 123456999999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=262.88 Aligned_cols=201 Identities=12% Similarity=0.174 Sum_probs=152.9
Q ss_pred cccccCCCcccee-------eEEeeCCe-----------------eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHH
Q 025816 2 VSRLKHENFVQLL-------GYCVDGTS-----------------RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 57 (247)
Q Consensus 2 l~~l~h~~i~~~~-------~~~~~~~~-----------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~ 57 (247)
|++++||||++++ +++..++. .+++|||+ +|+|.+++....... .....+++.
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~--~~~~~l~~~ 206 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHH 206 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT--TTTHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc--cccccccHH
Confidence 6678999999998 66665532 78999999 579999997643211 111225568
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC
Q 025816 58 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 137 (247)
Q Consensus 58 ~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 137 (247)
.++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..... ......| ..|+|||.+.+.
T Consensus 207 ~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 207 ARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhccc
Confidence 88899999999999999999 99999999999999999999999999875322 1123446 899999999887
Q ss_pred -----------CCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHH
Q 025816 138 -----------QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKM 206 (247)
Q Consensus 138 -----------~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 206 (247)
.++.++||||||+++|+|++|..||........... ... .....+.++
T Consensus 278 ~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~---------------~~~------~~~~~~~~~ 336 (377)
T 3byv_A 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW---------------IFR------SCKNIPQPV 336 (377)
T ss_dssp TSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG---------------GGS------SCCCCCHHH
T ss_pred ccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh---------------hhh------hccCCCHHH
Confidence 899999999999999999999999975432211110 000 011234569
Q ss_pred HHHHHhhcccCCCCCCCHHHHHH--HHHHhH
Q 025816 207 AAVAALCVQYEADFRPNMSIVVK--ALQPLL 235 (247)
Q Consensus 207 ~~li~~cl~~~p~~Rps~~~il~--~l~~~~ 235 (247)
.++|.+||..||.+|||+.++++ +++.+.
T Consensus 337 ~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 337 RALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 99999999999999999999997 555443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=262.38 Aligned_cols=226 Identities=19% Similarity=0.234 Sum_probs=151.5
Q ss_pred CcccccCCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 1 MVSRLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+|++++||||+++++++.. +...++||||+.+ +|.+++..............+++..++.++.|++.||.|||+.+
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 148 (405)
T 3rgf_A 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 148 (405)
T ss_dssp HHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678999999999999954 6789999999974 88888864322111111223899999999999999999999999
Q ss_pred CCeEeccCCCCceee----cCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcC-CCCccccchhhhHHH
Q 025816 79 PHIIHRDIKSSNVLI----FDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVL 152 (247)
Q Consensus 79 ~~i~h~di~~~nil~----~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l 152 (247)
|+||||||+||++ +.++.+||+|||++......... .......||..|+|||++.+. .++.++|||||||++
T Consensus 149 --ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 149 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 226 (405)
T ss_dssp --CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred --EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence 9999999999999 67789999999999866432211 122345689999999999874 589999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcc------hh---hhccccCCcchhhhh------------cccccCCCCC---------HHH
Q 025816 153 LELLTGRKPVDHTLPRGQQS------LV---TWATPKLSEDKVRQC------------VDARLGGDYP---------PKA 202 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~------~~---~~~~~~~~~~~~~~~------------~~~~~~~~~~---------~~~ 202 (247)
|+|++|..||.......... .. ...........+... .......... ...
T Consensus 227 ~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (405)
T 3rgf_A 227 AELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306 (405)
T ss_dssp HHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCT
T ss_pred HHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCC
Confidence 99999999997554321000 00 000000000000000 0000000000 011
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 203 VAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 203 ~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
+..+.+||.+||..||.+|||++++++.
T Consensus 307 ~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 307 DSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp TSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 4568899999999999999999999984
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.57 Aligned_cols=193 Identities=23% Similarity=0.276 Sum_probs=161.8
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
+||||+++++++.+...+++||||+.+|+|.+++..... +++..++.++.|++.||.|||+.+ |+|||
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---IiHrD 467 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRD 467 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTS---EECCC
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEecc
Confidence 799999999999999999999999999999999986432 999999999999999999999999 99999
Q ss_pred CCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCC
Q 025816 86 IKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165 (247)
Q Consensus 86 i~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 165 (247)
|||+|||++.++.+||+|||++........ ......||..|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 468 LKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp CCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999875322221 234467899999999999999999999999999999999999999754
Q ss_pred CCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 025816 166 LPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM-----SIVVK 229 (247)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~il~ 229 (247)
+.. .....+.... ..++...+.++.+||.+||+.||.+||++ ++|++
T Consensus 546 ~~~---------------~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 546 DED---------------ELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SHH---------------HHHHHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CHH---------------HHHHHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 221 1112222211 23455667789999999999999999997 77765
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=256.35 Aligned_cols=210 Identities=20% Similarity=0.213 Sum_probs=151.1
Q ss_pred cccccCCCccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++||||+++++++.... ..++||||+.+ +|.+.+... +++..+..++.|++.||.|||+
T Consensus 78 l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~lH~ 145 (371)
T 2xrw_A 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHS 145 (371)
T ss_dssp HHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhhc-----------cCHHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999997665 78999999975 888888631 8899999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ ++||||||+||+++.++.+||+|||++....... ......+|..|+|||++.+..++.++||||||+++|+|
T Consensus 146 ~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 219 (371)
T 2xrw_A 146 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219 (371)
T ss_dssp TT---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred CC---eecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHH
Confidence 99 9999999999999999999999999997653321 12335688999999999998999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccC----------------------CcchhhhhcccccCCC---CCHHHHHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKL----------------------SEDKVRQCVDARLGGD---YPPKAVAKMAAVA 210 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 210 (247)
++|..||.+.+............... ................ .....+..+.+++
T Consensus 220 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 299 (371)
T 2xrw_A 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 299 (371)
T ss_dssp HHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHH
Confidence 99999997654321111000000000 0000001111111000 1123367899999
Q ss_pred HhhcccCCCCCCCHHHHHH
Q 025816 211 ALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 211 ~~cl~~~p~~Rps~~~il~ 229 (247)
.+||..||.+|||++++++
T Consensus 300 ~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 300 SKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHSCSSGGGSCCHHHHHH
T ss_pred HHHCcCChhhCCCHHHHhC
Confidence 9999999999999999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=262.25 Aligned_cols=222 Identities=19% Similarity=0.239 Sum_probs=156.8
Q ss_pred CcccccCCCccceeeEEeeC-----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 1 MVSRLKHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+|++++||||+++++++... ...++||||+. ++|.+++..... +++..+..++.|++.||.|||+
T Consensus 78 ~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~i~~qil~aL~~LH~ 147 (432)
T 3n9x_A 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIF---------LTEEHIKTILYNLLLGENFIHE 147 (432)
T ss_dssp HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCC---------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHH
Confidence 36788999999999999776 57899999996 599999976432 9999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc--------------------ccccceeccccccCchhh-
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--------------------LHSTRVLGTFGYHAPEYA- 134 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~- 134 (247)
.+ |+||||||+||+++.++.+||+|||+++........ .......||..|+|||++
T Consensus 148 ~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 224 (432)
T 3n9x_A 148 SG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224 (432)
T ss_dssp TT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHT
T ss_pred CC---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh
Confidence 99 999999999999999999999999999865432211 112345689999999986
Q ss_pred hcCCCCccccchhhhHHHHHHHhCCCCCCC-----------CCCCCC-----------------cchhhhccccCCc---
Q 025816 135 MTGQLNAKSDVYSFGVVLLELLTGRKPVDH-----------TLPRGQ-----------------QSLVTWATPKLSE--- 183 (247)
Q Consensus 135 ~~~~~~~~~DvwslG~~l~~l~~g~~pf~~-----------~~~~~~-----------------~~~~~~~~~~~~~--- 183 (247)
....++.++|||||||++|+|++|..||.. ...... ...+.......+.
T Consensus 225 ~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~ 304 (432)
T 3n9x_A 225 LQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDL 304 (432)
T ss_dssp TCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHH
T ss_pred cCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHH
Confidence 456799999999999999999986555432 211000 0000000011111
Q ss_pred -----chhhhhcccccC-CCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhH
Q 025816 184 -----DKVRQCVDARLG-GDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLL 235 (247)
Q Consensus 184 -----~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~~~ 235 (247)
......+..... ...+ ...+.++.+|+.+||..||.+|||++++++ .++.+.
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 305 KNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 111111111000 0000 234567999999999999999999999998 455543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=260.28 Aligned_cols=224 Identities=20% Similarity=0.274 Sum_probs=162.4
Q ss_pred CcccccCCCccceeeEEeeC--------------------------------------CeeeEEEecCCCCChhhhhcCC
Q 025816 1 MVSRLKHENFVQLLGYCVDG--------------------------------------TSRVLAYEFASNGSLHDILHGR 42 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~--------------------------------------~~~~lv~e~~~~~~L~~~~~~~ 42 (247)
+|++++||||+++++++... ...++||||+.+ +|.+.+...
T Consensus 53 il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~ 131 (383)
T 3eb0_A 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSF 131 (383)
T ss_dssp HHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHH
T ss_pred HHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHH
Confidence 36889999999999998543 348899999974 887777532
Q ss_pred CCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeec-CCCceeeccccccCCcchhhhcccccc
Q 025816 43 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTR 121 (247)
Q Consensus 43 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~ 121 (247)
... +..+++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||.+........ ...
T Consensus 132 ~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~ 200 (383)
T 3eb0_A 132 IRS-----GRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVA 200 (383)
T ss_dssp HHT-----TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCC
T ss_pred Hhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcC
Confidence 110 123999999999999999999999999 99999999999997 688999999999976533222 234
Q ss_pred eeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcc---------
Q 025816 122 VLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD--------- 191 (247)
Q Consensus 122 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 191 (247)
..++..|+|||.+.+. .++.++||||+||++|+|++|..||.+.....+.............+.+.....
T Consensus 201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 280 (383)
T 3eb0_A 201 YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT 280 (383)
T ss_dssp CCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCC
T ss_pred cccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCc
Confidence 4678899999998875 489999999999999999999999986543322111111111111111111100
Q ss_pred ---cccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhHh
Q 025816 192 ---ARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLN 236 (247)
Q Consensus 192 ---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~~~~ 236 (247)
.......+...+.++.+++.+||+.||.+|||+.|+++ +++.+.+
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 281 LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred cCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 00000123335667999999999999999999999996 5555543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=262.27 Aligned_cols=216 Identities=22% Similarity=0.297 Sum_probs=164.7
Q ss_pred cccccC-CCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKH-ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++.|+| +++..+..++......++||||+ +++|.+++..... .+++..++.++.||+.||.|||+.+
T Consensus 56 l~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g--- 123 (483)
T 3sv0_A 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVHSKS--- 123 (483)
T ss_dssp HHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 456766 56666666677788899999999 7899999975332 2999999999999999999999999
Q ss_pred eEeccCCCCceee---cCCCceeeccccccCCcchhhhc-----ccccceeccccccCchhhhcCCCCccccchhhhHHH
Q 025816 81 IIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL 152 (247)
Q Consensus 81 i~h~di~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 152 (247)
|+||||||+|||+ +.++.+||+|||++......... .......||..|+|||.+.+..++.++||||||+++
T Consensus 124 IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil 203 (483)
T 3sv0_A 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL 203 (483)
T ss_dssp EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHH
Confidence 9999999999999 68889999999999865443221 112245689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
|+|++|..||.................. .+...+.. ....++.++.+++.+||+.+|.+||++++|++.|+
T Consensus 204 ~elltG~~Pf~~~~~~~~~~~~~~i~~~----~~~~~~~~-----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~ 274 (483)
T 3sv0_A 204 MYFLRGSLPWQGLKAGTKKQKYEKISEK----KVATSIEA-----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274 (483)
T ss_dssp HHHHHSSCTTSSCCCSSHHHHHHHHHHH----HHHSCHHH-----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHHhCCCCCccccchhHHHHHHHHhhc----cccccHHH-----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 9999999999765432221111111000 00000000 00123467999999999999999999999999999
Q ss_pred HhHhcC
Q 025816 233 PLLNAR 238 (247)
Q Consensus 233 ~~~~~~ 238 (247)
.++...
T Consensus 275 ~l~~~~ 280 (483)
T 3sv0_A 275 DLFIRE 280 (483)
T ss_dssp HHHHHT
T ss_pred HHHHHc
Confidence 886543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=259.78 Aligned_cols=214 Identities=21% Similarity=0.258 Sum_probs=161.0
Q ss_pred cccccCCCccceeeEEeeC-----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 2 VSRLKHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
|++++||||+++++++... ...++||||+. ++|.+++.... +++..+..++.|++.||.|||+.
T Consensus 79 l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~ 147 (364)
T 3qyz_A 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSA 147 (364)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 5788999999999998765 36899999997 49999997643 89999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
+ ++||||||+||+++.++.++|+|||++.......... ......||..|+|||.+.+ ..++.++||||||+++|+
T Consensus 148 ~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 224 (364)
T 3qyz_A 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224 (364)
T ss_dssp T---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHH
T ss_pred C---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHH
Confidence 9 9999999999999999999999999998654432221 1233568999999998765 458999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhc--------ccccC-CCC-----CHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCV--------DARLG-GDY-----PPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|..||.......................+.... ..... ... ....+.++.+++.+||+.||.+
T Consensus 225 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 304 (364)
T 3qyz_A 225 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 304 (364)
T ss_dssp HHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTT
T ss_pred HHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhh
Confidence 999999997654333222211111111111111100 00000 000 1233567999999999999999
Q ss_pred CCCHHHHHH
Q 025816 221 RPNMSIVVK 229 (247)
Q Consensus 221 Rps~~~il~ 229 (247)
|||++++++
T Consensus 305 R~t~~e~l~ 313 (364)
T 3qyz_A 305 RIEVEQALA 313 (364)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999998
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=263.10 Aligned_cols=210 Identities=25% Similarity=0.324 Sum_probs=147.3
Q ss_pred cccccCCCccceeeEEeeC------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDG------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
|++++||||+++++++... ...+++||++ +++|.+++.... +++..+..++.|++.||.|||+
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~ 150 (367)
T 2fst_X 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHS 150 (367)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----CC----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 5788999999999998754 5679999999 579999887532 9999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
.+ ++||||||+||+++.++.+||+|||+++..... .....+|..|+|||++.+ ..++.++|||||||++++
T Consensus 151 ~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 222 (367)
T 2fst_X 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222 (367)
T ss_dssp TT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHH
T ss_pred CC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHH
Confidence 99 999999999999999999999999999764322 133568999999999887 678999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcc--------hhhhhcccccCC-CC-----CHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSED--------KVRQCVDARLGG-DY-----PPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~-----~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|..||.+.+...+...+.......... .....+...... .. ....+..+.+|+.+||..||.+
T Consensus 223 ll~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~ 302 (367)
T 2fst_X 223 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302 (367)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCccc
Confidence 999999998655332222111111111111 111111110000 00 0123466899999999999999
Q ss_pred CCCHHHHHHH
Q 025816 221 RPNMSIVVKA 230 (247)
Q Consensus 221 Rps~~~il~~ 230 (247)
|||++++++.
T Consensus 303 R~t~~e~L~h 312 (367)
T 2fst_X 303 RITAAQALAH 312 (367)
T ss_dssp SCCHHHHHTS
T ss_pred CcCHHHHhcC
Confidence 9999999983
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=252.07 Aligned_cols=212 Identities=19% Similarity=0.282 Sum_probs=159.7
Q ss_pred cccCCCccceeeEEe-----eCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 4 RLKHENFVQLLGYCV-----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+++||||+++++++. .....++||||+. |+|.+++....... +++..++.++.|++.||.|||+.+
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~g- 140 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPG-------VPTETIKDMMFQLLRGLDFLHSHR- 140 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTC-------SCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCC-------CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 348999999999987 4567899999997 59999997654322 899999999999999999999999
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 141 --i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 215 (326)
T 1blx_A 141 --VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215 (326)
T ss_dssp --CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred --ceeccCCHHHeEEcCCCCEEEecCcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999986543322 2345678999999999988999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhh-------hccc---ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQ-------CVDA---RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
..||.......................+.. .... ..........+..+.+++.+||..||.+|||+++++
T Consensus 216 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 216 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 999976543211111100000000000000 0000 000112234456799999999999999999999999
Q ss_pred H
Q 025816 229 K 229 (247)
Q Consensus 229 ~ 229 (247)
+
T Consensus 296 ~ 296 (326)
T 1blx_A 296 S 296 (326)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=252.61 Aligned_cols=200 Identities=23% Similarity=0.335 Sum_probs=156.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..+...++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ +
T Consensus 70 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i 138 (302)
T 2j7t_A 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLHSKR---I 138 (302)
T ss_dssp HHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhcCC---c
Confidence 5678999999999999999999999999999999998865322 2899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-----cCCCCccccchhhhHHHHHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~~l~ 156 (247)
+|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+. +..++.++|+||||+++|+|+
T Consensus 139 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 216 (302)
T 2j7t_A 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216 (302)
T ss_dssp CCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHH
T ss_pred ccCCCCHHHEEECCCCCEEEEECCCCcccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHh
Confidence 9999999999999999999999998754322111 123346889999999984 567889999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||....... .......... ....+...+..+.+++.+||+.||.+|||++++++
T Consensus 217 ~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 217 QIEPPHHELNPMR---------------VLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HSSCTTTTSCHHH---------------HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCCCCccCCHHH---------------HHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 9999997442210 0011110000 01123345667999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=249.23 Aligned_cols=198 Identities=24% Similarity=0.281 Sum_probs=158.9
Q ss_pred ccccc-CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++ ||||+++++++..+...++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--- 144 (298)
T 1phk_A 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLN--- 144 (298)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 45564 9999999999999999999999999999999997643 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh------cCCCCccccchhhhHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM------TGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~~l~~ 154 (247)
++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+. ...++.++|+||||+++++
T Consensus 145 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~ 221 (298)
T 1phk_A 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221 (298)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred cccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHH
Confidence 99999999999999999999999999876543221 23346788999999985 3467889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCC--CCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG--DYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|++|..||...... ............. ......+..+.+++.+||+.||.+|||++++++
T Consensus 222 l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 222 LLAGSPPFWHRKQM---------------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHSSCSSCCSSHH---------------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCcCccHH---------------HHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 99999999643211 0011111111111 111345677999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=264.20 Aligned_cols=223 Identities=20% Similarity=0.232 Sum_probs=159.1
Q ss_pred CcccccCCCccceeeEEeeC------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVDG------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+|++++||||+++++++... ...++||||+.+ ++.+.+...... ...+++..+..++.|++.||.|||
T Consensus 100 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH 173 (420)
T 1j1b_A 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIH 173 (420)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 36789999999999988542 236799999975 777766432110 112899999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCC-CceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVL 152 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l 152 (247)
+.+ |+||||||+|||++.+ +.+||+|||+++....... .....+|..|+|||++.+. .++.++|||||||++
T Consensus 174 ~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 247 (420)
T 1j1b_A 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247 (420)
T ss_dssp TTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHH
Confidence 999 9999999999999965 5689999999976533221 2335689999999998764 789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCC------------CCCHHHHHHHHHHHHhhcccCCCC
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGG------------DYPPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|+|++|..||.+.....+...+.........+.+.+........ .++...+.++.+||.+||..||.+
T Consensus 248 ~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 327 (420)
T 1j1b_A 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327 (420)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhH
Confidence 99999999998654322211111111111111111110000000 012234567999999999999999
Q ss_pred CCCHHHHHH--HHHHhH
Q 025816 221 RPNMSIVVK--ALQPLL 235 (247)
Q Consensus 221 Rps~~~il~--~l~~~~ 235 (247)
|||+.++++ +++.+.
T Consensus 328 R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 328 RLTPLEACAHSFFDELR 344 (420)
T ss_dssp SCCHHHHHTSGGGGGGG
T ss_pred CCCHHHHhCCHhhcccc
Confidence 999999997 454443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=253.80 Aligned_cols=213 Identities=17% Similarity=0.215 Sum_probs=143.3
Q ss_pred ccccCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 3 SRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+.++||||+++++++.. +...++||||+.+|+|.+++...... .+++..++.++.|++.||.|||+.+
T Consensus 77 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~ql~~~l~~LH~~~- 148 (336)
T 3fhr_A 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-------AFTEREAAEIMRDIGTAIQFLHSHN- 148 (336)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CC-------CCBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 46789999999999876 44589999999999999999876432 2999999999999999999999999
Q ss_pred CCeEeccCCCCceeecCC---CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 79 PHIIHRDIKSSNVLIFDD---DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
++||||||+||+++.+ +.++|+|||++....... .....++..|+|||.+.+..++.++||||||+++|+|
T Consensus 149 --ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (336)
T 3fhr_A 149 --IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 222 (336)
T ss_dssp --EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHH
T ss_pred --eecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999764 459999999987553322 1334578899999999888899999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQP 233 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~ 233 (247)
++|..||............. . .................+..+.+++.+||+.||.+|||++++++ ++++
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 223 LCGFPPFYSNTGQAISPGMK--------R-RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp HHSSCCC------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHCCCCCCCccchhhhhhHH--------H-hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 99999997543221100000 0 00000000111111344667999999999999999999999998 5555
Q ss_pred hHhcC
Q 025816 234 LLNAR 238 (247)
Q Consensus 234 ~~~~~ 238 (247)
....+
T Consensus 294 ~~~~~ 298 (336)
T 3fhr_A 294 SMVVP 298 (336)
T ss_dssp GGGSC
T ss_pred cccCC
Confidence 44333
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=263.43 Aligned_cols=148 Identities=24% Similarity=0.295 Sum_probs=130.1
Q ss_pred cccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 025816 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 83 (247)
Q Consensus 4 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h 83 (247)
..+|+||+++++++......++||||+. ++|.+++....... +++..++.++.|++.||.|||+.+ |+|
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~aL~~LH~~~---ivH 223 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQG-------FSLPLVRKFAHSILQCLDALHKNR---IIH 223 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHHHT---EEC
T ss_pred ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 3478899999999999999999999996 59999998765433 899999999999999999999999 999
Q ss_pred ccCCCCceeecCCCc--eeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 84 RDIKSSNVLIFDDDV--AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 84 ~di~~~nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
|||||+||+++.++. +||+|||++...... .....+|..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 224 rDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~p 298 (429)
T 3kvw_A 224 CDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298 (429)
T ss_dssp SCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCC
Confidence 999999999999887 999999998653221 2334688999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 025816 162 VDHTLP 167 (247)
Q Consensus 162 f~~~~~ 167 (247)
|...+.
T Consensus 299 f~~~~~ 304 (429)
T 3kvw_A 299 LPGEDE 304 (429)
T ss_dssp SCCSSH
T ss_pred CCCCCH
Confidence 976543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=252.89 Aligned_cols=208 Identities=17% Similarity=0.245 Sum_probs=158.5
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 85 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~d 85 (247)
.|++++++++++......++||||+ +++|.+++....... +++..+..++.|++.||.|||+.+ ++|||
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 143 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLP-------FRLDHIRKMAYQICKSVNFLHSNK---LTHTD 143 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCC-------CcHHHHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence 3446999999999999999999999 779999997654322 889999999999999999999999 99999
Q ss_pred CCCCceeecC-------------------CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccch
Q 025816 86 IKSSNVLIFD-------------------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY 146 (247)
Q Consensus 86 i~~~nil~~~-------------------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 146 (247)
|||+||+++. ++.++|+|||.+...... .....+|..|+|||.+.+..++.++|||
T Consensus 144 lkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 218 (339)
T 1z57_A 144 LKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVW 218 (339)
T ss_dssp CCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHH
T ss_pred CCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhH
Confidence 9999999987 667999999998753321 2334689999999999998999999999
Q ss_pred hhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhh--------------------------hccc-ccCCCCC
Q 025816 147 SFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ--------------------------CVDA-RLGGDYP 199 (247)
Q Consensus 147 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~-~~~~~~~ 199 (247)
|||+++|+|++|..||...+...............+...+.. .... .......
T Consensus 219 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (339)
T 1z57_A 219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298 (339)
T ss_dssp HHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccc
Confidence 999999999999999976543221111111111111100000 0000 0001223
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 200 PKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 200 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
...+..+.+++.+||+.||.+|||++|+++
T Consensus 299 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 299 DVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp SHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 456788999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=259.99 Aligned_cols=199 Identities=11% Similarity=0.054 Sum_probs=141.2
Q ss_pred cCCCcccee-------eEEeeC-----------------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHH--
Q 025816 6 KHENFVQLL-------GYCVDG-----------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR-- 59 (247)
Q Consensus 6 ~h~~i~~~~-------~~~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~-- 59 (247)
+||||++++ +++... ...++||||+. |+|.+++...... +....+
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~~~~~~ 192 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--------YVFRGDEG 192 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--------CCCCHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--------cchhhhhh
Confidence 699977754 555433 33799999998 7999999864221 444445
Q ss_pred ----HHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh
Q 025816 60 ----VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 135 (247)
Q Consensus 60 ----~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 135 (247)
..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ....++..|+|||.+.
T Consensus 193 ~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~ 264 (371)
T 3q60_A 193 ILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLN 264 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHT
T ss_pred hhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhcc
Confidence 677799999999999999 9999999999999999999999999998653221 1334668999999998
Q ss_pred c--CCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhh
Q 025816 136 T--GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALC 213 (247)
Q Consensus 136 ~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 213 (247)
+ ..++.++||||||+++|+|++|..||........... .....................+..+.++|.+|
T Consensus 265 ~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 336 (371)
T 3q60_A 265 ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336 (371)
T ss_dssp CSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHH
T ss_pred CCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHH
Confidence 7 6799999999999999999999999976543221111 00000011111111112234567799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025816 214 VQYEADFRPNMSIVVK 229 (247)
Q Consensus 214 l~~~p~~Rps~~~il~ 229 (247)
|+.||.+|||++++++
T Consensus 337 L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 337 LNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCSSTTTCCCHHHHTT
T ss_pred cCCChhhCCCHHHHhc
Confidence 9999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=251.67 Aligned_cols=208 Identities=16% Similarity=0.241 Sum_probs=157.1
Q ss_pred ccccc-CCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 2 VSRLK-HENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+++++ ||||+++++++.. ....++||||+.+++|.+++.. ++...+..++.|++.||.|||+.+
T Consensus 84 l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~~- 150 (330)
T 3nsz_A 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSMG- 150 (330)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45676 9999999999987 6678999999999999999853 888999999999999999999999
Q ss_pred CCeEeccCCCCceeecCCC-ceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHH
Q 025816 79 PHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~ 156 (247)
++||||||+||+++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 151 --ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 225 (330)
T 3nsz_A 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225 (330)
T ss_dssp --EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred --eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHH
Confidence 99999999999999777 899999999975543222 234467889999999987 67899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhh---------------h--------cccccCCCCCHHHHHHHHHHHHhh
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQ---------------C--------VDARLGGDYPPKAVAKMAAVAALC 213 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~--------~~~~~~~~~~~~~~~~l~~li~~c 213 (247)
+|..||......... ..............+ . .............+.++.++|.+|
T Consensus 226 ~g~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 303 (330)
T 3nsz_A 226 FRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 303 (330)
T ss_dssp HTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTT
T ss_pred hCCCCcccCCchHHH--HHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHH
Confidence 999999533211000 000000000000000 0 000111112233567899999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025816 214 VQYEADFRPNMSIVVK 229 (247)
Q Consensus 214 l~~~p~~Rps~~~il~ 229 (247)
|+.||.+|||++++++
T Consensus 304 L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 304 LRYDHQSRLTAREAME 319 (330)
T ss_dssp SCSSGGGSCCHHHHHT
T ss_pred hcCCcccCCCHHHHhc
Confidence 9999999999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=250.40 Aligned_cols=201 Identities=21% Similarity=0.397 Sum_probs=154.0
Q ss_pred ccccc--CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 2 VSRLK--HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 2 l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+++++ ||||+++++++..+...+++||+ .+++|.+++..... +++..++.++.|++.||.|||+.+
T Consensus 80 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~-- 147 (313)
T 3cek_A 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG-- 147 (313)
T ss_dssp HHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 45565 59999999999999999999994 56799999976542 899999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-----------CCCCccccchhh
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLNAKSDVYSF 148 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dvwsl 148 (247)
++|+||||+||+++. +.++|+|||++................++..|+|||.+.+ ..++.++|||||
T Consensus 148 -ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 148 -IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp -CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred -ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 999999999999964 8999999999986644332222234568999999999875 467889999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 149 GVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 149 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
|+++|+|++|..||...... ...+....+.......+...+..+.+++.+||+.||.+|||+++++
T Consensus 226 G~il~el~~g~~pf~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 291 (313)
T 3cek_A 226 GCILYYMTYGKTPFQQIINQ--------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291 (313)
T ss_dssp HHHHHHHHHSSCTTTTCCSH--------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHhCCCchhhHHHH--------------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHh
Confidence 99999999999999643211 1112222333333334444466799999999999999999999999
Q ss_pred HH
Q 025816 229 KA 230 (247)
Q Consensus 229 ~~ 230 (247)
+.
T Consensus 292 ~h 293 (313)
T 3cek_A 292 AH 293 (313)
T ss_dssp TS
T ss_pred cC
Confidence 84
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=253.93 Aligned_cols=223 Identities=19% Similarity=0.225 Sum_probs=158.9
Q ss_pred cccccCCCccceeeEEeeCCe-------eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 2 VSRLKHENFVQLLGYCVDGTS-------RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+++++||||+++++++..... .++||||+.+ +|.+.+..... ....+++..+..++.|++.||.|||
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH 146 (360)
T 3e3p_A 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYR-----RQVAPPPILIKVFLFQLIRSIGCLH 146 (360)
T ss_dssp HHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHT
T ss_pred HHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHh
Confidence 356799999999999865433 7899999986 66554432110 0112889999999999999999999
Q ss_pred --cCCCCCeEeccCCCCceeecC-CCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhH
Q 025816 75 --EKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGV 150 (247)
Q Consensus 75 --~~~~~~i~h~di~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~ 150 (247)
+.+ |+||||||+||+++. ++.++|+|||++........ .....+|..|+|||.+.+. .++.++||||||+
T Consensus 147 ~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 220 (360)
T 3e3p_A 147 LPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGC 220 (360)
T ss_dssp STTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred CCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHH
Confidence 888 999999999999996 89999999999986543322 1234578899999998764 4899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcc---------------cccCCCCCHHHHHHHHHHHHhhcc
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD---------------ARLGGDYPPKAVAKMAAVAALCVQ 215 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~cl~ 215 (247)
++|+|++|..||.......................+..... ...........+..+.+++.+||+
T Consensus 221 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 300 (360)
T 3e3p_A 221 IFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300 (360)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTC
T ss_pred HHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhc
Confidence 99999999999976543221111111111111111100000 000112223356789999999999
Q ss_pred cCCCCCCCHHHHHH--HHHHhHh
Q 025816 216 YEADFRPNMSIVVK--ALQPLLN 236 (247)
Q Consensus 216 ~~p~~Rps~~~il~--~l~~~~~ 236 (247)
.||.+|||+.++++ +++++..
T Consensus 301 ~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 301 YLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGGGGGC
T ss_pred cCccccCCHHHHhcCccccccCC
Confidence 99999999999998 4555543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=248.91 Aligned_cols=199 Identities=24% Similarity=0.340 Sum_probs=146.2
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-CCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~-~~~~ 80 (247)
++.++||||+++++++..+...++||||+ ++.+..+...... .+++..++.++.|++.||.|||+. +
T Consensus 78 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~~--- 145 (318)
T 2dyl_A 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG--------PIPERILGKMTVAIVKALYYLKEKHG--- 145 (318)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHHHC---
T ss_pred HHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhhCC---
Confidence 46789999999999999999999999999 4466666543221 289999999999999999999995 8
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-----cCCCCccccchhhhHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~~l 155 (247)
++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+. ...++.++||||||+++|+|
T Consensus 146 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l 222 (318)
T 2dyl_A 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222 (318)
T ss_dssp CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHH
T ss_pred EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHH
Confidence 99999999999999999999999999875533221 13345888999999984 45688899999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc-CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL-GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
++|..||...... ...+........ ........+.++.+++.+||..||.+|||++++++
T Consensus 223 ~~g~~pf~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 223 ATGQFPYKNCKTD--------------FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHSSCTTTTCCSH--------------HHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HhCCCCCCCCCcc--------------HHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 9999999643211 001111111100 00111234567999999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=245.64 Aligned_cols=202 Identities=25% Similarity=0.370 Sum_probs=159.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++......++||||+.+++|.+.+..... +++..++.++.|++.||.|||+.+ +
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i 142 (287)
T 2wei_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN---I 142 (287)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5788999999999999999999999999999999998865432 899999999999999999999999 9
Q ss_pred EeccCCCCceeecCCC---ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 82 IHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 82 ~h~di~~~nil~~~~~---~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
+|+||+|+||+++.++ .++|+|||.+........ .....++..|+|||.+.+ .++.++|+||||+++++|++|
T Consensus 143 ~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g 218 (287)
T 2wei_A 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG 218 (287)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHS
T ss_pred eccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhC
Confidence 9999999999997644 699999999876533221 123357889999998876 489999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC--HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHh
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP--PKAVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPL 234 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~~ 234 (247)
..||....... ....+.........+ ...+.++.+++.+||+.||.+|||++++++ ++++.
T Consensus 219 ~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 219 TPPFYGKNEYD---------------ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp SCSSCCSSHHH---------------HHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred CCCCCCCCHHH---------------HHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99997542211 011111111111111 234567999999999999999999999998 44443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=257.51 Aligned_cols=213 Identities=21% Similarity=0.283 Sum_probs=151.2
Q ss_pred cccccCCCccceeeEEee-----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 2 VSRLKHENFVQLLGYCVD-----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+++++||||+++++++.. ....++||||+. |+|.+.+..... .+++..+..++.|++.||.|||+.
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~ 153 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--------VISPQHIQYFMYHILLGLHVLHEA 153 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 578899999999999854 346899999997 589888875432 289999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l 155 (247)
+ ++|+||||+||+++.++.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 154 ~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 227 (362)
T 3pg1_A 154 G---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227 (362)
T ss_dssp T---CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHH
T ss_pred c---CEecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHH
Confidence 9 99999999999999999999999999975433222 233467889999999887 6789999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCc--------chhhhhcccccCC-------CCCHHHHHHHHHHHHhhcccCCCC
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSE--------DKVRQCVDARLGG-------DYPPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~ 220 (247)
++|..||..................... ............. ......+..+.+++.+||+.||.+
T Consensus 228 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 307 (362)
T 3pg1_A 228 FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307 (362)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhh
Confidence 9999999754321111111000000000 0001111111100 011233567999999999999999
Q ss_pred CCCHHHHHH
Q 025816 221 RPNMSIVVK 229 (247)
Q Consensus 221 Rps~~~il~ 229 (247)
|||++++++
T Consensus 308 Rpt~~ell~ 316 (362)
T 3pg1_A 308 RISTEQALR 316 (362)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHHc
Confidence 999999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=246.40 Aligned_cols=214 Identities=21% Similarity=0.307 Sum_probs=155.6
Q ss_pred cccccCCCccceeeEEe--------------eCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHH
Q 025816 2 VSRLKHENFVQLLGYCV--------------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 67 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 67 (247)
+++++||||+++++++. .....++||||+. |+|.+++.... ++...++.++.|++
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~ 130 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP----------LLEEHARLFMYQLL 130 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCC----------CCHHHHHHHHHHHH
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcCC----------ccHHHHHHHHHHHH
Confidence 67899999999999873 3467899999997 59999997543 89999999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCceeec-CCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhc-CCCCcccc
Q 025816 68 KGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMT-GQLNAKSD 144 (247)
Q Consensus 68 ~~l~~lh~~~~~~i~h~di~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 144 (247)
.||.|||+.+ ++|+||||+||+++ .++.++|+|||.+......... .......++..|+|||.+.+ ..++.++|
T Consensus 131 ~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 207 (320)
T 2i6l_A 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAID 207 (320)
T ss_dssp HHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHH
T ss_pred HHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhh
Confidence 9999999999 99999999999997 5678999999999865432211 11233456889999998876 67899999
Q ss_pred chhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcc-------cccC-CC-----CCHHHHHHHHHHHH
Q 025816 145 VYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD-------ARLG-GD-----YPPKAVAKMAAVAA 211 (247)
Q Consensus 145 vwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~-----~~~~~~~~l~~li~ 211 (247)
+||||+++|+|++|..||.........................+... .... .. .....+.++.+++.
T Consensus 208 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 287 (320)
T 2i6l_A 208 MWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLE 287 (320)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHH
T ss_pred hHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHH
Confidence 99999999999999999976543211111111111111111111000 0000 00 11234567999999
Q ss_pred hhcccCCCCCCCHHHHHH
Q 025816 212 LCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 212 ~cl~~~p~~Rps~~~il~ 229 (247)
+||+.||.+|||++++++
T Consensus 288 ~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 288 QILTFSPMDRLTAEEALS 305 (320)
T ss_dssp TTSCSSGGGSCCHHHHHT
T ss_pred HHcCCCccccCCHHHHhC
Confidence 999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=249.17 Aligned_cols=206 Identities=28% Similarity=0.317 Sum_probs=140.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-CCCC
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~-~~~~ 80 (247)
++.++||||+++++++..+...++||||+.+ +|.+++...... ....+++..+..++.|++.||.|||+. +
T Consensus 75 ~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--- 146 (327)
T 3aln_A 75 MRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSV----LDDVIPEEILGKITLATVKALNHLKENLK--- 146 (327)
T ss_dssp HSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHT----TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred HHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhh----hcccCcHHHHHHHHHHHHHHHHHHhccCC---
Confidence 5678999999999999999999999999975 888877631100 011289999999999999999999998 8
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhh----hcCCCCccccchhhhHHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA----MTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~~l~~l~ 156 (247)
++|+||||+||+++.++.+||+|||++........ .....|+..|+|||.+ .+..++.++||||||+++|+|+
T Consensus 147 ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 223 (327)
T 3aln_A 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223 (327)
T ss_dssp CCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHH
T ss_pred EeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999976543221 1233588899999998 4567899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||.......... ... ................+..+.+++.+||..||.+|||++++++
T Consensus 224 ~g~~pf~~~~~~~~~~-~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 224 TGRFPYPKWNSVFDQL-TQV----------VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HSCCCSSCC--------CCC----------CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HCCCCCCCcchHHHHH-HHH----------hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 9999997532211000 000 0000000111112234567999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=255.43 Aligned_cols=208 Identities=21% Similarity=0.230 Sum_probs=156.4
Q ss_pred cCCCccceeeEEe----eCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-CCCC
Q 025816 6 KHENFVQLLGYCV----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPH 80 (247)
Q Consensus 6 ~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~-~~~~ 80 (247)
.|+||+++++++. .+...++||||+. ++|.+.+....... +++..++.++.|++.||.|||++ +
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~-------~~~~~~~~i~~qi~~aL~~lH~~~g--- 167 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQG-------LPLPCVKKIIQQVLQGLDYLHTKCR--- 167 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSC-------CCHHHHHHHHHHHHHHHHHHHHTTC---
T ss_pred CcceeeeeecceeecCCCCceEEEEEeccC-ccHHHHHHhcccCC-------CCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3889999999987 5568899999994 57777776543222 89999999999999999999998 8
Q ss_pred eEeccCCCCceeecCCC-------------------------------------------------ceeeccccccCCcc
Q 025816 81 IIHRDIKSSNVLIFDDD-------------------------------------------------VAKIADFDLSNQAP 111 (247)
Q Consensus 81 i~h~di~~~nil~~~~~-------------------------------------------------~~~l~d~g~~~~~~ 111 (247)
|+||||||+||+++.++ .++|+|||.+....
T Consensus 168 ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~ 247 (397)
T 1wak_A 168 IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247 (397)
T ss_dssp EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT
T ss_pred EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc
Confidence 99999999999998775 79999999987653
Q ss_pred hhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcch------hhhccccCCcch
Q 025816 112 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL------VTWATPKLSEDK 185 (247)
Q Consensus 112 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~------~~~~~~~~~~~~ 185 (247)
.. .....||..|+|||++.+..++.++|||||||++|+|++|..||........... ........+...
T Consensus 248 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 322 (397)
T 1wak_A 248 KH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322 (397)
T ss_dssp BC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHH
T ss_pred cc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHH
Confidence 22 2334689999999999999999999999999999999999999976543321110 000000000000
Q ss_pred h------hhhccc-------------------ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 186 V------RQCVDA-------------------RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 186 ~------~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+ .+.... ......+...+..+.+||.+||+.||.+|||++++++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 000000 0011345677888999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=251.29 Aligned_cols=208 Identities=24% Similarity=0.324 Sum_probs=154.3
Q ss_pred cccccCCCccceeeEEeeCCe------eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDGTS------RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++||||+++++++..... .+++|||+. ++|.+++.. .+++..+..++.|++.||.|||+
T Consensus 77 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~LH~ 144 (353)
T 3coi_A 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIHS 144 (353)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS-----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 567899999999999987654 499999997 588888743 18999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
.+ ++|+||||+||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||||+++++
T Consensus 145 ~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~e 216 (353)
T 3coi_A 145 AG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAE 216 (353)
T ss_dssp TT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHH
T ss_pred CC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHH
Confidence 99 999999999999999999999999998764322 123467889999999887 678999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchh--------hhhc---ccccC---CCCCHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV--------RQCV---DARLG---GDYPPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~---~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|..||........................ ...+ ..... .......+..+.+++.+||..||.+
T Consensus 217 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 296 (353)
T 3coi_A 217 MLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 296 (353)
T ss_dssp HHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTT
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCccc
Confidence 99999999765422111110000000000000 0000 00000 1122345678999999999999999
Q ss_pred CCCHHHHHH
Q 025816 221 RPNMSIVVK 229 (247)
Q Consensus 221 Rps~~~il~ 229 (247)
|||++++++
T Consensus 297 Rpt~~e~l~ 305 (353)
T 3coi_A 297 RLTAAQALT 305 (353)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=255.96 Aligned_cols=208 Identities=24% Similarity=0.329 Sum_probs=153.7
Q ss_pred cccccCCCccceeeEEeeCCee------eEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++||||+++++++...... ++||||+. ++|.+.+... +++..+..++.|++.||.|||+
T Consensus 95 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~i~~qi~~aL~~LH~ 162 (371)
T 4exu_A 95 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGME-----------FSEEKIQYLVYQMLKGLKYIHS 162 (371)
T ss_dssp HHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTSC-----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 5778999999999999877655 99999997 5898887431 8999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
.+ ++||||||+||+++.++.++|+|||.+....... ....+|..|+|||.+.+ ..++.++||||||+++++
T Consensus 163 ~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (371)
T 4exu_A 163 AG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAE 234 (371)
T ss_dssp TT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHH
T ss_pred CC---CcCCCcCHHHeEECCCCCEEEEecCcccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHH
Confidence 99 9999999999999999999999999997543321 23457899999999987 678999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcc--------hhhhhcccccCCC------CCHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSED--------KVRQCVDARLGGD------YPPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|..||...+.................. ............. .....+..+.++|.+||+.||.+
T Consensus 235 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 314 (371)
T 4exu_A 235 MLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 314 (371)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTT
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhh
Confidence 999999997543221111110000000000 0000000000000 11233567999999999999999
Q ss_pred CCCHHHHHH
Q 025816 221 RPNMSIVVK 229 (247)
Q Consensus 221 Rps~~~il~ 229 (247)
|||++++++
T Consensus 315 Rpt~~ell~ 323 (371)
T 4exu_A 315 RLTAAQALT 323 (371)
T ss_dssp SCCHHHHHT
T ss_pred cCCHHHHhc
Confidence 999999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=249.13 Aligned_cols=205 Identities=15% Similarity=0.216 Sum_probs=154.1
Q ss_pred CccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 025816 9 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 88 (247)
Q Consensus 9 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~ 88 (247)
+++.+++++......++||||+ ++++.+.+....... +++..++.++.|++.||.|||+.+ |+||||||
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-------~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp 151 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQP-------YPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKP 151 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCG
T ss_pred eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 3999999999999999999999 568877776544322 899999999999999999999999 99999999
Q ss_pred Cceee-------------------cCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhh
Q 025816 89 SNVLI-------------------FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFG 149 (247)
Q Consensus 89 ~nil~-------------------~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 149 (247)
+||++ +.++.++|+|||++...... .....||..|+|||++.+..++.++||||||
T Consensus 152 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 226 (355)
T 2eu9_A 152 ENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIG 226 (355)
T ss_dssp GGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHH
T ss_pred HHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHH
Confidence 99999 56789999999998753221 1334689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhh--------------------------ccc-ccCCCCCHHH
Q 025816 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC--------------------------VDA-RLGGDYPPKA 202 (247)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~-~~~~~~~~~~ 202 (247)
+++|+|++|..||...................+....... ... ..........
T Consensus 227 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (355)
T 2eu9_A 227 CILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306 (355)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHH
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchh
Confidence 9999999999999765432111111111111111000000 000 0001122345
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 203 VAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 203 ~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+..+.+++.+||+.||.+|||++++++
T Consensus 307 ~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 307 HVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 678999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=254.93 Aligned_cols=219 Identities=22% Similarity=0.262 Sum_probs=159.1
Q ss_pred cccccCCCccceeeEEeeC-----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 2 VSRLKHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+++++||||+++++++..+ ...+++|||+. ++|.+++.... +++..+..++.|++.||.|||+.
T Consensus 63 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~ 131 (353)
T 2b9h_A 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM----------LSDDHIQYFIYQTLRAVKVLHGS 131 (353)
T ss_dssp HHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 5778999999999988664 67899999997 59999987643 89999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcc--------cccceeccccccCchhhhc-CCCCccccchh
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL--------HSTRVLGTFGYHAPEYAMT-GQLNAKSDVYS 147 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 147 (247)
+ ++||||||+||+++.++.++|+|||++.......... ......||..|+|||.+.+ ..++.++|+||
T Consensus 132 ~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s 208 (353)
T 2b9h_A 132 N---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWS 208 (353)
T ss_dssp T---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHH
T ss_pred C---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHH
Confidence 9 9999999999999999999999999987654322111 0122457899999998765 67899999999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCCCcchhhhccccC---------CcchhhhhcccccC-CC-----CCHHHHHHHHHHHHh
Q 025816 148 FGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKL---------SEDKVRQCVDARLG-GD-----YPPKAVAKMAAVAAL 212 (247)
Q Consensus 148 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~ 212 (247)
||+++++|++|..||...+............... ......+....... .. .....+.++.+++.+
T Consensus 209 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (353)
T 2b9h_A 209 CGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288 (353)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHH
Confidence 9999999999999997654211111000000000 00001111110000 00 012345679999999
Q ss_pred hcccCCCCCCCHHHHHH--HHHHh
Q 025816 213 CVQYEADFRPNMSIVVK--ALQPL 234 (247)
Q Consensus 213 cl~~~p~~Rps~~~il~--~l~~~ 234 (247)
||+.||.+|||++++++ .++..
T Consensus 289 ~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 289 MLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hcCcCcccCCCHHHHhcCcccccc
Confidence 99999999999999998 45443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=255.07 Aligned_cols=200 Identities=22% Similarity=0.272 Sum_probs=148.4
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
|+++ +||||+++++++.++...++||||+. |+|.+++...... +....++.++.|++.||.|||+.+
T Consensus 71 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~--- 138 (432)
T 3p23_A 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLHSLN--- 138 (432)
T ss_dssp HHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHHHCc---
Confidence 4566 89999999999999999999999996 5999999865532 344456789999999999999999
Q ss_pred eEeccCCCCceeecC---C--CceeeccccccCCcchhhhc-ccccceeccccccCchhhh---cCCCCccccchhhhHH
Q 025816 81 IIHRDIKSSNVLIFD---D--DVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVV 151 (247)
Q Consensus 81 i~h~di~~~nil~~~---~--~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~ 151 (247)
|+||||||+||+++. + .+++|+|||++......... .......||..|+|||++. +..++.++|||||||+
T Consensus 139 ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~i 218 (432)
T 3p23_A 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218 (432)
T ss_dssp CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHH
T ss_pred CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHH
Confidence 999999999999953 2 35779999999866432211 1223456899999999997 4567889999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 152 LLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 152 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
+|+|++ |..||....... ......... ........+..+.++|.+||+.||.+|||+++++
T Consensus 219 l~ellt~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 219 FYYVISEGSHPFGKSLQRQ----------------ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp HHHHHTTSCBTTBSTTTHH----------------HHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHcCCCCCcchhhHHH----------------HHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 999999 999985332110 000000000 0112234566789999999999999999999999
Q ss_pred H
Q 025816 229 K 229 (247)
Q Consensus 229 ~ 229 (247)
+
T Consensus 283 ~ 283 (432)
T 3p23_A 283 K 283 (432)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=243.86 Aligned_cols=200 Identities=23% Similarity=0.400 Sum_probs=149.8
Q ss_pred cccccCCCccceeeEEee-------------CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHH
Q 025816 2 VSRLKHENFVQLLGYCVD-------------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 68 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 68 (247)
+++++||||+++++++.+ ....++||||+.+++|.+++..... .++...++.++.|++.
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~ 127 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILE 127 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHH
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHH
Confidence 678999999999998865 3567999999999999999975432 2788999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhh------------cccccceeccccccCchhhhc
Q 025816 69 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA------------RLHSTRVLGTFGYHAPEYAMT 136 (247)
Q Consensus 69 ~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~ 136 (247)
||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ........++..|+|||.+.+
T Consensus 128 ~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (303)
T 1zy4_A 128 ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204 (303)
T ss_dssp HHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS
T ss_pred HHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence 999999999 99999999999999999999999999876542210 111123458889999999986
Q ss_pred C-CCCccccchhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhh--cccccCCCCCHHHHHHHHHHHHhh
Q 025816 137 G-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQC--VDARLGGDYPPKAVAKMAAVAALC 213 (247)
Q Consensus 137 ~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~c 213 (247)
. .++.++|+||||+++|+|++ ||...... ....... .........+...+..+.+++.+|
T Consensus 205 ~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 267 (303)
T 1zy4_A 205 TGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--------------VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLL 267 (303)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--------------HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHH
T ss_pred CCCCcchhhHHHHHHHHHHHHh---ccCCchhH--------------HHHHHhccccccccCccccccchHHHHHHHHHH
Confidence 4 68999999999999999997 44311000 0000000 011112233445566799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025816 214 VQYEADFRPNMSIVVK 229 (247)
Q Consensus 214 l~~~p~~Rps~~~il~ 229 (247)
|+.||.+|||++++++
T Consensus 268 l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 268 IDHDPNKRPGARTLLN 283 (303)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred HhcCcccCcCHHHHhC
Confidence 9999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=246.85 Aligned_cols=144 Identities=25% Similarity=0.287 Sum_probs=124.6
Q ss_pred CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc--CCCCCeEec
Q 025816 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE--KADPHIIHR 84 (247)
Q Consensus 7 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~--~~~~~i~h~ 84 (247)
|++|+++++++......++||||+. ++|.+++....... +++..+..++.|++.||.|||. .+ |+||
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~al~~lH~~~~~---ivHr 183 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRG-------VSLNLTRKFAQQMCTALLFLATPELS---IIHC 183 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSC-------CCHHHHHHHHHHHHHHHHHHTSTTTC---EECC
T ss_pred ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCC-------CCHHHHHHHHHHHHHHHHHhccCCCC---EEcC
Confidence 3469999999999999999999996 59999998654322 8999999999999999999994 56 9999
Q ss_pred cCCCCceeec--CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCC
Q 025816 85 DIKSSNVLIF--DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 162 (247)
Q Consensus 85 di~~~nil~~--~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 162 (247)
||||+||+++ .++.+||+|||++...... .....+|..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 184 Dlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 258 (382)
T 2vx3_A 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258 (382)
T ss_dssp CCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999995 4778999999998765321 13356889999999999989999999999999999999999999
Q ss_pred CCCC
Q 025816 163 DHTL 166 (247)
Q Consensus 163 ~~~~ 166 (247)
....
T Consensus 259 ~~~~ 262 (382)
T 2vx3_A 259 SGAN 262 (382)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 8654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=247.92 Aligned_cols=213 Identities=19% Similarity=0.223 Sum_probs=158.1
Q ss_pred cCCCccceeeEEeeCC----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-CCCC
Q 025816 6 KHENFVQLLGYCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPH 80 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~-~~~~ 80 (247)
.||||+++++++.... ..+++||++ +++|.+++....... +++..++.++.|++.||.|||++ +
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~-------~~~~~~~~i~~qi~~aL~~lH~~~~--- 152 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-------IPLIYVKQISKQLLLGLDYMHRRCG--- 152 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSC-------CCHHHHHHHHHHHHHHHHHHHHTTC---
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccC-------CcHHHHHHHHHHHHHHHHHHHhcCC---
Confidence 4899999999987654 789999999 789999998654332 89999999999999999999998 8
Q ss_pred eEeccCCCCceeec------CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 81 IIHRDIKSSNVLIF------DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 81 i~h~di~~~nil~~------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
|+||||||+||+++ ..+.++|+|||++...... .....+|..|+|||++.+..++.++||||||+++|+
T Consensus 153 ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 227 (373)
T 1q8y_A 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227 (373)
T ss_dssp EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHH
T ss_pred EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHH
Confidence 99999999999995 3447999999998754321 133468999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchh------hhccccCCcc---------------------------hhhhhcccccCCCCCHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLV------TWATPKLSED---------------------------KVRQCVDARLGGDYPPK 201 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~------~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~ 201 (247)
|++|..||............ .......+.. ....... .....+..
T Consensus 228 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 305 (373)
T 1q8y_A 228 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKD 305 (373)
T ss_dssp HHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHH
T ss_pred HHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcc
Confidence 99999999765422111000 0000000000 0000000 11235667
Q ss_pred HHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhHh
Q 025816 202 AVAKMAAVAALCVQYEADFRPNMSIVVK--ALQPLLN 236 (247)
Q Consensus 202 ~~~~l~~li~~cl~~~p~~Rps~~~il~--~l~~~~~ 236 (247)
.+..+.++|.+||+.||.+|||++++++ .+++...
T Consensus 306 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred hHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 8889999999999999999999999998 5555443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=253.43 Aligned_cols=207 Identities=20% Similarity=0.273 Sum_probs=147.5
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
.+||||+++++++.++...++||||+. |+|.+++........ ......+..++.++.|++.||.|||+.+ |+||
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 139 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDE--NLKLQKEYNPISLLRQIASGVAHLHSLK---IIHR 139 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCch--hhhhccchhHHHHHHHHHHHHHHHHHCC---cccc
Confidence 389999999999999999999999996 599999986543210 0001233346789999999999999999 9999
Q ss_pred cCCCCceeecCC-------------CceeeccccccCCcchhhhcc--cccceeccccccCchhhhc-------CCCCcc
Q 025816 85 DIKSSNVLIFDD-------------DVAKIADFDLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMT-------GQLNAK 142 (247)
Q Consensus 85 di~~~nil~~~~-------------~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~ 142 (247)
||||+||+++.+ +.++|+|||++.......... ......||..|+|||++.+ ..++.+
T Consensus 140 DLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 219 (434)
T 2rio_A 140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219 (434)
T ss_dssp CCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTH
T ss_pred CCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchh
Confidence 999999999754 479999999998654332211 1223568999999999975 568999
Q ss_pred ccchhhhHHHHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCC
Q 025816 143 SDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFR 221 (247)
Q Consensus 143 ~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 221 (247)
+|||||||++|+|++ |..||....... .......... ...........+.++.++|.+||+.||.+|
T Consensus 220 ~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 287 (434)
T 2rio_A 220 IDIFSMGCVFYYILSKGKHPFGDKYSRE----SNIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKR 287 (434)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTCSTTTHH----HHHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGS
T ss_pred hhhHhHHHHHHHHHhCCCCCCCCchhhH----HHHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhC
Confidence 999999999999999 999996432110 0000000000 001112245677889999999999999999
Q ss_pred CCHHHHHH
Q 025816 222 PNMSIVVK 229 (247)
Q Consensus 222 ps~~~il~ 229 (247)
||+.++++
T Consensus 288 ps~~eil~ 295 (434)
T 2rio_A 288 PTAMKVLR 295 (434)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHHh
Confidence 99999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=245.42 Aligned_cols=185 Identities=22% Similarity=0.346 Sum_probs=149.9
Q ss_pred cCCCccceeeEEeeCCeeeEEEec-CCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEF-ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
+||||+++++++..++..+++||+ +.+++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 163 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG---------PLGEGPSRCFFGQVVAAIQHCHSRG---VVHR 163 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHHT---EECC
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 899999999999999999999999 77889999997643 2899999999999999999999999 9999
Q ss_pred cCCCCceeec-CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhCCCCC
Q 025816 85 DIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPV 162 (247)
Q Consensus 85 di~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf 162 (247)
||+|+||+++ .++.++|+|||++....... .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||
T Consensus 164 dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 239 (312)
T 2iwi_A 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF 239 (312)
T ss_dssp CCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCC
Confidence 9999999999 88999999999987654322 233458889999999987666 45899999999999999999999
Q ss_pred CCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 163 DHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..... .... ....+...+..+.++|.+||+.||.+|||++++++
T Consensus 240 ~~~~~---------------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 240 ERDQE---------------------ILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CSHHH---------------------HHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CChHH---------------------Hhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 63210 0000 11223345567999999999999999999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=244.58 Aligned_cols=189 Identities=21% Similarity=0.329 Sum_probs=154.7
Q ss_pred ccccc--CCCccceeeEEeeCCeeeEEEecCCC-CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 2 VSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 2 l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+++++ |+||+++++++..++..+++||++.+ ++|.+++.... .+++..++.++.|++.||.|||+.+
T Consensus 100 l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~- 169 (320)
T 3a99_A 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHNCG- 169 (320)
T ss_dssp HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 34554 69999999999999999999999975 79999987643 2899999999999999999999999
Q ss_pred CCeEeccCCCCceeec-CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHH
Q 025816 79 PHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELL 156 (247)
Q Consensus 79 ~~i~h~di~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~ 156 (247)
++||||||+||+++ .++.+||+|||++....... .....++..|+|||.+.+..+ +.++||||||+++|+|+
T Consensus 170 --ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 243 (320)
T 3a99_A 170 --VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243 (320)
T ss_dssp --EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred --cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHH
Confidence 99999999999999 78899999999987654321 123458899999999987765 67899999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||..... ..... ...+...+.++.+++.+||+.||.+|||++++++
T Consensus 244 ~g~~pf~~~~~---------------------~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 244 CGDIPFEHDEE---------------------IIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HSSCSCCSHHH---------------------HHHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HCCCCCCChhh---------------------hhccc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999963210 00000 0112234567999999999999999999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=255.33 Aligned_cols=224 Identities=21% Similarity=0.250 Sum_probs=162.4
Q ss_pred cccccCCCccceeeEEee------CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 2 VSRLKHENFVQLLGYCVD------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+++++||||+++++++.. +...++||||+.+|+|.+++...... ..+++..++.++.|++.||.|||+
T Consensus 66 L~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs 139 (676)
T 3qa8_A 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHE 139 (676)
T ss_dssp HHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 578899999999998765 66789999999999999999865421 138888999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCc---eeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDV---AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL 152 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~---~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 152 (247)
.+ ++||||+|+||+++.++. ++|+|||.+....... ......++..|+|||.+.+..++.++||||+|+++
T Consensus 140 ~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviL 213 (676)
T 3qa8_A 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213 (676)
T ss_dssp TT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHH
T ss_pred CC---CccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHH
Confidence 99 999999999999997765 8999999998654322 12345689999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcc--h-----hhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 153 LELLTGRKPVDHTLPRGQQS--L-----VTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
|+|++|..||.......... . ..........+..................+..+.+++.+||..||.+|||++
T Consensus 214 yeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~ 293 (676)
T 3qa8_A 214 FECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293 (676)
T ss_dssp HHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCT
T ss_pred HHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHH
Confidence 99999999996532110000 0 0000000000000000000011234456788999999999999999999998
Q ss_pred H-----HHHHHHHhHhc
Q 025816 226 I-----VVKALQPLLNA 237 (247)
Q Consensus 226 ~-----il~~l~~~~~~ 237 (247)
+ ..+.++.+.+.
T Consensus 294 elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 294 QNPNVGCFQALDSILSL 310 (676)
T ss_dssp TCCCCTTHHHHHHHHCC
T ss_pred HHhcCHHHHHHHHHHhc
Confidence 8 44566666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=231.14 Aligned_cols=187 Identities=16% Similarity=0.296 Sum_probs=143.6
Q ss_pred ccccCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 3 SRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+.++||||+++++++.. +...++||||+.+++|.+++...... .+++..++.++.|++.||.|||+.+
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~- 137 (299)
T 3m2w_A 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN- 137 (299)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTC-------CCBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45699999999999887 66789999999999999999875432 2999999999999999999999999
Q ss_pred CCeEeccCCCCceeecC---CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 79 PHIIHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
++||||||+||+++. ++.++|+|||++.... +..++.++|+||||+++|+|
T Consensus 138 --i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el 191 (299)
T 3m2w_A 138 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYIL 191 (299)
T ss_dssp --EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHH
T ss_pred --cccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHH
Confidence 999999999999998 7889999999875421 13467789999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCC----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH--
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYP----PKAVAKMAAVAALCVQYEADFRPNMSIVVK-- 229 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~il~-- 229 (247)
++|..||............ ...+... ....+ ...+.++.+++.+||+.||.+|||++++++
T Consensus 192 ~tg~~pf~~~~~~~~~~~~------------~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 192 LCGYPPFYSNHGLAISPGM------------KTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp HHSSCSCCC-------CCS------------CCSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHCCCCCCCCcchhhhHHH------------HHHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 9999999754322110000 0000000 00111 234567999999999999999999999998
Q ss_pred HHHHhHh
Q 025816 230 ALQPLLN 236 (247)
Q Consensus 230 ~l~~~~~ 236 (247)
++++...
T Consensus 259 ~~~~~~~ 265 (299)
T 3m2w_A 259 WIMQSTK 265 (299)
T ss_dssp HHHTGGG
T ss_pred hhccccc
Confidence 4554443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=256.20 Aligned_cols=190 Identities=19% Similarity=0.308 Sum_probs=150.4
Q ss_pred CcccccCCCccceeeEEeeCCe-----eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 1 MVSRLKHENFVQLLGYCVDGTS-----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
++++++||||+++++++..... .++||||+.+++|.+++.. . +++..++.++.|++.||.|||+
T Consensus 132 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-~----------l~~~~~~~~~~qi~~aL~~lH~ 200 (681)
T 2pzi_A 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-K----------LPVAEAIAYLLEILPALSYLHS 200 (681)
T ss_dssp GGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-C----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-C----------CCHHHHHHHHHHHHHHHHHHHH
Confidence 4788999999999999987665 7999999999999887654 1 9999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
.+ |+||||||+||+++.+ .+||+|||++...... ....||..|+|||++.+. ++.++||||||+++++|
T Consensus 201 ~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l 269 (681)
T 2pzi_A 201 IG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL 269 (681)
T ss_dssp TT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHH
T ss_pred CC---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHH
Confidence 99 9999999999999875 8999999998764322 334689999999998764 48899999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-HHHHHHHHHHh
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-MSIVVKALQPL 234 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~il~~l~~~ 234 (247)
++|..||....... .. ........+..+.++|.+||+.||.+||+ ++++...+..+
T Consensus 270 ~~g~~~~~~~~~~~-----------~~------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 270 TLDLPTRNGRYVDG-----------LP------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HSCCCEETTEECSS-----------CC------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HhCCCCCccccccc-----------cc------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 99988876321100 00 00011233467999999999999999995 66666666655
Q ss_pred H
Q 025816 235 L 235 (247)
Q Consensus 235 ~ 235 (247)
.
T Consensus 327 ~ 327 (681)
T 2pzi_A 327 L 327 (681)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=228.68 Aligned_cols=182 Identities=19% Similarity=0.173 Sum_probs=141.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..++||||+.+++|.+++... .....+..++.|++.||.|||+.+ |
T Consensus 85 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~g---i 150 (286)
T 3uqc_A 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRAG---V 150 (286)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCC---C
Confidence 56889999999999999999999999999999999999542 344568889999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 161 (247)
+||||||+||+++.+|.++|++++. .+ .++.++||||||+++|+|++|..|
T Consensus 151 vH~Dikp~NIll~~~g~~kl~~~~~----------------------~~-------~~~~~~Di~slG~il~elltg~~P 201 (286)
T 3uqc_A 151 ALSIDHPSRVRVSIDGDVVLAYPAT----------------------MP-------DANPQDDIRGIGASLYALLVNRWP 201 (286)
T ss_dssp CCCCCSGGGEEEETTSCEEECSCCC----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEEC
T ss_pred ccCCCCcccEEEcCCCCEEEEeccc----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999974432 22 358889999999999999999999
Q ss_pred CCCCCCCCCcchh-hhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 162 VDHTLPRGQQSLV-TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 162 f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
|............ ........ .. . ......+..+.+++.+||+.||.+| |++++++.|+++....
T Consensus 202 f~~~~~~~~~~~~~~~~~~~~~--~~-----~----~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 202 LPEAGVRSGLAPAERDTAGQPI--EP-----A----DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp SCCCSBCCCSEECCBCTTSCBC--CH-----H----HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CCcCCcchhhHHHHHHhccCCC--Ch-----h----hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 9865432211000 00000000 00 0 0112345669999999999999999 9999999999877543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=226.65 Aligned_cols=175 Identities=13% Similarity=0.170 Sum_probs=132.1
Q ss_pred eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceee
Q 025816 22 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 101 (247)
Q Consensus 22 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l 101 (247)
..+++|+++ +++|.+++....... ..+..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL 252 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFL 252 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEE
T ss_pred ceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEE
Confidence 467788877 469999985221000 01123888999999999999999999999 999999999999999999999
Q ss_pred ccccccCCcchhhhcccccceeccccccCchhh----------hcCCCCccccchhhhHHHHHHHhCCCCCCCCCCCCCc
Q 025816 102 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA----------MTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 171 (247)
Q Consensus 102 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~ 171 (247)
+|||++...... .....| ..|+|||++ .+..++.++|||||||++|+|++|..||.........
T Consensus 253 ~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~ 326 (413)
T 3dzo_A 253 TGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326 (413)
T ss_dssp CCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS
T ss_pred EeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH
Confidence 999998764332 233456 899999999 4445788999999999999999999999754321110
Q ss_pred chhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 172 SLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
...+... . ..+..+.++|.+||+.||.+|||+.++++
T Consensus 327 ---------------~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 327 ---------------EWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp ---------------GGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------------HHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111100 1 22467999999999999999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-33 Score=227.13 Aligned_cols=169 Identities=14% Similarity=0.111 Sum_probs=129.4
Q ss_pred CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh-cCCCCCeEeccCCCCceeecCCC-
Q 025816 20 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH-EKADPHIIHRDIKSSNVLIFDDD- 97 (247)
Q Consensus 20 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh-~~~~~~i~h~di~~~nil~~~~~- 97 (247)
+...++||||+.+|++.+.+.... +++..++.++.|++.||.||| +.+ |+||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~~~----------~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~ 200 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRTKL----------SSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSL 200 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTTTC----------CCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSC
T ss_pred cCeEEEEEEecCCCccHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCC
Confidence 678999999999987777664422 899999999999999999999 899 99999999999999887
Q ss_pred -------------------ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHH-HHHHHh
Q 025816 98 -------------------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV-LLELLT 157 (247)
Q Consensus 98 -------------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~-l~~l~~ 157 (247)
.+||+|||+++.... ....||..|+|||++.+.. +.++||||++++ .+++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~ 272 (336)
T 2vuw_A 201 KKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWG 272 (336)
T ss_dssp SEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTT
T ss_pred cceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCccccc
Confidence 899999999986532 2347899999999998766 889999998777 777888
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhccc-----ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-----RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
|..||... .+ ........... ..........+.++.+||.+||++| |+++++
T Consensus 273 g~~p~~~~---------~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 273 EYHPYSNV---------LW-----LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp SCCTHHHH---------HH-----HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ccCCCcch---------hh-----hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 98888410 00 00000011100 0001123467889999999999976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=222.00 Aligned_cols=142 Identities=18% Similarity=0.144 Sum_probs=104.8
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
|+++ +|+||++++++++++...||||||++|++|.+++..... ++.. .++.||+.||.|+|++|
T Consensus 295 l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~---------l~~~---~I~~QIl~AL~ylH~~G--- 359 (569)
T 4azs_A 295 LTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE---------IDRE---KILGSLLRSLAALEKQG--- 359 (569)
T ss_dssp HHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC---------CCHH---HHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC---------CCHH---HHHHHHHHHHHHHHHCC---
Confidence 5677 799999999999999999999999999999999986542 5543 57899999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+ .+..++|+|++|++.+.+.++..
T Consensus 360 IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 360 FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 99999999999999999999999999986543222 1234579999999999876 46678999999999887765544
Q ss_pred C
Q 025816 161 P 161 (247)
Q Consensus 161 p 161 (247)
+
T Consensus 437 ~ 437 (569)
T 4azs_A 437 N 437 (569)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-23 Score=181.65 Aligned_cols=140 Identities=17% Similarity=0.175 Sum_probs=115.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++..++......++||||+.+++|.+++.. +..++.|++++|.|||+++
T Consensus 392 il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~g--- 451 (540)
T 3en9_A 392 YLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKND--- 451 (540)
T ss_dssp HHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHCc---
Confidence 36789999999666666677788999999999999999875 3478999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcc-----cccceeccccccCchhhhc--CCCCccccchhhhHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ 153 (247)
|+||||||+||+++. .+||+|||+++......... ......||..|+|||++.. ..|+...|+|+..+-..
T Consensus 452 IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l 529 (540)
T 3en9_A 452 VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELM 529 (540)
T ss_dssp EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHH
T ss_pred CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHH
Confidence 999999999999998 99999999998765432211 1134568999999999987 67888999999988887
Q ss_pred HHHhCCCCC
Q 025816 154 ELLTGRKPV 162 (247)
Q Consensus 154 ~l~~g~~pf 162 (247)
+-..++.+|
T Consensus 530 ~~v~~r~rY 538 (540)
T 3en9_A 530 KDVERRARY 538 (540)
T ss_dssp HHHHTCSCC
T ss_pred HHHHhcccc
Confidence 777666555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=2.1e-17 Score=131.45 Aligned_cols=84 Identities=15% Similarity=0.193 Sum_probs=68.1
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
|++++ | +++++++.. +..++||||+.|++|.+ +.. .....++.|++.||.+||+.+ +
T Consensus 158 l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------------~~~~~i~~qi~~~l~~lH~~g---i 214 (282)
T 1zar_A 158 LQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------------ENPDEVLDMILEEVAKFYHRG---I 214 (282)
T ss_dssp HHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------------SCHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------------hhHHHHHHHHHHHHHHHHHCC---C
Confidence 44555 4 666665543 55699999999999998 421 123468999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
+||||||+||+++ ++.++|+|||++..
T Consensus 215 iHrDlkp~NILl~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 215 VHGDLSQYNVLVS-EEGIWIIDFPQSVE 241 (282)
T ss_dssp ECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred EeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence 9999999999999 99999999998863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=5.7e-14 Score=110.25 Aligned_cols=88 Identities=20% Similarity=0.259 Sum_probs=66.6
Q ss_pred cccccCCCc--cceeeEEeeCCeeeEEEecCCC-C----ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 2 VSRLKHENF--VQLLGYCVDGTSRVLAYEFASN-G----SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 2 l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
|++++|+++ +..++. ...++||||+.+ | +|.+.... .++..+..++.|++.+|.+||
T Consensus 124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHH
Confidence 456677654 334432 356899999942 3 66665432 234457789999999999999
Q ss_pred -cCCCCCeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 75 -EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 75 -~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
+.+ ++||||||.|||++. .++|+|||++...
T Consensus 188 ~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 QEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 998 999999999999988 8999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.19 E-value=1.6e-11 Score=100.82 Aligned_cols=70 Identities=13% Similarity=0.179 Sum_probs=57.5
Q ss_pred eeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCC-----
Q 025816 23 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----- 97 (247)
Q Consensus 23 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~----- 97 (247)
.++||||++|++|.++... .....++.|++.+|.+||+.| |+||||||.|||++.+|
T Consensus 186 ~~LVME~i~G~~L~~l~~~---------------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSSV---------------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp TEEEEECCSCEEGGGCCCC---------------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCT
T ss_pred ceEEEEecCCccHhhhccc---------------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccc
Confidence 3699999998888765432 123567899999999999999 99999999999998776
Q ss_pred -----ceeeccccccCCc
Q 025816 98 -----VAKIADFDLSNQA 110 (247)
Q Consensus 98 -----~~~l~d~g~~~~~ 110 (247)
.+.|+||+.+...
T Consensus 248 ~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECCCTTCEET
T ss_pred cccccceEEEEeCCcccC
Confidence 3899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=1.3e-08 Score=79.52 Aligned_cols=89 Identities=18% Similarity=0.142 Sum_probs=69.0
Q ss_pred CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC---------
Q 025816 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--------- 77 (247)
Q Consensus 7 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~--------- 77 (247)
+..+.++++++......++|||+++|.+|.+.+... .....++.+++.++..||+..
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~--------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~ 134 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--------------QSPEKIIELYAECIRLFHSIDISDCPYTNS 134 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCTT--------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCC
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccCCc--------------ccHHHHHHHHHHHHHHHhCCCcccCCCcch
Confidence 567888999999888999999999998988764211 123467788889999999810
Q ss_pred -----------------------------------------------CCCeEeccCCCCceeecCCCceeeccccccCC
Q 025816 78 -----------------------------------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 78 -----------------------------------------------~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
...++|+|+++.||+++.++.+.|+||+.+..
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 135 LDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13499999999999998765567999987654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.60 E-value=6.8e-08 Score=79.06 Aligned_cols=93 Identities=19% Similarity=0.255 Sum_probs=71.6
Q ss_pred CCCccceeeEEeeC---CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC------
Q 025816 7 HENFVQLLGYCVDG---TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA------ 77 (247)
Q Consensus 7 h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~------ 77 (247)
+..+++++.++.+. ...++||||+.|..+.+.... .++......++.+++..|..||+..
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~ 165 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSLP-----------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGL 165 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTCT-----------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTC
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCccc-----------cCCHHHHHHHHHHHHHHHHHHhCCCchhccc
Confidence 45678888888766 347899999998777542111 1677888889999999999999731
Q ss_pred -------------------------------------------------CCCeEeccCCCCceeecCCCc--eeeccccc
Q 025816 78 -------------------------------------------------DPHIIHRDIKSSNVLIFDDDV--AKIADFDL 106 (247)
Q Consensus 78 -------------------------------------------------~~~i~h~di~~~nil~~~~~~--~~l~d~g~ 106 (247)
...++|+|+++.||+++.++. +.|+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~ 245 (359)
T 3dxp_A 166 GDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWEL 245 (359)
T ss_dssp TTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTT
T ss_pred cccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccc
Confidence 135999999999999987653 68999998
Q ss_pred cCCc
Q 025816 107 SNQA 110 (247)
Q Consensus 107 ~~~~ 110 (247)
+...
T Consensus 246 a~~g 249 (359)
T 3dxp_A 246 STLG 249 (359)
T ss_dssp CEEE
T ss_pred cccC
Confidence 8654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.55 E-value=7.3e-08 Score=75.00 Aligned_cols=83 Identities=14% Similarity=0.109 Sum_probs=59.8
Q ss_pred ccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC------------
Q 025816 10 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA------------ 77 (247)
Q Consensus 10 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~------------ 77 (247)
+.+++++...+...++||||++|.+|. ... .. ...++.+++..+..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~ 139 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKH 139 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 566888888777889999999987773 211 11 1245566666777777542
Q ss_pred -------------------------------------------CCCeEeccCCCCceeecCCCceeeccccccCC
Q 025816 78 -------------------------------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 78 -------------------------------------------~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
...++|+|++|.||+++.++.+.|+||+.+..
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 140 RIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998766667999997654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.29 E-value=2e-07 Score=74.51 Aligned_cols=139 Identities=17% Similarity=0.142 Sum_probs=83.5
Q ss_pred ccceeeEEeeCC---eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC---------
Q 025816 10 FVQLLGYCVDGT---SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--------- 77 (247)
Q Consensus 10 i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~--------- 77 (247)
+.+.+.....+. ..|+||++++|.++.+..... ++......++.+++..+..||+..
T Consensus 75 vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~~-----------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~ 143 (304)
T 3sg8_A 75 IPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLNN-----------LPKQSQNQAAKDLARFLSELHSINISGFKSNLV 143 (304)
T ss_dssp CCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHHT-----------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGB
T ss_pred CCceEeecCCCCCCCcceEEEcccCCeECCcccccc-----------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccch
Confidence 344444433333 347899999988876533211 566667777777777777777511
Q ss_pred ----------------------------------------------CCCeEeccCCCCceeecC--CCceeeccccccCC
Q 025816 78 ----------------------------------------------DPHIIHRDIKSSNVLIFD--DDVAKIADFDLSNQ 109 (247)
Q Consensus 78 ----------------------------------------------~~~i~h~di~~~nil~~~--~~~~~l~d~g~~~~ 109 (247)
.+.++|+|+++.||+++. .+.+.++||+.+..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 144 LDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 134899999999999988 45678999998765
Q ss_pred cchhhhcccccceeccccccCchhhhc-----CCC---------CccccchhhhHHHHHHHhCCCCC
Q 025816 110 APDMAARLHSTRVLGTFGYHAPEYAMT-----GQL---------NAKSDVYSFGVVLLELLTGRKPV 162 (247)
Q Consensus 110 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~---------~~~~DvwslG~~l~~l~~g~~pf 162 (247)
............. . .-..|+.... ... ....+.|+++.+++.+.+|..+|
T Consensus 224 ~~~~~Dl~~~~~~--~-~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 224 SDPDNDFISLMED--D-EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp ECTTHHHHTTCCT--T-TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CChHHHHHHHHhh--c-cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 3221110000000 0 0012221110 010 12257899999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=2.8e-05 Score=60.72 Aligned_cols=87 Identities=14% Similarity=0.106 Sum_probs=61.7
Q ss_pred ccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC------------
Q 025816 10 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA------------ 77 (247)
Q Consensus 10 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~------------ 77 (247)
+.++++++.++...++|||++.|.++.+...... .....+..++...+..||...
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~-------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~ 148 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP-------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVF 148 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG-------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCCH-------------HHHHHHHHHHHHHHHHhcCCCcccCCcCccccc
Confidence 6678888899999999999999888776654322 112234445555555555321
Q ss_pred -------------------------------------------CCCeEeccCCCCceeecCCCceeeccccccCC
Q 025816 78 -------------------------------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 78 -------------------------------------------~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
.+.++|+|+.+.||+++..+.+-|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 149 RLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11389999999999999877777999997654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.81 E-value=5.1e-05 Score=56.81 Aligned_cols=101 Identities=16% Similarity=0.160 Sum_probs=65.1
Q ss_pred ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchh
Q 025816 34 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113 (247)
Q Consensus 34 ~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~ 113 (247)
+|.+.+..... +|.++++|.++.|.+.++.-+-.... -..+-+.|..+++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~--------PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----- 97 (229)
T 2yle_A 34 SLEEILRLYNQ--------PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----- 97 (229)
T ss_dssp EHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------
T ss_pred cHHHHHHHcCC--------CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-----
Confidence 78888876653 49999999999999999887732211 11333457889999999888753 1100
Q ss_pred hhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 114 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 114 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
.....+.+||... ...+.+.-|+|||+++|..+--..
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0122356787653 344677789999999999986333
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00029 Score=56.17 Aligned_cols=30 Identities=23% Similarity=0.302 Sum_probs=24.6
Q ss_pred CeEeccCCCCceeecC---CCc-eeeccccccCC
Q 025816 80 HIIHRDIKSSNVLIFD---DDV-AKIADFDLSNQ 109 (247)
Q Consensus 80 ~i~h~di~~~nil~~~---~~~-~~l~d~g~~~~ 109 (247)
.++|+|+++.|++++. ++. +.|+||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 4799999999999987 455 47999997654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0004 Score=56.44 Aligned_cols=32 Identities=22% Similarity=0.366 Sum_probs=26.3
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
..++|+|+.+.||+++.+..+.|+||+.+...
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~g 253 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVALG 253 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccccC
Confidence 35999999999999996445789999987643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.0093 Score=47.74 Aligned_cols=30 Identities=20% Similarity=0.358 Sum_probs=26.7
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 499999999999998888899999997653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.52 E-value=0.037 Score=45.91 Aligned_cols=31 Identities=26% Similarity=0.545 Sum_probs=27.0
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 111 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~ 111 (247)
.++|+|+.+.||+++.++ +.++||+.+....
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 399999999999998776 9999999887653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.57 E-value=0.38 Score=35.84 Aligned_cols=117 Identities=8% Similarity=0.088 Sum_probs=74.8
Q ss_pred ccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 025816 5 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 84 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~h~ 84 (247)
..||++++. .+-..++.+.+.++.-. +..++-.-.. .+....+.++.+|+....+++. -+|-
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik~----------~~~~eKlr~l~ni~~l~~~~~~-----r~tf 103 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIKS----------FTKNEKLRYLLNIKNLEEVNRT-----RYTF 103 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGGG----------SCHHHHHHHHHHGGGGGGGGGS-----SEEC
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHHh----------cCHHHHHHHHHHHHHHHHHhcC-----ceEE
Confidence 367888876 55666666555555543 2333322111 7778899999999887755543 4788
Q ss_pred cCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCCC
Q 025816 85 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163 (247)
Q Consensus 85 di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 163 (247)
-++|+|++++.++.+++.--|+.... +|. ..+...=.-.+=|++..+++++..|.
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEecceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 89999999999999999766643221 111 11111112356677888888877773
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.11 E-value=0.13 Score=41.09 Aligned_cols=32 Identities=22% Similarity=0.399 Sum_probs=27.0
Q ss_pred CCeEeccCCCCceeecCC----CceeeccccccCCc
Q 025816 79 PHIIHRDIKSSNVLIFDD----DVAKIADFDLSNQA 110 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~----~~~~l~d~g~~~~~ 110 (247)
..++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 349999999999999874 67899999887654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.44 E-value=0.82 Score=34.16 Aligned_cols=82 Identities=7% Similarity=-0.019 Sum_probs=57.3
Q ss_pred cCCCccceeeEEeeCCeeeEEEecCCCC-ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHH-HhhcCCCCCeEe
Q 025816 6 KHENFVQLLGYCVDGTSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE-YLHEKADPHIIH 83 (247)
Q Consensus 6 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~-~lh~~~~~~i~h 83 (247)
.||++ --.+-.+++.+.+.++.-.++ ++..+ .. .+....+.++.+++.... +++. -+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~~------------~~~~eKlrll~nl~~L~~~~~~~-----r~t 107 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-RK------------TTLLSRIRAAIHLVSKVKHHSAR-----RLI 107 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-HT------------SCHHHHHHHHHHHHHHHSSCCSS-----SEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-Hh------------cCHHHHHHHHHHHHHHHHHhhhC-----cee
Confidence 56777 233445666666666655333 44433 22 777889999999888766 4543 578
Q ss_pred ccCCCCceeecCCCceeecccccc
Q 025816 84 RDIKSSNVLIFDDDVAKIADFDLS 107 (247)
Q Consensus 84 ~di~~~nil~~~~~~~~l~d~g~~ 107 (247)
--+.|+|++++.++.+++.-.|+-
T Consensus 108 f~l~P~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 108 FIVCPENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp CCCCGGGEEECTTCCEEESCCEET
T ss_pred EEEeCceEEEeCCCcEEEEEcCCc
Confidence 889999999999999999866653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.10 E-value=0.046 Score=43.37 Aligned_cols=30 Identities=27% Similarity=0.561 Sum_probs=25.5
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
.++|+|+.+.||+++.++.+.++||+.+..
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 499999999999998876667999987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.05 E-value=0.15 Score=40.50 Aligned_cols=29 Identities=24% Similarity=0.306 Sum_probs=24.7
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
.++|+|+++.||+++ + .+.++||+.+...
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 489999999999998 4 8899999877543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.67 E-value=0.13 Score=41.24 Aligned_cols=32 Identities=31% Similarity=0.401 Sum_probs=27.4
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
..++|+|+.+.|++++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 34999999999999998888999999876543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=91.26 E-value=0.23 Score=41.72 Aligned_cols=15 Identities=33% Similarity=0.401 Sum_probs=14.1
Q ss_pred CeEeccCCCCceeec
Q 025816 80 HIIHRDIKSSNVLIF 94 (247)
Q Consensus 80 ~i~h~di~~~nil~~ 94 (247)
.++|+|+.+.||+++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 499999999999998
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=90.36 E-value=0.28 Score=38.49 Aligned_cols=31 Identities=23% Similarity=0.169 Sum_probs=25.8
Q ss_pred CCeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 79 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
..++|+|+.+.|++ ..++.+.++||..+...
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 45999999999999 56677899999877643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=90.29 E-value=0.12 Score=41.93 Aligned_cols=30 Identities=20% Similarity=0.402 Sum_probs=24.6
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
.++|+|+.+.||+++.++ +.++||+.+...
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g 242 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGFN 242 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCCC
Confidence 499999999999997654 899999877643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.10 E-value=0.11 Score=43.21 Aligned_cols=31 Identities=19% Similarity=0.393 Sum_probs=24.9
Q ss_pred CeEeccCCCCceeecCC----------------------------CceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDD----------------------------DVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~----------------------------~~~~l~d~g~~~~~ 110 (247)
.++|+|+.+.||+++.+ +.+.++||.++...
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~g 308 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASYN 308 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCcC
Confidence 49999999999999875 67899999877643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=89.01 E-value=0.18 Score=41.22 Aligned_cols=30 Identities=30% Similarity=0.597 Sum_probs=26.4
Q ss_pred CeEeccCCCCceeecCC----CceeeccccccCC
Q 025816 80 HIIHRDIKSSNVLIFDD----DVAKIADFDLSNQ 109 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~----~~~~l~d~g~~~~ 109 (247)
.++|+|+.+.||+++.+ +.+.++||.++..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 49999999999999876 6899999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=88.26 E-value=0.23 Score=40.67 Aligned_cols=30 Identities=17% Similarity=0.375 Sum_probs=25.1
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
.++|+|+.+.||+++.+ .++++||..+...
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G 257 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 257 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence 49999999999999876 4889999776644
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.33 E-value=0.28 Score=40.41 Aligned_cols=30 Identities=23% Similarity=0.447 Sum_probs=25.0
Q ss_pred eEeccCCCCceee------cCCCceeeccccccCCc
Q 025816 81 IIHRDIKSSNVLI------FDDDVAKIADFDLSNQA 110 (247)
Q Consensus 81 i~h~di~~~nil~------~~~~~~~l~d~g~~~~~ 110 (247)
++|+|+.+.||++ +....+.++||.++...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6799999999999 34567999999987643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=83.90 E-value=1 Score=34.92 Aligned_cols=26 Identities=38% Similarity=0.461 Sum_probs=21.2
Q ss_pred CCCeEeccCCCCceeecCCCceeeccc
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADF 104 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~ 104 (247)
.+.++|+|+.+.|++++.++. .+.|-
T Consensus 187 ~p~LvHGDlw~gNvl~~~~g~-~~iDp 212 (288)
T 3f7w_A 187 PPARIHGDLWNGNVLWQDDGA-VVIDP 212 (288)
T ss_dssp CCEEECSCCSGGGEEEETTEE-EECSC
T ss_pred CCeeeecCCCCCcEEEcCCCe-EEEec
Confidence 456999999999999998874 45563
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=82.93 E-value=0.51 Score=39.19 Aligned_cols=30 Identities=20% Similarity=0.427 Sum_probs=26.2
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~ 110 (247)
.++|+|+.+.|++ +.++.+.++||.++...
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 4999999999999 77888999999987643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=81.13 E-value=0.58 Score=37.11 Aligned_cols=27 Identities=22% Similarity=0.395 Sum_probs=23.5
Q ss_pred CCCeEeccCCCCceeecCCCceeecccc
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFD 105 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g 105 (247)
.+.++|+|+.+.|++++.++ +.|+|++
T Consensus 206 ~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 206 KPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred CceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 45699999999999999887 8888974
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 247 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-29 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-28 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-58
Identities = 58/242 (23%), Positives = 104/242 (42%), Gaps = 26/242 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ + +H N + +GY + ++ SL+ LH + + +
Sbjct: 57 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--------FEMIKLI 107
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
IA A+G++YLH K IIHRD+KS+N+ + +D KI DF L+ +
Sbjct: 108 DIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 121 RVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
++ G+ + APE + +SDVY+FG+VL EL+TG+ P + R Q
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------ 218
Query: 178 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
V + + M + A C++ + D RP ++ +++ L +
Sbjct: 219 -----IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
Query: 238 RP 239
P
Sbjct: 274 LP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-52
Identities = 56/237 (23%), Positives = 101/237 (42%), Gaps = 27/237 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +L+H+ V+L + E+ NGSL D L G+K L+ + +
Sbjct: 61 LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIK-------LTINKLL 112
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+A A+G+ ++ E+ + IHRD++++N+L+ D KIADF L+ D
Sbjct: 113 DMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-ARE 168
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ APE G KSDV+SFG++L E++T + P
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY---------------PG 213
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
++ +V Q ++ P ++ + LC + + RP + L+ A
Sbjct: 214 MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 3e-52
Identities = 52/246 (21%), Positives = 94/246 (38%), Gaps = 27/246 (10%)
Query: 1 MVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG---------VKGAQP 50
++S L H N V LLG C G ++ E+ G L + L ++
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 51 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 110
L + + + AKG+ +L K + IHRD+ + N+L+ + KI DF L+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 111 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 170
+ + + + APE +SDV+S+G+ L EL + +P
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--- 252
Query: 171 QSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230
+ K + + P A A+M + C + RP +V+
Sbjct: 253 -----------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 231 LQPLLN 236
++ ++
Sbjct: 302 IEKQIS 307
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 8e-51
Identities = 53/258 (20%), Positives = 95/258 (36%), Gaps = 32/258 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 56
L+HEN + + L ++ +GSL D L+ ++
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTV 99
Query: 57 QQRVKIAVGAAKGLEYLHEKA-----DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 111
+ +K+A+ A GL +LH + P I HRD+KS N+L+ + IAD L+ +
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159
Query: 112 DMAARLH--STRVLGTFGYHAPEYAMT------GQLNAKSDVYSFGVVLLELLTGRKP-- 161
+ +GT Y APE + ++D+Y+ G+V E+
Sbjct: 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219
Query: 162 --VDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDY-PPKAVAKMAAVAALCVQYEA 218
D+ LP + ++ + Q + + + +A+ MA + C
Sbjct: 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279
Query: 219 DFRPNMSIVVKALQPLLN 236
R + K L L
Sbjct: 280 AARLTALRIKKTLSQLSQ 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-50
Identities = 56/249 (22%), Positives = 95/249 (38%), Gaps = 31/249 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG--------------VK 46
M HEN V LLG C L +E+ G L + L ++ ++
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 47 GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 106
+ VL+++ + A AKG+E+L K +HRD+ + NVL+ V KI DF L
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 107 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 166
+ + + + APE G KSDV+S+G++L E+ + +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 167 PRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226
P + + D P A ++ + C +++ RP+
Sbjct: 271 PVDAN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 227 VVKALQPLL 235
+ L L
Sbjct: 317 LTSFLGCQL 325
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (415), Expect = 4e-50
Identities = 54/250 (21%), Positives = 95/250 (38%), Gaps = 33/250 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------------- 46
+++ + N V+LLG C G L +E+ + G L++ L
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 47 -GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 105
+ P LS +++ IA A G+ YL E +HRD+ + N L+ ++ V KIADF
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 106 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 165
LS + PE + +SDV+++GVVL E+ + +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY- 244
Query: 166 LPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225
++ ++V V P ++ + LC RP+
Sbjct: 245 --------------GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC 290
Query: 226 IVVKALQPLL 235
+ + LQ +
Sbjct: 291 SIHRILQRMC 300
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-49
Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 31/237 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
++++L+H N VQLLG V+ + + E+ + GSL D L R VL
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCL 105
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
+K ++ + +EYL + +HRD+ + NVL+ +D+VAK++DF L+ +A
Sbjct: 106 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q 157
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+ APE + + KSDV+SFG++L E+ + + P
Sbjct: 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY---------------P 202
Query: 180 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236
++ V V+ D P + V C +A RP+ + + L+ +
Sbjct: 203 RIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-49
Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 15/173 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ V G + E GSL +L + Q
Sbjct: 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILG 107
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
K+++ KGL YL EK I+HRD+K SN+L+ K+ DF +S Q D +
Sbjct: 108 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 161
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 173
+GT Y +PE + +SD++S G+ L+E+ GR P+ + + +
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 7e-49
Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 27/238 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ + H N ++L G ++ E+ NG+L L + G S Q V
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLV 113
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ G A G++YL + +HRD+ + N+L+ + V K++DF LS D ++T
Sbjct: 114 GMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 121 -RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+ APE + + SDV+SFG+V+ E++T +
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--------------- 215
Query: 180 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
+LS +V + ++ P + + + C Q E RP + +V L L+ A
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (403), Expect = 2e-48
Identities = 56/236 (23%), Positives = 99/236 (41%), Gaps = 26/236 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +KH N VQLLG C + EF + G+L D L + +S +
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLL 118
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+A + +EYL +K + IHRD+ + N L+ ++ + K+ADF LS H
Sbjct: 119 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-A 174
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ APE + + KSDV++FGV+L E+ T P
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------------PG 219
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236
+ +V + ++ + P K+ + C Q+ RP+ + + +A + +
Sbjct: 220 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 8e-48
Identities = 53/237 (22%), Positives = 102/237 (43%), Gaps = 27/237 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +L H VQL G C++ L +EF +G L D L ++G+ + + +
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--------AAETLL 104
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ + +G+ YL E +IHRD+ + N L+ ++ V K++DF ++ D ST
Sbjct: 105 GMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SST 160
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ +PE + ++KSDV+SFGV++ E+ + K
Sbjct: 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------------- 205
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
S +V + + P A + + C + + RP S +++ L + +
Sbjct: 206 RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-47
Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 29/233 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ L HE VQL G C + E+ +NG L + L + QQ +
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLL 103
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
++ + +EYL K +HRD+ + N L+ D V K++DF LS D S
Sbjct: 104 EMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSV 159
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATP 179
+ PE M + ++KSD+++FGV++ E+ + G+ P +
Sbjct: 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER--------------- 204
Query: 180 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
+ + + + L P A K+ + C +AD RP I++ +
Sbjct: 205 -FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (398), Expect = 1e-47
Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 29/238 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ + H N + L G T ++ EF NGSL L G + Q V
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--------TVIQLV 131
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ G A G++YL D + +HRD+ + N+L+ + V K++DF LS D + T
Sbjct: 132 GMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188
Query: 121 RVLG---TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
LG + APE + + SDV+S+G+V+ E+++ +
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER---------------P 233
Query: 178 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235
++ V ++ P + + + C Q + + RP +V L ++
Sbjct: 234 YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-47
Identities = 53/233 (22%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +L + V+L+G C + +L E A G LH L G++ +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVA 112
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHS 119
++ + G++YL EK + +HRD+ + NVL+ + AKI+DF LS D +
Sbjct: 113 ELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+ ++APE + +++SDV+S+GV + E L+ +
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---------------PYK 214
Query: 180 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
K+ +V ++ + PP+ ++ A+ + C Y+ + RP+ V + ++
Sbjct: 215 KMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-47
Identities = 57/246 (23%), Positives = 102/246 (41%), Gaps = 28/246 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPV 53
+ H N + LLG C LA E+A +G+L D L + ++
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
LS QQ + A A+G++YL +K IHRD+ + N+L+ ++ VAKIADF LS
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 173
+ T + A E SDV+S+GV+L E+++
Sbjct: 181 ---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY---------- 227
Query: 174 VTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233
++ ++ + + + P ++ + C + + RP+ + ++ +L
Sbjct: 228 -----CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
Query: 234 LLNARP 239
+L R
Sbjct: 283 MLEERK 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-47
Identities = 51/243 (20%), Positives = 93/243 (38%), Gaps = 29/243 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
++ H N + LLG C+ + + +G L + + + +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------PTVKDL 132
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARL 117
+ + AKG+++L +HRD+ + N ++ + K+ADF L+ D +
Sbjct: 133 IGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 118 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWA 177
+ T + A E T + KSDV+SFGV+L EL+T P P +
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDIT 244
Query: 178 TPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237
L ++ Q P + V C +A+ RP+ S +V + + +
Sbjct: 245 VYLLQGRRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
Query: 238 RPG 240
G
Sbjct: 295 FIG 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 8e-47
Identities = 60/241 (24%), Positives = 100/241 (41%), Gaps = 27/241 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +L+HE VQL + + E+ S GSL D L G G L Q V
Sbjct: 65 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETG-------KYLRLPQLV 116
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+A A G+ Y+ + +HRD++++N+L+ ++ V K+ADF L+ D
Sbjct: 117 DMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 172
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ APE A+ G+ KSDV+SFG++L EL T + P
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---------------PG 217
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240
+ +V V+ PP+ + + C + E + RP + L+ +
Sbjct: 218 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277
Query: 241 P 241
Sbjct: 278 Q 278
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-46
Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 25/242 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGPV 53
M KH+N + LLG C + E+AS G+L + L R+ P
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 113
LS + V A A+G+EYL K IHRD+ + NVL+ +D+V KIADF L+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 173
+T + APE +SDV+SFGV+L E+ T
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY---------- 238
Query: 174 VTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233
P + +++ + + D P ++ + C RP +V+ L
Sbjct: 239 -----PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 234 LL 235
++
Sbjct: 294 IV 295
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 5e-46
Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 31/235 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +L + V+++G C S +L E A G L+ L + + + +
Sbjct: 61 VMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH---------VKDKNII 110
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHS 119
++ + G++YL E + +HRD+ + NVL+ AKI+DF LS D
Sbjct: 111 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTWAT 178
T ++APE + ++KSDV+SFGV++ E + G+KP
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-------------- 213
Query: 179 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233
+ +V ++ P +M + LC Y+ + RP + V L+
Sbjct: 214 --MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-46
Identities = 46/236 (19%), Positives = 88/236 (37%), Gaps = 27/236 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+++ + + + +LLG C+ T +++ + G L D + K Q +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--------GSQYLL 114
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
V AKG+ YL ++ ++HRD+ + NVL+ KI DF L+ H+
Sbjct: 115 NWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ A E + +SDV+S+GV + EL+T
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDG 216
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236
+ ++ ++ PP + + C +AD RP ++ +
Sbjct: 217 IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-45
Identities = 48/233 (20%), Positives = 91/233 (39%), Gaps = 27/233 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 58
++ LKH N V+ +D T+ L E+ G L ++ KG + L +
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEF 110
Query: 59 RVKIAVGAAKGLEYLHEKAD--PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 116
+++ L+ H ++D ++HRD+K +NV + K+ DF L+ +
Sbjct: 111 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS- 169
Query: 117 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 176
+ +GT Y +PE N KSD++S G +L EL P +
Sbjct: 170 -FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA----- 223
Query: 177 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229
K+R+ R+ Y + + + + RP++ +++
Sbjct: 224 -------GKIREGKFRRIPYRYSDEL----NEIITRMLNLKDYHRPSVEEILE 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-45
Identities = 55/229 (24%), Positives = 86/229 (37%), Gaps = 33/229 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ S L+H N ++L GY D T L E+A G+++ L Q+
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTA 109
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
A L Y H K +IHRDIK N+L+ KIADF S AP T
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRT 162
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ GT Y PE + K D++S GV+ E L G+ P + + ++
Sbjct: 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 222
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229
+ D + + +++ RP + V++
Sbjct: 223 FPDFVTEGARD-----------------LISRLLKHNPSQRPMLREVLE 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-44
Identities = 51/236 (21%), Positives = 93/236 (39%), Gaps = 19/236 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-GPVLSWQQR 59
++ + V+LLG G ++ E + G L L + P S +
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
+++A A G+ YL+ +HRD+ + N ++ +D KI DF ++ +
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+ L + +PE G SDV+SFGVVL E+ T +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---------------Q 237
Query: 180 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235
LS ++V + V D P + + +C QY RP+ ++ +++ +
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-44
Identities = 52/234 (22%), Positives = 87/234 (37%), Gaps = 34/234 (14%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 56
M+ L+H N V+ VL E ++G+L L K V+
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------VMKI 111
Query: 57 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAA 115
+ KGL++LH + P IIHRD+K N+ I KI D L+
Sbjct: 112 KVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 175
+ V+GT + APE + + DVY+FG+ +LE+ T P Q
Sbjct: 169 --FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---- 221
Query: 176 WATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229
R+ + A+ ++ + C++ D R ++ ++
Sbjct: 222 ----------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-43
Identities = 58/245 (23%), Positives = 92/245 (37%), Gaps = 25/245 (10%)
Query: 1 MVSRLKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGP 52
++ H N V LLG C G ++ EF G+L L ++
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 53 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 112
L+ + + + AKG+E+L + IHRD+ + N+L+ + +V KI DF L+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 113 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 172
+ + APE +SDV+SFGV+L E+ + P
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVK 241
Query: 173 LVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
+ +L E + P +M C E RP S +V+ L
Sbjct: 242 IDEEFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 233 PLLNA 237
LL A
Sbjct: 293 NLLQA 297
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-43
Identities = 52/230 (22%), Positives = 87/230 (37%), Gaps = 32/230 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+++ H N V+LL + + EF + G++ ++ + L+ Q
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQ 113
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ L YLH+ IIHRD+K+ N+L D K+ADF +S + R S
Sbjct: 114 VVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS- 169
Query: 121 RVLGTFGYHAPEYAMTGQL-----NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 175
+GT + APE M + K+DV+S G+ L+E+ P P
Sbjct: 170 -FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL---- 224
Query: 176 WATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225
K+ + L P + + C++ D R S
Sbjct: 225 --------LKIAKSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTS 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-41
Identities = 50/235 (21%), Positives = 85/235 (36%), Gaps = 28/235 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ + H + V+L+G + + E + G L L RK L +
Sbjct: 61 TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--------LDLASLI 111
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
A + L YL K +HRDI + NVL+ +D K+ DF LS D ++
Sbjct: 112 LYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KAS 167
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ + APE + + SDV+ FGV + E+L
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ---------------G 212
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235
+ + V ++ PP + ++ C Y+ RP + + L +L
Sbjct: 213 VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 1e-41
Identities = 48/233 (20%), Positives = 89/233 (38%), Gaps = 38/233 (16%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ +L+H N +Q G + + L E+ + + +K L +
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---------LQEVEIA 118
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ GA +GL YLH ++IHRD+K+ N+L+ + + K+ DF ++
Sbjct: 119 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------N 169
Query: 121 RVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ-QSLVTW 176
+GT + APE + GQ + K DV+S G+ +EL + P+ + +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 177 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229
+P L + C+Q RP +++K
Sbjct: 230 ESPALQSG------------HWSEYF----RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-41
Identities = 54/230 (23%), Positives = 85/230 (36%), Gaps = 27/230 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ L HEN V+ G+ +G + L E+ S G L D + G +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQ 106
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ G+ YLH I HRDIK N+L+ + D KI+DF L+
Sbjct: 107 RFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163
Query: 121 RVLGTFGYHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
++ GT Y APE + +A DV+S G+VL +L G P D Q+
Sbjct: 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------- 215
Query: 180 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229
+ + + K + A+ + R + + K
Sbjct: 216 ------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-40
Identities = 54/233 (23%), Positives = 83/233 (35%), Gaps = 27/233 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ L H N ++L G + + + E A GSL D L +G
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGTLS 114
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHS 119
+ AV A+G+ YL K IHRD+ + N+L+ D+ KI DF L P + +
Sbjct: 115 RYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171
Query: 120 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
F + APE T + SD + FGV L E+ T + L Q
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------- 223
Query: 180 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232
+ + P + V C ++ + RP + L
Sbjct: 224 ------LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-40
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 31/226 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ K+ N V L + G + E+ + GSL D++ Q
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQIA 119
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ + LE+LH +IHRDIKS N+L+ D K+ DF Q + +
Sbjct: 120 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRS 174
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSLVTWATP 179
++GT + APE K D++S G++ +E++ G P ++ R + T TP
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
Query: 180 KLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225
+L P K A C+ + + R +
Sbjct: 235 EL---------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAK 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 8e-38
Identities = 42/191 (21%), Positives = 67/191 (35%), Gaps = 12/191 (6%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++SRL H FV+L D +A NG L +
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTR 111
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
LEYLH IIHRD+K N+L+ +D +I DF + + + +
Sbjct: 112 FYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+GT Y +PE SD+++ G ++ +L+ G P +
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 228
Query: 181 LSEDKVRQCVD 191
E + D
Sbjct: 229 FPEKFFPKARD 239
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 129 bits (324), Expect = 3e-36
Identities = 45/227 (19%), Positives = 77/227 (33%), Gaps = 29/227 (12%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+S L+H V L D V+ YEF S G L + + +S + V
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAV 127
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAPDMAARLH 118
+ KGL ++HE + +H D+K N++ K+ DF L+ +
Sbjct: 128 EYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 184
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
+T GT + APE A + +D++S GV+ LL+G P V
Sbjct: 185 TT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 241
Query: 179 PKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225
+ + + + + R +
Sbjct: 242 WNMDD-------------SAFSGISEDGKDFIRKLLLADPNTRMTIH 275
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 127 bits (320), Expect = 1e-35
Identities = 44/191 (23%), Positives = 72/191 (37%), Gaps = 16/191 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++++L H + L D VL EF S G L D + +S + +
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--------MSEAEVI 130
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI--FDDDVAKIADFDLSNQAPDMAARLH 118
A +GL+++HE I+H DIK N++ KI DF L+ +
Sbjct: 131 NYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
+T T + APE + +D+++ GV+ LL+G P V
Sbjct: 188 TT---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244
Query: 179 PKLSEDKVRQC 189
+ ED
Sbjct: 245 WEFDEDAFSSV 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 125 bits (315), Expect = 2e-35
Identities = 49/225 (21%), Positives = 78/225 (34%), Gaps = 34/225 (15%)
Query: 7 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 66
H N +QL T L ++ G L D L + LS ++ KI
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRAL 119
Query: 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 126
+ + LH+ +I+HRD+K N+L+ DD K+ DF S Q V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 127 GYHAPEYAMTGQLNA------KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
Y APE + + D++S GV++ LL G P H ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225
+ DY ++ + + R
Sbjct: 234 FGSPEWD---------DYSDTVKDLVSR----FLVVQPQKRYTAE 265
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-34
Identities = 42/191 (21%), Positives = 70/191 (36%), Gaps = 14/191 (7%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ +H + + E+ + G L + +
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRAT 106
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
A GL++LH K I++RD+K N+L+ D KIADF + + A+ +
Sbjct: 107 FYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TN 161
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
GT Y APE + + N D +SFGV+L E+L G+ P + P
Sbjct: 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 221
Query: 181 LSEDKVRQCVD 191
++ D
Sbjct: 222 YPRWLEKEAKD 232
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (305), Expect = 5e-34
Identities = 54/242 (22%), Positives = 91/242 (37%), Gaps = 31/242 (12%)
Query: 1 MVSRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 56
+ L H V + G + E+ +L DI+H ++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTP 110
Query: 57 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 116
++ +++ A + L + H+ IIHRD+K +N++I + K+ DF ++ D
Sbjct: 111 KRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167
Query: 117 LHST-RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 175
+ T V+GT Y +PE A ++A+SDVYS G VL E+LTG P P
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
Query: 176 WATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-NMSIVVKALQPL 234
P A + AV + + R + + L +
Sbjct: 228 REDPIPPS-------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
Query: 235 LN 236
N
Sbjct: 275 HN 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-34
Identities = 34/191 (17%), Positives = 73/191 (38%), Gaps = 16/191 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+++ +H N + L V+ +EF S + + ++ L+ ++ V
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIV 105
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAPDMAARLH 118
+ L++LH +I H DI+ N++ KI +F + Q +
Sbjct: 106 SYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---N 159
Query: 119 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 178
+ Y+APE ++ +D++S G ++ LL+G P + + A
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219
Query: 179 PKLSEDKVRQC 189
E+ ++
Sbjct: 220 YTFDEEAFKEI 230
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-33
Identities = 38/235 (16%), Positives = 72/235 (30%), Gaps = 19/235 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+ +H N V+L C + + P P + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD---QDLTTYLDKVPEPGVPTETIK 119
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ +GL++LH ++HRD+K N+L+ K+ADF L+ T
Sbjct: 120 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALT 173
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV------ 174
V+ T Y APE + D++S G + E+ + + Q +
Sbjct: 174 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233
Query: 175 ----TWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225
W + A+ + + C+ + R +
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 121 bits (304), Expect = 3e-33
Identities = 36/175 (20%), Positives = 64/175 (36%), Gaps = 17/175 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
+VS V + + + G LH L
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADMR 110
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
A GLE++H + +++RD+K +N+L+ + +I+D L+
Sbjct: 111 FYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPH 163
Query: 121 RVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
+GT GY APE G ++ +D +S G +L +LL G P + + +
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (292), Expect = 6e-32
Identities = 39/225 (17%), Positives = 68/225 (30%), Gaps = 25/225 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ ++KH N V L G L + S G L D + + + +
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---------FYTERDAS 110
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
++ ++YLH+ H + + +D I+DF LS + +
Sbjct: 111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---S 167
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
GT GY APE + D +S GV+ LL G P + A +
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 227
Query: 181 LSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225
Y ++ + + R
Sbjct: 228 FDS-------------PYWDDISDSAKDFIRHLMEKDPEKRFTCE 259
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (290), Expect = 9e-32
Identities = 42/244 (17%), Positives = 81/244 (33%), Gaps = 30/244 (12%)
Query: 1 MVSRLKHENFVQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
+ ++ + + +C +G V+ E + S +
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---------FSLKTV 105
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPD---- 112
+ +A +EY+H K + IHRD+K N L+ + I DF L+ + D
Sbjct: 106 LLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
Query: 113 -MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 171
+ + GT Y + + + + + D+ S G VL+ G P ++
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222
Query: 172 SLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKAL 231
+ K + L YP + A C D +P+ S + +
Sbjct: 223 QKYERISEKKMSTPIEV-----LCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLF 273
Query: 232 QPLL 235
+ L
Sbjct: 274 RNLF 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (291), Expect = 1e-31
Identities = 46/191 (24%), Positives = 73/191 (38%), Gaps = 17/191 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
M+S + H +++ G D + ++ G L +L +
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPVAK 107
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
A LEYLH K II+RD+K N+L+ + KI DF + PD+ +
Sbjct: 108 FYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TY 159
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ GT Y APE T N D +SFG+++ E+L G P + + A +
Sbjct: 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR 219
Query: 181 LSEDKVRQCVD 191
D
Sbjct: 220 FPPFFNEDVKD 230
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (277), Expect = 7e-30
Identities = 37/247 (14%), Positives = 73/247 (29%), Gaps = 32/247 (12%)
Query: 1 MVSRLKHENFV-QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
L + + + +G VL + + G S +
Sbjct: 53 TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---------LCGRKFSVKTV 103
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-----FDDDVAKIADFDLSNQAPDMA 114
A ++ +HEK +++RDIK N LI + ++ + DF + D
Sbjct: 104 AMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160
Query: 115 ARLH-----STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 169
+ H + GT Y + + + + + D+ + G V + L G P
Sbjct: 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
Query: 170 QQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229
+ K +R+ L +P + D P+ +
Sbjct: 221 NKQKYERIGEKKQSTPLRE-----LCAGFPE----EFYKYMHYARNLAFDATPDYDYLQG 271
Query: 230 ALQPLLN 236
+L
Sbjct: 272 LFSKVLE 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-29
Identities = 53/255 (20%), Positives = 93/255 (36%), Gaps = 30/255 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ L H N + LL ++ L ++F I L+
Sbjct: 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSHIK 103
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ +GLEYLH+ I+HRD+K +N+L+ ++ V K+ADF L+ T
Sbjct: 104 AYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYT 158
Query: 121 RVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATP 179
+ T Y APE ++ D+++ G +L ELL + Q + +
Sbjct: 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 218
Query: 180 KLSED------KVRQCVDARLGGDYPPKAVAKMAAVAAL-----CVQYEADFRPNMSIVV 228
+E+ + V + P + A L + R +
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT--- 275
Query: 229 KALQ-PLLNARPGPA 242
+AL+ + RPGP
Sbjct: 276 QALKMKYFSNRPGPT 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-29
Identities = 49/245 (20%), Positives = 90/245 (36%), Gaps = 33/245 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEF----ASNGSLHDILHGRKGVKGAQPGPVLSW 56
++ R +HEN + + T + + L+ +L + LS
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSN 108
Query: 57 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAA 115
+GL+Y+H +++HRD+K SN+L+ KI DF L+ A PD
Sbjct: 109 DHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
T + T Y APE + + KS D++S G +L E+L+ R Q + +
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225
Query: 175 TWATPKLSEDKVRQCVDARLGG--------------DYPPKAVAKMAAVAALCVQYEADF 220
S++ + ++ + P A +K + + +
Sbjct: 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285
Query: 221 RPNMS 225
R +
Sbjct: 286 RIEVE 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-28
Identities = 38/206 (18%), Positives = 67/206 (32%), Gaps = 18/206 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVL 54
++ +L H N V+L + + L ++ H + L
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------KQTL 119
Query: 55 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDM 113
+ L Y+H I HRDIK N+L+ D V K+ DF + Q
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR- 175
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 173
+ + + + + DV+S G VL ELL G+ Q
Sbjct: 176 -GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 174 VTWATPKLSEDKVRQCVDARLGGDYP 199
+ + +++R+ +P
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFP 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 3e-28
Identities = 32/168 (19%), Positives = 64/168 (38%), Gaps = 20/168 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 56
+ + V+++ + + ++ E G L + R +
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-------FTE 110
Query: 57 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDM 113
++ +I + ++YLH +I HRD+K N+L + + K+ DF + +
Sbjct: 111 REASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167
Query: 114 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ T Y APE + + D++S GV++ LL G P
Sbjct: 168 NSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-28
Identities = 45/229 (19%), Positives = 85/229 (37%), Gaps = 32/229 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ ++H N + L + T +L E + G L D L ++ L+ ++
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEAT 116
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLSNQAPDMAAR 116
+ G+ YLH I H D+K N+++ D +V KI DF L+++
Sbjct: 117 EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-- 171
Query: 117 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 176
+ GT + APE L ++D++S GV+ LL+G P + + V+
Sbjct: 172 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 177 ATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225
+ + +Y A + + R +
Sbjct: 231 VNYEFED-------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 9e-28
Identities = 35/163 (21%), Positives = 59/163 (36%), Gaps = 17/163 (10%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
++LL + S VL E +G L +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQEELARSFF 116
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRV 122
+ + + H ++HRDIK N+LI + K+ DF D T
Sbjct: 117 WQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDF 169
Query: 123 LGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 164
GT Y PE+ + + +S V+S G++L +++ G P +H
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-27
Identities = 33/161 (20%), Positives = 60/161 (37%), Gaps = 12/161 (7%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ L H N V+LL L +EF + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--------IPLPLIK 105
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+GL + H ++HRD+K N+LI + K+ADF L+ +A + R ++
Sbjct: 106 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTH 161
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
V+ + + D++S G + E++T R
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 103 bits (256), Expect = 6e-27
Identities = 35/237 (14%), Positives = 72/237 (30%), Gaps = 25/237 (10%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ LKH N V+L VL +E + G L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAK 103
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ G+ Y H++ ++HRD+K N+LI + KIADF L+ +
Sbjct: 104 SFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-H 159
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
++ + + + + D++S G + E++ G Q +
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219
Query: 181 LSE------------DKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225
+ D + + + + ++ + + R
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-26
Identities = 39/191 (20%), Positives = 65/191 (34%), Gaps = 14/191 (7%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ +H L E+A+ G L L + + ++
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERAR 108
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
LEYLH + +++RDIK N+++ D KI DF L + A +
Sbjct: 109 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-- 163
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
GT Y APE D + GVV+ E++ GR P + L+ +
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223
Query: 181 LSEDKVRQCVD 191
+
Sbjct: 224 FPRTLSPEAKS 234
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.1 bits (246), Expect = 5e-25
Identities = 34/184 (18%), Positives = 63/184 (34%), Gaps = 17/184 (9%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ + V+L D ++ + E+ + G + L S
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHAR 144
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
A EYLH +I+RD+K N+LI ++ DF + + +
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTW 196
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
+ GT APE ++ N D ++ GV++ E+ G P P + +
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256
Query: 181 LSED 184
Sbjct: 257 FPSH 260
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 6e-25
Identities = 42/195 (21%), Positives = 78/195 (40%), Gaps = 23/195 (11%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRV--------LAYEFASNGSLHDILHGRKGVKGAQPGP 52
++ LKHEN V L+ C S L ++F + + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-------- 113
Query: 53 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--A 110
+ + ++ GL Y+H I+HRD+K++NVLI D V K+ADF L+
Sbjct: 114 -FTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSL 169
Query: 111 PDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRG 169
+ T + T Y PE + + D++ G ++ E+ T + +
Sbjct: 170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
Query: 170 QQSLVTWATPKLSED 184
Q +L++ ++ +
Sbjct: 230 QLALISQLCGSITPE 244
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 3e-24
Identities = 34/161 (21%), Positives = 62/161 (38%), Gaps = 13/161 (8%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ LKH+N V+L L +EF + +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVK 104
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
KGL + H + +++HRD+K N+LI + K+A+F L+ +A + R +S
Sbjct: 105 SFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSA 160
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
V+ + + D++S G + EL +P
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 3e-24
Identities = 38/189 (20%), Positives = 70/189 (37%), Gaps = 12/189 (6%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 60
++ ++HEN + LL + +F G+ L +
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQ 124
Query: 61 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 120
+ KGL Y+H IIHRD+K N+ + +D KI DF L+ QA +
Sbjct: 125 FLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTG 177
Query: 121 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPK 180
V+ + + D++S G ++ E++TG+ + Q + T
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 181 LSEDKVRQC 189
+ V++
Sbjct: 238 PPAEFVQRL 246
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (219), Expect = 2e-21
Identities = 42/177 (23%), Positives = 69/177 (38%), Gaps = 16/177 (9%)
Query: 1 MVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 59
++ ++ F V L T L ++ + G L L R+ + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEV 131
Query: 60 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 119
LE+LH+ II+RDIK N+L+ + + DF LS + +
Sbjct: 132 QIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RA 187
Query: 120 TRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
GT Y AP+ G + D +S GV++ ELLTG P + Q+ +
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 86.0 bits (212), Expect = 2e-20
Identities = 31/159 (19%), Positives = 58/159 (36%), Gaps = 22/159 (13%)
Query: 7 HENFVQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 64
N + L D SR L +E +N + L+
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMY 136
Query: 65 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVL 123
K L+Y H I+HRD+K NV+I + ++ D+ L+ +
Sbjct: 137 EILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRV 190
Query: 124 GTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKP 161
+ + PE + Q+ + D++S G +L ++ ++P
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (208), Expect = 1e-19
Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 22/166 (13%)
Query: 1 MVSRLKHENFVQLLGYCVDGTS-----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 55
++ +KHEN + LL S V L++I+ +K L+
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LT 119
Query: 56 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 115
+ +GL+Y+H IIHRD+K SN+ + +D KI DF L+ D
Sbjct: 120 DDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 174
Query: 116 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 161
+ V + N D++S G ++ ELLTGR
Sbjct: 175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.5 bits (200), Expect = 1e-18
Identities = 36/180 (20%), Positives = 63/180 (35%), Gaps = 24/180 (13%)
Query: 1 MVSRLKHENFVQLLGYCV------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 54
++ + H+N + LL + L E I
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------------ 116
Query: 55 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 114
++ + G+++LH IIHRD+K SN+++ D KI DF L+
Sbjct: 117 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AG 170
Query: 115 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 174
T + T Y APE + D++S G ++ E++ + Q + V
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 81.2 bits (199), Expect = 2e-18
Identities = 32/171 (18%), Positives = 64/171 (37%), Gaps = 10/171 (5%)
Query: 1 MVSRLKHENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKG-----AQPGPV 53
++ R+ + + + ++L + NG ++ G
Sbjct: 62 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121
Query: 54 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPD 112
+ +I+ GL+Y+H + IIH DIK NVL+ D + +++
Sbjct: 122 IPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 179
Query: 113 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 163
H T + T Y +PE + +D++S ++ EL+TG +
Sbjct: 180 CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 48.6 bits (115), Expect = 9e-08
Identities = 18/118 (15%), Positives = 41/118 (34%), Gaps = 21/118 (17%)
Query: 4 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 63
R + +L G V Y + N L +++ + + + ++
Sbjct: 62 RNEFRALQKLQGLAV-----PKVYAWEGNAVLMELIDA-------KELYRVRVENPDEVL 109
Query: 64 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-----NQAPDMAAR 116
+ + + + I+H D+ NVL+ ++ + I DF S ++ R
Sbjct: 110 DMILEEVAKFYHR---GIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILER 163
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 247 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.08 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.23 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 89.88 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 84.82 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-50 Score=319.79 Aligned_cols=212 Identities=25% Similarity=0.418 Sum_probs=169.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|||||++++++..+...++||||+.+|+|.+++..... .+++..+..++.|+++||.|||+++
T Consensus 80 ~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH~~~--- 148 (299)
T d1jpaa_ 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLADMN--- 148 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHhhCC---
Confidence 47899999999999999999999999999999999998876543 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcc---cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL---HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
++||||||+|||++.++.+||+|||+++......... ......+|..|+|||.+.+..++.++|||||||++|+|++
T Consensus 149 iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t 228 (299)
T d1jpaa_ 149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228 (299)
T ss_dssp CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHh
Confidence 9999999999999999999999999998664432221 1122457889999999999999999999999999999998
Q ss_pred -CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 158 -GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 158 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
|..||.... ...+...+....+...+..++..+.+++.+||+.||.+|||+.+|++.|+++++
T Consensus 229 ~g~~Pf~~~~----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 229 YGERPYWDMT----------------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TSCCTTTTCC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCC----------------HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 899996432 223333344444555666778889999999999999999999999999999998
Q ss_pred cCC
Q 025816 237 ARP 239 (247)
Q Consensus 237 ~~~ 239 (247)
.+.
T Consensus 293 ~p~ 295 (299)
T d1jpaa_ 293 NPN 295 (299)
T ss_dssp SGG
T ss_pred Chh
Confidence 654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=313.95 Aligned_cols=203 Identities=26% Similarity=0.320 Sum_probs=166.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++|||||.+|+|.+++..... +++..+..++.|+++||.|||+++
T Consensus 56 ~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~ylH~~~--- 123 (271)
T d1nvra_ 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGIG--- 123 (271)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHHcC---
Confidence 46889999999999999999999999999999999999975432 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~ 159 (247)
|+||||||+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus 124 IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~ 203 (271)
T d1nvra_ 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203 (271)
T ss_dssp EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCC
Confidence 99999999999999999999999999987654333333345679999999999998776 67899999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
.||.......... ................+.++.+++.+||+.||.+|||++|+++
T Consensus 204 ~pf~~~~~~~~~~--------------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 204 LPWDQPSDSCQEY--------------SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp CSCSSSSTTSHHH--------------HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCChHHHHH--------------HHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9997543222111 1111111111222344567899999999999999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=314.62 Aligned_cols=212 Identities=27% Similarity=0.447 Sum_probs=166.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.. ...++||||+.+|+|.+++..... .+++..+..++.|+++||.|||+++
T Consensus 57 ~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~--- 124 (276)
T d1uwha_ 57 VLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAKS--- 124 (276)
T ss_dssp HHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhcCC---
Confidence 4688999999999998754 568999999999999999975442 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC---CCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+. .|+.++||||+|+++|+|++
T Consensus 125 ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~t 204 (276)
T d1uwha_ 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204 (276)
T ss_dssp CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHH
Confidence 999999999999999999999999999876543333333456789999999999753 47899999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC----CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG----GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
|..||....... .+...+..... ...+..++.++.+++.+||+.||.+|||+++|++.|+.
T Consensus 205 g~~Pf~~~~~~~---------------~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 205 GQLPYSNINNRD---------------QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp SSCTTTTCCCHH---------------HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCChHH---------------HHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 999997542211 11111111111 12234456789999999999999999999999999999
Q ss_pred hHhcCC
Q 025816 234 LLNARP 239 (247)
Q Consensus 234 ~~~~~~ 239 (247)
+.++.|
T Consensus 270 l~~~~P 275 (276)
T d1uwha_ 270 LARSLP 275 (276)
T ss_dssp HHHTCC
T ss_pred HHHcCC
Confidence 988765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=317.92 Aligned_cols=213 Identities=26% Similarity=0.426 Sum_probs=175.9
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC--------------CCCCCCCcCHHHHHHHHHHH
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK--------------GAQPGPVLSWQQRVKIAVGA 66 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~--------------~~~~~~~l~~~~~~~~~~~~ 66 (247)
|+++ +|||||++++++.+.+..++|||||++|+|.+++....... .......+++..++.++.|+
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 173 (325)
T d1rjba_ 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173 (325)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence 4566 89999999999999999999999999999999997654321 01122348999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccch
Q 025816 67 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY 146 (247)
Q Consensus 67 ~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 146 (247)
++||.|||+++ |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||
T Consensus 174 ~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Diw 250 (325)
T d1rjba_ 174 AKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250 (325)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceecc
Confidence 99999999999 999999999999999999999999999876544433333456689999999999999999999999
Q ss_pred hhhHHHHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH
Q 025816 147 SFGVVLLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS 225 (247)
Q Consensus 147 slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 225 (247)
||||++|+|++ |..||.+... ...+.+.+....+...+...+.++.+||.+||+.||.+|||++
T Consensus 251 S~Gvil~emlt~g~~Pf~~~~~---------------~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ 315 (325)
T d1rjba_ 251 SYGILLWEIFSLGVNPYPGIPV---------------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315 (325)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCC---------------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred chhHHHHHHHhCCCCCCCCCCH---------------HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999997 8999964321 2233444555555566677788899999999999999999999
Q ss_pred HHHHHHH
Q 025816 226 IVVKALQ 232 (247)
Q Consensus 226 ~il~~l~ 232 (247)
||++.|.
T Consensus 316 ei~~~L~ 322 (325)
T d1rjba_ 316 NLTSFLG 322 (325)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9999985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=309.01 Aligned_cols=208 Identities=25% Similarity=0.469 Sum_probs=165.0
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+++++||||+++++++..++..++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+++ |
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH~~~---i 122 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---V 122 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhhccc---e
Confidence 6789999999999999999999999999999999999876442 2889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC-CC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG-RK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g-~~ 160 (247)
+||||||+||+++.++.+||+|||+++........ ......||..|+|||++.+..++.++||||+|+++|+|+++ .+
T Consensus 123 iHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~ 201 (263)
T d1sm2a_ 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201 (263)
T ss_dssp CCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred eecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCC
Confidence 99999999999999999999999999865433222 12335688999999999999999999999999999999995 55
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
||... ....+.+.+....+...+..++.++.+++.+||+.||.+|||+++|++.|+++.++
T Consensus 202 ~~~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 202 PYENR----------------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TTCSC----------------CHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC----------------CHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 55321 12223333444444455566677899999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-49 Score=312.38 Aligned_cols=211 Identities=26% Similarity=0.389 Sum_probs=177.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++||||+.+|+|.+++....... +++..++.++.|++.||.|||+++
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~-------~~~~~~~~i~~qi~~gL~yLH~~~--- 135 (287)
T d1opja_ 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAMEYLEKKN--- 135 (287)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTT-------SCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccc-------hHHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999999999999987654332 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.++.+||+|||+++........ ......|+..|+|||.+.+..++.++||||+|+++|+|++|..
T Consensus 136 iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~ 214 (287)
T d1opja_ 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214 (287)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCccccCeEEECCCCcEEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCC
Confidence 999999999999999999999999999865443222 1233457889999999999999999999999999999999776
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
||... .....+.+.+....+...+..++.++.+++.+||+.||.+|||+++|++.|+.+.+.
T Consensus 215 p~~~~---------------~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 215 SPYPG---------------IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CSSTT---------------CCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCc---------------chHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 65422 122334444555555666677788899999999999999999999999999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-49 Score=307.54 Aligned_cols=196 Identities=28% Similarity=0.415 Sum_probs=165.4
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++|||||.+|+|.+++..... +++..+..++.|+++||.|||+++
T Consensus 59 il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~~lH~~~--- 126 (263)
T d2j4za1 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR--- 126 (263)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999976442 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.++.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 127 ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~ 202 (263)
T d2j4za1 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 202 (263)
T ss_dssp CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred eeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCC
Confidence 9999999999999999999999999997654322 234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||....... ....+.. .....+...+.++.+++.+||+.||.+|||++|+++
T Consensus 203 Pf~~~~~~~---------------~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 203 PFEANTYQE---------------TYKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTCCSSHHH---------------HHHHHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCHHH---------------HHHHHHc--CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 996432110 1111111 112234455678999999999999999999999997
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=310.13 Aligned_cols=199 Identities=24% Similarity=0.367 Sum_probs=166.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++|||||.+|+|.+++.... +++..+..++.|++.||.|||++|
T Consensus 70 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~yLH~~~--- 136 (293)
T d1yhwa1 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ--- 136 (293)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3678999999999999999999999999999999999987643 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.+|.+||+|||++........ ......||+.|+|||++.+..++.++||||+||++|+|++|..
T Consensus 137 iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 99999999999999999999999999986543222 2244569999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhccc-ccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDA-RLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||....... .+...... ......+...+.++.++|.+||+.||.+|||++|+++
T Consensus 215 Pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 215 PYLNENPLR---------------ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp TTTTSCHHH---------------HHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCHHH---------------HHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 996442211 11111111 1112234456678999999999999999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=308.27 Aligned_cols=206 Identities=26% Similarity=0.421 Sum_probs=171.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.. +..++||||+++|+|.+++..... +++..++.++.|++.||.|||+++
T Consensus 61 il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~---------l~~~~~~~i~~qi~~gl~ylH~~~--- 127 (277)
T d1xbba_ 61 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN--- 127 (277)
T ss_dssp HHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhccC---------CCHHHHHHHHHHHHHHHhhHHhCC---
Confidence 4688999999999999865 467899999999999999976542 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
|+||||||+||+++.++.+||+|||+++........ .......||..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 128 iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g 207 (277)
T d1xbba_ 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 207 (277)
T ss_dssp EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCC
Confidence 999999999999999999999999999765433222 22234568899999999999999999999999999999998 8
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
..||.+.. ..++...+..+.+...+..++.++.++|.+||+.||.+|||+++|++.|+..+
T Consensus 208 ~~Pf~~~~----------------~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 208 QKPYRGMK----------------GSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCSSTTCC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCC----------------HHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 99996432 22333444444555666677888999999999999999999999999888765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=308.60 Aligned_cols=209 Identities=26% Similarity=0.449 Sum_probs=174.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|||||++++++.. +..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 62 il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~~--- 129 (285)
T d1u59a_ 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN--- 129 (285)
T ss_dssp HHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678999999999998865 468999999999999999765432 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
|+||||||+||+++.++.+||+|||+++........ .......||..|+|||.+.+..++.++||||+|+++|+|++ |
T Consensus 130 iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G 209 (285)
T d1u59a_ 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 209 (285)
T ss_dssp EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCC
Confidence 999999999999999999999999999865433222 12233457889999999999999999999999999999998 8
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
..||.... ..++...+..+.+...+..++.++.++|.+||+.||.+|||+.+|++.|+....+
T Consensus 210 ~~Pf~~~~----------------~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 210 QKPYKKMK----------------GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCTTTTCC----------------THHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCC----------------HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99996432 2233334444455566677788899999999999999999999999999876643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=306.69 Aligned_cols=212 Identities=26% Similarity=0.396 Sum_probs=171.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|||||+++|++.+....++||||+.++++.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 62 il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~~~--- 130 (283)
T d1mqba_ 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN--- 130 (283)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhccccc---
Confidence 46789999999999999999999999999999999998765542 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
|+||||||+|||++.++.+||+|||+++......... ......||..|+|||.+.+..++.++||||||+++|+|+++.
T Consensus 131 iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~ 210 (283)
T d1mqba_ 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 210 (283)
T ss_dssp CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCC
Confidence 9999999999999999999999999998654332221 223345788999999999999999999999999999999966
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcC
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNAR 238 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~ 238 (247)
.|+... .....+.+.+..+.+...+...+..+.++|.+||+.||.+|||+.+|++.|+.+++++
T Consensus 211 ~~~~~~---------------~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 211 ERPYWE---------------LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp CCTTTT---------------CCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CCcccc---------------CCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 655322 1223344455555566667777888999999999999999999999999999998864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=306.99 Aligned_cols=210 Identities=26% Similarity=0.427 Sum_probs=171.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|||||++++++.+ +..++||||+.+|+|.+++....... +++..++.++.|++.||.|||+++
T Consensus 61 ~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~-------l~~~~~~~i~~qi~~gl~~lH~~~--- 129 (272)
T d1qpca_ 61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN--- 129 (272)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHT-------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3678999999999998754 56799999999999999886654433 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 130 ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~ 208 (272)
T d1qpca_ 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208 (272)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTC
T ss_pred cccCccchhheeeecccceeeccccceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCC
Confidence 999999999999999999999999999865432221 2234568889999999999899999999999999999999655
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
|+... .....+.+.+....+...+..++.++.+++.+||+.||.+|||+++|++.|++++++
T Consensus 209 ~~~~~---------------~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 209 IPYPG---------------MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CSSTT---------------CCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC---------------CCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 54321 112223333344444555666778899999999999999999999999999998864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=305.77 Aligned_cols=201 Identities=24% Similarity=0.357 Sum_probs=164.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++|||||.+|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 62 il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH~~~--- 130 (288)
T d2jfla1 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLHDNK--- 130 (288)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999999999999999999999999999764332 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhh-----cCCCCccccchhhhHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~~l 155 (247)
|+||||||+|||++.++.+||+|||++......... .....||+.|+|||++. +..|+.++||||+||++|+|
T Consensus 131 ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~--~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyem 208 (288)
T d2jfla1 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208 (288)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH--HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHH
T ss_pred EEEeecChhheeECCCCCEEEEechhhhccCCCccc--ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHH
Confidence 999999999999999999999999998765433221 23457899999999984 45688999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccc-cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR-LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
++|..||....... .+..+.... .....+...+.++.++|.+||+.||.+|||++|+++
T Consensus 209 ltg~~Pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 209 AEIEPPHHELNPMR---------------VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHSSCTTTTSCGGG---------------HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhCCCCCCCCCHHH---------------HHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999997543211 111111111 112233456678999999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=309.58 Aligned_cols=200 Identities=24% Similarity=0.327 Sum_probs=162.9
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++|||||.+|+|.+++..... +++..++.++.|++.||.|||+++
T Consensus 61 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~--- 128 (288)
T d1uu3a_ 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG--- 128 (288)
T ss_dssp HHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCC---------CCHHHHHHHHHHHHHHHHhhcccc---
Confidence 36789999999999999999999999999999999999876542 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||+||++|+|++|..
T Consensus 129 iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 208 (288)
T d1uu3a_ 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208 (288)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCC
Confidence 99999999999999999999999999987654333333345679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
||...+.. .....+... ....+...+.++.++|.+||+.||.+|||++|+++
T Consensus 209 Pf~~~~~~---------------~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 209 PFRAGNEY---------------LIFQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp SSCCSSHH---------------HHHHHHHTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCCcCHH---------------HHHHHHHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 99754211 111111111 12234455677999999999999999999998643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=306.99 Aligned_cols=206 Identities=20% Similarity=0.313 Sum_probs=153.9
Q ss_pred CcccccCCCccceeeEEee--CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC-
Q 025816 1 MVSRLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA- 77 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~- 77 (247)
+|++++||||+++++++.+ ++..++|||||.+|+|.+++...... +..+++..++.++.|++.||.|||+.+
T Consensus 56 il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~~ 130 (269)
T d2java1 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSD 130 (269)
T ss_dssp HTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4789999999999999864 45689999999999999998643211 122999999999999999999999864
Q ss_pred -CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHH
Q 025816 78 -DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 78 -~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 156 (247)
..+|+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 131 ~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~ 208 (269)
T d2java1 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208 (269)
T ss_dssp ---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHh
Confidence 22499999999999999999999999999986543222 123457899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||..... ..+...+........+...+.++.++|.+||+.||.+|||++|+++
T Consensus 209 tg~~Pf~~~~~----------------~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 209 ALMPPFTAFSQ----------------KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HSSCSCCCSSH----------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCCH----------------HHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 99999964321 1111112222222344556678999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=298.44 Aligned_cols=205 Identities=27% Similarity=0.449 Sum_probs=173.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++++++||||+++++++.+++..++||||+.+|+|.+++...... +++..++.++.|+++||.|||+.+
T Consensus 52 ~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~--------~~~~~~~~i~~qi~~gl~~LH~~~--- 120 (258)
T d1k2pa_ 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESKQ--- 120 (258)
T ss_dssp HHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGC--------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccC--------CcHHHHHHHHHHHHHHHHHHhhcC---
Confidence 367899999999999999999999999999999999997665432 889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
|+||||||+||+++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||+|+++|+|++ |+
T Consensus 121 iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~ 199 (258)
T d1k2pa_ 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 199 (258)
T ss_dssp BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCC
Confidence 999999999999999999999999999765433222 2233568889999999999999999999999999999998 89
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
.||... ...++...+....+...+...+..+.++|.+||+.||.+|||+++|++.|.+
T Consensus 200 ~Pf~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 200 MPYERF----------------TNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTTTS----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCC----------------CHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 999643 2233344444445555666677889999999999999999999999999865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=308.84 Aligned_cols=218 Identities=21% Similarity=0.318 Sum_probs=165.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~ 79 (247)
+|++++||||++++++|.++...++||||+.+|+|.+++.+... +++..+..++.|++.||.|||+ ++
T Consensus 57 il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~---------l~~~~~~~~~~qil~aL~yLH~~~~-- 125 (322)
T d1s9ja_ 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK-- 125 (322)
T ss_dssp GGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC--
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 57899999999999999999999999999999999999975432 9999999999999999999997 48
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
|+||||||+|||++.+|.+||+|||++...... ......||..|+|||++.+..|+.++||||+||++|+|++|+
T Consensus 126 -IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~ 200 (322)
T d1s9ja_ 126 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200 (322)
T ss_dssp -CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -EEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999998854322 123457999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchh-hhccc----------------------cCCcchhhhhcccccC---CCC-CHHHHHHHHHHHHh
Q 025816 160 KPVDHTLPRGQQSLV-TWATP----------------------KLSEDKVRQCVDARLG---GDY-PPKAVAKMAAVAAL 212 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~-~~~~~----------------------~~~~~~~~~~~~~~~~---~~~-~~~~~~~l~~li~~ 212 (247)
.||.+.+........ ..... ........+....... ... ....+.++.+++.+
T Consensus 201 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 280 (322)
T d1s9ja_ 201 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280 (322)
T ss_dssp CCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHH
Confidence 999765432110000 00000 0000000000000000 001 11235679999999
Q ss_pred hcccCCCCCCCHHHHHH--HHHHh
Q 025816 213 CVQYEADFRPNMSIVVK--ALQPL 234 (247)
Q Consensus 213 cl~~~p~~Rps~~~il~--~l~~~ 234 (247)
||..||.+|||++|+|+ ++++.
T Consensus 281 ~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 281 CLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp HTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred HcCCChhHCcCHHHHhhCHhhCcC
Confidence 99999999999999998 45543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-47 Score=303.95 Aligned_cols=199 Identities=23% Similarity=0.331 Sum_probs=154.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++|||||.||+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 60 il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~--- 127 (307)
T d1a06a_ 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---------YTERDASRLIFQVLDAVKYLHDLG--- 127 (307)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccC---------CCHHHHHHHHHHHHHHHHhhhhce---
Confidence 46889999999999999999999999999999999999976542 999999999999999999999999
Q ss_pred eEeccCCCCceeec---CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+||++. .++.+||+|||++........ .....||+.|+|||++.+..|+.++||||+||++|+|++
T Consensus 128 iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~ 204 (307)
T d1a06a_ 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 204 (307)
T ss_dssp CCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred eeeEEecccceeecccCCCceEEEeccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHh
Confidence 99999999999995 478899999999986533221 234569999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||...... .....+..... ........+.++.++|.+||+.||.+|||++|+++
T Consensus 205 g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 205 GYPPFYDENDA---------------KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp SSCSCCCSSHH---------------HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHH---------------HHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 99999743211 11111111111 11223345677999999999999999999999988
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=302.27 Aligned_cols=217 Identities=27% Similarity=0.415 Sum_probs=171.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|||||++++++. ++..++||||+.+|+|..++....... +++..++.++.|++.||+|||+++
T Consensus 65 ~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~-------l~~~~~~~i~~~i~~gl~~LH~~~--- 133 (285)
T d1fmka3 65 VMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKY-------LRLPQLVDMAAQIASGMAYVERMN--- 133 (285)
T ss_dssp HHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhccccc-------chHHHHHHHHHHHHHHHHHHhhhh---
Confidence 367899999999999985 456889999999999999987544322 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+||+++.++.+||+|||+++....... .......++..|+|||.+....++.++||||+|+++|+|++|..
T Consensus 134 ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~ 212 (285)
T d1fmka3 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 212 (285)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCC
Confidence 99999999999999999999999999986543322 12234568999999999999999999999999999999999666
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhcCCC
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNARPG 240 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~~~~ 240 (247)
|+.... ....+...+....+...+..++.++.++|.+||+.||.+|||+++|++.|+..+++..+
T Consensus 213 p~~~~~---------------~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 213 VPYPGM---------------VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp CSSTTC---------------CHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCC---------------CHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 654221 12223333333444556667778899999999999999999999999999998877765
Q ss_pred CCCC
Q 025816 241 PAGE 244 (247)
Q Consensus 241 ~~~~ 244 (247)
+..|
T Consensus 278 ~~~p 281 (285)
T d1fmka3 278 QYQP 281 (285)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 5554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=298.76 Aligned_cols=199 Identities=25% Similarity=0.410 Sum_probs=157.2
Q ss_pred CcccccCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 1 MVSRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+|++++||||+++++++.. +...++||||+.+|+|.+++..... +++..+..++.|+++||.|||++
T Consensus 61 il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~gl~yLH~~ 131 (270)
T d1t4ha_ 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTR 131 (270)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcccc---------ccHHHHHHHHHHHHHHHHHHHHC
Confidence 4789999999999999865 3467999999999999999976432 89999999999999999999987
Q ss_pred CCCCeEeccCCCCceeec-CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
+ .+|+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++.+ .++.++||||+||++|+|
T Consensus 132 ~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel 205 (270)
T d1t4ha_ 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 205 (270)
T ss_dssp S-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred C-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHH
Confidence 5 2399999999999996 4789999999999754322 1234578999999998865 699999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC-CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG-GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
++|..||...... ..+.+.+..... ...+...+.++.++|.+||+.||.+|||++|+++
T Consensus 206 ~~g~~Pf~~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 206 ATSEYPYSECQNA---------------AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHSSCTTTTCSSH---------------HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCCcccH---------------HHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 9999999643211 111111111111 1112233456899999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=299.25 Aligned_cols=208 Identities=25% Similarity=0.404 Sum_probs=162.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++. ++..++||||+.+|+|.+++..... .+++..++.++.|+++||.|||+++
T Consensus 61 ~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~--- 128 (273)
T d1mp8a_ 61 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR--- 128 (273)
T ss_dssp HHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhcccC---
Confidence 367899999999999985 4678999999999999998765442 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
++||||||+||+++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 129 iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~ 207 (273)
T d1mp8a_ 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 207 (273)
T ss_dssp CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred eeccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCC
Confidence 999999999999999999999999999865433222 2234567889999999999999999999999999999988 89
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
+||..... ..+.+.+........+...+..+.++|.+||+.||.+|||+++|++.|+.+++.
T Consensus 208 ~P~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 208 KPFQGVKN----------------NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CTTTTCCG----------------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99864422 122222233333445666778899999999999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-47 Score=303.11 Aligned_cols=196 Identities=23% Similarity=0.373 Sum_probs=161.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|||||++++++.+++..++|||||.+|+|..++.... .+++..++.++.|++.||.|||+++
T Consensus 68 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~--- 135 (309)
T d1u5ra_ 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSHN--- 135 (309)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4789999999999999999999999999999988877665443 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc---CCCCccccchhhhHHHHHHHh
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+|||++.++.+||+|||++..... .....||+.|+|||++.+ ..|+.++|||||||++|+|++
T Consensus 136 iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~ 209 (309)
T d1u5ra_ 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (309)
T ss_dssp CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred EeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH
Confidence 99999999999999999999999999986432 133569999999999864 358999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|..||...... ..+............+...+..+.++|.+||+.||.+|||++++++
T Consensus 210 g~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 210 RKPPLFNMNAM---------------SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SSCTTTTSCHH---------------HHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCHH---------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 99999643211 1111222221111223345677999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=295.63 Aligned_cols=206 Identities=30% Similarity=0.474 Sum_probs=166.8
Q ss_pred CcccccCCCccceeeEEee-CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+|++++||||++++|++.+ ++..++||||+.+|+|.+++...... .+++..++.++.|+++||.|||+.+
T Consensus 53 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~-------~l~~~~~~~i~~~i~~al~ylH~~~-- 123 (262)
T d1byga_ 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN-- 123 (262)
T ss_dssp HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHhhccccccCc--
Confidence 3688999999999999865 45689999999999999999654322 2899999999999999999999998
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
++||||||+||+++.++.++++|||+++...... ....++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 124 -ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~ 197 (262)
T d1byga_ 124 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197 (262)
T ss_dssp -CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -eeccccchHhheecCCCCEeecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCC
Confidence 9999999999999999999999999988643322 23356889999999999999999999999999999998 7
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
..||... ....+...+....+...+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 198 ~~p~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 198 RVPYPRI----------------PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCSCTTS----------------CGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCC----------------CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 8887532 22233344444555666777778899999999999999999999999999988754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=302.44 Aligned_cols=208 Identities=24% Similarity=0.399 Sum_probs=171.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++|||||++++++.++ ..+++++++.+|+|.+.+..... .+++..++.++.|++.||.|||+++
T Consensus 64 ~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~--- 131 (317)
T d1xkka_ 64 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR--- 131 (317)
T ss_dssp HHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHHHcC---
Confidence 36789999999999999865 56778888888999998876543 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-CC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~ 159 (247)
|+||||||+||+++.++.+||+|||+++...............||..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 132 iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~ 211 (317)
T d1xkka_ 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211 (317)
T ss_dssp CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCC
Confidence 99999999999999999999999999986544333322334568999999999999999999999999999999998 78
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
.||... +...+...+..+.+...+..++.++.+++.+||+.||.+|||+.+|++.+..+.+
T Consensus 212 ~p~~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 212 KPYDGI----------------PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CTTTTS----------------CGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC----------------CHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 888643 2233444455555566667778889999999999999999999999999987754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=297.45 Aligned_cols=215 Identities=29% Similarity=0.450 Sum_probs=179.2
Q ss_pred ccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 3 SRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 3 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+++ +||||++++++|.++...++||||+++|+|.+++....... ...+...+++..++.++.|++.||+|||
T Consensus 73 ~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH 152 (299)
T d1fgka_ 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152 (299)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh
Confidence 344 89999999999999999999999999999999997654211 1122345999999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
+.+ ++||||||+|||++.++.+||+|||.+................++..|+|||.+.+..|+.++||||||+++|+
T Consensus 153 ~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~e 229 (299)
T d1fgka_ 153 SKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 229 (299)
T ss_dssp HTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHH
Confidence 999 99999999999999999999999999987655444444455678899999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 025816 155 LLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQP 233 (247)
Q Consensus 155 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~ 233 (247)
|++ |..||.... ...+.+.+..+.+...+...+.++.++|.+||+.||.+|||+.||++.|++
T Consensus 230 ll~~g~~p~~~~~----------------~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 230 IFTLGGSPYPGVP----------------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp HHTTSCCSSTTCC----------------HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hccCCCCCCCCCC----------------HHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 998 788886332 223334444555556666777889999999999999999999999999999
Q ss_pred hHh
Q 025816 234 LLN 236 (247)
Q Consensus 234 ~~~ 236 (247)
++.
T Consensus 294 i~a 296 (299)
T d1fgka_ 294 IVA 296 (299)
T ss_dssp HHH
T ss_pred Hhh
Confidence 875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-46 Score=304.28 Aligned_cols=200 Identities=22% Similarity=0.277 Sum_probs=164.7
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||++++++|.++...++|||||+||+|.+.+..... .+++..++.++.|++.||.|||++|
T Consensus 79 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~--- 147 (352)
T d1koba_ 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS--- 147 (352)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 47899999999999999999999999999999999988765432 2999999999999999999999999
Q ss_pred eEeccCCCCceeec--CCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIF--DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~--~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
|+||||||+|||++ .++.+||+|||++........ .....||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 148 iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG 224 (352)
T d1koba_ 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224 (352)
T ss_dssp EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred eeecccccccccccccCCCeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhC
Confidence 99999999999997 678999999999986543222 2345689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccc--cCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDAR--LGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||.+..... .+..+.... .........+.++.+||.+||+.||.+|||++|+++
T Consensus 225 ~~Pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 225 LSPFAGEDDLE---------------TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSCCSSHHH---------------HHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCHHH---------------HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99997543211 111111111 111223345677999999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.9e-46 Score=303.09 Aligned_cols=201 Identities=22% Similarity=0.300 Sum_probs=164.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++|||||.+|+|.+++..... .+++..+..++.||+.||.|||+++
T Consensus 76 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~--- 144 (350)
T d1koaa2 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN--- 144 (350)
T ss_dssp HHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhcC---
Confidence 36789999999999999999999999999999999999865432 2999999999999999999999999
Q ss_pred eEeccCCCCceeecC--CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIFD--DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
|+||||||+|||++. ++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 145 iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G 221 (350)
T d1koaa2 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221 (350)
T ss_dssp EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred CeeeeechhHeeeccCCCCeEEEeecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhC
Confidence 999999999999964 67899999999986543222 2346789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhccccc--CCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARL--GGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
..||.+.... +.+..+..... ........+.++.++|.+||+.||.+|||++|+++.
T Consensus 222 ~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 222 LSPFGGENDD---------------ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCSSCCSSHH---------------HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCHH---------------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999754221 11111111111 111123446679999999999999999999999983
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=298.29 Aligned_cols=215 Identities=26% Similarity=0.362 Sum_probs=167.1
Q ss_pred ccCCCccceeeEEeeC-CeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 5 LKHENFVQLLGYCVDG-TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
.+|+||+.+++++..+ ...++|||||++|+|.+++....... .......+++..++.++.|+++||.|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4789999999988665 46899999999999999996543210 001123489999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 156 (247)
+ |+||||||+|||++.++.+||+|||+++...............||..|+|||.+.+..++.++||||+||++|+|+
T Consensus 154 ~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ell 230 (299)
T d1ywna1 154 K---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230 (299)
T ss_dssp T---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHH
Confidence 9 9999999999999999999999999998655444433344567899999999999999999999999999999999
Q ss_pred hC-CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhH
Q 025816 157 TG-RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLL 235 (247)
Q Consensus 157 ~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~ 235 (247)
+| ..||..... ...+...+....+...+...+.++.++|.+||+.||.+|||+++|++.|+.++
T Consensus 231 t~~~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 231 SLGASPYPGVKI---------------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp TTSCCSSTTCCC---------------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCH---------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 86 567753321 12233333444445556666778999999999999999999999999999998
Q ss_pred hc
Q 025816 236 NA 237 (247)
Q Consensus 236 ~~ 237 (247)
++
T Consensus 296 q~ 297 (299)
T d1ywna1 296 QA 297 (299)
T ss_dssp HH
T ss_pred hC
Confidence 75
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=295.72 Aligned_cols=219 Identities=27% Similarity=0.380 Sum_probs=176.3
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYL 73 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~l~~l 73 (247)
|+++ +||||+++++++.+++..++||||+.+|+|.+++....... ....+..+++..++.++.|++.||.||
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 5677 79999999999999999999999999999999997652100 001122399999999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHH
Q 025816 74 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLL 153 (247)
Q Consensus 74 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 153 (247)
|+.+ ++||||||+|||++.++.+||+|||+++....... .....+|..|+|||.+.+..++.++||||||+++|
T Consensus 144 H~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 144 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp HHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred hcCC---ccccccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 9999 99999999999999999999999999875433222 23345888999999999999999999999999999
Q ss_pred HHHhCC-CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 154 ELLTGR-KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 154 ~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
+|++|. +||... ....+.+.+..+.+...+...+.++.++|.+||+.||++|||+++|++.|+
T Consensus 218 ell~~~~~p~~~~----------------~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 281 (309)
T d1fvra_ 218 EIVSLGGTPYCGM----------------TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281 (309)
T ss_dssp HHHTTSCCTTTTC----------------CHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcCCCCCCCC----------------CHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999965 566432 122233333344445566667788999999999999999999999999999
Q ss_pred HhHhcCCCCC
Q 025816 233 PLLNARPGPA 242 (247)
Q Consensus 233 ~~~~~~~~~~ 242 (247)
++++......
T Consensus 282 ~i~~~~~~~~ 291 (309)
T d1fvra_ 282 RMLEERKTYV 291 (309)
T ss_dssp HHHHSSSCSB
T ss_pred HHHhcCcCCC
Confidence 9998765443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=296.87 Aligned_cols=198 Identities=21% Similarity=0.271 Sum_probs=166.8
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++.+++||||+.+|+|.+++..... +++..++.++.|++.||.|||+++
T Consensus 58 il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~---------~~e~~~~~~~~qil~al~ylH~~~--- 125 (337)
T d1o6la_ 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD--- 125 (337)
T ss_dssp HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccC---------CcHHHHHHHHHHHhhhhhhhhhcC---
Confidence 46789999999999999999999999999999999999987543 899999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+..|+.++|+|||||++|+|++|..
T Consensus 126 iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~ 203 (337)
T d1o6la_ 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCC
Confidence 99999999999999999999999999986533222 2244679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~ 229 (247)
||.+.+... ....+... ....+...+.++.+||.+||++||.+|++ ++++++
T Consensus 204 pf~~~~~~~---------------~~~~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 204 PFYNQDHER---------------LFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SSCCSSHHH---------------HHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCcCHHH---------------HHHHHhcC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 997543211 11111111 12344556678999999999999999995 888887
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=297.09 Aligned_cols=228 Identities=22% Similarity=0.266 Sum_probs=166.5
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++||||+.++++..+..... .+++..+..++.|++.||.|||+++
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~~~--- 120 (299)
T d1ua2a_ 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQHW--- 120 (299)
T ss_dssp HHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhhccc---
Confidence 3678999999999999999999999999998877666654332 2888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~ 159 (247)
|+||||||+||+++.++.+||+|||.+........ ......||..|+|||++.+ ..++.++||||+||++|+|++|.
T Consensus 121 iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~ 198 (299)
T d1ua2a_ 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198 (299)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred eecccCCcceEEecCCCccccccCccccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCc
Confidence 99999999999999999999999999976543222 1234568999999999875 46799999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhhcc------cccCCCCC-----HHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVD------ARLGGDYP-----PKAVAKMAAVAALCVQYEADFRPNMSIVV 228 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~il 228 (247)
.||.+.........+...........+..... .......+ ...+.++.+|+.+||+.||.+|||++|+|
T Consensus 199 ~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 199 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 99976543221111111100111000000000 00000111 12356799999999999999999999998
Q ss_pred HHHHHhHhcCCCCCCC
Q 025816 229 KALQPLLNARPGPAGE 244 (247)
Q Consensus 229 ~~l~~~~~~~~~~~~~ 244 (247)
+. ..++..|.|.++
T Consensus 279 ~H--p~f~~~p~p~~~ 292 (299)
T d1ua2a_ 279 KM--KYFSNRPGPTPG 292 (299)
T ss_dssp TS--GGGTSSSCCCCS
T ss_pred CC--HhhCCCCCCCCC
Confidence 73 344555544443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=297.34 Aligned_cols=199 Identities=22% Similarity=0.337 Sum_probs=162.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++|||||.+|+|.+++..... +++..++.++.|++.||.|||+.+
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~---------l~~~~~~~~~~qi~~al~yLH~~~--- 133 (293)
T d1jksa_ 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSLQ--- 133 (293)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccc---------cchhHHHHHHHHHHHHHHhhhhcc---
Confidence 36789999999999999999999999999999999999976432 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCC----ceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 81 i~h~di~~~nil~~~~~----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 156 (247)
|+||||||+||+++.++ .+|++|||++....... ......+|..|+|||++.+..++.++||||+||++|+|+
T Consensus 134 ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell 210 (293)
T d1jksa_ 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 210 (293)
T ss_dssp EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred eeecccccceEEEecCCCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHH
Confidence 99999999999998776 49999999987653322 123456889999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||.+..... .+..+...... ...+...+.++.++|++||+.||.+|||++++++
T Consensus 211 ~g~~Pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 211 SGASPFLGDTKQE---------------TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HSSCSSCCSSHHH---------------HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCCHHH---------------HHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999997543211 11111111000 0011234567999999999999999999999997
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=291.98 Aligned_cols=214 Identities=23% Similarity=0.362 Sum_probs=172.7
Q ss_pred CcccccCCCccceeeEEee-CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
+|++++||||++++|++.. +...++|||||.+|+|.+++...... +++..++.++.|++.||.|||+.+
T Consensus 81 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~--------~~~~~~~~i~~qia~gL~~lH~~~-- 150 (311)
T d1r0pa_ 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------PTVKDLIGFGLQVAKGMKFLASKK-- 150 (311)
T ss_dssp HHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCC--------CBHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcccccc--------chHHHHHHHHHHHHHhhhhhcccC--
Confidence 3678999999999999875 45889999999999999998765432 788899999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcc--cccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+|||++.++.+||+|||+++......... ......||..|.|||.+....++.++||||||+++|+|++
T Consensus 151 -iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t 229 (311)
T d1r0pa_ 151 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229 (311)
T ss_dssp -CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHH
Confidence 9999999999999999999999999998764433221 1223468899999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHhc
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLNA 237 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~~ 237 (247)
|..||...... ..+...+..+.+...+..++.++.++|.+||+.||.+|||+.||++.|+.+.++
T Consensus 230 ~~~p~~~~~~~---------------~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 230 RGAPPYPDVNT---------------FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp TSCCSCC---------------------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCCCH---------------HHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 88887533211 111222222233344455667899999999999999999999999999999876
Q ss_pred CCC
Q 025816 238 RPG 240 (247)
Q Consensus 238 ~~~ 240 (247)
-..
T Consensus 295 ~~~ 297 (311)
T d1r0pa_ 295 FIG 297 (311)
T ss_dssp CCS
T ss_pred hhh
Confidence 443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-46 Score=292.29 Aligned_cols=207 Identities=26% Similarity=0.372 Sum_probs=168.0
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+ ...++||||+.+|++.+.+..... .+++..++.++.|++.||.|||+++
T Consensus 64 ~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~--- 131 (273)
T d1u46a_ 64 AMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR--- 131 (273)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhhhCC---
Confidence 3678999999999999965 467899999999999998876543 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhc-ccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh-C
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g 158 (247)
|+||||||+||+++.++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 132 iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G 211 (273)
T d1u46a_ 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 211 (273)
T ss_dssp EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTS
T ss_pred EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCC
Confidence 999999999999999999999999999866443322 22233457788999999999999999999999999999998 8
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPL 234 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~ 234 (247)
..||..... .+....+.....+...+...+.++.++|.+||+.||.+|||+++|++.|+++
T Consensus 212 ~~Pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 212 QEPWIGLNG---------------SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCTTTTCCH---------------HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCH---------------HHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999964321 1222233333444455556677899999999999999999999999988865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-45 Score=294.79 Aligned_cols=216 Identities=25% Similarity=0.388 Sum_probs=172.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC---------------CCCCCCCcCHHHHHHHHHH
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---------------GAQPGPVLSWQQRVKIAVG 65 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------------~~~~~~~l~~~~~~~~~~~ 65 (247)
+|++++||||+++++++..+...+++|||+.+|+|.+++....... .......+++..++.++.|
T Consensus 69 il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 148 (301)
T d1lufa_ 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148 (301)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred HHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence 3678999999999999999999999999999999999996543211 1111234899999999999
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccc
Q 025816 66 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDV 145 (247)
Q Consensus 66 ~~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 145 (247)
++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||
T Consensus 149 i~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDV 225 (301)
T d1lufa_ 149 VAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225 (301)
T ss_dssp HHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhh
Confidence 999999999999 99999999999999999999999999875543333333344568889999999999999999999
Q ss_pred hhhhHHHHHHHhCC-CCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCH
Q 025816 146 YSFGVVLLELLTGR-KPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNM 224 (247)
Q Consensus 146 wslG~~l~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 224 (247)
||||+++|+|++|. +||.... ..++...+........+...+.++.+|+.+||+.||.+|||+
T Consensus 226 wS~Gvvl~ell~~~~~p~~~~~----------------~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~ 289 (301)
T d1lufa_ 226 WAYGVVLWEIFSYGLQPYYGMA----------------HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF 289 (301)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSC----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccchhhHHHHHccCCCCCCCCC----------------HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence 99999999999975 5675432 122222233333444556667789999999999999999999
Q ss_pred HHHHHHHHHhH
Q 025816 225 SIVVKALQPLL 235 (247)
Q Consensus 225 ~~il~~l~~~~ 235 (247)
.+|++.|+++.
T Consensus 290 ~ev~~~L~~i~ 300 (301)
T d1lufa_ 290 CSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHhc
Confidence 99999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.3e-45 Score=299.12 Aligned_cols=198 Identities=20% Similarity=0.274 Sum_probs=162.9
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
++.++||||+++++++.+++..++||||+.+|+|.+++..... +++..++.++.|++.||.|||+++ |
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~ylH~~~---i 128 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---V 128 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5678999999999999999999999999999999999976542 889999999999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHHHHHHhCCC
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
+||||||+|||++.+|.+||+|||++....... .....||+.|+|||++.. ..|+.++|||||||++|+|++|..
T Consensus 129 iHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~ 204 (364)
T d1omwa3 129 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 204 (364)
T ss_dssp ECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCC
Confidence 999999999999999999999999998654322 234579999999999964 568999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPN-----MSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~il~ 229 (247)
||..........+.... .......+...+.++.++|.+||+.||.+||| ++++++
T Consensus 205 Pf~~~~~~~~~~~~~~~--------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 205 PFRQHKTKDKHEIDRMT--------------LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSCSSCSSCHHHHHHHS--------------SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCHHHHHHHHHhc--------------ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 99754332211111100 01111233445677999999999999999999 788886
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-45 Score=293.58 Aligned_cols=195 Identities=25% Similarity=0.388 Sum_probs=165.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++||||+.||+|..++..... +++..+..++.|++.||.|||+++
T Consensus 57 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~--- 124 (316)
T d1fota_ 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD--- 124 (316)
T ss_dssp HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred HHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccccc---------ccccHHHHHHHHHHHhhhhhccCc---
Confidence 46789999999999999999999999999999999999987653 888999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.+|.+||+|||++...... .....||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus 125 iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~ 199 (316)
T d1fota_ 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199 (316)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred EEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCC
Confidence 999999999999999999999999999865432 234579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~ 229 (247)
||...... .....+.... ...+...+.++.+++.+||..||.+|+ |++++++
T Consensus 200 Pf~~~~~~---------------~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 200 PFYDSNTM---------------KTYEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTCCSSHH---------------HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCcCHH---------------HHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 99743211 1111221111 234445567799999999999999996 9999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=294.00 Aligned_cols=218 Identities=24% Similarity=0.393 Sum_probs=179.3
Q ss_pred cccc-cCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC---------CCCCCCCcCHHHHHHHHHHHHHHHH
Q 025816 2 VSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---------GAQPGPVLSWQQRVKIAVGAAKGLE 71 (247)
Q Consensus 2 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---------~~~~~~~l~~~~~~~~~~~~~~~l~ 71 (247)
++++ +||||+++++++.++...+++||||.+|+|.+++....... .......+++..+..++.|++.|++
T Consensus 80 ~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 3456 69999999999999999999999999999999987554211 0111234899999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHH
Q 025816 72 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV 151 (247)
Q Consensus 72 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~ 151 (247)
|||+++ ++||||||+||+++.++.++++|||.++...............+|+.|+|||.+.+..++.++||||||++
T Consensus 160 ~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~ 236 (311)
T d1t46a_ 160 FLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (311)
T ss_dssp HHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHH
Confidence 999999 99999999999999999999999999987655444444455678999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 152 LLELLT-GRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 152 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
+|+|++ |.+||.... ..+.+.+.+....+...+...+.++.+||.+||+.||.+|||+++|++.
T Consensus 237 l~ellt~g~p~~~~~~---------------~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 237 LWELFSLGSSPYPGMP---------------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp HHHHHTTTCCSSTTCC---------------SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCCCCCC---------------HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999998 556564321 2233445555566666666677889999999999999999999999999
Q ss_pred HHHhHhc
Q 025816 231 LQPLLNA 237 (247)
Q Consensus 231 l~~~~~~ 237 (247)
|++.+++
T Consensus 302 L~~~i~~ 308 (311)
T d1t46a_ 302 IEKQISE 308 (311)
T ss_dssp HHHHHHH
T ss_pred HHHhhcc
Confidence 9988765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=288.96 Aligned_cols=228 Identities=23% Similarity=0.294 Sum_probs=170.0
Q ss_pred cccccCCCccceeeEEeeCC----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 2 VSRLKHENFVQLLGYCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
+++++||||+++++++..++ ..++||||+.+|+|.+++++.. +++..++.++.|++.||.|+|+.+
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~ 120 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhh
Confidence 56789999999999997654 5799999999999999998653 999999999999999999999741
Q ss_pred -----CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc--ccccceeccccccCchhhhcCC------CCcccc
Q 025816 78 -----DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQ------LNAKSD 144 (247)
Q Consensus 78 -----~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~------~~~~~D 144 (247)
..+|+||||||+|||++.++.+||+|||++......... .......||..|+|||.+.+.. ++.++|
T Consensus 121 ~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~D 200 (303)
T d1vjya_ 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200 (303)
T ss_dssp CSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHH
T ss_pred hhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchh
Confidence 123999999999999999999999999998865433221 1223456899999999987642 567899
Q ss_pred chhhhHHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcc-hhhhhcccccCCCCC-----HHHHHHHHHHHHhhcccCC
Q 025816 145 VYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSED-KVRQCVDARLGGDYP-----PKAVAKMAAVAALCVQYEA 218 (247)
Q Consensus 145 vwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p 218 (247)
||||||++|+|++|..||........... .......... ......+...+...+ .+....+.+++.+||+.||
T Consensus 201 i~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp 279 (303)
T d1vjya_ 201 IYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSG
T ss_pred hhhhHHHHHHHhhCCCCCCcccccccchh-hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCH
Confidence 99999999999999988764332211111 1111111111 111222233333332 2456679999999999999
Q ss_pred CCCCCHHHHHHHHHHhHhcCCC
Q 025816 219 DFRPNMSIVVKALQPLLNARPG 240 (247)
Q Consensus 219 ~~Rps~~~il~~l~~~~~~~~~ 240 (247)
.+|||+.||++.|+++.+..+.
T Consensus 280 ~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 280 AARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp GGSCCHHHHHHHHHHHHHHHCC
T ss_pred hHCcCHHHHHHHHHHHHHhcCC
Confidence 9999999999999999876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=289.87 Aligned_cols=198 Identities=18% Similarity=0.249 Sum_probs=162.6
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+++..++|||||.||+|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 54 il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~--------~l~e~~~~~i~~qi~~al~yLH~~~--- 122 (321)
T d1tkia_ 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN--- 122 (321)
T ss_dssp HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHcC---
Confidence 36789999999999999999999999999999999999976532 2899999999999999999999999
Q ss_pred eEeccCCCCceeecCC--CceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIFDD--DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~--~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 158 (247)
|+||||||+||+++.+ +.++|+|||++........ .....+++.|+|||...+..++.++||||+||++|+|++|
T Consensus 123 iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred CCcccccccceeecCCCceEEEEcccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhC
Confidence 9999999999999854 4799999999876543221 2345688999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCH----HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPP----KAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
..||...... .....+..... ..+. ..+.++.++|.+||..||.+|||++|+++
T Consensus 200 ~~Pf~~~~~~---------------~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 200 INPFLAETNQ---------------QIIENIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp SCTTCCSSHH---------------HHHHHHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHH---------------HHHHHHHhCCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999754321 11111111111 1111 23567999999999999999999999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-44 Score=285.38 Aligned_cols=198 Identities=24% Similarity=0.291 Sum_probs=162.0
Q ss_pred ccccc-CCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
|++++ ||||+++++++.+++..++||||+++|+|.+++.... ++++..+..++.|++.||.|||+++
T Consensus 63 l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~~lH~~~--- 130 (277)
T d1phka_ 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLN--- 130 (277)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---
Confidence 45676 9999999999999999999999999999999997543 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhc------CCCCccccchhhhHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT------GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l~~ 154 (247)
|+||||||+||+++.++.+||+|||++....... ......||..|.|||.+.+ ..++.++||||+||++|+
T Consensus 131 ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilye 207 (277)
T d1phka_ 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 207 (277)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred CcccccccceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhh
Confidence 9999999999999999999999999998654322 1234568999999999864 246789999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC--CCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
|++|..||....... ....+...... .......+.++.+++.+||+.||.+|||++|+++
T Consensus 208 ml~g~~Pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 208 LLAGSPPFWHRKQML---------------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHSSCSSCCSSHHH---------------HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hccCCCCCCCCCHHH---------------HHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999999997543211 11111211111 1122356678999999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=292.19 Aligned_cols=204 Identities=17% Similarity=0.234 Sum_probs=159.4
Q ss_pred ccccCCCccceeeEEee----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 3 SRLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
+.++||||++++++|.+ +...|+|||||.||+|.+++...... .+++..+..++.|++.||.|||+++
T Consensus 60 ~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~-------~l~e~~~~~i~~qi~~al~ylH~~~- 131 (335)
T d2ozaa1 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSIN- 131 (335)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCC-------CEEHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCC-------CcCHHHHHHHHHHHHHHHHHHHHcC-
Confidence 34589999999999875 45789999999999999999765432 2999999999999999999999999
Q ss_pred CCeEeccCCCCceeecC---CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 79 PHIIHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
|+||||||+||+++. .+.+||+|||+++....... .....||+.|+|||++.+..|+.++|||||||++|+|
T Consensus 132 --iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~l 206 (335)
T d2ozaa1 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 206 (335)
T ss_dssp --EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHH
T ss_pred --CccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHH
Confidence 999999999999975 45799999999976543222 2445789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCC--CCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGD--YPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|..||.+........... ........... .....+.++.+||.+||+.||.+|||++++++.
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~-----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 207 LCGYPPFYSNHGLAISPGMK-----------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp TTSSCSCEETTCC-------------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhCCCCCCCCCHHHHHHHHH-----------HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 99999997543221110000 00000000001 112456789999999999999999999999983
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-44 Score=287.23 Aligned_cols=208 Identities=25% Similarity=0.372 Sum_probs=159.2
Q ss_pred CcccccCCCccceeeEEeeCC----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 1 MVSRLKHENFVQLLGYCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+|++++||||+++++++.... ..|+||||++|++|.+++..... +++..++.++.|++.||.|||++
T Consensus 60 ~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~---------l~~~~~~~i~~qi~~al~~lH~~ 130 (277)
T d1o6ya_ 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQN 130 (277)
T ss_dssp HHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCC---------CCHHHHHHHHHHHHHHHHHHHhC
Confidence 367899999999999987654 37899999999999998876542 99999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhh-cccccceeccccccCchhhhcCCCCccccchhhhHHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 155 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 155 (247)
+ |+||||||+||+++.++..+++|||.+........ ........||+.|+|||++.+..++.++||||+||++|+|
T Consensus 131 ~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyel 207 (277)
T d1o6ya_ 131 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207 (277)
T ss_dssp T---EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred C---ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHH
Confidence 9 99999999999999999999999998764432221 1223445689999999999998999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC--CCCCHHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHHH
Q 025816 156 LTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG--GDYPPKAVAKMAAVAALCVQYEADFRP-NMSIVVKALQ 232 (247)
Q Consensus 156 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~il~~l~ 232 (247)
++|..||....... ...+.+..... .......+.++.++|.+||+.||.+|| |++++++.|.
T Consensus 208 ltG~~Pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 208 LTGEPPFTGDSPVS---------------VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHSSCSCCCSSHHH---------------HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HhCCCCCCCcCHHH---------------HHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 99999997543211 01111111000 011223456799999999999999999 8999999988
Q ss_pred HhH
Q 025816 233 PLL 235 (247)
Q Consensus 233 ~~~ 235 (247)
++.
T Consensus 273 r~~ 275 (277)
T d1o6ya_ 273 RVH 275 (277)
T ss_dssp HHH
T ss_pred HHh
Confidence 775
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=291.78 Aligned_cols=196 Identities=22% Similarity=0.280 Sum_probs=163.7
Q ss_pred ccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 025816 3 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII 82 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i~ 82 (247)
+.++||||+++++++.+++..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+++ ++
T Consensus 58 ~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~---------~~e~~~~~~~~qi~~al~ylH~~~---ii 125 (320)
T d1xjda_ 58 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IV 125 (320)
T ss_dssp HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CB
T ss_pred HhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 468999999999999999999999999999999999976543 899999999999999999999999 99
Q ss_pred eccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCCCC
Q 025816 83 HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 162 (247)
Q Consensus 83 h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 162 (247)
||||||+|||++.++.+||+|||++........ ......||..|+|||++.+..++.++||||+||++|+|++|..||
T Consensus 126 HrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF 203 (320)
T d1xjda_ 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 203 (320)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCC
Confidence 999999999999999999999999986543322 223457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 025816 163 DHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMS-IVVK 229 (247)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~il~ 229 (247)
.+..... ....+.. .....+...+.++.+||.+||..||.+|||++ ++++
T Consensus 204 ~~~~~~~---------------~~~~i~~--~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 204 HGQDEEE---------------LFHSIRM--DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCSSHHH---------------HHHHHHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCHHH---------------HHHHHHc--CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 7543211 1111111 11233445567799999999999999999996 6764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-44 Score=292.20 Aligned_cols=195 Identities=19% Similarity=0.273 Sum_probs=164.7
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++......++||||+.+|+|.+.+..... +++..++.++.||+.||.|||+++
T Consensus 94 il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~~--- 161 (350)
T d1rdqe_ 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD--- 161 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 47899999999999999999999999999999999999976542 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhCCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 160 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 160 (247)
|+||||||+|||++.+|.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 162 iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~ 236 (350)
T d1rdqe_ 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236 (350)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCC
Confidence 999999999999999999999999999865432 234579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 025816 161 PVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK 229 (247)
Q Consensus 161 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~ 229 (247)
||.+.... .....+.... ...+...+.++.++|.+||..||.+|+ |++++++
T Consensus 237 Pf~~~~~~---------------~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 237 PFFADQPI---------------QIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SSCCSSHH---------------HHHHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCcCHH---------------HHHHHHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 99754211 1111111111 123445567899999999999999994 9999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-44 Score=285.44 Aligned_cols=217 Identities=23% Similarity=0.375 Sum_probs=176.1
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCC-CCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 79 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~ 79 (247)
++++++||||+++++++..+...++||||+.+|+|.+++....... .......+++..+..++.|++.||.|||+.+
T Consensus 76 il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-- 153 (308)
T d1p4oa_ 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 153 (308)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 4789999999999999999999999999999999999885432100 0011122788999999999999999999999
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHhC-
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG- 158 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g- 158 (247)
|+||||||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||+|+++|+|++|
T Consensus 154 -ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~ 232 (308)
T d1p4oa_ 154 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232 (308)
T ss_dssp -CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred -eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence 999999999999999999999999999876554444444455689999999999999999999999999999999997
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhHh
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQPLLN 236 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~~~~~ 236 (247)
..||... ....+.+.+........+..++..+.++|.+||+.||.+|||+++|++.|++.++
T Consensus 233 ~~p~~~~----------------~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 233 EQPYQGL----------------SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCTTTTS----------------CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCC----------------CHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 4677532 2222333333334445566677889999999999999999999999999987654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=281.54 Aligned_cols=217 Identities=20% Similarity=0.258 Sum_probs=159.7
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.++...++||||+.+ ++.+++....... +++..+..++.|++.||.|||+++
T Consensus 54 il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~-------l~e~~~~~~~~qil~~L~yLH~~~--- 122 (298)
T d1gz8a_ 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-------IPLPLIKSYLFQLLQGLAFCHSHR--- 122 (298)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccC-------CCHHHHHHHHHHHHHHHHHhhcCC---
Confidence 47899999999999999999999999999975 5555554433222 999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC-CCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~ 159 (247)
|+||||||+||+++.++.+||+|||.+....... .......||..|+|||.+.... ++.++|+||+|+++|+|++|+
T Consensus 123 IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~ 200 (298)
T d1gz8a_ 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200 (298)
T ss_dssp CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEccccCchheeecccCcceeccCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCC
Confidence 9999999999999999999999999987543221 2234457899999999887765 478999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhh---hcc------cccCCC---CCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQ---CVD------ARLGGD---YPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
.||...+...................... ..+ ...... .....+.++.+++.+||..||.+|||++|+
T Consensus 201 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el 280 (298)
T d1gz8a_ 201 ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280 (298)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99975432211100000000000000000 000 000000 011334678999999999999999999999
Q ss_pred HHH
Q 025816 228 VKA 230 (247)
Q Consensus 228 l~~ 230 (247)
++.
T Consensus 281 l~H 283 (298)
T d1gz8a_ 281 LAH 283 (298)
T ss_dssp HTS
T ss_pred hCC
Confidence 984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=277.71 Aligned_cols=189 Identities=21% Similarity=0.322 Sum_probs=154.3
Q ss_pred ccccc--CCCccceeeEEeeCCeeeEEEecCCC-CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 2 VSRLK--HENFVQLLGYCVDGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 2 l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
|++++ ||||+++++++.+++..++||||+.+ +++.+++..... +++..++.++.|++.||.|||+++
T Consensus 61 l~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~- 130 (273)
T d1xwsa_ 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCG- 130 (273)
T ss_dssp HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 44555 89999999999999999999999975 578888765432 999999999999999999999999
Q ss_pred CCeEeccCCCCceeecC-CCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCC-CccccchhhhHHHHHHH
Q 025816 79 PHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELL 156 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~ 156 (247)
|+||||||+||+++. ++.+||+|||++....... .....||..|+|||++.+..+ +.++||||+||++|+|+
T Consensus 131 --iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell 204 (273)
T d1xwsa_ 131 --VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204 (273)
T ss_dssp --EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred --CccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHh
Confidence 999999999999985 4789999999997543221 234568999999999988765 57789999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 025816 157 TGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 229 (247)
+|..||..... + ... ....+...+.++.++|.+||+.||.+|||++|+++
T Consensus 205 ~g~~Pf~~~~~------------------i---~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 205 CGDIPFEHDEE------------------I---IRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HSSCSCCSHHH------------------H---HHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCchH------------------H---hhc--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 99999964311 0 000 01122234567999999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=278.38 Aligned_cols=213 Identities=19% Similarity=0.257 Sum_probs=157.1
Q ss_pred ccccCCCccceeeEEee-----CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 025816 3 SRLKHENFVQLLGYCVD-----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 77 (247)
Q Consensus 3 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~ 77 (247)
+..+||||++++++|.. ....+++||++.++++......... .+++..++.++.|++.||.|||+++
T Consensus 65 ~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~yLH~~~ 136 (305)
T d1blxa_ 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHSHR 136 (305)
T ss_dssp HHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34589999999999853 3468999999987665544433322 2899999999999999999999999
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHHHHh
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 157 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 157 (247)
|+||||||+|||++.++.+||+|||.+........ .....||+.|+|||++.+..|+.++||||+||++|+|++
T Consensus 137 ---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~ 210 (305)
T d1blxa_ 137 ---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 210 (305)
T ss_dssp ---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ---EEecCCCccEEEEcCCCCeeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHH
Confidence 99999999999999999999999999876543332 245678999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhccccCCcchhh-------hh---cccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 158 GRKPVDHTLPRGQQSLVTWATPKLSEDKVR-------QC---VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 158 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
|..||.+.........+...........+. .. .............+..+.+|+.+||+.||.+|||++|+
T Consensus 211 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~ 290 (305)
T d1blxa_ 211 RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290 (305)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 999997654322111111100000000000 00 00000011223345678999999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
|+
T Consensus 291 L~ 292 (305)
T d1blxa_ 291 LS 292 (305)
T ss_dssp HT
T ss_pred hc
Confidence 87
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.5e-42 Score=273.24 Aligned_cols=215 Identities=18% Similarity=0.218 Sum_probs=157.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++..++..+++|+++.++.+..+..... .+++..+..++.|++.||+|||+.+
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~--- 120 (286)
T d1ob3a_ 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHDRR--- 120 (286)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcC---------CcchhhhHHHHHHHHHHHHHhccCc---
Confidence 5789999999999999999999999999998766666654433 2999999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~ 159 (247)
|+||||||+||+++.++.+|++|||.+........ ......++..|.|||.+.+. .++.++|+||+|+++|+|++|+
T Consensus 121 IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~ 198 (286)
T d1ob3a_ 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (286)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCC
Confidence 99999999999999999999999999876433221 12344578899999998764 5689999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhccccCCcchhhhh------------cccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 025816 160 KPVDHTLPRGQQSLVTWATPKLSEDKVRQC------------VDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIV 227 (247)
Q Consensus 160 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 227 (247)
.||........................... .............+.++.+++++||+.||++|||++|+
T Consensus 199 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~el 278 (286)
T d1ob3a_ 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278 (286)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999754322111110000000000000000 00000011223345679999999999999999999999
Q ss_pred HH
Q 025816 228 VK 229 (247)
Q Consensus 228 l~ 229 (247)
++
T Consensus 279 l~ 280 (286)
T d1ob3a_ 279 LE 280 (286)
T ss_dssp HT
T ss_pred hc
Confidence 85
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=274.92 Aligned_cols=223 Identities=20% Similarity=0.233 Sum_probs=158.1
Q ss_pred CcccccCCCccceeeEEeeC------CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVDG------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+|++++||||++++++|... .+.++||||+.++ +.+.+..... ....+++..+..++.|++.||.|||
T Consensus 66 il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~-----~~~~l~~~~~~~i~~qil~aL~yLH 139 (350)
T d1q5ka_ 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSR-----AKQTLPVIYVKLYMYQLFRSLAYIH 139 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhh-----ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 46789999999999998543 3578999999764 4333321110 0112999999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCC-ceeeccccccCCcchhhhcccccceeccccccCchhhhc-CCCCccccchhhhHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVL 152 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l 152 (247)
++| |+||||||+|||++.++ .+||+|||++........ .....|+..|+|||.+.+ ..++.++||||+||++
T Consensus 140 ~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il 213 (350)
T d1q5ka_ 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213 (350)
T ss_dssp TTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred hcC---CcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEE
Confidence 999 99999999999999775 899999999876543222 234568999999998875 5689999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccC------------CCCCHHHHHHHHHHHHhhcccCCCC
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLG------------GDYPPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|+|++|..||...........+.........+.+......... .......+.++.+|+.+||..||.+
T Consensus 214 ~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 293 (350)
T d1q5ka_ 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293 (350)
T ss_dssp HHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred EehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhH
Confidence 9999999999765432221111111111111111111111000 0112234567999999999999999
Q ss_pred CCCHHHHHH--HHHHhH
Q 025816 221 RPNMSIVVK--ALQPLL 235 (247)
Q Consensus 221 Rps~~~il~--~l~~~~ 235 (247)
|||++|+|+ +++++.
T Consensus 294 R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 294 RLTPLEACAHSFFDELR 310 (350)
T ss_dssp SCCHHHHHTSGGGGGGG
T ss_pred CcCHHHHhcCHhhcccc
Confidence 999999997 455543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=275.69 Aligned_cols=218 Identities=22% Similarity=0.295 Sum_probs=161.9
Q ss_pred CcccccCCCccceeeEEeeCC------eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+|++++||||++++++|.... ..++||||+ +++|.++..... +++..++.++.|++.||.|||
T Consensus 70 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH 138 (346)
T d1cm8a_ 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIH 138 (346)
T ss_dssp HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHH
Confidence 367899999999999997654 569999999 558888876543 999999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLL 153 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ 153 (247)
++| |+||||||+|||++.++.++++|||++...... .....+|..|+|||.+.+. .++.++||||+||++|
T Consensus 139 ~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 210 (346)
T d1cm8a_ 139 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210 (346)
T ss_dssp HTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred hCC---CcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHH
Confidence 999 999999999999999999999999999765332 2345689999999998764 5689999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchhhhccccCCcchhh-----------hhcccccC---CCCCHHHHHHHHHHHHhhcccCCC
Q 025816 154 ELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVR-----------QCVDARLG---GDYPPKAVAKMAAVAALCVQYEAD 219 (247)
Q Consensus 154 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~ 219 (247)
+|++|..||...+...............+..... ........ .......+.++.+||.+||..||.
T Consensus 211 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~ 290 (346)
T d1cm8a_ 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290 (346)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTT
T ss_pred HHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChh
Confidence 9999999997654322111111111111100000 00000000 011223456789999999999999
Q ss_pred CCCCHHHHHH--HHHHhHhc
Q 025816 220 FRPNMSIVVK--ALQPLLNA 237 (247)
Q Consensus 220 ~Rps~~~il~--~l~~~~~~ 237 (247)
+|||++|+|+ +++.+...
T Consensus 291 ~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 291 QRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp TSCCHHHHHHSGGGTTTC--
T ss_pred HCcCHHHHhcChhhCcCCCc
Confidence 9999999998 46665433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=266.86 Aligned_cols=202 Identities=23% Similarity=0.296 Sum_probs=162.6
Q ss_pred cccccC-CCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKH-ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
|++++| |||+++++++.+....+++|||+.+|+|.+++..... ++...+..++.|++.||.|||+++
T Consensus 82 l~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~~--- 149 (322)
T d1vzoa_ 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG--- 149 (322)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhhcCC---
Confidence 577877 8999999999999999999999999999999976653 788999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcC--CCCccccchhhhHHHHHHHhC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTG 158 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g 158 (247)
++||||||+||+++.++.++|+|||++......... ......|+..|.|||.+.+. .++.++|||||||++|+|++|
T Consensus 150 ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG 228 (322)
T d1vzoa_ 150 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228 (322)
T ss_dssp CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred EEeccCCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhC
Confidence 999999999999999999999999999765433322 22445689999999999764 468899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 025816 159 RKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRP-----NMSIVVK 229 (247)
Q Consensus 159 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~il~ 229 (247)
..||............. ... .......+...+.++.+++++||..||.+|| |++|+++
T Consensus 229 ~~PF~~~~~~~~~~~i~-----------~~~--~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 229 ASPFTVDGEKNSQAEIS-----------RRI--LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCTTSCTTSCCCHHHHH-----------HHH--HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCCCCCHHHHHHHHH-----------Hhc--ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 99997654332211110 000 0112234456677899999999999999999 5899987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=267.19 Aligned_cols=218 Identities=20% Similarity=0.266 Sum_probs=154.9
Q ss_pred CcccccCCCccceeeEEee--------CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHH
Q 025816 1 MVSRLKHENFVQLLGYCVD--------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 72 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 72 (247)
+|++++||||+++++++.. +...+++|||+.++.+........ .++...++.++.|++.||.|
T Consensus 62 il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~ 132 (318)
T d3blha1 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYY 132 (318)
T ss_dssp HHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHH
Confidence 3678999999999999855 346799999998755544433322 28899999999999999999
Q ss_pred hhcCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhc--ccccceeccccccCchhhhcC-CCCccccchhhh
Q 025816 73 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFG 149 (247)
Q Consensus 73 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG 149 (247)
||+++ |+||||||+||+++.++.+|++|||++......... .......||..|+|||++.+. .++.++||||+|
T Consensus 133 lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlG 209 (318)
T d3blha1 133 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 209 (318)
T ss_dssp HHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHH
T ss_pred hccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCC
Confidence 99999 999999999999999999999999999765432221 122335689999999998765 689999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhccccCCcch--------hhhhcccccCCCCCH-------HHHHHHHHHHHhhc
Q 025816 150 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDK--------VRQCVDARLGGDYPP-------KAVAKMAAVAALCV 214 (247)
Q Consensus 150 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl 214 (247)
|++|+|++|+.||.+..................... ............... ..+.++.+||.+||
T Consensus 210 vil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL 289 (318)
T d3blha1 210 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289 (318)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHS
T ss_pred ceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHC
Confidence 999999999999975443222111111111111110 111111111111111 11346789999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 025816 215 QYEADFRPNMSIVVKA 230 (247)
Q Consensus 215 ~~~p~~Rps~~~il~~ 230 (247)
+.||++|||++|+++.
T Consensus 290 ~~dP~~R~sa~elL~H 305 (318)
T d3blha1 290 VLDPAQRIDSDDALNH 305 (318)
T ss_dssp CSSTTTSCCHHHHHHS
T ss_pred cCChhHCcCHHHHHcC
Confidence 9999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=271.62 Aligned_cols=217 Identities=22% Similarity=0.267 Sum_probs=157.3
Q ss_pred CcccccCCCccceeeEEeeCC----eeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC
Q 025816 1 MVSRLKHENFVQLLGYCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 76 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~ 76 (247)
+|++++||||+++++++.... ..+++++++.+|+|.+++.... +++..++.++.|++.||.|||++
T Consensus 59 il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~~ 128 (345)
T d1pmea_ 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSA 128 (345)
T ss_dssp HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 468899999999999987653 2344455566889999997543 99999999999999999999999
Q ss_pred CCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcc-cccceeccccccCchhhhc-CCCCccccchhhhHHHHH
Q 025816 77 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 77 ~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~ 154 (247)
+ |+||||||+|||++.++.+||+|||++.......... ......|+..|+|||++.. ..++.++||||+||++|+
T Consensus 129 ~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~e 205 (345)
T d1pmea_ 129 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205 (345)
T ss_dssp T---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHH
T ss_pred C---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehH
Confidence 9 9999999999999999999999999997654433221 2244568999999999854 567899999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCcchh--------hhhcc-cccCCCC-----CHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSEDKV--------RQCVD-ARLGGDY-----PPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|..||........................ ..... ....... ....+.++.+++.+||..||.+
T Consensus 206 ml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 285 (345)
T d1pmea_ 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285 (345)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTT
T ss_pred HhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhH
Confidence 99999999755432111111111111100000 00000 0000001 1122356899999999999999
Q ss_pred CCCHHHHHHH
Q 025816 221 RPNMSIVVKA 230 (247)
Q Consensus 221 Rps~~~il~~ 230 (247)
|||++++|+.
T Consensus 286 R~ta~e~L~h 295 (345)
T d1pmea_ 286 RIEVEQALAH 295 (345)
T ss_dssp SCCHHHHHTS
T ss_pred CcCHHHHhcC
Confidence 9999999984
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-39 Score=258.40 Aligned_cols=220 Identities=17% Similarity=0.197 Sum_probs=168.8
Q ss_pred cccccC-CCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKH-ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
++.|+| +|++.+++++..+...++||||+ +++|.+++..... .++...+..++.|++.||.|||++|
T Consensus 54 ~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH~~g--- 121 (293)
T d1csna_ 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS--- 121 (293)
T ss_dssp HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred HHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHHHCC---
Confidence 345655 89999999999999999999999 5799999875442 2899999999999999999999999
Q ss_pred eEeccCCCCceeecC-----CCceeeccccccCCcchhhhc-----ccccceeccccccCchhhhcCCCCccccchhhhH
Q 025816 81 IIHRDIKSSNVLIFD-----DDVAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 150 (247)
Q Consensus 81 i~h~di~~~nil~~~-----~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 150 (247)
|+||||||+||+++. .+.++|+|||+++........ .......||+.|+|||++.+..++.++||||||+
T Consensus 122 iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~ 201 (293)
T d1csna_ 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 201 (293)
T ss_dssp EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhH
Confidence 999999999999974 568999999999865433221 1123456999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 025816 151 VLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKA 230 (247)
Q Consensus 151 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 230 (247)
++|+|++|..||.+....................... .+ ....+.++.+++..|+..+|.+||+++.+.+.
T Consensus 202 ~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-----~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~ 272 (293)
T d1csna_ 202 VFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR-----EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 272 (293)
T ss_dssp HHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH-----HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH-----Hh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 9999999999997554332211111100000000000 01 11234569999999999999999999999999
Q ss_pred HHHhHhcCCCCC
Q 025816 231 LQPLLNARPGPA 242 (247)
Q Consensus 231 l~~~~~~~~~~~ 242 (247)
|+++++......
T Consensus 273 l~~~~~~~~~~~ 284 (293)
T d1csna_ 273 FSKVLERLNTTE 284 (293)
T ss_dssp HHHHHHHTTCCS
T ss_pred HHHHHHHcCCCC
Confidence 999887655443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-39 Score=257.45 Aligned_cols=216 Identities=19% Similarity=0.240 Sum_probs=158.4
Q ss_pred cccccCCCccc-eeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 2 VSRLKHENFVQ-LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 2 l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+++++|+|++. +.+++.++...++||||+. +++.+.+..... .+++..+..++.|++.||.|||+++
T Consensus 56 ~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~--- 123 (299)
T d1ckia_ 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN--- 123 (299)
T ss_dssp HHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHccCCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56787766554 5555677888999999995 577777654432 2999999999999999999999999
Q ss_pred eEeccCCCCceeecC---CCceeeccccccCCcchhhhc-----ccccceeccccccCchhhhcCCCCccccchhhhHHH
Q 025816 81 IIHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL 152 (247)
Q Consensus 81 i~h~di~~~nil~~~---~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 152 (247)
|+||||||+||+++. +..++++|||+++........ .......||+.|+|||.+.+..++.++|||||||++
T Consensus 124 iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (299)
T d1ckia_ 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203 (299)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHH
T ss_pred eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHH
Confidence 999999999999854 456999999999866443221 112345699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhccccCCcchhhhhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 025816 153 LELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVRQCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSIVVKALQ 232 (247)
Q Consensus 153 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~il~~l~ 232 (247)
|+|++|..||.................. . ....... ....++.++.+++.+||+.+|.+||+++++.+.|+
T Consensus 204 ~el~tg~~P~~~~~~~~~~~~~~~~~~~----~-~~~~~~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 204 MYFNLGSLPWQGLKAATKRQKYERISEK----K-MSTPIEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp HHHHHSSCTTCCCC-------HHHHHHH----H-HHSCHHH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred HHHHhCCCcccccchHHHHHHHHHhhcc----c-CCCChhH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 9999999999754332221111100000 0 0000000 11233466999999999999999999999999998
Q ss_pred HhHhcC
Q 025816 233 PLLNAR 238 (247)
Q Consensus 233 ~~~~~~ 238 (247)
.++...
T Consensus 275 ~~~~~~ 280 (299)
T d1ckia_ 275 NLFHRQ 280 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHc
Confidence 887544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-39 Score=262.02 Aligned_cols=210 Identities=16% Similarity=0.209 Sum_probs=154.6
Q ss_pred ccccc-CCCccceeeEEeeC--CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 025816 2 VSRLK-HENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 78 (247)
Q Consensus 2 l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~ 78 (247)
|++++ ||||+++++++... ...++||||+.+++|.++... +++..+..++.|++.||.|||++|
T Consensus 83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~------------l~e~~i~~i~~qil~aL~~LH~~g- 149 (328)
T d3bqca1 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSMG- 149 (328)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTS------------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcC------------CCHHHHHHHHHHHHHHHHHHhhcc-
Confidence 56775 99999999999744 568999999999998776431 899999999999999999999999
Q ss_pred CCeEeccCCCCceeecCCC-ceeeccccccCCcchhhhcccccceeccccccCchhhhcC-CCCccccchhhhHHHHHHH
Q 025816 79 PHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELL 156 (247)
Q Consensus 79 ~~i~h~di~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~ 156 (247)
|+||||||+|||++.++ .++|+|||++........ .....+|..|+|||.+.+. .++.++|+||+||++++|+
T Consensus 150 --IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~ 224 (328)
T d3bqca1 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224 (328)
T ss_dssp --EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred --cccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhc
Confidence 99999999999998765 689999999976543222 2345688999999998865 4799999999999999999
Q ss_pred hCCCCCCCCCCCCCcc-hhhhccc------------cCCcchhhhh--------cccccCCCCCHHHHHHHHHHHHhhcc
Q 025816 157 TGRKPVDHTLPRGQQS-LVTWATP------------KLSEDKVRQC--------VDARLGGDYPPKAVAKMAAVAALCVQ 215 (247)
Q Consensus 157 ~g~~pf~~~~~~~~~~-~~~~~~~------------~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~ 215 (247)
+|..||.......... ....... .......... .............+.++.+||++||+
T Consensus 225 ~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~ 304 (328)
T d3bqca1 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304 (328)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSC
T ss_pred cCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHcc
Confidence 9999997543211100 0000000 0000000000 00111111223345679999999999
Q ss_pred cCCCCCCCHHHHHH
Q 025816 216 YEADFRPNMSIVVK 229 (247)
Q Consensus 216 ~~p~~Rps~~~il~ 229 (247)
+||.+|||++|+|+
T Consensus 305 ~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 305 YDHQSRLTAREAME 318 (328)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=257.13 Aligned_cols=216 Identities=18% Similarity=0.199 Sum_probs=161.2
Q ss_pred CcccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 025816 1 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 80 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~ 80 (247)
+|++++||||+++++++.+....+++++++.++++..++..... +++..+..++.|++.||+|||+++
T Consensus 54 il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~---------~~~~~~~~~~~q~~~aL~~lH~~~--- 121 (292)
T d1unla_ 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD---------LDPEIVKSFLFQLLKGLGFCHSRN--- 121 (292)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccc---------cchhHHHHHHHHHHHHHHHhhcCC---
Confidence 36889999999999999999999999999999888888775542 889999999999999999999999
Q ss_pred eEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC-CCccccchhhhHHHHHHHhCC
Q 025816 81 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGR 159 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~ 159 (247)
|+||||||+||+++.++.+||+|||.+........ ......++..|.|||.+.+.. ++.++||||+||++|+|++|.
T Consensus 122 IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~ 199 (292)
T d1unla_ 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred EeeecccCcccccccCCceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCC
Confidence 99999999999999999999999999986543222 123345677899999987655 689999999999999999999
Q ss_pred CCCCCCCCCCC-cchhhhccccCCcchh---h---------hhcccccCCCCCHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 025816 160 KPVDHTLPRGQ-QSLVTWATPKLSEDKV---R---------QCVDARLGGDYPPKAVAKMAAVAALCVQYEADFRPNMSI 226 (247)
Q Consensus 160 ~pf~~~~~~~~-~~~~~~~~~~~~~~~~---~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 226 (247)
.||........ ................ . ...............+..+.+|+.+||+.||.+|||++|
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e 279 (292)
T d1unla_ 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp CCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 99743221111 0000000000000000 0 000001111222344567999999999999999999999
Q ss_pred HHHH
Q 025816 227 VVKA 230 (247)
Q Consensus 227 il~~ 230 (247)
+|+.
T Consensus 280 ~L~H 283 (292)
T d1unla_ 280 ALQH 283 (292)
T ss_dssp HTTS
T ss_pred HhcC
Confidence 9873
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=266.26 Aligned_cols=211 Identities=19% Similarity=0.198 Sum_probs=151.0
Q ss_pred CcccccCCCccceeeEEee------CCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 025816 1 MVSRLKHENFVQLLGYCVD------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 74 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh 74 (247)
+|++++||||++++++|.. ....|+||||+.+ ++.+.+... +++..++.++.|++.||.|||
T Consensus 69 il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~~~-----------~~~~~i~~~~~qil~gl~~LH 136 (355)
T d2b1pa1 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLH 136 (355)
T ss_dssp HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhhcC-----------CCHHHHHHHHHHHHHHHHHhh
Confidence 3678999999999999964 3688999999976 555555321 899999999999999999999
Q ss_pred cCCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 75 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 75 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
++| |+||||||+||+++.++.++++|||+++...... ......+|..|+|||++.+..++.++||||+||++++
T Consensus 137 ~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~e 210 (355)
T d2b1pa1 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210 (355)
T ss_dssp HTT---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred hcc---cccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHH
Confidence 999 9999999999999999999999999987654322 2244568999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccc----------------------cCCcchhhhhcccccCCC---CCHHHHHHHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATP----------------------KLSEDKVRQCVDARLGGD---YPPKAVAKMAAV 209 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 209 (247)
|++|+.||.+............... .................. .....+.++.+|
T Consensus 211 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 290 (355)
T d2b1pa1 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHH
Confidence 9999999975542211110000000 000000111111111111 123456789999
Q ss_pred HHhhcccCCCCCCCHHHHHH
Q 025816 210 AALCVQYEADFRPNMSIVVK 229 (247)
Q Consensus 210 i~~cl~~~p~~Rps~~~il~ 229 (247)
+++||..||++|||++|+|+
T Consensus 291 l~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 291 LSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHCcCChhHCcCHHHHhc
Confidence 99999999999999999997
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-40 Score=267.81 Aligned_cols=218 Identities=24% Similarity=0.307 Sum_probs=156.6
Q ss_pred CcccccCCCccceeeEEeeC-----CeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 025816 1 MVSRLKHENFVQLLGYCVDG-----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 75 (247)
Q Consensus 1 ~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~ 75 (247)
+|++++||||+++++++... ...+++|+++.+|+|.+++.... +++..+..++.|++.||.|||+
T Consensus 70 il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~----------l~e~~~~~i~~qil~aL~~LH~ 139 (348)
T d2gfsa1 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHS 139 (348)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccccc----------ccHHHHHHHHHHHHHHHHHHHh
Confidence 46789999999999998643 33466677777899999996543 9999999999999999999999
Q ss_pred CCCCCeEeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCchhhhcCC-CCccccchhhhHHHHH
Q 025816 76 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLE 154 (247)
Q Consensus 76 ~~~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~ 154 (247)
+| |+||||||+||+++.++.++++|||.+....... ....|+..|+|||...+.. ++.++|+||+||++|+
T Consensus 140 ~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ 211 (348)
T d2gfsa1 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211 (348)
T ss_dssp TT---CCCCCCCGGGEEECTTCCEEECCC----CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHH
T ss_pred CC---CcccccCCccccccccccccccccchhcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHH
Confidence 99 9999999999999999999999999987653322 3356888999999877654 6889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhhhccccCCc--------chhhhhcccccC-CCC-----CHHHHHHHHHHHHhhcccCCCC
Q 025816 155 LLTGRKPVDHTLPRGQQSLVTWATPKLSE--------DKVRQCVDARLG-GDY-----PPKAVAKMAAVAALCVQYEADF 220 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~ 220 (247)
|++|..||.+.+.......+......... ............ ... ....+.++.+||.+||..||.+
T Consensus 212 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 291 (348)
T d2gfsa1 212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291 (348)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhh
Confidence 99999999765432211111111111000 000000000000 000 1123456899999999999999
Q ss_pred CCCHHHHHH--HHHHhHh
Q 025816 221 RPNMSIVVK--ALQPLLN 236 (247)
Q Consensus 221 Rps~~~il~--~l~~~~~ 236 (247)
|||++|+|+ ++++...
T Consensus 292 R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 292 RITAAQALAHAYFAQYHD 309 (348)
T ss_dssp SCCHHHHHTSGGGTTTCC
T ss_pred CcCHHHHhcCHhhCCCCC
Confidence 999999998 5665543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.4e-32 Score=225.02 Aligned_cols=216 Identities=20% Similarity=0.226 Sum_probs=148.2
Q ss_pred ccCCCccceeeEEeeC--CeeeEEEecCCCC-ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-CCCCC
Q 025816 5 LKHENFVQLLGYCVDG--TSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPH 80 (247)
Q Consensus 5 l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~-~~~~~ 80 (247)
+.|+||+++++++... ...+++|+++..+ +........... .+++..+..++.|+++|+.|||+ .+
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~i~~i~~qil~al~~lh~~~~--- 146 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHRRCG--- 146 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTC---
T ss_pred cCcCceEEEEEEeeeccccceeeeeeeccccccccccccccccc-------CCcHHHHHHHHHHHHHHHHHHhhhcC---
Confidence 4579999999988643 4566666665433 333333333322 28899999999999999999998 77
Q ss_pred eEeccCCCCceeecCCCc------eeeccccccCCcchhhhcccccceeccccccCchhhhcCCCCccccchhhhHHHHH
Q 025816 81 IIHRDIKSSNVLIFDDDV------AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 154 (247)
Q Consensus 81 i~h~di~~~nil~~~~~~------~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 154 (247)
|+||||||+|||++.++. ++++|||.+..... ......|+..|+|||++.+..++.++|+||+||++++
T Consensus 147 IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 221 (362)
T d1q8ya_ 147 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 221 (362)
T ss_dssp EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHH
T ss_pred cccccCChhHeeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHH
Confidence 999999999999986653 89999999875432 1234568999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchhh------hccccCCcchh------hh---------hccc----------ccCCCCCHHHH
Q 025816 155 LLTGRKPVDHTLPRGQQSLVT------WATPKLSEDKV------RQ---------CVDA----------RLGGDYPPKAV 203 (247)
Q Consensus 155 l~~g~~pf~~~~~~~~~~~~~------~~~~~~~~~~~------~~---------~~~~----------~~~~~~~~~~~ 203 (247)
|++|+.||............. ......+.... .. .+.. ..........+
T Consensus 222 l~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (362)
T d1q8ya_ 222 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301 (362)
T ss_dssp HHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHH
T ss_pred HHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccC
Confidence 999999997654322111000 00000000000 00 0000 01123445678
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhH
Q 025816 204 AKMAAVAALCVQYEADFRPNMSIVVK--ALQPLL 235 (247)
Q Consensus 204 ~~l~~li~~cl~~~p~~Rps~~~il~--~l~~~~ 235 (247)
.++.+|+.+||.+||.+|||++|+|+ ++++..
T Consensus 302 ~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 88999999999999999999999998 355443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.62 E-value=9.8e-17 Score=118.61 Aligned_cols=117 Identities=14% Similarity=0.151 Sum_probs=82.5
Q ss_pred cccccCCCccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 025816 2 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 81 (247)
Q Consensus 2 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~~~~i 81 (247)
+.++.|.+++..+++. ..+++|||+.+..+.+ ++...+..++.|++.++.+||+++ |
T Consensus 68 l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~g---i 124 (191)
T d1zara2 68 LQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHRG---I 124 (191)
T ss_dssp HHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHccCCCcceEEEec----CCEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhCC---E
Confidence 4567888988887653 2379999998755433 233345678999999999999999 9
Q ss_pred EeccCCCCceeecCCCceeeccccccCCcchhhhcccccceeccccccCch-----hhhcCCCCccccchhhhHHH
Q 025816 82 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE-----YAMTGQLNAKSDVYSFGVVL 152 (247)
Q Consensus 82 ~h~di~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~~~~~DvwslG~~l 152 (247)
+||||||+|||++.+ .++|+|||.+....+.... .|...+ .+....|+..+|+||+.--+
T Consensus 125 iHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 125 VHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEccCChhheeeeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999999999999865 4889999998655322211 011110 01235678899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.72 E-value=3.8e-05 Score=57.78 Aligned_cols=86 Identities=17% Similarity=0.155 Sum_probs=57.6
Q ss_pred ccceeeEEeeCCeeeEEEecCCCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC------------
Q 025816 10 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA------------ 77 (247)
Q Consensus 10 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~lh~~~------------ 77 (247)
+.+++++...++..++||+++.|.++.+...... ....++.++...+..||+..
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~--------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~ 137 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ--------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDS 137 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS--------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHH
T ss_pred CCcEEEEEecCCceEEEEEecccccccccccccc--------------cHHHHHHHHHHHHHHHhccCccccccCcchhh
Confidence 5677888888889999999999877765543211 01122333334444444321
Q ss_pred --------------------------------------------CCCeEeccCCCCceeecCCCceeeccccccCC
Q 025816 78 --------------------------------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 78 --------------------------------------------~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
...++|+|+.+.||+++.++...|+||+.+..
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 138 RLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11389999999999998776667999997764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.97 E-value=0.00074 Score=50.10 Aligned_cols=30 Identities=13% Similarity=0.165 Sum_probs=25.4
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
.++|+|+.|.||+++.+..+.|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 389999999999998876677999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.08 E-value=0.013 Score=46.35 Aligned_cols=31 Identities=19% Similarity=0.493 Sum_probs=26.0
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCCcc
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 111 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~~~ 111 (247)
.++|+|+.+.|||++.++ ++|+||..+....
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G~ 254 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYGP 254 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEEEC
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcccCC
Confidence 499999999999998765 8999998776543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.23 E-value=0.016 Score=44.11 Aligned_cols=30 Identities=27% Similarity=0.561 Sum_probs=26.6
Q ss_pred CeEeccCCCCceeecCCCceeeccccccCC
Q 025816 80 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 80 ~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
+++|+|+.+.|++++++...-++||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 499999999999999888778999997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=89.88 E-value=0.2 Score=38.06 Aligned_cols=30 Identities=23% Similarity=0.308 Sum_probs=23.7
Q ss_pred CCCeEeccCCCCceeecCCCceeeccccccCC
Q 025816 78 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 109 (247)
Q Consensus 78 ~~~i~h~di~~~nil~~~~~~~~l~d~g~~~~ 109 (247)
...++|+|+.+.||+++. + ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 345999999999999974 3 45789997764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=84.82 E-value=0.17 Score=39.61 Aligned_cols=15 Identities=27% Similarity=0.583 Sum_probs=13.3
Q ss_pred eEeccCCCCceeecC
Q 025816 81 IIHRDIKSSNVLIFD 95 (247)
Q Consensus 81 i~h~di~~~nil~~~ 95 (247)
++|+|+.+.||++..
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 689999999999854
|